{
  "bladder_cancer": {
    "top_institutions": {
      "columns": [
        "Institution",
        "# Studies",
        "Locations"
      ],
      "rows": [
        {
          "Institution": "Eva Mayr-Stihl Cancer Center",
          "# Studies": 5,
          "Locations": "Stuttgart, Germany"
        },
        {
          "Institution": "Dana-Farber Cancer Institute",
          "# Studies": 4,
          "Locations": "Boston, United States of America, Boston, United States of America, MA"
        },
        {
          "Institution": "Fondazione IRCCS",
          "# Studies": 4,
          "Locations": "Milan, Italy"
        },
        {
          "Institution": "MD Anderson Cancer Center, Madrid",
          "# Studies": 4,
          "Locations": "Madrid, Spain"
        },
        {
          "Institution": "IRCCS San Raffaele Hospital",
          "# Studies": 4,
          "Locations": "Milan, Italy"
        },
        {
          "Institution": "University Hospital Bonn",
          "# Studies": 3,
          "Locations": "Bonn, Germany"
        },
        {
          "Institution": "University of Glasgow",
          "# Studies": 3,
          "Locations": "Bearsden, United Kingdom"
        },
        {
          "Institution": "Comprehensive Cancer Center",
          "# Studies": 2,
          "Locations": "Berlin, Germany"
        },
        {
          "Institution": "Fudan University Shanghai Cancer Center",
          "# Studies": 2,
          "Locations": "Shanghai, China"
        },
        {
          "Institution": "Kantonsspital Graubünden",
          "# Studies": 2,
          "Locations": "Chur, Switzerland"
        },
        {
          "Institution": "Nanjing Drum Tower Hospital",
          "# Studies": 2,
          "Locations": "Nanjing, China"
        },
        {
          "Institution": "Netherlands Cancer Institute",
          "# Studies": 2,
          "Locations": "Amsterdam, Netherlands"
        },
        {
          "Institution": "Renji Hospital",
          "# Studies": 2,
          "Locations": "Shanghai, China"
        },
        {
          "Institution": "University of California San Diego",
          "# Studies": 2,
          "Locations": "La Jolla, United States of America"
        },
        {
          "Institution": "University of Washington Medical Center",
          "# Studies": 2,
          "Locations": "Seattle, United States of America"
        },
        {
          "Institution": "University Hospital of Strasbourg",
          "# Studies": 2,
          "Locations": "Strasbourg, France, CEDEX"
        },
        {
          "Institution": "Taussig Cancer Institute",
          "# Studies": 2,
          "Locations": "Cleveland, United States of America"
        },
        {
          "Institution": "Cancer Committee of the French Association of Urology (CCAFU)",
          "# Studies": 2,
          "Locations": "Villejuif, France, Paris, France"
        },
        {
          "Institution": "Memorial Sloan Kettering Cancer Center",
          "# Studies": 2,
          "Locations": "New York, United States of America"
        },
        {
          "Institution": "Centres Hospitaliers Universitaires HELORA",
          "# Studies": 1,
          "Locations": "Woluwe-Saint-Lambert, Belgium"
        },
        {
          "Institution": "Centro Hospitalar Vila Nova de Gaia/Espinho",
          "# Studies": 1,
          "Locations": "Vila Nova de Gaia, Portugal"
        },
        {
          "Institution": "China-Japan Friendship Hospital",
          "# Studies": 1,
          "Locations": "Nangchong, China"
        },
        {
          "Institution": "19University of California",
          "# Studies": 1,
          "Locations": "Los Angeles, United States of America"
        },
        {
          "Institution": "Barts Cancer Institute",
          "# Studies": 1,
          "Locations": "London, United Kingdom"
        },
        {
          "Institution": "Ankara University Cancer Research Institute",
          "# Studies": 1,
          "Locations": "Ankara, Turkey"
        },
        {
          "Institution": "Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine of Central South University",
          "# Studies": 1,
          "Locations": "Changsha, China"
        },
        {
          "Institution": "Hospital Universitario Ramón y Cajal",
          "# Studies": 1,
          "Locations": "Madrid, Spain"
        },
        {
          "Institution": "Hospital Universitario 12 de Octubre",
          "# Studies": 1,
          "Locations": "Madrid, Spain"
        },
        {
          "Institution": "Hoag Family Cancer Institute",
          "# Studies": 1,
          "Locations": "Newport Beach, United States of America"
        },
        {
          "Institution": "Hemostasis",
          "# Studies": 1,
          "Locations": "Essen, Germany"
        }
      ]
    },
    "table_context": "**TOP INSTITUTIONS TABLE:**\n| Institution                                                                                                    |   # Studies | Locations                                                              |\n|:---------------------------------------------------------------------------------------------------------------|------------:|:-----------------------------------------------------------------------|\n| Eva Mayr-Stihl Cancer Center                                                                                   |           5 | Stuttgart, Germany                                                     |\n| Dana-Farber Cancer Institute                                                                                   |           4 | Boston, United States of America, Boston, United States of America, MA |\n| Fondazione IRCCS                                                                                               |           4 | Milan, Italy                                                           |\n| MD Anderson Cancer Center, Madrid                                                                              |           4 | Madrid, Spain                                                          |\n| IRCCS San Raffaele Hospital                                                                                    |           4 | Milan, Italy                                                           |\n| University Hospital Bonn                                                                                       |           3 | Bonn, Germany                                                          |\n| University of Glasgow                                                                                          |           3 | Bearsden, United Kingdom                                               |\n| Comprehensive Cancer Center                                                                                    |           2 | Berlin, Germany                                                        |\n| Fudan University Shanghai Cancer Center                                                                        |           2 | Shanghai, China                                                        |\n| Kantonsspital Graubünden                                                                                       |           2 | Chur, Switzerland                                                      |\n| Nanjing Drum Tower Hospital                                                                                    |           2 | Nanjing, China                                                         |\n| Netherlands Cancer Institute                                                                                   |           2 | Amsterdam, Netherlands                                                 |\n| Renji Hospital                                                                                                 |           2 | Shanghai, China                                                        |\n| University of California San Diego                                                                             |           2 | La Jolla, United States of America                                     |\n| University of Washington Medical Center                                                                        |           2 | Seattle, United States of America                                      |\n| University Hospital of Strasbourg                                                                              |           2 | Strasbourg, France, CEDEX                                              |\n| Taussig Cancer Institute                                                                                       |           2 | Cleveland, United States of America                                    |\n| Cancer Committee of the French Association of Urology (CCAFU)                                                  |           2 | Villejuif, France, Paris, France                                       |\n| Memorial Sloan Kettering Cancer Center                                                                         |           2 | New York, United States of America                                     |\n| Centres Hospitaliers Universitaires HELORA                                                                     |           1 | Woluwe-Saint-Lambert, Belgium                                          |\n| Centro Hospitalar Vila Nova de Gaia/Espinho                                                                    |           1 | Vila Nova de Gaia, Portugal                                            |\n| China-Japan Friendship Hospital                                                                                |           1 | Nangchong, China                                                       |\n| 19University of California                                                                                     |           1 | Los Angeles, United States of America                                  |\n| Barts Cancer Institute                                                                                         |           1 | London, United Kingdom                                                 |\n| Ankara University Cancer Research Institute                                                                    |           1 | Ankara, Turkey                                                         |\n| Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine of Central South University |           1 | Changsha, China                                                        |\n| Hospital Universitario Ramón y Cajal                                                                           |           1 | Madrid, Spain                                                          |\n| Hospital Universitario 12 de Octubre                                                                           |           1 | Madrid, Spain                                                          |\n| Hoag Family Cancer Institute                                                                                   |           1 | Newport Beach, United States of America                                |\n| Hemostasis                                                                                                     |           1 | Essen, Germany                                                         |\n\n**ENRICHED INSTITUTION PROFILES (Top 10 with ClinicalTrials.gov Data):**\n\n\n**Eva Mayr-Stihl Cancer Center**\n  - ESMO 2025 Presentations: 5\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (5 total):\n    * Jens Bedke  - 3078P: Immune-mediated adverse events (imAEs) associated with sasanlimab in combination with Bacillus Calmette-Guerin (BCG): Phase 3 study (CREST) (10/18/2025, 12-13:00, Hall 25)\n    * Jens Bedke  - : Bladder Cancer Breakthroughs: Harnessing Immunotherapy for Better Outcomes (10/19/2025, 18:30 - 20:00, Essen Auditorium - Hall 7.2a)\n    * Jens Bedke  - : Panel Discussion and closing remarks (10/19/2025, 18:30 - 20:00, Essen Auditorium - Hall 7.2a)\n    * Jens Bedke  - : Welcome and introductions (10/19/2025, 18:30 - 20:00, Essen Auditorium - Hall 7.2a)\n    * Jens Bedke  - : Q&A (10/19/2025, 18:30 - 20:00, Essen Auditorium - Hall 7.2a)\n\n\n**Dana-Farber Cancer Institute**\n  - ESMO 2025 Presentations: 4\n  - Clinical Trials (2015-2025): 13 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06318871](https://clinicaltrials.gov/study/NCT06318871): Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma (EARLY_PHASE1, RECRUITING, Started 2024)\n    * [NCT06138561](https://clinicaltrials.gov/study/NCT06138561): Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments (Phase Not Specified, RECRUITING, Started 2024)\n    * [NCT05899361](https://clinicaltrials.gov/study/NCT05899361): A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest (NA, RECRUITING, Started 2023)\n    * [NCT05463796](https://clinicaltrials.gov/study/NCT05463796): InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer (Phase Not Specified, RECRUITING, Started 2023)\n    * [NCT05715684](https://clinicaltrials.gov/study/NCT05715684): Patient-Centered Surgical Prehabilitation (NA, RECRUITING, Started 2023)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT03747419](https://clinicaltrials.gov/study/NCT03747419): Avelumab and Radiation in Muscle-Invasive Bladder Cancer (PHASE2, TERMINATED, Started 2018) [EMD-ALIGNED]\n    * [NCT04724018](https://clinicaltrials.gov/study/NCT04724018): Sacituzumab Govitecan Plus EV in Metastatic UC (PHASE1, ENROLLING_BY_INVITATION, Started 2021) [COMPETITOR]\n    * [NCT03773666](https://clinicaltrials.gov/study/NCT03773666): A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2) (PHASE1, COMPLETED, Started 2019) [COMPETITOR]\n    * [NCT03333616](https://clinicaltrials.gov/study/NCT03333616): Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors (PHASE2, ACTIVE_NOT_RECRUITING, Started 2017) [COMPETITOR]\n    * [NCT02925533](https://clinicaltrials.gov/study/NCT02925533): Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial Tract (PHASE1, TERMINATED, Started 2016) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (4 total):\n    * Bradley A. McGregor  - : Invited Discussant (10/17/2025, 14:20 - 14:30, Dortmund Auditorium - Hall 7.1a)\n    * Clara Steiner  - : Invited Discussant (10/17/2025, 15:10 - 15:20, Dortmund Auditorium - Hall 7.1a)\n    * Ilana B. Epstein  - 3108P: Inflammatory biomarker panel predicting grade >=2 neurotoxicity in Enfortumab Vedotin (EV) treated patients (pts). (10/18/2025, 12-13:00, Hall 25)\n    * Joaquim Bellmunt  - : Combinations with ADCs (10/19/2025, 15:25 - 15:45, Nuremberg Auditorium - Hall 5.2)\n\n\n**Fondazione IRCCS**\n  - ESMO 2025 Presentations: 4\n  - Clinical Trials (2015-2025): 13 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06880757](https://clinicaltrials.gov/study/NCT06880757): 177Lu-FAP-2286 Treatment in Urethelial Neoplasms: Utility and Safety as a Novel Treatment. (PHASE2, NOT_YET_RECRUITING, Started 2025)\n    * [NCT06820255](https://clinicaltrials.gov/study/NCT06820255): DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer. (PHASE4, RECRUITING, Started 2025)\n    * [NCT06751667](https://clinicaltrials.gov/study/NCT06751667): Xpert Bladder Monitor: a Non-Invasive Follow-Up Tool for Detecting Relapse in High Grade or High Risk Bladder Cancer (NA, NOT_YET_RECRUITING, Started 2025)\n    * [NCT06355518](https://clinicaltrials.gov/study/NCT06355518): Pre-operative Immuno-Nutrition in Radical Cystectomy (NA, NOT_YET_RECRUITING, Started 2024)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT06528483](https://clinicaltrials.gov/study/NCT06528483): Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer (PHASE2, NOT_YET_RECRUITING, Started 2024) [COMPETITOR]\n    * [NCT05203913](https://clinicaltrials.gov/study/NCT05203913): Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer (PHASE2, RECRUITING, Started 2023) [COMPETITOR]\n    * [NCT03824691](https://clinicaltrials.gov/study/NCT03824691): hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study\" (PHASE2, UNKNOWN, Started 2019) [COMPETITOR]\n    * [NCT03832673](https://clinicaltrials.gov/study/NCT03832673): Pembrolizumab-Epacadostat Combination to Treat Muscle-invasive Bladder UrotheLIAl canceR: PECULIAR Study (PHASE2, WITHDRAWN, Started 2019) [COMPETITOR]\n    * [NCT03464734](https://clinicaltrials.gov/study/NCT03464734): Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial Carcinoma (PHASE2, COMPLETED, Started 2019) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (4 total):\n    * Patrizia Giannatempo  - : Personalising an mUC Patient's Journey: A Case Presentation (10/17/2025, 18:00 - 19:30, Heidelberg Auditorium - Hall 6.2)\n    * Patrizia Giannatempo  - : Clinical Compass for Treatment Individualisation in mUC Management (10/17/2025, 18:00 - 19:30, Heidelberg Auditorium - Hall 6.2)\n    * Patrizia Giannatempo  - 3092P: Impact of Dose Reductions on the Efficacy of Erdafitinib (Erda) in Patients (Pts) with Advanced or Metastatic Urothelial Carcinoma (mUC): A Post-hoc Analysis of the Phase 3 THOR Study Cohort-1 Evaluating Erda versus Chemotherapy (Chemo) (10/18/2025, 12-13:00, Hall 25)\n    * Patrizia Giannatempo  - : Trimodality therapy (10/18/2025, 17:10 - 17:30, Bonn Auditorium - Hall 7.1c)\n\n\n**MD Anderson Cancer Center, Madrid**\n  - ESMO 2025 Presentations: 4\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (4 total):\n    * Enrique Grande Pulido  - : LBA 109 - DISCUS: A phase II study comparing 3 vs 6 cycles of platinum-based chemotherapy prior to maintenance avelumab in advanced urothelial cancer. (10/17/2025, 14:40 - 14:50, Dortmund Auditorium - Hall 7.1a)\n    * Enrique Grande Pulido  - : A Guide to the Guidelines: Strategies for mUC Management (10/17/2025, 18:00 - 19:30, Heidelberg Auditorium - Hall 6.2)\n    * Enrique Grande Pulido  - : Novel ADCs (10/19/2025, 15:05 - 15:25, Nuremberg Auditorium - Hall 5.2)\n    * Enrique Grande Pulido  - : Orchestrating first-line treatment for la/mUC: clinical insights for treatment selection (10/20/2025, 13:00 - 14:30, Essen Auditorium - Hall 7.2a)\n\n\n**IRCCS San Raffaele Hospital**\n  - ESMO 2025 Presentations: 4\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (4 total):\n    * Andrea Necchi  - LBA110: A blinded, exploratory phase 2 trial of nivolumab and the GDF-15 neutralizing antibody visugromab or placebo as neoadjuvant treatment of patients with muscle-invasive bladder cancer (MIBC): Primary results of the GDFather-NEO trial (10/17/2025, 15:00 - 15:10, Dortmund Auditorium - Hall 7.1a)\n    * Andrea Necchi  - LBA112: Neoadjuvant gemcitabine intravesical system (TAR-200) + cetrelimab (CET) or CET alone in patients (pts) with muscle-invasive bladder cancer (MIBC): SunRISe-4 (SR-4) primary analysis and biomarker results (10/17/2025, 16:40 - 16:45, Karlsruhe Auditorium - Hall 5.2)\n    * Andrea Necchi  - : Existing ADCs (10/19/2025, 14:45 - 15:05, Nuremberg Auditorium - Hall 5.2)\n    * Andrea Necchi  - : Strategies for Today and the Future: Case-based Discussion on Personalized Care in MIBC (10/20/2025, 18:30 - 20:00, Flensburg Auditorium - Hall 23)\n\n\n**University Hospital Bonn**\n  - ESMO 2025 Presentations: 3\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (3 total):\n    * Niklas Klumper  - 3087P: NECTIN4 Amplification as a Predictive Biomarker of Response to Enfortumab Vedotin Plus Pembrolizumab in First-Line Metastatic Urothelial Carcinoma: A Multicenter Cohort Study (10/18/2025, 12-13:00, Hall 25)\n    * Niklas Klumper  - 3090P: NECTIN4 Amplification Predicts Enfortumab Vedotin Response and Survival in Metastatic Urothelial Carcinoma: Multicenter Validation (10/18/2025, 12-13:00, Hall 25)\n    * Niklas Klumper  - : Amplifying outcomes in la/mUC: emerging biomarkers for treatment selection (10/20/2025, 13:00 - 14:30, Essen Auditorium - Hall 7.2a)\n\n\n**University of Glasgow**\n  - ESMO 2025 Presentations: 3\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (3 total):\n    * Robert Jones  - : Welcome and Introduction (10/19/2025, 13:00 - 14:30, Nuremberg Auditorium - Hall 5.2)\n    * Robert Jones  - : Advanced bladder cancer Q&A (10/19/2025, 13:00 - 14:30, Nuremberg Auditorium - Hall 5.2)\n    * Robert Jones  - : Summary and close (10/19/2025, 13:00 - 14:30, Nuremberg Auditorium - Hall 5.2)\n\n\n**Comprehensive Cancer Center**\n  - ESMO 2025 Presentations: 2\n  - Clinical Trials (2015-2025): 37 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT07140315](https://clinicaltrials.gov/study/NCT07140315): DK222 Study at Hopkins (PHASE1, NOT_YET_RECRUITING, Started 2025)\n    * [NCT07118176](https://clinicaltrials.gov/study/NCT07118176): Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers (PHASE1, RECRUITING, Started 2025)\n    * [NCT06896162](https://clinicaltrials.gov/study/NCT06896162): PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival (NA, RECRUITING, Started 2025)\n    * [NCT06290687](https://clinicaltrials.gov/study/NCT06290687): Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy (PHASE2, RECRUITING, Started 2025)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT06263153](https://clinicaltrials.gov/study/NCT06263153): Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy (PHASE2, RECRUITING, Started 2024) [COMPETITOR]\n    * [NCT05775471](https://clinicaltrials.gov/study/NCT05775471): Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer (PHASE2, RECRUITING, Started 2024) [COMPETITOR]\n    * [NCT05833867](https://clinicaltrials.gov/study/NCT05833867): Adaptive RADiation Therapy with Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer (PHASE1, RECRUITING, Started 2024) [COMPETITOR]\n    * [NCT05312671](https://clinicaltrials.gov/study/NCT05312671): Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer (PHASE2, RECRUITING, Started 2022) [COMPETITOR]\n    * [NCT03978624](https://clinicaltrials.gov/study/NCT03978624): Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer (PHASE2, ACTIVE_NOT_RECRUITING, Started 2020) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (4 total):\n    * Maria De Santis  - LBA108: Durvalumab (D) in combination with bacillus Calmette-Guerin (BCG) for BCG-naive, high-risk non-muscle-invasive bladder cancer (NMIBC): final analysis of the phase 3, open-label, randomised POTOMAC trial (10/17/2025, 14:10 - 14:20, Dortmund Auditorium - Hall 7.1a)\n    * Terence Friedlander  - 3074P: EV-103 Cohort K: Efficacy and safety of enfortumab vedotin (EV) with or without pembrolizumab (P) in cisplatin (cis)-ineligible pts with previously untreated locally advanced or metastatic urothelial cancer (la/mUC) with a median (m) follow-up (FU) of ≈3.5 y (10/18/2025, 12-13:00, Hall 25)\n    * Charles B. Nguyen  - : Discussion led by Chair (10/19/2025, 09:05 - 09:30, Dortmund Auditorium - Hall 7.1a)\n    * Maria De Santis  - : Immunotherapy in Early-stage Bladder Cancer: What's New, What's Next? (10/20/2025, 18:30 - 20:00, Flensburg Auditorium - Hall 23)\n\n\n**Fudan University Shanghai Cancer Center**\n  - ESMO 2025 Presentations: 2\n  - Clinical Trials (2015-2025): 1 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT07207824](https://clinicaltrials.gov/study/NCT07207824): DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBC (PHASE3, NOT_YET_RECRUITING, Started 2025)\n  - Relevant to EMD Serono/Merck KGaA: None identified in ClinicalTrials.gov (2015-2025)\n  - Key Presenters at ESMO 2025 (2 total):\n    * Dingwei Ye  - 3098P: Fibroblast Growth Factor Receptor 3 (FGFR3) - Driven Genomic Landscape and the Impact on Clinical Outcomes of Fexagratinib (Fexa) in Chinese metastatic or unresectable Urothelial Carcinoma (mUC) (10/18/2025, 12-13:00, Hall 25)\n    * Maoping Cai  - 3099P: Proteogenomic characterization of the non-muscle-invasive bladder cancer response to BCG reveals potential therapeutic strategies (10/18/2025, 12-13:00, Hall 25)\n\n\n**Kantonsspital Graubünden**\n  - ESMO 2025 Presentations: 2\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (2 total):\n    * Richard Cathomas  - 3106P: Perioperative chemo-immunotherapy with Durvalumab for operable muscle-invasive urothelial carcinoma (MIUC): final analysis of the single arm phase II trial SAKK 06/17 (10/18/2025, 12-13:00, Hall 25)\n    * Richard Cathomas  - 3107P: Intravesical recombinant BCG followed by perioperative chemo-immunotherapy (chemo-IO) for patients with muscle-invasive bladder cancer (MIBC): interim analysis of SAKK 06/19 study (10/18/2025, 12-13:00, Hall 25)\n\n\n**COMPLETE SPEAKER DIRECTORY BY GEOGRAPHY:**\n\n\n** (1 institutions, 1 speakers)**\n  -  (1 speakers): \n\n**Australia (1 institutions, 1 speakers)**\n  - Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia (1 speakers): Arun A. Azad\n\n**Belgium (3 institutions, 3 speakers)**\n  - Department of Medical Oncology, Centres Hospitaliers Universitaires HELORA, La Louvière, Belgium. (1 speakers): Guillaume Grisay\n  - Department of Medical Oncology, Maria Middelares Hospital, Gent, Belgium, Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium. (1 speakers): Christof Vulsteke\n  - Medical Oncology Department, Brussels, Belgium. (1 speakers): Jeremy Blanc\n\n**CEDEX (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, University Hospital of Strasbourg, Place de L'hopital, Strasbourg, France. (1 speakers): Philippe Barthelemy\n\n**Canada (4 institutions, 4 speakers)**\n  - BC Cancer Agency, Vancouver, Canada. (1 speakers): J. Connor Wells\n  - Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada. (1 speakers): Francois-Michel Boisvert\n  - Department of Medicine, Medical Oncology Division, BC Cancer, Vancouver Centre, University of British Columbia, BC, Canada. (1 speakers): Guliz Ozgun\n  - University of Montreal Hospital Research Centre, Cancer Axis, Montreal, Canada. (1 speakers): Bertrand Routy\n\n**China (17 institutions, 17 speakers)**\n  - Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. (1 speakers): Zihan Xue\n  - Department of Digestive Surgery, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China. (1 speakers): Guanghui Xu\n  - Department of Pharmacy, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China. (1 speakers): Yin Zhang\n  - Department of Radiology, China-Japan Friendship Hospital, Beijing, China. (1 speakers): Sheng Xie\n  - Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China. (1 speakers): Maoping Cai\n  - Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China. dwyeli@163.com. (1 speakers): Dingwei Ye\n  - Department of Urology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine of Central South University, Changsha, China. (1 speakers): Shusuan Jiang\n  - Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing, China. (1 speakers): Wenli Diao\n  - Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Institute of Urology, Nanjing University, China. (1 speakers): Tianlei Xie\n  - Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Jiwei Huang\n  - Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Xingliang Tan\n  - Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou (1 speakers): Bin Huang\n  - Department of Urology, West China Hospital Sichuan University, Chengdu (1 speakers): Yige Bao\n  - Division of Abdominal Tumor Multimodality Treatment, Department of Radiation Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan (1 speakers): Yali Shen\n  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Urology, Peking University Cancer Hospital & Institute, Beijing 100142, China. (1 speakers): Yudong Cao\n  - Senior Department of Cardiology, the Sixth Medical Center of Chinese PLA General Hospital, Beijing, China. (1 speakers): Jun Guo\n  - Zhejiang Engineering Research Centre for Tissue Repair Materials, University of Chinese Academy of Sciences, China. (1 speakers): Feng Wen\n\n**Czech Republic (1 institutions, 1 speakers)**\n  - Department of Oncology, Palacký University Medical School and Teaching Hospital, I.P. Pavlova 6, Olomouc (1 speakers): Hana Studentova\n\n**France (7 institutions, 7 speakers)**\n  - Cancer Committee of the French Association of Urology (CCAFU), France, Department of Medical Oncology, Gustave Roussy Cancer Campus, Paris-Saclay University, Villejuif, France. (1 speakers): Laurence Albiges\n  - Cancer Committee of the French Association of Urology (CCAFU), France, Department of Urology, AP-HP, Hôpital La Pitié-Salpétrière, Sorbonne University, Paris, France. (1 speakers): Morgan Roupret\n  - Department of Medical Oncology, Georges Pompidou European Hospital, AP-HP, Paris Cité University, Paris, France. (1 speakers): Constance Thibault\n  - Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France. (1 speakers): Aude Flechon\n  - Department of Surgical Oncology, Paoli-Calmettes Institute, Marseille, France. (1 speakers): Geraldine Pignot\n  - Department of Urology, UROSUD, La Croix Du Sud Hospital, Quint-Fonsegrives, France. (1 speakers): Benjamin Pradere\n  - INSERM U1242, University of Rennes, Rennes, France. (1 speakers): Alice Blondel\n\n**Germany (9 institutions, 9 speakers)**\n  - Department of Hematology, Hemostasis, Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany. (1 speakers): Viktor Gruenwald\n  - Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. (1 speakers): Stefanie Zschabitz\n  - Department of Urology Uro-Oncology, University Hospital Cologne, Köln, Germany. (1 speakers): Richard Weiten\n  - Department of Urology and Transplantation Surgery, Eva Mayr-Stihl Cancer Center, Stuttgart, Germany. (1 speakers): Jens Bedke\n  - Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria, Department of Urology, Charité Universitätsmedizin Berlin, Berlin, Germany. (1 speakers): Maria De Santis\n  - Department of Urology, University Hospital Bonn, Bonn, Germany. (1 speakers): Niklas Klumper\n  - Department of Urology, Uro-Oncology, University Hospital Cologne, Cologne, Germany. (1 speakers): Constantin Rieger\n  - Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. (1 speakers): Markus Eckstein\n  - Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany. (1 speakers): Florian Viehweger\n\n**Israel (1 institutions, 1 speakers)**\n  - Division of Oncology, Rambam Health Care Campus, Haifa, Israel. (1 speakers): Tarek Taha\n\n**Italy (5 institutions, 6 speakers)**\n  - Department of Medical Oncology, Fondazione IRCCS, Milan, Italy. (1 speakers): Patrizia Giannatempo\n  - Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy, Vita-Salute San Raffaele University, Milan, Italy. (1 speakers): Andrea Necchi\n  - Department of Medical Oncology, Milan, Italy. (2 speakers): Brigida A. Maiorano, Elena Verzoni\n  - Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. (1 speakers): Veronica Mollica\n  - Vita-Salute San Raffaele University, Milan. (1 speakers): Giovanni Luigi Pastorino\n\n**Japan (1 institutions, 1 speakers)**\n  - Department of Urology, University of Tsukuba Institute of Medicine, Tsukuba, Ibaraki, Japan. (1 speakers): Yoshiyuki Nagumo\n\n**MA (2 institutions, 2 speakers)**\n  - Dana-Farber Cancer Institute/Brigham and Women's Hospital Harvard Medical School, Boston, MA. (1 speakers): Joaquim Bellmunt\n  - South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia. (1 speakers): Christopher Sweeney\n\n**Morocco (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Hassan II University Hospital, Fez 30000, Morocco. (1 speakers): Karima Oualla\n\n**Netherlands (1 institutions, 1 speakers)**\n  - Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: ms.vd.heijden@nki.nl. (1 speakers): Michiel S. Van der Heijden\n\n**Portugal (1 institutions, 1 speakers)**\n  - Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal. (1 speakers): Joana C. Marinho\n\n**Republic of Korea (1 institutions, 1 speakers)**\n  - Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Republic of Korea. (1 speakers): Sun Young Rha\n\n**Spain (7 institutions, 7 speakers)**\n  - Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Spain. (1 speakers): Pablo Alvarez Ballesteros\n  - Department of Medical Oncology, Ramon y Cajal University Hospital, Madrid, Spain. (1 speakers): Patricia Guerrero\n  - Department of Oncology, University Hospital Marqués of Valdecilla, IDIVAL Santander, Cantabria, Spain. (1 speakers): Ignacio Duran\n  - Department of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain. (1 speakers): Felix Guerrero-Ramos\n  - MD Anderson Cancer Center, Madrid, Spain. (1 speakers): Enrique Grande Pulido\n  - Navarra Institute for Health Research (IDISNA), Pamplona, Spain. (1 speakers): Ignacio Melero\n  - Oncology Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain. (1 speakers): Begona Perez Valderrama\n\n**Sweden (1 institutions, 1 speakers)**\n  - Division of Oncology and Therapeutic Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. (1 speakers): Sara Wahlin\n\n**Switzerland (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland. (1 speakers): Richard Cathomas\n\n**Turkey (2 institutions, 3 speakers)**\n  -  (2 speakers): Banu Iskender Izgi, Ilgin Akbiyik\n  - Ankara University Cancer Research Institute, Ankara, Turkey. (1 speakers): Emre Yekeduz\n\n**United Arab Emirates (1 institutions, 1 speakers)**\n  - College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Building 14 (1 speakers): Milad Nourianpour\n\n**United Kingdom (8 institutions, 8 speakers)**\n  - Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London, UK. (1 speakers): Francesca Jackson-Spence\n  - Barts Health Biomedical NIHR Research Centre, Queen Mary University of London, London, UK. (1 speakers): Thomas B. Powles\n  - School of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK. (1 speakers): Robert Jones\n  - St. Georges University Hospitals Foundation Trust and The Royal Marsden Foundation Trust, London, UK. (1 speakers): Lisa M. Pickering\n  - The Francis Crick Institute, London, UK, The Royal Marsden Hospital, London, UK. (1 speakers): Samra Turajlic\n  - The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK. (1 speakers): Nicholas D. James\n  - The University of Sheffield, Sheffield, UK. (1 speakers): James W. Catto\n  - University College London Hospital NHS Foundation Trust, London (1 speakers): Bernadett E. Szabados\n\n**United States of America (21 institutions, 21 speakers)**\n  - 19University of California, Los Angeles Medical Center, CA, USA. (1 speakers): Alexandra Drakaki\n  - Dana-Farber Cancer Institute, Boston, MA, USA, Harvard Medical School, Boston, MA, USA. (1 speakers): Clara Steiner\n  - Dana-Farber Cancer Institute/Brigham and Women's Hospital Harvard Medical School, Boston, MA. (1 speakers): Ilana B. Epstein\n  - Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas. (1 speakers): Tian Zhang\n  - Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA. (1 speakers): Charles B. Nguyen\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (1 speakers): Bradley A. McGregor\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, USA, Department of Medicine, Weil Cornell Medical College, NY, USA. (1 speakers): David H. Aggen\n  - Department of Medicine, School of Medicine, University of California San Diego, CA 92093, USA. (1 speakers): Rana R. McKay\n  - Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, CA. (1 speakers): Terence Friedlander\n  - Division of Oncology and Hematology, University of California Irvine Medical Center, Orange, CA, USA. (1 speakers): Nataliya Mar\n  - Division of Solid Tumor Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106 (1 speakers): Tanya Jindal\n  - Hoag Family Cancer Institute, CA, USA. (1 speakers): David J. Benjamin\n  - Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712, USA. (1 speakers): Joseph D. Dekker\n  - MD Anderson Cancer Center, University of Texas, Houston, TX, USA. (1 speakers): Cindy Y. Jiang\n  - Markey Cancer Center, University of Kentucky, Lexington, KY (1 speakers): Zin W. Myint\n  - Medical Imaging Research Center, Illinois Institute of Technology, Suite 100, Chicago, IL, USA. (1 speakers): Albert Juan Ramon\n  - Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon. (1 speakers): Jad El Masri\n  - Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, FL, USA. (1 speakers): Cesar A. Perez\n  - Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. (1 speakers): Shilpa Gupta\n  - Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NY, USA. (1 speakers): Matthew D. Galsky\n  - University of Washington Medical Center, Fred Hutchinson Cancer Center, Seattle, WA, USA. (1 speakers): Petros Grivas"
  },
  "tgct": {
    "top_institutions": {
      "columns": [
        "Institution",
        "# Studies",
        "Locations"
      ],
      "rows": [
        {
          "Institution": "German Cancer Consortium",
          "# Studies": 1,
          "Locations": "Essen, Germany"
        },
        {
          "Institution": "National Center for Orthopedics",
          "# Studies": 1,
          "Locations": "Beijing, China"
        }
      ]
    },
    "table_context": "**TOP INSTITUTIONS TABLE:**\n| Institution                     |   # Studies | Locations      |\n|:--------------------------------|------------:|:---------------|\n| German Cancer Consortium        |           1 | Essen, Germany |\n| National Center for Orthopedics |           1 | Beijing, China |\n\n**ENRICHED INSTITUTION PROFILES (Top 10 with ClinicalTrials.gov Data):**\n\n\n**German Cancer Consortium**\n  - ESMO 2025 Presentations: 1\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (1 total):\n    * Sebastian Bauer  - 2694P: Long-term efficacy and safety of vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT): 2-year results from the MOTION phase 3 trial (10/20/2025, 12-13:00, Hall 25)\n\n\n**National Center for Orthopedics**\n  - ESMO 2025 Presentations: 1\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (1 total):\n    * Xiaohui Niu  - 2690MO: Extended efficacy and safety from the Phase 3 MANEUVER trial of pimicotinib in patients with tenosynovial giant cell tumour (TGCT) (10/17/2025, 16:33 - 16:38, Essen Auditorium - Hall 7.2a)\n\n\n**COMPLETE SPEAKER DIRECTORY BY GEOGRAPHY:**\n\n\n**China (1 institutions, 1 speakers)**\n  - Department of Orthopaedic Oncology Surgery, National Center for Orthopedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China. (1 speakers): Xiaohui Niu\n\n**Germany (1 institutions, 1 speakers)**\n  - German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany. (1 speakers): Sebastian Bauer"
  },
  "lung_cancer": {
    "top_institutions": {
      "columns": [
        "Institution",
        "# Studies",
        "Locations"
      ],
      "rows": [
        {
          "Institution": "Medical Oncology Department",
          "# Studies": 11,
          "Locations": "Barcelona, Spain, Anderlecht, Belgium, Golnik, Slovenia"
        },
        {
          "Institution": "MD Anderson Cancer Center, Houston",
          "# Studies": 11,
          "Locations": "Houston, United States of America, Houston, United States of America, MO"
        },
        {
          "Institution": "Memorial Sloan Kettering Cancer Center",
          "# Studies": 8,
          "Locations": "New York, United States of America, NY, Commack, United States of America, New York, United States of America"
        },
        {
          "Institution": "Lung Clinic Grosshansdorf",
          "# Studies": 7,
          "Locations": "Grosshansdorf, Germany"
        },
        {
          "Institution": "H12O-CNIO Lung Cancer Clinical Research Unit",
          "# Studies": 6,
          "Locations": "Madrid, Spain"
        },
        {
          "Institution": "Guangdong Lung Cancer Institute",
          "# Studies": 6,
          "Locations": "Guangzhou, China, Guangzhou, China, Guangdong"
        },
        {
          "Institution": "Shanghai Chest Hospital",
          "# Studies": 6,
          "Locations": "Shanghai, China"
        },
        {
          "Institution": "Dana-Farber Cancer Institute",
          "# Studies": 6,
          "Locations": "Boston, United States of America, MA, Boston, United States of America, New York, United States of America"
        },
        {
          "Institution": "Shandong Cancer Hospital and Institute",
          "# Studies": 6,
          "Locations": "Jinan, China, Jinan,China, China, jinan, China"
        },
        {
          "Institution": "Medical Oncology Unit",
          "# Studies": 6,
          "Locations": "Parma, Italy, Pavia, Italy, Pesaro, Italy"
        },
        {
          "Institution": "Oncology Department",
          "# Studies": 5,
          "Locations": "Barcelona, Spain, Edmonton, Canada"
        },
        {
          "Institution": "eAsklepios Lung Clinic",
          "# Studies": 5,
          "Locations": "Gauting, Germany"
        },
        {
          "Institution": "McMaster University",
          "# Studies": 4,
          "Locations": "Hamilton, Canada"
        },
        {
          "Institution": "Karl Landsteiner Institute of Lung Research and Pulmonary Oncology",
          "# Studies": 4,
          "Locations": "Vienna, Austria"
        },
        {
          "Institution": "European Institute of Oncology",
          "# Studies": 4,
          "Locations": "Milan, Italy"
        },
        {
          "Institution": "Sarah Cannon Research Institute",
          "# Studies": 4,
          "Locations": "Nashville, United States of America, TN, Fort Myers, United States of America"
        },
        {
          "Institution": "National Cancer Center Hospital East",
          "# Studies": 4,
          "Locations": "Kashiwa, Japan, Kashiwa, Japan, Chiba"
        },
        {
          "Institution": "Department of Internal Medicine",
          "# Studies": 4,
          "Locations": "Uijeongbu, Republic of Korea, Jacksonville, United States of America, Tokyo, Japan"
        },
        {
          "Institution": "Shanghai Pulmonary Hospital",
          "# Studies": 4,
          "Locations": "Shanghai, China"
        },
        {
          "Institution": "Sun Yat-sen University Cancer Center",
          "# Studies": 4,
          "Locations": "Guangzhou, China"
        },
        {
          "Institution": "Thoracic Group and International Center for Thoracic Cancers",
          "# Studies": 4,
          "Locations": "Villejuif, France, CEDEX, Villejuif, France"
        },
        {
          "Institution": "University Hospital CHUV",
          "# Studies": 4,
          "Locations": "Lausanne, Switzerland"
        },
        {
          "Institution": "University of Turin",
          "# Studies": 4,
          "Locations": "Orbassano, Italy, Torino, Italy"
        },
        {
          "Institution": "Hirosaki University Graduate School of Medicine",
          "# Studies": 3,
          "Locations": "Hirosaki, Japan, Japan, Japan"
        },
        {
          "Institution": "Christoph Pöttgen",
          "# Studies": 3,
          "Locations": "Essen, Germany"
        },
        {
          "Institution": "Department of Surgery",
          "# Studies": 3,
          "Locations": "Osaka, Japan, Los Angeles, United States of America"
        },
        {
          "Institution": "IRCCS Regina Elena National Cancer Institute",
          "# Studies": 3,
          "Locations": "Rome, Italy"
        },
        {
          "Institution": "LMU University Hospital",
          "# Studies": 3,
          "Locations": "Munich, Germany"
        },
        {
          "Institution": "IRCCS Humanitas Research Hospital",
          "# Studies": 3,
          "Locations": "Pieve Emanuele, Italy, Rozzano, Italy"
        },
        {
          "Institution": "National Center for Tumor Diseases",
          "# Studies": 3,
          "Locations": "Dresden, Germany"
        }
      ]
    },
    "table_context": "**TOP INSTITUTIONS TABLE:**\n| Institution                                                        |   # Studies | Locations                                                                                                     |\n|:-------------------------------------------------------------------|------------:|:--------------------------------------------------------------------------------------------------------------|\n| Medical Oncology Department                                        |          11 | Barcelona, Spain, Anderlecht, Belgium, Golnik, Slovenia                                                       |\n| MD Anderson Cancer Center, Houston                                 |          11 | Houston, United States of America, Houston, United States of America, MO                                      |\n| Memorial Sloan Kettering Cancer Center                             |           8 | New York, United States of America, NY, Commack, United States of America, New York, United States of America |\n| Lung Clinic Grosshansdorf                                          |           7 | Grosshansdorf, Germany                                                                                        |\n| H12O-CNIO Lung Cancer Clinical Research Unit                       |           6 | Madrid, Spain                                                                                                 |\n| Guangdong Lung Cancer Institute                                    |           6 | Guangzhou, China, Guangzhou, China, Guangdong                                                                 |\n| Shanghai Chest Hospital                                            |           6 | Shanghai, China                                                                                               |\n| Dana-Farber Cancer Institute                                       |           6 | Boston, United States of America, MA, Boston, United States of America, New York, United States of America    |\n| Shandong Cancer Hospital and Institute                             |           6 | Jinan, China, Jinan,China, China, jinan, China                                                                |\n| Medical Oncology Unit                                              |           6 | Parma, Italy, Pavia, Italy, Pesaro, Italy                                                                     |\n| Oncology Department                                                |           5 | Barcelona, Spain, Edmonton, Canada                                                                            |\n| eAsklepios Lung Clinic                                             |           5 | Gauting, Germany                                                                                              |\n| McMaster University                                                |           4 | Hamilton, Canada                                                                                              |\n| Karl Landsteiner Institute of Lung Research and Pulmonary Oncology |           4 | Vienna, Austria                                                                                               |\n| European Institute of Oncology                                     |           4 | Milan, Italy                                                                                                  |\n| Sarah Cannon Research Institute                                    |           4 | Nashville, United States of America, TN, Fort Myers, United States of America                                 |\n| National Cancer Center Hospital East                               |           4 | Kashiwa, Japan, Kashiwa, Japan, Chiba                                                                         |\n| Department of Internal Medicine                                    |           4 | Uijeongbu, Republic of Korea, Jacksonville, United States of America, Tokyo, Japan                            |\n| Shanghai Pulmonary Hospital                                        |           4 | Shanghai, China                                                                                               |\n| Sun Yat-sen University Cancer Center                               |           4 | Guangzhou, China                                                                                              |\n| Thoracic Group and International Center for Thoracic Cancers       |           4 | Villejuif, France, CEDEX, Villejuif, France                                                                   |\n| University Hospital CHUV                                           |           4 | Lausanne, Switzerland                                                                                         |\n| University of Turin                                                |           4 | Orbassano, Italy, Torino, Italy                                                                               |\n| Hirosaki University Graduate School of Medicine                    |           3 | Hirosaki, Japan, Japan, Japan                                                                                 |\n| Christoph Pöttgen                                                  |           3 | Essen, Germany                                                                                                |\n| Department of Surgery                                              |           3 | Osaka, Japan, Los Angeles, United States of America                                                           |\n| IRCCS Regina Elena National Cancer Institute                       |           3 | Rome, Italy                                                                                                   |\n| LMU University Hospital                                            |           3 | Munich, Germany                                                                                               |\n| IRCCS Humanitas Research Hospital                                  |           3 | Pieve Emanuele, Italy, Rozzano, Italy                                                                         |\n| National Center for Tumor Diseases                                 |           3 | Dresden, Germany                                                                                              |\n\n**ENRICHED INSTITUTION PROFILES (Top 10 with ClinicalTrials.gov Data):**\n\n\n**Medical Oncology Department**\n  - ESMO 2025 Presentations: 11\n  - Clinical Trials (2015-2025): 1 total, 0 active\n  - Latest Trials (5 most recent):\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT05027165](https://clinicaltrials.gov/study/NCT05027165): Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab (Phase Not Specified, UNKNOWN, Started 2020) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (12 total):\n    * Alba Moll-Febrer  - 2986eP: Clinical profile of patients with lung cancer with multiple cancers: identifying a population at risk (10/18/2025, 12-13:00, Hall 25)\n    * Anouk Goudsmit  - 2036eP: Risk factors for developing brain metastases (BM) among patients (pts) with non-small cell lung cancer (NSCLC): A retrospective study. (10/18/2025, 12-13:00, Hall 25)\n    * Katja Mohorcic  - 2051eP: The frequency of driver mutations in non-small cell lung cancer patients: Slovenian nationwide observational cohort trial (10/18/2025, 12-13:00, Hall 25)\n    * Luis Posado-Dominguez  - 2070eP: Prognostic Impact of TTF-1 Negativity in Stage IV Lung Adenocarcinoma with Low PD-L1 Expression Treated with Pemetrexed-Based Chemo-Immunotherapy (10/18/2025, 12-13:00, Hall 25)\n    * Nesrine Mejri  - 1902P: Single-Organ Oligometastatic NSCLC: Can They Hope for Cure? (10/18/2025, 12-13:00, Hall 25)\n    * ... and 7 more presenters\n\n\n**MD Anderson Cancer Center, Houston**\n  - ESMO 2025 Presentations: 11\n  - Clinical Trials (2015-2025): 1 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT07045103](https://clinicaltrials.gov/study/NCT07045103): A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study (Phase Not Specified, RECRUITING, Started 2023)\n  - Relevant to EMD Serono/Merck KGaA: None identified in ClinicalTrials.gov (2015-2025)\n  - Key Presenters at ESMO 2025 (12 total):\n    * Xiuning Le  - LBA75: Sevabertinib (BAY 2927088) in advanced HER2-mutant non-small cell lung cancer (NSCLC): Results from the SOHO-01 study (10/17/2025, 16:25 - 16:35, Berlin Auditorium - Hub 27)\n    * Yasir Y. Elamin  - LBA72: NorthStar: A Phase II Randomized Study of Osimertinib (OSI) With or Without Local Consolidative Therapy (LCT) for Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) (10/17/2025, 16:00 - 16:10, Berlin Auditorium - Hub 27)\n    * Carl M. Gay  - : Evolving treatment strategies in early-stage lung cancer (10/18/2025, 18:30 - 20:00, Heidelberg Auditorium - Hall 6.2)\n    * John Heymach  - 2020P: Circulating tumor DNA (ctDNA) analysis following zongertinib treatment (tx) in patients (pts) with human epidermal growth factor receptor 2 (HER2)-mutant non-small cell lung cancer (NSCLC): Phase Ia/Ib Beamion LUNG-1 study (10/18/2025, 12-13:00, Hall 25)\n    * John Heymach  - : Relentless research for novel treatment options: meeting the diverse needs of patients with lung cancer (10/18/2025, 13:00 - 14:30, Nuremberg Auditorium - Hall 5.2)\n    * ... and 7 more presenters\n\n\n**Memorial Sloan Kettering Cancer Center**\n  - ESMO 2025 Presentations: 8\n  - Clinical Trials (2015-2025): 50 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06941480](https://clinicaltrials.gov/study/NCT06941480): A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate (PHASE1, NOT_YET_RECRUITING, Started 2025)\n    * [NCT06957314](https://clinicaltrials.gov/study/NCT06957314): A Study of Hospital-at-Home for People Receiving Tarlatamab (NA, RECRUITING, Started 2025)\n    * [NCT06863233](https://clinicaltrials.gov/study/NCT06863233): A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer (PHASE1, RECRUITING, Started 2025)\n    * [NCT06741085](https://clinicaltrials.gov/study/NCT06741085): A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain (PHASE2, RECRUITING, Started 2024)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT06807632](https://clinicaltrials.gov/study/NCT06807632): A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer (PHASE1, RECRUITING, Started 2025) [COMPETITOR]\n    * [NCT06477419](https://clinicaltrials.gov/study/NCT06477419): A Study of Sacituzumab Govitecan in People With Mesothelioma (PHASE2, RECRUITING, Started 2024) [COMPETITOR]\n    * [NCT04991025](https://clinicaltrials.gov/study/NCT04991025): Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery (PHASE2, RECRUITING, Started 2022) [COMPETITOR]\n    * [NCT04897022](https://clinicaltrials.gov/study/NCT04897022): A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma (PHASE1, RECRUITING, Started 2021) [COMPETITOR]\n    * [NCT04162015](https://clinicaltrials.gov/study/NCT04162015): A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma (PHASE1, ACTIVE_NOT_RECRUITING, Started 2019) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (10 total):\n    * Helena A. Yu  - 921MO: Phase 1 Global Study of Iza-Bren (BL-B01D1), an EGFR x HER3 Bispecific Antibody-drug Conjugate (ADC), in Patients with Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors (10/17/2025, 16:00 - 16:05, Heidelberg Auditorium - Hall 6.2)\n    * Alissa J. Cooper  - 2778P: ABBV-706, a seizure-related homolog protein 6 (SEZ6)-targeting antibody-drug conjugate (ADC), in patients (pts) with relapsed/refractory (R/R) small cell lung cancer (SCLC): Circulating biomarker and molecular response analyses (10/18/2025, 12-13:00, Hall 25)\n    * Ram Kannan  - 1977P: SGR-5573 is a Potent, Selective, Brain-Penetrant Inhibitor of Osimertinib-Resistant EGFR Variants (10/18/2025, 12-13:00, Hall 25)\n    * Helena A. Yu  - 1847MO: Activity of Zipalertinib Against Active Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer (NSCLC) Harboring EGFR Exon 20 Insertion (Ex20ins)/Other Uncommon Mutations (10/19/2025, 08:58 - 09:03, Berlin Auditorium - Hub 27)\n    * Jamie Chaft  - : Optimised adaptive strategies with systemic immunotherapy (10/19/2025, 10:50 - 11:05, Dortmund Auditorium - Hall 7.1a)\n    * ... and 5 more presenters\n\n\n**Lung Clinic Grosshansdorf**\n  - ESMO 2025 Presentations: 7\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (7 total):\n    * Martin Reck  - : Clinical factors (10/17/2025, 14:00 - 14:15, Bonn Auditorium - Hall 7.1c)\n    * Martin Reck  - : Chair's welcome and introductions (10/17/2025, 18:00 - 19:30, Koblenz Auditorium - Hall 5.2)\n    * Martin Reck  - : Unmet needs and future perspectives for treatment of lung cancer (10/17/2025, 18:00 - 19:30, Koblenz Auditorium - Hall 5.2)\n    * Martin Reck  - : Panel discussion and audience Q&A (10/17/2025, 18:00 - 19:30, Koblenz Auditorium - Hall 5.2)\n    * Martin Reck  - : Chair's closing remarks (10/17/2025, 18:00 - 19:30, Koblenz Auditorium - Hall 5.2)\n    * ... and 2 more presenters\n\n\n**H12O-CNIO Lung Cancer Clinical Research Unit**\n  - ESMO 2025 Presentations: 6\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (6 total):\n    * Jon Zugazagoitia  - : Career path: Clinician scientist (10/17/2025, 16:00 - 16:00, Erfurt Auditorium - CityCube A)\n    * Luis Paz-Ares  - 2798eTiP: Trial in progress: A Phase Ib/II study assessing [177Lu]Lu-DOTA-TATE plus standard of care as a first-line treatment for patients with extensive-stage small cell lung cancer (10/18/2025, 12-13:00, Hall 25)\n    * Luis Paz-Ares  - 2762MO: Patterns of disease progression (PD) and efficacy associated with tumour burden from the Phase 3 IMforte study of lurbinectedin (lurbi) + atezolizumab (atezo) as first-line (1L) maintenance treatment (tx) in ES-SCLC (10/18/2025, 17:15 - 17:20, Hamburg Auditorium - CityCube A)\n    * Luis Paz-Ares  - : A new era: maintenance treatment for first line ES-SCLC (10/18/2025, 18:30 - 20:00, Flensburg Auditorium - Hall 23)\n    * Luis Paz-Ares  - : The developing treatment landscape in extensive stage SCLC (10/20/2025, 13:00 - 14:30, Heidelberg Auditorium - Hall 6.2)\n    * ... and 1 more presenters\n\n\n**Guangdong Lung Cancer Institute**\n  - ESMO 2025 Presentations: 6\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (6 total):\n    * Chen Huang  - 1822P: CTONG 1804: Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC: 4-year survival update and MRD outcome (10/18/2025, 12-13:00, Hall 25)\n    * Jin-Ji Yang  - 1953P: PLB-1004 in advanced non-small cell lung cancer (NSCLC) with exon 20 insertion mutations (ex20ins): a multicenter, single-arm, phase 2 study (10/18/2025, 12-13:00, Hall 25)\n    * Si-Yang Liu  - 1970P: NGS utilization in dynamic monitoring and identifying resistance mechanism for later-line osimertinib treatment and outcomes in patients with advanced NSCLC: Results from the ADELOS study (10/18/2025, 12-13:00, Hall 25)\n    * Wei-Chi Luo  - 1812eP: Microenvironment feature by bulk RNA analysis and its clinical meaningful in pCR patients with IO treatment: data from CTONG1804 Clinical Trial (10/18/2025, 12-13:00, Hall 25)\n    * Yi-Long Wu  - 1989P: Efficacy and safety of fulzerasib in patients (pts) with KRAS G12C-mutant non-small cell lung cancer (NSCLC): updated results from phase 1/2 studies (10/18/2025, 12-13:00, Hall 25)\n    * ... and 1 more presenters\n\n\n**Shanghai Chest Hospital**\n  - ESMO 2025 Presentations: 6\n  - Clinical Trials (2015-2025): 50 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT07135297](https://clinicaltrials.gov/study/NCT07135297): Novel Thin Bronchoscope Versus Ultrathin Bronchoscope for the Diagnosis of Peripheral Pulmonary Nodules (NA, NOT_YET_RECRUITING, Started 2025)\n    * [NCT07091305](https://clinicaltrials.gov/study/NCT07091305): A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy (PHASE2, ACTIVE_NOT_RECRUITING, Started 2025)\n    * [NCT06982924](https://clinicaltrials.gov/study/NCT06982924): A Clinical Study on the Efficacy and Safety of the Combination of Limertinib and Bevacizumab Versus Limertinib as First-line Treatment for NSCLC. (PHASE2, NOT_YET_RECRUITING, Started 2025)\n    * [NCT06904547](https://clinicaltrials.gov/study/NCT06904547): Resistance Mechanisms and Sequential Treatment Strategies Following First-Line Lorlatinib in ALK-Positive NSCLC (Phase Not Specified, NOT_YET_RECRUITING, Started 2025)\n    * [NCT06924710](https://clinicaltrials.gov/study/NCT06924710): Adaptive Therapy for Resected Stage ⅠA2-Ⅱ NSCLC Patients With Undetectable MRD (NA, RECRUITING, Started 2025)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT05078931](https://clinicaltrials.gov/study/NCT05078931): A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC Patients (PHASE2, ACTIVE_NOT_RECRUITING, Started 2021) [COMPETITOR]\n    * [NCT04613284](https://clinicaltrials.gov/study/NCT04613284): Rh-Endostatin Combined With CCRT(50 Gy) Followed by Durvalumab Maintenance for the Treatment of Specific Phase III NSCLC (PHASE4, UNKNOWN, Started 2020) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (6 total):\n    * Kuofang Huang  - 2058eP: Real-world outcomes of trastuzumab deruxtecan in patients with HER2-mutant metastatic non-small cell lung cancer: a retrospective study (10/18/2025, 12-13:00, Hall 25)\n    * Tianqing Chu  - 1891P: Tislelizumab-based First-line Therapy in Advanced NSCLC: A Real-World Study (10/18/2025, 12-13:00, Hall 25)\n    * Yongfeng Yu  - 1954P: ctDNA analysis in phase 3 SACHI trial: savolitinib (savo) plus osimertinib (osi) versus chemotherapy (chemo) in MET-amplified (METamp) advanced NSCLC after disease progression (PD) on EGFR tyrosine kinase inhibitor (TKI) (10/18/2025, 12-13:00, Hall 25)\n    * Shun Lu  - LBA4: Title: Phase III Study of Ivonescimab plus chemotherapy versus Tislelizumab plus chemotherapy as First-line Treatment for advanced squamous non-small cell lung cancer (HARMONi-6) (10/19/2025, 16:30 - 16:42, Berlin Auditorium - Hub 27)\n    * Huawei Du  - 18P: Clinical Efficacy and Immune Mechanism of PD-1/CTLA-4 Bispecific Antibody Cadonilimab (AK104) in Early-Stage Multiple Primary Lung Cancer (MPLC) (10/20/2025, 12-13:00, Hall 25)\n    * ... and 1 more presenters\n\n\n**Dana-Farber Cancer Institute**\n  - ESMO 2025 Presentations: 6\n  - Clinical Trials (2015-2025): 38 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06945120](https://clinicaltrials.gov/study/NCT06945120): ACT Lung Health Intervention: Phase Two (NA, NOT_YET_RECRUITING, Started 2025)\n    * [NCT06716580](https://clinicaltrials.gov/study/NCT06716580): EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations (NA, RECRUITING, Started 2025)\n    * [NCT06472869](https://clinicaltrials.gov/study/NCT06472869): Assessing E-Cigarettes for Tobacco Harm Reduction in the Context of Lung Cancer Screening (NA, ACTIVE_NOT_RECRUITING, Started 2024)\n    * [NCT06026111](https://clinicaltrials.gov/study/NCT06026111): Preliminary Efficacy of Different Exercise Training During Immunotherapy in Patients With Lung Cancer: The ENHANCE Trial (NA, RECRUITING, Started 2024)\n    * [NCT05463796](https://clinicaltrials.gov/study/NCT05463796): InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer (Phase Not Specified, RECRUITING, Started 2023)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT04201145](https://clinicaltrials.gov/study/NCT04201145): Pembrolizumab + Defactinib In Pleural Mesothelioma (PHASE1, WITHDRAWN, Started 2020) [COMPETITOR]\n    * [NCT03425331](https://clinicaltrials.gov/study/NCT03425331): Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC (PHASE2, TERMINATED, Started 2018) [COMPETITOR]\n    * [NCT03333616](https://clinicaltrials.gov/study/NCT03333616): Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors (PHASE2, ACTIVE_NOT_RECRUITING, Started 2017) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (9 total):\n    * Pasi A. Janne  - LBA77: FLAURA2: exploratory overall survival (OS) analysis in patients (pts) with poorer prognostic factors treated with osimertinib (osi) +/- platinum-pemetrexed chemotherapy (CTx) as first-line (1L) treatment (tx) for EGFR-mutated (EGFRm) advanced NSCLC (10/17/2025, 17:00 - 17:10, Berlin Auditorium - Hub 27)\n    * Himisha Beltran  - 2758MO: Updated results from a phase 1/2 study of gocatamig for small cell lung cancer (SCLC) and other neuroendocrine cancers (10/18/2025, 16:35 - 16:40, Hamburg Auditorium - CityCube A)\n    * Jacob Sands  - : Invited Discussant (10/18/2025, 17:25 - 17:35, Hamburg Auditorium - CityCube A)\n    * Julia Rotow  - 1967P: MET testing and treatment (tx) sequencing after progression on first line (1L) osimertinib (osi) in patients (pts) with EGFRm advanced NSCLC and acquired MET overexpression and/or amplification (OverExp/Amp): interim analysis of a global real world (rw) study (10/18/2025, 12-13:00, Hall 25)\n    * Julia Rotow  - : Overcoming resistance in EGFRm NSCLC: strategies after progression (10/18/2025, 18:30 - 20:00, Heidelberg Auditorium - Hall 6.2)\n    * ... and 4 more presenters\n\n\n**Shandong Cancer Hospital and Institute**\n  - ESMO 2025 Presentations: 6\n  - Clinical Trials (2015-2025): 35 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06930807](https://clinicaltrials.gov/study/NCT06930807): Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer (NA, RECRUITING, Started 2025)\n    * [NCT06716775](https://clinicaltrials.gov/study/NCT06716775): Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer. (NA, NOT_YET_RECRUITING, Started 2024)\n    * [NCT06672133](https://clinicaltrials.gov/study/NCT06672133): Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC (PHASE3, NOT_YET_RECRUITING, Started 2024)\n    * [NCT06778382](https://clinicaltrials.gov/study/NCT06778382): Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer. (PHASE2, RECRUITING, Started 2024)\n    * [NCT06690216](https://clinicaltrials.gov/study/NCT06690216): Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors (PHASE1, ENROLLING_BY_INVITATION, Started 2024)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT04982549](https://clinicaltrials.gov/study/NCT04982549): A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC (PHASE2, UNKNOWN, Started 2021) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (6 total):\n    * Changxing Feng  - 2772P: Impact of radiation dose to immune cells on Survival in Patients with Extensive-Stage Small Cell Lung Cancer Receiving Consolidative Thoracic Radiotherapy After Chemoimmunotherapy (10/18/2025, 12-13:00, Hall 25)\n    * Haiyong Wang  - 1897P: PD-1/IL-2 Bispecific Antibody Reprograms CD8+ T Cells and Prevents Macrophage-Mediated Clearance to Overcome Immunotherapy Resistance in SMARCA4-Deficient Lung Cancer (10/18/2025, 12-13:00, Hall 25)\n    * JIanfeng Peng  - 1942P: First-line camrelizumab plus chemotherapy in patients with advanced non-squamous NSCLC and brain metastases: Effectiveness results from a nationwide retrospective study (10/18/2025, 12-13:00, Hall 25)\n    * Xiaoling Shang  - 2795eP: The LDH-H3K18La-Nur77 Axis Potentiates Immune Escape in Small Cell Lung Cancer (10/18/2025, 12-13:00, Hall 25)\n    * Xudong Hu  - 2089eTiP: Prospective, Single-Arm Phase II Clinical Study of Tislelizumab Combined with Chemotherapy Followed by Sequential Chest Consolidation Radiotherapy in the Treatment of Advanced First-Line Non-Small Cell Lung Cancer (10/18/2025, 12-13:00, Hall 25)\n    * ... and 1 more presenters\n\n\n**Medical Oncology Unit**\n  - ESMO 2025 Presentations: 6\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (9 total):\n    * Alessandra Dodi  - 1910P: Development of a multiomic machine learning model to predict the outcome of advanced non-small cell lung cancer patients treated with immunotherapy. (10/18/2025, 12-13:00, Hall 25)\n    * Federico Sottotetti  - 2055eP: Occupational Exposure to Carcinogens and Non-Oncogene Addicted Phenotypes in Lung Cancer: Insights from a Real-Life Observational Study (10/18/2025, 12-13:00, Hall 25)\n    * Giuseppe Lamberti  - 2786P: Baseline onconeural antibodies and immune-related adverse events on immune checkpoint inhibitors in patients with small-cell lung cancer: a prospective cohort study (10/18/2025, 12-13:00, Hall 25)\n    * Maria Gonzalez Cao  - 2779P: Phase Ib-II trial of tumor-loaded monocyte-derived dendritic cell vaccination plus atezolizumab in ES-SCLC (10/18/2025, 12-13:00, Hall 25)\n    * Rita Chiari  - 1898P: Multicenter prospective study of programmed death 1 (PD-1) single-nucleotide polymorphisms (SNPs) in patients with metastatic lung adenocarcinoma (MLA) treated with pembrolizumab (P) (10/18/2025, 12-13:00, Hall 25)\n    * ... and 4 more presenters\n\n\n**COMPLETE SPEAKER DIRECTORY BY GEOGRAPHY:**\n\n\n** (1 institutions, 1 speakers)**\n  -  (1 speakers): \n\n**Aichi (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Kindai University Hospital, Osaka-sayama, Japan. (1 speakers): Seiichiro Mitani\n\n**Australia (5 institutions, 5 speakers)**\n  - Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. (1 speakers): Joanna Chan\n  - Garvan Institute of Medical Research, Sydney, Australia. (1 speakers): Frank P. Lin\n  - Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. (1 speakers): Jayesh Desai\n  - School of Biomedical Science and Pharmacy, University of Newcastle, Newcastle, Australia. (1 speakers): Darren Shafren\n  - Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. (1 speakers): Lavinia Spain\n\n**Austria (1 institutions, 1 speakers)**\n  - Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Clinic Floridsdorf, Vienna, Austria. (1 speakers): Maximilian J. Hochmair\n\n**BA (1 institutions, 1 speakers)**\n  - Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, Department of Surgical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. (1 speakers): Paula Ugalde\n\n**Belgium (6 institutions, 6 speakers)**\n  - Department of Pulmonology and Thoracic Oncology, Jessa Hospital, Hasselt, Belgium. (1 speakers): Kristof Cuppens\n  - Medical Oncology Department, Brussels (1 speakers): Anouk Goudsmit\n  - Niel, Belgium. (1 speakers): Dirk Goossens\n  - Team Laboratory for Medical and Molecular Oncology (LMMO), Translational Oncology Research Center (TORC), Laarbeeklaan 101, Belgium. (1 speakers): Iris Dirven\n  - University Hospitals Leuven (UZ), Louvain, Belgium. (1 speakers): Johan F. Vansteenkiste\n  - University Hospitals Leuven, Leuven, Belgium. (1 speakers): Annelies T. Verbiest\n\n**Brazil (4 institutions, 5 speakers)**\n  -  (2 speakers): Breno Jeha, Henrique Larsen\n  - Alfenas Federal University (Unifal-MG), Minas Gerais, Brazil. Electronic address: daniel.faria@unifal-mg.edu.br. (1 speakers): Daniel V. Almeida\n  - Department of Medical Biology, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia. (1 speakers): William William\n  - Department of Medical Oncology and Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, Hospital Israelita Albert, São Paulo, São Paulo, Brazil. (1 speakers): Miguel Zugman\n\n**Bulgaria (2 institutions, 2 speakers)**\n  - Department of Radiotherapy, MHAT \"Heart and Brain\", Pleven, Bulgaria. (1 speakers): Kiril Z. Zhelev\n  - Oncodermatology Department, National Oncology Center, Sofia, Bulgaria. (1 speakers): Iva Gavrilova\n\n**CA (2 institutions, 2 speakers)**\n  - Department of Medicine, Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA, USA. (1 speakers): Heather Wakelee\n  - Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. (1 speakers): David R. Gandara\n\n**CEDEX (6 institutions, 6 speakers)**\n  - Department of Cancer Medicine, Thoracic Group and International Center for Thoracic Cancers, Paris-Saclay University, Villejuif, France. (1 speakers): Benjamin Besse\n  - Department of Medical Oncology, Hospital Foch, Suresnes, France. (1 speakers): Jaafar Bennouna\n  - Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France. (1 speakers): Maurice Perol\n  - Departments of Neurosurgery and Neurology, University Hospital Zurich, Ramistrasse 102, Zurich, Switzerland. (1 speakers): Emilie Le Rhun\n  - Drug Development Department, Gustave Roussy Cancer Campus, France. (1 speakers): Capucine Baldini\n  - EFS, INSERM, UMR RIGHT, France, Department of Medical Oncology, University Hospital of Besançon (1 speakers): Olivier Adotevi\n\n**CEDEX 9 (1 institutions, 1 speakers)**\n  - Immunity and Cancer Team, Cancer Research Centre of Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Paoli-Calmettes Institute, Aix-Marseille University Marseille, France. (1 speakers): Philippe Rochigneux\n\n**Canada (17 institutions, 17 speakers)**\n  -  (1 speakers): Marie-Frederique Damours\n  - Centre Intégré de Cancérologie de la Montérégie, Université de Sherbrooke, Longueuil, QC J4V 2H1, Canada. (1 speakers): Nathalie Daaboul\n  - Centre de Recherche du Centre Hospitalier Universitaire de Montréal, Montréal, Canada. (1 speakers): Julie Malo\n  - Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. (1 speakers): Chloe Lim\n  - Department of Life Science, Aberystwyth University, UK. (1 speakers): Amanda J. Gibson\n  - Department of Oncology, McMaster University, Hamilton, ON, Canada. (1 speakers): Rosalyn Juergens\n  - Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada. (1 speakers): Omar F. Khan\n  - Division of Hematology-Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC H2X 0C1, Canada. (1 speakers): Marie Florescu\n  - Division of Medical Oncology, Moncton Hospital, Moncton, NB, Canada. (1 speakers): Mahmoud Abdelsalam\n  - Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada. (1 speakers): Stephanie Mercier\n  - Glans-Look Lung Cancer Research, Cumming School of Medicine, University of Calgary, Alberta, Canada. (1 speakers): Vishal Navani\n  - Oncology Department, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. (1 speakers): Quincy Siu-chung Chu\n  - Princess Margaret Hospital, Toronto, ON, Canada. (1 speakers): Natasha Leighl\n  - University Health Network-Princess Margaret Cancer Center, Ontario, Canada. (1 speakers): Beatriz E. Jimenez Munarriz\n  - University of British Columbia, BC, Canada. (1 speakers): Florence T. Wu\n  - University of Montreal Research Center (CR-CHUM), Montreal, QC, Canada. (1 speakers): Jade Maillou\n  - University of Western Ontario, Ontario, Canada. (1 speakers): Jonathan Moroniti\n\n**Chiba (1 institutions, 1 speakers)**\n  - Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Yoshitaka Zenke\n\n**Chile (1 institutions, 1 speakers)**\n  - eDepartment of Oncology, Bradford Hill Clinical Research Center, Santiago, Chile. (1 speakers): Mauricio Burotto\n\n**China (121 institutions, 127 speakers)**\n  -  (2 speakers): Ruihe Liu, Yu Ruofan\n  - Aurora Sinai/Aurora St. Luke's Medical Centers, Milwaukee, WI, USA. (1 speakers): Chi Cho\n  - BioBank, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China. (1 speakers): Ying Yuan\n  - CAS Key Laboratory of Nutrition, Metabolism and Food Safety Shanghai Institute of Nutrition and Health University of Chinese Academy of Sciences Chinese Academy of Sciences Shanghai China. (1 speakers): Wei Zhang\n  - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (1 speakers): Xiaorong Dong\n  - Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, TX, USA. (1 speakers): Qiang Wang\n  - Center of Stomatology, Xiangya Hospital, Central South University, Changsha, China. (1 speakers): Jijia Li\n  - Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge (1 speakers): Xin Yang\n  - Changchun University of Chinese Medicine, Jilin, Changchun, China. (1 speakers): Shuang Zhang\n  - China Medical University, Shenyang, Liaoning, China. (1 speakers): Siyuan Chen\n  - China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. (1 speakers): Cai Chen Li\n  - Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China. (1 speakers): Shuhang Wang\n  - College of Animal Science and Technology, Henan University of Animal Husbandry and Economy, Zhengzhou, China. (1 speakers): Haoyuan Han\n  - College of Computer Science and Technology, Xinjiang University, Urumqi, China. (1 speakers): Cheng Chen\n  - College of Health Science and Technology (B.S., L.W., X.L., J.T., J.X., Y.Z., H.Z.), Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Yan Zhou\n  - Department of Basic Public Health, Guangzhou Center for Disease Control and Prevention, Guangzhou 510440, China. (1 speakers): Hui Liu\n  - Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Chongqing Medical University Chongqing 400010 P. R. China 302118@cqmu.edu.cn. (1 speakers): Xiaoqing Yu\n  - Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195. (1 speakers): Fei Zhou\n  - Department of Clinical Laboratory Center, Shaoxing People's Hospital, Shaoxing, Zhejiang, China. (1 speakers): Yi Feng\n  - Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, China. (1 speakers): Tony S.K. Mok\n  - Department of Clinical and Health Informatics, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Suite 600, Houston, TX (1 speakers): Liwei Wang\n  - Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200080, China. (1 speakers): Mengting Chen\n  - Department of Dermatology, Xiangya Hospital, Central South University, Hu Nan Key Laboratory of Aging Biology, Changsha, China. (1 speakers): Min Li\n  - Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing 100044, China. (1 speakers): Fang Lv\n  - Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou 450001, China. (1 speakers): Linlin Li\n  - Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. (1 speakers): Zheng-Hao Ye\n  - Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. (1 speakers): Leping Li\n  - Department of Gynaecology and Obstetrics, West China Second Hospital, Sichuan University, No. 20, Sect. 3, Chengdu, Sichuan, People's Republic of China. (1 speakers): Yu Fan\n  - Department of Gynecology and Oncology, Beijing Obstetrics and Gynecology Hospital Affiliated to Capital Medical University, Beijing, China. (1 speakers): Yue He\n  - Department of Hematology, Jinan Central Hospital affiliated to Shandong First Medical University, Jinan, China. (1 speakers): Juan Wang\n  - Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, China (1 speakers): Xueli Bai\n  - Department of Internal Medicine Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Number 440, Jinan 250117, China. (1 speakers): Haiyong Wang\n  - Department of Internal Medicine-Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China. (1 speakers): Xiaoling Shang\n  - Department of Laboratory Medicine The Affiliated Changsha Hospital of Xiangya School of Medicine (The First Hospital of Changsha) Central South University Changsha Hunan China. (1 speakers): Wu Yong\n  - Department of Laboratory Medicine, School of Medical Technology, Tianjin Medical University, Tianjin, China. (1 speakers): Jinhao Yang\n  - Department of Lung Cancer Surgery, Tianjin Lung Cancer Institute, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. (1 speakers): Mengzhe Zhang\n  - Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. (1 speakers): Dongsheng Yue\n  - Department of Medical Oncology Shanghai Pulmonary Hospital, School of Medicine, Tongji University Shanghai People's Republic of China. (1 speakers): Anwen Xiong\n  - Department of Medical Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China. (1 speakers): Yanfang Zheng\n  - Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (2 speakers): Haohua Zhu, Yuan-Kai Shi\n  - Department of Medical Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Shun Lu\n  - Department of Medical Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China. (1 speakers): Yongfeng Yu\n  - Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China. (1 speakers): Wengang Zhang\n  - Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. (1 speakers): Caicun Zhou\n  - Department of Medical Oncology, Sun Yat-sen University Cancer Center, China, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer (1 speakers): Ting Zhou\n  - Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China. (1 speakers): Wen Feng Fang\n  - Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine (1 speakers): Huaqiang Zhou\n  - Department of Medical Oncology, The affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China. (1 speakers): Shuyi Hu\n  - Department of Occupational and Environmental Health, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China (1 speakers): Shaowei Wu\n  - Department of Oncology Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China. (1 speakers): Huiying Li\n  - Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China. (1 speakers): Weiran Xu\n  - Department of Oncology, Dongying People's Hospital, Dongying, China. (1 speakers): Longxiang Guo\n  - Department of Oncology, Lishui Municipal Central Hospital, Lishui 323000, China. (1 speakers): Jianhui Huang\n  - Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. (1 speakers): Shudong Ma\n  - Department of Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. (1 speakers): Aiping Zhou\n  - Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China. (1 speakers): Meiqi Shi\n  - Department of Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China. (1 speakers): Qiming Wang\n  - Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, P. R. China. (1 speakers): Xicheng Wang\n  - Department of Oncology, the Second Affiliated Hospital of Harbin Medical University, Harbin, China. (1 speakers): Chengjuan Fan\n  - Department of Otorhinolaryngology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. (1 speakers): Weiwei Wang\n  - Department of Palliative Care and Department of Geriatric Oncology, Chongqing University Cancer Hospital, Chongqing400030, People's Republic of China. (1 speakers): Huiqing Yu\n  - Department of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): QIN YAN\n  - Department of Psychiatry, Zhejiang Hospital, Hangzhou, China. (1 speakers): Liling Ma\n  - Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. (1 speakers): Liwen Wang\n  - Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China hg7913@hotmail.com 39390822@qq.com. (1 speakers): Guang Han\n  - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China (1 speakers): JIanfeng Peng\n  - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. (1 speakers): Xudong Hu\n  - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Jinan, Shandong, China. (1 speakers): Changxing Feng\n  - Department of Radiology, Shanghai Jiao Tong University School of Medicine Affiliated Shanghai Sixth People's Hospital, Shanghai 200233, China. (1 speakers): Hui Li\n  - Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041 Sichuan, China. (1 speakers): Ying Liu\n  - Department of Radiotherapy, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China. (1 speakers): Liangjun Zhu\n  - Department of Respiratory Disease, Thoracic Disease Center, Zhejiang University School of Medicine First Affiliated Hospital, China. (1 speakers): Jianya Zhou\n  - Department of Respiratory Medicine, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China. (1 speakers): Lan Wang\n  - Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. (1 speakers): Xiaoyi Feng\n  - Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (4 speakers): Huawei Du, Kuofang Huang, Tianqing Chu, Yanwei Zhang\n  - Department of Thoracic Medical Oncology Cancer Hospital Chinese Academy of Medical Sciences Beijing China. (1 speakers): Jie Wang\n  - Department of Thoracic Oncology and Surgery, The First Affiliated Hospital of Guangzhou Medical University (1 speakers): Feng Li\n  - Department of Thoracic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. (1 speakers): Qian Chu\n  - Department of Thoracic Surgery and Oncology, Hengqin Hospital, First Affiliated Hospital of Guangzhou Medical University, Hengqin, Guangdong, China. (1 speakers): Wenjun Ye\n  - Department of Thoracic Surgery, National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. (1 speakers): Runchen Wang\n  - Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China. (1 speakers): Shaoyi Chen\n  - Department of Thoracic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Wangrui Liu\n  - Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. (1 speakers): Suyu Wang\n  - Department of Thoracic Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Yitao Yang\n  - Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi'an, Shaanxi, China. (1 speakers): Weibo Cao\n  - Department of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. (1 speakers): Cheng Hu\n  - Department of VIP Clinic General Division, Shanghai East Hospital, School of Medicine Tongji University Shanghai China. (1 speakers): Yan Zhang\n  - Departments of Oncology Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China. (1 speakers): Sheng Yang\n  - Endoscopy Center, Minhang District Central Hospital, Fudan University, Shanghai, China. (1 speakers): Feng Li\n  - Graduate School, Chinese PLA General Hospital/Medical School of Chinese PLA, Beijing, PR China. (1 speakers): An Wang\n  - Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. (2 speakers): Chen Huang, Si-Yang Liu\n  - Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. Electronic address: syylwu@live.cn. (1 speakers): Yi-Long Wu\n  - Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, People's Republic of China. (1 speakers): Wei-Chi Luo\n  - Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. (1 speakers): Xu-Chao Zhang\n  - Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center (1 speakers): Yue Pan\n  - Guangzhou Institute of Respiratory Health, Guangzhou, China. (1 speakers): Bo Cheng\n  - Hangzhou Cancer Institution, Affiliated Hangzhou Cancer Hospital, Zhejiang University School of Medicine, Hangzhou, China (1 speakers): Hongfang Zhang\n  - Harbin Medical University Cancer Hospital, Harbin, China. (1 speakers): Yanbin Zhao\n  - Hengqin Hospital, First Affiliated Hospital of Guangzhou Medical University, Hengqin, China. (1 speakers): Wenhai Fu\n  - Inc., Guangdong, Guangzhou, China. (1 speakers): Dongmei Chen\n  - Jinan Central Hospital, Shandong University, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, People's Republic of China. (1 speakers): Mei Li Sun\n  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China. (1 speakers): Zhijie Wang\n  - Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing, Jiangsu, People's Republic of China. (1 speakers): Xin Lv\n  - Nanjing Stomatological Hospital, Research institute of Stomatology, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. (1 speakers): Meng Yuan\n  - Neurosurgery Department, Dezhou People's Hospital, Dezhou, PR China. (1 speakers): Li Zhang\n  - Prince of Wales Hospital, Hong Kong Special Administrative Region, China. (1 speakers): Kingsley Sze Yuen Cheung\n  - Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Hangzhou, China. (1 speakers): Zhangsheng Jiang\n  - School of Artificial Intelligence, The University of Chinese Academy of Sciences, Beijing 100190, China. (1 speakers): Yang Du\n  - School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China. (1 speakers): Ting Liu\n  - School of Basic Medicine, Ningxia Medical University, Yinchuan, P.R. China. (1 speakers): Jie Xu\n  - School of Food Science and Technology, State Key Laboratory of Food Science and Technology, National Engineering Research Center for Functional Food, Jiangnan University, Wuxi, China. (1 speakers): Li Wang\n  - School of Public Health, Fudan University, Shanghai, People's Republic of China. z_yibiao@hotmail.com. (1 speakers): Yu-Wen Zhou\n  - Senior Department of Infectious Diseases The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases Beijing China. (1 speakers): Xiaoyan Li\n  - Shandong Cancer Hospital and Institute, 250117, China. (1 speakers): Zhonghui Z. Wei\n  - State Key Laboratory of Molecular Oncology, First Department of Thoracic Surgery, Peking University Cancer Hospital & Institute, Beijing, China. (1 speakers): Shaohua Ma\n  - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yatsen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China. (1 speakers): Yuan Zhang\n  - The First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China. (1 speakers): Manya Yu\n  - Thoracic Oncology Institute and Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Peking University People's Hospital, Beijing, China. (1 speakers): Zheng Liu\n  - Tianjin Medical University Cancer Institute & Hospital, Tianjin, China. (1 speakers): Dingzhi Huang\n  - Translational Medical Research Platform for Thoracic Oncology, China. 18930858216@163.com. (1 speakers): Baohui Han\n  - iHuman Institute, ShanghaiTech University, Shanghai, China, School of Life Science and Technology, ShanghaiTech University, Shanghai, China. (1 speakers): Fei Xu\n\n**Cyprus (1 institutions, 1 speakers)**\n  - Karaiskakio Foundation, Nicosia, Cyprus. (1 speakers): Petroula Gerasimou\n\n**Denmark (4 institutions, 5 speakers)**\n  -  (2 speakers): Mette J. Syberg, Yago Garitaonaindia Diaz\n  - Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark. (1 speakers): Eva Ellebaek\n  - National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, University Hospital Herlev, Herlev, Denmark. (1 speakers): Katharina Leuchte\n  - National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark. (1 speakers): Sidsel Pedersen\n\n**Egypt (1 institutions, 1 speakers)**\n  - Alexandria University, Alexandria, Egypt. (1 speakers): Israa Ahmed Ali Abdelrahem Qutob\n\n**Estonia (1 institutions, 1 speakers)**\n  - University of Tartu, Tartu 50090, Estonia. (1 speakers): Ann Valter\n\n**Ethiopia (1 institutions, 1 speakers)**\n  -  (1 speakers): Bethlehem Getachew Ayele\n\n**Finland (1 institutions, 1 speakers)**\n  - Department of Oncology, Tampere University Hospital, and University of Tampere, Tampere, Finland. (1 speakers): Pia J. Osterlund\n\n**France (32 institutions, 36 speakers)**\n  -  (4 speakers): ARNAUD DE GUNTEN, Diego Diaz-Jimenez, Elise Dominjon, Teo Bodergat\n  - Chest Department and Thoracic Oncology, Tenon Hospital, Sorbonne Université, GRC4 Theranoscan, Paris, France. (1 speakers): Jacques Cadranel\n  - Department of Cancer Medicine, Gustave Roussy, Villejuif, France. (1 speakers): Tarek Ben Ahmed\n  - Department of Cancer Medicine, Thoracic Group and International Center for Thoracic Cancers, Paris-Saclay University, Villejuif, France. (2 speakers): Claudia Parisi, David Planchard\n  - Department of Cancer Medicine, Villejuif, France. (1 speakers): Jordi Remon Masip\n  - Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. (1 speakers): Anthony Tarabay\n  - Department of Medical Oncology, Henri Mondor Hospital, Créteil, France. (1 speakers): Pascal Piedbois\n  - Department of Medical Oncology, Leon Berard Cancer Center, Lyon, France. (1 speakers): Philippe Cassier\n  - Department of Multidisciplinary Oncology and Therapeutic Innovations, Aix Marseille University, Marseille, France. (1 speakers): Laurent Greillier\n  - Department of Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, UMR INSERM 1240, University Clermont Auvergne, Clermont-Ferrand, France. (1 speakers): Frederique Penault-Llorca\n  - Department of Pneumology, Angers University Hospital, Angers, France. (1 speakers): Gregoire Justeau\n  - Department of Pneumology, Lyon, France. (1 speakers): Thomas Pierret\n  - Department of Pulmonary and Thoracic Oncology, Centre Hospitalier Universitaire Lille, University of Lille, U1019 INSERM, Center of Infection and Immunity of Lille, Lille, France. (1 speakers): Arnaud Scherpereel\n  - Department of Pulmonology, Centre Hospitalier Le Mans, France. (1 speakers): Olivier Molinier\n  - Department of Respiratory Medicine and Early Phase (EPSILYON), Louis Pradel Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France. (1 speakers): Michael Duruisseaux\n  - EORTC HQ, Belgium, Villejuif, France. (1 speakers): Marie Morfouace\n  - Grenoble-Alpes University Hospital, Grenoble, France. (1 speakers): Anne Claire Toffart\n  - INSERM U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. (1 speakers): Cinzia Ungolo\n  - Institut Bergonié, Bordeaux, France. (1 speakers): Jerome Caron\n  - Institute of Materials Science (1 speakers): NGUYEN T. Yen\n  - La Paz University Hospital, 28046 Madrid, Spain. (1 speakers): Maria Virginia Sanchez Becerra\n  - Medical Oncology Dept, Hospital Universitario 12 de Octubre and i+12 Research Institute, Madrid, Spain. (1 speakers): Nerea Munoz\n  - Oncostat U1018, Institut National de la Santé et de la Recherche Médicale (INSERM), Ligue Contre le Cancer, Paris-Saclay University, Villejuif, France. (1 speakers): Noemie Simon-Tillaux\n  - Pneumology Department, Intercommunal Hospital of Creteil, Créteil, France. (1 speakers): Christos Chouaid\n  - Respiratory Diseases Department, University Hospital of Reims, Reims, France. (1 speakers): Julien Ancel\n  - Respiratory Medicine Department, GHRMSA, Hospital Emile Muller, Mulhouse, France. (1 speakers): Didier Debieuvre\n  - Respiratory Medicine Department, L'Hôpital Nord-Ouest, Villefranche-Sur-Saône, France. (1 speakers): Lionel Falchero\n  - Saint-Herblain, France. (1 speakers): Judith Raimbourg\n  - Service de Pneumologie, Hôpital Cochin, AP-HP. Centre, Université Paris Cité, Paris, France. (1 speakers): Gaspard Naulleau\n  - Sorbonne University, Department of Hepato-Gastroenterology, Pitié-Salpêtrière Hospital, Paris, France. (1 speakers): Jean-Baptiste Bachet\n  - Thorax Institute Curie Montsouris, Department of Medical Oncology, Paris, France. (1 speakers): Nicolas Girard\n  - University of Burgundy, Dijon, France. (1 speakers): Francois Ghiringhelli\n\n**Georgia (1 institutions, 1 speakers)**\n  - Todua Clinic Department of Oncology and Haematology, Tbilisi, Georgia. (1 speakers): Elene Mariamidze\n\n**Germany (40 institutions, 41 speakers)**\n  -  (1 speakers): Nicoline Ehrhardt\n  - Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany. (1 speakers): Jurgen Wolf\n  - Charité Comprehensive Cancer Center, Charité-Universitätsmedizin Berlin, Berlin, Germany. (1 speakers): Nikolaj Frost\n  - Charité-University Medicine Berlin, Berlin, Germany. (1 speakers): Nele Danielle Wagener\n  - Christoph Pöttgen, Karl-Heinz Jöckel, University Hospital Essen, University of Duisburg-Essen, Ruhrlandklinik, Essen, University Hospital Tübingen, University of Tübingen, Tübingen (1 speakers): Martin H. Schuler\n  - Clinic I for Internal Medicine, University Clinic Cologne, Germany. (1 speakers): Anna Rasokat\n  - Clinic of Cardiology and Pneumology, Esslingen Hospital, Germany. (1 speakers): Martin Faehling\n  - Clinical Department for Internal Medicine II, University Medical Center, Technical University of Munich (TUM), Germany. (1 speakers): Sebastian Lange\n  - Clinical State Registry Baden-Württemberg GmbH, Baden-Württemberg Cancer Registry (BWCR), Stuttgart, Germany. (1 speakers): Irina Surovtsova\n  - Comprehensive Cancer Center (CCC Munich LMU), LMU University Hospital Munich, Munich, Germany. (1 speakers): Christoph Benedikt Westphalen\n  - Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne (1 speakers): Heather Scharpenseel\n  - Department for Oncology, University Comprehensive Cancer Center, Hamburg, Germany. (1 speakers): Nikolaus Berenbrok\n  - Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Germany. (1 speakers): Wiebke Pirschel\n  - Department of Dermatology, Elbe Clinic Buxtehude, Buxtehude, Germany. (1 speakers): Peter Mohr\n  - Department of Dermatology, Skin Cancer Center, University Hospital Schleswig-Holstein, Kiel, Germany. (1 speakers): Michael Weichenthal\n  - Department of Hematology and Oncology, UCT-University Cancer Center, Frankfurt, Germany. (1 speakers): Akin Atmaca\n  - Department of Hematology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany. (1 speakers): Sebastian Stintzing\n  - Department of Hematology, Oncology, and Cancer Immunology, Charité University Hospital Berlin, Berlin, Germany. (1 speakers): Dominik P. Modest\n  - Department of Internal Medicine II, Hematology, Oncology, University Hospital Frankfurt, Frankfurt, Germany. (1 speakers): Sophie Heinzen\n  - Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany. (1 speakers): Daniel Heudobler\n  - Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany. (1 speakers): Martin Metzenmacher\n  - Department of Medicine A, Hematology, Hemostaseology, Oncology and Pneumology, University Hospital Muenster, Münster, Germany. (1 speakers): Marcel Kemper\n  - Department of Medicine II, Hematology/Oncology, University Hospital Frankfurt, Frankfurt, Germany. (1 speakers): Friederike Althoff\n  - Department of Medicine V, LMU University Hospital, Munich, Germany. (2 speakers): Amanda Tufman, Blerina Resuli\n  - Department of Medicine, Clinic III - Hematology, Oncology, Rostock University Medical Center, University of Rostock, Germany. (1 speakers): Claudia Maletzki\n  - Department of Molecular Oncology and Pneumological Oncology, Robert-Bosch-Centrum für Tumorerkrankungen, Robert-Bosch Hospital, Stuttgart, Germany. (1 speakers): Hans-Georg Kopp\n  - Department of Pneumology, Berlin, Germany. (1 speakers): Christian Grohe\n  - Department of Pneumology, University Hospital Ulm, Ulm, Germany. (1 speakers): Cornelia Kropf-Sanchen\n  - Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Airway Research Censer North, German Center of Lung Research, Grosshansdorf, Germany. (1 speakers): Martin Reck\n  - Department of Thoracic Oncology, Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany. (1 speakers): Michael Thomas\n  - Department of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. (1 speakers): Johannes Bragelmann\n  - Department of Translational Pulmonology, Heidelberg University Hospital, Heidelberg, Germany. (1 speakers): Petros Christopoulos\n  - Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany, Division of Stem Cells and Cancer, Heidelberg, Germany, German Cancer Consortium (DKTK) (1 speakers): Christian Eisen\n  - Lung Cancer Center, Hospital Havelhöhe, Germany. (1 speakers): Christian Grah\n  - National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany, Clinical Trial Center, NCT Heidelberg, Heidelberg (1 speakers): Richard F. Schlenk\n  - National Center for Tumor Diseases, University Hospital Carl Gustav Carus TU Dresden, Germany. (1 speakers): Martin Wermke\n  - School of Medicine and Health Sciences, University Department Internal Medicine-Oncology, Oldenburg, Germany. (1 speakers): Frank Griesinger\n  - University Cancer Center Frankfurt (UCT), Frankfurt am Main, Germany, Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany, German Cancer Research Center (DKFZ) Heidelberg (1 speakers): Martin Sebastian\n  - Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstr. 55, Essen, Deutschland. (1 speakers): Wilfried E. Eberhardt\n  - eAsklepios Lung Clinic, German Center for Lung Research (DZL), Munich-Gauting, Germany. (1 speakers): Niels Reinmuth\n\n**Greece (4 institutions, 4 speakers)**\n  - Department of Cardiology, Venizeleion General Hospital, GRC. (1 speakers): Eleni Eleftheriadou\n  - Division of Oncology, Department of Medicine, University of Patras Medical School, Patras, Greece. (1 speakers): Fotinos-Ioannis D. Dimitrakopoulos\n  - Fourth Department of Medical Oncology and Clinical Trials Unit, Henry Dunant Hospital Center Athens, Greece. (1 speakers): Giannis Mountzios\n  - University of Crete, 70013 Heraklion, Greece. (1 speakers): Andreas V. Koulouris\n\n**Guangdong (1 institutions, 1 speakers)**\n  - Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China (1 speakers): Jin-Ji Yang\n\n**Hiroshima (1 institutions, 1 speakers)**\n  - Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. (1 speakers): Takahiro Mimae\n\n**Hunan (1 institutions, 1 speakers)**\n  - Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China, Hunan Cancer Mega-Data Intelligent Application and Engineering Research Centre, Changsha, Hunan (1 speakers): Fang Wu\n\n**Hungary (1 institutions, 1 speakers)**\n  - Department of Pulmonology, Semmelweis University, Budapest, Hungary. (1 speakers): Veronika Muller\n\n**India (5 institutions, 5 speakers)**\n  -  (1 speakers): Madhavi R. Indani\n  - Armed Forces Medical College, Maharashtra, India. bisht53rahul@gmail.com. (1 speakers): Rahul S. Bisht\n  - Department of Interventional Pulmonology Yashoda Hospitals Hyderabad India. (1 speakers): Hari Kishan Gonuguntla\n  - Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India. (1 speakers): Navneet Singh\n  - Homi Bhabha National Institute, Training School Complex, Mumbai, Maharashtra, India, Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India. (1 speakers): Vijay M. Patil\n\n**Ireland (2 institutions, 2 speakers)**\n  -  (1 speakers): Julie Twomey\n  - Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland, Sidney Kimmel Comprehensive Cancer Centre at Johns Hopkins University, USA. (1 speakers): Jarushka Naidoo\n\n**Ishikawa (1 institutions, 1 speakers)**\n  - Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Ishikawa 920-8641, Japan. (1 speakers): Seiji Yano\n\n**Israel (5 institutions, 5 speakers)**\n  - Department of Oncology, Shaare Zedek Medical Center, Jerusalem 9103102, Israel. (1 speakers): Nir Peled\n  - Fishman Oncology Institute, Rambam Health Care Campus, Haifa, Israel. (1 speakers): Sameh Daher\n  - Fred Hutchinson Cancer Research Center, Seattle, WA, USA. (1 speakers): Noa Granot\n  - Institute of Oncology, Rambam Health Campus, Haifa, Israel. (1 speakers): Alona Zer\n  - Jusidman Institute of Oncology, Sheba Medical Center, Israel. (1 speakers): Jair Bar\n\n**Italy (42 institutions, 48 speakers)**\n  -  (2 speakers): Filippo Morocutti, Rebecca Mencarini\n  - Clinical and Experimental Medicine Program, University of Modena and Reggio Emilia, Modena, Italy. (1 speakers): Lucia Trudu\n  - Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. (1 speakers): Maria Alessandra Calegari\n  - Department of Agraria, Mediterranean University of Reggio Calabria, Italy. (1 speakers): Francesco Larocca\n  - Department of Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy. (1 speakers): Pasquale Persico\n  - Department of Medical Oncology and Hematology, IRCCS Humanitas Research Hospital, Milan, Italy. (1 speakers): Matteo Simonelli\n  - Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy. (1 speakers): Francesca Rita Ogliari\n  - Department of Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy. (1 speakers): Francesco G. Sullo\n  - Department of Medical Oncology, Milan, Italy. (1 speakers): Teresa Beninato\n  - Department of Medical Oncology, University Hospital of Udine, Udine, Italy. (1 speakers): Francesco Cortiula\n  - Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum-University of Bologna, Medical Oncology Unit, Bologna, Italy. (1 speakers): Giuseppe Lamberti\n  - Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. (1 speakers): Ilaria Ricciotti\n  - Department of Medicine and Surgery, Medical Oncology Unit, University Hospital of Parma, Parma, Italy. (2 speakers): Alessandra Dodi, Marcello Tiseo\n  - Department of Oncology and Haematology, University of Milan, Milan, Italy, European Institute of Oncology, IRCCS, Milan, Italy. (1 speakers): Dario Trapani\n  - Department of Oncology, University of Torino, San Luigi Gonzaga University Hospital, Orbassano, Italy. (1 speakers): Silvia Novello\n  - Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital-Orbassano, Turin, Italy. (1 speakers): Massimiliano Cani\n  - Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Torino, Italy. (1 speakers): Ornella Cantale\n  - Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy. (2 speakers): Giovanni Farinea, Luca Cozzone\n  - Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy. (2 speakers): Laura Bonanno, Loc Carlo Bao\n  - Department of Surgical, Section of Medical Oncology, University of Palermo, Palermo, Italy. (1 speakers): Alessandra Dimino\n  - Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO), IRCCS, Milan, Italy. (1 speakers): Francesca Spada\n  - Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy. (1 speakers): Federica Biello\n  - Division of Thoracic Oncology, European Institute of Oncology, IEO, IRCCS, Milan 20141, Italy. (1 speakers): Antonio Passaro\n  - Genoa, Italy. (1 speakers): Eugenia Cella\n  - Gynecologic Oncology Department, European Institute of Oncology, Milan, Italy. (1 speakers): Fedro A. Peccatori\n  - IRCCS Humanitas Research Hospital, Cancer Center, Rozzano, Italy. (1 speakers): Luca Toschi\n  - IRCCS Regina Elena National Cancer Institute, Rome, Italy. (1 speakers): Federico Cappuzzo\n  - Medical Oncology Department, Milan, Italy. (2 speakers): Marta Brambilla, Monica Ganzinelli\n  - Medical Oncology Department, University and Hospital Trust of Verona, Verona, Italy. (1 speakers): Jessica Menis\n  - Medical Oncology Unit, AST1, Pesaro, Italy. (1 speakers): Rita Chiari\n  - Medical Oncology Unit, Department of Oncology and Hematology, Belcolle Hospital, Viterbo, Italy. (1 speakers): Marta Schirripa\n  - Medical Oncology Unit, Pavia, Italy. (1 speakers): Federico Sottotetti\n  - Medical Oncology Unit, University Hospital and University of Cagliari, Italy. (1 speakers): Andrea Pretta\n  - Medical Oncology, Sant'Andrea University Hospital, Rome, Italy. (1 speakers): Marco Siringo\n  - Medical Oncology, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy. (1 speakers): Giulio Metro\n  - Medical Oncology, Versilia Hospital, Azienda USL Toscana Nord Ovest, Lido di Camaiore, Italy. (1 speakers): Andrea Camerini\n  - Naples, Italy. (1 speakers): Anna Maria Trotta\n  - Radiation Oncology Department, Milan, Italy, Department of Oncology, University of Milan, Milan, Italy. (1 speakers): Andrea Riccardo Filippi\n  - Section of Oncology, Department of Engineering for Innovation Medicine (DIMI), University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy. (2 speakers): Lorenzo Belluomini, Serena Eccher\n  - University of Campania Luigi Vanvitelli, 80131 Naples, Italy. (1 speakers): Caterina De Rosa\n  - University of Milan, Milan, Italy. (1 speakers): Filippo Guglielmo Maria De Braud\n  - University of Pisa, Pisa, Italy. (1 speakers): Marco Maria M. Germani\n\n**Japan (31 institutions, 32 speakers)**\n  -  (1 speakers): Ishida Masaki\n  - Advanced Cancer Translational Research Institute, Showa Medical University, Tokyo, Japan. (1 speakers): Junji Tsurutani\n  - Biostatistics Division, Center for Research Administration and Support, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Masashi Wakabayashi\n  - Department of Breast Medical Oncology, The Cancer Institute Hospital of JFCR, Tokyo, Japan. (1 speakers): Takayuki Kobayashi\n  - Department of Clinical Oncology, St. Marianna University School of Medicine, Sugao, Miyamae-ku, Kawasaki, Kanagawa, Japan. y.suna0825@gmail.com. (1 speakers): Yu Sunakawa\n  - Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. (2 speakers): Yasutoshi Kuboki, Yuki Matsubara\n  - Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Nagasaki, Japan. (1 speakers): Kohei Hayashi\n  - Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. (1 speakers): Yuri Maegawa\n  - Department of Medical Oncology, Tohoku University Hospital, Sendai 980-8547, Japan. (1 speakers): Shiori Ishikawa\n  - Department of Orthopaedic Oncology and Surgery, Saitama Medical University International Medical Center, Saitama, Japan. (1 speakers): Takuya Watanabe\n  - Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kajii-cho, Kamigyo-ku, Kyoto 602-8566, Japan. (1 speakers): Tadaaki Yamada\n  - Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. (1 speakers): Haruka Nakatani\n  - Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan. (1 speakers): Shunsuke Misono\n  - Department of Radiology, Kawasaki Medical School, Okayama, Japan. (1 speakers): Yuki Sato\n  - Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Aomori, Japan. (1 speakers): Tomonori Makiguchi\n  - Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. (1 speakers): Hisashi Tanaka\n  - Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan. (1 speakers): Akinari Tsukada\n  - Department of Respiratory Medicine, Osaka International Cancer Institute, Osaka, Japan. (1 speakers): Kiyohide Komuta\n  - Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo, Tokyo, Japan. (1 speakers): Shingo Kitagawa\n  - Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan. (1 speakers): Seigo Katakura\n  - Department of Thoracic Surgery, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan (1 speakers): Fumihiro Shoji\n  - Division of Lower G.I., Department of Gastroenterological Surgery, School of Medicine, Hyogo Medical University, Nishinomiya 663-8501, Japan. (1 speakers): Kozo Kataoka\n  - Division of Lower GI, Department of Gastroenterological Surgery, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya, Hyogo (1 speakers): Yuko Fukumoto\n  - Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan. (1 speakers): Tetsuo Shimizu\n  - Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, Nagaizumi, Japan. (1 speakers): KAZUSHIGE WAKUDA\n  - Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan. (1 speakers): Akira Hamada\n  - Ltd, Tsukuba, Japan. (1 speakers): Ken Ito\n  - National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Hiroki Izumi\n  - The Cancer Institute Hospital, Tokyo, Koto-ku, Japan. (1 speakers): Hiroki Osumi\n  - University of Tsukuba, Tsukuba, Japan. (1 speakers): Markus Y. Widjaja Lomanto\n  - Wakayama Medical University, Wakayama, Japan. (1 speakers): Yuichi Ozawa\n\n**Jordan (3 institutions, 3 speakers)**\n  - Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan, School of Medicine, The University of Jordan. Amman, Jordan. (1 speakers): Kamal Al-rabi\n  - King Hussein Cancer Center, Amman, Jordan. (1 speakers): Anas M. Zayed\n  - School of Medicine, The University of Jordan, Amman, Jordan. (1 speakers): Yazan I. Hamadneh\n\n**Kazakhstan (1 institutions, 1 speakers)**\n  - Department of Oncology, Astana Medical University, Oncologist-Surgeon, Multidisciplinary Medical Center, Astana, Kazakhstan. (1 speakers): Aizhan Bekisheva\n\n**MA (2 institutions, 2 speakers)**\n  - Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA. (1 speakers): Lori J. Wirth\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (1 speakers): Pasi A. Janne\n\n**MD (1 institutions, 1 speakers)**\n  - Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, USA. (1 speakers): Julie R. Brahmer\n\n**MN (1 institutions, 1 speakers)**\n  - Department of Oncology, Mayo Clinic, Rochester, MN, USA. (1 speakers): Aaron S. Mansfield\n\n**MO (1 institutions, 1 speakers)**\n  - Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Tina Cascone\n\n**Mexico (2 institutions, 2 speakers)**\n  - Instituto Nacional de Cancerología (INCan), Mexico. (1 speakers): Norma Y. Hernandez-Pedro\n  - Instituto Nacional de Cancerología, Mexico City 14080, Mexico. (1 speakers): Oscar Gerardo Arrieta Rodriguez\n\n**N. Faliro (1 institutions, 1 speakers)**\n  - Fourth Oncology Department & Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece. (1 speakers): Helena Linardou\n\n**NY (4 institutions, 4 speakers)**\n  - Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY, USA. (1 speakers): Richard J. Gralla\n  - Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. (1 speakers): Shigehisa Kitano\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, USA. (1 speakers): Helena A. Yu\n  - Departments of Pathology, Upstate Medical University, Syracuse, NY USA. (1 speakers): Jeffrey S. Ross\n\n**Netherlands (15 institutions, 17 speakers)**\n  -  (3 speakers): Jet Wies Ankersmid-Matos Miguel, Karlijn D. Joode, Stef Elings\n  - Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, the Netherlands. (1 speakers): Suresh Senan\n  - Department of Clinical Pharmacy and Toxicology, CARIM, Research Institute for Cardiovascular Diseases, Maastricht University Medical Center+, Maastricht (1 speakers): Paul D. Kruithof\n  - Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands. (1 speakers): Barend J. Sikkema\n  - Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Amsterdam, CX (1 speakers): Olga Husson\n  - Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam (1 speakers): Harry De Koning\n  - Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, Netherlands. (1 speakers): Anne-Marie C. Dingemans\n  - Department of Pulmonary Medicine, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands. (1 speakers): Ilias Houda\n  - Department of Research and Development, IKNL, Utrecht, the Netherlands. (1 speakers): Femke J. Jacobs\n  - Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, Department of Pulmonary Diseases, Leiden University Medical Centre, Leiden (1 speakers): Egbert F. Smit\n  - Erasmus University Medical Center, Rotterdam, the Netherlands. (1 speakers): Daan Lanser\n  - The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. (1 speakers): Diana I. Rodriguez Sanchez\n  - The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. (1 speakers): Gerrina Ruiter\n  - The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China. (1 speakers): En Hu\n  - University of Groningen, Groningen, The Netherlands. (1 speakers): Anthonie Jan Van Der Wekken\n\n**Norway (4 institutions, 4 speakers)**\n  -  (1 speakers): Magdalena S. Robertsen\n  - Department of Oncology, Oslo University Hospital, Oslo, Norway. (1 speakers): Henrik Horndalsveen\n  - Institute of Basic Medical Sciences, Section of Physiology, University of Oslo, Oslo, Norway. (1 speakers): Anna Christina Garvert\n  - Oslo University Hospital, Oslo, Norway. (1 speakers): Hanne Marte G. Nymoen\n\n**Nuevo Leon (1 institutions, 1 speakers)**\n  - Brigham and Women's Hospital, Memorial Sloan Kettering Cancer Center, New York (R.J.M.). (1 speakers): Victor M. Oyervides Juarez\n\n**Ontario (2 institutions, 2 speakers)**\n  - Department of Medicine, University of Ottawa, and the Ottawa Hospital Research Institute, Ottawa, ON K1H8L6, Canada. (1 speakers): Glenwood Goss\n  - Medical Oncology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. (1 speakers): Mark D. Vincent\n\n**Pakistan (3 institutions, 3 speakers)**\n  - Rawalpindi Medical University, Pakistan. (1 speakers): Anam Rafique\n  - Rawalpindi Medical University, Rawalpindi, Pakistan. (1 speakers): Shahzaib M. Maqbool\n  - University of Texas Southwestern Medical Center/Parkland Memorial Hospital, Dallas, TX. (1 speakers): Syed M. Kazmi\n\n**Poland (4 institutions, 4 speakers)**\n  - Clinical Department of Oncology, Oncology Centre - Prof. Franciszek Łukaszczyk Memorial Hospital, Bydgoszcz, Poland. (1 speakers): Jedrzej Borowczak\n  - Department of Clinical Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland. (1 speakers): Rafal Dziadziuszko\n  - Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. (1 speakers): Anna M. Czarnecka\n  - Lung Cancer and Chest Tumours Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. (1 speakers): Magdalena Knetki-Wroblewska\n\n**Portugal (2 institutions, 2 speakers)**\n  - Hospital de Braga, Braga, Portugal. (1 speakers): Marta Sofia C. Viana Pereira\n  - Medical Oncology Department, Pedro Hispano Hospital, Portugal. (1 speakers): Catarina Lopes Fernandes\n\n**Republic of Korea (9 institutions, 9 speakers)**\n  - College of Medicine, Cancer Research Institute, The Catholic University of Korea, Seoul, Republic of Korea. (1 speakers): SORA JEON\n  - Department of Oral and Maxillofacial Surgery, School of Medicine, Ewha Womans University, Seoul, Republic of Korea. (1 speakers): Jin Woo Kim\n  - Department of Science in Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea. (1 speakers): Seung Hyeon Lee\n  - Division of Hematology-Oncology, Department of Medicine, Seoul, Republic of Korea. (1 speakers): Jong-Mu Sun\n  - Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. (1 speakers): Byoung Chul Cho\n  - Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. (1 speakers): Shihwan Chang\n  - Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. (1 speakers): Kyu Yean Kim\n  - Hematology-Oncology Department, Samsung Medical Center (SMC), Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. (1 speakers): Myung-Ju Ahn\n  - ROKIT HEALTHCARE, Seoul 08514, Republic of Korea. (1 speakers): Jeehee Kim\n\n**Russian Federation (1 institutions, 1 speakers)**\n  - Institute for Personalized Oncology, Sechenov First Moscow State Medical University, Moscow 119048, Russia. (1 speakers): Alexandra Lebedeva\n\n**SA (1 institutions, 1 speakers)**\n  - National Cancer Centre Singapore, Singapore, Singapore. (1 speakers): Johan Chan\n\n**Saudi Arabia (1 institutions, 1 speakers)**\n  - School of Physics, University College Dublin, Belfield, Dublin 4, Ireland. (1 speakers): Ahmed Alanazi\n\n**Singapore (2 institutions, 2 speakers)**\n  -  (1 speakers): Pei Li Stephanie Saw\n  - National University Hospital, Singapore, Singapore. (1 speakers): Kenneth Sooi\n\n**Slovenia (1 institutions, 1 speakers)**\n  - Medical Oncology Department, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia. (1 speakers): Katja Mohorcic\n\n**Spain (42 institutions, 46 speakers)**\n  -  (5 speakers): Edurne Arriola Aperribay, Lucia Navarro Berlanga, Marc Oliva Bernal, Mariam Stephanie Rojas Piedra, Pau Mascaro Baselga\n  - Complejo Hospitalario Universitario de Badajoz, E-06080 Badajoz, Spain. (1 speakers): Alvaro B. Garcia\n  - Departamento de Eléctrica, Electrónica y Telecomunicaciones, Sangolquí 171103, Ecuador. (1 speakers): Kevin Valencia\n  - Department of Ecology and Evolution, Estación Biológica de Doñana (CSIC), Seville, Spain. (1 speakers): Antonio Rueda Lara\n  - Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain. (1 speakers): Laura Mezquita\n  - Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. (1 speakers): Noemi Reguart\n  - Department of Medical Oncology, L'Hospitalet de Llobregat, Barcelona, Spain. (1 speakers): Noelia Vilarino\n  - Department of Medical Oncology, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain. (1 speakers): Elena Elez Fernandez\n  - Department of Medical Oncology, Vall d´Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Barcelona, Spain. (1 speakers): Ilaria Priano\n  - Galdakao University Hospital, Galdakao, Spain. (1 speakers): Amaia Moreno Paul\n  - Guangdong Provincial Key Laboratory of Food Quality and Safety, College of Food Science, South China Agricultural University, China. (1 speakers): Mengxin Zhou\n  - H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (imas12)/Spanish National Cancer Research Center (CNIO), Madrid, Spain. (1 speakers): Jon Zugazagoitia\n  - H12O-CNIO Lung Cancer Clinical Research Unit, Instituto de Investigación Hospital 12 de Octubre (i+12) & Centro Nacional de Investigaciones Oncológicas (CNIO), CIBERONC, UCM, Madrid, Spain. (1 speakers): Luis Paz-Ares\n  - Hospital 12 de Octubre, Madrid, Spain. (1 speakers): Juan Carlos Laguna Montes\n  - Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain. (1 speakers): Maria Jose De Miguel Arroyo\n  - Hospital Universitario Ramon y Cajal, Madrid, Spain. (1 speakers): Miguel Garcia Pardo de Santayana\n  - Hospital Universitario Ramón y Cajal, Spain. (1 speakers): Pilar Garrido Lopez\n  - Hospital Universitario Río Hortega., Oncología Médica, Hospital Universitario Río Hortega. (1 speakers): Paula M. Molina Terron\n  - Hospital Universitario de Araba - Txagorritxu, Araba, Spain. (1 speakers): Mireia Martinez Kareaga\n  - Hospital del Mar Research Institute (IMIM), Barcelona, Spain. (1 speakers): Clara Montagut\n  - Medical Oncology Department, Hospital Clínic-IDIBAPS, Barcelona, Spain. (1 speakers): Alba Moll-Febrer\n  - Medical Oncology Department, University Hospital of Salamanca, Salamanca, Spain. (1 speakers): Luis Posado-Dominguez\n  - Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain. (1 speakers): Pedro Rocha\n  - Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. (1 speakers): Alejandro Garcia Alvarez\n  - Morales Meseguer University Hospital, Murcia, Spain. (1 speakers): Javier Lopez Robles\n  - Navarra Institute for Health Research (IDISNA), Pamplona, Spain. (1 speakers): Ignacio Melero\n  - Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain. (1 speakers): Enriqueta Felip\n  - Pathology Department, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 de Octubre (imas12), CIBERONC, Madrid, Spain. (1 speakers): Fernando Lopez-Rios\n  - Pfizer S.L.U, Alcobendas, Madrid, Spain. maria.montoro@pfizer.com. (1 speakers): Maria Isabel Sanchez Montoro\n  - Preclinical and experimental research in thoracic tumors (PRETT) group, ONCOBELL Program, L'Hospitalet de Llobregat, Spain, Department of Medical Oncology, Institut Català d'Oncologia (1 speakers): Ernest Nadal\n  - Quiron Dexeus University Hospital, Barcelona 08028, Spain, Barcelona 08028, Spain, 3 Medical Oncology Unit, Human Pathology Department, University of Messina, Messina 98122, Italy (1 speakers): Maria Gonzalez Cao\n  - Spanish lung cancer group (Grupo Español de Cancer de Pulmón (GECP)), Barcelona, Spain, Hospital Universitario Alicante, Alicante, Spain. (1 speakers): Bartomeu Massuti Sureda\n  - Thoracic Surgery Department, Hospital de la Santa Creu i Sant Pau and Hospital del Mar, Barcelona, Spain. (1 speakers): Juan Carlos Trujillo\n  - UOMI Cancer Center, Barcelona, Cataluña, Spain. (1 speakers): Santiago Viteri\n  - Universidad Bolivariana de Venezuela, Caracas, Venezuela. (1 speakers): Jose Carlos Benitez Montanez\n  - University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain. (1 speakers): Marina Garcia Gomez\n  - University Hospital of Torrevieja, Alicante, Spain. (1 speakers): Jose Miguel Jurado Garcia\n  - University of Barcelona, Barcelona, Spain. (1 speakers): Daniel Olmo Gonzalez\n  - Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, IOB-Quirón, Barcelona, Spain. (1 speakers): Josep Tabernero\n  - Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. (1 speakers): Rodrigo Dienstmann\n  - Vall d'Hebron Research Institute (VHIR), Barcelona, Spain. (1 speakers): Alejandro Olivares Hernandez\n  - Vall d'Hebron University Hospital, Barcelona, Spain. (1 speakers): Pedro F. Simoes da Rocha\n\n**Surrey (1 institutions, 1 speakers)**\n  - Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, UK. (1 speakers): Angela George\n\n**Sweden (2 institutions, 2 speakers)**\n  -  (1 speakers): Elin Backman-Staelnacke\n  - Department of Oncology-Pathology & Karolinska Comprehensive Cancer Center, Solna, Sweden. (1 speakers): Helena Ullgren\n\n**Switzerland (7 institutions, 7 speakers)**\n  - Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. (1 speakers): Louis C. Gros\n  - Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland. (1 speakers): Laura A. Boos\n  - Department of Medical Oncology, University Hospital Basel, Basel, Switzerland. (1 speakers): Sacha I. Rothschild\n  - Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland. (1 speakers): Michael Weller\n  - Department of Oncology, University Hospital CHUV, Lausanne, Switzerland. (1 speakers): Solange Peters\n  - Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland. (1 speakers): Isabelle Opitz\n  - Oncology and Haematology Department, Bern, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Switzerland. (1 speakers): Sabine Schmid\n\n**TN (1 institutions, 1 speakers)**\n  - Sarah Cannon Research Institute, Nashville, TN. (1 speakers): Melissa L. Johnson\n\n**TO (1 institutions, 1 speakers)**\n  - Department of Oncology, University of Torino, San Luigi Gonzaga University Hospital, Orbassano, Italy. (1 speakers): Paolo Bironzo\n\n**Taiwan (7 institutions, 7 speakers)**\n  -  (1 speakers): Pie-Hsin Chen\n  - City University of Hong Kong, 518057, P. R. China. (1 speakers): Yang Yao Ren\n  - Department of Nursing, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan, Research Center in Nursing Clinical Practice, Wan Fang Hospital, Taipei Medical University, Taipei 11696 (1 speakers): Mei Fen Tang\n  - Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan. (1 speakers): Shao-Lun Lu\n  - Institute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, Taipei, Taiwan. (1 speakers): Pei-Hsing Chen\n  - National Taiwan University Cancer Center and National Taiwan University Hospital, Taipei, Taiwan. (1 speakers): James Chih-Hsin Yang\n  - School of Medicine, College of Medicine, National Yang Ming Chiao Tung University Taipei, Taiwan. (1 speakers): Chia-I Shen\n\n**Thailand (1 institutions, 1 speakers)**\n  - Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. (1 speakers): Narumol Trachu\n\n**Tunisia (1 institutions, 1 speakers)**\n  - Medical Oncology Department SOMA, Abderrahmen Mami Hospital, Ariana, Tunisia, Tunis El Manar University, Tunis. (1 speakers): Nesrine Mejri\n\n**Turkey (6 institutions, 6 speakers)**\n  - Clinic of Medical Oncology, Faculty of Medicine, Necmettin Erbakan University, Konya 42090, Turkey. (1 speakers): Ahmet Oruc\n  - Department of Medical Oncology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey. (1 speakers): Furkan Ceylan\n  - Department of Urology, Haseki Training and Research Hospital, Istanbul, Turkey. (1 speakers): Oguzhan Yildiz\n  - Faculty of Pharmacy, Department of Clinical Pharmacy, 113886Hacettepe University, Ankara, Turkey. (1 speakers): Esin Aysel Kandemir\n  - Istanbul Technical University, Istanbul 34469, Turkey. (1 speakers): Onur O. Arslan\n  - Medical Oncology Department, Etlik City Hospital, Ankara, Turkey. (1 speakers): Kadriye Baskurt\n\n**Ukraine (1 institutions, 1 speakers)**\n  - Institute of Molecular Biology and Genetics NASU, Kyiv, Ukraine. (1 speakers): Denys Kozakov\n\n**United Kingdom (24 institutions, 25 speakers)**\n  -  (2 speakers): Gini Harrison, Matthew Beggs\n  - Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. (1 speakers): Wing Kin Liu\n  - Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK, Pre-Cancer Immunology Laboratory (1 speakers): James L. Reading\n  - Cancer Research UK Manchester Institute, Manchester M20 4BX, UK. R.M. is also in the Faculty of Biology, Medicine and Health, The University of Manchester. (1 speakers): Rebecca J. Lee\n  - Centre for Trials Research, Cardiff University, Cardiff, UK. (1 speakers): Magdalena Meissner\n  - Department of Infectious Diseases and Immunity, Faculty of Medicine and Wellcome Trust Centre for Clinical Tropical Medicine, Imperial College, Hammersmith Hospital, London, UK. (1 speakers): Jasim Uddin\n  - Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK, Division of Cancer Sciences, The University of Manchester, Manchester, UK. (1 speakers): Fiona Blackhall\n  - Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Ana Sofia D. Parreira\n  - Department of Radiotherapy Related Research, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. (1 speakers): Corinne Faivre-Finn\n  - Department of Surgery, Leiden University Medical Center, Albinusdreef 2, Leiden (1 speakers): Tessa P. Sandberg\n  - Department of Thoracic Surgery, Clinic for Thoracic Surgery, Institute for Pulmonary Diseases of Vojvodina, University of Novi Sad. (1 speakers): Debra Montague\n  - Department of Vascular Surgery, York & Scarborough Teaching Hospitals NHS Trust, York, UK. (1 speakers): Andrew Thompson\n  - Division of Cancer Sciences, The University of Manchester and Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Matthew G. Krebs\n  - King's College Hospital NHS Foundation Trust, King's College Hospital, London SE5 9RS, UK. (1 speakers): Sharmistha Ghosh\n  - Nuffield Department of Surgical Sciences, University of Oxford, Oxford (1 speakers): Elysia Upton\n  - Rome, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Federico Monaca\n  - Royal Marsden Hospital, London SW3 6JJ, UK. (1 speakers): Sheela Rao\n  - The Christie Hospital NHS Trust, Manchester University NHS Foundation Trust, Manchester, UK. (1 speakers): Yvonne Summers\n  - The Royal Marsden Hospital and The Institute of Cancer Research, Sutton (1 speakers): Anna R. Minchom\n  - The Royal Marsden Hospital, London, UK. (1 speakers): Sanjay Popat\n  - The University of Manchester, Manchester, United Kingdom. (1 speakers): Colin R R. Lindsay\n  - Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. (1 speakers): Debra Josephs\n  - University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. (1 speakers): Philippe Taniere\n  - University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK. (1 speakers): Eleanor Wheeler\n\n**United States of America (64 institutions, 65 speakers)**\n  - . Hospital de Clínicas de Porto Alegre, Faculdade de Medicina, Brasil. (1 speakers): Wallace Klein Schwengber\n  - 1Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (1 speakers): David S. Hong\n  - Abramson Cancer Center, University of Pennsylvania, Philadelphia. (1 speakers): Charu Aggarwal\n  - Atlanta, GA. (1 speakers): Kenneth W. Culver\n  - CA, USA. (1 speakers): Jelena Levi\n  - Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY (1 speakers): Yonina R. Murciano-Goroff\n  - Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. (1 speakers): Jacob Sands\n  - Department of Bioengineering, McGill University, Montreal, QC, Canada. (1 speakers): Nikolaos M. Dimitriou\n  - Department of Cancer Biology and Genetics, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, NY 10065. (1 speakers): Ram Kannan\n  - Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Calgary, AB T2N 5G2, Canada. (1 speakers): Lin Yang\n  - Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Scott Kopetz\n  - Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. (1 speakers): Van Morris\n  - Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. (1 speakers): Hossein Borghaei\n  - Department of Hematology/Oncology, Yale New Haven Hospital, CT, USA. (1 speakers): Amin Nassar\n  - Department of Internal Medicine, University of Chicago, KCBD 7114, Chicago, IL 60637, USA. (1 speakers): Sulin Wu\n  - Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX. (1 speakers): Rodney E. Infante\n  - Department of Internal Medicine, Yale New Haven Hospital, CT 06504, USA. (1 speakers): Ashish Sharma\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. (1 speakers): Himisha Beltran\n  - Department of Medical Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. (1 speakers): Julia Rotow\n  - Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, NY, USA. (1 speakers): Neil H. Segal\n  - Department of Medical Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA. (1 speakers): Balazs Halmos\n  - Department of Medicine (Medical Oncology), Yale School of Medicine and Yale Cancer Center, CT (1 speakers): Anne C. Chiang\n  - Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN. (1 speakers): Christine M. Lovly\n  - Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, CA. (1 speakers): Edward B. Garon\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY. (2 speakers): Alissa J. Cooper, James J. Harding\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, USA. (1 speakers): Jamie Chaft\n  - Department of Medicine, New York University Langone Perlmutter Cancer Center, USA. (1 speakers): Elaine Shum\n  - Department of Medicine, the University of Chicago, Chicago, IL, USA. (1 speakers): Marina C. Garassino\n  - Department of Molecular Medicine, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea. (1 speakers): Seung-Hoon Lee\n  - Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, NY 10029, USA, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NY 10029 (1 speakers): Triparna Sen\n  - Department of Pathology, Memorial Sloan Kettering Cancer Center, NY, USA. (1 speakers): Chad M. Vanderbilt\n  - Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. (1 speakers): Wei Zhong\n  - Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Yasir Y. Elamin\n  - Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): John Heymach\n  - Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. (1 speakers): Carl M. Gay\n  - Division of Hematology and Medical Oncology, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL (1 speakers): Shenduo Li\n  - Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA (1 speakers): Melina E. Marmarelis\n  - Division of Hematology and Oncology, The Warren Alpert Medical School of Brown University, Providence, RI, USA. (1 speakers): Hina Khan\n  - Division of Hematology/Oncology/Stem cell transplant Rush University Medical Center Chicago IL. (1 speakers): Mary J. Fidler\n  - Division of Medical Oncology, Department of Medicine, University of Kentucky, Lexington, KY, USA. (1 speakers): Zhonglin Hao\n  - Division of Thoracic Surgery, Department of Surgery, University of California (1 speakers): Jay M. Lee\n  - Dr. Panjwani Center for Molecular Medicine and Drug Research, ICCBS, University of Karachi, Karachi, Pakistan. (1 speakers): Faiza Chaudhary\n  - Duke Cancer Institute, Duke University, Durham, NC, USA. (1 speakers): John H. Strickler\n  - Edinburgh Cancer Research, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK. (1 speakers): Muhammad Furqan\n  - Flatiron Health, NY, USA. (1 speakers): Cheryl Cho-Phan\n  - From Dana-Farber Cancer Institute (M.M.A., S.L., J.D., J.O.J., K.E.L., H.F., K.M.H., B.M.W., P.A.J., A.J.A.), Massachusetts General Hospital (R.S.H., Y.P.H.), and Brigham and Women's Hospital (L.M.S. (1 speakers): Kathryn C. Arbour\n  - Greehey Children's Cancer Research Institute, UT Health San Antonio, TX, USA. (1 speakers): Aparna Gorthi\n  - HOAG Family Cancer Institute, CA, USA. (1 speakers): Chaitali Nangia\n  - Hospital for Special Surgery, NY 10021, USA. (1 speakers): Junho Song\n  - Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, NY, USA. (1 speakers): Salman Punekar\n  - Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia. (1 speakers): Stephen V. Liu\n  - Mass General Cancer Center, Boston, MA, USA. (1 speakers): Jessica J. Lin\n  - Massachusetts General Hospital Cancer Center, Boston, MA, USA. (1 speakers): Zofia Piotrowska\n  - Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA. (1 speakers): Zouina Sarfraz\n  - Northwest Medical Specialties, Seattle, WA. (1 speakers): Sibel Blau\n  - Sarah Cannon Research Institute, Nashville, TN (1 speakers): Manish R. Patel\n  - Stratingh Institute for Chemistry, University of Groningen, Nijenborgh 4, AG Groningen (1 speakers): Hangyul Lee\n  - Tegucigalpa, Honduras, USA. (1 speakers): MIchael Galo\n  - The Second Clinical Medical College of Guangzhou University of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, PR China (1 speakers): Lina Ding\n  - The University of Texas MD Anderson Cancer Center, Houston, TX (1 speakers): Xiuning Le\n  - The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. (1 speakers): Jordi Rodon\n  - Virginia Cancer Specialists, Fairfax, VA, USA. (1 speakers): Alexander I. Spira\n  - Winship Cancer Institute of Emory University, Atlanta, Georgia, USA. (1 speakers): Ticiana A. Leal\n  - Yale New Haven Hospital, CT, USA. (1 speakers): Michael Cecchini\n\n**VIC (2 institutions, 2 speakers)**\n  - Department of Medical Oncology, Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore. (1 speakers): Puey Ling Chia\n  - Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. (1 speakers): Ben J. Solomon"
  },
  "colorectal_cancer": {
    "top_institutions": {
      "columns": [
        "Institution",
        "# Studies",
        "Locations"
      ],
      "rows": [
        {
          "Institution": "MD Anderson Cancer Center, Houston",
          "# Studies": 9,
          "Locations": "Houston, United States of America, Houston, United States of America, TX"
        },
        {
          "Institution": "National Cancer Center Hospital East",
          "# Studies": 7,
          "Locations": "Kashiwa, Japan, Minato-ku, Japan, Kashiwa, Japan, Chiba"
        },
        {
          "Institution": "Medical Oncology Department",
          "# Studies": 5,
          "Locations": "L'Hospitalet de Llobregat, Spain, Ankara, Turkey, Porto, Portugal"
        },
        {
          "Institution": "Royal Marsden Hospital",
          "# Studies": 5,
          "Locations": "London, United Kingdom"
        },
        {
          "Institution": "University Medical Center Utrecht",
          "# Studies": 4,
          "Locations": "Utrecht, Netherlands"
        },
        {
          "Institution": "University of Pisa",
          "# Studies": 4,
          "Locations": "Pisa, Italy"
        },
        {
          "Institution": "Wellcome-MRC Institute of Metabolic Science",
          "# Studies": 3,
          "Locations": "Lisbon, Portugal"
        },
        {
          "Institution": "Norris Comprehensive Cancer Center",
          "# Studies": 3,
          "Locations": "Los Angeles, United States of America, CA"
        },
        {
          "Institution": "Department of Gastroenterological Surgery",
          "# Studies": 3,
          "Locations": "Nishinomiya, Japan"
        },
        {
          "Institution": "Charité-Universitätsmedizin Berlin",
          "# Studies": 3,
          "Locations": "Freudenstadt, Germany, Berlin, Germany"
        },
        {
          "Institution": "Fudan University Shanghai Cancer Center",
          "# Studies": 3,
          "Locations": "Shanghai, China"
        },
        {
          "Institution": "Department of General Surgery",
          "# Studies": 3,
          "Locations": "Guangzhou, China, Madrid, Spain"
        },
        {
          "Institution": "AC Camargo Cancer Center",
          "# Studies": 2,
          "Locations": "Sao Paulo, Brazil"
        },
        {
          "Institution": "Gastrointestinal Research Unit",
          "# Studies": 2,
          "Locations": "Rochester, United States of America, MN"
        },
        {
          "Institution": "Helsinki University Hospital and University of Helsinki",
          "# Studies": 2,
          "Locations": "Turku, Finland"
        },
        {
          "Institution": "Medical Oncology Unit",
          "# Studies": 2,
          "Locations": "Monserrato, Italy, Viterbo, Italy"
        },
        {
          "Institution": "Leeds Institute of Medical Research at St James's",
          "# Studies": 2,
          "Locations": "Leeds, United Kingdom, Yorkshire"
        },
        {
          "Institution": "Sorbonne University and Department of Medical Oncology",
          "# Studies": 2,
          "Locations": "Paris, France"
        },
        {
          "Institution": "Veneto Institute of Oncology IOV-IRCCS",
          "# Studies": 2,
          "Locations": "Padua, Italy"
        },
        {
          "Institution": "West German Cancer Center",
          "# Studies": 2,
          "Locations": "Essen, Germany"
        },
        {
          "Institution": "University Hospital Heidelberg",
          "# Studies": 2,
          "Locations": "Heidelberg, Germany, Amsterdam, Netherlands"
        },
        {
          "Institution": "Sun Yat-sen University Cancer Center",
          "# Studies": 2,
          "Locations": "Guangzhou, China"
        },
        {
          "Institution": "Department of Colorectal Surgery",
          "# Studies": 2,
          "Locations": "Shanghai, China"
        },
        {
          "Institution": "Cell and Matrix Research Institute",
          "# Studies": 1,
          "Locations": "Rockville, United States of America"
        },
        {
          "Institution": "College of Medicine and Public Health",
          "# Studies": 1,
          "Locations": "Bedford Park, Australia, South Australia"
        },
        {
          "Institution": "Department of Internal Medicine",
          "# Studies": 1,
          "Locations": "Seoul, Republic of Korea"
        },
        {
          "Institution": "Department of Surgery National Hospital Organization Osaka National Hospital Osaka Japan.",
          "# Studies": 1,
          "Locations": "Osaka, Japan"
        },
        {
          "Institution": "Central Clinical Hospital of the Russian Academy of Sciences",
          "# Studies": 1,
          "Locations": "Moscow, Russian Federation"
        },
        {
          "Institution": "City of Hope Comprehensive Cancer Center",
          "# Studies": 1,
          "Locations": "Duarte, United States of America, CA"
        },
        {
          "Institution": "Cleveland Clinic",
          "# Studies": 1,
          "Locations": "Cleveland, United States of America"
        }
      ]
    },
    "table_context": "**TOP INSTITUTIONS TABLE:**\n| Institution                                                                               |   # Studies | Locations                                                                |\n|:------------------------------------------------------------------------------------------|------------:|:-------------------------------------------------------------------------|\n| MD Anderson Cancer Center, Houston                                                        |           9 | Houston, United States of America, Houston, United States of America, TX |\n| National Cancer Center Hospital East                                                      |           7 | Kashiwa, Japan, Minato-ku, Japan, Kashiwa, Japan, Chiba                  |\n| Medical Oncology Department                                                               |           5 | L'Hospitalet de Llobregat, Spain, Ankara, Turkey, Porto, Portugal        |\n| Royal Marsden Hospital                                                                    |           5 | London, United Kingdom                                                   |\n| University Medical Center Utrecht                                                         |           4 | Utrecht, Netherlands                                                     |\n| University of Pisa                                                                        |           4 | Pisa, Italy                                                              |\n| Wellcome-MRC Institute of Metabolic Science                                               |           3 | Lisbon, Portugal                                                         |\n| Norris Comprehensive Cancer Center                                                        |           3 | Los Angeles, United States of America, CA                                |\n| Department of Gastroenterological Surgery                                                 |           3 | Nishinomiya, Japan                                                       |\n| Charité-Universitätsmedizin Berlin                                                        |           3 | Freudenstadt, Germany, Berlin, Germany                                   |\n| Fudan University Shanghai Cancer Center                                                   |           3 | Shanghai, China                                                          |\n| Department of General Surgery                                                             |           3 | Guangzhou, China, Madrid, Spain                                          |\n| AC Camargo Cancer Center                                                                  |           2 | Sao Paulo, Brazil                                                        |\n| Gastrointestinal Research Unit                                                            |           2 | Rochester, United States of America, MN                                  |\n| Helsinki University Hospital and University of Helsinki                                   |           2 | Turku, Finland                                                           |\n| Medical Oncology Unit                                                                     |           2 | Monserrato, Italy, Viterbo, Italy                                        |\n| Leeds Institute of Medical Research at St James's                                         |           2 | Leeds, United Kingdom, Yorkshire                                         |\n| Sorbonne University and Department of Medical Oncology                                    |           2 | Paris, France                                                            |\n| Veneto Institute of Oncology IOV-IRCCS                                                    |           2 | Padua, Italy                                                             |\n| West German Cancer Center                                                                 |           2 | Essen, Germany                                                           |\n| University Hospital Heidelberg                                                            |           2 | Heidelberg, Germany, Amsterdam, Netherlands                              |\n| Sun Yat-sen University Cancer Center                                                      |           2 | Guangzhou, China                                                         |\n| Department of Colorectal Surgery                                                          |           2 | Shanghai, China                                                          |\n| Cell and Matrix Research Institute                                                        |           1 | Rockville, United States of America                                      |\n| College of Medicine and Public Health                                                     |           1 | Bedford Park, Australia, South Australia                                 |\n| Department of Internal Medicine                                                           |           1 | Seoul, Republic of Korea                                                 |\n| Department of Surgery National Hospital Organization Osaka National Hospital Osaka Japan. |           1 | Osaka, Japan                                                             |\n| Central Clinical Hospital of the Russian Academy of Sciences                              |           1 | Moscow, Russian Federation                                               |\n| City of Hope Comprehensive Cancer Center                                                  |           1 | Duarte, United States of America, CA                                     |\n| Cleveland Clinic                                                                          |           1 | Cleveland, United States of America                                      |\n\n**ENRICHED INSTITUTION PROFILES (Top 10 with ClinicalTrials.gov Data):**\n\n\n**MD Anderson Cancer Center, Houston**\n  - ESMO 2025 Presentations: 9\n  - Clinical Trials (2015-2025): 1 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT04090060](https://clinicaltrials.gov/study/NCT04090060): The Prevent Anal Cancer Palpation Study (NA, COMPLETED, Started 2020)\n  - Relevant to EMD Serono/Merck KGaA: None identified in ClinicalTrials.gov (2015-2025)\n  - Key Presenters at ESMO 2025 (10 total):\n    * Van Morris  - : Can we improve drug development in colorectal cancer? Turning failure into success (10/18/2025, 09:30 - 09:50, Hanover Auditorium - Hall 7.2c)\n    * David S. Hong  - 743P: Combined analysis of overall survival (OS) from the phase 3 CodeBreaK 300 and phase 1b CodeBreaK 101 studies of sotorasib 960 mg plus panitumumab (soto960+pani) therapy for chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC) (10/19/2025, 12-13:00, Hall 25)\n    * Denise Langabeer  - 893eP: Boarding time as a predictor of short-term mortality in colorectal cancer patients visiting the emergency department (10/19/2025, 12-13:00, Hall 25)\n    * Kanwal Raghav  - 737MO: Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-positive (HER2+) metastatic colorectal cancer (mCRC): final analysis of DESTINY-CRC02, a randomized, phase 2 trial (10/19/2025, 15:15 - 15:35, Cologne Auditorium - CityCube A)\n    * Michael LaPelusa  - 909eTiP: Open-label phase 2 trial of AMB-05X for patients with ctDNA(+) colorectal cancer after curative-intent treatment (10/19/2025, 12-13:00, Hall 25)\n    * ... and 5 more presenters\n\n\n**National Cancer Center Hospital East**\n  - ESMO 2025 Presentations: 7\n  - Clinical Trials (2015-2025): 5 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT05646511](https://clinicaltrials.gov/study/NCT05646511): TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer (PHASE3, RECRUITING, Started 2022)\n    * [NCT04457297](https://clinicaltrials.gov/study/NCT04457297): Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection (PHASE3, UNKNOWN, Started 2020)\n    * [NCT04288999](https://clinicaltrials.gov/study/NCT04288999): Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer (PHASE3, RECRUITING, Started 2019)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT02948348](https://clinicaltrials.gov/study/NCT02948348): Study to Nivolumab Following Preoperative Chemoradiotherapy (PHASE1, UNKNOWN, Started 2016) [COMPETITOR]\n    * [NCT02851004](https://clinicaltrials.gov/study/NCT02851004): Special Combination of BBI608 and Pembrolizumab (PHASE1, TERMINATED, Started 2016) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (8 total):\n    * Hideaki Bando  - 777P: Spatial transcriptomic dynamics of the tumor microenvironment after chemoradiotherapy followed by immune checkpoint blockade in locally advanced rectal cancer: A translational study from VOLTAGE trial (10/19/2025, 12-13:00, Hall 25)\n    * Kazumasa Yamamoto  - 825P: Chronological Changes in Clinical Outcomes of Standard First-Line Oxaliplatin-Based Chemotherapy + Targeted Agents for Metastatic Colorectal Cancer: Updated Analysis of the ARCAD Database (10/19/2025, 12-13:00, Hall 25)\n    * Mitsuho Imai  - 808P: Spatial Transcriptomics (ST) Reveals Tumor Microenvironment (TME) Heterogeneity and Resistance Mechanisms to HER2 Inhibition in HER2-positive (HER2+) Metastatic Colorectal Cancer (CRC) (10/19/2025, 12-13:00, Hall 25)\n    * Shin Kobayashi  - 768P: Survival and benefit of adjuvant chemotherapy (ACT) by circulating tumor DNA (ctDNA)-based pretreatment genomic profile and postoperative molecular residual disease (MRD) in resectable colorectal oligometastases (CRM): PRECISION, a prospective multicenter study (10/19/2025, 12-13:00, Hall 25)\n    * Tadayoshi Hashimoto  - 767P: Analysis of baseline alterations and ctDNA to predict colorectal cancer recurrence (10/19/2025, 12-13:00, Hall 25)\n    * ... and 3 more presenters\n\n\n**Medical Oncology Department**\n  - ESMO 2025 Presentations: 5\n  - Clinical Trials (2015-2025): 2 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06940947](https://clinicaltrials.gov/study/NCT06940947): Endoscopic Therapy Or Surgery for Early Colon Cancer (PHASE3, NOT_YET_RECRUITING, Started 2025)\n    * [NCT06057350](https://clinicaltrials.gov/study/NCT06057350): Surgery Versus Endoscopic Resection for Incompletely Removed Early Colon CAnceR (NA, RECRUITING, Started 2023)\n  - Relevant to EMD Serono/Merck KGaA: None identified in ClinicalTrials.gov (2015-2025)\n  - Key Presenters at ESMO 2025 (5 total):\n    * Cristina Santos Vivas  - 849P: : Pro-inflammatory Immune Cell Infiltration (ICI) Predicts Survival in Stage II Colorectal Cancer (CRC) Independently of  Consensus Molecular Subtype (CMS) classification (10/19/2025, 12-13:00, Hall 25)\n    * Galip Can Uyar  - 2881P: Integrating Inflammatory, Nutritional, and Sarcopenia-Based Biomarkers for Predicting Pathological Response in Rectal Cancer Patients Receiving Total Neoadjuvant Therapy: A Regression and AI-Supported Approach (10/19/2025, 12-13:00, Hall 25)\n    * Maria Joao Oura  - 890eP: Trifluridine-Tipiracil with or without Bevacizumab: what's the benefit in real world experience for metastatic colorectal cancer? (10/19/2025, 12-13:00, Hall 25)\n    * Ruth Vera Garcia  - 789P: Characterization of locally advanced rectal cancer (LARC) patients (pt) in Spanish TTD-RETUD registry (10/19/2025, 12-13:00, Hall 25)\n    * Nadia Hitchen  - 1772eP: Clinical Performance of a Blood-only, Targeted Methylation Circulating Tumor DNA (ctDNA) Assay for Minimal Residual Disease (MRD) Detection in Colorectal Cancer (CRC) (10/20/2025, 12-13:00, Hall 25)\n\n\n**Royal Marsden Hospital**\n  - ESMO 2025 Presentations: 5\n  - Clinical Trials (2015-2025): 1 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT04075305](https://clinicaltrials.gov/study/NCT04075305): The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (Phase Not Specified, UNKNOWN, Started 2019)\n  - Relevant to EMD Serono/Merck KGaA: None identified in ClinicalTrials.gov (2015-2025)\n  - Key Presenters at ESMO 2025 (6 total):\n    * Naureen Starling  - : The promise of liquid biopsy in CRC: A road from early detection to disease monitoring (10/18/2025, 08:30 - 08:50, Hanover Auditorium - Hall 7.2c)\n    * Nina Tunariu  - 1009eP: First-in-Human Study of Acoustic Cluster Therapy consisting of PS101 combined with Chemotherapy and insonation in Patients with Liver Metastases of Colorectal Cancer Origin (10/19/2025, 12-13:00, Hall 25)\n    * Sheela Rao  - : Introduction and welcome (10/20/2025, 18:30 - 20:00, Essen Auditorium - Hall 7.2a)\n    * Sheela Rao  - : Immunotherapy and beyond: The evolving treatment landscape in advanced anal cancer (10/20/2025, 18:30 - 20:00, Essen Auditorium - Hall 7.2a)\n    * Sheela Rao  - : Present and future targets in CRC: Focus on KRAS and TGFbeta (10/20/2025, 18:30 - 20:00, Essen Auditorium - Hall 7.2a)\n    * ... and 1 more presenters\n\n\n**University Medical Center Utrecht**\n  - ESMO 2025 Presentations: 4\n  - Clinical Trials (2015-2025): 4 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT05619614](https://clinicaltrials.gov/study/NCT05619614): The Influence of Artificial Intelligence (AI )Assisted Polyp Detection (Discovery System) on Visual Gaze Patterns During Real-time Colonoscopy (Phase Not Specified, COMPLETED, Started 2024)\n    * [NCT04754672](https://clinicaltrials.gov/study/NCT04754672): Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome (NA, RECRUITING, Started 2021)\n    * [NCT04291976](https://clinicaltrials.gov/study/NCT04291976): Back-to-back Endoscopy Versus Single-pass Endoscopy and Chromoendoscopy in IBD Surveillance (NA, COMPLETED, Started 2020)\n    * [NCT04075305](https://clinicaltrials.gov/study/NCT04075305): The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (Phase Not Specified, UNKNOWN, Started 2019)\n  - Relevant to EMD Serono/Merck KGaA: None identified in ClinicalTrials.gov (2015-2025)\n  - Key Presenters at ESMO 2025 (4 total):\n    * Jeanine Roodhart  - 872eP: Identifying fit-for-use real-world data (RWD) to benchmark complete clinical response at 12 months (cCR12) in the AZUR-1 clinical trial in dMMR/MSI-H locally advanced rectal cancer (LARC) (10/19/2025, 12-13:00, Hall 25)\n    * Jeanine Roodhart  - 2921eP: Adherence and safety of a medical oral nutrition supplement in metastatic colorectal cancer patients receiving first line treatment: main findings of the NUTRACT trial (10/19/2025, 12-13:00, Hall 25)\n    * Renee A. Lunenberg  - 897eP: Patient-reported quality of life after treatment with chemoradiation in patients with non-metastatic anal squamous cell carcinoma (10/19/2025, 12-13:00, Hall 25)\n    * Marie-Christine E. Bakker  - 726O: Prognostic value of the Combined Analysis of Pathologists and Artificial Intelligence (CAPAI) in high-risk stage II-III colon cancer treated without chemotherapy: interim report from a nationwide validation (10/20/2025, 16:40 - 16:50, Munich Auditorium - CityCube B)\n\n\n**University of Pisa**\n  - ESMO 2025 Presentations: 4\n  - Clinical Trials (2015-2025): 4 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06950996](https://clinicaltrials.gov/study/NCT06950996): A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum (Phase Not Specified, COMPLETED, Started 2024)\n    * [NCT03668418](https://clinicaltrials.gov/study/NCT03668418): Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos (Phase Not Specified, UNKNOWN, Started 2018)\n    * [NCT03391232](https://clinicaltrials.gov/study/NCT03391232): PolyPEPI1018 Vaccine and CDx for the Treatment of Metastatic Colorectal Cancer (OBERTO) (PHASE1, COMPLETED, Started 2018)\n    * [NCT04122937](https://clinicaltrials.gov/study/NCT04122937): Defining Inflammation Related to Peritoneal Carcinomatosis in Women With Ovarian or Colon Cancer. (Phase Not Specified, COMPLETED, Started 2017)\n  - Relevant to EMD Serono/Merck KGaA: None identified in ClinicalTrials.gov (2015-2025)\n  - Key Presenters at ESMO 2025 (5 total):\n    * Marco Maria M. Germani  - LBA32: Panitumumab retreatment followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA (ctDNA): Final results of the randomized PARERE trial by GONO (10/18/2025, 15:35 - 15:45, Hamburg Auditorium - CityCube A)\n    * Ada Taravella  - 745P: Estimating the clinical benefit of the secondary resection of metastases in liver-limited metastatic colorectal cancer: an individual patient data-based pooled analysis of nine randomized trials. (10/19/2025, 12-13:00, Hall 25)\n    * Chiara Cremolini  - : Immunotherapy in MSS/pMMR colorectal cancer: Lessons learned (10/19/2025, 08:45 - 09:00, Hamburg Auditorium - CityCube A)\n    * Veronica Conca  - 730MO: Trifluridine/Tipiracil in combination with Capecitabine and Bevacizumab as upfront treatment for metastatic colorectal cancer: first results of the phase II TriComB study by GONO (10/19/2025, 16:00 - 16:05, Cologne Auditorium - CityCube A)\n    * Carlotta Antoniotti  - : Presentation of case/condition (10/20/2025, 10:15 - 10:20, Bremen Auditorium - Hall 6.2)\n\n\n**Wellcome-MRC Institute of Metabolic Science**\n  - ESMO 2025 Presentations: 3\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (3 total):\n    * Ana Rita Dias  - : Opening remarks (10/20/2025, 12:00 - 12:05, Oldenburg Auditorium - Hall 5.1)\n    * Ana Rita Dias  - : Q&A & discussion (10/20/2025, 13:00 - 13:25, Oldenburg Auditorium - Hall 5.1)\n    * Ana Rita Dias  - : Conclusion remarks (10/20/2025, 13:25 - 13:30, Oldenburg Auditorium - Hall 5.1)\n\n\n**Norris Comprehensive Cancer Center**\n  - ESMO 2025 Presentations: 3\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (3 total):\n    * Heinz Josef Lenz  - : MSI-H/dMMR CRC in Practice: Translating Clinical Advances Through Real-World Cases (10/17/2025, 10:15 - 11:45, Bremen Auditorium - Hall 6.2)\n    * Heinz Josef Lenz  - : Audience Q&A (10/17/2025, 10:15 - 11:45, Bremen Auditorium - Hall 6.2)\n    * Heinz Josef Lenz  - 841P: Phase 1/2 dose-escalation study evaluating ginisortamab (UCB6114), an anti-gremlin-1 monoclonal antibody (mAb) with first-in-class potential, in combination with 5-fluorouracil, leucovorin and oxaliplatin (mFOLFOX6) in advanced solid tumours (10/19/2025, 12-13:00, Hall 25)\n\n\n**Department of Gastroenterological Surgery**\n  - ESMO 2025 Presentations: 3\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (4 total):\n    * Kozo Kataoka  - 817P: Negative Hyperselection by DNA Methylation Status for First-Line anti-EGFR Therapy in Patients with Right-Sided Metastatic Colorectal Cancer (10/19/2025, 12-13:00, Hall 25)\n    * Kozo Kataoka  - 823P: A Phase II Study of mFOLFOXIRI Following Metastasectomy in Oligometastatic Colorectal Cancer: (FANTASTIC) (10/19/2025, 12-13:00, Hall 25)\n    * Ryoma Yokoi  - 829P: Transcriptomic-Based Prediction of Therapeutic Response in Metastatic RAS-Mutant Colorectal Cancer (10/19/2025, 12-13:00, Hall 25)\n    * Yuko Fukumoto  - 846P: Dynamics of Acquired RAS, BRAF, and PIK3CA Mutations in Metastatic Colorectal Cancer Patients Treated with Anti-EGFR Monoclonal Antibodies via Longitudinal ctDNA Analysis (RAS trace) (10/19/2025, 12-13:00, Hall 25)\n\n\n**Charité-Universitätsmedizin Berlin**\n  - ESMO 2025 Presentations: 3\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (3 total):\n    * Andrey Mitroshkin  - 848P: Treatment pathways and efficacy outcomes of patients with metastatic colorectal cancer (mCRC): a real-world prospective, longitudinal, cohort study (PROMETCO) (10/19/2025, 12-13:00, Hall 25)\n    * Sebastian Stintzing  - 835P: Effectiveness and quality of life in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma treated with encorafenib plus cetuximab - data from the European multi-centric, multi-national, non-interventional study - BERING CRC (10/19/2025, 12-13:00, Hall 25)\n    * Sebastian Stintzing  - 908eTiP: Phase 1b/2 study of arfolitixorin in combination with 5-fluorouracil (5FU), oxaliplatin, and bevacizumab as first-line therapy for metastatic colorectal cancer (mCRC) (10/19/2025, 12-13:00, Hall 25)\n\n\n**COMPLETE SPEAKER DIRECTORY BY GEOGRAPHY:**\n\n\n** (1 institutions, 1 speakers)**\n  -  (1 speakers): \n\n**Australia (6 institutions, 6 speakers)**\n  - Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Central Adelaide Local Health Network, Adelaide, SA 5011, Australia. (1 speakers): Timothy J. Price\n  - Cabrini Health, Malvern, Australia. (1 speakers): Shehara R. Mendis\n  - Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia. (1 speakers): Ye Kyaw Aung\n  - Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. (1 speakers): Nadia Hitchen\n  - NHMRC Clinical Trials Centre, University of Sydney, Australia. (1 speakers): John Simes\n  - School of Biomedical Science and Pharmacy, University of Newcastle, Newcastle, Australia. (1 speakers): Darren Shafren\n\n**Belgium (1 institutions, 1 speakers)**\n  - Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, Belgium. (1 speakers): Oliver E. Bechter\n\n**Brazil (2 institutions, 2 speakers)**\n  - AC Camargo Cancer Center, São Paulo 01509-900, Brazil. (1 speakers): Marcos Camandaroba\n  - Department of Clinical Oncology, AC Camargo Cancer Center, São Paulo, Brazil. (1 speakers): Rachel Riechelmann\n\n**British Columbia (1 institutions, 1 speakers)**\n  - Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. (1 speakers): Sharlene Gill\n\n**CA (2 institutions, 2 speakers)**\n  - Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA (1 speakers): Marwan Fakih\n  - Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, CA, USA. (1 speakers): Heinz Josef Lenz\n\n**CEDEX (1 institutions, 1 speakers)**\n  - Department of Gastroenterology and Hepatology, Poitiers University Hospital, France. (1 speakers): David Tougeron\n\n**Canada (1 institutions, 1 speakers)**\n  - Faculty of Medicine, King Saud Bin Abdul-Aziz University for Health Sciences (KSAU-HS), King Fahad Medical City, Riyadh (1 speakers): Anas A. Alghamdi\n\n**Chiba (1 institutions, 1 speakers)**\n  - Department of Hepato-Biliary-Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. (1 speakers): Shin Kobayashi\n\n**China (38 institutions, 40 speakers)**\n  -  (2 speakers): Guingying Wang, Xie Jiaxin\n  - Department of Anorectal Surgery, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. (1 speakers): Qingming Wang\n  - Department of Cancer Screening and Prevention, Zhongshan Hospital, Fudan University, Shanghai, China, Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China (1 speakers): Tianshu Liu\n  - Department of Colorectal Surgery, Cancer Hospital Chinese Academy of Medical Sciences, Beijing 100021, China. (1 speakers): Xu Guan\n  - Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, PR China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, Shanghai, PR China. (1 speakers): Guoxiang Cai\n  - Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032 (1 speakers): Xinxiang Li\n  - Department of Colorectal Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. (1 speakers): Weifeng Lao\n  - Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Jing-Hua Tang\n  - Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China. (1 speakers): Pei-Rong Ding\n  - Department of Endocrinology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, People's Republic of China. (1 speakers): Ting Wang\n  - Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, P.R. China. (1 speakers): Ning Zhao\n  - Department of Gastroenterology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China. Electronic address: ndefy20358@ncu.edu.cn. (1 speakers): Lingling Yang\n  - Department of Gastrointestinal Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China. (1 speakers): Jianping Zhou\n  - Department of General Surgery, Department of Colorectal Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. (1 speakers): Wentao Tang\n  - Department of Medical Oncology, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China (2 speakers): RunKai Cai, Weixiang Zhan\n  - Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. (1 speakers): Fei Tian\n  - Department of Oncology, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou, China. (1 speakers): Hanjue Dai\n  - Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, P. R. China. (1 speakers): Xicheng Wang\n  - Department of Pathology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang (1 speakers): Dan Su\n  - Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Feng Xu\n  - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China (1 speakers): Weiqing Lu\n  - Department of Radiology, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, China. (1 speakers): Menghong Zou\n  - Department of Radiotherapy, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China. (1 speakers): Liangjun Zhu\n  - Department of Spine Surgery, Shanghai East Hospital, Tongji University School of Medicine Shanghai China. (1 speakers): Qian Wang\n  - Department of Surgery, NY 10065, USA, Key Laboratory of Pesticide and Chemical Biology (CCNU), Ministry of Education, College of Chemistry, Central China Normal University, Wuhan, Hubei 430079, China. (1 speakers): Lingling Feng\n  - Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China, Biomedical Innovation Center (1 speakers): Zerong Cai\n  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing (1 speakers): Xi Zhang\n  - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China. (1 speakers): Zheng Liu\n  - Obstetrics & Gynecology Hospital of Fudan University, Shanghai, China. (1 speakers): Panpan Zhang\n  - Pharmaron U.K., Pharmaron UK Ltd., Hoddesdon (1 speakers): Fang He\n  - School of Medicine, Tsinghua University, Beijing, China. (1 speakers): Xiaoshuang Lyu\n  - School of Public Health, Fudan University, Shanghai, People's Republic of China. z_yibiao@hotmail.com. (1 speakers): Yu-Wen Zhou\n  - State Key Laboratory of Tropic Ocean Engineering Materials and Materials Evaluation, School of Materials Science and Engineering, Beihang University, Beijing, P. R. China. (1 speakers): Liwei Fan\n  - University of Chinese Academy of Sciences, Beijing, China. (1 speakers): Dan Liu\n  - University of Western Australia, Western Australia 6009, Australia. (1 speakers): Chung B. Zhao\n  - Xiangya Stomatological Hospital, Changsha 410008, China. liwenj@csu.edu.cn. (1 speakers): Wenjie W. Li\n  - Zhejiang Chinese Medical University Affiliated Four-Province-Bordering Hospital of Traditional Chinese Medicine (Quzhou Hospital of Traditional Chinese Medicine), PR China. (1 speakers): Hong-Hong Zhu\n  - Zhejiang Provincial Clinical Research Center for CANCER, Cancer Center of Zhejiang University, Hangzhou, China. (1 speakers): Kefeng Ding\n\n**Croatia (1 institutions, 1 speakers)**\n  - University J.J. Strossmayer Osijek, Osijek, Croatia. (1 speakers): Silvija Piskorjanac\n\n**Denmark (1 institutions, 1 speakers)**\n  - Aarhus University Hospital, Aarhus N, Denmark. (1 speakers): Karen-Lise G. Spindler\n\n**Finland (2 institutions, 2 speakers)**\n  - Department of Oncology, Tampere University Hospital, and University of Tampere, Tampere, Finland. (1 speakers): Pia J. Osterlund\n  - Department of Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. (1 speakers): Emerik Osterlund\n\n**Florida (1 institutions, 1 speakers)**\n  - Medical Oncology, Washington University in St. Louis, Siteman Cancer Center, St. Louis, Missouri. (1 speakers): Moh'd M. Khushman\n\n**France (16 institutions, 16 speakers)**\n  - ARCAD Foundation, Paris, France. (1 speakers): Morteza Raeisi\n  - Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. (1 speakers): Emmanouil Angelidakis\n  - Department of Cancer Medicine, Villejuif, France. (1 speakers): Valerie Boige\n  - Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, SIRIC CARPEM, Paris-Cité University, Paris, France. (1 speakers): Claire Gallois\n  - Department of Hepatogastroenterology and Digestive Oncology, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France. (1 speakers): Marie Muller\n  - Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. (1 speakers): Anthony Tarabay\n  - Department of Pathology, Saint Louis Hospital, Université Paris Cité, Paris, France. (1 speakers): Maxime Remond\n  - Department of Radiation Oncology, CHU de Bordeaux, Pessac, France. (1 speakers): Veronique Vendrely\n  - Department of Surgery, Paul-Brousse Hospital, Centre Hépato-Biliaire, Villejuif, France. (1 speakers): Rene Adam\n  - Equity Research Team, Centre d'Epidémiologie et de Recherche en santé des POPulations (CERPOP), UMR 1295 (Team Labellised « Ligue Contre le Cancer »), Inserm, University Toulouse III Paul Sabatier (1 speakers): Nadine Hamieh\n  - Institut Régional du Cancer de Montpellier, Montpellier, France. (1 speakers): Emmanuelle Samalin-Scalzi\n  - Medical Oncology Departement, Centre Léon Bérard, Lyon, France. (1 speakers): Christelle De la Fouchardiere\n  - Paris, France. (1 speakers): Corentin Wiscart\n  - Sorbonne University and Department of Medical Oncology, Saint-Antoine Hospital, Paris 75015, France. (1 speakers): Romain Cohen\n  - Sorbonne University, Department of Hepato-Gastroenterology, Pitié-Salpêtrière Hospital, Paris, France. (1 speakers): Jean-Baptiste Bachet\n  - Université Paris Cité, Paris, France. (1 speakers): Gustave Ronteix\n\n**Fujian (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Fujian Medical University Cancer Hospital and Fujian Cancer Hospital, Fuzhou, Fujian, People's Republic of China. (1 speakers): Rongbo Lin\n\n**Germany (13 institutions, 13 speakers)**\n  -  (1 speakers): Timo Gottlieb\n  - Clinical State Registry Baden-Württemberg GmbH, Baden-Württemberg Cancer Registry (BWCR), Stuttgart, Germany. (1 speakers): Irina Surovtsova\n  - Department of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim. (1 speakers): Freba Grawe\n  - Department of Hematology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany. (1 speakers): Sebastian Stintzing\n  - Department of Hematology, Oncology, and Cancer Immunology, Charité University Hospital Berlin, Berlin, Germany. (1 speakers): Dominik P. Modest\n  - Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Berlin, Germany. (1 speakers): Andrey Mitroshkin\n  - Department of Internal Medicine and Nature-Based Therapies, Immanuel Hospital Berlin, Berlin, Germany. (1 speakers): Carolin Breinlinger\n  - Department of Medical Oncology, University Hospital Heidelberg, Heidelberg, Germany. (1 speakers): Bruno C. Kohler\n  - Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, Essen 45147, Germany. (1 speakers): Stefan Kasper-Virchow\n  - Institute of Clinical Cancer Research IKF, Frankfurt am Main, Germany. (1 speakers): Thorsten O. Goetze\n  - Medical Clinic and Polyclinic I, University Hospital Carl Gustav Carus, Dresden, Germany. (1 speakers): Gunnar Folprecht\n  - Research Institute Havelhöhe, Germany. (1 speakers): Shiao Li Oei\n  - Risk Adapted Cancer Prevention Group, Division of Primary Cancer Prevention, German Cancer Research Center (DKFZ), Germany. (1 speakers): Zehui Chen\n\n**Guangdong (1 institutions, 1 speakers)**\n  - Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. (1 speakers): Wangjun Liao\n\n**India (3 institutions, 3 speakers)**\n  -  (1 speakers): Bharatsinha Bhosale\n  - Aster International Institute Of Oncology, Aster Hospitals, Bengaluru, India. (1 speakers): Ashwin Kr\n  - Department of Radiation Oncology, Mahamana Pandit Madan Mohan Malaviya Cancer Centre and Homi Bhabha Cancer Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India. (1 speakers): Abhishek Shinghal\n\n**Ireland (2 institutions, 2 speakers)**\n  - Department of Oncology, St. John of God Hospital, Subiaco, WA, Australia. (1 speakers): Alice Talbot\n  - St Vincent's University Hospital and University College Dublin, Dublin, Ireland. (1 speakers): Mary O. O'Reilly\n\n**Italy (19 institutions, 20 speakers)**\n  -  (1 speakers): Filippo Morocutti\n  - Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. (1 speakers): Maria Alessandra Calegari\n  - Department of Hematology, Oncology, Italy, Department of Oncology and Hemato-Oncology, Milano, Italy. (1 speakers): Caterina Vaghi\n  - Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Italy. (1 speakers): Valentino Martelli\n  - Department of Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy. (1 speakers): Francesco G. Sullo\n  - Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. (1 speakers): Gianluca Mauri\n  - Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy, IFOM ETS, The AIRC Institute of Molecular Oncology, Milano, Italy. (1 speakers): Alberto Bardelli\n  - Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. (1 speakers): Sara Lonardi\n  - Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. (1 speakers): Ada Taravella\n  - Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy. (2 speakers): Carlotta Antoniotti, Chiara Cremolini\n  - Gastroenterology and Digestive Oncology Department, Georges Pompidou European Hospital, AP-HP, Paris, France, Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy (1 speakers): Annalice Gandini\n  - Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Liguria, Italy. (1 speakers): Alessandro Pastorino\n  - Medical Oncology Unit, Department of Oncology and Hematology, Belcolle Hospital, Viterbo, Italy. (1 speakers): Marta Schirripa\n  - Medical Oncology Unit, University Hospital and University of Cagliari, Italy. (1 speakers): Andrea Pretta\n  - Meldola, Italy. (1 speakers): Nicola Normanno\n  - Niguarda Cancer Center, Milan, Italy. (1 speakers): Silvia Marsoni\n  - Unit of Medical Oncology 2, Pisa, Italy, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. (1 speakers): Veronica Conca\n  - University Hospital of Modena, 41124 Modena, Italy. (1 speakers): Elisa D'Agostino\n  - University of Pisa, Pisa, Italy. (1 speakers): Marco Maria M. Germani\n\n**Japan (16 institutions, 20 speakers)**\n  -  (1 speakers): Tsumugu Harada\n  - Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Japan. (1 speakers): Yoshito Komatsu\n  - Department of Clinical Oncology, St. Marianna University School of Medicine, Sugao, Miyamae-ku, Kawasaki, Kanagawa, Japan. y.suna0825@gmail.com. (1 speakers): Yu Sunakawa\n  - Department of Gastroenterological Chemotherapy, Japanese Foundation for Cancer Research, Ganken Ariake Byoin Cancer Institute Hospital, Koto-ku, Tokyo, Japan. (1 speakers): Shota Fukuoka\n  - Department of Gastroenterological Surgery, Gifu University Hospital, Gifu, Gifu 501-1194, Japan. (1 speakers): Ryoma Yokoi\n  - Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. (4 speakers): Kazumasa Yamamoto, Tadayoshi Hashimoto, Yasutoshi Kuboki, Yuki Matsubara\n  - Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan. (2 speakers): Hideaki Bando, Yoshiaki Nakamura\n  - Department of Medical Oncology, Saitama Medical University International Medical Center, Saitama, Japan. (1 speakers): Yoshiaki Mihara\n  - Department of Medical Oncology, Tohoku University Hospital, Sendai 980-8547, Japan. (1 speakers): Shiori Ishikawa\n  - Department of Surgery National Hospital Organization Osaka National Hospital Osaka Japan. (1 speakers): Masaaki Miyo\n  - Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. (1 speakers): Ryosuke Mizuno\n  - Department of Surgery, Kyoto University Graduate School of Medicine, Sakyo-Ku, Kyoto, Japan. (1 speakers): Haruku Fujita\n  - Division of Lower G.I., Department of Gastroenterological Surgery, School of Medicine, Hyogo Medical University, Nishinomiya 663-8501, Japan. (1 speakers): Kozo Kataoka\n  - Division of Lower GI, Department of Gastroenterological Surgery, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya, Hyogo (1 speakers): Yuko Fukumoto\n  - The Cancer Institute Hospital, Tokyo, Koto-ku, Japan. (1 speakers): Hiroki Osumi\n  - Translational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Mitsuho Imai\n\n**MN (1 institutions, 1 speakers)**\n  - Department of Medicine, Gastrointestinal Research Unit, Mayo Clinic Alix School of Medicine, Rochester, MN (1 speakers): Frank A. Sinicrope\n\n**Morocco (1 institutions, 1 speakers)**\n  - National Institute of Oncology, Morocco. (1 speakers): Amine Lachgar\n\n**Netherlands (11 institutions, 12 speakers)**\n  -  (2 speakers): Deborah Ophoff, Niels Klaassen\n  - Catharina Hospital, 5623 EJ Eindhoven, The Netherlands. (1 speakers): Sofia L. Peeters\n  - Department of Epidemiology, GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands. (1 speakers): Nadira R. Querido\n  - Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam (1 speakers): Yara L. Verschoor\n  - Department of General, University Hospital Heidelberg, Heidelberg, Germany. (1 speakers): Nerma Crnovrsanin\n  - Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands, Department of Clinical Chemistry, Erasmus University Medical Centre (1 speakers): Niels Heersche\n  - Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht (1 speakers): Renee A. Lunenberg\n  - Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht 80125, the Netherlands. (1 speakers): Jeanine Roodhart\n  - Department of Medicine, University Medical Center Utrecht, Netherlands. (1 speakers): Marie-Christine E. Bakker\n  - Location University of Amsterdam, Amsterdam, the Netherlands. (1 speakers): Peter De Gooyer\n  - Wageningen University & Research, Wageningen, The Netherlands. (1 speakers): Nienke R. Zwart\n\n**Norway (2 institutions, 2 speakers)**\n  -  (1 speakers): Mari F. Ystgaard\n  - Cancer Clinic, Haukeland University Hospital, Bergen, Norway. (1 speakers): Siren Morken\n\n**PO (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Prato, Italy. (1 speakers): Samantha Di Donato\n\n**Pakistan (1 institutions, 1 speakers)**\n  - Rawalpindi Medical University, Rawalpindi, Pakistan. (1 speakers): Shahzaib M. Maqbool\n\n**Peru (1 institutions, 1 speakers)**\n  -  (1 speakers): Wagner E. Cruz Diaz\n\n**Portugal (3 institutions, 3 speakers)**\n  - Medical Oncology Department, Porto, Portugal. (1 speakers): Maria Joao Oura\n  - University of Porto, Porto, Portugal. (1 speakers): Luisa Soares Miranda\n  - Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK. (1 speakers): Ana Rita Dias\n\n**Republic of Korea (4 institutions, 4 speakers)**\n  - Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. (1 speakers): Keun-Wook Lee\n  - Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. (1 speakers): Ho Jung An\n  - Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea. (1 speakers): Soohyeon Lee\n  - Jason TG, Seoul, Korea. (1 speakers): Min-Hyeok Jeong\n\n**Russian Federation (3 institutions, 3 speakers)**\n  -  (1 speakers): Amina Yusupova\n  - Central Clinical Hospital of the Russian Academy of Sciences, Russia. (1 speakers): Evgenii Goncharov\n  - Institute for Personalized Oncology, Sechenov First Moscow State Medical University, Moscow 119048, Russia. (1 speakers): Alexandra Lebedeva\n\n**Singapore (2 institutions, 2 speakers)**\n  - Department of Hematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore. (1 speakers): Gloria Chan\n  - Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. (1 speakers): Wei Yu Chua\n\n**South Africa (1 institutions, 1 speakers)**\n  - The Medical Oncology Centre of Rosebank, Johannesburg (1 speakers): Teresa Smit\n\n**South Australia (1 institutions, 1 speakers)**\n  - College of Medicine and Public Health, Flinders University, Australia. (1 speakers): Sina Vatandoust\n\n**South Moravian (1 institutions, 1 speakers)**\n  - Masaryk University, Brno, Czech Republic. (1 speakers): Radka L. Obermannova\n\n**Spain (14 institutions, 16 speakers)**\n  -  (3 speakers): Judit Sanz Beltran, Mariam Stephanie Rojas Piedra, Pau Mascaro Baselga\n  - Department of Gastrointestinal Surgery Section 2, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China (1 speakers): Weiyao Li\n  - Hospital Clinic de Barcelona, CIBEREHD, Barcelona, Spain. (1 speakers): Joan Maurel\n  - Hospital del Mar Research Institute (IMIM), Barcelona, Spain. (1 speakers): Clara Montagut\n  - Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain. (1 speakers): Pablo Perez-Martinez\n  - Medical Oncology Department, Barcelona, Spain, Universitat de Barcelona, Barcelona, Spain. (1 speakers): Cristina Santos Vivas\n  - Medical Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain. (1 speakers): Ruth Vera Garcia\n  - Ramon y Cajal University Hospital, Madrid, Spain. (1 speakers): Coral Garcia de Quevedo Suero\n  - Reina Sofia University Hospital, Cordoba, Spain. (1 speakers): Alvaro Arjona-Sanchez\n  - University of Valladolid, Castilla y León, Spain. (1 speakers): Irene Lopez Sanchez\n  - Vall D'Hebron University Hospital (HUVH) and Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain. (1 speakers): Francisco Javier Ros Montana\n  - Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, IOB-Quirón, Barcelona, Spain. (1 speakers): Josep Tabernero\n  - Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Spain. (1 speakers): Clara Salva de Torres\n  - Vall d'Hebron Institute of Oncology, Barcelona, Spain. (1 speakers): Paolo G. Nuciforo\n\n**Surrey (1 institutions, 1 speakers)**\n  - The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, Surrey, London (1 speakers): Nina Tunariu\n\n**Sweden (2 institutions, 2 speakers)**\n  - Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden. (1 speakers): Shabane Barot\n  - Division of Biomolecular and Cellular Medicine, Karolinska Institutet, ANA Futura, Huddinge, Stockholm, Sweden. (1 speakers): Maximilian Kordes\n\n**TX (3 institutions, 3 speakers)**\n  - Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. (1 speakers): Kanwal Raghav\n  - Division of Hematology and Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. (1 speakers): Cathy Eng\n  - The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Siqing Fu\n\n**Taiwan (1 institutions, 1 speakers)**\n  - National Institute of Cancer Research, Tainan, Taiwan. (1 speakers): Yi-hsin Yang\n\n**Thailand (2 institutions, 2 speakers)**\n  - Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. (1 speakers): Krittiya Korphaisarn\n  - Siriraj Cancer Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. (1 speakers): Pariyada Tanjak\n\n**Tunisia (1 institutions, 1 speakers)**\n  -  (1 speakers): Nesrine Kooli\n\n**Turkey (4 institutions, 4 speakers)**\n  - Ankara University Cancer Research Institute, Ankara University, Ankara 06620, Turkey. (1 speakers): Mehmet Kayaalp\n  - Department of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey. (1 speakers): Mehmet C. Icli\n  - Medical Faculty, Department of Medical Oncology, Medipol University, No:1, Bagcilar, Istanbul, Turkey. (1 speakers): Sabin Goktas Aydin\n  - Medical Oncology Department, Etlik City Hospital, Ankara, Turkey. (1 speakers): Galip Can Uyar\n\n**United Kingdom (11 institutions, 13 speakers)**\n  -  (2 speakers): Perminder Tony Singh Dhillon, Shikiera Wheeler\n  - CLL Society, CA. (1 speakers): Chris Stewart\n  - Department of Laboratory Medicine, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China (1 speakers): Yifan Xing\n  - Department of Research Oncology, Guys Hospital, Kings College London, SE1 9RT London, UK. (1 speakers): Debashis Sarker\n  - Department of medical oncology, Institute of Cancer Research, Sutton, SM2 5NG (1 speakers): Ian Chau\n  - Division of Oncology, School of Medicine, University of Leeds, Leeds, UK. (1 speakers): James R. Platt\n  - Hull York Medical School, University of Hull, Hull, UK. (1 speakers): Holly Butler\n  - Royal Marsden Hospital, London SW3 6JJ, UK. (2 speakers): Naureen Starling, Sheela Rao\n  - University of Coimbra, Coimbra, Portugal. (1 speakers): Marisa R. Durao Portela De Lima\n  - Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, Hampshire, UK. (1 speakers): David Hunt\n  - Women's Health Research Group, Leeds Institute of Medical Research, St James's University Hospital, University of Leeds, Leeds (1 speakers): Nicholas Bennett\n\n**United States of America (17 institutions, 17 speakers)**\n  - 1Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (1 speakers): David S. Hong\n  - David Geffen School of Medicine at University of California, Los Angeles, Los Angeles. (1 speakers): Zev A. A. Wainberg\n  - Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Scott Kopetz\n  - Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. (1 speakers): Van Morris\n  - Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA 15213, USA. (1 speakers): Anwaar Saeed\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, USA, Department of Medicine, Weill Cornell Medicine and New York Presbyterian Hospital, NY, USA. (1 speakers): Alan L. Ho\n  - Department of Molecular Medicine, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea. (1 speakers): Seung-Hoon Lee\n  - Department of Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA. (1 speakers): Smitha Krishnamurthi\n  - Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston 77030, TX USA. (1 speakers): Michael LaPelusa\n  - GSK, London (1 speakers): Aikaterini Fameli\n  - MD Anderson Cancer Center, Houston, TX. (1 speakers): N. Arvind Dasari\n  - NYCH+H/Woodhull, Brooklyn, NY, USA. (1 speakers): Aria Khan\n  - Ryan White Center for Pediatric Infectious Disease and Global Health, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN. (1 speakers): Wesley Boland\n  - The University of Texas MD MD Anderson Cancer Center, Houston, Texas. (1 speakers): Denise Langabeer\n  - Washington University School of Medicine, MO. (1 speakers): Nikolaos Trikalinos\n  - Yale New Haven Hospital, CT, USA. (1 speakers): Michael Cecchini\n  - a Department of Biology, City College of New York, NY, USA. (1 speakers): Emma Schatoff\n\n**VIC (1 institutions, 1 speakers)**\n  - Personalised Oncology Division, Walter and Eliza Hall Institute for Medical Research, Melbourne, VIC, Australia. (1 speakers): Jeanne Tie\n\n**Yorkshire (1 institutions, 1 speakers)**\n  - Division of Oncology, Leeds Institute of Medical Research at St James's, School of Medicine, University of Leeds, Leeds, UK. (1 speakers): Jenny Seligmann"
  },
  "head_and_neck_cancer": {
    "top_institutions": {
      "columns": [
        "Institution",
        "# Studies",
        "Locations"
      ],
      "rows": [
        {
          "Institution": "Sun Yat-sen University Cancer Center",
          "# Studies": 12,
          "Locations": "Guangzhou, China, guangzhou, China, Guangzhou, China, Guangdong"
        },
        {
          "Institution": "MD Anderson Cancer Center, Houston",
          "# Studies": 12,
          "Locations": "Houston, United States of America, Surrey, Houston, United States of America, Houston, United States of America, TX"
        },
        {
          "Institution": "Dana-Farber Cancer Institute",
          "# Studies": 9,
          "Locations": "Boston, United States of America"
        },
        {
          "Institution": "Medical Oncology Department",
          "# Studies": 6,
          "Locations": "Limoges, France, CEDEX, Madrid, Spain, Badalona, Spain, Barcelona"
        },
        {
          "Institution": "Memorial Sloan Kettering Cancer Center",
          "# Studies": 5,
          "Locations": "New York, United States of America, NY, New York, United States of America"
        },
        {
          "Institution": "Institute of Cancer and Genomic Sciences",
          "# Studies": 5,
          "Locations": "Birmingham, United Kingdom"
        },
        {
          "Institution": "Medical Oncology and Hematology Unit",
          "# Studies": 4,
          "Locations": "Rozzano, Italy"
        },
        {
          "Institution": "Medical Oncology Unit",
          "# Studies": 4,
          "Locations": "Haidari, Greece, Rozzano, Italy, Parma, Italy"
        },
        {
          "Institution": "Ramon y Cajal University Hospital",
          "# Studies": 4,
          "Locations": "Madrid, Spain"
        },
        {
          "Institution": "Vall d'Hebron Barcelona Hospital Campus",
          "# Studies": 4,
          "Locations": "Barcelona, Spain"
        },
        {
          "Institution": "The Institute of Cancer Research",
          "# Studies": 3,
          "Locations": "Sutton, United Kingdom"
        },
        {
          "Institution": "University of Milan",
          "# Studies": 3,
          "Locations": "Milan, Italy"
        },
        {
          "Institution": "Paris-Saclay University",
          "# Studies": 3,
          "Locations": "Villejuif, France, Paris, France"
        },
        {
          "Institution": "IRCCS Humanitas Research Hospital",
          "# Studies": 3,
          "Locations": "Pieve Emanuele, Italy"
        },
        {
          "Institution": "Fudan University Shanghai Cancer Center",
          "# Studies": 3,
          "Locations": "Shanghai, China"
        },
        {
          "Institution": "Cancer Center",
          "# Studies": 2,
          "Locations": "Isehara, Japan, Beijing, China"
        },
        {
          "Institution": "Brigham and Women's Hospital",
          "# Studies": 2,
          "Locations": "Boston, United States of America"
        },
        {
          "Institution": "University of São Paulo",
          "# Studies": 2,
          "Locations": "Sao Paulo, Brazil"
        },
        {
          "Institution": "Cancer Center Clínica Universidad de Navarra (CCUN)",
          "# Studies": 2,
          "Locations": "Madrid, Spain"
        },
        {
          "Institution": "State Key Laboratory of Oncology in South China",
          "# Studies": 2,
          "Locations": "Guangzhou, China, GuangZhou, China"
        },
        {
          "Institution": "The Christie NHS Foundation Trust",
          "# Studies": 2,
          "Locations": "Manchester, United Kingdom, Boston, United States of America"
        },
        {
          "Institution": "The First Hospital of China Medical University",
          "# Studies": 2,
          "Locations": "Shenyang, China"
        },
        {
          "Institution": "The University of Hong Kong",
          "# Studies": 2,
          "Locations": "Hong Kong, Hong Kong SAR, China, Hong Kong, Hong Kong SAR, China, Pokfulam"
        },
        {
          "Institution": "Charite University Hospital",
          "# Studies": 2,
          "Locations": "Berlin, Germany"
        },
        {
          "Institution": "City of Hope National Medical Center",
          "# Studies": 2,
          "Locations": "Duarte, United States of America"
        },
        {
          "Institution": "Sir Peter MacCallum Department of Oncology",
          "# Studies": 2,
          "Locations": "Melbourne, Australia"
        },
        {
          "Institution": "Saarland University Medical Center",
          "# Studies": 2,
          "Locations": "Homburg, Germany"
        },
        {
          "Institution": "Mayo Clinic",
          "# Studies": 2,
          "Locations": "Rochester, United States of America"
        },
        {
          "Institution": "Medical Oncologist",
          "# Studies": 2,
          "Locations": "Milan, Italy"
        },
        {
          "Institution": "National Cancer Center Hospital East",
          "# Studies": 2,
          "Locations": "Kashiwa, Japan"
        }
      ]
    },
    "table_context": "**TOP INSTITUTIONS TABLE:**\n| Institution                                         |   # Studies | Locations                                                                                                           |\n|:----------------------------------------------------|------------:|:--------------------------------------------------------------------------------------------------------------------|\n| Sun Yat-sen University Cancer Center                |          12 | Guangzhou, China, guangzhou, China, Guangzhou, China, Guangdong                                                     |\n| MD Anderson Cancer Center, Houston                  |          12 | Houston, United States of America, Surrey, Houston, United States of America, Houston, United States of America, TX |\n| Dana-Farber Cancer Institute                        |           9 | Boston, United States of America                                                                                    |\n| Medical Oncology Department                         |           6 | Limoges, France, CEDEX, Madrid, Spain, Badalona, Spain, Barcelona                                                   |\n| Memorial Sloan Kettering Cancer Center              |           5 | New York, United States of America, NY, New York, United States of America                                          |\n| Institute of Cancer and Genomic Sciences            |           5 | Birmingham, United Kingdom                                                                                          |\n| Medical Oncology and Hematology Unit                |           4 | Rozzano, Italy                                                                                                      |\n| Medical Oncology Unit                               |           4 | Haidari, Greece, Rozzano, Italy, Parma, Italy                                                                       |\n| Ramon y Cajal University Hospital                   |           4 | Madrid, Spain                                                                                                       |\n| Vall d'Hebron Barcelona Hospital Campus             |           4 | Barcelona, Spain                                                                                                    |\n| The Institute of Cancer Research                    |           3 | Sutton, United Kingdom                                                                                              |\n| University of Milan                                 |           3 | Milan, Italy                                                                                                        |\n| Paris-Saclay University                             |           3 | Villejuif, France, Paris, France                                                                                    |\n| IRCCS Humanitas Research Hospital                   |           3 | Pieve Emanuele, Italy                                                                                               |\n| Fudan University Shanghai Cancer Center             |           3 | Shanghai, China                                                                                                     |\n| Cancer Center                                       |           2 | Isehara, Japan, Beijing, China                                                                                      |\n| Brigham and Women's Hospital                        |           2 | Boston, United States of America                                                                                    |\n| University of São Paulo                             |           2 | Sao Paulo, Brazil                                                                                                   |\n| Cancer Center Clínica Universidad de Navarra (CCUN) |           2 | Madrid, Spain                                                                                                       |\n| State Key Laboratory of Oncology in South China     |           2 | Guangzhou, China, GuangZhou, China                                                                                  |\n| The Christie NHS Foundation Trust                   |           2 | Manchester, United Kingdom, Boston, United States of America                                                        |\n| The First Hospital of China Medical University      |           2 | Shenyang, China                                                                                                     |\n| The University of Hong Kong                         |           2 | Hong Kong, Hong Kong SAR, China, Hong Kong, Hong Kong SAR, China, Pokfulam                                          |\n| Charite University Hospital                         |           2 | Berlin, Germany                                                                                                     |\n| City of Hope National Medical Center                |           2 | Duarte, United States of America                                                                                    |\n| Sir Peter MacCallum Department of Oncology          |           2 | Melbourne, Australia                                                                                                |\n| Saarland University Medical Center                  |           2 | Homburg, Germany                                                                                                    |\n| Mayo Clinic                                         |           2 | Rochester, United States of America                                                                                 |\n| Medical Oncologist                                  |           2 | Milan, Italy                                                                                                        |\n| National Cancer Center Hospital East                |           2 | Kashiwa, Japan                                                                                                      |\n\n**ENRICHED INSTITUTION PROFILES (Top 10 with ClinicalTrials.gov Data):**\n\n\n**Sun Yat-sen University Cancer Center**\n  - ESMO 2025 Presentations: 12\n  - Clinical Trials (2015-2025): 7 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT07201337](https://clinicaltrials.gov/study/NCT07201337): Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma. (PHASE3, NOT_YET_RECRUITING, Started 2025)\n    * [NCT07188584](https://clinicaltrials.gov/study/NCT07188584): Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer (PHASE3, RECRUITING, Started 2025)\n    * [NCT06957938](https://clinicaltrials.gov/study/NCT06957938): Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma (PHASE3, NOT_YET_RECRUITING, Started 2025)\n    * [NCT06712888](https://clinicaltrials.gov/study/NCT06712888): Toripalimab Vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma (PHASE3, RECRUITING, Started 2025)\n    * [NCT06241612](https://clinicaltrials.gov/study/NCT06241612): Individualized Elective Neck Irradiation in NPC Patients (PHASE3, RECRUITING, Started 2024)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT03544099](https://clinicaltrials.gov/study/NCT03544099): Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA (PHASE2, TERMINATED, Started 2019) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (16 total):\n    * Huaqiang Zhou  - LBA35: Iza-Bren (BL-B01D1), an EGFR×HER3 Bispecific Antibody-drug Conjugate, versus Physician's Choice of Chemotherapy in Heavily Pretreated Recurrent/Metastatic Nasopharyngeal Carcinoma: A Randomized, Open-Label, Multicenter, Phase III, Pivotal study (BL-B01D1-303) (10/19/2025, 15:52 - 16:02, Bremen Auditorium - Hall 6.2)\n    * Zhi-Ming Li  - 1245MO: Combination of Mitoxantrone Hydrochloride Liposome with Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma: Updated Results of the Phase II Study (10/19/2025, 08:53 - 08:58, Solingen Auditorium - Hall 23)\n    * Chunyan Chen  - 1467eTiP: Neoadjuvant SBRT sequential Tislelizumab in locally advanced head and neck squamous cell carcinoma: A single-arm, phase II trial (NEOSTART study). (10/20/2025, 12-13:00, Hall 25)\n    * Jie Yi Lin  - 19P: Metabolic reprogramming of cancer cells reshapes TME through extracellular vesicles (10/20/2025, 12-13:00, Hall 25)\n    * Jingjing Miao  - 1321O: Concurrent Chemoradiotherapy with/without Adjuvant Capecitabine in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized Controlled Phase III Trial (10/20/2025, 09:10 - 09:20, Dortmund Auditorium - Hall 7.1a)\n    * ... and 11 more presenters\n\n\n**MD Anderson Cancer Center, Houston**\n  - ESMO 2025 Presentations: 12\n  - Clinical Trials (2015-2025): 1 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06309225](https://clinicaltrials.gov/study/NCT06309225): Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly (NA, RECRUITING, Started 2025)\n  - Relevant to EMD Serono/Merck KGaA: None identified in ClinicalTrials.gov (2015-2025)\n  - Key Presenters at ESMO 2025 (14 total):\n    * Timothy Anthony Yap  - 924MO: First data disclosure of the first-in-class DNA polymerase theta inhibitor, ART6043, as monotherapy and in combination with olaparib, in patients with molecularly-selected advanced solid tumors (10/17/2025, 16:30 - 16:35, Heidelberg Auditorium - Hall 6.2)\n    * Carl M. Gay  - : Panel discussion and Q&A (10/18/2025, 18:30 - 20:00, Heidelberg Auditorium - Hall 6.2)\n    * Carl M. Gay  - : Panel discussion/Q&A and closing remarks (10/18/2025, 18:30 - 20:00, Heidelberg Auditorium - Hall 6.2)\n    * Scott Woodman  - 113MO: Multimodal Molecular Investigation of >1,000 Rare Cancer Patients (pts) Reveals Key Tumor States and Germline Susceptibility Genetics (10/18/2025, 08:30 - 08:35, Cologne Auditorium - CityCube A)\n    * Fadi G. Haddad  - 1250MO: Outcomes of Patients with Chronic Myeloid Leukemia Receiving Second-Line Therapy (10/19/2025, 09:33 - 09:38, Solingen Auditorium - Hall 23)\n    * ... and 9 more presenters\n\n\n**Dana-Farber Cancer Institute**\n  - ESMO 2025 Presentations: 9\n  - Clinical Trials (2015-2025): 33 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06940180](https://clinicaltrials.gov/study/NCT06940180): Toripalimab With Chemotherapy for Sinus Cancer (PHASE2, RECRUITING, Started 2025)\n    * [NCT06805617](https://clinicaltrials.gov/study/NCT06805617): A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers (PHASE2, RECRUITING, Started 2025)\n    * [NCT06239220](https://clinicaltrials.gov/study/NCT06239220): PD-L1 t-haNK, N-803 IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC (PHASE2, RECRUITING, Started 2024)\n    * [NCT05524025](https://clinicaltrials.gov/study/NCT05524025): The SPOT-HPV Study (Phase Not Specified, ACTIVE_NOT_RECRUITING, Started 2022)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT05726370](https://clinicaltrials.gov/study/NCT05726370): Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC (PHASE2, RECRUITING, Started 2023) [COMPETITOR]\n    * [NCT03894891](https://clinicaltrials.gov/study/NCT03894891): Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer (PHASE2, COMPLETED, Started 2019) [COMPETITOR]\n    * [NCT03692325](https://clinicaltrials.gov/study/NCT03692325): Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia (PHASE2, COMPLETED, Started 2018) [COMPETITOR]\n    * [NCT03341936](https://clinicaltrials.gov/study/NCT03341936): Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN (PHASE2, ACTIVE_NOT_RECRUITING, Started 2018) [COMPETITOR]\n    * [NCT03246958](https://clinicaltrials.gov/study/NCT03246958): Nivolumab Plus Ipilimumab in Thyroid Cancer (PHASE2, COMPLETED, Started 2017) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (6 total):\n    * Jacob Sands  - : Invited Discussant (10/18/2025, 17:25 - 17:35, Hamburg Auditorium - CityCube A)\n    * Sylvan Baca  - : Invited Discussant (10/18/2025, 09:03 - 09:11, Cologne Auditorium - CityCube A)\n    * Marc Machaalani  - 2599MO: Soluble MAdCAM-1 predicts outcomes in patients with metastatic renal cell carcinoma: results from three independent clinical trials (10/19/2025, 09:40 - 09:45, Bonn Auditorium - Hall 7.1c)\n    * Erica Mayer  - 486MO: Patient-reported outcomes (PROs) from the SERENA-6 trial of camizestrant (CAMI) + CDK4/6 inhibitor (CDK4/6i) for emergent ESR1m during first-line (1L) endocrine-based therapy and ahead of disease progression in patients (pts) with HR+/HER2- advanced breast cancer (ABC) (10/20/2025, 10:25 - 10:30, Munich Auditorium - CityCube B)\n    * Glenn J. Hanna  - 1349P: Tipifarnib (TIP) and alpelisib (ALP) in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): Phase 1 results from KURRENT-HN (10/20/2025, 12-13:00, Hall 25)\n    * ... and 1 more presenters\n\n\n**Medical Oncology Department**\n  - ESMO 2025 Presentations: 6\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (9 total):\n    * Elise Deluche  - 2803MO: High-Fidelity Simulation Reduces Stress and Enhances Communication Skills in Oncology Residents: Results from the ACACIAS 2 Study (10/18/2025, 14:50 - 14:55, Karlsruhe Auditorium - Hall 5.2)\n    * Ivan Marquez-Rodas  - : Invited Discussant (10/18/2025, 15:25 - 15:35, Dortmund Auditorium - Hall 7.1a)\n    * Beatriz Cirauqui Cirauqui  - 1446eP: Multidisciplinary Care in Head and Neck Cancer in Spain: Results from the FETTCC National Survey (10/20/2025, 12-13:00, Hall 25)\n    * Gema Bruixola  - 1400P: Circulating Tumor DNA as a Marker of Minimal Residual Disease After Chemoradiation in Locally Advanced Head and Neck Cancer (10/20/2025, 12-13:00, Hall 25)\n    * Laura D. Locati  - 1442TiP: Peri-radiotherapy immunotherapy in undifferentiated sinonasal cancer (10/20/2025, 12-13:00, Hall 25)\n    * ... and 4 more presenters\n\n\n**Memorial Sloan Kettering Cancer Center**\n  - ESMO 2025 Presentations: 5\n  - Clinical Trials (2015-2025): 50 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06984861](https://clinicaltrials.gov/study/NCT06984861): A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer (PHASE2, RECRUITING, Started 2025)\n    * [NCT06676592](https://clinicaltrials.gov/study/NCT06676592): A Study of the Use of 3D Technology to Guide Head and Neck Surgery (NA, RECRUITING, Started 2024)\n    * [NCT06563479](https://clinicaltrials.gov/study/NCT06563479): A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer (PHASE3, RECRUITING, Started 2024)\n    * [NCT06558786](https://clinicaltrials.gov/study/NCT06558786): Registry for Esophageal and Gastroesophageal Junction Cancer (Phase Not Specified, RECRUITING, Started 2024)\n    * [NCT06485778](https://clinicaltrials.gov/study/NCT06485778): A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma (PHASE2, RECRUITING, Started 2024)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT06123338](https://clinicaltrials.gov/study/NCT06123338): A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer (PHASE2, RECRUITING, Started 2024) [COMPETITOR]\n    * [NCT05859074](https://clinicaltrials.gov/study/NCT05859074): A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer (PHASE1, ACTIVE_NOT_RECRUITING, Started 2023) [COMPETITOR]\n    * [NCT04757363](https://clinicaltrials.gov/study/NCT04757363): A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer (PHASE2, ACTIVE_NOT_RECRUITING, Started 2021) [COMPETITOR]\n    * [NCT04722523](https://clinicaltrials.gov/study/NCT04722523): A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer (PHASE1, RECRUITING, Started 2021) [COMPETITOR]\n    * [NCT04209660](https://clinicaltrials.gov/study/NCT04209660): Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers (PHASE2, ACTIVE_NOT_RECRUITING, Started 2020) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (7 total):\n    * Dana E. Rathkopf  - LBA91: Patient (pt) reported outcomes (PROs) from AMPLITUDE, a randomized placebo-controlled phase 3 trial of niraparib (NIRA) and abiraterone acetate (AA) plus prednisone (P) in metastatic hormone-sensitive prostate cancer (mHSPC) with homologous recombination repair mutations (HRRm) (10/17/2025, 14:00 - 14:05, Heidelberg Auditorium - Hall 6.2)\n    * Karen Autio  - 2385MO: Translational analyses of T-cell phenotypes and their association with clinical efficacy in the first-in-human (FIH) trial of JNJ-78278343 (pasritamig) in metastatic castration-resistant prostate cancer (mCRPC) (10/17/2025, 14:40 - 14:45, Heidelberg Auditorium - Hall 6.2)\n    * Michael Bonner B. Foote  - 925MO: First-in-human phase I/Ib study of the oral Werner (WRN) helicase inhibitor HRO761 in patients (pts) with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) advanced solid tumors: Interim safety and efficacy analysis from HRO761 single agent dose escalation (10/17/2025, 16:35 - 16:40, Heidelberg Auditorium - Hall 6.2)\n    * Manuel J. Rodrigues  - LBA58: PLUME: A single-arm phase II trial of pembrolizumab (pembro) plus lenvatinib (lenva) in patients (pts) with metastatic uveal melanoma (mUM) (10/18/2025, 15:15 - 15:20, Dortmund Auditorium - Hall 7.1a)\n    * Alan L. Ho  - 1018eTiP: A Phase I Trial of RGT-61159, an Oral MYB Transcription Factor Inhibitor, for patients with Relapsed/Refractory (R/R) Adenoid Cystic Carcinoma (ACC) and Colorectal Cancer (CRC) (10/19/2025, 12-13:00, Hall 25)\n    * ... and 2 more presenters\n\n\n**Institute of Cancer and Genomic Sciences**\n  - ESMO 2025 Presentations: 5\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (5 total):\n    * Hisham M. Mehanna  - 1317O: Results from CompARE phase III RCT: neoadjuvant durvalumab plus chemoradiotherapy (CRT) followed by adjuvant durvalumab immunotherapy (IO) vs CRT alone in intermediate and high-risk oropharyngeal cancer (OPC) (10/18/2025, 10:15 - 10:25, Dortmund Auditorium - Hall 7.1a)\n    * Hisham M. Mehanna  - : Welcome and Introduction (10/18/2025, 13:00 - 14:30, Bremen Auditorium - Hall 6.2)\n    * Hisham M. Mehanna  - : Treatment Landscape in Resectable LA HNSCC (10/18/2025, 13:00 - 14:30, Bremen Auditorium - Hall 6.2)\n    * Hisham M. Mehanna  - : Closing Remarks (10/18/2025, 13:00 - 14:30, Bremen Auditorium - Hall 6.2)\n    * Hisham M. Mehanna  - 1399P: Prognostic model driven by explainable AI integrating multilingual EHR data outperforms TNM staging in locally advanced HNSCC (10/20/2025, 12-13:00, Hall 25)\n\n\n**Medical Oncology and Hematology Unit**\n  - ESMO 2025 Presentations: 4\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (4 total):\n    * Lorenza Rimassa  - : Invited Discussant (10/18/2025, 11:20 - 11:30, Hanover Auditorium - Hall 7.2c)\n    * Luigi Lorini  - 1338P: Neoadjuvant PARP inhibitor and immunotherapy in locally advanced HPV-negative head and neck squamous cell carcinoma (PRIME H&N Study) (10/20/2025, 12-13:00, Hall 25)\n    * Paolo Bossi  - 1341P: HETECO: a prospective randomized trial to assess the best follow-up (FUP) strategy for curatively treated head and neck squamous cell carcinoma (HNSCC) (10/20/2025, 12-13:00, Hall 25)\n    * Paolo Bossi  - : Circulating EBV DNA for treatment selection/stratification (10/20/2025, 10:20 - 10:40, Koblenz Auditorium - Hall 5.2)\n\n\n**Medical Oncology Unit**\n  - ESMO 2025 Presentations: 4\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (4 total):\n    * Amanda Psyrri  - 1348MO: SKYSCRAPER-09: phase 2, randomised study of tiragolumab (tira) + atezolizumab (atezo) and atezo + placebo (pbo) as first-line (1L) treatment in patients (pts) with recurrent/metastatic PD-L1+ squamous cell carcinoma of the head and neck (R/M SCCHN) (10/19/2025, 16:45 - 16:50, Cologne Auditorium - CityCube A)\n    * Erika Stucchi  - 1392P: The Impede phase II trial: Avelumab (A) in High-Risk Oral Potentially Malignant Disorders (OPMDs) for Prevention of Malignant Transformation (10/20/2025, 12-13:00, Hall 25)\n    * Marcello Tiseo  - : Invited discussant (10/20/2025, 15:00 - 15:10, Hamburg Auditorium - CityCube A)\n    * Matteo Carpani  - 1359P: Real world efficacy data of 1st line treatment in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in Italian and Spanish cohorts. The REALKEY study (10/20/2025, 12-13:00, Hall 25)\n\n\n**Ramon y Cajal University Hospital**\n  - ESMO 2025 Presentations: 4\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (4 total):\n    * Ana Maria Barrill Corpa  - 2209eP: The use of intravenous (ivST) versus (vs) oral systemic treatment (oST) in the last month of life. (10/19/2025, 12-13:00, Hall 25)\n    * Ana Maria Barrill Corpa  - 2949eP: Are we overtreating cancer patients at end of life? The impact of oral treatments. (10/19/2025, 12-13:00, Hall 25)\n    * Coral Garcia de Quevedo Suero  - 889eP: Limited benefit of adjuvant treatment in localized colorectal cancer patients >= 75 years: results from a retrospective cohort study (10/19/2025, 12-13:00, Hall 25)\n    * Coral Garcia de Quevedo Suero  - 2189P: Active oncologic treatment in the last month of life: real-world patterns and missed opportunities for earlier palliative care (10/19/2025, 12-13:00, Hall 25)\n\n\n**Vall d'Hebron Barcelona Hospital Campus**\n  - ESMO 2025 Presentations: 4\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (5 total):\n    * Elena Garralda  - 1522MO: A Phase 1 Study Of INCA33890, A PD-1/TGFbetaR2 Bispecific Antibody, For Advanced Solid Tumours (10/17/2025, 15:05 - 15:10, Nuremberg Auditorium - Hall 5.2)\n    * Ana Oaknin  - 1065MO: First-in-human study of AZD5335, a folate receptor alpha (FRalpha)-targeted antibody-drug conjugate, in patients with platinum-resistant recurrent ovarian cancer (10/19/2025, 10:33 - 10:38, Cologne Auditorium - CityCube A)\n    * Elena Garralda  - 919O: A first-in-human study of oral IAG933 in adult patients with advanced mesothelioma and other solid tumours (10/19/2025, 16:30 - 16:40, Hanover Auditorium - Hall 7.2c)\n    * Irene Brana  - 1443TiP: EORTC 2014-HNCG PROLoNg: Pembrolizumab and Radiotherapy for OLigometastatic squamous cell carcinoma of the head and Neck, randomized phase III trial (10/20/2025, 12-13:00, Hall 25)\n    * Irene Brana  - : Invited Discussant (10/20/2025, 08:50 - 09:00, Dortmund Auditorium - Hall 7.1a)\n\n\n**COMPLETE SPEAKER DIRECTORY BY GEOGRAPHY:**\n\n\n** (1 institutions, 1 speakers)**\n  -  (1 speakers): \n\n**Australia (6 institutions, 6 speakers)**\n  - Fiona Stanley Hospital and Edith Cowan University, Perth, WA, Australia. (1 speakers): Muhammad A. Khattak\n  - Melanoma Institute Australia, Wollstonecraft, Australia. (1 speakers): Ines Pires da Silva\n  - Monash Health, Clayton, VIC, Australia. (1 speakers): Khunthong Peechatanan\n  - Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. (1 speakers): Jayesh Desai\n  - Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia (1 speakers): Arun A. Azad\n  - Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia, Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. (1 speakers): Danny Rischin\n\n**Austria (2 institutions, 2 speakers)**\n  - Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria, Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I (1 speakers): Angelika M. Starzer\n  - Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. (1 speakers): Lynn Gottmann\n\n**Barcelona (1 institutions, 1 speakers)**\n  - Medical Oncology Department, Badalona, Spain. (1 speakers): Beatriz Cirauqui Cirauqui\n\n**Belgium (9 institutions, 9 speakers)**\n  -  (1 speakers): Patrick Schoeffski\n  - Breast Cancer Translational Research Laboratory, Department of Medical Oncology, Brussels, Belgium. (1 speakers): Laetitia Collet\n  - Bruxelles 1070, Belgium. (1 speakers): Evandro De Azambuja\n  - Clinical Trials Conduct Unit, Brussels, Belgium. (1 speakers): Philippe Aftimos\n  - Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium. (1 speakers): Michael Saerens\n  - Division of Gynaecological Oncology, Leuven Cancer Institute, University Hospital Leuven and KU Leuven, Leuven, Belgium. (1 speakers): Toon Van Gorp\n  - European Organisation for Research and Treatment of Cancer, Belgium. (1 speakers): Iryna Shakhnenko\n  - Institut Roi Albert II, Cliniques Universitaires Saint-Luc and Institute for Experimental and Clinical Research (IREC, Brussels, Belgium. (1 speakers): Jean-Pascal Machiels\n  - King Albert II Cancer Institute, Department of Medical Oncology, B-1200, Brussels, Belgium. (1 speakers): Sandra Schmitz\n\n**Brazil (6 institutions, 6 speakers)**\n  -  (1 speakers): Leila C. Taguchi\n  - Department of Medical Oncology and Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, Hospital Israelita Albert, São Paulo, São Paulo, Brazil. (1 speakers): Miguel Zugman\n  - Department of Microbiology, School of Medicine, University of California, CA 90095-1747, USA. (1 speakers): Debora M. Santana\n  - Department of Social Medicine, University of São Paulo, São Paulo, Brazil. (1 speakers): Joao Souza\n  - University of Campinas (UNICAMP), SP, Brazil. (1 speakers): Ericka F. Costa\n  - University of São Paulo, São Paulo, Brazil. (1 speakers): Larissa Garcia\n\n**CEDEX (4 institutions, 4 speakers)**\n  - Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France. (1 speakers): Maurice Perol\n  - Department of Medical Oncology, University of Lyon, Centre Léon Bérard, Lyon, France. (1 speakers): Jerome Fayette\n  - ICO René Gauducheau, France. (1 speakers): Mario Campone\n  - Medical Oncology Department, University Hospital Dupuytren, Limoges, France. (1 speakers): Elise Deluche\n\n**CEDEX 3 (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France. (1 speakers): Armelle Dufresne\n\n**CEDEX 5 (1 institutions, 1 speakers)**\n  - Columbia University Medical Center, Memorial Sloan Kettering Cancer Center, NY, Paris, Centre Antoine-Lacassagne, Nice, France, Leiden University Medical Center, Leiden, the Netherlands (1 speakers): Manuel J. Rodrigues\n\n**CO (1 institutions, 1 speakers)**\n  - Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, University of Toronto, Toronto, ON, Canada. (1 speakers): Anna Spreafico\n\n**Canada (5 institutions, 5 speakers)**\n  - Centre Hospitalier de l'Université de Montréal, Montreal, QC H3C 3J7, Canada. (1 speakers): Denis Soulieres\n  - Division of Cancer Care and Epidemiology, Sinclair Cancer Research Institute at Queen's University, Kingston, ON, Canada. (1 speakers): Christopher M. Booth\n  - Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. (1 speakers): Philippe L. Bedard\n  - Division of Medical Oncology, University of Toronto, Princess Margaret Cancer Center, Toronto, ON, Canada. (1 speakers): Srikala S. Sridhar\n  - Toronto General Hospital, Princess Margaret Centre, University of Toronto, Toronto, ON, Canada. (1 speakers): Arndt Vogel\n\n**Chiba (1 institutions, 1 speakers)**\n  - Department of Head and Neck Medical Oncology, National Cancer Center East Hospital, Kashiwa, Chiba (1 speakers): Makoto Tahara\n\n**China (83 institutions, 88 speakers)**\n  -  (1 speakers): Ji Dongmei\n  - Beijing Institute of Biological Products Co., Ltd, Beijing, China. (1 speakers): Wanping Guo\n  - Breast Tumour Centre, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. (1 speakers): Erwei Song\n  - Central Laboratory, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center ... (1 speakers): CHONG DING\n  - Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China, Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China (1 speakers): Sufang Qiu\n  - College & Hospital of Stomatology, Anhui Medical University, Key Lab. of Oral Diseases Research of Anhui, Hefei, China. (1 speakers): Qingqing Wang\n  - College of Animal Science and National Engineering Research Center for Breeding Swine Industry, South China Agricultural University, Guangdong, P.R. China. (1 speakers): Cineng Xu\n  - College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi 712100, PR China. (1 speakers): Xiaoyu Wang\n  - Department of Abdominal Surgery, Ganzhou Cancer Hospital, Ganzhou, China. (1 speakers): Zhenhua Liu\n  - Department of Anaesthesiology, Peking University First Hospital, Beijing, China. (1 speakers): Mo Li\n  - Department of Brain Disease, Nanjing Hospital of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China. (1 speakers): Xiaoyu Liu\n  - Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Chongqing Medical University Chongqing 400010 P. R. China 302118@cqmu.edu.cn. (1 speakers): Xiaoqing Yu\n  - Department of Clinical Oncology, The University of Hong Kong (1 speakers): Aya El-Helali\n  - Department of Clinical Oncology, University of Hong Kong and Queen Mary Hospital (1 speakers): Dora L. Kwong\n  - Department of Clinical Pharmacology, School of Pharmacy, China Medical University, Liaoning (1 speakers): Yang Bai\n  - Department of Gastrointestinal, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China. (1 speakers): Defeng Chen\n  - Department of Gynaecologic Oncology Fudan University Shanghai Cancer Center, Fudan University Shanghai China. (1 speakers): Jin Li\n  - Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. (1 speakers): Chunyan Song\n  - Department of Gynecology and Oncology, Beijing Obstetrics and Gynecology Hospital Affiliated to Capital Medical University, Beijing, China. (1 speakers): Yue He\n  - Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China. (3 speakers): Shida Yan, Shuwei Chen, Xuekui Liu\n  - Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing, China. (1 speakers): Li Su\n  - Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China, Key Laboratory of Carcinogenesis and Cancer Invasion (1 speakers): Hui-Chuan Sun\n  - Department of Hepatobiliary Surgery and Liver Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China (2 speakers): Guoming Shi, Jia Fan\n  - Department of Laboratory Medicine, Guangdong Second Provincial General Hospital, Guangzhou 510317, China. (1 speakers): Li-Mei ZHONG\n  - Department of Laboratory Medicine, School of Medical Technology, Tianjin Medical University, Tianjin, China. (1 speakers): Jinhao Yang\n  - Department of Lymphoma & Head and Neck Oncology, College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou, China. (1 speakers): Jiesong Wang\n  - Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China. (1 speakers): Danyun Ruan\n  - Department of Medical Oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (1 speakers): Liuliu Quan\n  - Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China. (1 speakers): Zhi-Ming Li\n  - Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine (1 speakers): Huaqiang Zhou\n  - Department of Nasopharyngeal Carcinoma Sun Yat-sen University Cancer Center Guangzhou China. (1 speakers): Zhuoying Luo\n  - Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China. (1 speakers): Jie Yi Lin\n  - Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China. (1 speakers): Jingjing Miao\n  - Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China. (1 speakers): Xuguang Wang\n  - Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital Capital Medical University Beijing China. (1 speakers): Wenbin Li\n  - Department of Neurosurgery, Guangdong Provincial People's Hospital, Guangzhou, People's Republic of China (C.P.). (1 speakers): Chao Peng\n  - Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (1 speakers): Wenjie Wu\n  - Department of Nursing, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China. (1 speakers): Ying Peng\n  - Department of Oncology, First Medical Center, General Hospital of the People'S Liberation Army, Beijing, China. (1 speakers): Sisi Ye\n  - Department of Oncology, Shanghai Dongfang Hospital, Tongji University, Shanghai, China. (1 speakers): Ye Guo\n  - Department of Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China. (1 speakers): Chuanhua Zhao\n  - Department of Oncology, The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, P. R. China. (1 speakers): Yiqian Liu\n  - Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. (1 speakers): Xiang Huang\n  - Department of Orthopaedic Oncology Surgery, National Center for Orthopedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China. (1 speakers): Xiaohui Niu\n  - Department of Orthopaedics, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Qiyuan Bao\n  - Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. (1 speakers): Xiaohong Chen\n  - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China (2 speakers): Chaosu Hu, Xiaomin Ou\n  - Department of Radiation Oncology, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan 410013, P.R. China. (1 speakers): Yaqian Han\n  - Department of Radiation Oncology, Institute of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, China. (1 speakers): Xinyu Sun\n  - Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiao Tong University Medical School of medicine, Shanghai, China. (1 speakers): Cheng Xu\n  - Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, P.R. China. (2 speakers): Chunyan Chen, Yani Zhang\n  - Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China. (1 speakers): Qiao Qiao\n  - Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Hangzhou, Zhejiang, China. (1 speakers): Ting Jin\n  - Department of Radiation Oncology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. (1 speakers): Danfang Yan\n  - Department of Radiation Therapy, The First Affiliated Hospital With Nanjing Medical University, Nanjing, People's Republic of China. (1 speakers): Yinjiao Fei\n  - Department of Radiology, The University of Hong Kong - Shenzhen Hospital, Shenzhen, PR China. (1 speakers): Ziyan Zhou\n  - Department of Radiotherapy, Jiangsu Province Hospital, Nanjing, China. (1 speakers): Weilin Xu\n  - Department of Radiotherapy, The 900th Hospital of the Joint Logistics Team (Dongfang Hospital), Xiamen University, Fuzhou, China, Department of Radiotherapy (1 speakers): Wenmin Ying\n  - Department of Stomatology Huashan Hospital, Fudan University, Shanghai, China. (1 speakers): Laiping Zhong\n  - Department of Thoracic Surgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou 45003, China. (1 speakers): Tian Xia\n  - Department of Urology, Institute of Urology, Sichuan Clinical Research Center for Kidney and Urologic Diseases, West China Hospital, Sichuan University, Chengdu, China. (1 speakers): Zilin Wang\n  - Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Jiwei Huang\n  - Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou (1 speakers): Bin Huang\n  - Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China. (1 speakers): Sicong Zhang\n  - Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. (1 speakers): Jia Jiang\n  - Institute of Molecular Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Kangli Ma\n  - Ltd, Shanghai, People's Republic of China. (1 speakers): Xiaohui Wang\n  - Marine College, Shandong University, Weihai, Shandong, PR China. (1 speakers): Chuanhao Zhang\n  - National Institute of TCM, Beijing University of Chinese Medicine, Beijing, China. (1 speakers): Wang-Zhong Li\n  - Phase I Clinical Trial Center, Shanghai Cancer Center, Fudan University, Shanghai, China. (1 speakers): Yanchun Meng\n  - Princess Margaret Hospital, Hong Kong, Hong Kong SAR. (1 speakers): Matthew Lun M. Wong\n  - School of Geography and Resources, Guizhou Education University, Guiyang 550018, China. (1 speakers): Xuqiang Luo\n  - School of Physics and Optoelectronic Engineering, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China. (1 speakers): Cong Sun\n  - School of Sports Medicine and Rehabilitation, Beijing Sport University, Beijing 100084, China. (1 speakers): Yiting Li\n  - Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China. (1 speakers): Chen Zihan\n  - State Key Laboratory of Flexible Electronics (LoFE) & Institute of Flexible Electronics (IFE), Xi'an Institute of Biomedical Materials & Engineering (IBME), Northwestern Polytechnical University (1 speakers): Kun Wang\n  - State Key Laboratory of Neurology and Oncology Drug Development, Ltd, Nanjing Simcere Medical Laboratory Science Co., Ltd, Nanjing, China. (1 speakers): Xing Zhang\n  - State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. (1 speakers): YanFeng Chen\n  - State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Tian-Liang Xia\n  - Sun Yat-Sen University Cancer Center, Guangzhou, China. (1 speakers): Shuhui Dong\n  - The 111 Project Laboratory of Biomechanics and Tissue Repair, College of Bioengineering, Chongqing University, Chongqing, China. (1 speakers): Zheng Wu\n  - Third Affiliated Hospital of Southern Medical University, Guangzhou 510000, China. (1 speakers): Lei H. Tan\n  - Zhejiang Key Laboratory of Precision Medicine Research on Head & Neck Cancer, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China. (1 speakers): Jiajie Xu\n\n**Croatia (1 institutions, 1 speakers)**\n  - University J.J. Strossmayer Osijek, Osijek, Croatia. (1 speakers): Silvija Piskorjanac\n\n**Cyprus (1 institutions, 1 speakers)**\n  - Karaiskakio Foundation, Nicosia, Cyprus. (1 speakers): Petroula Gerasimou\n\n**Denmark (2 institutions, 2 speakers)**\n  -  (1 speakers): Sebastian Soby\n  - Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital-Rigshospitalet & Department of Biomedical Sciences University of Copenhagen Copen... (1 speakers): Andreas Kjaer\n\n**Egypt (1 institutions, 1 speakers)**\n  -  (1 speakers): Rana El-Shewy\n\n**FL (1 institutions, 1 speakers)**\n  - Department of Biomedical Sciences and Human Oncology, University of Bari, Italy. (1 speakers): Mauro Cives\n\n**Finland (2 institutions, 2 speakers)**\n  - Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Finland. (1 speakers): Mika Kontro\n  - Department of Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. (1 speakers): Emerik Osterlund\n\n**France (25 institutions, 25 speakers)**\n  -  (1 speakers): Nael Alshatti\n  - Académie nationale de pharmacie, Unicancer, Paris, France. (1 speakers): Muriel Dahan\n  - Cancer Committee of the French Association of Urology (CCAFU), France, Department of Medical Oncology, Gustave Roussy Cancer Campus, Paris-Saclay University, Villejuif, France. (1 speakers): Laurence Albiges\n  - Centre Francois-Baclesse, Medical Oncology, Caen, France. (1 speakers): Florence Joly Lobbedez\n  - Centre Léon Bérard, Lyon, France, Lyon, France, Centre de Recherche en Cancérologie de Lyon, Lyon, France. (1 speakers): Quentin Devin\n  - Centre Médical de Bligny, Briis-sous-Forges, France. (1 speakers): Ingrid Alexandre\n  - Department of Cancer Medicine, Thoracic Group and International Center for Thoracic Cancers, Paris-Saclay University, Villejuif, France. (1 speakers): David Planchard\n  - Department of Drug Development & Innovation (D3i), Paris-Saclay University, Paris, France. (1 speakers): Christophe Le Tourneau\n  - Department of ENT-Head and Neck Surgery Toulouse University Hospital, Hôpital Larrey Toulouse France. (1 speakers): MATHILDE MIRALLIE\n  - Department of Hepatology and Gastroenterology, Groupement Hospitalier Lyon Nord, Lyon, France. (1 speakers): Philippe Merle\n  - Department of Medical Oncology, Leon Berard Cancer Center, Lyon, France. (1 speakers): Philippe Cassier\n  - Department of Medicine, Institut Bergonié, Bordeaux, France, Faculty of Medicine, University of Bordeaux, Bordeaux, France, Bordeaux, France. (1 speakers): Florent Peyraud\n  - Department of Otorhinolaryngology - Head and Neck Surgery, Gustave Roussy Cancer Center, Villejuif, France. (1 speakers): Caroline Even\n  - Department of Pulmonary and Thoracic Oncology, Centre Hospitalier Universitaire Lille, University of Lille, U1019 INSERM, Center of Infection and Immunity of Lille, Lille, France. (1 speakers): Arnaud Scherpereel\n  - Department of Radiation Oncology, François Baclesse Comprehensive Cancer Center, Caen, France. (1 speakers): DInu STEFAN\n  - Department of Radiation Oncology, Paris-Saclay University, Villejuif, France. (1 speakers): Yungan Tao\n  - Faculty of Medicine, University of Bordeaux, Bordeaux, France. (1 speakers): Antoine Italiano\n  - France (L.D., S.A., J.H., S. Morer, C.D., F. Bidault, C.B., S. Muller, N.L.), Université Paris-Saclay, Inserm, Centre national de la recherche scientifique, Villejuif, France (Y.B., L. Lawrance, O.G. (1 speakers): Maria Fernanda Mosele\n  - GI Oncology, Medical Oncology Department, Curie Institute, Versailles Saint-Quentin University-Paris Saclay University, France. (1 speakers): Matthieu Delaye\n  - Health Technologies Institute, Inserm, Paris, France. (1 speakers): Frederique Nowak\n  - INSERM U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. (1 speakers): Cinzia Ungolo\n  - Interdisciplinary Department for the Organization of Patient Pathways (DIOPP), Gustave Roussy, Villejuif, France. (1 speakers): Ines V. Vaz-Luis\n  - Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France. (1 speakers): Killian Carnet Le Provost\n  - Sorbonne University, Department of Hepato-Gastroenterology, Pitié-Salpêtrière Hospital, Paris, France. (1 speakers): Jean-Baptiste Bachet\n  - Université de Paris, Institut du Cancer Paris CARPEM, F-75006 Paris, France, Department of medical oncology, APHP.Centre, Paris, France. (1 speakers): Claire Gervais\n\n**Fukushima (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Fukushima Medical University School of Medicine, Fukushima, Japan. (1 speakers): Shigehira Saji\n\n**Germany (26 institutions, 26 speakers)**\n  -  (1 speakers): Tina Holzgen\n  - Charité Comprehensive Cancer Center, Charité-Universitätsmedizin Berlin, Berlin, Germany. (1 speakers): Max Schmidt\n  - Department of Clinical Oncology, Hamburg, Germany. (1 speakers): Georgia Schilling\n  - Department of Dermatology, University Hospital Tuebingen, Tübingen, Germany. (1 speakers): Lukas Flatz\n  - Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 21-23 (1 speakers): Peter A. Fasching\n  - Department of Gynecology, Medical Center, Leipzig University, Germany. (1 speakers): Laura Weydandt\n  - Department of Hematology, Charité University Medicine Berlin, Berlin, Germany. (1 speakers): Lars Bullinger\n  - Department of Hematology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany. (1 speakers): Sebastian Stintzing\n  - Department of Hematology/Oncology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany. (1 speakers): Marit Ahrens\n  - Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. (1 speakers): Stefanie Zschabitz\n  - Department of Nuclear Medicine, University Hospital Essen, German Cancer Consortium, West German Cancer Center, Essen, Germany. (1 speakers): Alina T. Kuper\n  - Department of Otolaryngology and Head & Neck Surgery, Hospital of the Ludwig-Maximilians-University, Munich, Germany. (1 speakers): Susanne Flach\n  - Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center and Comprehensive Cancer Center Ulm, Ulm, Germany. (1 speakers): Simon Laban\n  - Department of Otorhinolaryngology, Head and Neck Surgery, Luzerner Kantonsspital, Switzerland. (1 speakers): Christoph R. Schlegel\n  - Department of Otorhinolaryngology, University of Leipzig Medical Center, Leipzig, Germany. (1 speakers): Andreas Dietz\n  - Department of Radiooncology and Radiotherapy, Charite University Hospital, Berlin, Germany. (1 speakers): Ingeborg Tinhofer-Keilholz\n  - Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Germany. (1 speakers): Soren Schnellhardt\n  - Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Homburg, Germany. (1 speakers): Markus Hecht\n  - Department of Urology, Friedrich-Schiller-University Jena, Jena University Hospital, Germany. (1 speakers): Marc-Oliver Grimm\n  - Director of the I. Medical Department at the University Medical Center, Johannes Gutenberg University, Mainz, Germany. (1 speakers): Peter R. Galle\n  - GBG Forschungs GmbH and Goethe University Frankfurt, Neu-Isenburg, Germany. (1 speakers): Sibylle Loibl\n  - Gerhard-Domagk-Institute of Pathology, University Hospital Muenster, Germany. (1 speakers): Eva Wardelmann\n  - Hospital Gemeinschaftskrankenhaus Havelhöhe, Berlin, Germany. (1 speakers): Friedemann T. Schad\n  - Institute of Clinical Cancer Research IKF, Frankfurt am Main, Germany. (1 speakers): Thorsten O. Goetze\n  - Laboratory of Experimental Oncology, Department of Oncology, University Medical Center Hamburg-Eppendorf, Germany. (1 speakers): Gunhild Von Amsberg\n  - Medical Clinic II, University Hospital Frankfurt, Frankfurt, Germany. (1 speakers): Lothar Bergmann\n\n**Greece (4 institutions, 4 speakers)**\n  - 2nd Department of Internal Medicine, Attikon University Hospital, Athens, Greece. (1 speakers): Maria Anastasiou\n  - Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra General Hospital, Greece. (1 speakers): Ioannis Ntanasis-Stathopoulos\n  - Medical Oncology Unit, 2nd Department of Internal Medicine-Propaedeutic, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Chaidari, Greece. (1 speakers): Amanda Psyrri\n  - Second Propaedeutic Department of Medicine, Attikon University Hospital, Chaidari, Greece. (1 speakers): Anastasios Pantazopoulos\n\n**Guangdong (1 institutions, 1 speakers)**\n  - Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, The People's Republic of China. chmingy@mail.sysu.edu.cn. (1 speakers): Mingyuan Chen\n\n**India (5 institutions, 5 speakers)**\n  -  (1 speakers): Ishita Rastogi\n  - Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, India. (1 speakers): Arnab Pal\n  - Dr. Rai - Comprehensive Blood and Cancer Center Oncology Services, Tamil Nadu, India. (1 speakers): Rajesh K. Narayanasamy\n  - Medical Services, Medical Affairs Division, Mumbai, IND. (1 speakers): Maneesha Khalse\n  - Tata Memorial Hospital, Mumbai 400 012, India. (1 speakers): Goutam S. Panda\n\n**Israel (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel. (1 speakers): Nathan I. Cherny\n\n**Italy (34 institutions, 34 speakers)**\n  - Department of Biomedicine and Prevention, Tor Vergata University of Rome, Rome, Italy. (1 speakers): Federica Lacarbonara\n  - Department of Experimental Oncology, European Institute of Oncology IRCCS (IEO), Milan, Italy. (1 speakers): Luca Mazzarella\n  - Department of Experimental, University of Bologna, Sant' Orsola-Malpighi Hospital, Bologna I-40138, Italy. (1 speakers): Daria Maria Filippini\n  - Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. (1 speakers): Luca Arecco\n  - Department of Medical Oncology and Hematology, IRCCS Humanitas Research Hospital, Milan, Italy. (1 speakers): Matteo Simonelli\n  - Department of Medical Oncology, CRO di Aviano, National Cancer Institute, IRCCS, Italy, Department of Medicine, University of Udine, Italy. (1 speakers): Lorenzo Foffano\n  - Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy, Vita-Salute San Raffaele University, Milan, Italy. (1 speakers): Andrea Necchi\n  - Department of Medical Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy. (1 speakers): Giuseppe Lombardi\n  - Department of Medical Oncology, Pancreas Translational & Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy. (1 speakers): Michele Reni\n  - Department of Medicine and Surgery, Medical Oncology Unit, University Hospital of Parma, Parma, Italy. (1 speakers): Marcello Tiseo\n  - Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy. (1 speakers): Antonio Marra\n  - Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. (1 speakers): Gianluca Mauri\n  - Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. (1 speakers): Stefano Cavalieri\n  - Department of Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto IOV, IRCCS, Padova, Italy. (1 speakers): Antonella Brunello\n  - Department of Otolaryngology-Head and Neck Surgery, Provincial Hospital of Bolzano (SABES-ASDAA), Bolzano, Italy. (1 speakers): Francesca Zanghi\n  - Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy, Division of Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy. (1 speakers): Maria Vittoria Dieci\n  - Head and Neck Medical Oncology Department, Milan, Italy. (1 speakers): Laura D. Locati\n  - Humanitas Hospital San Pio X, Humanitas University, Milan, Italy. (1 speakers): Domenica Lorusso\n  - IRCCS Humanitas Research Hospital, Cancer Center, Rozzano, Italy. (1 speakers): Sara Farinatti\n  - IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy. (1 speakers): Francesca Gaino\n  - Maggiore University Hospital, 28100 Novara, Italy. (1 speakers): Tommaso L. Landolfo\n  - Maugeri Clinical Research Institutes IRCCS, Pavia, Italy. (1 speakers): Sara Demurtas\n  - Medical Oncologist, Department of Otorhinolaryngology, IRCCS San Raffaele Scientific Institute, Milano, Italy. (1 speakers): Aurora Mirabile\n  - Medical Oncology Unit, Bergamo, Italy, Department of Biomedical Sciences, Humanitas University, Rozzano, Italy. (1 speakers): Erika Stucchi\n  - Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Italy. (1 speakers): Matteo Carpani\n  - Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. (1 speakers): Lorenza Rimassa\n  - Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy, Department of Biomedical Sciences, Humanitas University, Milan, Italy. (1 speakers): Paolo Bossi\n  - Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. (1 speakers): Luigi Lorini\n  - Melanoma, Oncological Immunotherapy and Innovative Therapies Department INT - IRCCS \"Fondazione G. Pascale\" Naples Italy. (1 speakers): Paolo A. Ascierto\n  - Milan, Italy. (1 speakers): Patrizia Pasanisi\n  - Nervous System Medical Oncology Department, Bologna, Italy. (1 speakers): Vincenzo Di Nunno\n  - Section of Oncology, Department of Engineering for Innovation Medicine (DIMI), University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy. (1 speakers): Daniela Tregnago\n  - U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy. (1 speakers): Eva Blondeaux\n  - Unit of Medical Oncology 2, Pisa, Italy, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. (1 speakers): Veronica Conca\n\n**Japan (10 institutions, 11 speakers)**\n  - Department of Dermatologic Oncology, National Cancer Center Hospital, Chuo-Ku, Tokyo, Japan. (1 speakers): Eiji Nakano\n  - Department of Early Clinical Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan. (1 speakers): Chiaki Suzuki\n  - Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan. (2 speakers): Hideaki Bando, Yoshiaki Nakamura\n  - Department of Medical Oncology and Hematology, Cancer Center, Kobe University Hospital, Kobe, Japan, Japan Clinical Oncology Group (JCOG) Data Center, National Cancer Center Hospital, Tokyo, Japan (1 speakers): Koichiro Wasano\n  - Department of Medical Oncology, Hokkaido University Hospital, N14, W5, Kita-ku, Sapporo, Japan. (1 speakers): Yasushi Shimizu\n  - Department of Otolaryngology-Head & Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. (1 speakers): Akihiro Homma\n  - Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. (1 speakers): Takeshi Kodaira\n  - Division of Gastrointestinal Oncology, Shizuoka Cancer Center Hospital, Shizuoka, Japan. (1 speakers): Tomoya Yokota\n  - MSD K.K., Tokyo, Japan. (1 speakers): Tetsu Kamitani\n  - Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, Center for Genomic Medicine and Cardiovascular Research Center, Massachusetts General Hospital, Boston (1 speakers): Satoshi Koyama\n\n**Jerusalem (1 institutions, 1 speakers)**\n  - Radiation Oncology Department, Augusta Victoria Hospital, Jerusalem 9511208, Palestine. (1 speakers): Elias E. Lahham\n\n**MA (1 institutions, 1 speakers)**\n  - Massachusetts General Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA, USA. (1 speakers): Dejan Juric\n\n**MD (1 institutions, 1 speakers)**\n  - Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, USA. (1 speakers): Julie R. Brahmer\n\n**MI (1 institutions, 1 speakers)**\n  - Yale University Cancer Center, Connecticut. (1 speakers): Patricia M. Lorusso\n\n**MO (1 institutions, 1 speakers)**\n  - Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Tina Cascone\n\n**Mexico (1 institutions, 1 speakers)**\n  - Santiago de Querétaro, Mexico. (1 speakers): Carla D. Robles-Espinoza\n\n**Morocco (2 institutions, 2 speakers)**\n  -  (1 speakers): Rania Chakir\n  - National Institute of Oncology, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco. (1 speakers): Hassan Errihani\n\n**N. Faliro (1 institutions, 1 speakers)**\n  - Fourth Oncology Department & Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece. (1 speakers): Helena Linardou\n\n**NSW (1 institutions, 1 speakers)**\n  - Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia. (1 speakers): David Goldstein\n\n**NY (3 institutions, 3 speakers)**\n  - Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. (1 speakers): Shigehisa Kitano\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, USA. (1 speakers): Dana E. Rathkopf\n  - Department of Medicine, Weill Cornell Medical College, NY, Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY (1 speakers): Carol Aghajanian\n\n**Netherlands (11 institutions, 11 speakers)**\n  -  (1 speakers): Stef Elings\n  - Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands. (1 speakers): Noor Wortelboer\n  - Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands. (1 speakers): Ellen Kapiteijn\n  - Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands. (1 speakers): Sjoukje F. Oosting\n  - Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht 80125, the Netherlands. (1 speakers): Jeanine Roodhart\n  - Department of Pulmonary Medicine, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands. (1 speakers): Ilias Houda\n  - Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, Department of Pulmonary Diseases, Leiden University Medical Centre, Leiden (1 speakers): Egbert F. Smit\n  - Erasmus University Medical Center, Rotterdam, The Netherlands. (1 speakers): Winette T. Van Der Graaf\n  - Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: ms.vd.heijden@nki.nl. (1 speakers): Michiel S. Van der Heijden\n  - The Netherlands Cancer Institute, Amsterdam, the Netherlands. (1 speakers): Daniela S. Thommen\n  - Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. (1 speakers): Yan Sun\n\n**Norway (3 institutions, 3 speakers)**\n  -  (1 speakers): Synne-Kristin H. Bohn\n  - Department of Oncology, Lovisenberg Diaconal Hospital, Oslo, Norway. (1 speakers): Katarina Puco\n  - Department of Oncology, Oslo University Hospital, Oslo, Norway. pbk@ous-hf.no. (1 speakers): Kjetil Boye\n\n**Oxfordshire (1 institutions, 1 speakers)**\n  - Department of Oncology, Queen Elizabeth Hospital, Birmingham B15 2GW, UK. (1 speakers): Shivan Sivakumar\n\n**Pakistan (2 institutions, 2 speakers)**\n  - Department of Medicine, Ziauddin Medical College, Karachi, Pakistan. (1 speakers): Aryan Tareen\n  - School of Public Health, Dow University of Health Sciences, Department of Medicine, Aga Khan University, Karachi, Pakistan. (1 speakers): Akbar Shoukat\n\n**Pokfulam (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, The University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China. (1 speakers): Janice Wing-Hang Tsang\n\n**Portugal (3 institutions, 3 speakers)**\n  - Center for Drug Discovery and Innovative Medicines (MedInUP) and RISE-Health: Health Research Network, Portugal. (1 speakers): Diogo Silva\n  - Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal. (1 speakers): Joana C. Marinho\n  - Hospital Divino Espírito Santo, Ponta Delgada, Portugal. (1 speakers): Tiago A. Pina Cabral\n\n**QLD (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Royal North Shore Hospital, Australia, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia. (1 speakers): Rahul Ladwa\n\n**Republic of Korea (6 institutions, 6 speakers)**\n  - Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Korea. (1 speakers): Do-Youn Oh\n  - Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea. (1 speakers): Ho-Shin Gwak\n  - Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. (1 speakers): Bhumsuk Keam\n  - Department of Medical Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. (1 speakers): Sung-Bae Kim\n  - Hematology-Oncology Department, Samsung Medical Center (SMC), Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. (1 speakers): Myung-Ju Ahn\n  - Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Republic of Korea. (1 speakers): Sun Young Rha\n\n**Romania (1 institutions, 1 speakers)**\n  - Advanced Center for Research and Development in Experimental Medicine (CEMEX), \"Grigore T. Popa\" University of Medicine and Pharmacy, Iași, Romania. (1 speakers): Ioana Creanga-Murariu\n\n**Samoa American (1 institutions, 1 speakers)**\n  - College of Life Sciences, Northwest A&F University, Yangling, Shaanxi, China. (1 speakers): Abdur Rehman\n\n**Serbia (1 institutions, 1 speakers)**\n  - Faculty of Chemistry, University of Belgrade, Serbia. (1 speakers): Aleksandar Popovic\n\n**Singapore (3 institutions, 3 speakers)**\n  - Cancer Therapeutics Research Laboratory, National Cancer Centre Singapore, Singapore 168583, Singapore, Duke-NUS Medical School, National University of Singapore, Singapore 169857, Singapore. (1 speakers): N Gopalakrishna Iyer\n  - Department of Radiation Oncology, National Cancer Center Singapore, Singapore, Singapore. (1 speakers): Melvin Lee Kiang Chua\n  - Office of Academic and Clinical Development, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore. (1 speakers): Darren Wan-Teck Lim\n\n**Spain (22 institutions, 28 speakers)**\n  -  (5 speakers): Cristina Saura Manich, Edurne Arriola Aperribay, Patricia Capdevila Gaudens, Pau Mascaro Baselga, Zara Vidales Sepulveda\n  - Childhood Cancer and Blood Disorders Research Group, Vall d'Hebron Research Institute, Barcelona, Spain. (1 speakers): Lorena Valero-Arrese\n  - Complejo Hospitalario Universitario de Badajoz, E-06080 Badajoz, Spain. (1 speakers): Alvaro B. Garcia\n  - Department of Medical Oncology and Program in Solid Tumors Cima-Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Madrid, Spain. (1 speakers): Antonio Gonzalez-Martin\n  - Department of Medical Oncology, Hospital General Universitario Gregorio Marañon Instituto de Investigacion Sanitaria Gregorio Marañon, Madrid, Spain. (1 speakers): Miguel Martin\n  - Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, Spain. (2 speakers): Elena Garralda, Irene Brana\n  - Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. (1 speakers): Jaume Capdevila\n  - Department of Oncology, Hospital Universitari Arnau de Vilanova, University of Lleida, IRB-Lleida, No. 80, Lleida, Spain. (1 speakers): Antonio Llombart Cussac\n  - Department of Oncology, Hospital of the Holy Cross and Saint Paul, Barcelona, Catalonia, Spain. (1 speakers): Alejandra Romano Cardozo\n  - Department of Oncology, University Hospital Marqués of Valdecilla, IDIVAL Santander, Cantabria, Spain. (1 speakers): Ignacio Duran\n  - H12O-CNIO Lung Cancer Clinical Research Unit, Instituto de Investigación Hospital 12 de Octubre (i+12) & Centro Nacional de Investigaciones Oncológicas (CNIO), CIBERONC, UCM, Madrid, Spain. (1 speakers): Luis Paz-Ares\n  - Hospital General Universitario Gregorio Marañón, Spanish Society of Medical Oncology (SEOM), Spain. (1 speakers): Javier Soto Alsar\n  - Medical Oncology Department, Hospital Clinico Universitario de Valencia-INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain. (1 speakers): Gema Bruixola\n  - Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain. (1 speakers): Ivan Marquez-Rodas\n  - Medical Oncology Department, Hospital Universitario 12 de Octubre, IIS Imas12, Facultad de Medicina, Madrid, Spain. (1 speakers): Rocio Garcia-Carbonero\n  - Medical Oncology Service, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. (1 speakers): Ana Oaknin\n  - Ramon y Cajal University Hospital, Madrid, Spain. (2 speakers): Ana Maria Barrill Corpa, Coral Garcia de Quevedo Suero\n  - Research Health Institute of Fundacion Jimenez Diaz (IIS/FJD, UAM), Madrid, Spain. (1 speakers): Javier Martin-Broto\n  - The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey (1 speakers): Victor Moreno Garcia\n  - University Hospital La Fe, Valencia, Spain. (1 speakers): Maribel Del Olmo\n  - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. (1 speakers): Maria Alsina Maqueda\n  - Vall d'Hebron Institute of Oncology, Spain. (1 speakers): Stefania Napoli\n\n**Surrey (1 institutions, 1 speakers)**\n  - Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. (1 speakers): Timothy Anthony Yap\n\n**Sweden (2 institutions, 2 speakers)**\n  - Department of Hematology and Oncology Akademiska Hospital Uppsala Sweden. (1 speakers): Ingrid Glimelius\n  - Lund University and IHE, Lund, Sweden. (1 speakers): Thomas Hofmarcher\n\n**Switzerland (8 institutions, 8 speakers)**\n  - Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland. (1 speakers): Michael Weller\n  - Department of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland. (1 speakers): Raffaella Casolino\n  - Department of Oncology, University of Lausanne and Lausanne University Hospital, 1011 Lausanne, Switzerland. (1 speakers): Petr Szturz\n  - Department of Radiation Oncology, University Hospital Basel, Basel, Switzerland. (1 speakers): Alexandros Papachristofilou\n  - Medicine and Technology, Faculty of Law, University of Zurich, Zurich, Switzerland. (1 speakers): Simon Hediger\n  - University of Zurich, Switzerland (C.E.G.G., L.W.). (1 speakers): Camille Glaus\n  - University of Zurich, Zurich, Switzerland. (1 speakers): Miquel S. Serra-Burriel\n  - cUniversity Hospital Zurich, Zurich, Switzerland. (1 speakers): Reinhard Dummer\n\n**TN (1 institutions, 1 speakers)**\n  - Sarah Cannon Research Institute, Nashville, TN. (1 speakers): Melissa L. Johnson\n\n**TX (1 institutions, 1 speakers)**\n  - Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. (1 speakers): Kanwal Raghav\n\n**Taiwan (1 institutions, 1 speakers)**\n  - National Institute of Cancer Research, National Health Research Institute, Tainan, Taiwan, Department of Oncology, College of Medicine, Tainan, Taiwan, Department of Internal Medicine (1 speakers): Li-Tzong Chen\n\n**Thailand (1 institutions, 1 speakers)**\n  - Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Dusit, Bangkok (1 speakers): Aniwat Berpan\n\n**Turkey (2 institutions, 2 speakers)**\n  - Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey. (1 speakers): Yuksel Urun\n  - Institute of Cancer Research, Ankara University, Ankara, Turkey. (1 speakers): Enes Erul\n\n**United Kingdom (22 institutions, 22 speakers)**\n  -  (1 speakers): Isobel Read\n  - Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London, UK. (1 speakers): Sara Coca Membribes\n  - Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London EC1M 6AU, UK. (1 speakers): Peter Schmid\n  - Centre for Host-Microbiome Interactions, King's College London, London, UK. (1 speakers): Anjali Chander\n  - Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK, Division of Cancer Sciences, The University of Manchester, Manchester, UK. (1 speakers): Fiona Blackhall\n  - Department of Oncology, Oxford University, Oxford, UK. (1 speakers): Eileen E. Parkes\n  - Department of Surgery and Cancer, Imperial College London, Faculty of Medicine, Hammersmith Hospital, W120NN, London, UK, Department of Translational Medicine (DIMET) (1 speakers): David J. Pinato\n  - Division of Cancer Sciences, The University of Manchester and Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Matthew G. Krebs\n  - Edinburgh Cancer Research, University of Edinburgh, Edinburgh, Scotland, UK. (1 speakers): Barry Laird\n  - Faculty of Biosciences, Heidelberg University, Heidelberg, Germany. (1 speakers): Aino-Maija Leppa\n  - Institute of Head and Neck Studies and Education, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. (1 speakers): Hisham M. Mehanna\n  - Institute of Reproductive and Developmental Biology, Imperial College London, London, W12 0HS, UK. (1 speakers): Jonathan Krell\n  - MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK. (1 speakers): Peter J. Godolphin\n  - Manchester Foundation Trust, Manchester, UK. (1 speakers): Sian Dobbs\n  - Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Center, University of Edinburgh, Edinburgh, UK. (1 speakers): Charlie Gourley\n  - The Christie NHS Foundation Trust and University of Manchester, Manchester, UK. (1 speakers): Fiona Thistlethwaite\n  - The Institute of Cancer Research, London, England, UK. (1 speakers): Kevin J. Harrington\n  - The Royal Marsden Hospital., The Institute of Cancer Research, The Royal Marsden Hospital. (1 speakers): Ben O'Leary\n  - The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK. (1 speakers): Nicholas D. James\n  - Ulster Hospital, South Eastern Health and Social Care Trust, Dundonald, UK. (1 speakers): Cherith J. Semple\n  - University Hospitals Sussex NHS Foundation Trust, Brighton BN1 9RW, UK. (1 speakers): Rille Pihlak\n  - University of Leicester, Leicester, UK, University Hospitals of Leicester NHS Trust, Leicester, UK. (1 speakers): Dean A. Fennell\n\n**United States of America (57 institutions, 58 speakers)**\n  -  (1 speakers): Iole Ribizzi-Akhtar\n  - 19University of California, Los Angeles Medical Center, CA, USA. (1 speakers): Alexandra Drakaki\n  - 3Division of Hematology-Oncology, Department of Medicine, VAGLAHS/David Geffen School of Medicine at University of California, CA. (1 speakers): Daniel S. Shin\n  - Clinical Research, START, TX. (1 speakers): Kyriakos P. Papadopoulos\n  - Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. (1 speakers): Jacob Sands\n  - David Geffen School of Medicine at University of California, Los Angeles, Los Angeles. (1 speakers): Zev A. A. Wainberg\n  - Department of Biomedical Engineering, GA, USA, Department of Biomedical Engineering, Emory University, GA, USA. (1 speakers): Mayukhmala Jana\n  - Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. (1 speakers): Scott Woodman\n  - Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. (1 speakers): Neil Gross\n  - Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Cancer Neuroscience Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (1 speakers): Moran Amit\n  - Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. (1 speakers): Hossein Borghaei\n  - Department of Internal Medicine and The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH. (1 speakers): Marcelo Bonomi\n  - Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas. (1 speakers): Tian Zhang\n  - Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston (1 speakers): Fadi G. Haddad\n  - Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA. (1 speakers): Jonathan Schoenfeld\n  - Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA. (2 speakers): Aditya Shreenivas, Amanda Reyes\n  - Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA. (1 speakers): Robert Haddad\n  - Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA. (1 speakers): Wenxin Xu\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA, USA. (1 speakers): Sylvan Baca\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. (1 speakers): Marc Machaalani\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. (1 speakers): Glenn J. Hanna\n  - Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA (1 speakers): Aparna Parikh\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center (1 speakers): Karen Autio\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, USA, Department of Medicine, Weill Cornell Medicine and New York Presbyterian Hospital, NY, USA. (1 speakers): Alan L. Ho\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY. (1 speakers): James J. Harding\n  - Department of Medicine, School of Medicine, University of California San Diego, CA 92093, USA. (1 speakers): Rana R. McKay\n  - Department of Otolaryngology-Head and Neck Surgery Stanford University School of Medicine Stanford California USA. (1 speakers): Alexander Dimitrios Colevas\n  - Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (1 speakers): Berkay Simsek\n  - Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. (1 speakers): Jennifer Hwang\n  - Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Simon Heeke\n  - Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): John Heymach\n  - Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. (1 speakers): Carl M. Gay\n  - Division of Hematology-Oncology, Mayo Clinic Rochester, Minnesota. (1 speakers): Jacob Orme\n  - Division of Medical Oncology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. (1 speakers): Aman Chauhan\n  - Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA. (1 speakers): Thorvardur R. Halfdanarson\n  - Division of Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, NC, USA. (1 speakers): Siddharth Sheth\n  - Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA. (1 speakers): Ravi Uppaluri\n  - Don S. Dizon, Massachusetts General Hospital, Boston, Dana-Farber Cancer Institute, Boston, MA, Alexandria, VA, University of California San Diego, Patricia A. Ganz (1 speakers): Erica Mayer\n  - From the Department of Diagnostic Radiology (J.N., D.P., K.L., E.W., M.K.G.), The University of Texas M.D. MD Anderson Cancer Center, Houston, TX 77030, USA (1 speakers): Maura Gillison\n  - Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Milind Javle\n  - Greco-Hainsworth Center for Cancer Research, Nashville, TN, USA. (1 speakers): Kathryn Beckermann\n  - HonorHealth Research Institute, Scottsdale, AZ, USA. (1 speakers): Michael Gordon\n  - Institute: Department of Internal Medicine, AdventHealth Sebring, FL, USA. (1 speakers): Muhammad Sohaib Asghar\n  - Mass General Cancer Center, Boston, MA, USA. (1 speakers): Gregory M. Cote\n  - Medical Oncology, Huntsman Cancer Institute Cancer Hospital, Utah, USA. (1 speakers): Ignacio Garrido-Laguna\n  - Memorial Sloan Kettering Cancer Center, NY, USA 10065. (1 speakers): Michael Bonner B. Foote\n  - Moffitt Cancer Center & Research Institute in Tampa, Tampa, Florida. (1 speakers): Amir Alishani Tabriz\n  - Moffitt Cancer Center, Tampa, FL, USA. (1 speakers): Jonathan R. Strosberg\n  - Norris Comprehensive Cancer Center, University of Southern California, California. (1 speakers): Jacob Thomas\n  - Oregon Health & Science University. (1 speakers): Thomas Hwang\n  - Rogel Cancer Center, University of Michigan, MI, USA. (1 speakers): Paul L Swiecicki\n  - Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. (1 speakers): Shilpa Gupta\n  - The Angeles Clinic & Research Institute, California. (1 speakers): Justin T. Moyers\n  - The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Michael Dennis\n  - The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. (1 speakers): Renata Ferrarotto\n  - University of Alicante, Alicante, Spain. (1 speakers): Guillermo Argiles Martinez\n  - Yale New Haven Hospital, CT, USA. (1 speakers): Michael Cecchini\n\n**Vietnam (2 institutions, 2 speakers)**\n  - Can Tho Central General Hospital, Ninh Kieu, Vietnam. (1 speakers): Phong D. Le Pham\n  - Harvard University, Boston, Massachusetts. (1 speakers): Dang N. Van Nguyen"
  },
  "melanoma": {
    "top_institutions": {
      "columns": [
        "Institution",
        "# Studies",
        "Locations"
      ],
      "rows": [
        {
          "Institution": "MD Anderson Cancer Center, Houston",
          "# Studies": 62,
          "Locations": "Houston, United States of America, Surrey, Houston, United States of America, Houston, United States of America, TX"
        },
        {
          "Institution": "Medical Oncology Department",
          "# Studies": 58,
          "Locations": "Barcelona, Spain, Milan, Italy, Madrid, Spain"
        },
        {
          "Institution": "Dana-Farber Cancer Institute",
          "# Studies": 51,
          "Locations": "Boston, United States of America, Boston, United States of America, MA, New York, United States of America"
        },
        {
          "Institution": "Memorial Sloan Kettering Cancer Center",
          "# Studies": 47,
          "Locations": "New York, United States of America, NY, New York, United States of America, Commack, United States of America"
        },
        {
          "Institution": "Sun Yat-sen University Cancer Center",
          "# Studies": 29,
          "Locations": "Guangzhou, China, guangzhou, China, Guangzhou, China, Guangdong"
        },
        {
          "Institution": "Fudan University Shanghai Cancer Center",
          "# Studies": 22,
          "Locations": "Shanghai, China"
        },
        {
          "Institution": "Department of Internal Medicine",
          "# Studies": 19,
          "Locations": "Seoul, Republic of Korea, Salt Lake City, United States of America, Uijeongbu, Republic of Korea"
        },
        {
          "Institution": "National Cancer Center Hospital East",
          "# Studies": 19,
          "Locations": "Kashiwa, Japan, Kanagawa, Kashiwa, Japan, Kashiwa, Japan, Chiba"
        },
        {
          "Institution": "Medical Oncology Unit",
          "# Studies": 17,
          "Locations": "Parma, Italy, Pavia, Italy, Florence, Italy"
        },
        {
          "Institution": "Mayo Clinic",
          "# Studies": 14,
          "Locations": "Rochester, United States of America, Rochester, United States of America, MN, New Orleans, United States of America"
        },
        {
          "Institution": "Leiden University Medical Center",
          "# Studies": 13,
          "Locations": "Leiden, Netherlands, Belfast, United Kingdom"
        },
        {
          "Institution": "Department of Medicine I",
          "# Studies": 13,
          "Locations": "Vienna, Austria"
        },
        {
          "Institution": "IRCCS San Raffaele Hospital",
          "# Studies": 13,
          "Locations": "Milan, Italy, Pisa, Italy"
        },
        {
          "Institution": "Comprehensive Cancer Center",
          "# Studies": 12,
          "Locations": "Berlin, Germany, Munich, Germany, Rome, Italy"
        },
        {
          "Institution": "National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital",
          "# Studies": 12,
          "Locations": "Beijing, China, Bejing, China, Tianjin, China"
        },
        {
          "Institution": "University of Milan",
          "# Studies": 12,
          "Locations": "Milan, Italy"
        },
        {
          "Institution": "Netherlands Cancer Institute",
          "# Studies": 11,
          "Locations": "Amsterdam, Netherlands"
        },
        {
          "Institution": "Cancer Center",
          "# Studies": 11,
          "Locations": "Wuhan, China, Chengdu, China, Boston, United States of America"
        },
        {
          "Institution": "University of California San Francisco Helen Diller Family Comprehensive Cancer Center",
          "# Studies": 11,
          "Locations": "Los Angeles, United States of America, CA"
        },
        {
          "Institution": "University Hospital CHUV",
          "# Studies": 11,
          "Locations": "Lausanne, Switzerland"
        },
        {
          "Institution": "Oncology Department",
          "# Studies": 11,
          "Locations": "Seville, Spain, Reggio Emilia, Italy, Barcelona, Spain"
        },
        {
          "Institution": "University of California San Diego",
          "# Studies": 11,
          "Locations": "La Jolla, United States of America"
        },
        {
          "Institution": "Erasmus MC Cancer Institute",
          "# Studies": 10,
          "Locations": "Rotterdam, Netherlands"
        },
        {
          "Institution": "European Institute of Oncology",
          "# Studies": 10,
          "Locations": "Milan, Italy"
        },
        {
          "Institution": "Toronto General Hospital",
          "# Studies": 10,
          "Locations": "Toronto, Canada"
        },
        {
          "Institution": "West German Cancer Center",
          "# Studies": 10,
          "Locations": "Essen, Germany, Munster, Germany"
        },
        {
          "Institution": "Sarah Cannon Research Institute",
          "# Studies": 10,
          "Locations": "Nashville, United States of America, TN, Nashville, United States of America, Fort Myers, United States of America"
        },
        {
          "Institution": "Royal Marsden Hospital",
          "# Studies": 9,
          "Locations": "London, United Kingdom, Sutton, United Kingdom"
        },
        {
          "Institution": "Barts Cancer Institute",
          "# Studies": 9,
          "Locations": "London, United Kingdom"
        },
        {
          "Institution": "Vanderbilt-Ingram Cancer Center",
          "# Studies": 9,
          "Locations": "Nashville, United States of America, OH, Nashville, United States of America, TX"
        }
      ]
    },
    "table_context": "**TOP INSTITUTIONS TABLE:**\n| Institution                                                                            |   # Studies | Locations                                                                                                           |\n|:---------------------------------------------------------------------------------------|------------:|:--------------------------------------------------------------------------------------------------------------------|\n| MD Anderson Cancer Center, Houston                                                     |          62 | Houston, United States of America, Surrey, Houston, United States of America, Houston, United States of America, TX |\n| Medical Oncology Department                                                            |          58 | Barcelona, Spain, Milan, Italy, Madrid, Spain                                                                       |\n| Dana-Farber Cancer Institute                                                           |          51 | Boston, United States of America, Boston, United States of America, MA, New York, United States of America          |\n| Memorial Sloan Kettering Cancer Center                                                 |          47 | New York, United States of America, NY, New York, United States of America, Commack, United States of America       |\n| Sun Yat-sen University Cancer Center                                                   |          29 | Guangzhou, China, guangzhou, China, Guangzhou, China, Guangdong                                                     |\n| Fudan University Shanghai Cancer Center                                                |          22 | Shanghai, China                                                                                                     |\n| Department of Internal Medicine                                                        |          19 | Seoul, Republic of Korea, Salt Lake City, United States of America, Uijeongbu, Republic of Korea                    |\n| National Cancer Center Hospital East                                                   |          19 | Kashiwa, Japan, Kanagawa, Kashiwa, Japan, Kashiwa, Japan, Chiba                                                     |\n| Medical Oncology Unit                                                                  |          17 | Parma, Italy, Pavia, Italy, Florence, Italy                                                                         |\n| Mayo Clinic                                                                            |          14 | Rochester, United States of America, Rochester, United States of America, MN, New Orleans, United States of America |\n| Leiden University Medical Center                                                       |          13 | Leiden, Netherlands, Belfast, United Kingdom                                                                        |\n| Department of Medicine I                                                               |          13 | Vienna, Austria                                                                                                     |\n| IRCCS San Raffaele Hospital                                                            |          13 | Milan, Italy, Pisa, Italy                                                                                           |\n| Comprehensive Cancer Center                                                            |          12 | Berlin, Germany, Munich, Germany, Rome, Italy                                                                       |\n| National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital    |          12 | Beijing, China, Bejing, China, Tianjin, China                                                                       |\n| University of Milan                                                                    |          12 | Milan, Italy                                                                                                        |\n| Netherlands Cancer Institute                                                           |          11 | Amsterdam, Netherlands                                                                                              |\n| Cancer Center                                                                          |          11 | Wuhan, China, Chengdu, China, Boston, United States of America                                                      |\n| University of California San Francisco Helen Diller Family Comprehensive Cancer Center |          11 | Los Angeles, United States of America, CA                                                                           |\n| University Hospital CHUV                                                               |          11 | Lausanne, Switzerland                                                                                               |\n| Oncology Department                                                                    |          11 | Seville, Spain, Reggio Emilia, Italy, Barcelona, Spain                                                              |\n| University of California San Diego                                                     |          11 | La Jolla, United States of America                                                                                  |\n| Erasmus MC Cancer Institute                                                            |          10 | Rotterdam, Netherlands                                                                                              |\n| European Institute of Oncology                                                         |          10 | Milan, Italy                                                                                                        |\n| Toronto General Hospital                                                               |          10 | Toronto, Canada                                                                                                     |\n| West German Cancer Center                                                              |          10 | Essen, Germany, Munster, Germany                                                                                    |\n| Sarah Cannon Research Institute                                                        |          10 | Nashville, United States of America, TN, Nashville, United States of America, Fort Myers, United States of America  |\n| Royal Marsden Hospital                                                                 |           9 | London, United Kingdom, Sutton, United Kingdom                                                                      |\n| Barts Cancer Institute                                                                 |           9 | London, United Kingdom                                                                                              |\n| Vanderbilt-Ingram Cancer Center                                                        |           9 | Nashville, United States of America, OH, Nashville, United States of America, TX                                    |\n\n**ENRICHED INSTITUTION PROFILES (Top 10 with ClinicalTrials.gov Data):**\n\n\n**MD Anderson Cancer Center, Houston**\n  - ESMO 2025 Presentations: 62\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (65 total):\n    * Timothy Anthony Yap  - 924MO: First data disclosure of the first-in-class DNA polymerase theta inhibitor, ART6043, as monotherapy and in combination with olaparib, in patients with molecularly-selected advanced solid tumors (10/17/2025, 16:30 - 16:35, Heidelberg Auditorium - Hall 6.2)\n    * Xiuning Le  - LBA75: Sevabertinib (BAY 2927088) in advanced HER2-mutant non-small cell lung cancer (NSCLC): Results from the SOHO-01 study (10/17/2025, 16:25 - 16:35, Berlin Auditorium - Hub 27)\n    * Yasir Y. Elamin  - LBA72: NorthStar: A Phase II Randomized Study of Osimertinib (OSI) With or Without Local Consolidative Therapy (LCT) for Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) (10/17/2025, 16:00 - 16:10, Berlin Auditorium - Hub 27)\n    * Amado J. Zurita  - 2518TiP: Presurgical Phase II study of talazoparib in combination with enzalutamide in de novo metastatic to lymph nodes prostate cancer (TEN+) (10/18/2025, 12-13:00, Hall 25)\n    * Andrew W. Hahn  - LBA94: LenCabo: A randomized phase II multicenter trial of lenvatinib plus everolimus (len/eve) versus (vs) cabozantinib (cabo) in patients (pts) with metastatic clear cell RCC (ccRCC) that progressed on PD-1 immune checkpoint inhibition (ICI) (10/18/2025, 08:40 - 08:50, Berlin Auditorium - Hub 27)\n    * ... and 60 more presenters\n\n\n**Medical Oncology Department**\n  - ESMO 2025 Presentations: 58\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (73 total):\n    * Alejo Rodriguez-Vida  - : Optimising Outcomes: Patient-centred Care in mHSPC (10/17/2025, 18:00 - 19:30, Heidelberg Auditorium - Hall 6.2)\n    * Filippo Pietrantonio  - : How to move forward from early stage (10/17/2025, 16:45 - 17:00, Munich Auditorium - CityCube B)\n    * Alba Moll-Febrer  - 2986eP: Clinical profile of patients with lung cancer with multiple cancers: identifying a population at risk (10/18/2025, 12-13:00, Hall 25)\n    * Alfonso Cortes Salgado  - 1158P: Folate receptor alpha (FRalpha) expression in a molecularly characterized cohort of endometrial cancer (EC) cases: SPECTRUM-FRalpha/GEICO 163-T study. (10/18/2025, 12-13:00, Hall 25)\n    * Alvaro Pinto Marin  - 2652eP: Succinate-dehydrogenase B protein expression and prognosis of localized clear cell renal cell carcinoma (10/18/2025, 12-13:00, Hall 25)\n    * ... and 68 more presenters\n\n\n**Dana-Farber Cancer Institute**\n  - ESMO 2025 Presentations: 51\n  - Clinical Trials (2015-2025): 21 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06298734](https://clinicaltrials.gov/study/NCT06298734): High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial (NA, RECRUITING, Started 2024)\n    * [NCT05463796](https://clinicaltrials.gov/study/NCT05463796): InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer (Phase Not Specified, RECRUITING, Started 2023)\n    * [NCT05482074](https://clinicaltrials.gov/study/NCT05482074): Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2 (PHASE2, WITHDRAWN, Started 2022)\n    * [NCT05225428](https://clinicaltrials.gov/study/NCT05225428): Video Education With Result Dependent dIsclosure (NA, RECRUITING, Started 2022)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT04930783](https://clinicaltrials.gov/study/NCT04930783): NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma (PHASE1, RECRUITING, Started 2022) [COMPETITOR]\n    * [NCT03929029](https://clinicaltrials.gov/study/NCT03929029): Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma (PHASE1, ACTIVE_NOT_RECRUITING, Started 2020) [COMPETITOR]\n    * [NCT04007588](https://clinicaltrials.gov/study/NCT04007588): A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma (PHASE2, WITHDRAWN, Started 2019) [COMPETITOR]\n    * [NCT03161431](https://clinicaltrials.gov/study/NCT03161431): SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab (PHASE1, RECRUITING, Started 2019) [COMPETITOR]\n    * [NCT03239145](https://clinicaltrials.gov/study/NCT03239145): Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor (PHASE1, COMPLETED, Started 2017) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (53 total):\n    * Bradley A. McGregor  - : Invited Discussant (10/17/2025, 14:20 - 14:30, Dortmund Auditorium - Hall 7.1a)\n    * Clara Steiner  - : Invited Discussant (10/17/2025, 15:10 - 15:20, Dortmund Auditorium - Hall 7.1a)\n    * Pasi A. Janne  - LBA77: FLAURA2: exploratory overall survival (OS) analysis in patients (pts) with poorer prognostic factors treated with osimertinib (osi) +/- platinum-pemetrexed chemotherapy (CTx) as first-line (1L) treatment (tx) for EGFR-mutated (EGFRm) advanced NSCLC (10/17/2025, 17:00 - 17:10, Berlin Auditorium - Hub 27)\n    * Alicia K. Morgans  - 2455P: Prevalence and severity of hot flashes and their association with prostate-specific antigen (PSA) response: results from the initial treatment phase of LIBERTAS, a phase 3 study in metastatic hormone-sensitive prostate cancer (mHSPC) (10/18/2025, 12-13:00, Hall 25)\n    * Alicia K. Morgans  - 2477P: Real-world prostate-specific antigen (PSA) response with darolutamide or abiraterone in metastatic hormone-sensitive prostate cancer (mHSPC) triplet therapy (10/18/2025, 12-13:00, Hall 25)\n    * ... and 48 more presenters\n\n\n**Memorial Sloan Kettering Cancer Center**\n  - ESMO 2025 Presentations: 47\n  - Clinical Trials (2015-2025): 28 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT05837767](https://clinicaltrials.gov/study/NCT05837767): A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue (NA, RECRUITING, Started 2023)\n    * [NCT05640193](https://clinicaltrials.gov/study/NCT05640193): A Study of LN-144 in People With Metastatic Melanoma to the Brain (PHASE1, ACTIVE_NOT_RECRUITING, Started 2022)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT06594991](https://clinicaltrials.gov/study/NCT06594991): A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma (PHASE2, RECRUITING, Started 2024) [COMPETITOR]\n    * [NCT05912244](https://clinicaltrials.gov/study/NCT05912244): A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma (PHASE2, RECRUITING, Started 2023) [COMPETITOR]\n    * [NCT05859074](https://clinicaltrials.gov/study/NCT05859074): A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer (PHASE1, ACTIVE_NOT_RECRUITING, Started 2023) [COMPETITOR]\n    * [NCT05384496](https://clinicaltrials.gov/study/NCT05384496): Axitinib and Nivolumab for the Treatment of Mucosal Melanoma (PHASE2, RECRUITING, Started 2022) [COMPETITOR]\n    * [NCT02978443](https://clinicaltrials.gov/study/NCT02978443): A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab (PHASE2, TERMINATED, Started 2017) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (51 total):\n    * Andrea Cercek  - : Discussion led by Chair (10/17/2025, 16:35 - 17:00, Cologne Auditorium - CityCube A)\n    * Dana E. Rathkopf  - LBA91: Patient (pt) reported outcomes (PROs) from AMPLITUDE, a randomized placebo-controlled phase 3 trial of niraparib (NIRA) and abiraterone acetate (AA) plus prednisone (P) in metastatic hormone-sensitive prostate cancer (mHSPC) with homologous recombination repair mutations (HRRm) (10/17/2025, 14:00 - 14:05, Heidelberg Auditorium - Hall 6.2)\n    * Helena A. Yu  - 921MO: Phase 1 Global Study of Iza-Bren (BL-B01D1), an EGFR x HER3 Bispecific Antibody-drug Conjugate (ADC), in Patients with Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors (10/17/2025, 16:00 - 16:05, Heidelberg Auditorium - Hall 6.2)\n    * Karen Autio  - 2385MO: Translational analyses of T-cell phenotypes and their association with clinical efficacy in the first-in-human (FIH) trial of JNJ-78278343 (pasritamig) in metastatic castration-resistant prostate cancer (mCRPC) (10/17/2025, 14:40 - 14:45, Heidelberg Auditorium - Hall 6.2)\n    * Michael Bonner B. Foote  - 925MO: First-in-human phase I/Ib study of the oral Werner (WRN) helicase inhibitor HRO761 in patients (pts) with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) advanced solid tumors: Interim safety and efficacy analysis from HRO761 single agent dose escalation (10/17/2025, 16:35 - 16:40, Heidelberg Auditorium - Hall 6.2)\n    * ... and 46 more presenters\n\n\n**Sun Yat-sen University Cancer Center**\n  - ESMO 2025 Presentations: 29\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (39 total):\n    * Jihong Liu  - 1212P: Iparomlimab and tuvonralimab (QL1706) vs cadonilimab for previously treated recurrent/metastatic cervical cancer (r/mCC): An unanchored matching-adjusted indirect comparison (MAIC) (10/18/2025, 12-13:00, Hall 25)\n    * Mian Xi  - LBA82: Tislelizumab combined with induction chemotherapy and concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, phase II trial (EC-CRT-002) (10/18/2025, 10:20 - 10:25, Hanover Auditorium - Hall 7.2c)\n    * Pei Dong  - 2602P: Safety and efficacy of iparomlimab and tuvonralimab (QL1706) plus lenvatinib in previously untreated patients with clear cell renal cell carcinoma: results from a phase 1b study (10/18/2025, 12-13:00, Hall 25)\n    * Pei Dong  - 2648P: Phase II Clinical Study of the Safety and Efficacy of Sintilimab in Combination with Axitinib and Stereotactic Radiotherapy in the Treatment of Local-regional Recurrent Renal Cell Carcinoma (10/18/2025, 12-13:00, Hall 25)\n    * Ting Zhou  - 1945P: Sacituzumab Tirumotecan (sac-TMT) in Participants (pts) With Previously Treated, Advanced KRAS-Mutant NSCLC: Results From Cohort 5d of the SKB264-II-08 Study (10/18/2025, 12-13:00, Hall 25)\n    * ... and 34 more presenters\n\n\n**Fudan University Shanghai Cancer Center**\n  - ESMO 2025 Presentations: 22\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (30 total):\n    * Bo Dai  - 2434P: The efficacy of rezvilutamide (Rez) plus androgen-deprivation therapy (ADT) in patients (pts) with high-volume, nonvisceral metastatic hormone-sensitive prostate cancer (HSPC): a post hoc analysis of CHART study (10/18/2025, 12-13:00, Hall 25)\n    * Dingwei Ye  - 3098P: Fibroblast Growth Factor Receptor 3 (FGFR3) - Driven Genomic Landscape and the Impact on Clinical Outcomes of Fexagratinib (Fexa) in Chinese metastatic or unresectable Urothelial Carcinoma (mUC) (10/18/2025, 12-13:00, Hall 25)\n    * Maoping Cai  - 3099P: Proteogenomic characterization of the non-muscle-invasive bladder cancer response to BCG reveals potential therapeutic strategies (10/18/2025, 12-13:00, Hall 25)\n    * Xiaohua Wu  - 1097P: Senaparib monotherapy for patients (pts) with BRCA1/2 mutated recurrent platinum-sensitive ovarian cancer (PSOC): final analysis of study SABRINA (10/18/2025, 12-13:00, Hall 25)\n    * Xiaojie Bian  - 2421P: Sacituzumab Tirumotecan (sac-TMT) + Pembrolizumab (Pembro) in Metastatic Castration-Resistant Prostate Cancer (mCRPC): Results from Phase 2 MK-2870-002/SKB264-II-06 Study (10/18/2025, 12-13:00, Hall 25)\n    * ... and 25 more presenters\n\n\n**Department of Internal Medicine**\n  - ESMO 2025 Presentations: 19\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (88 total):\n    * Markus Moehler  - : Welcome and introductions (10/17/2025, 10:15 - 11:45, Flensburg Auditorium - Hall 23)\n    * Markus Moehler  - : Lighting the way for targeted treatment in Claudin 18.2-positive advanced G/GEJ adenocarcinoma (10/17/2025, 10:15 - 11:45, Flensburg Auditorium - Hall 23)\n    * Markus Moehler  - : Bringing the patient to focus: A case-based exploration of Claudin 18.2-positive advanced G/GEJ adenocarcinoma (10/17/2025, 10:15 - 11:45, Flensburg Auditorium - Hall 23)\n    * Markus Moehler  - : Looking ahead: Anticipating the clinical impact of CLDN18.2 targeted treatments in advanced G/GEJ adenocarcinoma (10/17/2025, 10:15 - 11:45, Flensburg Auditorium - Hall 23)\n    * Markus Moehler  - : Symposium close (10/17/2025, 10:15 - 11:45, Flensburg Auditorium - Hall 23)\n    * ... and 83 more presenters\n\n\n**National Cancer Center Hospital East**\n  - ESMO 2025 Presentations: 19\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (23 total):\n    * Kenichi Harano  - : Novel immunotherapy (10/17/2025, 16:30 - 16:45, Hamburg Auditorium - CityCube A)\n    * Hideaki Bando  - 115MO: Comprehensive Multi-Omics Analysis of Early-Onset Cancer: Insights from the MONSTAR-SCREEN-2 Experience (10/18/2025, 08:58 - 09:03, Cologne Auditorium - CityCube A)\n    * Hiroki Izumi  - 2006P: Conducive multi-level screening of genetic and protein aberrations in non-small cell lung cancer: A report from LC-SCRUM-Asia (10/18/2025, 12-13:00, Hall 25)\n    * Misao Fukuda  - 1135P: Differential Expression of Key Therapeutic Target Proteins Across Ovarian Cancer Histologic Subtypes (10/18/2025, 12-13:00, Hall 25)\n    * Yoshitaka Zenke  - 1912P: Inflamed immune phenotype as a novel predictive marker of immune checkpoint inhibitors for non-small cell lung cancer (10/18/2025, 12-13:00, Hall 25)\n    * ... and 18 more presenters\n\n\n**Medical Oncology Unit**\n  - ESMO 2025 Presentations: 17\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (24 total):\n    * Alessandra Dodi  - 1910P: Development of a multiomic machine learning model to predict the outcome of advanced non-small cell lung cancer patients treated with immunotherapy. (10/18/2025, 12-13:00, Hall 25)\n    * Federico Sottotetti  - 2055eP: Occupational Exposure to Carcinogens and Non-Oncogene Addicted Phenotypes in Lung Cancer: Insights from a Real-Life Observational Study (10/18/2025, 12-13:00, Hall 25)\n    * Francesca Trentini  - 2985eP: Identification of Prognostic Immune-Genomic Signatures in Pleural Mesothelioma (PM) patients treated with immunotherapy (10/18/2025, 12-13:00, Hall 25)\n    * Giuseppe Lamberti  - 2786P: Baseline onconeural antibodies and immune-related adverse events on immune checkpoint inhibitors in patients with small-cell lung cancer: a prospective cohort study (10/18/2025, 12-13:00, Hall 25)\n    * Maria Gonzalez Cao  - 2779P: Phase Ib-II trial of tumor-loaded monocyte-derived dendritic cell vaccination plus atezolizumab in ES-SCLC (10/18/2025, 12-13:00, Hall 25)\n    * ... and 19 more presenters\n\n\n**Mayo Clinic**\n  - ESMO 2025 Presentations: 14\n  - Clinical Trials (2015-2025): 30 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT05717140](https://clinicaltrials.gov/study/NCT05717140): Aerosolized Sargramostim Added to Immunotherapy for the Treatment of Patients With Metastatic Melanoma to the Lung (PHASE1, WITHDRAWN, Started 2025)\n    * [NCT06675643](https://clinicaltrials.gov/study/NCT06675643): Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity: A Feasibility Study of the Vigilant App (Vigilant-2) (Phase Not Specified, RECRUITING, Started 2024)\n    * [NCT05653661](https://clinicaltrials.gov/study/NCT05653661): Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid Tumors (PHASE1, WITHDRAWN, Started 2024)\n    * [NCT05969860](https://clinicaltrials.gov/study/NCT05969860): At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer (PHASE2, RECRUITING, Started 2023)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT06265285](https://clinicaltrials.gov/study/NCT06265285): Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program (PHASE2, RECRUITING, Started 2024) [COMPETITOR]\n    * [NCT05269381](https://clinicaltrials.gov/study/NCT05269381): Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors (PHASE1, RECRUITING, Started 2022) [COMPETITOR]\n    * [NCT04967196](https://clinicaltrials.gov/study/NCT04967196): Ipilimumab and Nivolumab for the Treatment of Stage III-IV Unresectable Metastatic Melanoma (PHASE1, TERMINATED, Started 2021) [COMPETITOR]\n    * [NCT04581382](https://clinicaltrials.gov/study/NCT04581382): Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma (EARLY_PHASE1, COMPLETED, Started 2020) [COMPETITOR]\n    * [NCT04007744](https://clinicaltrials.gov/study/NCT04007744): Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors (PHASE1, ACTIVE_NOT_RECRUITING, Started 2020) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (17 total):\n    * Jacob Orme  - 1518MO: Rescuing Cancer Immunotherapy with Plasma Exchange in Melanoma (the ReCIPE-M1 study) (10/17/2025, 14:30 - 14:35, Nuremberg Auditorium - Hall 5.2)\n    * Aaron S. Mansfield  - 1948P: Treatment outcomes in patients (pts) with advanced c-Met overexpressing (OE) EGFR wildtype (WT) nonsquamous (NSQ) NSCLC who had telisotuzumab vedotin (Teliso-V) dose modifications in the LUMINOSITY trial (10/18/2025, 12-13:00, Hall 25)\n    * Andrea E. Wahner Hendrickson  - 1074P: Claudin- 6 (CLDN6) is a Therapeutic Target in Ovarian Cancer (OC): Emerging Results from the CATALINA 1 (CAT1) Study (10/18/2025, 12-13:00, Hall 25)\n    * Evanthia Galanis  - : Exploring personalized care in patients with IDH mutations: a multidisciplinary discussion in Glioma (10/18/2025, 13:00 - 14:30, Flensburg Auditorium - Hall 23)\n    * Oliver Sartor  - 2542eTiP: Phase 1/2 Dose Escalation and Expansion of AB001 in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC): The ARTISAN Trial (10/18/2025, 12-13:00, Hall 25)\n    * ... and 12 more presenters\n\n\n**COMPLETE SPEAKER DIRECTORY BY GEOGRAPHY:**\n\n\n** (1 institutions, 1 speakers)**\n  -  (1 speakers): \n\n**Aichi (2 institutions, 2 speakers)**\n  - Department of Gastrointestinal Surgery, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8550, Japan. (1 speakers): Dai Shimizu\n  - Department of Medical Oncology, Kindai University Hospital, Osaka-sayama, Japan. (1 speakers): Seiichiro Mitani\n\n**Algeria (2 institutions, 3 speakers)**\n  -  (2 speakers): Arezki Arab, Fatma zohra Macheroum\n  - Faculty of Medicine, Djillali Liabes University, Sidi Bel Abbes 22000, Algeria. (1 speakers): Zineddine Belabaci\n\n**Andhra Pradesh (1 institutions, 1 speakers)**\n  -  (1 speakers): Suresh V. Attili\n\n**Andorra (1 institutions, 1 speakers)**\n  - Hospital Clínic, IDIBAPS, Barcelona. (1 speakers): Cristina Royo\n\n**Argentina (6 institutions, 7 speakers)**\n  -  (2 speakers): Carlos A. Brocca, Guillermo Cordoba\n  - Alexander Fleming Institute, Buenos Aires 1426, Argentina. (1 speakers): Juan Manuel Ramon O'Connor\n  - Clinical Oncology Unit, Argentina. (1 speakers): Federico D. Waisberg\n  - Hospital Bernardo Houssay, Mar del Plata, Argentina. (1 speakers): Ignacio A. Casarini\n  - Junín 956, C1113AA, Argentina. (1 speakers): Viviana C. Blank\n  - Valencia University, 46010, Spain. (1 speakers): Enrique A. Diaz Canton\n\n**Armenia (1 institutions, 3 speakers)**\n  -  (3 speakers): Merine Babayan, Vahe Grigoryan, Yeva Ghukasyan\n\n**Atlantico (1 institutions, 1 speakers)**\n  - Clinical Oncology, Valledupar, Colombia. (1 speakers): Ray Manneh Kopp\n\n**Attica (1 institutions, 1 speakers)**\n  - Department of Oncology, Athens Medical Center, Marousi, Greece. (1 speakers): Marinos Tsiatas\n\n**Attiki (2 institutions, 2 speakers)**\n  - Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece. (1 speakers): Michalis Liontos\n  - First Department of Internal Medicine, Laikon General Hospital, School of Medicine, National Kapodistrian University of Athens, Athens, Greece. (1 speakers): Helen Gogas\n\n**Australia (49 institutions, 51 speakers)**\n  - 1 James Cook University, Townsville, Queensland, Australia. (1 speakers): Hayley Roberts\n  - Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Central Adelaide Local Health Network, Adelaide, SA 5011, Australia. (1 speakers): Timothy J. Price\n  - Biotechnology Research Centre, La Trobe University, Bendigo, Victoria 3552, Australia. (1 speakers): Daniel Tillett\n  - Cabrini Health, Malvern, Australia. (1 speakers): Shehara R. Mendis\n  - Cancer Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK. (1 speakers): Vineet Kwatra\n  - Centre for Cancer Cell Biology and Drug Discovery, Institute for Biomedicine and Glycomics, Griffith University, Southport, Queensland, Australia. (1 speakers): Devina Laurencia\n  - Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia. (1 speakers): Ye Kyaw Aung\n  - Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, NSW, Australia, Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. (1 speakers): Joe Wei\n  - Department of Child Health, Wates District Hospital, Kulonprogo, Yogyakarta, Indonesia. (1 speakers): Dian Anggraini\n  - Department of Internal Medicine, University of Michigan, MI 48109, USA. (1 speakers): Jason Qin\n  - Department of Medical Oncology, Bendigo Health, Bendigo, Victoria, Australia. (1 speakers): Samuel J. Harris\n  - Department of Medical Oncology, Peter MacCallum Cancer Centre, Australia, The Sir Peter MacCallum Department of Oncology, University of Melbourne (1 speakers): Wanda Cui\n  - Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. (1 speakers): Joanna Chan\n  - Department of Oncology, Alfred Health, Melbourne, Australia, Central Clinical School, Monash University, Melbourne, Australia. (1 speakers): Malaka Ameratunga\n  - Division of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China. (1 speakers): Chen Yong\n  - Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. (1 speakers): Victoria Choi\n  - Fiona Stanley Hospital and Edith Cowan University, Perth, WA, Australia. (1 speakers): Muhammad A. Khattak\n  - Garvan Institute of Medical Research, Darlinghurst, Australia. (1 speakers): Jia Jenny Liu\n  - Garvan Institute of Medical Research, Sydney, Australia. (3 speakers): Frank P. Lin, Rhiannon Mellor, Subotheni Thavaneswaran\n  - Liverpool Hospital, New South Wales, Australia. Electronic address: roger.liang@health.nsw.gov.au. (1 speakers): Roger L. Liang\n  - Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. (1 speakers): Nadia Hitchen\n  - Medical Oncology, The Kinghorn Cancer Care Centre, St Vincent's Hospital, Sydney, Australia. (1 speakers): Wei Yen Chan\n  - Medical School, University of Western Australia, Perth, WA 6009, Australia. (1 speakers): Anna K. Nowak\n  - Melanoma Institute Australia, The University of Sydney, NSW, Australia, Faculty of Medicine and Health, The University of Sydney, NSW, Australia (1 speakers): Andrea Boutros\n  - Melanoma Institute Australia, Wollstonecraft, Australia. (1 speakers): Ines Pires da Silva\n  - Monash Health, Clayton, VIC, Australia. (1 speakers): Khunthong Peechatanan\n  - Murdoch Children's Research Institute, Parkville, Victoria, Australia. (1 speakers): Kortnye Smith\n  - NHMRC Clinical Trials Centre, University of Sydney, Australia. (1 speakers): John Simes\n  - Pancreatic Cancer Translational Research Group, School of Biomedical Sciences, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia. (1 speakers): Omali Pitiyarachchi\n  - Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. (1 speakers): Jayesh Desai\n  - Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. (1 speakers): Shahneen K. Sandhu\n  - School of Biomedical Science and Pharmacy, University of Newcastle, Newcastle, Australia. (1 speakers): Darren Shafren\n  - School of Clinical Medicine, Faculty of Medicine and Health, University of NSW, Sydney, NSW 2010, Australia. (1 speakers): Maya Kansara\n  - School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia. (1 speakers): Lucy Haggstrom\n  - School of Clinical Medicine, University of New South Wales, Sydney, Australia. (1 speakers): Monica Tang\n  - School of Medicine, University of Sydney, Camperdown, NSW, Australia. (1 speakers): Tahlia Scheinberg\n  - Seoul National University, Seoul, Korea. (1 speakers): Nur Sakinah Zulkifli\n  - Sir Peter MacCallum Cancer Centre Department of Oncology, The University of Melbourne, Melbourne, Australia. (1 speakers): Roslyn Wallace\n  - Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. (1 speakers): Lavinia Spain\n  - Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia (1 speakers): Arun A. Azad\n  - Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia, Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. (1 speakers): Danny Rischin\n  - Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia, Department of Radiation Oncology, Peter MacCallum Cancer Centre (1 speakers): Shankar Siva\n  - Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. (1 speakers): Michael Michael\n  - Sunshine Coast University Private Hospital, Birtinya, Queensland, Australia. (1 speakers): Michelle Morris\n  - The Kinghorn Cancer Centre, St Vincent's Hospital Sydney, Darlinghurst, NSW 2010, Australia. (1 speakers): Barak Talmor\n  - Theranostics and Nuclear Medicine Department, St Vincent's Hospital Sydney, Darlinghurst, Australia (1 speakers): Louise Emmett\n  - University of Illinois Chicago, IL, USA. (1 speakers): Jennifer W. Lim\n  - University of Melbourne, VIC, Australia. (1 speakers): Louise K. Kostos\n  - University of Western Australia, Medical School, Division of Obstetrics and Gynaecology, Perth, Australia. (1 speakers): Paul A. Cohen\n\n**Austria (21 institutions, 25 speakers)**\n  -  (1 speakers): Emil T. Bauernhofer\n  - Department of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria. (1 speakers): Michaela Bayerle-Eder\n  - Department of Gynecology and Gynecological Oncology, Medical University of Vienna, Vienna, Austria. (1 speakers): Christine Deutschmann\n  - Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria. Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. (1 speakers): Christoph Minichsdorfer\n  - Department of Medicine I, Division of Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. (1 speakers): Rupert Bartsch\n  - Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria. (3 speakers): Elisabeth S. Bergen, Hannah C. Puhr, Julia M. Berger\n  - Department of Obstetrics and Gynaecology, Breast Cancer Center Tirol, Medical University of Innsbruck, Innsbruck, Austria. (1 speakers): Christian Marth\n  - Department of Obstetrics and Gynaecology, Comprehensive Cancer Center - Gynaecologic Cancer Unit, Medical University of Vienna, Vienna, Austria. (1 speakers): Nicole Concin\n  - Department of Orthopaedics and Traumatology, Medical University of Graz, Graz, Austria. (1 speakers): Andreas Leithner\n  - Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria. (1 speakers): Veronika I. Engele\n  - Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna/AKH Wien, Währinger Gürtel 18-20, Vienna, Austria. (1 speakers): Alina E. Sturdza\n  - Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. (1 speakers): Gero Kramer\n  - Division of Neuroradiology and Musculoskeletal Radiology, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria. (1 speakers): Julia Furtner\n  - Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. (1 speakers): Nina Dobric\n  - Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria, Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I (1 speakers): Angelika M. Starzer\n  - Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. (1 speakers): Gerald Prager\n  - Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. (3 speakers): Anna Sophie Berghoff, Lynn Gottmann, Markus Kleinberger\n  - Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Gürtel 18-20, Vienna (1 speakers): Vincent Sunder-Plassmann\n  - Institute for Nursing Science and Practice, Paracelsus Medical University, Salzburg (1 speakers): Verena Leinemann\n  - Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Clinic Floridsdorf, Vienna, Austria. (1 speakers): Maximilian J. Hochmair\n  - Sigmund Freud University, 1090 Vienna, Austria. (1 speakers): Louisa C. Hempel\n\n**Azerbaijan (1 institutions, 1 speakers)**\n  - National Center of Oncology, Baku, Azerbaijan. (1 speakers): Samira R. Mahmudova\n\n**BA (1 institutions, 1 speakers)**\n  - Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, Department of Surgical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. (1 speakers): Paula Ugalde\n\n**Barcelona (2 institutions, 2 speakers)**\n  - Cancer Institute and Blood Disorders, Hospital Clinic de Barcelona, Barcelona, Spain. (1 speakers): Milana A. Bergamino\n  - Medical Oncology Department, Badalona, Spain. (1 speakers): Beatriz Cirauqui Cirauqui\n\n**Beit Jala (1 institutions, 1 speakers)**\n  - Beit Jala Governmental Hospital, Ministry of Health, Palestine. (1 speakers): Bilal Awad\n\n**Belarus (1 institutions, 1 speakers)**\n  -  (1 speakers): Marina Puchinskaya\n\n**Belgium (47 institutions, 53 speakers)**\n  -  (4 speakers): Annika M. Nowak, Maya Matthews, Michele Morel, Patrick Schoeffski\n  - 1International Rice Research Institute, DAPO Box 7777, Los Baños (1 speakers): Joshua Cobb\n  - Antwerp, Belgium. (1 speakers): Andre Deschamps\n  - Berlin, EU-OPENSCREEN, Germany. (1 speakers): Wolfgang Fecke\n  - Breast Cancer Translational Research Laboratory J-C Heuson, Brussels, Belgium, Brussels, Belgium. (1 speakers): Marcela Carausu\n  - Breast Cancer Translational Research Laboratory, Brussels, Belgium. (1 speakers): Christos Sotiriou\n  - Breast Cancer Translational Research Laboratory, Department of Medical Oncology, Brussels, Belgium. (1 speakers): Laetitia Collet\n  - Brussels, Belgium. (1 speakers): Soraia Lobo-Martins\n  - Bruxelles 1070, Belgium. (1 speakers): Evandro De Azambuja\n  - Clinical Trials Conduct Unit, Brussels, Belgium. (1 speakers): Philippe Aftimos\n  - Department of Dermatology, University Hospital Ghent, Ghent, Belgium. (1 speakers): Amber Shen\n  - Department of General Medical Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, Leuven, B-3000, Belgium. (1 speakers): Hans Wildiers\n  - Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, Belgium. (1 speakers): Oliver E. Bechter\n  - Department of Hepatology and Digestive Oncology, University Hospital Gasthuisberg, Leuven, Belgium. (1 speakers): Chris Verslype\n  - Department of Medical Oncology - NETwerk, University Hospital Antwerp, Edegem, Flanders, Belgium. (1 speakers): Siddharth Chhajlani\n  - Department of Medical Oncology, Brussels, Belgium. (2 speakers): Emmanuel Seront, Gil Awada\n  - Department of Medical Oncology, Centres Hospitaliers Universitaires HELORA, La Louvière, Belgium. (1 speakers): Guillaume Grisay\n  - Department of Medical Oncology, Ghent University Hospital, Gent, Belgium. (1 speakers): Alexander Decruyenaere\n  - Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium. (2 speakers): Hannelore Denys, Michael Saerens\n  - Department of Medical Oncology, Institute Jules Bordet, Brussels, Belgium. (1 speakers): Michail Ignatiadis\n  - Department of Medical Oncology, Laarbeeklaan 101, Brussels, Belgium. (1 speakers): Nathalie Vanlaer\n  - Department of Medical Oncology, Maria Middelares Hospital, Gent, Belgium, Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium. (1 speakers): Christof Vulsteke\n  - Department of Oncology, Yvoir, Belgium. (1 speakers): Maxime Collin\n  - Department of Pulmonology and Thoracic Oncology, Jessa Hospital, Hasselt, Belgium. (1 speakers): Kristof Cuppens\n  - Department of Radiation Oncology, Wilrijk-Antwerp, Belgium, University of Antwerp, Faculty of Medicine and Health Sciences, Wilrijk-Antwerp, Belgium. (1 speakers): Philip Poortmans\n  - Department of Urology, Brussels, Belgium. (1 speakers): Bertrand Tombal\n  - Division of Gynaecological Oncology, Leuven Cancer Institute, University Hospital Leuven and KU Leuven, Leuven, Belgium. (1 speakers): Toon Van Gorp\n  - European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium. (1 speakers): Denis A. Lacombe\n  - European Organisation for Research and Treatment of Cancer, Belgium. (1 speakers): Iryna Shakhnenko\n  - General Hospital Sint-Maarten, Mechelen, Belgium. Electronic address: alex.decaluwe@bordet.be. (1 speakers): Alex De Caluwe\n  - Imaging and Pathology, Belgium, Department of Nuclear Medicine, University Hospitals UZ Leuven 3000 Leuven, Belgium. (1 speakers): Karolien Goffin\n  - Institut Roi Albert II, Cliniques Universitaires Saint-Luc and Institute for Experimental and Clinical Research (IREC, Brussels, Belgium. (1 speakers): Jean-Pascal Machiels\n  - King Albert II Cancer Institute, Department of Medical Oncology, B-1200, Brussels, Belgium. (1 speakers): Sandra Schmitz\n  - Laboratory for Medical and Molecular Oncology (LMMO), Translational Oncology Research Center (TORC), Brussels, Belgium. (1 speakers): Bart Neyns\n  - Laboratory for Medical and Molecular Oncology, Translational Oncology Research Center, Brussels, Belgium. (1 speakers): Marthe Verhaert\n  - Medical Oncology Department, Brussels (1 speakers): Anouk Goudsmit\n  - Medical Oncology Department, Brussels, Belgium. (1 speakers): Jeremy Blanc\n  - Niel, Belgium. (1 speakers): Dirk Goossens\n  - Patient Advocat, Hasselt, Belgium. (1 speakers): Erik A. Briers\n  - Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. (1 speakers): Madeline Pe\n  - School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul 34752, Türkiye. (1 speakers): Bengisu Karakose\n  - Science, Graz University of Technology, Graz, Austria. (1 speakers): Monica Racovita\n  - Team Laboratory for Medical and Molecular Oncology (LMMO), Translational Oncology Research Center (TORC), Laarbeeklaan 101, Belgium. (1 speakers): Iris Dirven\n  - University Hospitals Leuven (UZ), Louvain, Belgium. (1 speakers): Johan F. Vansteenkiste\n  - University Hospitals Leuven, Leuven, Belgium. (2 speakers): Annelies T. Verbiest, Eric Van Cutsem\n  - University of Brescia, Brescia, Italy. (1 speakers): Edoardo Pisani\n  - aDepartment of General Oncology, Center Oscar Lambret, Lille, France bMedical Oncology Clinic, Brussels, Belgium. (1 speakers): Nuria Kotecki\n\n**Bolivia (1 institutions, 1 speakers)**\n  - University Hospital Marqués de Valdecilla, Santander, Spain. (1 speakers): Lucia Richter Paz\n\n**Bolzano (1 institutions, 1 speakers)**\n  - Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK. (1 speakers): Melissa Frizziero\n\n**Brazil (40 institutions, 50 speakers)**\n  -  (11 speakers): Amanda F. Villarino, Andre L. Cicilini, Breno Jeha, Henrique Larsen, Leila C. Taguchi, Lin I. Ter, Lygia Maria Costa Soares Rego, Nathalia Machado Soldi, Patrick V. Cerqueira, Pedro Cacilhas, Taina Da Rosa Bourckhardt\n  - AC Camargo Cancer Center, São Paulo 01509-900, Brazil. (1 speakers): Marcos Camandaroba\n  - Alfenas Federal University (Unifal-MG), Minas Gerais, Brazil. Electronic address: daniel.faria@unifal-mg.edu.br. (1 speakers): Daniel V. Almeida\n  - BP-The São Paulo Portuguese Beneficence. (1 speakers): Jessica R. Gomes\n  - CLION, CAM Group, Salvador, Brazil. (1 speakers): Rodrigo S. Guindalini\n  - Clinical Oncology, Natal, Brazil. (1 speakers): Sulene C. Oliveira\n  - Clinical Research and Technological Development Division, Rio de Janeiro, Brazil. (1 speakers): Gustavo D. Bretas\n  - Department of Anthropology, University of Texas at San Antonio, TX, USA. (1 speakers): Fernando A. Campos\n  - Department of Clinical Oncology, A.C. Camargo Cancer Center, São Paulo 01509-010, Brazil. (1 speakers): Angelo B. Brito\n  - Department of Clinical Oncology, AC Camargo Cancer Center, São Paulo, Brazil. (1 speakers): Rachel Riechelmann\n  - Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas. (1 speakers): Denis Leonardo F. Jardim\n  - Department of Medical Biology, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia. (1 speakers): William William\n  - Department of Medical Oncology and Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, Hospital Israelita Albert, São Paulo, São Paulo, Brazil. (1 speakers): Miguel Zugman\n  - Department of Microbiology, School of Medicine, University of California, CA 90095-1747, USA. (1 speakers): Debora M. Santana\n  - Department of Oncology and Hematology, Santa Lucia Hospital, Brasília, Brazil. (1 speakers): Fernando S. Monteiro\n  - Department of Social Medicine, University of São Paulo, São Paulo, Brazil. (1 speakers): Joao Souza\n  - Division of Clinical Research and Technological Development, Rio de Janeiro, Brazil. (1 speakers): Bruna B. Lopes David\n  - Federal Fluminense University, Rio de Janeiro, Brazil. luis_leite@id.uff.br. (1 speakers): Luis F. Leite\n  - Federal University of Ceará Medical School, Fortaleza, Brazil. (1 speakers): Joao Evangelista P. Conrado\n  - Federal University of Ceará, Ceara, Brazil. (1 speakers): Mariana M. Noronha\n  - Graduate Program in Nutrition and Health, Health Sciences Center at the Federal University of Espírito Santo (UFES), Vitória 29040-091, ES, Brazil. (1 speakers): Luis Carlos Lopes-Junior\n  - Guarapuava, Brazil. (1 speakers): Maria I. Dacoregio\n  - HCor Hospital, SP, Brazil. (1 speakers): Henrique A. Helber\n  - Health Sciences Postgraduate Program, Federal University of Rio Grande Norte (UFRN), Natal, Brazil. (1 speakers): Kleyton S. Medeiros\n  - Hospital Beneficência Portuguesa, Departamento de Oncologia, São Paulo, SP, Brasil, Hospital Erasto Gaertner, Curitiba, PR, Brasil. (1 speakers): Murilo De Almeida Luz\n  - Hospital Sirio-Libanes, SP, Brazil. (1 speakers): Carlos H. Dos Anjos\n  - Hospital Universitário da Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil. vivi.reumato@gmail.com. (1 speakers): Viviane P. Basilio de Souza\n  - Hospital das Clínicas HCFMUSP, SP, Brazil. (1 speakers): Allan I. Strauss\n  - Instituto de Psiquiatria, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. (1 speakers): Rafael T. Costa\n  - Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, MG, Brazil. (1 speakers): Fernanda C. Oliveira\n  - Laboratório de Desenvolvimento de Vacinas, Instituto Butantan, São Paulo, Brazil. (1 speakers): Luciana D. Leite\n  - Laboratório de Sanidade Animal (LSA), Universidade Estadual do Norte Fluminense Darcy Ribeiro (UENF), Campos dos Goytacazes, RJ, 28013-602, Brazil. (1 speakers): Luanna Oliveira\n  - Liga Norte Riograndense Contra O Câncer, Avenida Miguel Castro, 1355-Nossa Senhora de Nazaré, Natal, RN, 59062-000, Brazil. (1 speakers): Danielli De Almeida Matias\n  - National Institute of Cardiology, RJ, Brazil. (1 speakers): Mariana C. Carvalho\n  - Oncology Center, Albert Einstein Hospital, SP, Brazil. (1 speakers): Juliana R. Beal\n  - Oncology Research Center, Hospital São Lucas, Brazil. (1 speakers): Carlos H. Barrios\n  - Professor Edgard Santos University Hospital, Medical School, Salvador (BA), Brazil. (1 speakers): Diego Lopes Paim Miranda\n  - Research Centre in Sports, Health, University of Beira Interior, Portugal. (1 speakers): Joao P. Oliveira\n  - University of Campinas (UNICAMP), SP, Brazil. (1 speakers): Ericka F. Costa\n  - University of São Paulo, São Paulo, Brazil. (1 speakers): Larissa Garcia\n\n**British Columbia (2 institutions, 2 speakers)**\n  - Department of Medicine, University of British Columbia, Vancouver, Canada. (1 speakers): Kim Nguyen Chi\n  - Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. (1 speakers): Sharlene Gill\n\n**Bulgaria (3 institutions, 3 speakers)**\n  - Department of Radiotherapy, MHAT \"Heart and Brain\", Pleven, Bulgaria. (1 speakers): Kiril Z. Zhelev\n  - Oncodermatology Department, National Oncology Center, Sofia, Bulgaria. (1 speakers): Iva Gavrilova\n  - University of Amsterdam and Amsterdam Public Health research institute, University of Amsterdam and Amsterdam Public Health research institute, The Netherlands. (1 speakers): Tsvetan Y. Yordanov\n\n**CA (14 institutions, 14 speakers)**\n  - David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, California. (1 speakers): Gottfried E. Konecny\n  - Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA. (1 speakers): Sumanta K. Pal\n  - Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA (1 speakers): Marwan Fakih\n  - Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, USA. (1 speakers): Samuel J. Klempner\n  - Department of Medicine, Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA, USA. (1 speakers): Heather Wakelee\n  - Department of Surgery, University of California San Francisco, CA, USA. (1 speakers): Laura Esserman\n  - Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. (1 speakers): David R. Gandara\n  - Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, CA 90048, USA, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, CA 90048, USA, Department of Urology (1 speakers): Edwin M. Posadas\n  - Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, CA, USA. (1 speakers): Heinz Josef Lenz\n  - Jonsson Comprehensive Cancer Center, University of California Los Angeles, CA, USA. (1 speakers): Antoni Ribas\n  - Sarcoma Oncology Center/Cancer Center of Southern California, CA 90403, USA. (1 speakers): Sant P. Chawla\n  - University of California San Diego Moores Cancer Center, CA, USA. (1 speakers): Lyudmila Bazhenova\n  - University of California San Francisco Helen Diller Family Comprehensive Cancer Center, CA (1 speakers): Hope S. Rugo\n  - University of Washington Fred Hutchinson Cancer Center, Seattle, WA, USA. (1 speakers): Sara A. Hurvitz\n\n**CEDEX (25 institutions, 25 speakers)**\n  - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London NW1 1AT, UK, Université de Lorraine, Service de Biopathologie, France. (1 speakers): Alexandre Harle\n  - Department of Cancer Medicine, Thoracic Group and International Center for Thoracic Cancers, Paris-Saclay University, Villejuif, France. (1 speakers): Benjamin Besse\n  - Department of Drug Development and Innovation (D3i), Paris, France. (1 speakers): Raphael Sanchez\n  - Department of Gastroenterology and Hepatology, Poitiers University Hospital, France. (1 speakers): David Tougeron\n  - Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. (1 speakers): Stephane Champiat\n  - Department of Medical Oncology, Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France. (1 speakers): Mehdi Brahmi\n  - Department of Medical Oncology, Hospital Foch, Suresnes, France. (1 speakers): Jaafar Bennouna\n  - Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France. (1 speakers): Maurice Perol\n  - Department of Medical Oncology, Strasbourg, France. (1 speakers): Justine Gantzer\n  - Department of Medical Oncology, University Hospital of Besançon, Besançon, France. (1 speakers): Stefano Kim\n  - Department of Medical Oncology, University Hospital of Strasbourg, Place de L'hopital, Strasbourg, France. (1 speakers): Philippe Barthelemy\n  - Department of Medical Oncology, University of Lyon, Centre Léon Bérard, Lyon, France. (1 speakers): Jerome Fayette\n  - Department of Medicine, Centre Leon Berard, UNICANCER & University Lyon I, Lyon, France. (1 speakers): Jean-Yves Blay\n  - Department of Oncology, University Hospital Besancon, Besancon, France. (1 speakers): Elsa Curtit\n  - Departments of Neurosurgery and Neurology, University Hospital Zurich, Ramistrasse 102, Zurich, Switzerland. (1 speakers): Emilie Le Rhun\n  - Drug Development Department, Gustave Roussy Cancer Campus, France. (1 speakers): Capucine Baldini\n  - Département d'Oncologie Médicale, France. (1 speakers): Vincent Massard\n  - EFS, INSERM, UMR RIGHT, France, Department of Medical Oncology, University Hospital of Besançon (1 speakers): Olivier Adotevi\n  - ICO René Gauducheau, France. (1 speakers): Mario Campone\n  - Medical Oncology Department, Centre Eugene - Marquis, Rennes, France. (1 speakers): Julien Edeline\n  - Medical Oncology Department, Centre Léon Bérard, GINECO, Lyon, France. (1 speakers): Isabelle L. Ray-Coquard\n  - Medical Oncology Department, Saint-Herblain, France. (1 speakers): Jean-Sebastien Frenel\n  - Medical Oncology Department, University Hospital Dupuytren, Limoges, France. (1 speakers): Elise Deluche\n  - Paris-Saclay University, Department of Cancer Medicine, Villejuif, France. (1 speakers): Jean-Charles Soria\n  - Unité d'Oncologie médicale, Groupement Hospitalier Sud, Pierre-Bénite, France. (1 speakers): Benoit You\n\n**CEDEX 10 (2 institutions, 2 speakers)**\n  - AP-HP Dermato-oncology, Cancer institute APHP.nord Paris cité, INSERM U976, Saint Louis Hospital, Paris, France. (1 speakers): Celeste Lebbe\n  - Department of Medical Oncology, Paris, France. (1 speakers): Sophie Frank\n\n**CEDEX 3 (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France. (1 speakers): Armelle Dufresne\n\n**CEDEX 5 (5 institutions, 5 speakers)**\n  - Columbia University Medical Center, Memorial Sloan Kettering Cancer Center, NY, Paris, Centre Antoine-Lacassagne, Nice, France, Leiden University Medical Center, Leiden, the Netherlands (1 speakers): Manuel J. Rodrigues\n  - Department of Medical Oncology, Institute Curie, Université Paris Cité, France. (1 speakers): Jean-Yves Pierga\n  - Department of Medical Oncology, PSL Research University, Paris, France. (1 speakers): Sophie Piperno-Neumann\n  - Montpellier Cancer Institute, Montpellier, France. (1 speakers): Diego Tosi\n  - Oncology Department, Centre for Cancer Immunotherapy, INSERM U932, PSL Research University, Paris, France. (1 speakers): Emanuela Romano\n\n**CEDEX 9 (1 institutions, 1 speakers)**\n  - Immunity and Cancer Team, Cancer Research Centre of Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Paoli-Calmettes Institute, Aix-Marseille University Marseille, France. (1 speakers): Philippe Rochigneux\n\n**CO (2 institutions, 2 speakers)**\n  - Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, University of Toronto, Toronto, ON, Canada. (1 speakers): Anna Spreafico\n  - University of Colorado Cancer Center, Aurora, CO. (1 speakers): Sapna P. Patel\n\n**Cambridgeshire (1 institutions, 1 speakers)**\n  - Cambridge University Hospitals NHS Foundation Trust (Addenbrooke's Hospital), Cambridge CB2 0QQ, UK. (1 speakers): Philippa G. Corrie\n\n**Canada (59 institutions, 64 speakers)**\n  -  (4 speakers): Alda Aleksi, Camille S. Piquette, Madeline Rhind, Marie-Frederique Damours\n  - BC Cancer Agency, Vancouver, Canada. (1 speakers): J. Connor Wells\n  - BC Cancer Research Centre, Vancouver, BC, Canada. (1 speakers): Stephen Chia\n  - BC Cancer, University of British Columbia, Vancouver, BC, Canada. (1 speakers): Janessa Laskin\n  - Cancer Therapeutics Program, The Ottawa Hospital Research Institute, Ottawa, Canada. (1 speakers): Terry L. Ng\n  - Centre Hospitalier de l'Université de Montréal, Montreal, QC H3C 3J7, Canada. (1 speakers): Denis Soulieres\n  - Centre Intégré de Cancérologie de la Montérégie, Université de Sherbrooke, Longueuil, QC J4V 2H1, Canada. (1 speakers): Nathalie Daaboul\n  - Centre de Recherche du Centre Hospitalier Universitaire de Montréal, Montréal, Canada. (1 speakers): Julie Malo\n  - Cumming School of Medicine, University of Calgary, Calgary, AB T2N 2T8, Canada. (1 speakers): Steven M. Yip\n  - Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. (1 speakers): Chloe Lim\n  - Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China. (1 speakers): Xin Ye\n  - Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada. (1 speakers): Francois-Michel Boisvert\n  - Department of Life Science, Aberystwyth University, UK. (1 speakers): Amanda J. Gibson\n  - Department of Medical Oncology, Juravinski Cancer Center, McMaster University, Hamilton, Ontario, Canada. (1 speakers): Aly-Khan Lalani\n  - Department of Medicine, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Institut du cancer de Montréal, Montréal, Québec, Canada. (1 speakers): Fred Saad\n  - Department of Medicine, McGill University Health Centre, Montreal, QC, Canada, Center for Innovative Medicine, McGill University Health Centre, Montreal, QC (1 speakers): Thierry Alcindor\n  - Department of Medicine, Medical Oncology Division, BC Cancer, Vancouver Centre, University of British Columbia, BC, Canada. (1 speakers): Guliz Ozgun\n  - Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1 (1 speakers): Ana Elisa Lohmann\n  - Department of Medicine, University of Toronto, Toronto, ON, Canada. (2 speakers): David W. Cescon, Simron Singh\n  - Department of Molecular Oncology, BC Cancer Agency, Part of the Provincial Health Services Authority, Vancouver, Canada. (1 speakers): Annalena F. Renner\n  - Department of Oncology, McMaster University, Hamilton, ON, Canada. (1 speakers): Rosalyn Juergens\n  - Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada. (1 speakers): Omar F. Khan\n  - Department of Pathology & Laboratory Medicine, The University of British Columbia, Vancouver, Canada. (1 speakers): Diana Ionescu\n  - Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, 620 University Ave., Toronto, ON, M5G 2C1, Canada. (1 speakers): Camilla Zimmermann\n  - Department of Supportive Care, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. (1 speakers): Kaviya Devaraja\n  - Division of Cancer Care and Epidemiology, Sinclair Cancer Research Institute at Queen's University, Kingston, ON, Canada. (1 speakers): Christopher M. Booth\n  - Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada. (1 speakers): David Maj\n  - Division of Hematology-Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC H2X 0C1, Canada. (1 speakers): Marie Florescu\n  - Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. (1 speakers): Philippe L. Bedard\n  - Division of Medical Oncology and Haematology, Department of Medicine, Princess Margaret Hospital Cancer Centre, University of Toronto, Toronto, Ontario, Canada. (1 speakers): Erick F. Saldanha\n  - Division of Medical Oncology, Moncton Hospital, Moncton, NB, Canada. (1 speakers): Mahmoud Abdelsalam\n  - Division of Medical Oncology, Princess Margaret Cancer Centre (PMCC), University Health Network (UHN), Toronto, ON, Canada, Faculty of Medicine, University of Toronto, Toronto, ON (1 speakers): Jamie Feng\n  - Division of Medical Oncology, University of Toronto, Princess Margaret Cancer Center, Toronto, ON, Canada. (1 speakers): Srikala S. Sridhar\n  - Division of Urology, Department of Surgery, McMaster University, Hamilton, Ontario, Canada. (1 speakers): Jehonathan H. Pinthus\n  - Faculty of Medicine and Health Sciences of Sherbrooke, Sherbrooke, Canada. (1 speakers): Nissim M. Frija-Gruman\n  - Faculty of Medicine, King Saud Bin Abdul-Aziz University for Health Sciences (KSAU-HS), King Fahad Medical City, Riyadh (1 speakers): Anas A. Alghamdi\n  - Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. (1 speakers): Ali Shahini\n  - Faculty of Medicine, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada. (1 speakers): Sarah Yeo\n  - Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada. (1 speakers): Stephanie Mercier\n  - Faculty of Nursing, University of Calgary, Calgary, AB, Canada, Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada (1 speakers): Colleen Cuthbert\n  - Glans-Look Lung Cancer Research, Cumming School of Medicine, University of Calgary, Alberta, Canada. (1 speakers): Vishal Navani\n  - Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, Keele, UK. (1 speakers): James Nolan\n  - Montreal, Canada. (1 speakers): Patrick Gagnon-Sanschagrin\n  - Oncology Department, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. (1 speakers): Quincy Siu-chung Chu\n  - Princess Margaret Hospital, Toronto, ON, Canada. (1 speakers): Natasha Leighl\n  - Toronto General Hospital, Princess Margaret Centre, University of Toronto, Toronto, ON, Canada. (1 speakers): Arndt Vogel\n  - University Health Network, ON M5G 1L7, Canada. Electronic address: daniel.decarvalho@uhn.ca. (1 speakers): Daniel De Carvalho\n  - University Health Network-Princess Margaret Cancer Center, Ontario, Canada. (1 speakers): Beatriz E. Jimenez Munarriz\n  - University Medical Imaging Toronto, Joint Department Medical Imaging, University Health Network, Sinai Health System, Women's College Hospital, University of Toronto, Toronto, ON, M5G 2N2, Canada. (1 speakers): Patrick Veit-haibach\n  - University of British Columbia, BC, Canada. (2 speakers): Amy X. Wang, Florence T. Wu\n  - University of Montreal Hospital Research Centre, Cancer Axis, Montreal, Canada. (1 speakers): Bertrand Routy\n  - University of Montreal Research Center (CR-CHUM), Montreal, QC, Canada. (1 speakers): Jade Maillou\n  - University of Toronto 200 College St Toronto ON Canada., Department of Chemical Engineering and Applied Chemistry, University of Toronto 200 College St Toronto ON Canada. (1 speakers): Charles Y. Jia\n  - University of Western Ontario, Ontario, Canada. (1 speakers): Jonathan Moroniti\n  - Université de Montréal, Centre de Recherche du CHUM (CRCHUM), Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada. (1 speakers): Vanessa Samouelian\n  - Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. (1 speakers): Alexander W. Wyatt\n  - Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. (1 speakers): Sofie H. Tolmeijer\n  - Washington University School of Medicine in St Louis, St Louis, Missouri. (1 speakers): Justin D. Long\n  - Western University, Ontario, Canada. (1 speakers): CARLOS U. MUZLERA\n\n**Changning (1 institutions, 1 speakers)**\n  - Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. China. (1 speakers): Zhichao Wang\n\n**Chiba (4 institutions, 4 speakers)**\n  - Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. (1 speakers): Kohei Shitara\n  - Department of Head and Neck Medical Oncology, National Cancer Center East Hospital, Kashiwa, Chiba (1 speakers): Makoto Tahara\n  - Department of Hepato-Biliary-Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. (1 speakers): Shin Kobayashi\n  - Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Yoshitaka Zenke\n\n**Chile (1 institutions, 1 speakers)**\n  - eDepartment of Oncology, Bradford Hill Clinical Research Center, Santiago, Chile. (1 speakers): Mauricio Burotto\n\n**China (547 institutions, 604 speakers)**\n  -  (19 speakers): Anwaier Aihetaimujiang, Feiei Li, Guingying Wang, Huang Qingting, Huang Y. Jie, Ji Dongmei, Mi I. Xue, Nan'jieanjie Xiao, Quan-feng Shao, Ruihe Liu, Song Q. Le, Su Du, Tangtao Gong, Wang Xiao Hua, Wener He, Xiangting Dai, Xie Jiaxin, Yu Ruofan, ZHENG JINCAO\n  - Affiliated Hospital of Guizhou Medical University, Guizhou Cancer Hospital, Guiyang, Guizhou, China. (1 speakers): TAO WU\n  - Artificial Intelligence Innovation and Incubation Institute of Fudan University & Shanghai Academy of Artificial Intelligence for Science, Shanghai 201111, China. (1 speakers): Zixin Hu\n  - Aurora Sinai/Aurora St. Luke's Medical Centers, Milwaukee, WI, USA. (1 speakers): Chi Cho\n  - BGI Genomics, Shenzhen, China, HIM-BGI Omics Center, Hangzhou Institute of Medicine, BGI Research, Hangzhou (1 speakers): Kui Wu\n  - Beijing Cancer Hospital, Beijing, China. (1 speakers): Jifang Gong\n  - Beijing Institute of Biological Products Co., Ltd, Beijing, China. (1 speakers): Wanping Guo\n  - Beijing Shijitan Hospital, Capital Medical University, Beijing, China. (1 speakers): Liang Wang\n  - BioBank, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China. (1 speakers): Ying Yuan\n  - Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. (1 speakers): Jianli Zhao\n  - Breast Tumour Centre, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. (1 speakers): Erwei Song\n  - CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Shanghai, China. (1 speakers): Jin Li\n  - CAS Key Laboratory of Nutrition, Metabolism and Food Safety Shanghai Institute of Nutrition and Health University of Chinese Academy of Sciences Chinese Academy of Sciences Shanghai China. (1 speakers): Wei Zhang\n  - Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (1 speakers): Chenzhao Feng\n  - Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. (1 speakers): Ruixia Song\n  - Cancer Center, The First Hospital of Jilin University, Changchun, China. (1 speakers): Zhen Guo\n  - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (1 speakers): Xiaorong Dong\n  - Canhelp Genomics Research Center, Ltd., Hangzhou, China. (1 speakers): Qinghua Xu\n  - Center for Reproductive Medicine, Department of Reproductive Endocrinology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China. (1 speakers): Min Zheng\n  - Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, TX, USA. (1 speakers): Qiang Wang\n  - Center of Stomatology, Xiangya Hospital, Central South University, Changsha, China. (1 speakers): Jijia Li\n  - Central Laboratory, Fujian Medical University Union Hospital, Fuzhou, China. (1 speakers): Xiaofang Wen\n  - Central Laboratory, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center ... (1 speakers): CHONG DING\n  - Central Laboratory, School of Medicine, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, Fujian, P.R. China. (1 speakers): Yuxuan Wei\n  - Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge (1 speakers): Xin Yang\n  - Changchun University of Chinese Medicine, Jilin, Changchun, China. (1 speakers): Shuang Zhang\n  - Changzhi Cite People's Hospital, Changzhi, China. (1 speakers): Jun Zhao\n  - China Medical University, Shenyang, Liaoning, China. (1 speakers): Siyuan Chen\n  - China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. (1 speakers): Cai Chen Li\n  - Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. (1 speakers): Zhe Cao\n  - Clinical Medical College, Xuzhou Medical University, Xuzhou, Jiangsu 221000, China, Department of Gynecology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002 (1 speakers): Buze Chen\n  - Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China, Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China (1 speakers): Sufang Qiu\n  - Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China. (2 speakers): Ning Li, Shuhang Wang\n  - Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. (1 speakers): Peiwen Ma\n  - College & Hospital of Stomatology, Anhui Medical University, Key Lab. of Oral Diseases Research of Anhui, Hefei, China. (1 speakers): Qingqing Wang\n  - College of Animal Science and National Engineering Research Center for Breeding Swine Industry, South China Agricultural University, Guangdong, P.R. China. (1 speakers): Cineng Xu\n  - College of Animal Science and Technology, Henan University of Animal Husbandry and Economy, Zhengzhou, China. (1 speakers): Haoyuan Han\n  - College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi 712100, PR China. (1 speakers): Xiaoyu Wang\n  - College of Computer Science and Technology, Xinjiang University, Urumqi, China. (1 speakers): Cheng Chen\n  - College of Ecology Lanzhou University Lanzhou China. (1 speakers): Zhao Zhigang\n  - College of Health Science and Technology (B.S., L.W., X.L., J.T., J.X., Y.Z., H.Z.), Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Yan Zhou\n  - College of Life Sciences, Zhejiang University, Hangzhou 310058, PR China. (1 speakers): Can Chen\n  - Department of Abdominal Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (1 speakers): Xinjun Liang\n  - Department of Abdominal Oncology, Zhejiang Cancer Hospital, Hangzhou, China. (1 speakers): Jieer Ying\n  - Department of Abdominal Surgery, Ganzhou Cancer Hospital, Ganzhou, China. (1 speakers): Zhenhua Liu\n  - Department of Abdominal Surgery, Guiqian International Hospital, China. (1 speakers): Yang Jun\n  - Department of Anaesthesiology, Peking University First Hospital, Beijing, China. (1 speakers): Mo Li\n  - Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China. (1 speakers): Ke Cui\n  - Department of Anesthesiology, Yantaishan Hospital Affiliated to Binzhou Medical University, Yantai, China. ni518866@163.com. (1 speakers): Shuqin Ni\n  - Department of Anorectal Surgery, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. (1 speakers): Qingming Wang\n  - Department of Basic Medicine, Haihe Clinical School, Tianjin Medical University, Tianjin 300350, China. (1 speakers): Guiying Xu\n  - Department of Basic Medicine, School of Medicine, Foshan University, Foshan, China. (1 speakers): Yang Xun\n  - Department of Basic Public Health, Guangzhou Center for Disease Control and Prevention, Guangzhou 510440, China. (1 speakers): Hui Liu\n  - Department of Biology, University of Washington, Seattle, WA 98195. (1 speakers): Renyu LI\n  - Department of Brain Disease, Nanjing Hospital of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China. (1 speakers): Xiaoyu Liu\n  - Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China. (1 speakers): Quchang Ouyang\n  - Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China. (1 speakers): Xiaoqi Zhang\n  - Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, No.127, Zhengzhou, People's Republic of China. (1 speakers): Hui Hui Sun\n  - Department of Breast Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China. (1 speakers): Shoubing Zhou\n  - Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. (1 speakers): Chunfang Hao\n  - Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer (1 speakers): Xiaojing Guo\n  - Department of Breast Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. (4 speakers): Chenglong Duan, Jianing Zhang, Jinsui Du, Yudong Zhou\n  - Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China. (1 speakers): Shunyi Liu\n  - Department of Breast Surgery, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China. (1 speakers): Sujin Yang\n  - Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, China. (1 speakers): Juan Huang\n  - Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Chongqing Medical University Chongqing 400010 P. R. China 302118@cqmu.edu.cn. (1 speakers): Xiaoqing Yu\n  - Department of Breeding, Shandong Peanut Research Institute, Qingdao, China. Electronic address: 18761869832@163.com. (1 speakers): Qianqian Wang\n  - Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195. (1 speakers): Fei Zhou\n  - Department of Cancer Screening and Prevention, Zhongshan Hospital, Fudan University, Shanghai, China, Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China (1 speakers): Tianshu Liu\n  - Department of Chemistry, University of Warwick, Coventry CV4 7AL (1 speakers): Yujing Chang\n  - Department of Clinical Laboratory Center, Shaoxing People's Hospital, Shaoxing, Zhejiang, China. (1 speakers): Yi Feng\n  - Department of Clinical Laboratory, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin Neurosurgical Institute, Tianjin Huanhu Hospital, Tianjin, China. (1 speakers): Zhi Ji\n  - Department of Clinical Medicine, School of Medical, Wuhan University of Science and Technology, Wuhan 430065, China. (1 speakers): Huiting Wang\n  - Department of Clinical Oncology, Faculty of Medicine, Chinese University of Hong Kong, China. (1 speakers): Herbert Ho Fung Loong\n  - Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, China. (1 speakers): Tony S.K. Mok\n  - Department of Clinical Oncology, The University of Hong Kong (1 speakers): Aya El-Helali\n  - Department of Clinical Oncology, University of Hong Kong and Queen Mary Hospital (1 speakers): Dora L. Kwong\n  - Department of Clinical Pharmacology, School of Pharmacy, China Medical University, Liaoning (1 speakers): Yang Bai\n  - Department of Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (1 speakers): Da-wei Wu\n  - Department of Clinical and Health Informatics, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Suite 600, Houston, TX (1 speakers): Liwei Wang\n  - Department of Colorectal Surgery, Cancer Hospital Chinese Academy of Medical Sciences, Beijing 100021, China. (1 speakers): Xu Guan\n  - Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, PR China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, Shanghai, PR China. (1 speakers): Guoxiang Cai\n  - Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032 (1 speakers): Xinxiang Li\n  - Department of Colorectal Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. (1 speakers): Weifeng Lao\n  - Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Jing-Hua Tang\n  - Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China. (1 speakers): Pei-Rong Ding\n  - Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200080, China. (1 speakers): Mengting Chen\n  - Department of Day Ward, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China. (1 speakers): Yaoyao Jing\n  - Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. (1 speakers): Zihan Xue\n  - Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China, National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology (1 speakers): Hong Liu\n  - Department of Dermatology, Xiangya Hospital, Central South University, Hu Nan Key Laboratory of Aging Biology, Changsha, China. (1 speakers): Min Li\n  - Department of Digestive Surgery, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China. (1 speakers): Guanghui Xu\n  - Department of Disease Prevention and Control, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China. (1 speakers): Wei Ge\n  - Department of Early Drug Development Centre, Peking University Cancer Hospital and Institute, Beijing, China. (1 speakers): Ran Xue\n  - Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Ningning Zhang\n  - Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing 100044, China. (1 speakers): Fang Lv\n  - Department of Endocrinology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, People's Republic of China. (1 speakers): Ting Wang\n  - Department of Endoscopy, General Hospital of Northern Theater Command, China. (1 speakers): Zhuo Yang\n  - Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou 450001, China. (1 speakers): Linlin Li\n  - Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, P.R. China. (1 speakers): Ning Zhao\n  - Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200032, China. (1 speakers): Jing Gao\n  - Department of GI Medical Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin (1 speakers): Ting Deng\n  - Department of Gastric Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou 510060 (1 speakers): Run-Cong Nie\n  - Department of Gastric Surgery, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China. (1 speakers): Xuewei Ding\n  - Department of Gastroenterology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China. Electronic address: ndefy20358@ncu.edu.cn. (1 speakers): Lingling Yang\n  - Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. (1 speakers): Zheng-Hao Ye\n  - Department of Gastrointestinal Medical Oncology National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer (1 speakers): Rui Liu\n  - Department of Gastrointestinal Medical Oncology, Shanxi Province Cancer Hospital / Shanxi Hospital Affiliated to Cancer Hospital (1 speakers): Wenhui Yang\n  - Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China (1 speakers): Lin Shen\n  - Department of Gastrointestinal Oncology, The First Medical Center, Chinese PLA General Hospital, Beijing, China. (1 speakers): Rongrui Liu\n  - Department of Gastrointestinal Surgery Shandong Provincial Hospital Shandong University Jinan Shandong China. (1 speakers): Yuan Liu\n  - Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. (1 speakers): Leping Li\n  - Department of Gastrointestinal Surgery, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China. (1 speakers): FEI MA\n  - Department of Gastrointestinal Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China. (1 speakers): Jianping Zhou\n  - Department of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China (1 speakers): Chenan Liu\n  - Department of Gastrointestinal, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China. (1 speakers): Defeng Chen\n  - Department of General Surgery, Department of Colorectal Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. (1 speakers): Wentao Tang\n  - Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China. litao7706@163.com. (1 speakers): Qi-Hang Cao\n  - Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. (1 speakers): Qiwu Zhao\n  - Department of General Surgery, Sir Run Run Shaw Hospital & Zhejiang University School of Medicine, Hangzhou, China. (1 speakers): Defei Hong\n  - Department of General Surgery, Tangdu Hospital, The Air Force Medical University, Xi'an, China. (1 speakers): Jiaxing He\n  - Department of General Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, People's Republic of China. (1 speakers): Junyuan Lv\n  - Department of General Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. (1 speakers): Kai Xu\n  - Department of Gynaecologic Oncology Fudan University Shanghai Cancer Center, Fudan University Shanghai China. (2 speakers): Jin Li, Xiaohua Wu\n  - Department of Gynaecology and Obstetrics, West China Second Hospital, Sichuan University, No. 20, Sect. 3, Chengdu, Sichuan, People's Republic of China. (1 speakers): Yu Fan\n  - Department of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing 400030, China. (1 speakers): Dongling Zou\n  - Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. (1 speakers): Chunyan Song\n  - Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (1 speakers): Lingying Wu\n  - Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. (1 speakers): Jihong Liu\n  - Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (1 speakers): Canhui Cao\n  - Department of Gynecology and Oncology, Beijing Obstetrics and Gynecology Hospital Affiliated to Capital Medical University, Beijing, China. (1 speakers): Yue He\n  - Department of Gynecology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang 110042, China, Department of Gynecology (1 speakers): Danbo Wang\n  - Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 420, Jin'an District, Fuzhou, Fujian, China. (2 speakers): Lele Chang, Yaxin Kang\n  - Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China. (4 speakers): Kang Ning, Shida Yan, Shuwei Chen, Xuekui Liu\n  - Department of Hematology, Jinan Central Hospital affiliated to Shandong First Medical University, Jinan, China. (1 speakers): Juan Wang\n  - Department of Hematology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. (1 speakers): Shuzhao Chen\n  - Department of Hematology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P.R. China. (2 speakers): Haotian Yan, Ruotong Chen\n  - Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing, China. (1 speakers): Li Su\n  - Department of Hepatobiliary Surgery & Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China. (1 speakers): Jian Zhou\n  - Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China, Key Laboratory of Carcinogenesis and Cancer Invasion (1 speakers): Hui-Chuan Sun\n  - Department of Hepatobiliary Surgery and Liver Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China (2 speakers): Guoming Shi, Jia Fan\n  - Department of Hepatobiliary Surgery and Liver Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China. (1 speakers): Xinrong Yang\n  - Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (1 speakers): Ruoyu Zhang\n  - Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, China (1 speakers): Xueli Bai\n  - Department of Hospital Administration, Fourth People's Hospital of Changzhou, Changzhou, China. (1 speakers): Jingping Yu\n  - Department of Immunology, Medical School of Nantong University, Nantong, Jiangsu, China. (1 speakers): Ling Zuo\n  - Department of Internal Medicine Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Number 440, Jinan 250117, China. (1 speakers): Haiyong Wang\n  - Department of Internal Medicine-Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China. (1 speakers): Xiaoling Shang\n  - Department of Interventional Radiology, Guangdong Provincial People's Hospital, Guangzhou, People's Republic of China. (1 speakers): Feng Shi\n  - Department of Interventional Radiology, The First Affiliated Hospital of South University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen People's Hospital (1 speakers): Jianxi Guo\n  - Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. (1 speakers): Bailu Wu\n  - Department of Laboratory Medicine The Affiliated Changsha Hospital of Xiangya School of Medicine (The First Hospital of Changsha) Central South University Changsha Hunan China. (1 speakers): Wu Yong\n  - Department of Laboratory Medicine, Guangdong Second Provincial General Hospital, Guangzhou 510317, China. (1 speakers): Li-Mei ZHONG\n  - Department of Laboratory Medicine, School of Medical Technology, Tianjin Medical University, Tianjin, China. (1 speakers): Jinhao Yang\n  - Department of Laboratory Medicine, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. (1 speakers): Ting Ye\n  - Department of Liver Surgery & Liver Transplantation, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy (1 speakers): Mingheng Liao\n  - Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. (1 speakers): Mingjian Piao\n  - Department of Liver Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China (1 speakers): Kefei Yuan\n  - Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China. (1 speakers): Xinhao Xiong\n  - Department of Lung Cancer Surgery, Tianjin Lung Cancer Institute, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. (1 speakers): Mengzhe Zhang\n  - Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. (1 speakers): Dongsheng Yue\n  - Department of Lymphoma & Head and Neck Oncology, College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou, China. (1 speakers): Jiesong Wang\n  - Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Yijing Li\n  - Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China. (1 speakers): Wenyu Li\n  - Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy (1 speakers): Yaxiao Lu\n  - Department of Medical Oncology Shanghai Pulmonary Hospital, School of Medicine, Tongji University Shanghai People's Republic of China. (1 speakers): Anwen Xiong\n  - Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China. (1 speakers): Danyun Ruan\n  - Department of Medical Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China. (1 speakers): Yanfang Zheng\n  - Department of Medical Oncology, Beijing Chao yang District San huan Cancer Hospital, Beijing, China. (1 speakers): Jinping Pi\n  - Department of Medical Oncology, Beijing Chaoyang District Sanhuan Cancer Hospital, Beijing, China, Department of Medical Oncology, The Second Hospital of Dalian Medical University, Liaoning, China. (1 speakers): Die Sang\n  - Department of Medical Oncology, Beijing Chaoyang District Sanhuan Cancer Hospital, Beijing, China. (1 speakers): Yanfang Su\n  - Department of Medical Oncology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China. (1 speakers): Yi-Kun Kang\n  - Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (2 speakers): Haohua Zhu, Yuan-Kai Shi\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (1 speakers): Jingrui Jiang\n  - Department of Medical Oncology, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China (2 speakers): RunKai Cai, Weixiang Zhan\n  - Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China. (1 speakers): Biyun Wang\n  - Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. (3 speakers): Jian Zhang, Weijian Guo, Yuxin Mu\n  - Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China. (1 speakers): Na Yao\n  - Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China. Electronic address: 0566@hrbmu.edu.cn. (1 speakers): Qingyuan Zhang\n  - Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (3 speakers): Jiayu Wang, Pin Zhang, Ying Fan\n  - Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (4 speakers): Hangcheng Xu, Jiaxuan Liu, Linyan Tian, Xuenan Peng\n  - Department of Medical Oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (1 speakers): Liuliu Quan\n  - Department of Medical Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Shun Lu\n  - Department of Medical Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China. (1 speakers): Yongfeng Yu\n  - Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China. (1 speakers): Wengang Zhang\n  - Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. (1 speakers): Caicun Zhou\n  - Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Jiajia Huang\n  - Department of Medical Oncology, Sun Yat-sen University Cancer Center, China, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer (1 speakers): Ting Zhou\n  - Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China. (1 speakers): Zhi-Ming Li\n  - Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China. (1 speakers): Wen Feng Fang\n  - Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine (1 speakers): Huaqiang Zhou\n  - Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. (1 speakers): Ran Ran\n  - Department of Medical Oncology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453199, China. (1 speakers): Yinghua Ji\n  - Department of Medical Oncology, The affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing (1 speakers): Xiaohua Wang\n  - Department of Medical Oncology, The affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China. (1 speakers): Shuyi Hu\n  - Department of Medical Oncology, Xi'an, China. (1 speakers): Xiaohui Jia\n  - Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China. (1 speakers): Yiyi Yu\n  - Department of Medical Oncology, the Fifth Medical Center, Chinese PLA General Hospital, Beijing 100071, China. (1 speakers): Guanghai Dai\n  - Department of Medical Ultrasound, Shandong Medicine and Health Key Laboratory of Abdominal Medical Imaging (1 speakers): Wei Liu\n  - Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, PR China, Department of Neurosurgery, Beijing Tiantan Hospital (1 speakers): You Zhai\n  - Department of Nasopharyngeal Carcinoma Sun Yat-sen University Cancer Center Guangzhou China. (1 speakers): Zhuoying Luo\n  - Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China. (1 speakers): Jie Yi Lin\n  - Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China. (1 speakers): Jingjing Miao\n  - Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China. (1 speakers): Xuguang Wang\n  - Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. (1 speakers): Zhuang Kang\n  - Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital Capital Medical University Beijing China. (1 speakers): Wenbin Li\n  - Department of Neurology Children's Hospital Capital Institute of Pediatrics Beijing China. (1 speakers): Jun Wang\n  - Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. (1 speakers): Fei Tian\n  - Department of Neurosurgery Xuanwu Hospital, China International Neuroscience Institute, Capital Medical University, National Center for Neurological Disorders Beijing China. (1 speakers): Tao Wang\n  - Department of Neurosurgery, Guangdong Provincial People's Hospital, Guangzhou, People's Republic of China (C.P.). (1 speakers): Chao Peng\n  - Department of Neurosurgery, Neurosurgery Centre, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China. (1 speakers): Aierpati Maimaiti\n  - Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (1 speakers): Wenjie Wu\n  - Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China. (1 speakers): Cheng Liu\n  - Department of Nursing, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China. (1 speakers): Ying Peng\n  - Department of Nutritional, Shanghai Pulmonary Hospital Affiliated to Tongji University, Shanghai, China. (1 speakers): Qin Ding\n  - Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (2 speakers): MO LI, Qinglei Gao\n  - Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (1 speakers): Ting Peng\n  - Department of Obstetrics and Gynecology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China. (1 speakers): Shujuan Liu\n  - Department of Occupational and Environmental Health, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China (1 speakers): Shaowei Wu\n  - Department of Ocular Oncology and Orbital Diseases, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, People's Republic of China. (1 speakers): Lijuan Tang\n  - Department of Oncology Shanghai Medical College Fudan University Shanghai China. (1 speakers): Qifeng Wang\n  - Department of Oncology Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China. (1 speakers): Huiying Li\n  - Department of Oncology Zhujiang Hospital Southern Medical University Guangzhou Guangdong China. (1 speakers): Peng Luo\n  - Department of Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China. (1 speakers): Hui Yu\n  - Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China. (1 speakers): Qing Lian Wen\n  - Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China. (1 speakers): Weiran Xu\n  - Department of Oncology, Dongying People's Hospital, Dongying, China. (1 speakers): Longxiang Guo\n  - Department of Oncology, First Medical Center, General Hospital of the People'S Liberation Army, Beijing, China. (1 speakers): Sisi Ye\n  - Department of Oncology, Lishui Municipal Central Hospital, Lishui 323000, China. (1 speakers): Jianhui Huang\n  - Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. (1 speakers): Shudong Ma\n  - Department of Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. (1 speakers): Aiping Zhou\n  - Department of Oncology, Shanghai Dongfang Hospital, Tongji University, Shanghai, China. (1 speakers): Ye Guo\n  - Department of Oncology, Shanghai Medical College, Fudan University, Shanghai Genitourinary Cancer Institute, Shanghai 200032, China. (1 speakers): Linhui Zhang\n  - Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China. (1 speakers): Meiqi Shi\n  - Department of Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China. (1 speakers): Qiming Wang\n  - Department of Oncology, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou (1 speakers): Wenyu Zhu\n  - Department of Oncology, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou, China. (1 speakers): Hanjue Dai\n  - Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. cnhzxyq@163.com. (1 speakers): Zhengxiang Han\n  - Department of Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China. (1 speakers): Chuanhua Zhao\n  - Department of Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China. jmxu2003@163.com. (1 speakers): Jianming Xu\n  - Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, P. R. China. (1 speakers): Xicheng Wang\n  - Department of Oncology, The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, P. R. China. (1 speakers): Yiqian Liu\n  - Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. (1 speakers): Xiang Huang\n  - Department of Oncology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China. (1 speakers): Lijuan Meng\n  - Department of Oncology, The First Hospital of Jilin University, Changchun, China. (1 speakers): Ziling Liu\n  - Department of Oncology, The Second Affiliated Hospital, Guizhou Medical University, Kaili, China. (1 speakers): Lili Zhao\n  - Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China. (1 speakers): Qiping Zhuo\n  - Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. (1 speakers): Xueqing Zhang\n  - Department of Oncology, Yibin Second People's Hospital, Yibin, Sichuan, P.R. China. (1 speakers): ShanBing Wang\n  - Department of Oncology, the Second Affiliated Hospital of Harbin Medical University, Harbin, China. (1 speakers): Chengjuan Fan\n  - Department of Ophthalmology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China. (1 speakers): Liping Su\n  - Department of Orthopaedic Oncology Surgery, National Center for Orthopedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China. (1 speakers): Xiaohui Niu\n  - Department of Orthopaedic Oncology Surgery, Peking University Fourth School of Clinical Medicine, Beijing, China. (1 speakers): Qing Zhang\n  - Department of Orthopaedics, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Qiyuan Bao\n  - Department of Orthopaedics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. (1 speakers): Xingyu Yang\n  - Department of Orthopedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopedics, Ruijin Hospital (1 speakers): Yucheng Fu\n  - Department of Otolaryngology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. (1 speakers): Junhui Zhang\n  - Department of Otolaryngology, West China Second University Hospital, Sichuan University, Chengdu, China. (1 speakers): WEI KOU\n  - Department of Otolaryngology-Head Neck Surgery Sleep Medicine Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine Tsinghua University Beijing China. (1 speakers): Juan Li\n  - Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. (1 speakers): Xiaohong Chen\n  - Department of Otorhinolaryngology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. (1 speakers): Weiwei Wang\n  - Department of Palliative Care and Department of Geriatric Oncology, Chongqing University Cancer Hospital, Chongqing400030, People's Republic of China. (1 speakers): Huiqing Yu\n  - Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032 (1 speakers): Xianjun Yu\n  - Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. (1 speakers): HeLi Gao\n  - Department of Pathology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China. (1 speakers): Xiaowei Zhang\n  - Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China. (1 speakers): Midie Xu\n  - Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. (1 speakers): Xujie Sun\n  - Department of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): QIN YAN\n  - Department of Pathology, The Second Affiliated Hospital of Guilin Medical University, Guilin, China. (1 speakers): Yue Fu\n  - Department of Pathology, University of Massachusetts Medical School, Worcester, MA 01655, USA. (1 speakers): Siwei Nie\n  - Department of Pathology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang (1 speakers): Dan Su\n  - Department of Pediatric Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, China. (1 speakers): Hao Fu\n  - Department of Pediatrics, Wuhan Fourth Hospital, No.76, Wuhan, Hubei, China. (1 speakers): Jing Chen\n  - Department of Pharmacology and Regenerative Medicine, University of Illinois at Chicago, Chicago, IL 60612 (1 speakers): Xinyi Liu\n  - Department of Pharmacology, College of Basic Medical Sciences, Binzhou Medical University, Yantai, SD, China. (1 speakers): Xin Xie\n  - Department of Pharmacy College of Veterinary Medicine Sichuan Agricultural University Chengdu China. (1 speakers): Yang Chen\n  - Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai, China. (1 speakers): Jiefeng Luo\n  - Department of Pharmacy, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China. (1 speakers): Yin Zhang\n  - Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Feng Xu\n  - Department of Plastic and Reconstructive Surgery, Zhongda Hospital, Southeast University, Nanjing, China. (1 speakers): Ke Wang\n  - Department of Psychiatry, Zhejiang Hospital, Hangzhou, China. (1 speakers): Liling Ma\n  - Department of Pulmonary Oncology, Hubei Key Laboratory of Tumor Biological Behavior, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China (1 speakers): Conghua Xie\n  - Department of Pulmonary and Critical Care Medicine, Beijing Hospital, National Centre of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China. (1 speakers): Tongji Xie\n  - Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, China. (1 speakers): Yue Ma\n  - Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. (1 speakers): Liwen Wang\n  - Department of Radiation Oncology, Beijing Tsinghua Changgeng Hospital, Tsinghua University, Beijing, China. (1 speakers): Guangxin Li\n  - Department of Radiation Oncology, Cancer Center, The Tenth Affiliated Hospital, China. (1 speakers): Tianwang Guan\n  - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China (3 speakers): Chaosu Hu, Weiqing Lu, Xiaomin Ou\n  - Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China hg7913@hotmail.com 39390822@qq.com. (1 speakers): Guang Han\n  - Department of Radiation Oncology, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan 410013, P.R. China. (1 speakers): Yaqian Han\n  - Department of Radiation Oncology, Institute of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, China. (1 speakers): Xinyu Sun\n  - Department of Radiation Oncology, Peking University First Hospital, Beijing, China. (1 speakers): Mingwei Ma\n  - Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center (1 speakers): Lei Wu\n  - Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiao Tong University Medical School of medicine, Shanghai, China. (1 speakers): Cheng Xu\n  - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China (1 speakers): JIanfeng Peng\n  - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. (1 speakers): Xudong Hu\n  - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Jinan, Shandong, China. (1 speakers): Changxing Feng\n  - Department of Radiation Oncology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, China. (1 speakers): Lin Ding\n  - Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Sifen Wang\n  - Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, China. (2 speakers): Baoqing Chen, Mian Xi\n  - Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China. (1 speakers): XinLei Ai\n  - Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, P.R. China. (2 speakers): Chunyan Chen, Yani Zhang\n  - Department of Radiation Oncology, The Affiliated Huizhou Hospital, Guangzhou Medical University, Huizhou, China. (1 speakers): Zhenyu Pan\n  - Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. (1 speakers): Shu Zhou\n  - Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, China. (1 speakers): Jingjing Wang\n  - Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China. (1 speakers): Qiao Qiao\n  - Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China. (1 speakers): Juan Li\n  - Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Hangzhou, Zhejiang, China. (1 speakers): Ting Jin\n  - Department of Radiation Oncology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. (1 speakers): Danfang Yan\n  - Department of Radiation Therapy, The First Affiliated Hospital With Nanjing Medical University, Nanjing, People's Republic of China. (1 speakers): Yinjiao Fei\n  - Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China. (1 speakers): Qiuji Wu\n  - Department of Radiology, China-Japan Friendship Hospital, Beijing, China. (1 speakers): Sheng Xie\n  - Department of Radiology, Peking University People's Hospital, No.11, Beijing, China. (1 speakers): Wenjia Zhang\n  - Department of Radiology, Shanghai Jiao Tong University School of Medicine Affiliated Shanghai Sixth People's Hospital, Shanghai 200233, China. (1 speakers): Hui Li\n  - Department of Radiology, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, China. (1 speakers): Menghong Zou\n  - Department of Radiology, The University of Hong Kong - Shenzhen Hospital, Shenzhen, PR China. (1 speakers): Ziyan Zhou\n  - Department of Radiology, Tianjin Medical University Baodi Hospital, China. (1 speakers): ZHENWEI MIAO\n  - Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P.R. China. (1 speakers): Yang Peng\n  - Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041 Sichuan, China. (1 speakers): Ying Liu\n  - Department of Radiotherapy, Jiangsu Province Hospital, Nanjing, China. (1 speakers): Weilin Xu\n  - Department of Radiotherapy, The 900th Hospital of the Joint Logistics Team (Dongfang Hospital), Xiamen University, Fuzhou, China, Department of Radiotherapy (1 speakers): Wenmin Ying\n  - Department of Radiotherapy, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China. (1 speakers): Liangjun Zhu\n  - Department of Respiratory Disease, Thoracic Disease Center, Zhejiang University School of Medicine First Affiliated Hospital, China. (1 speakers): Jianya Zhou\n  - Department of Respiratory Medicine, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China. (1 speakers): Lan Wang\n  - Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. (1 speakers): Xiaoyi Feng\n  - Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (4 speakers): Huawei Du, Kuofang Huang, Tianqing Chu, Yanwei Zhang\n  - Department of Rheumatology and Immunology, Deyang People's Hospital, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Deyang 618000, China. (1 speakers): Jie Zhang\n  - Department of Spine Surgery, Shanghai East Hospital, Tongji University School of Medicine Shanghai China. (1 speakers): Qian Wang\n  - Department of Stomatology Huashan Hospital, Fudan University, Shanghai, China. (1 speakers): Laiping Zhong\n  - Department of Surgery, NY 10065, USA, Key Laboratory of Pesticide and Chemical Biology (CCNU), Ministry of Education, College of Chemistry, Central China Normal University, Wuhan, Hubei 430079, China. (1 speakers): Lingling Feng\n  - Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, California, USA. (1 speakers): Rui Su\n  - Department of Thoracic Medical Oncology Cancer Hospital Chinese Academy of Medical Sciences Beijing China. (1 speakers): Jie Wang\n  - Department of Thoracic Oncology and Surgery, The First Affiliated Hospital of Guangzhou Medical University (1 speakers): Feng Li\n  - Department of Thoracic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. (1 speakers): Qian Chu\n  - Department of Thoracic Radiotherapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Hangzhou, China. Electronic address: xuyj@zjcc.org.cn. (1 speakers): Yujin Xu\n  - Department of Thoracic Surgery and Oncology, Hengqin Hospital, First Affiliated Hospital of Guangzhou Medical University, Hengqin, Guangdong, China. (1 speakers): Wenjun Ye\n  - Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (1 speakers): Shan Xiong\n  - Department of Thoracic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China. (1 speakers): Qiao Li\n  - Department of Thoracic Surgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou 45003, China. (1 speakers): Tian Xia\n  - Department of Thoracic Surgery, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China. (1 speakers): Chengzhi Ding\n  - Department of Thoracic Surgery, National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. (1 speakers): Runchen Wang\n  - Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China. (1 speakers): Shaoyi Chen\n  - Department of Thoracic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Wangrui Liu\n  - Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Zhigang Li\n  - Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. (1 speakers): Suyu Wang\n  - Department of Thoracic Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Yitao Yang\n  - Department of Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, China. (1 speakers): Xiaobing Li\n  - Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China. (1 speakers): Renquan Zhang\n  - Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi'an, Shaanxi, China. (1 speakers): Weibo Cao\n  - Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China. (1 speakers): Zhenyu Yang\n  - Department of Trauma Center, Zhongda Hospital, Southeast University, Nanjing, People's Republic of China. (1 speakers): Cheng Zhang\n  - Department of Ultrasound and Electrocardiography, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang, People's Republic of China. (1 speakers): Yu Cheng\n  - Department of Urology Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Yulu Peng\n  - Department of Urology Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China. (1 speakers): Pei Dong\n  - Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, China, West China School of Medicine, Sichuan University, Chengdu, China. (1 speakers): Qihao Wang\n  - Department of Urology, Affiliated Drum Tower Hospital Medical School of Nanjing University, Nanjing, People's Republic of China. (1 speakers): Shun Zhang\n  - Department of Urology, First People's Hospital of Kashi, Kashi, China. (1 speakers): Wenkai Zhu\n  - Department of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China (1 speakers): Bo Dai\n  - Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China (1 speakers): Xiaojie Bian\n  - Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China. (3 speakers): Maoping Cai, Xudong Ni, Yao Zhu\n  - Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China. dwyeli@163.com. (1 speakers): Dingwei Ye\n  - Department of Urology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine of Central South University, Changsha, China. (1 speakers): Shusuan Jiang\n  - Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, P.R. China . (1 speakers): Rang Gao\n  - Department of Urology, Institute of Urology, Sichuan Clinical Research Center for Kidney and Urologic Diseases, West China Hospital, Sichuan University, Chengdu, China. (1 speakers): Zilin Wang\n  - Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing, China. (1 speakers): Wenli Diao\n  - Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Institute of Urology, Nanjing University, China. (1 speakers): Tianlei Xie\n  - Department of Urology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, China. (1 speakers): Junlong Zhuang\n  - Department of Urology, Peking University First Hospital, Beijing 100034, China. (1 speakers): Kaiwei Yang\n  - Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Jiwei Huang\n  - Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (2 speakers): Jiayi Lu, Wei Xue\n  - Department of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, People's Republic of China. (1 speakers): Mao Ding\n  - Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Ruofan Shi\n  - Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Xingliang Tan\n  - Department of Urology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China. (1 speakers): Xuefeng Qiu\n  - Department of Urology, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, China. (1 speakers): Jian-ting Xu\n  - Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China. (1 speakers): Qiang Song\n  - Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou (1 speakers): Bin Huang\n  - Department of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China. (1 speakers): Yurong Zhang\n  - Department of Urology, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Yichang, Hubei, China. (1 speakers): Cheng Yi\n  - Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China. (1 speakers): Sicong Zhang\n  - Department of Urology, The Second Affiliated Hospitalof Naval Medical Uiversity, Shanghai, China. (1 speakers): Duocai Li\n  - Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. (1 speakers): Jiahao Wang\n  - Department of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. (1 speakers): Cheng Hu\n  - Department of Urology, The Third Medical Center, Chinese PLA General Hospital, Beijing, China. (1 speakers): Liangyou Gu\n  - Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. (1 speakers): Kang Chen\n  - Department of Urology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. (1 speakers): Yue Che\n  - Department of Urology, West China Hospital Sichuan University, Chengdu (1 speakers): Yige Bao\n  - Department of VIP Clinic General Division, Shanghai East Hospital, School of Medicine Tongji University Shanghai China. (1 speakers): Yan Zhang\n  - Department of the Comprehensive Cancer Center, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China. (1 speakers): Zhengyun Zou\n  - Department of urology, Peking University First Hospital, Beijing, China. (1 speakers): Yelin Mulati\n  - Departments of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou 350014, Fujian, China. (1 speakers): Fei Zhu\n  - Departments of Oncology Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China. (1 speakers): Sheng Yang\n  - Digital Diagnosis and Treatment Innovation Center for Cancer, Institute of Translational Medicine, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Wantao Chen\n  - Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041 Sichuan, China. Electronic address: maji@wchscu.cn. (1 speakers): Ji Ma\n  - Division of Abdominal Tumor Multimodality Treatment, Department of Radiation Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan (1 speakers): Yali Shen\n  - Division of Natural and Applied Sciences, Duke Kunshan University, Kunshan, Jiangsu, China. (1 speakers): Ferdinand Kappes\n  - Division of Pancreatic Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China. (1 speakers): Ziheng Guo\n  - Division of Thyroid Surgery, Department of General Surgery, Laboratory of Thyroid and Parathyroid Diseases, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital (1 speakers): Jiaye Liu\n  - ENT Institute and Department of Otorhinolaryngology, Eye and ENT Hospital, Fudan University, Shanghai, China. (1 speakers): Jinghan Wang\n  - Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. (1 speakers): Yijun Dong\n  - Endoscopy Center, Minhang District Central Hospital, Fudan University, Shanghai, China. (1 speakers): Feng Li\n  - GMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, Guangdong, China. (1 speakers): Linlin Wang\n  - Gastric Cancer Center/Cancer Center, West China Hospital, Sichuan University, Sichuan, China. (1 speakers): Mo Cheng\n  - Gastroenterology, Yanan University Affiliated Hospital, Yan'an, China. (1 speakers): Min Bai\n  - General Surgery Center, First Hospital of Jilin University, Changchun, China. (1 speakers): Zhongqi Fan\n  - Graduate School, Chinese PLA General Hospital/Medical School of Chinese PLA, Beijing, PR China. (1 speakers): An Wang\n  - Graduate School, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, PR China. (1 speakers): Jianan Jin\n  - Guangdong Laboratory of Lingnan Modern Agriculture, Genome Analysis Laboratory of the Ministry of Agriculture, Agricultural Genomics Institute at Shenzhen, Shenzhen, China. (1 speakers): Yance Feng\n  - Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. (2 speakers): Chen Huang, Si-Yang Liu\n  - Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. Electronic address: syylwu@live.cn. (1 speakers): Yi-Long Wu\n  - Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, People's Republic of China. (1 speakers): Wei-Chi Luo\n  - Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. (1 speakers): Xu-Chao Zhang\n  - Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China, Biomedical Innovation Center (1 speakers): Zerong Cai\n  - Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center (1 speakers): Yue Pan\n  - Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. chenyt58@mail.sysu.edu.cn. (1 speakers): Jiajia Li\n  - Guangzhou Institute of Respiratory Health, Guangzhou, China. (1 speakers): Bo Cheng\n  - Hainan Pharmaceutical Research and Development Science and Technology Park, Haikou, China. Electronic address: z_xp1412@163.com. (1 speakers): Xiaopo Zhang\n  - Hangzhou Cancer Institution, Affiliated Hangzhou Cancer Hospital, Zhejiang University School of Medicine, Hangzhou, China (1 speakers): Hongfang Zhang\n  - Harbin Medical University Cancer Hospital, Harbin, China. (1 speakers): Yanbin Zhao\n  - Hengqin Hospital, First Affiliated Hospital of Guangzhou Medical University, Hengqin, China. (1 speakers): Wenhai Fu\n  - Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. (2 speakers): Jia Jiang, Yue Huang\n  - Inc., Guangdong, Guangzhou, China. (1 speakers): Dongmei Chen\n  - Institute of Molecular Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Kangli Ma\n  - Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China. (1 speakers): Jian Pan\n  - Jinan Central Hospital, Shandong University, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, People's Republic of China. (1 speakers): Mei Li Sun\n  - Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou 510632, China. (1 speakers): Yangqiu Li\n  - Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China. (1 speakers): FEILIN QU\n  - Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Precision Cancer Medicine Center, Fudan University Shanghai Cancer Center, Shanghai 200032, P. R. China. (1 speakers): Lei Fan\n  - Key Laboratory of Cancer Prevention and Therapy, The Sino-United States Center for Lymphoma and Leukemia Research, Tianjin, China. (1 speakers): Wenhua Wang\n  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Department of Lymphoma Peking University Cancer Hospital & Institute Beijing China. (1 speakers): Yuqin Song\n  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China. (1 speakers): Zhijie Wang\n  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Urology, Peking University Cancer Hospital & Institute, Beijing 100142, China. (1 speakers): Yudong Cao\n  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing (1 speakers): Xi Zhang\n  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genitourinary Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China. (1 speakers): Xinan Sheng\n  - Key Laboratory of Carcinogenesis and Translational Research, Department of Thoracic Surgery I, Peking University Cancer Hospital & Institute, Beijing, China. (1 speakers): Luyan Shen\n  - Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center National Clinical Research Center for Geriatrics West China Hospital Sichuan University Chengdu... (1 speakers): Xiangrong Song\n  - Laboratory of Biomaterials and Translational Medicine, Department of Joint and Trauma Surgery, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China. (1 speakers): Yu Tao\n  - Ltd, Shanghai, People's Republic of China. (1 speakers): Xiaohui Wang\n  - Marine College, Shandong University, Weihai, Shandong, PR China. (1 speakers): Chuanhao Zhang\n  - Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering, Shenzhen University Medical School (1 speakers): Jing Lin\n  - Medical Imaging Center, First Affiliated Hospital of Jinan University, Guangzhou, China. (1 speakers): Jing Li\n  - Michigan Center for Translational Pathology. (1 speakers): Yu Chang\n  - Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing 100044, China. (1 speakers): Lu Xie\n  - Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing, Jiangsu, People's Republic of China. (1 speakers): Xin Lv\n  - Nanjing Stomatological Hospital, Research institute of Stomatology, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. (1 speakers): Meng Yuan\n  - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China. (2 speakers): Fei Ma, Zheng Liu\n  - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang, Beijing, China. (1 speakers): Qingyao Shang\n  - National Institute of TCM, Beijing University of Chinese Medicine, Beijing, China. (1 speakers): Wang-Zhong Li\n  - Neurosurgery Department, Dezhou People's Hospital, Dezhou, PR China. (1 speakers): Li Zhang\n  - Ningxia Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Sciences, General Hospital of Ningxia Medical University, No. 804, Yinchuan, China. (1 speakers): Yujie Zhang\n  - Nursing Department, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. (1 speakers): Shiyu Liang\n  - Obstetrics & Gynecology Hospital of Fudan University, Shanghai, China. (2 speakers): Panpan Zhang, Qi Zhou\n  - Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China (2 speakers): Junjun Qiu, Keqin Hua\n  - Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. (1 speakers): Yongjie Xu\n  - Orthopedics, Ruijin Hospital, Shanghai, Shanghai, China. (1 speakers): Zhusheng Zhang\n  - Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. (1 speakers): Kuirong Jiang\n  - Pharmaron U.K., Pharmaron UK Ltd., Hoddesdon (1 speakers): Fang He\n  - Phase I Clinical Trial Center, Shanghai Cancer Center, Fudan University, Shanghai, China. (1 speakers): Yanchun Meng\n  - Precision Cancer Medicine Center, Fudan University Shanghai Cancer Center, Shanghai, China. (1 speakers): Xichun Hu\n  - Prince of Wales Hospital, Hong Kong Special Administrative Region, China. (1 speakers): Kingsley Sze Yuen Cheung\n  - Prince of Wales Hospital, The Chinese University of Hong Kong, China. (1 speakers): Brigette B. Ma\n  - Princess Margaret Hospital, Hong Kong, Hong Kong SAR. (1 speakers): Matthew Lun M. Wong\n  - Renmin Hospital of Wuhan University, Wuhan, China. (1 speakers): Junxiao Wang\n  - Research Center for Nanosensor Molecular Diagnostic & Treatment Technology, College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen, Guangdong 518060, P. R. China. (1 speakers): Yizhen Liu\n  - Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. (1 speakers): Caining Zhao\n  - Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Hangzhou, China. (1 speakers): Zhangsheng Jiang\n  - School of Artificial Intelligence, The University of Chinese Academy of Sciences, Beijing 100190, China. (1 speakers): Yang Du\n  - School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China. (1 speakers): Ting Liu\n  - School of Basic Medicine, Ningxia Medical University, Yinchuan, P.R. China. (1 speakers): Jie Xu\n  - School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou, China. (1 speakers): Dong Luo\n  - School of Business, Guilin Tourism University, Guilin, Guangxi, China. (1 speakers): Yan Li\n  - School of Clinical Medicine, Peking University Health Science Center, Beijing 100191, China. (1 speakers): Huizhu Chen\n  - School of Food Science and Technology, State Key Laboratory of Food Science and Technology, National Engineering Research Center for Functional Food, Jiangnan University, Wuxi, China. (1 speakers): Li Wang\n  - School of Geography and Resources, Guizhou Education University, Guiyang 550018, China. (1 speakers): Xuqiang Luo\n  - School of Medicine, Tsinghua University, Beijing, China. (1 speakers): Xiaoshuang Lyu\n  - School of Pharmacy and Minhang Hospital, Fudan University, Shanghai 201203, China. (1 speakers): Wei Li\n  - School of Physics and Optoelectronic Engineering, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China. (1 speakers): Cong Sun\n  - School of Public Health, Fudan University, Shanghai, People's Republic of China. z_yibiao@hotmail.com. (1 speakers): Yu-Wen Zhou\n  - School of Sports Medicine and Rehabilitation, Beijing Sport University, Beijing 100084, China. (1 speakers): Yiting Li\n  - School of Textile Science and Engineering, Xi'an Polytechnic University, Xi'an (1 speakers): Wu Fan\n  - Senior Department of Cardiology, the Sixth Medical Center of Chinese PLA General Hospital, Beijing, China. (1 speakers): Jun Guo\n  - Senior Department of Hepatology, The 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China. (1 speakers): Hongli Yu\n  - Senior Department of Infectious Diseases The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases Beijing China. (1 speakers): Xiaoyan Li\n  - Shandong Cancer Hospital and Institute, 250117, China. (1 speakers): Zhonghui Z. Wei\n  - Shanghai Institute of Hematology, State Key Laboratory of Medica Genomics, National Research Center for Translational Medicine at Shanghai Ruijin Hospital Affiliated to Shanghai Jiao Tong University S... (1 speakers): Li Wang\n  - Shanghai Key Laboratory of Atmospheric Particle Pollution and Prevention (LAP3), Department of Environmental Science and Engineering, Fudan University, Shanghai 200433, China (1 speakers): Shanshan Wang\n  - Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China. (1 speakers): Yingjie Hu\n  - Shanghai University, Shanghai 200444, China. (1 speakers): Yufan Y. Zhao\n  - Shanghai, China. (1 speakers): Xiaokun Shen\n  - Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University Taiyuan 030001, Shanxi (1 speakers): Jinfeng Ma\n  - Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China. (1 speakers): Xiao Chen\n  - Shenzhen Research Institute, The Chinese University of Hong Kong, China. (1 speakers): Yuhan Zhang\n  - Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China. (1 speakers): Chen Zihan\n  - Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. (1 speakers): Hongming Pan\n  - State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. (1 speakers): Jie Liu\n  - State Key Laboratory of Flexible Electronics (LoFE) & Institute of Flexible Electronics (IFE), Xi'an Institute of Biomedical Materials & Engineering (IBME), Northwestern Polytechnical University (1 speakers): Kun Wang\n  - State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, China. (1 speakers): Lei Yang\n  - State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute (1 speakers): Changsong Qi\n  - State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China. (1 speakers): Zhi Peng\n  - State Key Laboratory of Molecular Oncology, First Department of Thoracic Surgery, Peking University Cancer Hospital & Institute, Beijing, China. (1 speakers): Shaohua Ma\n  - State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. (1 speakers): Yiran Zhou\n  - State Key Laboratory of Neurology and Oncology Drug Development, Ltd, Nanjing Simcere Medical Laboratory Science Co., Ltd, Nanjing, China. (1 speakers): Xing Zhang\n  - State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. (1 speakers): YanFeng Chen\n  - State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Miaozhen Qiu\n  - State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Tian-Liang Xia\n  - State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. (1 speakers): Yunfei Yuan\n  - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yatsen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China. (1 speakers): Yuan Zhang\n  - State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong Cancer Institute, Faculty of Medicine, The Chinese University of Hong Kong, China. (2 speakers): Stephen L. Chan, Winnie Yeo\n  - State Key Laboratory of Tropic Ocean Engineering Materials and Materials Evaluation, School of Materials Science and Engineering, Beihang University, Beijing, P. R. China. (1 speakers): Liwei Fan\n  - Sun Yat-Sen University Cancer Center, Guangzhou, China. (1 speakers): Shuhui Dong\n  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. Electronic address: xurh@sysucc.org.cn. (1 speakers): Rui-Hua Xu\n  - The 111 Project Laboratory of Biomechanics and Tissue Repair, College of Bioengineering, Chongqing University, Chongqing, China. (1 speakers): Zheng Wu\n  - The 900th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Fuzhou, China. (1 speakers): Xi Chen\n  - The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. (1 speakers): Min Yan\n  - The Chinese University of Hong Kong, Hong Kong, China. (1 speakers): Winnie KW W. So\n  - The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. (1 speakers): Yong Y. Chen\n  - The First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China. (1 speakers): Manya Yu\n  - The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China, Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou (1 speakers): Ruxue Lv\n  - The Harbin Medical University Cancer Hospital, Harbin, China. (1 speakers): Yanqiao Zhang\n  - The Key Laboratory of Biomarker High throughput screening and target translation of breast and gastrointestinal tumor, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China. (1 speakers): Guanxuan CHEN\n  - The School of Clinical Medicine, Fujian Medical University, Fuzhou 350000, Fujian, China. (1 speakers): Xiaojing Huang\n  - The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China. (1 speakers): Fuming Qiu\n  - The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, P. R. China. lamp197311@126.com. (1 speakers): Yongyi Zeng\n  - The Wistar Institute (1 speakers): Qing Zhu\n  - Third Affiliated Hospital of Southern Medical University, Guangzhou 510000, China. (1 speakers): Lei H. Tan\n  - Thoracic Oncology Institute and Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Peking University People's Hospital, Beijing, China. (1 speakers): Zheng Liu\n  - Tianjin Medical University Cancer Institute & Hospital, Tianjin, China. (2 speakers): Dingzhi Huang, Yehui Shi\n  - Tianjin Medical University Cancer Institute and Hospital, China. (1 speakers): Huikai Li\n  - Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. (1 speakers): Zhongsheng Tong\n  - Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China. (2 speakers): Chuntao Gao, Song Gao\n  - Translational Medical Research Platform for Thoracic Oncology, China. 18930858216@163.com. (1 speakers): Baohui Han\n  - University of Chinese Academy of Sciences, Beijing, China. (1 speakers): Dan Liu\n  - University of Western Australia, Western Australia 6009, Australia. (1 speakers): Chung B. Zhao\n  - Wenzhou Medical University, Wenzhou, China, Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou (1 speakers): Xiangdong Cheng\n  - West China School of Medicine West China Hospital Sichuan University Chengdu Sichuan China. (1 speakers): Chenhao Xu\n  - West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China. (1 speakers): Wei Peng\n  - Xiangya Stomatological Hospital, Changsha 410008, China. liwenj@csu.edu.cn. (1 speakers): Wenjie W. Li\n  - Xinjiang Key Laboratory of Herbivore Drug Research and Creation, College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi, Xinjiang, China. (1 speakers): Yang Li\n  - Yanbian University, Jilin, China. (1 speakers): Cai Gang G. Liu\n  - Zhejiang Cancer Hospital, The Key Laboratory of Zhejiang Province for Basic and Clinical Application of Functional Nucleic Acids, Hangzhou Institute of Medicine (HIM), Hangzhou, China. (1 speakers): Xiaojia Wang\n  - Zhejiang Chinese Medical University Affiliated Four-Province-Bordering Hospital of Traditional Chinese Medicine (Quzhou Hospital of Traditional Chinese Medicine), PR China. (1 speakers): Hong-Hong Zhu\n  - Zhejiang Engineering Research Centre for Tissue Repair Materials, University of Chinese Academy of Sciences, China. (1 speakers): Feng Wen\n  - Zhejiang Key Laboratory of Precision Medicine Research on Head & Neck Cancer, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China. (1 speakers): Jiajie Xu\n  - Zhejiang Provincial Clinical Research Center for CANCER, Cancer Center of Zhejiang University, Hangzhou, China. (1 speakers): Kefeng Ding\n  - Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, Research Center for Clinical Pharmacy, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (1 speakers): Xingjiang Hu\n  - Zhongshan Hospital, Fudan University, Shanghai, China. (1 speakers): Wenbin Jiang\n  - iHuman Institute, ShanghaiTech University, Shanghai, China, School of Life Science and Technology, ShanghaiTech University, Shanghai, China. (1 speakers): Fei Xu\n\n**Colombia (3 institutions, 3 speakers)**\n  - Centre for Scientific and Technological Research of Extremadura (CICYTEX), Department of Horticulture, Finca La Orden, Regional Government of Extremadura, Highway A-V, Km 372, 06187 Guadajira, Badajoz, Spain. (1 speakers): Sandra Ximena Franco Millan\n  - Health Faculty, Cali 760035, Colombia. (1 speakers): Leidy T. Ordonez-Mora\n  - Universidad de La Sabana-Hospital Militar Central, Bogotá, Colombia. (1 speakers): Juan Guillermo Santacruz\n\n**Costa Rica (1 institutions, 1 speakers)**\n  - Hospital San Juan de Dios, San José (1 speakers): Allan Ramos-Esquivel\n\n**Croatia (2 institutions, 2 speakers)**\n  - Department of Hematology, Oncology and Clinical Immunology, General Hospital Varazdin, Croatia. (1 speakers): Renata Kelemenic-Drazin\n  - University J.J. Strossmayer Osijek, Osijek, Croatia. (1 speakers): Silvija Piskorjanac\n\n**Cuba (1 institutions, 1 speakers)**\n  -  (1 speakers): Lazara Y. Martinez Espinosa\n\n**Cyprus (3 institutions, 3 speakers)**\n  - Cyprus University of Technology, Limassol, Cyprus, Faculty for Dental Medicine and Health, Osijek, Croatia. (1 speakers): Nikolina Dodlek\n  - Department of Nursing, School of Sciences, Cyprus University of Technology, Limassol 3041, Cyprus. (1 speakers): Andreas Charalambous\n  - Karaiskakio Foundation, Nicosia, Cyprus. (1 speakers): Petroula Gerasimou\n\n**Czech Republic (6 institutions, 6 speakers)**\n  -  (1 speakers): Adam Vokurka\n  - Department of Gynaecology, Obstetrics and Neonatology, General University Hospital, Prague (1 speakers): David Cibula\n  - Department of Oncology, Palacký University Medical School and Teaching Hospital, I.P. Pavlova 6, Olomouc (1 speakers): Hana Studentova\n  - Department of Oncology, Regional Hospital Liberec, Liberec (1 speakers): Igor Richter\n  - Oncology Department of Czech Krumlov Hospital (1 speakers): Nadzeya Piatrouskaya\n  - Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno (1 speakers): Martin Bartosik\n\n**Delhi (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Fortis Memorial Research Institute, Gurugram, India. (1 speakers): Nitesh Rohatgi\n\n**Denmark (23 institutions, 31 speakers)**\n  -  (7 speakers): Asbjorn Kjaer, Astrid N. Vendelsoe, Kristina Norskov, Mette J. Syberg, Regina Wittchen Sorensen, Sebastian Soby, Yago Garitaonaindia Diaz\n  - Aarhus University Hospital, Aarhus N, Denmark. (1 speakers): Karen-Lise G. Spindler\n  - Centre for Physical Activity Research, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. (1 speakers): Casper Simonsen\n  - Copenhagen University Hospital, Rigshospitalet, Denmark. (1 speakers): Christine Federspiel Secher\n  - Danish Breast Cancer Group, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, Department of Clinical Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. (1 speakers): Tobias Berg\n  - Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital-Rigshospitalet & Department of Biomedical Sciences University of Copenhagen Copen... (1 speakers): Andreas Kjaer\n  - Department of Clinical Research, University of Southern Denmark, Campusvej 55, Odense (1 speakers): Laerke K. Tolstrup\n  - Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, Copenhagen, Denmark. (1 speakers): Lene Baeksgaard\n  - Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Denmark. (1 speakers): Troels D. Christensen\n  - Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark. (1 speakers): Eva Ellebaek\n  - Department of Oncology, National Center of Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Hovedstaden, Denmark. (1 speakers): Rebecca S. Jurlander\n  - Department of Oncology, Odense University Hospital, Odense, Denmark. (1 speakers): Christina H. Ruhlmann\n  - Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. (1 speakers): Bent Ejlertsen\n  - Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Denmark, Department of Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Denmark. (1 speakers): Maj Kamille Kjeldsen\n  - Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia. (1 speakers): Stine V. Eriksen\n  - Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. (1 speakers): Inna M. Chen\n  - National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. (1 speakers): Mario Presti\n  - National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, University Hospital Herlev, Herlev, Denmark. (1 speakers): Katharina Leuchte\n  - National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark. (1 speakers): Sidsel Pedersen\n  - National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. (3 speakers): Inge M. Noringriis, Inge Marie Svane, Marco Donia\n  - Odense University Hospital, University of Southern, Denmark. Electronic address: soeren.kjaer@rsyd.dk. (1 speakers): Soeren K. Petersen\n  - Research Center of Ageing and Osteoporosis, Department of Diagnostics, Copenhagen University Hospital Glostrup, Glostrup, Denmark. (1 speakers): Tina M. Kringelbach\n  - Xinhua Hospital, Shanghai, China. (1 speakers): Juanjuan U. Wang\n\n**Derbyshire (1 institutions, 1 speakers)**\n  - University Hospitals of Derby and Burton NHS Foundation Trust, Derby (1 speakers): Prantik Das\n\n**Ecuador (1 institutions, 1 speakers)**\n  - Respiralab Research Group, Guayaquil, Ecuador. (1 speakers): Walter Morquecho\n\n**Egypt (15 institutions, 19 speakers)**\n  -  (5 speakers): Dalia K. Harhash, Emadeldin Shash, Hebat Allah M. Ahmed, Lama Kamal, Rana El-Shewy\n  - Alexandria University, Alexandria, Egypt. (1 speakers): Israa Ahmed Ali Abdelrahem Qutob\n  - Beni-Suef University, Beni-Suef, Egypt. (1 speakers): Mennat-Allah Abdelsamed\n  - Cairo University, Cairo, Egypt. (1 speakers): Fatma M. Bektash\n  - Central Laboratory, Ministry of Higher Education and Scientific Research, Khartoum, Sudan. (1 speakers): Dina A. Hassan\n  - Clinical Oncology Department, Ain Shams University, Cairo, Egypt. (1 speakers): Hagar ElGhazawy\n  - Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt. (1 speakers): Amr S. Saad\n  - Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS (1 speakers): Mohamed Elgendy\n  - Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA. (1 speakers): H M. Amin\n  - Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo 12613, Egypt. (1 speakers): Omnia M. Korani\n  - Faculty of Medicine, Mansoura University, Egypt. (1 speakers): Khaled M. Abouelkhair\n  - Faculty of Medicine, Suez Canal, Egypt. (1 speakers): Ibrahim I. Hassan\n  - Helwan University, Cairo, Egypt. (1 speakers): Abdulrahman E. ElHelbawy\n  - Newgiza University, Giza, Egypt. (1 speakers): Yomna A. Mohamed\n  - Suez Canal University, Ismailia 41522, Egypt. (1 speakers): Kareem W. Raafat\n\n**Estonia (2 institutions, 2 speakers)**\n  - Pharmacy Department, Tartu University Hospital, Tartu, Estonia. (1 speakers): Marika Saar\n  - University of Tartu, Tartu 50090, Estonia. (1 speakers): Ann Valter\n\n**Ethiopia (1 institutions, 1 speakers)**\n  -  (1 speakers): Bethlehem Getachew Ayele\n\n**FL (2 institutions, 2 speakers)**\n  - Department of Biomedical Sciences and Human Oncology, University of Bari, Italy. (1 speakers): Mauro Cives\n  - Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, USA. (1 speakers): Jose Lutzky\n\n**FR (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Cochin University Hospital, Université Paris Cité, Institut du Cancer Paris CARPEM, Paris, France, Centre de Recherche des Cordeliers, UMR1138, Université Paris Cité (1 speakers): Guillaume Beinse\n\n**Finland (12 institutions, 13 speakers)**\n  - Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. (2 speakers): Elise Jirovec, Nea Ojala\n  - Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland. (1 speakers): Katriina Jalkanen\n  - Department of Chemistry University of Jyväskylä Jyväskylä Finland. (1 speakers): Sauli Vuoti\n  - Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Finland. (1 speakers): Mika Kontro\n  - Department of Nursing Science, University of Turku, Turku, Finland. Electronic address: hejopal@utu.fi. (1 speakers): Heli Arffman\n  - Department of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, Finland, Department of Obstetrics and Gynecology, Wellbeing Services County of Central Finland (1 speakers): Anna Rajavuori\n  - Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland. (1 speakers): Sari Voutilainen\n  - Department of Oncology, Tampere University Hospital, and University of Tampere, Tampere, Finland. (1 speakers): Pia J. Osterlund\n  - Department of Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. (1 speakers): Emerik Osterlund\n  - FICAN West Cancer Center, Turku, Finland. (1 speakers): Anniina E. Hyvakka\n  - Orionintie 1, FIN-02200, Espoo, Finland. (1 speakers): Anu Moilanen\n  - Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland. (1 speakers): Matilda Salko\n\n**Florida (1 institutions, 1 speakers)**\n  - Medical Oncology, Washington University in St. Louis, Siteman Cancer Center, St. Louis, Missouri. (1 speakers): Moh'd M. Khushman\n\n**France (182 institutions, 209 speakers)**\n  -  (18 speakers): ARNAUD DE GUNTEN, Diego Diaz-Jimenez, Elise Dominjon, Erwan Vo Quang, Flavien Minoc, Gauduchon Thibault, Hayat H. Mcheik, Jeanne Pongerard, Khalida Berkane, LOUIS-MARIE CHENET, Liora Bowers, Lucie Laplagne, Lucile Mercier, Marian Gil Delgado, Nael Alshatti, Roula Amine Hneineh, Teo Bodergat, Walid Ben Yedder\n  - AIDES, Pantin, France. (1 speakers): Tristan Alain\n  - ANTICIPE UMR 1086, Department of Pharmacology, Caen, France. (1 speakers): Louis Boismoreau\n  - ARCAD Foundation, Paris, France. (1 speakers): Morteza Raeisi\n  - Académie nationale de pharmacie, Unicancer, Paris, France. (1 speakers): Muriel Dahan\n  - Accenture, Paris, France. (1 speakers): Marion Narbeburu\n  - Augusta University, GA, USA. (1 speakers): Nadine Mansour\n  - CHU Besançon, Stomatologie et Odontologie Hospitalière, F-25000 Besançon, France. (1 speakers): Camille Gaudet\n  - CRCL, Centre Léon Bérard, Lyon, France. (1 speakers): Louise OLGIATI\n  - Cancer Committee of the French Association of Urology (CCAFU), France, Department of Medical Oncology, Gustave Roussy Cancer Campus, Paris-Saclay University, Villejuif, France. (1 speakers): Laurence Albiges\n  - Cancer Committee of the French Association of Urology (CCAFU), France, Department of Urology, AP-HP, Hôpital La Pitié-Salpétrière, Sorbonne University, Paris, France. (1 speakers): Morgan Roupret\n  - Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. (1 speakers): Heloise Halse\n  - Cancer Institute of Montpellier, INSERM U1194, University of Montpellier, Montpellier, France. (1 speakers): William Jacot\n  - Cancer Survivorship Program - INSERM Unit 981 Molecular Predictors and New Targets in Oncology - Gustave Roussy, Villejuif, France. (1 speakers): Antonio Di Meglio\n  - Centre Eugène Marquis, Rennes, France. (1 speakers): Thibault De La Motte Rouge\n  - Centre Francois-Baclesse, Medical Oncology, Caen, France. (1 speakers): Florence Joly Lobbedez\n  - Centre Léon Bérard, Lyon, France, Lyon, France, Centre de Recherche en Cancérologie de Lyon, Lyon, France. (1 speakers): Quentin Devin\n  - Centre Médical de Bligny, Briis-sous-Forges, France. (1 speakers): Ingrid Alexandre\n  - Chest Department and Thoracic Oncology, Tenon Hospital, Sorbonne Université, GRC4 Theranoscan, Paris, France. (1 speakers): Jacques Cadranel\n  - Clinical Study Center (CSC) of Charité and BIH, Berlin, Germany. (1 speakers): Petya Zyumbileva\n  - Computational Clinical Oncology Laboratory, Villejuif, France. (1 speakers): Elsa Bernard\n  - Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. (1 speakers): Emmanouil Angelidakis\n  - Department of Biostatistics and Epidemiology, University Paris-Saclay, Villejuif, France. (1 speakers): Stefan Michiels\n  - Department of Cancer Medicine, Gustave Roussy, Villejuif, France. (1 speakers): Tarek Ben Ahmed\n  - Department of Cancer Medicine, Thoracic Group and International Center for Thoracic Cancers, Paris-Saclay University, Villejuif, France. (3 speakers): Adrien Rousseau, Claudia Parisi, David Planchard\n  - Department of Cancer Medicine, University Paris-Saclay, Villejuif, France. (2 speakers): Suzette Delaloge, Thomas Pudlarz\n  - Department of Cancer Medicine, University of Paris Saclay, Villejuif, France. (1 speakers): Alice Bernard-Tessier\n  - Department of Cancer Medicine, University of Paris-Saclay Villejuif France. (1 speakers): Karim Fizazi\n  - Department of Cancer Medicine, University of Paris-Saclay, Villejuif, France. (1 speakers): David Malka\n  - Department of Cancer Medicine, Villejuif, France. (2 speakers): Jordi Remon Masip, Valerie Boige\n  - Department of Clinical Hematology, Gustave Roussy Institute, France. (1 speakers): Stephane De Botton\n  - Department of Drug Development & Innovation (D3i), Paris-Saclay University, Paris, France. (1 speakers): Christophe Le Tourneau\n  - Department of ENT-Head and Neck Surgery Toulouse University Hospital, Hôpital Larrey Toulouse France. (1 speakers): MATHILDE MIRALLIE\n  - Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, SIRIC CARPEM, Paris-Cité University, Paris, France. (1 speakers): Claire Gallois\n  - Department of Gastroenterology and Gastrointestinal Oncology, CARPEM Comprehensive Cancer Centre, Georges-Pompidou European Hospital, AP-HP, Université Paris-Cité, Paris, France. (1 speakers): Julien Taieb\n  - Department of Gastroenterology, Rennes University Hospital, Rennes, France. (1 speakers): Astrid Lievre\n  - Department of Gynecology and Obstetrics, Lille, France. (1 speakers): Julie Demetz\n  - Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. (1 speakers): Hassan Badreddine\n  - Department of Hepato-Gastroenterology and Medical Oncology, University of Bordeaux Hospital, Haut Leveque Hospital, France. (1 speakers): Jean Frederic Blanc\n  - Department of Hepatogastroenterology and Digestive Oncology, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France. (1 speakers): Marie Muller\n  - Department of Hepatogastroenterology, La Pitié Salpétrière Hospital (APHP), Paris, France. (1 speakers): Manon Allaire\n  - Department of Hepatology and Gastroenterology, Groupement Hospitalier Lyon Nord, Lyon, France. (1 speakers): Philippe Merle\n  - Department of Internal Medicine Lyon, Centre Léon Bérard, Lyon, France; Department of Oncology, Centre Léon Bérard, Lyon, France. (1 speakers): Axel De Bernardi\n  - Department of Medical Imaging, Gustave Roussy Cancer Campus, Villejuif, France. (1 speakers): Julien Hadoux\n  - Department of Medical Oncology, Centre Léon Bérard, Cancer Research Center of Lyon (UMR Inserm 1052 - CNRS 5286), Lyon, France. (1 speakers): Olivier Tredan\n  - Department of Medical Oncology, Cochin University Hospital, Université Paris Cité, Institut du Cancer Paris CARPEM, Paris, France. (1 speakers): Juliette Renard\n  - Department of Medical Oncology, Georges Pompidou European Hospital, AP-HP, Paris Cité University, Paris, France. (1 speakers): Constance Thibault\n  - Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. (1 speakers): Anthony Tarabay\n  - Department of Medical Oncology, Henri Mondor Hospital, Créteil, France. (1 speakers): Pascal Piedbois\n  - Department of Medical Oncology, IMMUCARE, Centre Hospitalier Lyon Sud, France. (1 speakers): DENIS MAILLET\n  - Department of Medical Oncology, INSERM, PSL Research University, Paris, France. (1 speakers): Sarah Watson\n  - Department of Medical Oncology, Institut Bergonié, Bordeaux, France. (1 speakers): Guilhem Roubaud\n  - Department of Medical Oncology, Institut Bergonié, INSERM U1312 BRIC, Bordeaux, France. (1 speakers): Monica Arnedos\n  - Department of Medical Oncology, Leon Berard Cancer Center, Lyon, France. (1 speakers): Philippe Cassier\n  - Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France. (1 speakers): Aude Flechon\n  - Department of Medical Oncology, PSL Research University, Paris, France. (1 speakers): Francois Clement Bidard\n  - Department of Medical Oncology, Paris (1 speakers): Diana Bello Roufai\n  - Department of Medical Oncology, Sorbonne Université, Institut du Cancer Paris CARPEM, AP-HP, Paris, France. (1 speakers): Julie Berthet\n  - Department of Medical Oncology, Strasbourg, France. (1 speakers): Safa Abdallahoui\n  - Department of Medical Oncology, University Hospital of Besançon, Besançon, France. (1 speakers): Angelique Vienot\n  - Department of Medical Oncology, University Hospital of Strasbourg, Place de L'hopital, Strasbourg, France. (1 speakers): Fabien Moinard-Butot\n  - Department of Medical Oncology, Villejuif, France, Paris-Saclay University, Paris, France, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston (1 speakers): Mihaela Aldea\n  - Department of Medical Oncology, Villejuif, France. (3 speakers): Benjamin Verret, Chayma Bousrih, Ronan Flippot\n  - Department of Medicine, Institut Bergonié, Bordeaux, France, Faculty of Medicine, University of Bordeaux, Bordeaux, France, Bordeaux, France. (1 speakers): Florent Peyraud\n  - Department of Medicine, Villejuif (1 speakers): Antoine Lefevre\n  - Department of Multidisciplinary Oncology and Therapeutic Innovations, Aix Marseille University, Marseille, France. (1 speakers): Laurent Greillier\n  - Department of Neurology 2-Mazarin, INSERM, CNRS, Brain and Spine Institute, ICM, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France. (1 speakers): Khe Hoang-Xuan\n  - Department of Nuclear Medicine, Cancer Institute Eugene Marquis, Rennes, France. (1 speakers): Etienne Garin\n  - Department of Oncology, Sorbonne University, Tenon Hospital, AP-HP, Paris, France. (1 speakers): Joseph Gligorov\n  - Department of Ophthalmology, Faculty of Medicine, Beykent University, Istanbul, Turkey. (1 speakers): Semih Dogan\n  - Department of Otorhinolaryngology - Head and Neck Surgery, Gustave Roussy Cancer Center, Villejuif, France. (1 speakers): Caroline Even\n  - Department of Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, UMR INSERM 1240, University Clermont Auvergne, Clermont-Ferrand, France. (1 speakers): Frederique Penault-Llorca\n  - Department of Pathology, Groupe Hospitalier Henri Mondor, Créteil, France. (1 speakers): Julien Calderaro\n  - Department of Pathology, Saint Louis Hospital, Université Paris Cité, Paris, France. (1 speakers): Maxime Remond\n  - Department of Pediatric Hematology-Oncology, Trousseau Hospital, Paris, France. (1 speakers): Celine Khouri\n  - Department of Pneumology, Angers University Hospital, Angers, France. (1 speakers): Gregoire Justeau\n  - Department of Pneumology, Lyon, France. (1 speakers): Thomas Pierret\n  - Department of Prevention, Cancer and Environment, Léon Bérard Cancer Center, Lyon, France. (1 speakers): Beatrice Fervers\n  - Department of Pulmonary and Thoracic Oncology, Centre Hospitalier Universitaire Lille, University of Lille, U1019 INSERM, Center of Infection and Immunity of Lille, Lille, France. (1 speakers): Arnaud Scherpereel\n  - Department of Pulmonology, Centre Hospitalier Le Mans, France. (1 speakers): Olivier Molinier\n  - Department of Pulmonology, Hôpital Larrey, University Hospital of Toulouse, Toulouse, France. (1 speakers): Julien Mazieres\n  - Department of Radiation Oncology Institut Gustave Roussy University of Paris Saclay Villejuif France. (1 speakers): Pierre Blanchard\n  - Department of Radiation Oncology, CHU de Bordeaux, Pessac, France. (1 speakers): Veronique Vendrely\n  - Department of Radiation Oncology, François Baclesse Comprehensive Cancer Center, Caen, France. (1 speakers): DInu STEFAN\n  - Department of Radiation Oncology, Paris-Saclay University, Villejuif, France. (1 speakers): Yungan Tao\n  - Department of Radiotherapy, Hartmann Radiotherapy Center Levallois-Perret France, Rafael Institute, center for integrative oncology Levallois-Perret France. (1 speakers): Nathaniel Scher\n  - Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway. (1 speakers): Elisabete Weiderpass\n  - Department of Respiratory Medicine and Early Phase (EPSILYON), Louis Pradel Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France. (1 speakers): Michael Duruisseaux\n  - Department of Supportive and Palliative Care, CNRS, INSERM, Marseille, France. (1 speakers): Vanessa Collin\n  - Department of Surgery, Paul-Brousse Hospital, Centre Hépato-Biliaire, Villejuif, France. (1 speakers): Rene Adam\n  - Department of Surgical Oncology, Paoli-Calmettes Institute, Marseille, France. (1 speakers): Geraldine Pignot\n  - Department of Urology, Foch Hospital, Paris-Saclay University, Suresnes, France. (1 speakers): Yann Neuzillet\n  - Department of Urology, UROSUD, La Croix Du Sud Hospital, Quint-Fonsegrives, France. (1 speakers): Benjamin Pradere\n  - Dermatology Department, University Hospital of Caen, Caen (1 speakers): Elena Prospero\n  - Drug Development Department (DITEP), Gustave-Roussy, Université Paris-Saclay, Villejuif, France, INSERM U1030, Université Paris-Saclay, Villejuif, France, Centre Léon Bérard, Lyon (1 speakers): Loic Verlingue\n  - Drug Development Department (DITEP), Villejuif, France. (1 speakers): Julien Vibert\n  - Drug Development Department, Villejuif, France, INSERM U1015, CIC1428 BIOTHERIS, Villejuif, France, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA (1 speakers): Francois-Xavier Danlos\n  - Drug Development Department, Villejuif, France. (1 speakers): Kaissa Ouali\n  - Département de Médecine, Villejuif, France. (1 speakers): Geraldine M Camilleri\n  - EORTC HQ, Belgium, Villejuif, France. (1 speakers): Marie Morfouace\n  - Edouard Herriot University Hospital, Lyon, France. (1 speakers): Thomas Walter\n  - Equipe d'Accueil 7285, Risk and safety in clinical medicine for women and perinatal health, University Versailles-Saint-Quentin, Montigny-le-Bretonneux (1 speakers): Delphine Hequet\n  - Equity Research Team, Centre d'Epidémiologie et de Recherche en santé des POPulations (CERPOP), UMR 1295 (Team Labellised « Ligue Contre le Cancer »), Inserm, University Toulouse III Paul Sabatier (1 speakers): Nadine Hamieh\n  - Faculty of Medicine, University of Bordeaux, Bordeaux, France. (1 speakers): Antoine Italiano\n  - France (L.D., S.A., J.H., S. Morer, C.D., F. Bidault, C.B., S. Muller, N.L.), Université Paris-Saclay, Inserm, Centre national de la recherche scientifique, Villejuif, France (Y.B., L. Lawrance, O.G. (1 speakers): Maria Fernanda Mosele\n  - GI Oncology, Medical Oncology Department, Curie Institute, Versailles Saint-Quentin University-Paris Saclay University, France, Hepato-Gastroenterology Department, Ambroise Paré University Hospital (1 speakers): Cindy Neuzillet\n  - GI Oncology, Medical Oncology Department, Curie Institute, Versailles Saint-Quentin University-Paris Saclay University, France. (1 speakers): Matthieu Delaye\n  - Gastro-enterology, Hopital Beaujon, Clichy, France. (1 speakers): Louis De Mestier du Bourg\n  - Grenoble-Alpes University Hospital, Grenoble, France. (1 speakers): Anne Claire Toffart\n  - Gustave Roussy Cancer Campus, ClinicObiome, Villejuif, France. (1 speakers): Marine Fidelle\n  - Gustave Roussy Cancer Center, INSERM U981, and Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Villejuif, France. (1 speakers): Alexandra Leary\n  - Gustave Roussy Cancer Center, Université Paris-Saclay, Villejuif, France. (1 speakers): Pablo Berlanga\n  - Gustave Roussy Institute, Villejuif, France. (1 speakers): Arthur Geraud\n  - Gustave Roussy and Paris Saclay University, Villejuif, France. (1 speakers): Caroline Robert\n  - Gustave-Roussy, Villejuif, France, Sorbonne Université, Paris (1 speakers): Alexandre Xu-Vuillard\n  - HUPSSD, Hôpital René Muret, AP-HP, Sevran, France. (1 speakers): Thierry Landre\n  - Health Technologies Institute, Inserm, Paris, France. (1 speakers): Frederique Nowak\n  - Hematology Department, Gustave Roussy Institute, Villejuif, France. (1 speakers): Camille Bigenwald\n  - Hematology Department, Institut Gustave Roussy, Villejuif, France. (1 speakers): Myriam Ben Khelil\n  - Henri Mondor Hospital, Créteil, France. (1 speakers): Iona Campo le Brun\n  - INSERM U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. (1 speakers): Cinzia Ungolo\n  - INSERM U1242, University of Rennes, Rennes, France. (1 speakers): Alice Blondel\n  - INSERM U1245, Department of Metabolic Biochemistry, UNIROUEN, CHU Rouen, Rouen, France. (1 speakers): Jean David HEISBOURG\n  - INSERM U981, Villejuif, France, Department of Medical Oncology, Villejuif, France, Department of Oncology and Hematology-Oncology, University of Milano, Milan, Italy. (1 speakers): Federica Giugliano\n  - INSERM, EFS, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France. (1 speakers): Caroline Laheurte\n  - INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France. (1 speakers): Maria Alice Franzoi\n  - Imaging Department, BIOMAPS, UMR1281, INSERM, CEA, CNRS, Villejuif, Paris, France. (1 speakers): Caroline Caramella\n  - Inserm U1242, University of Rennes, France, Centre de Lutte Contre le Cancer Eugène Marquis, France. (1 speakers): Sophie MARTIN\n  - Inserm, IRD, ISSPAM, SESSTIM, Marseille, France. (1 speakers): Julien Mancini\n  - Institut Bergonié, Bordeaux, France. (1 speakers): Jerome Caron\n  - Institut Hospitalo-Universitaire des Cancers des Femmes (ANR-23-IAHU-0006), Saint-Cloud, France. Electronic address: etienne.brain@curie.fr. (1 speakers): Etienne G. Brain\n  - Institut Régional du Cancer de Montpellier, Montpellier, France. (1 speakers): Emmanuelle Samalin-Scalzi\n  - Institute of Materials Science (1 speakers): NGUYEN T. Yen\n  - Interdisciplinary Department for the Organization of Patient Course (Supportive Care Department), Paris-Saclay University, Villejuif, France. (1 speakers): Florian Scotte\n  - Interdisciplinary Department for the Organization of Patient Pathways (DIOPP), Gustave Roussy, Villejuif, France. (1 speakers): Ines V. Vaz-Luis\n  - International Agency for Research on Cancer, Lyon, France. (1 speakers): Joachim Schuz\n  - International Agency for Research on Cancer, World Health Organization, Lyon, France. (1 speakers): Carolina Espina\n  - Jonsson Comprehensive Cancer Center, University of California Los Angeles, CA, Massachusetts General Hospital Cancer Center, Boston, MA, Gustave Roussy Cancer Center, Villejuif, France (1 speakers): Barbara Pistilli\n  - La Paz University Hospital, 28046 Madrid, Spain. (1 speakers): Maria Virginia Sanchez Becerra\n  - Laboratoire d'Imagerie Biomedicale Multimodale Paris-Saclay (BioMAPS), Université Paris-Saclay, Inserm, Centre National de la Recherche Scientifique, Villejuif 94800, France, Département d'Imagerie (1 speakers): Aurelie Choucair\n  - Liver Cancer Unit, Beaujon University Hospital, Clichy, France. (1 speakers): Mohamed Bouattour\n  - Medical Oncology Departement, Centre Léon Bérard, Lyon, France. (1 speakers): Christelle De la Fouchardiere\n  - Medical Oncology Department, Paris, France. (1 speakers): Paul Matte\n  - Medical Oncology Department, Poitiers University Hospital, Poitiers, France. (1 speakers): Matthieu Bainaud\n  - Medical Oncology Department, Strasbourg, France. (1 speakers): Jean-Baptiste Barbe-Richaud\n  - Medical Oncology Dept, Hospital Universitario 12 de Octubre and i+12 Research Institute, Madrid, Spain. (1 speakers): Nerea Munoz\n  - Medical oncology Department, Georges-Pompidou European Hospital, Paris Cité University, Paris, France. (1 speakers): Charles Vauchier\n  - Memorial Sloan Kettering Cancer Center, NY, USA, CHU Poitiers, Université de Poitiers, Poitiers, France. (1 speakers): Violaine Randrian\n  - Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France. (1 speakers): Killian Carnet Le Provost\n  - Military Hospital Begin, France, 33 679526487. (1 speakers): Carole F. Helissey\n  - Oncostat U1018, Institut National de la Santé et de la Recherche Médicale (INSERM), Ligue Contre le Cancer, Paris-Saclay University, Villejuif, France. (1 speakers): Noemie Simon-Tillaux\n  - PSL University, Paris 75014, France. (1 speakers): Nicolas A. Fraunhoffer Navarro\n  - Paris Descartes University, Necker Hospital, Paris, France. (1 speakers): Simon Nicoletti\n  - Paris, France, Clinical Pharmacy, Cochin University Hospital, AP-HP, Centre-Université Paris-Cité, Paris, France. (1 speakers): Christophe Bardin\n  - Paris, France. (4 speakers): Alexandre Grimaldi, Corentin Wiscart, Oussama Tchita, Paul H. Cottu\n  - Paris-Saclay University, Villejuif, France. (2 speakers): Filippo G. Dall'Olio, Francesco Facchinetti\n  - Pneumology Department, Intercommunal Hospital of Creteil, Créteil, France. (1 speakers): Christos Chouaid\n  - Radiation Oncology Department, La Pitié Salpêtrière University Hospital, Assistance Publique des Hôpitaux de Paris.Sorbonne University, France. (1 speakers): Raphael Serre\n  - Research On Healthcare Performance (RESHAPE), INSERM, Lyon, France. (1 speakers): Romain Varnier\n  - Research on Healthcare Performance (RESHAPE), INSERM U1290, Lyon, France. (1 speakers): Gisele Chvetzoff\n  - Respiratory Diseases Department, University Hospital of Reims, Reims, France. (1 speakers): Julien Ancel\n  - Respiratory Medicine Department, GHRMSA, Hospital Emile Muller, Mulhouse, France. (1 speakers): Didier Debieuvre\n  - Respiratory Medicine Department, L'Hôpital Nord-Ouest, Villefranche-Sur-Saône, France. (1 speakers): Lionel Falchero\n  - Saint-Herblain, France. (1 speakers): Judith Raimbourg\n  - Service de Pneumologie, Hôpital Cochin, AP-HP. Centre, Université Paris Cité, Paris, France. (1 speakers): Gaspard Naulleau\n  - Sorbonne University and Department of Medical Oncology, Saint-Antoine Hospital, Paris 75015, France. (1 speakers): Romain Cohen\n  - Sorbonne University, Department of Hepato-Gastroenterology, Pitié-Salpêtrière Hospital, Paris, France. (1 speakers): Jean-Baptiste Bachet\n  - Sorbonne Université, CNRS, Villefranche-sur-mer, France. (1 speakers): Francois Lahaye\n  - Thorax Institute Curie Montsouris, Department of Medical Oncology, Paris, France. (1 speakers): Nicolas Girard\n  - Toulouse CEDEX, France. (1 speakers): Pierre Fons\n  - University Hospital of Montpellier, Montpellier, France. (1 speakers): Adrien C. Maire\n  - University of Burgundy, Dijon, France. (1 speakers): Francois Ghiringhelli\n  - University of Grenoble Alpes, Institute for Advanced Biosciences, Grenoble, France. (1 speakers): Thomas Decaens\n  - University of Paris Saclay, Villejuif, France. (1 speakers): Aurelien Marabelle\n  - University of Paris-Saclay, Villejuif, France. (1 speakers): Michel P. Ducreux\n  - Université Paris Cité, EA-3518, University Hospital Saint-Louis, Paris, France. (1 speakers): Nicolas Boissel\n  - Université Paris Cité, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, France. (1 speakers): Jeanne Duval\n  - Université Paris Cité, Paris, France. (1 speakers): Gustave Ronteix\n  - Université Paris-Saclay, Gustave-Roussy Cancer Campus, Inserm U981, Villejuif, France. (1 speakers): Elisa Yaniz\n  - Université Paris-Saclay, Inserm, Radiothérapie Moléculaire, France. (1 speakers): Kenza Nedara\n  - Université de Paris, BFA, UMR 8251, CNRS, Paris, France (Q.N., J.B., W.Z., L.-C.B., R.L., F.B., J.-M.D., F.R.L.), Key Laboratory of Marine Drugs, School of Medicine and Pharmacy (1 speakers): Christine Chomienne\n  - Université de Paris, Institut du Cancer Paris CARPEM, F-75006 Paris, France, Department of medical oncology, APHP.Centre, Paris, France. (1 speakers): Claire Gervais\n\n**Fujian (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Fujian Medical University Cancer Hospital and Fujian Cancer Hospital, Fuzhou, Fujian, People's Republic of China. (1 speakers): Rongbo Lin\n\n**Fukushima (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Fukushima Medical University School of Medicine, Fukushima, Japan. (1 speakers): Shigehira Saji\n\n**GA (1 institutions, 1 speakers)**\n  - Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA. (1 speakers): Nabil F. Saba\n\n**Georgia (1 institutions, 1 speakers)**\n  - Todua Clinic Department of Oncology and Haematology, Tbilisi, Georgia. (1 speakers): Elene Mariamidze\n\n**Germany (206 institutions, 219 speakers)**\n  -  (8 speakers): Anke Pregler, Ellen Ahmann, Isabell Kaufhold, Katharina Rauscher-Stamer, Lis Puga, Nicoline Ehrhardt, Timo Gottlieb, Tina Holzgen\n  - 3rd Department of Medicine, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, Mannheim (1 speakers): Hanna Hirschinger\n  - Asklepios Cancer Center, Hamburg, Germany. (1 speakers): Dirk Arnold\n  - Breast Center, Department of Gynecology & Obstetrics & Comprehensive Cancer Center Munich, Ludwig-Maximilians-University (LMU) University Hospital, Munich, Germany. (1 speakers): Nadia Harbeck\n  - Center for Integrated Oncology (CIO) Köln-Bonn, Cologne, Germany. (1 speakers): Axel Heidenreich\n  - Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany. (1 speakers): Jurgen Wolf\n  - Charité Comprehensive Cancer Center, Charité-Universitätsmedizin Berlin, Berlin, Germany. (2 speakers): Max Schmidt, Nikolaj Frost\n  - Charité-University Medicine Berlin, Berlin, Germany. (1 speakers): Nele Danielle Wagener\n  - Christoph Pöttgen, Karl-Heinz Jöckel, University Hospital Essen, University of Duisburg-Essen, Ruhrlandklinik, Essen, University Hospital Tübingen, University of Tübingen, Tübingen (1 speakers): Martin H. Schuler\n  - Claudia Von Schilling Comprehensive Cancer Center Lower Saxony, Hannover, Germany. (1 speakers): Tabea Frohlich\n  - Clinic I for Internal Medicine, University Clinic Cologne, Germany. (1 speakers): Anna Rasokat\n  - Clinic for Visceral-, General, University Medicine Magdeburg, Otto-von Guericke University Magdeburg, Magdeburg, Germany. (1 speakers): Wenjie Shi\n  - Clinic of Cardiology and Pneumology, Esslingen Hospital, Germany. (1 speakers): Martin Faehling\n  - Clinical Department for Internal Medicine II, University Medical Center, Technical University of Munich (TUM), Germany. (1 speakers): Sebastian Lange\n  - Clinical State Registry Baden-Württemberg GmbH, Baden-Württemberg Cancer Registry (BWCR), Stuttgart, Germany. (1 speakers): Irina Surovtsova\n  - Clinics for Obstetrics and Gynecology, University Medicine Charité Campus Virchow, Berlin, Germany. (1 speakers): Ioana Braicu\n  - Comprehensive Cancer Center (CCC Munich LMU), LMU University Hospital Munich, Munich, Germany. (1 speakers): Christoph Benedikt Westphalen\n  - Comprehensive Cancer Center, Ludwig Maximilian University Hospital Munich, Pettenkoferstrße 8a, Munich, Germany (1 speakers): Rachel Wuerstlein\n  - Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne (1 speakers): Heather Scharpenseel\n  - Department for Health Economics and Health Care Management, School of Public Health, Bielefeld University, Bielefeld, Germany. (1 speakers): Sophie Pauge\n  - Department for Oncology, University Comprehensive Cancer Center, Hamburg, Germany. (1 speakers): Nikolaus Berenbrok\n  - Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Germany. (1 speakers): Wiebke Pirschel\n  - Department of Biostatistics, University of North Carolina, NC, USA. (1 speakers): Elena Kharitonova\n  - Department of Clinical Oncology, Hamburg, Germany. (1 speakers): Georgia Schilling\n  - Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Berlin, Germany. (1 speakers): Fenja Klima\n  - Department of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim. (1 speakers): Freba Grawe\n  - Department of Dermatology, Elbe Clinic Buxtehude, Buxtehude, Germany. (1 speakers): Peter Mohr\n  - Department of Dermatology, Skin Cancer Center, University Hospital Schleswig-Holstein, Kiel, Germany. (1 speakers): Michael Weichenthal\n  - Department of Dermatology, University Hospital Essen, Essen, Germany. (1 speakers): Lea Jessica Albrecht\n  - Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Germany, German Cancer Consortium (DKTK), Germany, University Alliance Ruhr, Research Center One Health (1 speakers): Dirk Schadendorf\n  - Department of Dermatology, University Hospital Heidelberg Dermatological Clinic Centre, Heidelberg, Germany. (1 speakers): Jessica C. Hassel\n  - Department of Dermatology, University Hospital Tuebingen, Tübingen, Germany. (1 speakers): Lukas Flatz\n  - Department of Gastroenterology, Hepatology, University Hospital Heidelberg, Heidelberg, Germany. (1 speakers): Michael T. Dill\n  - Department of Gynaecology and Obstetrics, University Hospital Aachen, Aachen, Germany. (1 speakers): Elmar Stickeler\n  - Department of Gynaecology and Obstetrics, University Hospital of Essen, Germany. (1 speakers): Fabinshy Thangarajah\n  - Department of Gynaecology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg, Germany. (1 speakers): Elena Laakmann\n  - Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 21-23 (1 speakers): Peter A. Fasching\n  - Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, CCC, NCT Dresden, Technische Universität Dresden, Dresden, Germany. (1 speakers): Pauline Wimberger\n  - Department of Gynecology and Obstetrics, University Hospital Mannheim, Mannheim, Germany. (1 speakers): Frederik Marme\n  - Department of Gynecology and Obstetrics, University Hospital Münster, Münster, Germany. (1 speakers): Ludwig Kiesel\n  - Department of Gynecology and Obstetrics, University Hospital Ulm, Germany. (3 speakers): Angelina Fink, Kerstin Pfister, Wolfgang Janni\n  - Department of Gynecology, Hamburg-Eppendorf University Medical Center, Martinistraße 52, Hamburg, Germany. (1 speakers): Volkmar Mueller\n  - Department of Gynecology, Medical Center, Leipzig University, Germany. (1 speakers): Laura Weydandt\n  - Department of Gynecology, University Medical Center Hamburg-Eppendorf, Germany, Colposcopy Center at the Jerusalem Hospital Hamburg, Germany. (1 speakers): Linn Woelber\n  - Department of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Universitätsstraße 25, Bielefeld, Germany. (1 speakers): Birthe Aufenberg\n  - Department of Hematology and Oncology, UCT-University Cancer Center, Frankfurt, Germany. (1 speakers): Akin Atmaca\n  - Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany. (1 speakers): Emre Kocakavuk\n  - Department of Hematology, Berlin, Germany. (1 speakers): Christopher Neumann\n  - Department of Hematology, Charité University Medicine Berlin, Berlin, Germany. (1 speakers): Lars Bullinger\n  - Department of Hematology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany. (1 speakers): Sebastian Stintzing\n  - Department of Hematology, Ernst von Bergmann Hospital Potsdam, Germany, Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg (1 speakers): Karin Jordan\n  - Department of Hematology, Hemostasis, Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany. (1 speakers): Viktor Gruenwald\n  - Department of Hematology, Oncology, and Cancer Immunology, Charité University Hospital Berlin, Berlin, Germany. (1 speakers): Dominik P. Modest\n  - Department of Hematology/Oncology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany. (1 speakers): Marit Ahrens\n  - Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Berlin, Germany. (1 speakers): Andrey Mitroshkin\n  - Department of Internal Medicine I, Ulm University Hospital, Albert-Einstein-Allee 23, Ulm, Germany. (1 speakers): Anton Lahusen\n  - Department of Internal Medicine I, University Hospital Frankfurt, Goethe University Frankfurt Am Main, Theodor-Stern-Kai 7, Germany. (1 speakers): Christine Koch\n  - Department of Internal Medicine I, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany. (1 speakers): Markus Moehler\n  - Department of Internal Medicine II, Hematology, Oncology, University Hospital Frankfurt, Frankfurt, Germany. (1 speakers): Sophie Heinzen\n  - Department of Internal Medicine III (Haematology/Medical Oncology), Technical University of Munich Hospital Rechts der Isar, Munich, Germany. (1 speakers): Sylvie Lorenzen\n  - Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany. (1 speakers): Daniel Heudobler\n  - Department of Internal Medicine and Nature-Based Therapies, Immanuel Hospital Berlin, Berlin, Germany. (1 speakers): Carolin Breinlinger\n  - Department of Internal Medicine, University Hospital of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. (1 speakers): Thorsten Langer\n  - Department of Medical Oncology, Memorial Hospital, Antalya, Turkey. (1 speakers): Mevlude Ergen\n  - Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. (1 speakers): Stefanie Zschabitz\n  - Department of Medical Oncology, University Hospital Heidelberg, Heidelberg, Germany. (1 speakers): Bruno C. Kohler\n  - Department of Medical Oncology, University Hospital of Wuerzburg, Wuerzburg, Germany. (1 speakers): Volker Kunzmann\n  - Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany. (1 speakers): Martin Metzenmacher\n  - Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, Essen 45147, Germany. (1 speakers): Stefan Kasper-Virchow\n  - Department of Medicine 1, Endocrinology and Diabetology, Friedrich Alexander University of Erlangen-Nürnberg, Erlangen, Germany. (1 speakers): Marianne E. Pavel\n  - Department of Medicine 2, University Cancer Center Leipzig (UCCL), Leipzig University Medical Center, Cancer Center Central Germany (CCCG), Leipzig, Germany. (1 speakers): Benjamin Kobitzsch\n  - Department of Medicine A, Hematology, Hemostaseology, Oncology and Pneumology, University Hospital Muenster, Münster, Germany. (1 speakers): Marcel Kemper\n  - Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany. (1 speakers): Wolfgang E. Berdel\n  - Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. (1 speakers): Jann Arends\n  - Department of Medicine II, Hematology/Oncology, University Hospital Frankfurt, Frankfurt, Germany. (1 speakers): Friederike Althoff\n  - Department of Medicine II, Hospital of the LMU, Munich, Germany. (1 speakers): Jianying Xu\n  - Department of Medicine II, University Hospital Schleswig-Holstein - Campus Kiel, Kiel, Germany. (1 speakers): Christiane Pott\n  - Department of Medicine II, University Hospital, LMU Munich, Munich, Germany. (1 speakers): Alexander B. Philipp\n  - Department of Medicine III LMU University Hospital LMU Munich Munich Germany. (1 speakers): Marion Subklewe\n  - Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, Munich, Germany. (1 speakers): Lena Weiss\n  - Department of Medicine V, LMU University Hospital, Munich, Germany. (2 speakers): Amanda Tufman, Blerina Resuli\n  - Department of Medicine, Clinic III - Hematology, Oncology, Rostock University Medical Center, University of Rostock, Germany. (1 speakers): Claudia Maletzki\n  - Department of Medicine, Clinic III - Hematology, Oncology, Rostock University Medical Center, University of Rostock, Rostock, Germany. (2 speakers): Philipp Kaps, Thomas Freitag\n  - Department of Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. (1 speakers): Lynn Leppla\n  - Department of Molecular Oncology and Pneumological Oncology, Robert-Bosch-Centrum für Tumorerkrankungen, Robert-Bosch Hospital, Stuttgart, Germany. (1 speakers): Hans-Georg Kopp\n  - Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany. (1 speakers): Wolfgang Wick\n  - Department of Neurology, Klinikum Großhadern, Ludwig-Maximilians-University, Marchioninistr. 15, Munich 81377, Germany. (1 speakers): Louisa Von Baumgarten\n  - Department of Nuclear Medicine, CURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany. (1 speakers): Richard P. Baum\n  - Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany. (1 speakers): Sebastian Hoberuck\n  - Department of Nuclear Medicine, University Hospital Essen, German Cancer Consortium, West German Cancer Center, Essen, Germany. (1 speakers): Alina T. Kuper\n  - Department of Nuclear Medicine, University Hospital Muenster, Albert-Schweitzer-Campus 1, Muenster (1 speakers): Kambiz Rahbar\n  - Department of Nuclear Medicine, West German Cancer Center, German Cancer Consortium and National Center for Tumor Diseases site, University Hospital Essen, Essen, Germany. (1 speakers): Ken Herrmann\n  - Department of Obstetrics and Gynecology, Technical University of Munich, Munich, Germany, Cancer Center Kempten/ Allgäu (CCKA) (1 speakers): Johannes Ettl\n  - Department of Obstetrics and Gynecology, University Hospital of Schleswig-Holstein, Campus Lübeck, Lubeck, Germany. (1 speakers): Nikolas Tauber\n  - Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany. (1 speakers): Fabian Trillsch\n  - Department of Obstetrics, Charite University Hospital Berlin, Berlin, Germany. (1 speakers): Jalid Sehouli\n  - Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. (1 speakers): Antonia Beitzen-Heineke\n  - Department of Oncology, Hematology and Stem Cell Transplantation with Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. (1 speakers): Finn-Ole Paulsen\n  - Department of Otolaryngology and Head & Neck Surgery, Hospital of the Ludwig-Maximilians-University, Munich, Germany. (1 speakers): Susanne Flach\n  - Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center and Comprehensive Cancer Center Ulm, Ulm, Germany. (1 speakers): Simon Laban\n  - Department of Otorhinolaryngology, Head and Neck Surgery, Luzerner Kantonsspital, Switzerland. (1 speakers): Christoph R. Schlegel\n  - Department of Otorhinolaryngology, University of Leipzig Medical Center, Leipzig, Germany. (1 speakers): Andreas Dietz\n  - Department of Pneumology, Berlin, Germany. (1 speakers): Christian Grohe\n  - Department of Pneumology, University Hospital Ulm, Ulm, Germany. (1 speakers): Cornelia Kropf-Sanchen\n  - Department of Radiation Therapy and Special Oncology, Medical School Hannover, Hannover, Germany. (1 speakers): Burcu Babadag Savas\n  - Department of Radiology, University Hospital RWTH Aachen, Aachen, Germany. (1 speakers): Daniel Truhn\n  - Department of Radiooncology and Radiotherapy, Charite University Hospital, Berlin, Germany. (1 speakers): Ingeborg Tinhofer-Keilholz\n  - Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Germany. (1 speakers): Soren Schnellhardt\n  - Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Homburg, Germany. (1 speakers): Markus Hecht\n  - Department of Surgery, Mannheim School of Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim (1 speakers): Cui Yang\n  - Department of Surgery, University of Lübeck & University Medical Center Schleswig-Holstein/Lübeck, Lübeck, Germany. (1 speakers): Larysa Liubich\n  - Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Airway Research Censer North, German Center of Lung Research, Grosshansdorf, Germany. (1 speakers): Martin Reck\n  - Department of Thoracic Oncology, Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany. (1 speakers): Michael Thomas\n  - Department of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. (1 speakers): Johannes Bragelmann\n  - Department of Translational Pulmonology, Heidelberg University Hospital, Heidelberg, Germany. (1 speakers): Petros Christopoulos\n  - Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg, Germany. (1 speakers): Jana Loptien\n  - Department of Urology Uro-Oncology, University Hospital Cologne, Köln, Germany. (1 speakers): Richard Weiten\n  - Department of Urology and Paediatric Urology, Julius Maximilians University Medical Center of Würzburg, Würzburg, Germany. (1 speakers): Charis Kalogirou\n  - Department of Urology and Transplantation Surgery, Eva Mayr-Stihl Cancer Center, Stuttgart, Germany. (1 speakers): Jens Bedke\n  - Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria, Department of Urology, Charité Universitätsmedizin Berlin, Berlin, Germany. (1 speakers): Maria De Santis\n  - Department of Urology, Faculty of Medicine, University Hospital Cologne, University Cologne, Cologne, Germany. (1 speakers): David Pfister\n  - Department of Urology, Friedrich-Schiller-University Jena, Jena University Hospital, Germany. (1 speakers): Marc-Oliver Grimm\n  - Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany, Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. (1 speakers): Philipp Mandel\n  - Department of Urology, University Hospital Bonn, Bonn, Germany. (1 speakers): Niklas Klumper\n  - Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany. (1 speakers): Cristina Cano Garcia\n  - Department of Urology, University of Cologne, Cologne, Germany. (2 speakers): Julian Heidenreich, Olivia Steenbock\n  - Department of Urology, University of Muenster Medical Center, Muenster, Germany, West German Cancer Center, Muenster, Germany. (1 speakers): Martin Boegemann\n  - Department of Urology, Uro-Oncology, University Hospital Cologne, Cologne, Germany. (1 speakers): Constantin Rieger\n  - Department of Urology, Urooncology, University Hospital Magdeburg, Otto-von Guericke University Magdeburg, Magdeburg, Germany. (1 speakers): Melis Gur\n  - Director of the I. Medical Department at the University Medical Center, Johannes Gutenberg University, Mainz, Germany. (1 speakers): Peter R. Galle\n  - Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany. (1 speakers): Sebastian Kobold\n  - Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany. (1 speakers): Florian Van Bommel\n  - Division of Personalized Cancer Therapy, Fraunhofer Institute of Toxicology and Experimental Medicine ITEM-R, Regensburg, Germany. (1 speakers): Bernhard Polzer\n  - Else Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany. (1 speakers): Jakob N. Kather\n  - Essen, Germany and Department of Gynecology with Breast Unit, Charité Hospital Berlin, Berlin, Germany. (1 speakers): Sherko Kuemmel\n  - FOM University of Applied Sciences, Essen, Germany. (1 speakers): Florian Kron\n  - Faculty of Medicine, Institute for Medical Information Processing, Biometry, LMU Munich, Munich, Germany. (1 speakers): Verena Loidl\n  - Fraunhofer Institute for Toxicology and Experimental Medicine ITEM-R, Germany. (1 speakers): Giancarlo Feliciello\n  - From the Department of Visceral, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. (1 speakers): David Digomann\n  - From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany, Department of Nuclear Medicine (1 speakers): Konstantin E. Seifert\n  - GBG Forschungs GmbH and Goethe University Frankfurt, Neu-Isenburg, Germany. (1 speakers): Sibylle Loibl\n  - Gerhard-Domagk-Institute of Pathology, University Hospital Muenster, Germany. (1 speakers): Eva Wardelmann\n  - German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany. (1 speakers): Sebastian Bauer\n  - German Cancer Research Center (DKFZ), Division of Signaling and Functional Genomics and Heidelberg University, Department Cell and Molecular Biology, Heidelberg, Germany. (1 speakers): Johannes Werner\n  - Goethe University Frankfurt, University Hospital, Department of Urology, Frankfurt am Main, Germany. (1 speakers): Mike Wenzel\n  - GynOnco Duesseldorf, Duesseldorf, Germany. (1 speakers): Athina Kostara\n  - Gynecology, Obstetrics and Senology, Faculty of Medicine, University of Augsburg, Breast Center, University Hospital Augsburg, CCC Alliance WERA, Augsburg, Germany. (1 speakers): Nina Ditsch\n  - Health Service Research Working Group| Acute Care, Medical Faculty of Martin Luther, University Medicine Halle (Saale), University Halle-Wittenberg, Halle, Germany. (1 speakers): Patrick Jahn\n  - Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany, Division of Stem Cells and Cancer, Heidelberg, Germany, German Cancer Consortium (DKTK) (1 speakers): Christian Eisen\n  - Heidelberg University Hospital, Heidelberg, Germany. danielmichaeli@yahoo.com. (1 speakers): Daniel T. Michaeli\n  - Hospital Gemeinschaftskrankenhaus Havelhöhe, Berlin, Germany. (1 speakers): Friedemann T. Schad\n  - Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Department of Urology, Germany. (1 speakers): Jonathan Jeutner\n  - II. Medical Clinic and Polyclinic, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. (1 speakers): Joseph Tintelnot\n  - Immanuel Hospital Berlin, Berlin, Germany. (1 speakers): Daniela Koppold\n  - Immanuel Hospital Märkische Schweiz & Immanuel Campus Rüdersdorf, Rüdersdorf bei Berlin, Germany. (1 speakers): Diana I. Luftner\n  - Institute for Diabetes and Cancer, Helmholtz Center Munich - German Research Center for Environmental Health, Neuherberg, Germany. (1 speakers): Bhargavi Karna\n  - Institute for Patient Safety (IfPS), Medical Faculty, University Hospital Bonn, Bonn, Germany. (1 speakers): Larissa Brust\n  - Institute for Quality and Efficiency in Health Care, Cologne, Germany. (1 speakers): Beate Wieseler\n  - Institute of Clinical Cancer Research IKF, Frankfurt am Main, Germany. (1 speakers): Thorsten O. Goetze\n  - Institute of Human Genetics, Heidelberg University Hospital, Heidelberg Germany and German Cancer Consortium (DKTK), Heidelberg, Germany, Division of Translational Medical Oncology (1 speakers): Stefan Frohling\n  - Institute of Immunology, Medical Faculty, University of Duisburg-Essen, Hufelandstr. 55, Germany. (1 speakers): Karl Lang\n  - Institute of Pathology, Ludwig Maximilians University, Munich, Germany, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. (1 speakers): Philipp Jurmeister\n  - Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. (1 speakers): Markus Eckstein\n  - Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany. (1 speakers): Florian Viehweger\n  - Institute of Pathology, University of Erlangen-Nuremberg, Erlangen, Germany. (1 speakers): Abbas Agaimy\n  - Institute of Pathology, Universitätsklinikum Marburg, Marburg, Germany. (1 speakers): Marcel Romey\n  - LMU University Hospital, Munich, Germany. (1 speakers): Dorit Di Gioia\n  - Laboratory of Experimental Oncology, Department of Oncology, University Medical Center Hamburg-Eppendorf, Germany. (1 speakers): Gunhild Von Amsberg\n  - Ludwig Maximilians University, LMU University Hospital, Department of Obstetrics and Gynecology, Munich, Germany. (1 speakers): Sven Mahner\n  - Lung Cancer Center, Hospital Havelhöhe, Germany. (1 speakers): Christian Grah\n  - MVZ am Klinikum Aschaffenburg, Aschaffenburg, Germany. (1 speakers): Manfred K. Welslau\n  - Mannheim Cancer Center (MCC), Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany. (1 speakers): Bernd Kasper\n  - Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. (1 speakers): Derya Tilki\n  - Medical Bioninformatics Workgroup, Pathological Institute, University Hospital Heidelberg, Heidelberg, Germany. (1 speakers): Albrecht Stenzinger\n  - Medical Clinic II, University Hospital Frankfurt, Frankfurt, Germany. (1 speakers): Lothar Bergmann\n  - Medical Clinic and Polyclinic I, University Hospital Carl Gustav Carus, Dresden, Germany. (1 speakers): Gunnar Folprecht\n  - Medical Faculty and University Hospital Magdeburg, Clinic for General, Visceral, Otto-von-Guericke University, Magdeburg, Germany. (1 speakers): Ulf Dietrich Kahlert\n  - Medical University Hospital, Tuebingen, Germany. Electronic address: linus.kloker@med.uni-tuebingen.de. (1 speakers): Linus Daniel Kloker\n  - Mindpeak, Hamburg, Germany. (1 speakers): Patrick Frey\n  - NMI TT Pharmaservices, Berlin, Germany. (1 speakers): Gerrit Erdmann\n  - National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany. (1 speakers): Simon Kreutzfeldt\n  - National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany, Clinical Trial Center, NCT Heidelberg, Heidelberg (1 speakers): Richard F. Schlenk\n  - National Center for Tumor Diseases, University Hospital Carl Gustav Carus TU Dresden, Germany. (1 speakers): Martin Wermke\n  - Quality Conferences Office at the Clinical State Registry Baden-Württemberg GmbH, Baden-Württemberg Cancer Registry (BWCR), Stuttgart, Germany. (1 speakers): Philipp Morakis\n  - Research Institute Havelhöhe, Germany. (1 speakers): Shiao Li Oei\n  - Richard-Willstätter-Allee, D-76128 Karlsruhe (Germany), Fax: (+49) 721-6084823. (1 speakers): Rainer Nitsche\n  - Risk Adapted Cancer Prevention Group, Division of Primary Cancer Prevention, German Cancer Research Center (DKFZ), Germany. (1 speakers): Zehui Chen\n  - School of Medicine and Health Sciences, University Department Internal Medicine-Oncology, Oldenburg, Germany. (1 speakers): Frank Griesinger\n  - Section Global Health, Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany, Department of Medicine II, Hematology and Oncology, University Hospital (1 speakers): Maximilian Rost\n  - Transfusion Medicine Center Bayreuth, Kurpromenade 2, Germany. (1 speakers): Monika Pizon\n  - University Cancer Center Frankfurt (UCT), Frankfurt am Main, Germany, Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany, German Cancer Research Center (DKFZ) Heidelberg (1 speakers): Martin Sebastian\n  - University Hospital Carl Gustav Carus, Dresden, Germany. (1 speakers): Miriam Gediga\n  - University Hospital Ludwig-Maximilians-University Munich, Munich, Germany. (1 speakers): Martin H. Dreyling\n  - University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. (1 speakers): Axel S. Merseburger\n  - University Hospital Schleswig-Holstein, University Cancer Center Schleswig-Holstein, Kiel, Germany. (1 speakers): Anne Letsch\n  - University Medical Center Hamburg-Eppendorf, Department of Gynecology and Gynecologic Oncology, Hamburg, Germany. (1 speakers): Barbara Schmalfeldt\n  - University Medical Center Hamburg-Eppendorf, Hamburg, Germany. (1 speakers): Charlotte L. Sachs\n  - University of Freiburg, 79106, Germany. (1 speakers): Christian J. Gratzke\n  - University of Greifswald, Institute for Community Medicine, Greifswald, Germany. (1 speakers): Thomas Kohlmann\n  - University of Leipzig Medical Center, Department of Gynecology, Leipzig, Germany. (1 speakers): Bahriye Aktas\n  - Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstr. 55, Essen, Deutschland. (1 speakers): Wilfried E. Eberhardt\n  - Universitätsklinikum Tübingen & M3 Research Center, Universitätsklinikum Tübingen. (1 speakers): Christoph Stein-Thoeringer\n  - Urology, Ulm University Hospital, Ulm, Germany. (1 speakers): Friedemann Zengerling\n  - West German Cancer Center, Essen, Germany. (1 speakers): Simon S. Bogner\n  - West German Cancer Center, University Hospital Muenster, Muenster, Germany. (1 speakers): Katharina M. Richter\n  - eAsklepios Lung Clinic, German Center for Lung Research (DZL), Munich-Gauting, Germany. (1 speakers): Niels Reinmuth\n\n**Greece (22 institutions, 28 speakers)**\n  -  (5 speakers): Antonios Mingos, Asimina Pelteki, Evangeli Bista, Katerina C. Aravantinou Fatorou, Sofia I. CHRYSOGLOU\n  - 2nd Department of Internal Medicine, Attikon University Hospital, Athens, Greece. (1 speakers): Maria Anastasiou\n  - 401 General Military Hospital of Athens, Athens, Greece. (1 speakers): Nikolaos G. Tsoukalas\n  - 4th Oncology Dept. & Comprehensive Clinical Trials Center, Metropolitan Hospital, Ethn. Makariou 9, Athens 18547, Greece. (1 speakers): Stavroula Sgourou\n  - Department of Cardiology, Venizeleion General Hospital, GRC. (1 speakers): Eleni Eleftheriadou\n  - Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra General Hospital, Greece. (3 speakers): Charalampos Filippatos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis\n  - Department of Gynecology, Euroclinic Hospital, Athens. (1 speakers): George Marios Makris\n  - Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Greece. (1 speakers): Panagiotis Filis\n  - Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece. (1 speakers): Dimitrios Mavroudis\n  - Department of Nursing, School of Health Sciences, University of Peloponnese, Tripoli, Greece. (1 speakers): Athanasios Pitis\n  - Division of Oncology, Department of Medicine, University of Patras Medical School, Patras, Greece. (1 speakers): Fotinos-Ioannis D. Dimitrakopoulos\n  - First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens - School of Medicine, Athens, Greece. (1 speakers): Dimitrios C. Ziogas\n  - Fourth Department of Medical Oncology and Clinical Trials Unit, Henry Dunant Hospital Center Athens, Greece. (1 speakers): Giannis Mountzios\n  - Hellenic Ministry of Health, Athens, Greece. (1 speakers): Dimitrios Protogiros\n  - Laboratory of Biochemistry, Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece. (1 speakers): Nikolaos Politis\n  - Medical Oncology Unit, 2nd Department of Internal Medicine-Propaedeutic, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Chaidari, Greece. (1 speakers): Amanda Psyrri\n  - School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece. (1 speakers): STYLIANOS KATSARAGAKIS\n  - Second Department of Internal Medicine, Attikon University Hospital, Athens, Greece. (1 speakers): Anna Boulouta\n  - Second Propaedeutic Department of Medicine, Attikon University Hospital, Chaidari, Greece. (1 speakers): Anastasios Pantazopoulos\n  - Thessaloniki, Greece, Medical Oncology Department, Euromedica General Clinic, Thessaloniki, Greece, Interbalkan European Medical Center, Thessaloniki, Greece. (1 speakers): Konstantinos Papazisis\n  - Third Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece. (1 speakers): Anastasios Boutis\n  - University of Crete, 70013 Heraklion, Greece. (1 speakers): Andreas V. Koulouris\n\n**Guangdong (3 institutions, 3 speakers)**\n  - Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, The People's Republic of China. chmingy@mail.sysu.edu.cn. (1 speakers): Mingyuan Chen\n  - Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. (1 speakers): Wangjun Liao\n  - Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China (1 speakers): Jin-Ji Yang\n\n**Gyeonsang Nam-Do (1 institutions, 1 speakers)**\n  - Division of Pulmonology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea. (1 speakers): Yun Seong Kim\n\n**Helsinki (1 institutions, 1 speakers)**\n  - Gynecological Cancer Patients in Finland, Helsinki, Finland. (1 speakers): Eva-Maria Stromsholm\n\n**Henan (1 institutions, 1 speakers)**\n  - The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. (1 speakers): Hong Zong\n\n**Hiroshima (1 institutions, 1 speakers)**\n  - Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. (1 speakers): Takahiro Mimae\n\n**Hunan (1 institutions, 1 speakers)**\n  - Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China, Hunan Cancer Mega-Data Intelligent Application and Engineering Research Centre, Changsha, Hunan (1 speakers): Fang Wu\n\n**Hungary (2 institutions, 3 speakers)**\n  -  (2 speakers): Seba Aljomaa, Viola Z. Koros-Angyal\n  - Department of Pulmonology, Semmelweis University, Budapest, Hungary. (1 speakers): Veronika Muller\n\n**IL (2 institutions, 2 speakers)**\n  - Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell School of Medicine, NY, USA. (1 speakers): Massimo Cristofanilli\n  - Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. (1 speakers): William J. Gradishar\n\n**India (39 institutions, 49 speakers)**\n  -  (11 speakers): Abhishikha Sharma, Antapura H. Rudresha, Ashwini K Nanda, Bharatsinha Bhosale, FNU Prateek, Himaprathyusha Parupalli, Ishita Rastogi, Madhavi R. Indani, Nallabothula S. Kiran, Roopesh Narayanachary, Supreeth N. Ramesh\n  - Armed Forces Medical College, Maharashtra, India. bisht53rahul@gmail.com. (1 speakers): Rahul S. Bisht\n  - Armed Forces Medical College, Pune, 411040 India. (1 speakers): Makarand A. Randive\n  - Army Hospital (R&R), Delhi, India. (1 speakers): Niharika Bisht\n  - Aster International Institute Of Oncology, Aster Hospitals, Bengaluru, India. (1 speakers): Ashwin Kr\n  - Biosciences, College of Life and Environmental Sciences, University of Exeter, EX4 4PS, UK. (1 speakers): Debapriya Mondal\n  - Chemomicrobiomics Laboratory, Department of Biochemistry and Microbiology, KMCH Research Foundation, Coimbatore, India. (1 speakers): Srinidhi Narayani Seenivasan\n  - Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, India. (1 speakers): Arnab Pal\n  - Department of Biotechnology, School of Life Sciences, Central University of Kashmir, Tulmulla, Jammu, Kashmir, India. (1 speakers): Santosh Kumar\n  - Department of General Medicine, Institute of Medical Sciences, Banaras Hindu University, India. (1 speakers): Ankur N. Varshney\n  - Department of Gynaecological Oncology, Churchill Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. (1 speakers): Aakriti Aggarwal\n  - Department of Interventional Pulmonology Yashoda Hospitals Hyderabad India. (1 speakers): Hari Kishan Gonuguntla\n  - Department of Medical Oncology and Hematology, Institute of Oncology, AIG Hospitals, Hyderabad, India. (1 speakers): Vamshi Krishna Muddu\n  - Department of Medical Oncology, All India Institute of Medical Sciences, India. (1 speakers): Sameer Rastogi\n  - Department of Medical Oncology, Apollo Cancer Center, Chennai, India. (1 speakers): Raja Thirumalairaj\n  - Department of Medical Oncology, Rajagiri Cancer Centre, Rajagiri Hospital, Kochi, India. (1 speakers): Aswin Joy\n  - Department of Medical Oncology, Saroj Gupta Cancer Centre and Research Institute, Kolkata, India. (1 speakers): Nihanthy D. Sreenath\n  - Department of Medical Oncology, Shalby Hospital, Ahmedabad, Gujarat, India. (1 speakers): Viraj Lavingia\n  - Department of Medical Oncology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, India. (1 speakers): Ajas Ibrahim\n  - Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha Cancer Hospital, Sangrur, Punjab, India. (1 speakers): Alok K. Goel\n  - Department of Medical Oncology, Yashoda Hospitals, Somajiguda, Hyderabad, Telangana 500082, India. (1 speakers): Nikhil S. Ghadyalpatil\n  - Department of Psychiatry, AIIMS, India. (1 speakers): Barre Vijaya Prasad\n  - Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India. (1 speakers): Navneet Singh\n  - Department of Radiation Oncology, Mahamana Pandit Madan Mohan Malaviya Cancer Centre and Homi Bhabha Cancer Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India. (1 speakers): Abhishek Shinghal\n  - Dr. Rai - Comprehensive Blood and Cancer Center Oncology Services, Tamil Nadu, India. (1 speakers): Rajesh K. Narayanasamy\n  - Homi Bhabha National Institute, Training School Complex, Mumbai, Maharashtra, India, Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India. (1 speakers): Vijay M. Patil\n  - Institute of Breast Disease, Netaji Subhas Chandra Bose Cancer Hospital, Kolkata, India. (1 speakers): Soumen Das\n  - Medanta Cancer Institute, Gurugram, Haryana, India. (1 speakers): Ashok Kumar Vaid\n  - Medical Oncologist, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana 500034 India. (1 speakers): Krishna Mohan Mallavarapu\n  - Medical Oncology, Caritas Hospital, Kottayam, IND. (1 speakers): Boben Thomas\n  - Medical Oncology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences (AIIMS), India. (1 speakers): Atul Batra\n  - Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, India. (1 speakers): Mansi Sharma\n  - Medical Services, Medical Affairs Division, Mumbai, IND. (1 speakers): Maneesha Khalse\n  - Netaji Subhas Cancer Hospital, Kolkata, India. Electronic address: tanmoy.nrs@gmail.com. (1 speakers): Tanmoy K. Mandal\n  - North-East Cancer Hospital and Research Institute, Guwahati 781023, Assam, India. (1 speakers): Imliwati Longkumer\n  - SVKM's Dr. Bhanuben Nanavati College of Pharmacy, 400056, India. (1 speakers): Swapnil R. Raut\n  - Sir HN Reliance Foundation Hospital and Research Centre, Mumbai, India. (1 speakers): Sewanti Limaye\n  - TSET Health Promotion Research Center, Stephenson Cancer Center, The University of Oklahoma Health Sciences, OK 73104, USA. (1 speakers): Gaurav Kumar\n  - Tata Memorial Hospital, Mumbai 400 012, India. (1 speakers): Goutam S. Panda\n\n**Indonesia (1 institutions, 4 speakers)**\n  -  (4 speakers): Annes Waren, Faisal Syarifuddin, Michelle A. Hutapea, Nanda N. Nasution\n\n**Iran (4 institutions, 4 speakers)**\n  - Clinical Research Development Center, Amir Oncology Teaching Hospital, Shiraz University of Medical Sciences, Shiraz (1 speakers): Sadra Valiee\n  - Department of Clinical Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran. (1 speakers): Zohreh Ghoreishi\n  - Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran, Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. (1 speakers): Fatemeh Alizadeh\n  - Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran. (1 speakers): Seyed Reza Abdipour Mehrian\n\n**Iraq (1 institutions, 2 speakers)**\n  -  (2 speakers): Ariwan O. Saeed, Moez J. Mobarek\n\n**Ireland (24 institutions, 26 speakers)**\n  -  (3 speakers): Aoife Walshe, Julie Twomey, Ornagh Kestell\n  - Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland, Sidney Kimmel Comprehensive Cancer Centre at Johns Hopkins University, USA. (1 speakers): Jarushka Naidoo\n  - Cork University Hospital, Wilton, T12 DC4A Cork, Ireland. (1 speakers): Hailey K. Carroll\n  - Department of Cardio-Oncology, Gill Heart & Vascular Institute, University of Kentucky, Gill Heart & Vascular Institute, University of Kentucky, Lexington, KY, USA. (1 speakers): Zain Ul Abedin\n  - Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland. (1 speakers): Ciara S. McNevin\n  - Department of Imaging Sciences and Interventional Radiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum 695011, India. (1 speakers): Abhishek Nayak\n  - Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA. (1 speakers): Abeera Mehmood\n  - Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland. (1 speakers): John P. Crown\n  - Department of Oncology, Letterkenny University Hospital, Donegal, Ireland. (1 speakers): Janice Richmond\n  - Department of Oncology, St. John of God Hospital, Subiaco, WA, Australia. (1 speakers): Alice Talbot\n  - Dublin, Ireland. (1 speakers): Conor Moloney\n  - Medical Oncology, Beaumont RCSI Cancer Centre, Dublin, Ireland. (1 speakers): Maggie L. O'Connor\n  - Oncology Department, Midlands Regional Hospital, Tullamore, Co. Offaly, Ireland. (1 speakers): Elizabeth Meade\n  - Princess Margaret Cancer Centre, Toronto, ON M5G 1Z5, Canada. (1 speakers): Harry M. Harvey\n  - School of Nursing and Midwifery, University of Galway, Ireland. (1 speakers): Maura Dowling\n  - St Vincent's University Hospital and School of Medicine, Dublin, Republic of Ireland. (1 speakers): Grainne M. O'Kane\n  - St Vincent's University Hospital and University College Dublin, Dublin, Ireland. (1 speakers): Mary O. O'Reilly\n  - St. Vincent's University Hospital & University College Dublin, Dublin, Ireland. (1 speakers): Donal O' Shea\n  - Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland, St James's Hospital, Dublin, Ireland. (1 speakers): Niamh Coleman\n  - Trinity St. James Cancer Institute, Trinity College Dublin, Dublin, Ireland. (1 speakers): Maeve A. Lowery\n  - Trinity Translational Medicine Institute, Trinity College, University of Dublin, Ireland. (1 speakers): Anne-Marie Baird\n  - UCD School of Computer Science, University College Dublin, Ireland. (1 speakers): Polat Goktas\n  - University Hospital Galway, Galway, Ireland. (1 speakers): Aoife Lowery\n  - University of Limerick Hospital Group, Health Service Executive, Limerick, Ireland. (1 speakers): Ruth Hutch\n\n**Ishikawa (1 institutions, 1 speakers)**\n  - Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Ishikawa 920-8641, Japan. (1 speakers): Seiji Yano\n\n**Israel (18 institutions, 18 speakers)**\n  - Davidoff Cancer Center. Rabin Medical Center, Israel. (1 speakers): Ofer Rotem\n  - Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel. (1 speakers): Nathan I. Cherny\n  - Department of Occupational Therapy, Stanley Steyer School of Health Professions, Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Tel-Aviv, Israel. (1 speakers): Khawla Loubani\n  - Department of Oncology, Shaare Zedek Medical Center, Jerusalem 9103102, Israel. (1 speakers): Nir Peled\n  - Division of Oncology, Rambam Health Care Campus, Haifa, Israel. (1 speakers): Tarek Taha\n  - Division of Oncology, Tel Aviv Sourasky Medical Center, Israel. (1 speakers): Mirika Brezis\n  - Division of Oncology, Tel-Aviv Sourasky Medical Center, Israel. (1 speakers): Tal Etan\n  - Ella Lemelbaum Institute for Immuno-Oncology, Chaim Sheba Medical Center, Israel. (1 speakers): Shirly Grynberg\n  - Fishman Oncology Institute, Rambam Health Care Campus, Haifa, Israel. (1 speakers): Sameh Daher\n  - Fred Hutchinson Cancer Research Center, Seattle, WA, USA. (1 speakers): Noa Granot\n  - Institue of Oncology, Sheba Medical Center, Tel-Hashomer, Gray Faculty of Medicine and Health Sciences, Tel-Aviv University, Tel-Aviv 69978, Israel. (1 speakers): Talia Golan\n  - Institute of Oncology, Rambam Health Campus, Haifa, Israel. (1 speakers): Alona Zer\n  - Israel, Department of Public Health, Faculty of Medicine, Tel Aviv University, Israel. (1 speakers): Bar Levy\n  - Jusidman Institute of Oncology, Sheba Medical Center, Israel. (1 speakers): Jair Bar\n  - Sharett Institute of Oncology, Hadassah University Medical Center, Jerusalem, Israel. (1 speakers): Shani Paluch-Shimon\n  - Technion Integrated Cancer Center, Technion-Israel Institute of Technology, Haifa, Israel. i_benaharon@rambam.health.gov.il. (1 speakers): Irit Ben-Aharon\n  - The Institute of Oncology, Sheba Medical Center, Tel-Hashomer, Israel. (1 speakers): Rinat Bernstein Molho\n  - The Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel-Canada of The Faculty of Medicine, The Hebrew University Hadassah Medical School, Jerusalem, Israel. (1 speakers): Pini Tsukerman\n\n**Italy (225 institutions, 267 speakers)**\n  -  (9 speakers): Arianna Scipilliti, Delia Lucia Bellino, Filippo Morocutti, Giorgia Bortolus, Letizia Matera, Maria Giorgia D'Alonzo, Maria Laura Malgarini, Rebecca Mencarini, Serena Ricchiuto\n  - Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, Milan, Italy. (1 speakers): Roberto Grasso\n  - Applied Research Division for Cognitive and Psychological Science, IEO European Institute of Oncology IRCCS, Milan, Italy. (1 speakers): Gabriella Pravettoni\n  - August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy, Division of Medical Oncology (1 speakers): Benedetta Conte\n  - Aviano, Italy. (1 speakers): Lucia Cadorin\n  - Bergamo, Italy. (1 speakers): Vittoria Fotia\n  - Biomedical, Clinical and Experimental Sciences, Department of Medicine, University of Verona, Verona, Italy, Department of Engineering for Innovation Medicine (DIMI) (1 speakers): Alice Avancini\n  - Bruxelles, Belgium, Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy. (1 speakers): Chiara Dauccia\n  - Cancer Epidemiology Unit, National Cancer Institute, Aviano, Italy. (1 speakers): Diego Serraino\n  - Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy. (1 speakers): Emilio F. Giunta\n  - Careggi University Hospital, Italy. (1 speakers): Luca Visani\n  - Clinical Oncology Unit, Careggi University Hospital, Florence, Italy. (1 speakers): Giulia Massaro\n  - Clinical and Experimental Medicine Program, University of Modena and Reggio Emilia, Modena, Italy. (1 speakers): Lucia Trudu\n  - Clinical and Translational Oncology, Napoli 80134, Italy, Department of Breast & Thoracic Oncology, Division of Breast Medical Oncology, Napoli, Italy. (1 speakers): Roberto Buonaiuto\n  - Comprehensive Cancer Center, Agostino Gemelli University Polyclinic (IRCCS), Rome, Italy. (1 speakers): Floriana Camarda\n  - Comprehensive Cancer Center, Fondazione Policlinico Universitario A. Gemelli, I.R.C.C.S., Rome, Italy. (1 speakers): Antonio Vitale\n  - Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. (1 speakers): Maria Alessandra Calegari\n  - Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy. (1 speakers): Sergio Pannunzio\n  - Current Affiliation: Department of Medical Oncology, Careggi University Hospital, Florence, Italy. (1 speakers): Jacopo Venturini\n  - Department of Agraria, Mediterranean University of Reggio Calabria, Italy. (1 speakers): Francesco Larocca\n  - Department of Biomedical Sciences, Humanitas University, Milan, Italy, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. (1 speakers): Antonella Cammarota\n  - Department of Biomedicine and Prevention, Tor Vergata University of Rome, Rome, Italy. (1 speakers): Federica Lacarbonara\n  - Department of Clinical Medicine Sapienza University of Rome Rome Italy. (1 speakers): Alessandro Laviano\n  - Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. (1 speakers): Annarita Peddio\n  - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. (1 speakers): Alessandra Longobardi\n  - Department of Diagnostic Imaging and Radiotherapy, Milan - Italy. (1 speakers): Sarah C. Frasca\n  - Department of Diagnostic and Interventional Radiology, Milan, Italy. (1 speakers): Andrea Vanzulli\n  - Department of Electronics, Information, Polytechnic University of Milan, Milan, Italy. (1 speakers): Arsela Prelaj\n  - Department of Experimental Oncology, European Institute of Oncology IRCCS (IEO), Milan, Italy. (1 speakers): Luca Mazzarella\n  - Department of Experimental, University of Bologna, Sant' Orsola-Malpighi Hospital, Bologna I-40138, Italy. (1 speakers): Daria Maria Filippini\n  - Department of Food, Italy. (1 speakers): Letizia Negrini\n  - Department of Health Sciences - University of Genova (1 speakers): Gianluca Catania\n  - Department of Health Sciences, University of Florence, Florence, Italy. (1 speakers): Carla Amato\n  - Department of Hematology, Oncology, Italy, Department of Oncology and Hemato-Oncology, Milano, Italy. (1 speakers): Caterina Vaghi\n  - Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. (1 speakers): Luca Arecco\n  - Department of Internal Medicine and Medical Specialties (DIMI), School, University of Genova, Genoa, Italy, Medical Oncology Department, U.O.C. Clinica di Oncologia Medica (1 speakers): Matteo Lambertini\n  - Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy. (1 speakers): Chiara Molinelli\n  - Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Italy. (1 speakers): Valentino Martelli\n  - Department of Internal Medicine and Medical Therapy, University of Pavia, Italy. (1 speakers): Federica Mascaro\n  - Department of Medical Epidemiology, Milan, Italy. (1 speakers): Cristina Bosetti\n  - Department of Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy. (2 speakers): Chiara Barigazzi, Pasquale Persico\n  - Department of Medical Oncology and Hematology, IRCCS Humanitas Research Hospital, Milan, Italy. (1 speakers): Matteo Simonelli\n  - Department of Medical Oncology and Medicine, Galliera Hospital, Genoa, Italy. (1 speakers): Alessio Carbone\n  - Department of Medical Oncology, CRO di Aviano, National Cancer Institute, IRCCS, Italy, Department of Medicine, University of Udine, Italy. (1 speakers): Lorenzo Foffano\n  - Department of Medical Oncology, Fondazione IRCCS, Milan, Italy. (3 speakers): Amedeo Nuzzo, Eleonora Gusmaroli, Patrizia Giannatempo\n  - Department of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico & University Campus Bio-Medico, Rome, Italy. (2 speakers): Alessandro Mazzocca, Bruno Vincenzi\n  - Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy, Unit of Medical Oncology 2, Pisa, Italy. (1 speakers): Chiara Mercinelli\n  - Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy, Vita-Salute San Raffaele University, Milan, Italy. (1 speakers): Andrea Necchi\n  - Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy. (1 speakers): Valentina Tateo\n  - Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy. (1 speakers): Francesca Rita Ogliari\n  - Department of Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy. (1 speakers): Francesco G. Sullo\n  - Department of Medical Oncology, Meldola, Italy. (3 speakers): Alberto Farolfi, Michela Palleschi, Ugo De Giorgi\n  - Department of Medical Oncology, Milan, Italy. (7 speakers): Anna Maria Frezza, Brigida A. Maiorano, Elena Verzoni, Francesca Ricchini, Mario Occhipinti, Silvia Stacchiotti, Teresa Beninato\n  - Department of Medical Oncology, Milano, Italy. (1 speakers): Roberta Fazio\n  - Department of Medical Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy. (1 speakers): Giuseppe Lombardi\n  - Department of Medical Oncology, Pancreas Translational & Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy. (1 speakers): Michele Reni\n  - Department of Medical Oncology, San Raffaele Hospital, Milan, Italy. (1 speakers): Giampaolo Bianchini\n  - Department of Medical Oncology, San Raffaele Scientific Institute IRCCS, Milan, Italy. (1 speakers): Andrea Casadei Gardini\n  - Department of Medical Oncology, University Hospital of Udine, Udine, Italy. (1 speakers): Francesco Cortiula\n  - Department of Medical and Surgical Sciences (DIMEC) - Alma Mater Studiorum, University of Bologna, Italy. (1 speakers): Elisa Andrini\n  - Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum-University of Bologna, Medical Oncology Unit, Bologna, Italy. (1 speakers): Giuseppe Lamberti\n  - Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. (2 speakers): Matteo Rosellini, Veronica Mollica\n  - Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. (1 speakers): Ilaria Ricciotti\n  - Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy. (1 speakers): Valentina Biagioli\n  - Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, Brescia, Italy. (1 speakers): Greta Schivardi\n  - Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, School of Medicine, Brescia, Italy. (1 speakers): Claudia Assoni\n  - Department of Medicine (DAME), University of Udine, Udine, Italy. (1 speakers): Giulia Zapelloni\n  - Department of Medicine and Surgery, Federico II University, Naples, Italy. (1 speakers): Giuseppe Neola\n  - Department of Medicine and Surgery, Medical Oncology Unit, University Hospital of Parma, Parma, Italy. (2 speakers): Alessandra Dodi, Marcello Tiseo\n  - Department of Medicine, University of Padua, Italy, Veneto Institute of Oncology, IOV-IRCCS, Padua (1 speakers): Matteo Fassan\n  - Department of Medicine, University of Salerno, Baronissi, Italy. (1 speakers): Valeria Conti\n  - Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Naples, Italy. (1 speakers): Margaret Ottaviano\n  - Department of Neurology, \"SS Annunziata\" Hospital, Italy. (1 speakers): Antonio Di Muzio\n  - Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy. (1 speakers): Antonio Marra\n  - Department of Oncology and Haematology, University of Milan, Milan, Italy, European Institute of Oncology, IRCCS, Milan, Italy. (1 speakers): Dario Trapani\n  - Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy, Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan (1 speakers): Carmen Criscitiello\n  - Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. (3 speakers): Gianluca Mauri, Julian D. Etessami, Lisa F. Licitra\n  - Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. (1 speakers): Stefano Cavalieri\n  - Department of Oncology and Hematology Azienda Ospedaliero-Universitaria di Modena Modena Italy. Electronic address: hbc@unimore.it. (1 speakers): Laura Cortesi\n  - Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy. (1 speakers): Claudio Vernieri\n  - Department of Oncology and Onco-Hematology, University of Milan and Hematology Section Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. (1 speakers): Niccolo Bolli\n  - Department of Oncology, Hospital of Prato Azienda USL Toscana Centro, Prato, Italy. (1 speakers): Laura Biganzoli\n  - Department of Oncology, IRCCS Humanitas Research Hospital, Milan, Italy. (1 speakers): Luigi G. Cecchi\n  - Department of Oncology, IRCCS Ospedale Policlinico San Martino and University of Genova, Genova, Italy. (1 speakers): Gianluca Sacco\n  - Department of Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto IOV, IRCCS, Padova, Italy. (1 speakers): Antonella Brunello\n  - Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy, IFOM ETS, The AIRC Institute of Molecular Oncology, Milano, Italy. (1 speakers): Alberto Bardelli\n  - Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Italy. (1 speakers): Giulia Cerretti\n  - Department of Oncology, Ospedale San Rocco ASL Caserta, Sessa Aurunca 81037, Campania, Italy. mariar.damato@gmail.com. (1 speakers): Mariarosaria D'amato\n  - Department of Oncology, Spedali Riuniti University of Brescia, Brescia 25123, Italy. (1 speakers): Alfredo Berruti\n  - Department of Oncology, Terni, Italy. (1 speakers): Annalisa Guida\n  - Department of Oncology, University of Torino, San Luigi Gonzaga University Hospital, Orbassano, Italy. (1 speakers): Silvia Novello\n  - Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital-Orbassano, Turin, Italy. (1 speakers): Massimiliano Cani\n  - Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Torino, Italy. (1 speakers): Ornella Cantale\n  - Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy. (2 speakers): Giovanni Farinea, Luca Cozzone\n  - Department of Oncology, University of Turin, Turin, Italy. (1 speakers): Massimo Di Maio\n  - Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. (1 speakers): Sara Lonardi\n  - Department of Otolaryngology-Head and Neck Surgery, Provincial Hospital of Bolzano (SABES-ASDAA), Bolzano, Italy. (1 speakers): Francesca Zanghi\n  - Department of Precision Medicine in Medical, Section of Medical Oncology, University of Palermo, Italy. (1 speakers): Lorena Incorvaia\n  - Department of Precision Medicine in Medical, Section of Medical Oncology, University of Palermo, Palermo, Italy. (1 speakers): Clarissa Mujacic\n  - Department of Precision Medicine in Medical, University of Palermo, Palermo, Italy. (1 speakers): Tancredi Didier Bazan Russo\n  - Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Section of Pharmacology, University of Bari Aldo Moro Medical School, Bari, Italy. (1 speakers): Vanessa Desantis\n  - Department of Public Health, Università degli Studi di Napoli-AOU Federico II, Naples, Italy. (1 speakers): Umberto Malapelle\n  - Department of Radiation Oncology, Institute of Radiology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. (1 speakers): Luca Tagliaferri\n  - Department of Research, Milan, Italy. (1 speakers): Mario P. Colombo\n  - Department of Surgery, Milan, Italy. (1 speakers): Paolo G. Casali\n  - Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy, Division of Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy. (1 speakers): Maria Vittoria Dieci\n  - Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, IT, Italy. (2 speakers): Federica Miglietta, Michele Bottosso\n  - Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy. (2 speakers): Laura Bonanno, Loc Carlo Bao\n  - Department of Surgery, University of Padova, Padova, Italy. (1 speakers): Valentina Guarneri\n  - Department of Surgical, Section of Medical Oncology, University of Palermo, Palermo, Italy. (1 speakers): Alessandra Dimino\n  - Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. (1 speakers): Ada Taravella\n  - Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy. (2 speakers): Carlotta Antoniotti, Chiara Cremolini\n  - Department of Woman, Child and Public Health, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy. (1 speakers): Camilla Nero\n  - Department of Women's and Children's Health, Padua, Italy. (1 speakers): Andrea Mastria\n  - Dietetics and Clinical Nutrition Unit, Hospital Policlinico San Matteo of Pavia, Pavia, Italy. (1 speakers): Riccardo Caccialanza\n  - Digestive Molecular Clinical Oncology Research Unit, Verona, Italy. (1 speakers): Alberto Quinzii\n  - Dipartimento di Internistica Clinica e Sperimentale \"F. Magrassi\", Napoli, Italy. (1 speakers): Claudia Cardone\n  - Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO), IRCCS, Milan, Italy. (1 speakers): Francesca Spada\n  - Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milan, Italy, Molecular Medicine Department, University of Pavia, Pavia, Italy. (1 speakers): Lorenzo Gervaso\n  - Division of Gynecologic Oncology, European Institute of Oncology, IRCCS, Milan, Italy. (1 speakers): Marta Mongillo\n  - Division of Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy. (1 speakers): Gaia Griguolo\n  - Division of Medical Oncology, Maggiore University Hospital, Italy. (1 speakers): Ida Taglialatela\n  - Division of Medical Oncology, Maggiore University Hospital, Novara, Italy. (1 speakers): Alessandra Gennari\n  - Division of Medical Senology, European Institute of Oncology IRCCS, Milan, Italy. (1 speakers): Emilia Montagna\n  - Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy. (1 speakers): Nadia Bianco\n  - Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy, Department of Oncology and Hemato-Oncology, University of Milan, Milan (2 speakers): Gabriele Antonarelli, Jalissa Katrini\n  - Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy. (1 speakers): Federica Biello\n  - Division of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy. (1 speakers): Stefano Partelli\n  - Division of Radiotherapy - Department of Imaging Diagnostics, \"A. Gemelli\" University Hospital Foundation IRCCS. 00168 Rome, Italy. (1 speakers): Valeria Masiello\n  - Division of Thoracic Oncology, European Institute of Oncology, IEO, IRCCS, Milan 20141, Italy. (1 speakers): Antonio Passaro\n  - European Institute of Oncology IRCCS and University of Milan-Bicocca, Milan, Italy. (1 speakers): Nicoletta Colombo\n  - European Institute of Oncology IRCCS, Milan, Italy, University of Milano, Milan, Italy. (1 speakers): Giuseppe Curigliano\n  - FPO-IRCCS, Candiolo Cancer Institute, Department of Medical Oncology, Candiolo, Italy. (1 speakers): Elena Geuna\n  - Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy. (1 speakers): Tiziano Zinicola\n  - Gastroenterology and Digestive Oncology Department, Georges Pompidou European Hospital, AP-HP, Paris, France, Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy (1 speakers): Annalice Gandini\n  - Genoa, Italy. (1 speakers): Eugenia Cella\n  - Gynecologic Oncology Department, European Institute of Oncology, Milan, Italy. (1 speakers): Fedro A. Peccatori\n  - Gynecologic Oncology Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy. (1 speakers): Rosanna Mancari\n  - Head and Neck Medical Oncology Department, Milan, Italy. (1 speakers): Laura D. Locati\n  - Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy. (2 speakers): Flavia Jacobs, Mariangela Gaudio\n  - Humanitas Hospital San Pio X, Humanitas University, Milan, Italy. (1 speakers): Domenica Lorusso\n  - IRCCS Humanitas Research Hospital, Cancer Center, Rozzano, Italy. (2 speakers): Luca Toschi, Sara Farinatti\n  - IRCCS Humanitas Research Hospital, Rozzano, Italy. (1 speakers): Agnese Losurdo\n  - IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy. (1 speakers): Francesca Gaino\n  - IRCCS Ospedale Policlinico San Martino, Genova, Italy. (1 speakers): Lorenzo Ferrando\n  - IRCCS Regina Elena National Cancer Institute, Rome, Italy. (1 speakers): Federico Cappuzzo\n  - IRCCS San Raffaele Scientific Institute, Milan, Italy. (1 speakers): Andres J. Ferreri\n  - Institute of Pharmacological Research Mario Negri, Department of Oncology, Milan, Italy. (1 speakers): Valter Torri\n  - Interdisciplinary Department of Medicina, Division of Medical Oncology, University of Bari \"Aldo Moro\", A.O.U. Consorziale Policlinico di Bari, Bari, Italy. (1 speakers): Mimma Rizzo\n  - Interdisciplinary Department of Medicine, University of Bari \"Aldo Moro\", Bari, Italy. (1 speakers): Nada Chaoul\n  - Maggiore University Hospital, 28100 Novara, Italy. (1 speakers): Tommaso L. Landolfo\n  - Maugeri Clinical Research Institutes IRCCS, Pavia, Italy. (1 speakers): Sara Demurtas\n  - Medical Oncologist, Department of Otorhinolaryngology, IRCCS San Raffaele Scientific Institute, Milano, Italy. (1 speakers): Aurora Mirabile\n  - Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy. (1 speakers): Giulia Pasello\n  - Medical Oncology Department, Milan, Italy. (4 speakers): Filippo Pietrantonio, Marta Brambilla, Monica Ganzinelli, Simone Oldani\n  - Medical Oncology Department, National Cancer Institute, Aviano, Italy. (1 speakers): Lucia Fratino\n  - Medical Oncology Department, University and Hospital Trust of Verona, Verona, Italy. (1 speakers): Jessica Menis\n  - Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy. (1 speakers): Veronica Murianni\n  - Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Liguria, Italy. (1 speakers): Alessandro Pastorino\n  - Medical Oncology Unit 2, Italy, University of Milano, Italy. (1 speakers): Claudia Giani\n  - Medical Oncology Unit, AST1, Pesaro, Italy. (1 speakers): Rita Chiari\n  - Medical Oncology Unit, Bergamo, Italy, Department of Biomedical Sciences, Humanitas University, Rozzano, Italy. (1 speakers): Erika Stucchi\n  - Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Italy. (1 speakers): Matteo Carpani\n  - Medical Oncology Unit, Department of Oncology and Hematology, Belcolle Hospital, Viterbo, Italy. (1 speakers): Marta Schirripa\n  - Medical Oncology Unit, Department of Oncology, Azienda USL Toscana Centro, Florence, Italy. (1 speakers): Maria Simona Pino\n  - Medical Oncology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy. (1 speakers): Cristina Morelli\n  - Medical Oncology Unit, Pavia, Italy. (1 speakers): Federico Sottotetti\n  - Medical Oncology Unit, Sant'Andrea Hospital of Rome, Italy. (1 speakers): Raffaele Giusti\n  - Medical Oncology Unit, Savona 17100, Italy. (1 speakers): Sara Elena Rebuzzi\n  - Medical Oncology Unit, University Hospital and University of Cagliari, Italy. (1 speakers): Andrea Pretta\n  - Medical Oncology Unit, University Hospital of Parma, Parma, Italy. (2 speakers): Francesca Trentini, Sebastiano Buti\n  - Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. (1 speakers): Lorenza Rimassa\n  - Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy, Department of Biomedical Sciences, Humanitas University, Milan, Italy. (2 speakers): Carlo Resteghini, Paolo Bossi\n  - Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. (1 speakers): Luigi Lorini\n  - Medical Oncology, Bologna, Italy, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. (1 speakers): Francesco Massari\n  - Medical Oncology, Comprehensive Cancer Centre IRCCS - AUSL Reggio Emilia, Italy. (1 speakers): Cristina Masini\n  - Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy. (2 speakers): Elena Speziale, Luisana Sisca\n  - Medical Oncology, Rome, Italy. (1 speakers): Antonio Cigliola\n  - Medical Oncology, Sant'Andrea University Hospital, Rome, Italy. (1 speakers): Marco Siringo\n  - Medical Oncology, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy. (1 speakers): Giulio Metro\n  - Medical Oncology, St Andrea Hospital, Rome, Italy. (1 speakers): Marco Filetti\n  - Medical Oncology, University and University Hospital of Cagliari, Cagliari, Italy. (1 speakers): Mara Persano\n  - Medical Oncology, Versilia Hospital, Azienda USL Toscana Nord Ovest, Lido di Camaiore, Italy. (1 speakers): Andrea Camerini\n  - Melanoma, Oncological Immunotherapy and Innovative Therapies Department INT - IRCCS \"Fondazione G. Pascale\" Naples Italy. (1 speakers): Paolo A. Ascierto\n  - Meldola, Italy. (1 speakers): Nicola Normanno\n  - Memorial Sloan Kettering Cancer Center, NY, USA. (1 speakers): Michelangelo Marasco\n  - Milan - Italy. (1 speakers): Giovanni Leuzzi\n  - Milan, Italy. (2 speakers): Michele Del Vecchio, Patrizia Pasanisi\n  - Monaldi Hospital AO Dei Colli, 80131 Naples, Italy. (1 speakers): Maria D'Amato\n  - Naples, Italy. (1 speakers): Anna Maria Trotta\n  - National Centre for HIV Oncology, Chelsea Westminster Hospital, London, UK, Milan, Italy. (1 speakers): Alberto Giovanni Leone\n  - NearLab, Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy. (1 speakers): Alessandra Pedrocchi\n  - Nervous System Medical Oncology Department, Bologna, Italy. (1 speakers): Vincenzo Di Nunno\n  - Niguarda Cancer Center, Milan, Italy. (1 speakers): Silvia Marsoni\n  - Niguarda Cancer Center, Milano, Italy, Department of Hematology & Oncology, University of Milan, Milan, Italy. (1 speakers): Rebecca Romano\n  - Oncology Department, Azienda USL-IRCCS di Reggio Emilia, Italy. (1 speakers): Carmine Pinto\n  - Pisa, Italy. (1 speakers): Chiara Maria Mazzanti\n  - Policlinico Umberto I University Hospital, Rome, Italy. (1 speakers): Mattia A. Di Civita\n  - Policlinico Umberto I, Department of Radiological, ″Sapienza″ University of Rome, Rome, Italy. (1 speakers): Giuseppe Minniti\n  - Policlinico Umberto I, Rome, Italy, Department of Radiological, Sapienza University, Rome, Italy. (1 speakers): Andrea Botticelli\n  - Radiation Oncology Department, Milan, Italy, Department of Oncology, University of Milan, Milan, Italy. (1 speakers): Andrea Riccardo Filippi\n  - Research Nurses Team, European Institute of Oncology, Milan, Italy. (1 speakers): Teresa Profeta\n  - San Maurizio Central Hospital of Bolzano, BZ, Italy. Electronic address: gaboristvan.liposits@sabes.it. (1 speakers): Gabor I. Liposits\n  - Sapienza University of Rome, Rome, Italy. (1 speakers): Federica D'Antonio\n  - Section of Medical Oncology, Department of Precision Medicine in Medical, University of Palermo, Palermo, Italy. (1 speakers): Daniele Fanale\n  - Section of Oncology, Department of Engineering for Innovation Medicine (DIMI), University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy. (4 speakers): Daniela Tregnago, Lorenzo Belluomini, Sara Pilotto, Serena Eccher\n  - Translational Research Unit, Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy. (1 speakers): Luca Malorni\n  - U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy. (1 speakers): Eva Blondeaux\n  - Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy. (1 speakers): Marzia Del Re\n  - Unit of Medical Oncology 2, Pisa, Italy, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. (2 speakers): Martina Carullo, Veronica Conca\n  - Unit of Medical Oncology 2, Pisa, Italy, Institute of Interdisciplinary Research \"Health Science, Pisa, Italy, Unit of Medical Oncology 2, Pisa, Italy (1 speakers): Virginia Genovesi\n  - Unit of Medical Oncology and Biomolecular Therapy, Department of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Foggia, Italy. (1 speakers): Vincenza Conteduca\n  - Unit of Medical Oncology, Carpi Civil Hospital, Carpi, Medicine Department, Local Health Unit, Modena, Italy. (1 speakers): Emilia Gianotti\n  - Unit of Medical Oncology, Department of Medical and Surgical Specialties, and Public Health, University of Brescia, Brescia, Italy. (1 speakers): Marco Bergamini\n  - Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Milan, Italy. (1 speakers): Alice Indini\n  - Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Naples, Italy. (1 speakers): Claudia Trojaniello\n  - University Department of Anesthesiology and Intensive Care Medicine, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany. (1 speakers): Eleonora Gorgati\n  - University Hospital of Modena, 41124 Modena, Italy. (1 speakers): Elisa D'Agostino\n  - University of Bari \"A. Moro\" and Division of Medical Oncology, Bari, Italy. (1 speakers): Camillo Guglielmo Porta\n  - University of Campania Luigi Vanvitelli, 80131 Naples, Italy. (1 speakers): Caterina De Rosa\n  - University of Milan, Milan, Italy. (1 speakers): Filippo Guglielmo Maria De Braud\n  - University of Naples \"Federico II\", Naples 80131, Italy. (1 speakers): Andrea D'Arienzo\n  - University of Perugia, Santa Maria Misericordia Hospital, Perugia, Italy. (1 speakers): Mario Mandala\n  - University of Pisa, Pisa, Italy. (1 speakers): Marco Maria M. Germani\n  - Vita-Salute San Raffaele University, Milan. (1 speakers): Giovanni Luigi Pastorino\n\n**Japan (93 institutions, 103 speakers)**\n  -  (6 speakers): Emiko Tange, Giorgia Amelia Intilisano, Ishida Masaki, NAOTO KOASHI, Shota Uesawa, Tsumugu Harada\n  - Advanced Cancer Translational Research Institute, Showa Medical University, Tokyo, Japan. (1 speakers): Junji Tsurutani\n  - Biostatistics Division, Center for Research Administration and Support, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Masashi Wakabayashi\n  - Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan. (1 speakers): Yukinori Ozaki\n  - Breast Oncology Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Koto, Tokyo, Japan. (1 speakers): Meiko Nishimura\n  - Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan. (1 speakers): Toshifumi Yamaguchi\n  - Clinical Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Takashi Ikeno\n  - Department of Advanced Clinical Research and Development, Graduate School of Medical Sciences, Nagoya City University, Aichi, Japan. (1 speakers): Kazuki Nozawa\n  - Department of Breast Medical Oncology, The Cancer Institute Hospital of JFCR, Tokyo, Japan. (1 speakers): Takayuki Kobayashi\n  - Department of Breast and Endocrine Surgery, Graduate School of Medicine, University of Osaka, Suita, Osaka 565-0871, Japan. (1 speakers): Tetsuhiro Yoshinami\n  - Department of Breast and Endocrine Surgical Oncology Graduate School of Medicine Tohoku University, Aoba-ku, Sendai 980-8574, Japan. (1 speakers): Akiko Ebata\n  - Department of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan. (1 speakers): Hiroshi Tada\n  - Department of Breast and Thyroid Surgery, Kawasaki Medical School Hospital, Kurashiki, Japan. (1 speakers): Takayuki Iwamoto\n  - Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Japan. (1 speakers): Yoshito Komatsu\n  - Department of Clinical Oncology, Aichi Cancer Center Hospital, Chikusa-Ku, Nagoya, Aichi, Japan. (1 speakers): Yasunobu Ishizuka\n  - Department of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan. (1 speakers): Motoo Nomura\n  - Department of Clinical Oncology, St. Marianna University School of Medicine, Sugao, Miyamae-ku, Kawasaki, Kanagawa, Japan. y.suna0825@gmail.com. (1 speakers): Yu Sunakawa\n  - Department of Clinical Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan. (1 speakers): Hisato Kawakami\n  - Department of Dermatologic Oncology, National Cancer Center Hospital, Chuo-Ku, Tokyo, Japan. (1 speakers): Eiji Nakano\n  - Department of Dermatology, Kawasaki Municipal Hospital. (1 speakers): Sayuka Arakawa\n  - Department of Early Clinical Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan. (1 speakers): Chiaki Suzuki\n  - Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. (1 speakers): Chikako Funasaka\n  - Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto-Ku, Tokyo, Japan. (1 speakers): Keitaro Shimozaki\n  - Department of Gastroenterological Chemotherapy, Japanese Foundation for Cancer Research, Ganken Ariake Byoin Cancer Institute Hospital, Koto-ku, Tokyo, Japan. (1 speakers): Shota Fukuoka\n  - Department of Gastroenterological Surgery, Gifu University Hospital, Gifu, Gifu 501-1194, Japan. (1 speakers): Ryoma Yokoi\n  - Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. (4 speakers): Kazumasa Yamamoto, Tadayoshi Hashimoto, Yasutoshi Kuboki, Yuki Matsubara\n  - Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Nagasaki, Japan. (1 speakers): Kohei Hayashi\n  - Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. (1 speakers): Nobumasa Mizuno\n  - Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan. (1 speakers): Keisuke Koroki\n  - Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division Kanagawa Cancer Center Yokohama Japan. (1 speakers): Makoto Ueno\n  - Department of Gastroenterology, Institute of Biomedical & Health Sciences, Hiroshima University, Japan. (1 speakers): Tomokazu Kawaoka\n  - Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. (1 speakers): Ken Kato\n  - Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan. (2 speakers): Hideaki Bando, Yoshiaki Nakamura\n  - Department of Hematology and Cell Therapy, NHO Kyushu Cancer Center, Minami-ku, Fukuoka 811-1395, Japan. (1 speakers): Youko Suehiro\n  - Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. (1 speakers): Yuri Maegawa\n  - Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Hiroshi Imaoka\n  - Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. (1 speakers): Yuta Maruki\n  - Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. (1 speakers): Kouji Izumi\n  - Department of Medical Oncology and Hematology, Cancer Center, Kobe University Hospital, Kobe, Japan, Japan Clinical Oncology Group (JCOG) Data Center, National Cancer Center Hospital, Tokyo, Japan (1 speakers): Koichiro Wasano\n  - Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research (JFCR), Koto-ku, Tokyo 135-8550, Japan. (1 speakers): Yuji Miura\n  - Department of Medical Oncology, Hokkaido University Hospital, N14, W5, Kita-ku, Sapporo, Japan. (1 speakers): Yasushi Shimizu\n  - Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Misao Fukuda\n  - Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, Japan. (2 speakers): Mai Hoshino, Rui Kitadai\n  - Department of Medical Oncology, Saitama Medical University International Medical Center, Saitama, Japan. (1 speakers): Yoshiaki Mihara\n  - Department of Medical Oncology, Tohoku University Hospital, Sendai 980-8547, Japan. (1 speakers): Shiori Ishikawa\n  - Department of Molecular Imaging and Diagnosis, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan. (1 speakers): Koji Yamashita\n  - Department of Orthopaedic Oncology and Surgery, Saitama Medical University International Medical Center, Saitama, Japan. (1 speakers): Takuya Watanabe\n  - Department of Otolaryngology-Head & Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. (1 speakers): Akihiro Homma\n  - Department of Otorhinolaryngology and Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan. (1 speakers): Sho Iwaki\n  - Department of Palliative Medicine, Kobe University Graduate School of Medicine, Kobe, Japan. (1 speakers): Takashi Yamaguchi\n  - Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan. (1 speakers): Hiroto Ishiki\n  - Department of Pediatric Surgery (1 speakers): Masayasu Sato\n  - Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kajii-cho, Kamigyo-ku, Kyoto 602-8566, Japan. (1 speakers): Tadaaki Yamada\n  - Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. (1 speakers): Haruka Nakatani\n  - Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan. (1 speakers): Shunsuke Misono\n  - Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. (1 speakers): Takeshi Kodaira\n  - Department of Radiation Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. (1 speakers): Tairo Kashihara\n  - Department of Radiology, Kawasaki Medical School, Okayama, Japan. (1 speakers): Yuki Sato\n  - Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Aomori, Japan. (1 speakers): Tomonori Makiguchi\n  - Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. (1 speakers): Hisashi Tanaka\n  - Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan. (1 speakers): Akinari Tsukada\n  - Department of Respiratory Medicine, Osaka International Cancer Institute, Osaka, Japan. (1 speakers): Kiyohide Komuta\n  - Department of Surgery National Hospital Organization Osaka National Hospital Osaka Japan. (1 speakers): Masaaki Miyo\n  - Department of Surgery Osaka Rosai Hospital Sakai Japan. (1 speakers): Ryohei Kawabata\n  - Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. (1 speakers): Ryosuke Mizuno\n  - Department of Surgery, Kyoto University Graduate School of Medicine, Sakyo-Ku, Kyoto, Japan. (1 speakers): Haruku Fujita\n  - Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Minami-ku, Hiroshima, Hiroshima, Japan. (1 speakers): Momoko Takaya\n  - Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo, Tokyo, Japan. (1 speakers): Shingo Kitagawa\n  - Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan. (1 speakers): Seigo Katakura\n  - Department of Thoracic Surgery, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan (1 speakers): Fumihiro Shoji\n  - Department of Urology, University of Tsukuba Institute of Medicine, Tsukuba, Ibaraki, Japan. (1 speakers): Yoshiyuki Nagumo\n  - Division of Cancer Evolution, National Cancer Center Japan Research Institute, Tokyo, Japan. (1 speakers): Yuji Uehara\n  - Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Japan. (1 speakers): Kenro Hirata\n  - Division of Gastrointestinal Oncology, Shizuoka Cancer Center Hospital, Shizuoka, Japan. (1 speakers): Tomoya Yokota\n  - Division of Lower G.I., Department of Gastroenterological Surgery, School of Medicine, Hyogo Medical University, Nishinomiya 663-8501, Japan. (1 speakers): Kozo Kataoka\n  - Division of Lower GI, Department of Gastroenterological Surgery, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya, Hyogo (1 speakers): Yuko Fukumoto\n  - Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Chuo-ku, Kobe, Hyogo, Japan. (1 speakers): Yoshiaki Nagatani\n  - Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan. (1 speakers): Tetsuo Shimizu\n  - Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, Nagaizumi, Japan. (1 speakers): KAZUSHIGE WAKUDA\n  - Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan. (1 speakers): Akira Hamada\n  - Ltd, Tsukuba, Japan. (1 speakers): Ken Ito\n  - MSD K.K., Tokyo, Japan. (1 speakers): Tetsu Kamitani\n  - Molecular Pharmacology Research Group, Department of Pharmacology and Toxicology, German University in Cairo, Egypt. (1 speakers): Nada H. Hussein\n  - National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Hiroki Izumi\n  - Neutron Science and Technology Center, Comprehensive Research Organization for Science and Society, Tokai 319-1106, Japan. (1 speakers): Kazuki Iida\n  - Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Osaka, Japan. (1 speakers): Hiroki Yukami\n  - Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, Center for Genomic Medicine and Cardiovascular Research Center, Massachusetts General Hospital, Boston (1 speakers): Satoshi Koyama\n  - Shien-Lab, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan. (1 speakers): Takeshi Sawada\n  - The Cancer Institute Hospital, Tokyo, Koto-ku, Japan. (1 speakers): Hiroki Osumi\n  - Translational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Mitsuho Imai\n  - University of Tsukuba, Tsukuba, Japan. (1 speakers): Markus Y. Widjaja Lomanto\n  - Wakayama Medical University, Wakayama 641-8509, Japan. (1 speakers): Ryota Shibaki\n  - Wakayama Medical University, Wakayama, Japan. (1 speakers): Yuichi Ozawa\n\n**Jerusalem (1 institutions, 1 speakers)**\n  - Radiation Oncology Department, Augusta Victoria Hospital, Jerusalem 9511208, Palestine. (1 speakers): Elias E. Lahham\n\n**Jordan (8 institutions, 9 speakers)**\n  -  (1 speakers): Awab Al-Ani\n  - Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan, School of Medicine, The University of Jordan. Amman, Jordan. (2 speakers): Hikmat Abdel-Razeq, Kamal Al-rabi\n  - King Hussein Cancer Center, 11941, Jordan. (1 speakers): Faris T. Tamimi\n  - King Hussein Cancer Center, Amman, Jordan. (1 speakers): Anas M. Zayed\n  - Mater Misericordiae University Hospital, Dublin, Ireland. (1 speakers): Khaled N. Taha\n  - Medical Oncology, Faculty of Medicine, Al-Balqa' Applied University, Amman, JOR. (1 speakers): Bara M. Hammadeh\n  - School of Medicine, The University of Jordan, Amman, Jordan. (1 speakers): Yazan I. Hamadneh\n  - University of Jordan, Amman, Jordan. (1 speakers): Hamza M. Alakhras\n\n**Kanagawa (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Kenichi Harano\n\n**Karnataka (2 institutions, 2 speakers)**\n  - Department of Oncology, Mysore Medical College & Research Institute, India. Electronic address: dal_muk1@hotmail.com. (1 speakers): Mukesh Shanthilal\n  - Manipal Hospital, Bengaluru, Karnataka, India. (1 speakers): Amit Rauthan\n\n**Kazakhstan (2 institutions, 2 speakers)**\n  -  (1 speakers): Mariya Dmitrenko\n  - Department of Oncology, Astana Medical University, Oncologist-Surgeon, Multidisciplinary Medical Center, Astana, Kazakhstan. (1 speakers): Aizhan Bekisheva\n\n**Kenya (2 institutions, 2 speakers)**\n  -  (1 speakers): Sujana Bhikam Babu\n  - Avenue Hospital, Nairobi, Kenya. (1 speakers): Karishma Sharma\n\n**Kerala (1 institutions, 1 speakers)**\n  - Department of Radiation Oncology, All India Institute of Medical Sciences, India. (1 speakers): Anjali V. Ramdulari\n\n**Latvia (1 institutions, 1 speakers)**\n  -  (1 speakers): Lasma Nikolaisone\n\n**Lebanon (2 institutions, 2 speakers)**\n  - American University of Beirut, Hariri School of Nursing, Beirut, Lebanon. (1 speakers): Myrna Doumit\n  - Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. (1 speakers): Hazem I. Assi\n\n**Libya (1 institutions, 1 speakers)**\n  - University of Tripoli, Tripoli, Libya. (1 speakers): Ekram H. Hasanin\n\n**Lithuania (1 institutions, 1 speakers)**\n  -  (1 speakers): Edita Balasova\n\n**London (1 institutions, 1 speakers)**\n  - Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK. (1 speakers): Sergio Quezada\n\n**Luxembourg (1 institutions, 1 speakers)**\n  -  (1 speakers): Ingrid Krucken\n\n**MA (8 institutions, 8 speakers)**\n  -  (1 speakers): Guillermo Antonio De Velasco Oria\n  - Boston, Massachusetts (1 speakers): Rachel Salazar\n  - Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA. (1 speakers): Lori J. Wirth\n  - Dana-Farber Cancer Institute/Brigham and Women's Hospital Harvard Medical School, Boston, MA. (1 speakers): Joaquim Bellmunt\n  - Dana-Farber/Harvard Cancer Center, Boston, MA, USA. (1 speakers): Sara M. Tolaney\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (1 speakers): Pasi A. Janne\n  - Massachusetts General Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA, USA. (1 speakers): Dejan Juric\n  - South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia. (1 speakers): Christopher Sweeney\n\n**MASSACHUSSETS (1 institutions, 1 speakers)**\n  - Medical Oncology, INCLIVA, Valencia, Spain. (1 speakers): Tania C. Fleitas\n\n**MD (3 institutions, 3 speakers)**\n  - Cork University Hospital, Wilton, T12 DC4A Cork, Ireland. (1 speakers): Roisin M. Connolly\n  - Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, US. (1 speakers): Suzanne L. Topalian\n  - Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, USA. (1 speakers): Julie R. Brahmer\n\n**MI (1 institutions, 1 speakers)**\n  - Yale University Cancer Center, Connecticut. (1 speakers): Patricia M. Lorusso\n\n**MN (3 institutions, 3 speakers)**\n  - Department of Medicine, Gastrointestinal Research Unit, Mayo Clinic Alix School of Medicine, Rochester, MN (1 speakers): Frank A. Sinicrope\n  - Department of Oncology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. (1 speakers): Evanthia Galanis\n  - Department of Oncology, Mayo Clinic, Rochester, MN, USA. (1 speakers): Aaron S. Mansfield\n\n**MO (1 institutions, 1 speakers)**\n  - Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Tina Cascone\n\n**Madrid (1 institutions, 1 speakers)**\n  - Valencia, Spain. (1 speakers): Sonia Macia\n\n**Martinique (1 institutions, 1 speakers)**\n  - Inserm, IRD, SESSTIM, ISSPAM, Marseille, France, University Hospital of Martinique, Research & Development in Oncology, Oncology Hematology Urology department, Fort-de-France (1 speakers): Remi Houpert\n\n**Mexico (10 institutions, 11 speakers)**\n  -  (2 speakers): Josette R. Staufert Gutierrez, Luisa Rivero Zambrano\n  - Hospital School of Veterinary Medicine, University of Buenos Aires, Argentina. (1 speakers): Victor A. Castillo\n  - Instituto Nacional de Cancerología (INCan), Mexico. (1 speakers): Norma Y. Hernandez-Pedro\n  - Instituto Nacional de Cancerología, Mexico City 14080, Mexico. (1 speakers): Oscar Gerardo Arrieta Rodriguez\n  - Instituto Nacional de Cancerología, Mexico. (1 speakers): Enrique Caballe Perez\n  - National Institute of Cancer (Instituto Nacional de Cancerología, INCan), Mexico. (1 speakers): Rosa Maria Alvarez-Gomez\n  - Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City, 14080, Mexico. (1 speakers): Jose M. Lucio-Lozada\n  - Santiago de Querétaro, Mexico. (1 speakers): Carla D. Robles-Espinoza\n  - State University of Londrina, 86051-990, Brazil. (1 speakers): Brenda L. Alvarez Diaz\n  - University Center Against Cancer, University Hospital \"José E. González\", Monterrey, Mexico. (1 speakers): Adelina Alcorta-Garza\n\n**Middlesex (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, Middlesex, HA6 2RN, UK. (1 speakers): Paul Nathan\n\n**Morocco (6 institutions, 8 speakers)**\n  -  (3 speakers): IHSANE SKITIOUI, Rania Chakir, Salma Ichou\n  - Department of Medical Oncology, Hassan II University Hospital, Fez 30000, Morocco. (1 speakers): Karima Oualla\n  - Medical Oncology, Mohammed VI University Hospital, Oujda, Morocco. (1 speakers): Ouissam Al Jarroudi\n  - Médical Oncology, Régional Hospital Center, Tangier, Morocco. (1 speakers): Saoussane Kharmoum\n  - National Institute of Oncology, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco. (1 speakers): Hassan Errihani\n  - National Institute of Oncology, Morocco. (1 speakers): Amine Lachgar\n\n**Mozambique (1 institutions, 1 speakers)**\n  - Department of Medicine, Universidade Eduardo Mondlane, Maputo, Mozambique. (1 speakers): Assaina T. Tomo\n\n**N. Faliro (1 institutions, 1 speakers)**\n  - Fourth Oncology Department & Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece. (1 speakers): Helena Linardou\n\n**NC (1 institutions, 1 speakers)**\n  - The Department of Medicine, Duke Cancer Institute, Durham, NC 27710, USA. (1 speakers): Jeffrey Crawford\n\n**NSW (3 institutions, 3 speakers)**\n  - Cancer Care Centre, St George Hospital, Kogarah, NSW, Australia. (1 speakers): Katrin Sjoquist\n  - Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, NSW, Australia, St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia (1 speakers): Megan Crumbaker\n  - Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia. (1 speakers): David Goldstein\n\n**NY (10 institutions, 15 speakers)**\n  - Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY, USA. (1 speakers): Richard J. Gralla\n  - Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. (1 speakers): Shigehisa Kitano\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, USA. (4 speakers): Dana E. Rathkopf, Helena A. Yu, Jonathan E. Rosenberg, Neil M. Iyengar\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY. (3 speakers): Andrea Cercek, Ghassan K. Abou-Alfa, Yelena Y. Janjigian\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, USA. (1 speakers): William D. Tap\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, NY, USA. (1 speakers): Shanu Modi\n  - Department of Medicine, Weill Cornell Medical College, NY, Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY (1 speakers): Carol Aghajanian\n  - Departments of Pathology, Upstate Medical University, Syracuse, NY USA. (1 speakers): Jeffrey S. Ross\n  - H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. (1 speakers): Nikhil I. Khushalani\n  - Memorial Sloan Kettering Cancer Center, Department of Medicine, NY. (1 speakers): Tiffany A. Traina\n\n**Nepal (2 institutions, 2 speakers)**\n  - B.P. Koirala Institute of Health Sciences, Dharan, Nepal. (1 speakers): Nitesh K. Karna\n  - Tribhuvan University Teaching Hospital Kathmandu Nepal. (1 speakers): Naveen Gautam\n\n**Netherlands (109 institutions, 124 speakers)**\n  -  (9 speakers): Cato D. Boreel, Deborah Ophoff, Jet Wies Ankersmid-Matos Miguel, Karlijn D. Joode, Laura Lammens, Niels Klaassen, Sissi Chen, Stef Elings, Tissing Wim\n  - Amsterdam (1 speakers): Ralf Herold\n  - Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands. (1 speakers): Judith S. Quik\n  - Amsterdam UMC, Department of Medical Oncology, Amsterdam. (1 speakers): Sebastiaan Siegerink\n  - Amsterdam University Medical Center, Naples, Italy (P.A.A.). (1 speakers): Judith Lijnsvelt\n  - Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, the Netherlands. (1 speakers): Suresh Senan\n  - Amsterdam, the Netherlands. (1 speakers): Francesco Pignatti\n  - Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands. (1 speakers): Anna Visser\n  - Cardiovascular Research Center, Massachusetts General Hospital, CPZN3200, Boston, MA 02114, USA, Department of Pharmaceutical Sciences, Utrecht University, Netherlands. (1 speakers): Sheraz Ditta\n  - Catharina Hospital, 5623 EJ Eindhoven, The Netherlands. (1 speakers): Sofia L. Peeters\n  - Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden (1 speakers): Amy Rieborn\n  - Department of Clinical Pharmacy and Toxicology, CARIM, Research Institute for Cardiovascular Diseases, Maastricht University Medical Center+, Maastricht (1 speakers): Paul D. Kruithof\n  - Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands. (1 speakers): Marlies Wakkee\n  - Department of Epidemiology and Health Economics, Julius Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. (1 speakers): Denice Kamp\n  - Department of Epidemiology, GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands. (1 speakers): Nadira R. Querido\n  - Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam (1 speakers): Yara L. Verschoor\n  - Department of General, University Hospital Heidelberg, Heidelberg, Germany. (1 speakers): Nerma Crnovrsanin\n  - Department of Health Policy, Zeist, Netherlands. (1 speakers): Atse Huisman\n  - Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands. (1 speakers): Michiel Zietse\n  - Department of Hospital Pharmacy, Rotterdam, The Netherlands. (1 speakers): Tom J. Uyl\n  - Department of Internal Medicine, University Medical Center Groningen, Groningen (1 speakers): Carolien Schroder\n  - Department of Internal Medicine, University Medical Centre Utrecht, Utrecht (1 speakers): Hilde Nienhuis\n  - Department of Medical Informatics, Erasmus MC, Rotterdam (1 speakers): Anton Barchuk\n  - Department of Medical Oncology, Amsterdam UMC, Free University, Amsterdam, the Netherlands, Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands. (1 speakers): Sarah Derks\n  - Department of Medical Oncology, Elisabeth-TweeSteden Hospital, Dr. Deelenlaan 5, Tilburg, the Netherlands. (1 speakers): Laurens V. Beerepoot\n  - Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands. (1 speakers): Barend J. Sikkema\n  - Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands, Department of Clinical Chemistry, Erasmus University Medical Centre (1 speakers): Niels Heersche\n  - Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands. (1 speakers): Noor Wortelboer\n  - Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Netherlands. (1 speakers): Ingrid A. Boere\n  - Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands, Dutch Breast Cancer Research Group (BOOG), the Netherlands. (1 speakers): Judith R. Kroep\n  - Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands. (2 speakers): Ellen Kapiteijn, Hans Gelderblom\n  - Department of Medical Oncology, Netherlands Cancer Institute (NKI), Amsterdam (2 speakers): John B. Haanen, Sebastian Klobuch\n  - Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam (2 speakers): Femke Burgers, Marleen Kok\n  - Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Amsterdam, CX (1 speakers): Olga Husson\n  - Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. (1 speakers): Niven Mehra\n  - Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands. (2 speakers): Mathilde Jalving, Sjoukje F. Oosting\n  - Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. (1 speakers): Anna Reyners\n  - Department of Medical Oncology, University Medical Center Utrecht, Utrecht (1 speakers): Danielle Zweers\n  - Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht (1 speakers): Renee A. Lunenberg\n  - Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht 80125, the Netherlands. (1 speakers): Jeanine Roodhart\n  - Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam (1 speakers): Jasmine Moustaquim\n  - Department of Medical Psychology, Radboud Institute for Health Sciences, Radboud University Medical Center, P.O. Box 9101, Radboudumc, Nijmegen 6500 HB, the Netherlands. (1 speakers): Jose Custers\n  - Department of Medicine, University Medical Center Utrecht, Netherlands. (1 speakers): Marie-Christine E. Bakker\n  - Department of Molecular Biology, Faculty of Science, Oncode Institute, Radboud University Nijmegen, Nijmegen, Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam (1 speakers): Michiel Vermeulen\n  - Department of Neurosurgery Haaglanden Medical Center The Hague, the Netherlands. (1 speakers): Marike Broekman\n  - Department of Nursing Studies, University of Applied Sciences Utrecht, Utrecht (1 speakers): Sandrien Weda\n  - Department of Pathology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Amsterdam, the Netherlands, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. (1 speakers): Petur Snaebjornsson\n  - Department of Pathology, Erasmus Medical Center, Rotterdam, the Netherlands. (1 speakers): Jan Von der Thusen\n  - Department of Psychosocial Oncology and Epidemiology, Netherlands Cancer Institute, Amsterdam (1 speakers): Mees Egeler\n  - Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam (1 speakers): Harry De Koning\n  - Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, Netherlands. (1 speakers): Anne-Marie C. Dingemans\n  - Department of Pulmonary Diseases, GROW-School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands. (1 speakers): Lizza Hendriks\n  - Department of Pulmonary Medicine, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands. (1 speakers): Ilias Houda\n  - Department of Radiology, Leiden University Medical Center, Leiden, Biomedical Photonic Imaging Group, University of Twente, Enschede (1 speakers): Fleur Kleiburg\n  - Department of Radiology, The Netherlands Cancer Institute, Amsterdam (1 speakers): Sajjad Rostami\n  - Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, the Netherlands. (1 speakers): Ritse Mann\n  - Department of Radiotherapy, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. (1 speakers): Francine E. Voncken\n  - Department of Research and Development, IKNL, Utrecht, the Netherlands. (1 speakers): Femke J. Jacobs\n  - Department of Surgery, Amsterdam UMC, Location University of Amsterdam, Amsterdam (1 speakers): Annuska Schoorlemmer\n  - Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands. (1 speakers): Bas Groot Koerkamp\n  - Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands. (1 speakers): Marie-France Jilderda\n  - Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, Department of Pulmonary Diseases, Leiden University Medical Centre, Leiden (1 speakers): Egbert F. Smit\n  - Department of Urology Radboud University Medical Center Nijmegen the Netherlands. (1 speakers): Dianne Bosch\n  - Department of Urology, Erasmus Medical Center, Rotterdam (1 speakers): Lionne Venderbos\n  - Department of Urology, University Medical Center Groningen, Groningen (1 speakers): Igle Jan de Jong\n  - Dept. of Research, The Netherlands Comprehensive Cancer Organisation, Utrecht, IQ Health Department, Radboud University Medical Center, Nijmegen (1 speakers): Anke Richters\n  - Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands. (2 speakers): Nan Ding, Renee Visserman\n  - Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Oncode Institute, Plesmanlaan 121, the Netherlands. (1 speakers): Lotte Hoeijmakers\n  - Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam (1 speakers): Jos Jonkers\n  - Division of Pharmacology, Netherlands Cancer Institute, Amsterdam, Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam (1 speakers): Pauline Buitelaar\n  - Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. (1 speakers): Adrianne L. Rolfes\n  - Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands. (1 speakers): Songul Kucukcelebi\n  - Erasmus University Medical Center, Rotterdam 3015GD, Netherlands. (1 speakers): Astrid A. Van der Veldt\n  - Erasmus University Medical Center, Rotterdam, The Netherlands. (1 speakers): Winette T. Van Der Graaf\n  - Erasmus University Medical Center, Rotterdam, the Netherlands. (1 speakers): Daan Lanser\n  - Erasmus University, Rotterdam, the Netherlands. (1 speakers): Hannah M. Van Schoubroeck\n  - European Research Institute for the Biology of Ageing, University of Groningen, Groningen (1 speakers): Ruifang Tian\n  - Hartwig Medical Foundation, Amsterdam, the Netherlands. (1 speakers): Paul Roepman\n  - Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. (1 speakers): Pedro B. Tan\n  - Isala Hospital, Zwolle (1 speakers): Elise Smolders\n  - Isala Hospital, Zwolle, the Netherlands. (1 speakers): Elianne De Boer\n  - Leiden University Medical Center, Amsterdam, the Netherlands. s.f.haj_mohammad@lumc.nl. (1 speakers): Soemeya F. Haj Mohammad\n  - Leiden University Medical Center, Department of Medical Oncology, Leiden (1 speakers): Merve Kaya\n  - Leiden University Medical Center, Leiden, The Netherlands. (1 speakers): Judith V. Bovee\n  - Leiden University Medical Center, Leiden, the Netherlands. (2 speakers): Ellen De Nijs, Sahar B. Van Waalwijk van Doorn-Khosrovani\n  - Leiden University, Leiden, Netherlands. (1 speakers): Gerard Van Oortmerssen\n  - Location University of Amsterdam, Amsterdam, the Netherlands. (1 speakers): Peter De Gooyer\n  - Medical oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands. (1 speakers): Bianca Mostert\n  - Netherland Cancer Institute, Amsterdam (1 speakers): Winan Van Houdt\n  - Netherlands Cancer Institute, Amsterdam, the Netherlands. (1 speakers): Berit M. Van Linder\n  - Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: ms.vd.heijden@nki.nl. (1 speakers): Michiel S. Van der Heijden\n  - Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands. (2 speakers): Minke W. Lucas, Willemijn S. Tak\n  - Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. (1 speakers): Merel Van Klinken\n  - Onze Lieve Vrouwe Hospital, Amsterdam, the Netherlands. (1 speakers): Aernout Ogilvie\n  - Radboud University Medical Center, Nijmegen, The Netherlands. (1 speakers): Kim J. Van der Velden\n  - The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. (1 speakers): Diana I. Rodriguez Sanchez\n  - The Netherlands Cancer Institute, Amsterdam, the Netherlands. (1 speakers): Daniela S. Thommen\n  - The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. (1 speakers): Gerrina Ruiter\n  - The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China. (1 speakers): En Hu\n  - Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. (1 speakers): Yan Sun\n  - University Medical Center Groningen, Groningen, Netherlands. (1 speakers): Floris Foijer\n  - University Medical Center Groningen, Groningen, The Netherlands. (1 speakers): E.G. Elisabeth De Vries\n  - University Medical Center Rotterdam, 3000 CA Rotterdam, the Netherlands. (1 speakers): Andrea Van Puffelen\n  - University Medical Center Rotterdam, Rotterdam, the Netherlands. (1 speakers): Tanja C. Van Dijk\n  - University Medical Center Utrecht & Princess Maxima Center, Utrecht, Netherlands, Comprehensive Cancer Center Munchen of the Technical University Munich & Ludwig Maximilians University, Munich (1 speakers): Alexander M. Eggermont\n  - University Medical Center, Rotterdam, The Netherlands. (1 speakers): Micha J. De Neijs\n  - University of Groningen, Groningen, The Netherlands. (1 speakers): Anthonie Jan Van Der Wekken\n  - University of Oulu, Oulu, Finland. (1 speakers): Renske Visser\n  - Wageningen University & Research, Wageningen, The Netherlands. (1 speakers): Nienke R. Zwart\n\n**Noord Brabant (1 institutions, 1 speakers)**\n  - Department of Pulmonary Medicine, Erasmus Medical Centre, Rotterdam, the Netherlands, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam (1 speakers): Joachim G. Aerts\n\n**Norway (19 institutions, 26 speakers)**\n  -  (5 speakers): Live Fagereng, Magdalena S. Robertsen, Mari F. Ystgaard, Martin Stoyten, Synne-Kristin H. Bohn\n  - Cancer Clinic, Haukeland University Hospital, Bergen, Norway. (2 speakers): Halfdan Sorbye, Siren Morken\n  - Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø (1 speakers): Endre Gabrielsen\n  - Department of Oncology, Akershus University Hospital, L⊘renskog, Norway, Medical Faculty, University of Oslo, Oslo, Norway. (1 speakers): Jan Oldenburg\n  - Department of Oncology, Lovisenberg Diaconal Hospital, Oslo, Norway. (1 speakers): Katarina Puco\n  - Department of Oncology, Oslo University Hospital, Oslo, Norway. (1 speakers): Henrik Horndalsveen\n  - Department of Oncology, Oslo University Hospital, Oslo, Norway. pbk@ous-hf.no. (1 speakers): Kjetil Boye\n  - Department of Pathology, Stavanger University Hospital, Stavanger, Norway. (1 speakers): Emiel A. Janssen\n  - Department of Surgical Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. (1 speakers): Kristina Lindemann\n  - Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway. (1 speakers): Wanja Kildal\n  - Institute for Cancer Research, Oslo University Hospital, Oslo, Norway, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. (1 speakers): Ingrid Dyvik\n  - Institute of Basic Medical Sciences, Section of Physiology, University of Oslo, Oslo, Norway. (1 speakers): Anna Christina Garvert\n  - Institute of Clinical Medicine, UIT-The Arctic University, Tromsø, Norway. (1 speakers): Hege Sagstuen Haugnes\n  - KG Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. (1 speakers): Kjetil Tasken\n  - Oslo University Hospital, Oslo, Norway. (3 speakers): Hanne Marte G. Nymoen, Saima J. Farooqi, Sigmund Brabrand\n  - Oslo University Hospital, Oslo, Norway. solthu@ous-hf.no. (1 speakers): Solfrid M. Thunold\n  - The Norwegian Radium Hospital, Oslo, Norway. (1 speakers): Lise H. Willumsen\n  - University of Oslo, Oslo, Norway. (1 speakers): Mari E. Rasmussen\n  - Western Norway University of Applied Sciences, Bergen, Norway. (1 speakers): Elisabeth G. Beisland\n\n**Nuevo Leon (1 institutions, 1 speakers)**\n  - Brigham and Women's Hospital, Memorial Sloan Kettering Cancer Center, New York (R.J.M.). (1 speakers): Victor M. Oyervides Juarez\n\n**OH (1 institutions, 1 speakers)**\n  - Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. (1 speakers): Brian I. Rini\n\n**Oman (1 institutions, 1 speakers)**\n  - Armed Forces Hospital, Muscat, Oman. (1 speakers): Khalid Nasser M. Al Hashmi\n\n**Ontario (5 institutions, 5 speakers)**\n  - Department of Medicine, University of Ottawa, and the Ottawa Hospital Research Institute, Ottawa, ON K1H8L6, Canada. (1 speakers): Glenwood Goss\n  - Department of Medicine, University of Queensland, Brisbane, QLD 4072, Australia. (1 speakers): Aaron R. Hansen\n  - Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. (1 speakers): Lillian L. Siu\n  - Medical Oncology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. (1 speakers): Mark D. Vincent\n  - Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Department of Immunology, University of Toronto, Toronto, ON, Canada. (1 speakers): Marcus O. Butler\n\n**Oxfordshire (2 institutions, 2 speakers)**\n  - Churchill Hospital and University of Oxford, Oxford (1 speakers): Mark R. Middleton\n  - Department of Oncology, Queen Elizabeth Hospital, Birmingham B15 2GW, UK. (1 speakers): Shivan Sivakumar\n\n**PA (2 institutions, 2 speakers)**\n  - Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA (1 speakers): Adam M. Brufsky\n  - Penn Medicine Abramson Cancer Center, Philadelphia, PA, USA. (1 speakers): Angela DeMichele\n\n**PO (2 institutions, 2 speakers)**\n  - Department of Medical Oncology, Prato, Italy. (1 speakers): Samantha Di Donato\n  - Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Florence, Italy. (1 speakers): Emanuela Risi\n\n**PT (1 institutions, 1 speakers)**\n  - Faculty of Nutrition and Food Sciences of the University of Porto, Porto, Portugal. Electronic address: tamaral@fcna.up.pt. (1 speakers): Teresa M. Amaral\n\n**Pakistan (11 institutions, 13 speakers)**\n  - Aga Khan University Hospital, Karachi, Pakistan. (1 speakers): Asfia A. Khursheed\n  - Department of Medical Oncology, Aga Khan University Hospital, Karachi, Pakistan. (1 speakers): Saad Nasir\n  - Department of Medicine, Ziauddin Medical College, Karachi, Pakistan. (2 speakers): Anoud Khan, Aryan Tareen\n  - Medicine, Nishtar Medical University, Multan, PAK. (1 speakers): Furqan Hassan\n  - Rawalpindi Medical University, Pakistan. (1 speakers): Anam Rafique\n  - Rawalpindi Medical University, Rawalpindi, Pakistan. (2 speakers): Hina Javed, Shahzaib M. Maqbool\n  - Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, Department of Pharmacy, Kohat University of Science and Technology, Kohat 26000, Pakistan. (1 speakers): Saeed Ahmad Khan\n  - School of Public Health, Dow University of Health Sciences, Department of Medicine, Aga Khan University, Karachi, Pakistan. (1 speakers): Akbar Shoukat\n  - Surgery, Rawalpindi Medical University, Rawalpindi, PAK. (1 speakers): Hafsa Arshad Azam Raja\n  - The Aga University Hospital, Karachi, Pakistan. (1 speakers): Laraib Khan\n  - University of Texas Southwestern Medical Center/Parkland Memorial Hospital, Dallas, TX. (1 speakers): Syed M. Kazmi\n\n**Peru (3 institutions, 3 speakers)**\n  -  (1 speakers): Wagner E. Cruz Diaz\n  - Hospital San Vicente de Paul, San José, Costa Rica. (1 speakers): Daniel Delgado Quezada\n  - Trujillo, Peru. (1 speakers): Shamir Barros-Sevillano\n\n**Philippines (2 institutions, 2 speakers)**\n  -  (1 speakers): BERNARD JOHANNES A. JIMENO\n  - National Cancer Institute, MD, United States. (1 speakers): Mary Antonette G. Ong\n\n**Pokfulam (2 institutions, 2 speakers)**\n  - Department of Medical Oncology, The University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China. (1 speakers): Janice Wing-Hang Tsang\n  - School of Nursing, The Hong Kong Polytechnic University, China, College of Arts, Humanities and Education, University of Derby, Derby (1 speakers): Alex Molasiotis\n\n**Poland (17 institutions, 19 speakers)**\n  -  (2 speakers): Agata I. Polinska, Claudia S. Sienko\n  - Breast Cancer Center, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland. (1 speakers): Marcin Kubeczko\n  - Clinical Department of Oncology, Oncology Centre - Prof. Franciszek Łukaszczyk Memorial Hospital, Bydgoszcz, Poland. (1 speakers): Jedrzej Borowczak\n  - Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. (1 speakers): Katarzyna Pogoda\n  - Department of Clinical Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland. (1 speakers): Rafal Dziadziuszko\n  - Department of General and Transplantation Surgery, Medical University of Warsaw, Warsaw, Poland. (1 speakers): Paulina Kalman\n  - Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. (1 speakers): Sylwia Tabor\n  - Department of Nursing, Faculty of Health, University of Applied Sciences in Tarnów, Poland. (1 speakers): Malgorzata Pasek\n  - Department of Oncology, Wrocław Medical University, Poland, Lower Silesian Comprehensive Cancer Center, Poland. (1 speakers): Malgorzata Pieniazek\n  - Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland, Maria Sklodowska-Curie National Research Institute of Oncology (1 speakers): Pawel Teterycz\n  - Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. (2 speakers): Anna M. Czarnecka, Katarzyna Kozak\n  - Department of Soft Tissue/Bone Sarcoma and Melanoma, The Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Warsaw, Poland. (1 speakers): Piotr Rutkowski\n  - Department of Transplantology, Immunology, Medical University of Warsaw, Poland. (1 speakers): Rafał Staros\n  - Laboratory of Hematology and Flow Cytometry, Department of Internal Medicine and Hematology, Military Institute of Medicine-National Research Institute, Szaserów 128 Street, Poland. (1 speakers): Alicja Dudzik\n  - Lung Cancer and Chest Tumours Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. (1 speakers): Magdalena Knetki-Wroblewska\n  - Maria Sklodowska-Curie National Research Institute of Oncology Warsaw Poland, Warsaw, Poland. (1 speakers): Katarzyna E. Kisielewska\n  - Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. (1 speakers): Iwona Lugowska\n\n**Pordenone (1 institutions, 1 speakers)**\n  - National Cancer Institute, Aviano, Italy. (1 speakers): Maurizio Polano\n\n**Portugal (30 institutions, 30 speakers)**\n  -  (1 speakers): Gil R. Magalhaes\n  - Berlin, Germany. (1 speakers): Anabela Isidro\n  - Cancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal. (1 speakers): Arnaud D. Da Cruz Paula\n  - Center for Drug Discovery and Innovative Medicines (MedInUP) and RISE-Health: Health Research Network, Portugal. (1 speakers): Diogo Silva\n  - Centre of Marine Sciences, Campus de Gambelas, Faro, Portugal. (1 speakers): Sandra C. Silva\n  - Centro Hospitalar Do Algarve, Faro, Portugal. (1 speakers): Cristiana Honrado Martins\n  - Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal. (1 speakers): Joana C. Marinho\n  - Centro Hospitalar de Entre Douro e Vouga, Santa Maria da Feira, PRT. (1 speakers): Ana R. Aranha\n  - Centro Hospitalar e Universitário São João, Porto, Portugal. (1 speakers): Marisa C. Couto\n  - Champalimaud Clinical Center/Champalimaud Foundation and ABC Global Alliance, Lisbon, Portugal. (1 speakers): Fatima Cardoso\n  - Champalimaud Foundation and Lisbon University Faculty of Medicine, Champalimaud Foundation and Lisbon University Faculty of Medicine, Portugal. (1 speakers): Maria-Joao D. Cardoso\n  - Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal. (1 speakers): Rita Fior\n  - Coimbra Hospital and University Centre (CHUC), Coimbra, Portugal. (1 speakers): Leonor I. Silva Pinto\n  - Department of Genetics, Laboratory of Human Cytogenetics, Federal University of Pará, Guamá, Belém, Pará 66075-970, Brazil. (1 speakers): Bruno M. Soares\n  - Faculty of Medicine University of Coimbra Cuf Hospitais Coimbra Portugal. (1 speakers): Ricardo Leao\n  - Faculty of Medicine, Porto University, Portugal. (1 speakers): Jorge Lima\n  - Hospital Divino Espírito Santo, Ponta Delgada, Portugal. (1 speakers): Tiago A. Pina Cabral\n  - Hospital São Francisco Xavier, Lisbon, PRT. (1 speakers): Vanessa Duarte Branco\n  - Hospital de Braga, Braga, Portugal. (1 speakers): Marta Sofia C. Viana Pereira\n  - Medical Oncology Department, Pedro Hispano Hospital, Portugal. (1 speakers): Catarina Lopes Fernandes\n  - Medical Oncology Department, Porto, Portugal. (1 speakers): Maria Joao Oura\n  - Polytechnic Institute of Beja, 7800-000 Beja, Portugal. (1 speakers): Helga T. Martins\n  - Portuguese Oncology Institute, Lisbon, Portugal. (1 speakers): Bernardo A. Pereira\n  - Pulmonology Department. Hospital Beatriz Ângelo. Unidade Local de Saúde Loures-Odivelas. Lisboa. Portugal. (1 speakers): Sofia Silva\n  - Research Institute for Medicines (iMed.ULisboa), 1649-003 Lisbon, Portugal. Electronic address: aimatos@ff.ulisboa.pt. (1 speakers): Ana C. Pardal de Matos\n  - School of Medicine, Braga, PRT. (1 speakers): Maria M. Pereira\n  - University of Lisbon - Católica Medical School, Lisbon, Portugal. Electronic address: pravasco@ucp.pt. (1 speakers): Paula C. Ravasco\n  - University of Porto, Porto, Portugal. (1 speakers): Luisa Soares Miranda\n  - University of Porto, University of Porto, Portugal. (1 speakers): Catia S. Teixeira\n  - Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK. (1 speakers): Ana Rita Dias\n\n**QLD (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Royal North Shore Hospital, Australia, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia. (1 speakers): Rahul Ladwa\n\n**Qatar (3 institutions, 3 speakers)**\n  -  (1 speakers): Zaineh Alnoubani\n  - Division of Internal Medicine, Department of Medicine, Hamad Medical Corporation, Doha 3050, Qatar. (1 speakers): Muhammed Hajmusa\n  - Hamad General Hospital, Doha, Qatar. (1 speakers): Salha B. Al-Bader\n\n**Republic of Korea (58 institutions, 61 speakers)**\n  -  (2 speakers): Minseung Suh, Yooonyoung Lee\n  - Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Korea. (1 speakers): Do-Youn Oh\n  - College of Medicine, Cancer Research Institute, The Catholic University of Korea, Seoul, Republic of Korea. (1 speakers): SORA JEON\n  - Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea. (1 speakers): Ho-Shin Gwak\n  - Department of Functional Genomics, Korea Research Institute of Bioscience and Biotechnology (KRIBB) School of Bioscience, University of Science and Technology, Daejeon 34113, Korea. (1 speakers): Byul Moon\n  - Department of Hematology and Oncology Ulsan University Hospital College of Medicine University of Ulsan Ulsan Republic of Korea. (1 speakers): Sujin Koh\n  - Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea. (1 speakers): Hye Ryeon Kim\n  - Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. (1 speakers): Keun-Wook Lee\n  - Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Republic of Korea. (1 speakers): Jee Hung Kim\n  - Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea. (1 speakers): Jeesun Yoon\n  - Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. (1 speakers): Bhumsuk Keam\n  - Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. (1 speakers): Ho Jung An\n  - Department of Life Science, College of Science, Ewha Womans University, Seoul, Republic of Korea. (1 speakers): Sanghyuk Lee\n  - Department of Medical Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. (2 speakers): Sook Ryun Park, Sung-Bae Kim\n  - Department of Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam (1 speakers): Hong Jae Chon\n  - Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Republic of Korea. (1 speakers): Eun-Jung Yang\n  - Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Republic of Korea. (1 speakers): Jung-Yun Lee\n  - Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: svass@yuhs.ac. (1 speakers): Yong Jae Lee\n  - Department of Oceanography, Pusan National University, Busan (1 speakers): InHee Lee\n  - Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea. (1 speakers): Jaewon Hyung\n  - Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. (1 speakers): Yeonghak Bang\n  - Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. (1 speakers): Hyehyun Jeong\n  - Department of Oral and Maxillofacial Surgery, School of Medicine, Ewha Womans University, Seoul, Republic of Korea. (1 speakers): Jin Woo Kim\n  - Department of Pathology, College of Medicine, Hanyang University, Seoul, Republic of Korea. (1 speakers): Jae  Kyung Myung\n  - Department of Pharmacology, Columbia University, USA. (1 speakers): Misun Park\n  - Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seodaemun-Gu, Seoul, Republic of Korea. carnival0126@gmail.com. (1 speakers): Sunyoung Lee\n  - Department of Science in Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea. (1 speakers): Seung Hyeon Lee\n  - Department of Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea. (1 speakers): Kwang Hyun Yoon\n  - Department of Thoracic and Cardiovascular Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea. (1 speakers): Sehhoon Park\n  - Department of Urology, Kangwon National University School of Medicine, Chuncheon, Korea. (1 speakers): Jeong-Hyun Kim\n  - Department of Urology, Kyungpook National University School of Medicine, Daegu, Korea. (1 speakers): Tae-Hwan Kim\n  - Department of Urology, Seoul National University Hospital, Jongno-Gu, Seoul, Republic of Korea. (1 speakers): Seung-hwan Jeong\n  - Division of Breast Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. (1 speakers): Jin Ah Lee\n  - Division of Cardiology, Hallym University Medical Center, Seoul (1 speakers): Min Kyung Kang\n  - Division of Hemato-Oncology, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea. (1 speakers): Sora Kang\n  - Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. (2 speakers): Jin Seok Ahn, Yeon Hee Park\n  - Division of Hematology-Oncology, Department of Medicine, Seoul, Republic of Korea. (1 speakers): Jong-Mu Sun\n  - Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea. (1 speakers): Hee Kyung Ahn\n  - Division of Medical Oncology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. (1 speakers): Seoyoung Lee\n  - Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea. (1 speakers): Soohyeon Lee\n  - Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. (1 speakers): Chang Gon Kim\n  - Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. (1 speakers): Byoung Chul Cho\n  - Division of Nuclear Medicine, Department of Radiology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea. (1 speakers): Joo Hyun O\n  - Division of Pediatric Neurosurgery, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea. (1 speakers): Seung Ah Choi\n  - Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. (1 speakers): Shihwan Chang\n  - Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. (1 speakers): Kyu Yean Kim\n  - Divisions of Hematology-Oncology, Korea University School of Medicine, Korea University Medical Center, Seoul (1 speakers): Seung T. Kim\n  - Graduate School of Inha University, Michuhol-gu, Incheon, Republic of Korea. (1 speakers): Minwoo Baek\n  - Hanyang University Medical Center, Seoul, Republic of Korea. (1 speakers): Chihwan D. Cha\n  - Hematology-Oncology Department, Samsung Medical Center (SMC), Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. (1 speakers): Myung-Ju Ahn\n  - Institute of BioInnovation Research, Inc., Magok-dong (1 speakers): Jinwon Seo\n  - Jason TG, Seoul, Korea. (1 speakers): Min-Hyeok Jeong\n  - Laboratory of Biomedical Genomics, Department of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea. (1 speakers): Sunyoung Jang\n  - Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggi-, Republic of Korea. (1 speakers): Won Suk Lee\n  - ROKIT HEALTHCARE, Seoul 08514, Republic of Korea. (1 speakers): Jeehee Kim\n  - Rare & Pediatric Cancer Branch and Immuno-oncology Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang, Republic of Korea. (1 speakers): Myong Cheol Lim\n  - Seoul National University College of Medicine, Department of Obstetrics and Gynecology, Seoul, Republic of Korea. (1 speakers): Se Ik Kim\n  - Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Republic of Korea. (1 speakers): Sun Young Rha\n\n**Romania (4 institutions, 4 speakers)**\n  - \"Carol Davila\" University of Medicine and Pharmacy, Romania. (1 speakers): Ancuta Nastac\n  - 'Iuliu Hateganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania. (1 speakers): Radu A. Vidra\n  - Advanced Center for Research and Development in Experimental Medicine (CEMEX), \"Grigore T. Popa\" University of Medicine and Pharmacy, Iași, Romania. (1 speakers): Ioana Creanga-Murariu\n  - Youth Cancer Europe, Cluj-Napoca, Romania. (1 speakers): Katie Rizvi\n\n**Russian Federation (8 institutions, 11 speakers)**\n  -  (4 speakers): Alina Kolomeytseva, Amina Yusupova, Angelina Letuchikh, Nadezhda Sultanbaeva\n  - Central Clinical Hospital of the Russian Academy of Sciences, Russia. (1 speakers): Evgenii Goncharov\n  - Institute for Personalized Oncology, Sechenov First Moscow State Medical University, Moscow 119048, Russia. (1 speakers): Alexandra Lebedeva\n  - Institute of Strength Physics and Material Science, Av. Akademicheskii, Russia. (1 speakers): Elena Glazkova\n  - N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia. (1 speakers): Alexey Rumyantsev\n  - N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation. (1 speakers): Edgar R. Israelyan\n  - Oncological Center No.1 of Moscow City Hospital Named After S.S. Yudin, Moscow, Russia. (1 speakers): Ilya Pokataev\n  - Russian Society of Clinical Oncology, Kidney Cancer Research Bureau, Moscow, Russia. (1 speakers): Ilya Tsimafeyeu\n\n**SA (2 institutions, 2 speakers)**\n  - Flinders University, SA, Australia. (1 speakers): Shawgi Sukumaran\n  - National Cancer Centre Singapore, Singapore, Singapore. (1 speakers): Johan Chan\n\n**SP (2 institutions, 2 speakers)**\n  - Center for Translational Research in Oncology, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. (1 speakers): Camila Motta Venchiarutti Moniz\n  - Yale Cancer Center, Yale School of Medicine, CT, USA. (1 speakers): Adriana Kahn\n\n**Samoa American (1 institutions, 1 speakers)**\n  - College of Life Sciences, Northwest A&F University, Yangling, Shaanxi, China. (1 speakers): Abdur Rehman\n\n**Saudi Arabia (3 institutions, 3 speakers)**\n  -  (1 speakers): Sultana M. Al Harbi\n  - Medical Oncology King Faisal Specialist Hospital & Research Centre. (1 speakers): Khadijah Al Shankati\n  - School of Physics, University College Dublin, Belfield, Dublin 4, Ireland. (1 speakers): Ahmed Alanazi\n\n**Schleswig-Holstein (1 institutions, 1 speakers)**\n  - Department of Dermatology, University Medical Center Schleswig-Holstein (UKSH), Kiel, Germany. (1 speakers): Axel Hauschild\n\n**Sec. 2 (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France. (1 speakers): Silvia Mihaela Ilie\n\n**Serbia (3 institutions, 4 speakers)**\n  - Center of Research Excellence in Nutrition and Metabolism, Institute for Medical Research-National Institute of Republic of Serbia, University of Belgrade, Serbia. (2 speakers): Aleksandra Arsic, Snjezana Petrovic\n  - Faculty of Chemistry, University of Belgrade, Serbia. (1 speakers): Aleksandar Popovic\n  - Medical Oncology Department, Institute of Oncology and Radiology of Serbia, Belgrade. (1 speakers): Ivana Bozovic Spasojevic\n\n**Singapore (18 institutions, 20 speakers)**\n  -  (2 speakers): Jonan Z. Tan, Pei Li Stephanie Saw\n  - Cancer Therapeutics Research Laboratory, National Cancer Centre Singapore, Singapore 168583, Singapore, Duke-NUS Medical School, National University of Singapore, Singapore 169857, Singapore. (1 speakers): N Gopalakrishna Iyer\n  - Department of Haematology-Oncology, National University Cancer Institute Singapore, Singapore 119074, Singapore. (1 speakers): Cheng Ean Chee\n  - Department of Haematology-Oncology, National University Cancer Institute, Level 7, Singapore 119228, Singapore. (1 speakers): Robert J. Walsh\n  - Department of Haematology-Oncology, National University Cancer Institute, Singapore. (1 speakers): David SP Tan\n  - Department of Hematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore. (1 speakers): Gloria Chan\n  - Department of Medicine, National University Hospital, Singapore, Singapore, Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Yong Loo Lin School of Medicine (1 speakers): Joseph J. Zhao\n  - Department of Radiation Oncology, National Cancer Center Singapore, Singapore, Singapore. (1 speakers): Melvin Lee Kiang Chua\n  - Department of Radiation Oncology, National University Cancer Institute, Singapore, Singapore. (1 speakers): Yu Yang Soon\n  - Division of Medical Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, Singapore, Singapore. (1 speakers): Nicole-Ann Lim\n  - Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Duke-NUS Medical School, National University of Singapore, Singapore. (1 speakers): Daniel Shao Weng Tan\n  - Duke-NUS Medical School, Singapore, Singapore. (1 speakers): David W. Tai\n  - National Cancer Center Singapore, Singapore, Singapore. (1 speakers): Rebecca A. Dent\n  - National University Hospital, Singapore, Singapore. (2 speakers): Kenneth Sooi, Ross A. Soo\n  - National University of Singapore, National University of Singapore, Singapore. (1 speakers): Ryan M. Lim\n  - Office of Academic and Clinical Development, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore. (1 speakers): Darren Wan-Teck Lim\n  - Translational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore. (1 speakers): Florent Ginhoux\n  - Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. (1 speakers): Wei Yu Chua\n\n**Slovakia (1 institutions, 1 speakers)**\n  - Faculty Hospital Trencin, Department of Oncology and Faculty of Health Sciences, Trencin University, Trencin 91171, Slovakia. (1 speakers): Filip Kohutek\n\n**Slovenia (5 institutions, 5 speakers)**\n  -  (1 speakers): Amadej Senk Juh\n  - Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia, Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. (1 speakers): Tina Pavlin\n  - Faculty of Medicine, University of Ljubljana, Slovenia. (1 speakers): Tit Albreht\n  - Ljubljana, Slovenia and Europa Donna - The European Breast Cancer Coalition, Milan, Italy. (1 speakers): Tanja Spanic\n  - Medical Oncology Department, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia. (1 speakers): Katja Mohorcic\n\n**South Africa (2 institutions, 2 speakers)**\n  - The Medical Oncology Centre of Rosebank, Clinical and Translational Research Unit (CTRU), Saxonwold, South Africa and Department of Immunology, Faculty of Health Sciences, University of Pretoria (1 speakers): Bernardo L. Rapoport\n  - The Medical Oncology Centre of Rosebank, Johannesburg (1 speakers): Teresa Smit\n\n**South Australia (1 institutions, 1 speakers)**\n  - College of Medicine and Public Health, Flinders University, Australia. (1 speakers): Sina Vatandoust\n\n**South Moravian (1 institutions, 1 speakers)**\n  - Masaryk University, Brno, Czech Republic. (1 speakers): Radka L. Obermannova\n\n**South Yorkshire (1 institutions, 1 speakers)**\n  - Weston Park Hospital, Sheffield, UK. (1 speakers): Robin Young\n\n**Spain (144 institutions, 175 speakers)**\n  -  (27 speakers): Berta Vilar Anglada, Carlos Galamba, Cristina Saura Manich, David Lluis Garulo, Diego A. Gomez Puerto, Edurne Arriola Aperribay, Elena Nunez Berrueco, Isabela Diaz de Corcuera Frutos, Jesus G. Yaringano Cerna, Jorgina Serra Lopez, Judit Sanz Beltran, Lucia Navarro Berlanga, Marc Oliva Bernal, Marco Sanduzzi Zamparelli, Maria Die-Trill, Mariam Stephanie Rojas Piedra, Marianela Bringas Beranek, Natalia Jimenez Blasco, Pablo Flores Paco, Pablo Martinez-Albaladejo, Pablo Palao Contell, Patricia Capdevila Gaudens, Pau Mascaro Baselga, Rodrigo Sanchez Bayona, Sandra Llop Serna, Wagner G. Parra Paladines, Zara Vidales Sepulveda\n  - August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. (1 speakers): Aleix Prat\n  - Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain, Medical Oncology Department, Vall d'Hebron Hospital, Barcelona (1 speakers): Mafalda Oliveira\n  - CCUN, Navarra University Clinic, Pamplona, Spain. (1 speakers): Bruno Sangro\n  - Cellular Immunotherapies for Cancer, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. (1 speakers): Sonia Guedan\n  - Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. (1 speakers): Lisardo Ugidos De La Varga\n  - Childhood Cancer and Blood Disorders Research Group, Vall d'Hebron Research Institute, Barcelona, Spain. (1 speakers): Lorena Valero-Arrese\n  - Complejo Hospitalario Universitario de Badajoz, E-06080 Badajoz, Spain. (1 speakers): Alvaro B. Garcia\n  - Departamento de Eléctrica, Electrónica y Telecomunicaciones, Sangolquí 171103, Ecuador. (1 speakers): Kevin Valencia\n  - Department of Ecology and Evolution, Estación Biológica de Doñana (CSIC), Seville, Spain. (1 speakers): Antonio Rueda Lara\n  - Department of Gastrointestinal Surgery Section 2, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China (1 speakers): Weiyao Li\n  - Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, Spain. (1 speakers): Ibone Labiano\n  - Department of Medical Oncology and Program in Solid Tumors Cima-Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Madrid, Spain. (1 speakers): Antonio Gonzalez-Martin\n  - Department of Medical Oncology, Catalan Institute of Oncology Girona, IDIBGI-CERCA, Girona, Spain. (1 speakers): Maria Pilar Barretina Ginesta\n  - Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain. (1 speakers): Laura Mezquita\n  - Department of Medical Oncology, Hospital Clinico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain. (1 speakers): Andres Cervantes\n  - Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. (1 speakers): Noemi Reguart\n  - Department of Medical Oncology, Hospital General Universitario Gregorio Marañon Instituto de Investigacion Sanitaria Gregorio Marañon, Madrid, Spain. (1 speakers): Miguel Martin\n  - Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain. (1 speakers): Jesus Pena-Lopez\n  - Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Majadahonda. IDIPHISA, Madrid, Spain. (1 speakers): Ana Ruiz-Casado\n  - Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Spain. (1 speakers): Pablo Alvarez Ballesteros\n  - Department of Medical Oncology, L'Hospitalet de Llobregat, Barcelona, Spain. (1 speakers): Noelia Vilarino\n  - Department of Medical Oncology, La Paz Hospital, Madrid, Spain. (1 speakers): Andres Redondo\n  - Department of Medical Oncology, Ramon y Cajal University Hospital, Madrid, Spain. (1 speakers): Patricia Guerrero\n  - Department of Medical Oncology, Spain. (1 speakers): Teresa Zumarraga Lizundia\n  - Department of Medical Oncology, Vall D'Hebron University Hospital, Spain, Vall d'Hebron Institute of Oncology, Spain. (1 speakers): Joan Carles Galceran\n  - Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, Spain. (2 speakers): Elena Garralda, Irene Brana\n  - Department of Medical Oncology, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain. (1 speakers): Elena Elez Fernandez\n  - Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. (1 speakers): Jaume Capdevila\n  - Department of Medical Oncology, Vall d´Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Barcelona, Spain. (1 speakers): Ilaria Priano\n  - Department of Oncology, CUN, CCUN and IdisNA, University of Navarra, Pamplona, Spain. (1 speakers): Maria Pilar Andueza\n  - Department of Oncology, Hospital Universitari Arnau de Vilanova, University of Lleida, IRB-Lleida, No. 80, Lleida, Spain. (1 speakers): Antonio Llombart Cussac\n  - Department of Oncology, Hospital of the Holy Cross and Saint Paul, Barcelona, Catalonia, Spain. (1 speakers): Alejandra Romano Cardozo\n  - Department of Oncology, University Hospital Marqués of Valdecilla, IDIVAL Santander, Cantabria, Spain. (1 speakers): Ignacio Duran\n  - Department of Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain. (1 speakers): Cristina Suarez Rodriguez\n  - Department of Surgery, Hospital Universitario San Agustín, Spain. (1 speakers): Nuria Aguado\n  - Department of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain. (1 speakers): Felix Guerrero-Ramos\n  - Departments of Immunology-Immunotherapy and Radiation Oncology, Cancer Center Clinica Universidad de Navarra, Pamplona, Navarra, Spain. (1 speakers): Maria E. RodrIguez-Ruiz\n  - ETSI Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain. Electronic address: a.gutierrez@upm.es. (1 speakers): Alvaro Lopez Gutierrez\n  - Escuela de Química, AA 678, Bucaramanga, Colombia. (1 speakers): Diego F. Rodriguez\n  - European University of Madrid, Madrid, Spain. (1 speakers): Maria Pilar Juan Gonzalez\n  - Fundación Jiménez Díaz University Hospital - Health Research Institute Fundación Jiménez Díaz (IIS-FJD) - Universidad Autónoma de Madrid (UAM), Madrid, Spain. (1 speakers): Angela Lamarca\n  - Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain. (1 speakers): Mercedes Avedillo Ruidiaz\n  - Galdakao University Hospital, Galdakao, Spain. (1 speakers): Amaia Moreno Paul\n  - Guangdong Provincial Key Laboratory of Food Quality and Safety, College of Food Science, South China Agricultural University, China. (1 speakers): Mengxin Zhou\n  - H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (imas12)/Spanish National Cancer Research Center (CNIO), Madrid, Spain. (1 speakers): Jon Zugazagoitia\n  - H12O-CNIO Lung Cancer Clinical Research Unit, Instituto de Investigación Hospital 12 de Octubre (i+12) & Centro Nacional de Investigaciones Oncológicas (CNIO), CIBERONC, UCM, Madrid, Spain. (1 speakers): Luis Paz-Ares\n  - Heriot-Watt University, Edinburgh EH14 4AS, United Kingdom. (1 speakers): Natalia S. Tissera Valencia\n  - Hospital 12 de Octubre, 28041, Spain. (1 speakers): Katerin I. Rojas Laimito\n  - Hospital 12 de Octubre, Madrid, Spain. (1 speakers): Juan Carlos Laguna Montes\n  - Hospital Clinic de Barcelona, CIBEREHD, Barcelona, Spain. (1 speakers): Joan Maurel\n  - Hospital Clinic of Barcelona, Barcelona, Spain. (1 speakers): Lydia Gaba Garcia\n  - Hospital Clinic, Barcelona, Spain. (1 speakers): Marta Garcia De Herreros\n  - Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain. (1 speakers): Maria Jose De Miguel Arroyo\n  - Hospital Clínico Universitario Miguel Servet, Zaragoza, Spain. (1 speakers): Maria Elisa Reig Monzon\n  - Hospital General Universitario Gregorio Marañón, Spanish Society of Medical Oncology (SEOM), Spain. (1 speakers): Javier Soto Alsar\n  - Hospital General Universitario, Valencia, Spain. (1 speakers): Lucas Sanz Monge\n  - Hospital HM Sanchinarro, Madrid, Spain. (1 speakers): Maria Jose De Miguel\n  - Hospital Reina Sofía, Córdoba, Spain. (1 speakers): Maria Jesus Rubio Perez\n  - Hospital Universitario 12 de Octubre, Madrid, Spain. (1 speakers): Daniel E. Castellano Gauna\n  - Hospital Universitario Puerta de Hierro, Madrid, Spain. (1 speakers): Beatriz Nunez Garcia\n  - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. (1 speakers): Jose Vicente Monton Bueno\n  - Hospital Universitario Ramon y Cajal, Madrid, Spain. (1 speakers): Miguel Garcia Pardo de Santayana\n  - Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain. (1 speakers): Diana I. Rosero Rodriguez\n  - Hospital Universitario Ramón y Cajal, Spain. (1 speakers): Pilar Garrido Lopez\n  - Hospital Universitario Río Hortega., Oncología Médica, Hospital Universitario Río Hortega. (1 speakers): Paula M. Molina Terron\n  - Hospital Universitario Santa Lucía, Murcia, España. (1 speakers): Sofia Wikstrom Fernandez\n  - Hospital Universitario de Araba - Txagorritxu, Araba, Spain. (1 speakers): Mireia Martinez Kareaga\n  - Hospital Universitario de Canarias, Spain. (1 speakers): Valle Rodriguez-Moron\n  - Hospital Universitario de Donostia, Donostia, Spain. (1 speakers): Laura Basterretxea\n  - Hospital del Mar Research Institute (IMIM), Barcelona, Spain. (1 speakers): Clara Montagut\n  - INCLIVA, CIBERONC, GEICO, Hospital Clinico Universitario de Valencia, Valencia, Spain. (1 speakers): Ignacio Romero\n  - Institute for Research in Biomedicine Barcelona, The Barcelona Institute of Science and Technology, Barcelona, Spain. (1 speakers): Nuria Lopez-Bigas\n  - Institute of Rare Diseases Research, 28029 Madrid, Spain. elopez@isciii.es. (1 speakers): Estrella Varga Lopez\n  - International Breast Cancer Center (IBCC), Barcelona, Spain. (1 speakers): Javier C. Cortes\n  - La Paz University Hospital, Madrid, Spain. (1 speakers): Susana M. Cedres Perez\n  - MD Anderson Cancer Center, Madrid, Spain. (1 speakers): Enrique Grande Pulido\n  - Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain. (1 speakers): Pablo Perez-Martinez\n  - Medical Oncology Department, Barcelona, Spain, Universitat de Barcelona, Barcelona, Spain. (1 speakers): Cristina Santos Vivas\n  - Medical Oncology Department, Hospital Clinic of Barcelona, Barcelona, Spain, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona (1 speakers): Francesco Schettini\n  - Medical Oncology Department, Hospital Clinico Universitario de Valencia-INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain. (1 speakers): Gema Bruixola\n  - Medical Oncology Department, Hospital Clínic-IDIBAPS, Barcelona, Spain. (2 speakers): Alba Moll-Febrer, Joan Padrosa\n  - Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain. (2 speakers): Andres J. Munoz Martin, Ivan Marquez-Rodas\n  - Medical Oncology Department, Hospital Universitario 12 de Octubre, IIS Imas12, Facultad de Medicina, Madrid, Spain. (1 speakers): Rocio Garcia-Carbonero\n  - Medical Oncology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain. (1 speakers): Maria Gion\n  - Medical Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain. (1 speakers): Ruth Vera Garcia\n  - Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona (1 speakers): Francisco J. Pelegrin Mateo\n  - Medical Oncology Department, Hospital del Mar, Barcelona, Spain. (1 speakers): Alejo Rodriguez-Vida\n  - Medical Oncology Department, L'Hospitalet de Llobregat, Spain. (1 speakers): Sonia Pernas Simon\n  - Medical Oncology Department, Ramón y Cajal University Hospital, Km 9.100, Madrid, CP, Spain. (1 speakers): Alfonso Cortes Salgado\n  - Medical Oncology Department, University Hospital La Paz (1 speakers): Alvaro Pinto Marin\n  - Medical Oncology Department, University Hospital of Salamanca, Salamanca, Spain. (1 speakers): Luis Posado-Dominguez\n  - Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain. (1 speakers): Pedro Rocha\n  - Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. (1 speakers): Alejandro Garcia Alvarez\n  - Medical Oncology Department. Hospital, Institute of Oncology (VHIO), Barcelona, Spain. (1 speakers): Eva Munoz-Couselo\n  - Medical Oncology Departments: Hospital Universitario Donostia-OSI Donostialdea, Gipuzkoa, Spain. (1 speakers): Laura Basterrechea Badiola\n  - Medical Oncology Service, Hospital Clínico Universitario Lozano Blesa, Zaragoza (1 speakers): Raquel Andres Conejero\n  - Medical Oncology Service, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. (1 speakers): Ana Oaknin\n  - Medical Oncology, Catalan Institute of Oncology (ICO), Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. (1 speakers): Marta Gil Martin\n  - Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Spain. (1 speakers): Juan Martin-Liberal\n  - Medical Oncology, Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain. (1 speakers): Maria Torrente\n  - Morales Meseguer University Hospital, Murcia, Spain. (1 speakers): Javier Lopez Robles\n  - National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, London, UK. (1 speakers): Patricia Toquero Diez\n  - Navarra Institute for Health Research (IDISNA), Pamplona, Spain. (1 speakers): Ignacio Melero\n  - New York University, NY, USA. (1 speakers): Manuel Pedregal Trujillo\n  - Oncology Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain. (1 speakers): Begona Perez Valderrama\n  - Oncology Department, University Hospital of Salamanca, Salamanca, Spain. (1 speakers): Eduardo Teran Brage\n  - Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain. (1 speakers): Enriqueta Felip\n  - Pathology Department, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 de Octubre (imas12), CIBERONC, Madrid, Spain. (1 speakers): Fernando Lopez-Rios\n  - Pfizer S.L.U, Alcobendas, Madrid, Spain. maria.montoro@pfizer.com. (1 speakers): Maria Isabel Sanchez Montoro\n  - Preclinical and experimental research in thoracic tumors (PRETT) group, ONCOBELL Program, L'Hospitalet de Llobregat, Spain, Department of Medical Oncology, Institut Català d'Oncologia (1 speakers): Ernest Nadal\n  - Quiron Dexeus University Hospital, Barcelona 08028, Spain, Barcelona 08028, Spain, 3 Medical Oncology Unit, Human Pathology Department, University of Messina, Messina 98122, Italy (1 speakers): Maria Gonzalez Cao\n  - Ramon y Cajal University Hospital, Madrid, Spain. (2 speakers): Ana Maria Barrill Corpa, Coral Garcia de Quevedo Suero\n  - Reina Sofia University Hospital, Cordoba, Spain. (1 speakers): Alvaro Arjona-Sanchez\n  - Research Health Institute of Fundacion Jimenez Diaz (IIS/FJD, UAM), Madrid, Spain. (1 speakers): Javier Martin-Broto\n  - Southern Illinois University Carbondale, IL, United States. Electronic address: agustinjz@siu.edu. (1 speakers): Francisco J Jimenez-Ruiz\n  - Spanish lung cancer group (Grupo Español de Cancer de Pulmón (GECP)), Barcelona, Spain, Hospital Universitario Alicante, Alicante, Spain. (1 speakers): Bartomeu Massuti Sureda\n  - The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey (1 speakers): Victor Moreno Garcia\n  - Thoracic Surgery Department, Hospital de la Santa Creu i Sant Pau and Hospital del Mar, Barcelona, Spain. (1 speakers): Juan Carlos Trujillo\n  - UOMI Cancer Center, Barcelona, Cataluña, Spain. (1 speakers): Santiago Viteri\n  - Universidad Bolivariana de Venezuela, Caracas, Venezuela. (1 speakers): Jose Carlos Benitez Montanez\n  - University Hospital A Coruña. Biomedical Research Institute (INIBIC, Galicia, Spain. (1 speakers): Beatriz Alonso de Castro\n  - University Hospital La Fe, Valencia, Spain. (1 speakers): Maribel Del Olmo\n  - University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain. (1 speakers): Marina Garcia Gomez\n  - University Hospital of Salamanca/IBSAL, Salamanca, Spain. (1 speakers): Maria-Victoria Mateos\n  - University Hospital of Torrevieja, Alicante, Spain. (1 speakers): Jose Miguel Jurado Garcia\n  - University of Alcalá de Henares, 28805 Madrid, Spain. (1 speakers): Guillermo Hernandez Torrado\n  - University of Barcelona, Barcelona, Spain. (1 speakers): Daniel Olmo Gonzalez\n  - University of León, 24071 León, Spain. (1 speakers): Elena Castro Marcos\n  - University of Valencia, Valencia, Spain. (1 speakers): Isabel Redondo Canovas del Castillo\n  - University of Valladolid, Castilla y León, Spain. (1 speakers): Irene Lopez Sanchez\n  - Vall D'Hebron University Hospital (HUVH) and Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain. (1 speakers): Francisco Javier Ros Montana\n  - Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, IOB-Quirón, Barcelona, Spain. (1 speakers): Josep Tabernero\n  - Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Spain. (1 speakers): Clara Salva de Torres\n  - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. (1 speakers): Maria Alsina Maqueda\n  - Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. (1 speakers): Rodrigo Dienstmann\n  - Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain. (1 speakers): Omar Saavedra\n  - Vall d'Hebron Institute of Oncology, Barcelona, Spain. (1 speakers): Paolo G. Nuciforo\n  - Vall d'Hebron Institute of Oncology, Spain. (1 speakers): Stefania Napoli\n  - Vall d'Hebron Research Institute (VHIR), Barcelona, Spain. (1 speakers): Alejandro Olivares Hernandez\n  - Vall d'Hebron University Hospital, 08035 Barcelona, Spain. (1 speakers): Kreina S. Vega Cano\n  - Vall d'Hebron University Hospital, Barcelona, Spain. (2 speakers): Pedro F. Simoes da Rocha, Teresa Macarulla Mercade\n  - Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. (1 speakers): Jorge Hernando Cubero\n  - Virgen of Arrixaca University Clinical Hospital, Murcia, Spain. (1 speakers): Ana Paisan Ruiz\n\n**Sudan (1 institutions, 1 speakers)**\n  - Faculty of Medicine, International University of Africa, Khartoum, Sudan. (1 speakers): Mohamed Hisham Alamin\n\n**Surrey (6 institutions, 6 speakers)**\n  - Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. (1 speakers): Timothy Anthony Yap\n  - Department of Medicine, The Royal Marsden National Health Service Foundation Trust, London and Surrey, UK. (1 speakers): Sing Yu Moorcraft\n  - Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, UK. (1 speakers): Angela George\n  - Radiology Department, The Royal Marsden Hospital Trust and Institute of Cancer Research, Sutton, London, SM2 5NG, UK. (1 speakers): Raquel Perez Lopez\n  - The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, Surrey, London (1 speakers): Nina Tunariu\n  - The Institute of Cancer Research, Sutton, Surrey SM2 5NG (1 speakers): Ros Eeles\n\n**Sweden (38 institutions, 41 speakers)**\n  -  (2 speakers): Anki Delin Eriksson, Elin Backman-Staelnacke\n  - Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden. (1 speakers): Daniel R. Smith\n  - Department of Care Science, Sophiahemmet University, Stockholm, Sweden, Regional Cancer Centre Stockholm-Gotland, Stockholm (1 speakers): Bodil Westman\n  - Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden. (3 speakers): Balazs Acs, Johan Hartman, Sanna Steen\n  - Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden. (1 speakers): Shabane Barot\n  - Department of Clinical Science, Solna, Sweden. (1 speakers): Berit H. Sunde\n  - Department of Clinical Sciences, Division of Internal Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden. (1 speakers): Fredrika Wannberg\n  - Department of Hematology and Oncology Akademiska Hospital Uppsala Sweden. (1 speakers): Ingrid Glimelius\n  - Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. (1 speakers): Camilla Skold\n  - Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. (1 speakers): Julia Winter\n  - Department of Neurobiology, Karolinska Institutet, Stockholm, Sweden. (1 speakers): Kathrin Wode\n  - Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden. (1 speakers): Theodoros Foukakis\n  - Department of Oncology, Faculty of Medicine and Health, Örebro University Hospital, Örebro University, Örebro SE-70182, Sweden. (1 speakers): Antonis Valachis\n  - Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Carina Dahlen\n  - Department of Oncology, Uppsala University Hospital, Uppsala 751 85, Sweden. (1 speakers): Henrik Lindman\n  - Department of Oncology, Uppsala University Hospital, Uppsala, Sweden. (1 speakers): Gustav Ullenhag\n  - Department of Oncology-Pathology & Karolinska Comprehensive Cancer Center, Solna, Sweden. (1 speakers): Helena Ullgren\n  - Department of Oncology-Pathology, Karolinska Institute and Breast Center, Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Alexios Matikas\n  - Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. (1 speakers): Qiao Yang\n  - Department of Upper Abdominal Diseases, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Tina Gustavell\n  - Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden. (1 speakers): Astrid Kuylenstierna\n  - Division of Biomolecular and Cellular Medicine, Karolinska Institutet, ANA Futura, Huddinge, Stockholm, Sweden. (1 speakers): Maximilian Kordes\n  - Division of Medical/Radiation Oncology and Hematology, Skåne University Hospital, Lund, Sweden. (1 speakers): Gilberto Morgan\n  - Division of Oncology and Therapeutic Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. (1 speakers): Sara Wahlin\n  - Division of Oncology, Department of Clinical Sciences Lund, and Lund University Cancer Center, Lund University, Lund, Sweden. (1 speakers): Jenny-Maria Jonsson\n  - Division of Oncology, Department of Clinical Sciences, Lund, Faculty of Medicine, Lund University, Lund, Sweden. (1 speakers): Martin Sjostrom\n  - Division of Surgery and Oncology, Department of Clinical Science, Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Magnus Nilsson\n  - Karolinska Institutet and Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Renske Altena\n  - Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Shahrzad S. Kordnejad\n  - Lund University and IHE, Lund, Sweden. (1 speakers): Thomas Hofmarcher\n  - Regional Cancer Center, Stockholm, Gotland, Sweden. (1 speakers): Lena Sharp\n  - Sahlgrenska Center for Cancer Research, University of Gothenburg, Göteborg, Sweden. (1 speakers): Jonas A. Nilsson\n  - Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden. (1 speakers): Thomas Helleday\n  - Theme Cancer, Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Hildur Helgadottir\n  - Thoracic Oncology Center, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Simon Ekman\n  - University Health Research Centre, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. (1 speakers): Sofia Axelsson\n  - University of Gothenburg, Gothenburg, Sweden. (1 speakers): Axel F. Nelson\n  - Value & Implementation Outcomes Research, MSD, Stockholm, Sweden. (1 speakers): Stina Salomonsson\n\n**Switzerland (55 institutions, 56 speakers)**\n  -  (1 speakers): Leonhard Schatz\n  - Breast Centre, Luzern, Switzerland, University of Lucerne, Department of Health Sciences and Medicine, Luzern, Switzerland. (1 speakers): Peter Dubsky\n  - Cantonal Hospital St. Gallen, St. Gallen, Switzerland. (1 speakers): Matthias B. Hellberg-Naegele\n  - Center of Research in Epidemiology and Statistics (CRESS-U1153), Université Paris Cité, INSERM, Paris, France. (1 speakers): Silvia Metelli\n  - Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. (1 speakers): Louis C. Gros\n  - Clinic of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland. (1 speakers): Anastasios Stathis\n  - Department of Computational Biology, University of Lausanne, Lausanne, Switzerland, Swiss Cancer Center Léman, Lausanne, Switzerland, Swiss Institute of Bioinformatics, Lausanne, Switzerland. (1 speakers): Giovanni Ciriello\n  - Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. (1 speakers): Joanna Mangana\n  - Department of Dermatology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland. (1 speakers): Egle Ramelyte\n  - Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland. (1 speakers): Laura A. Boos\n  - Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland. (1 speakers): Anja Lorch\n  - Department of Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland. (1 speakers): Richard Cathomas\n  - Department of Medical Oncology, Tumor Center Aarau, Aarau, Switzerland. (1 speakers): Razvan A. Popescu\n  - Department of Medical Oncology, University Hospital Basel, Basel, Switzerland. (1 speakers): Sacha I. Rothschild\n  - Department of Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. (1 speakers): Michel Obeid\n  - Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland. (1 speakers): Michael Weller\n  - Department of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland. (1 speakers): Raffaella Casolino\n  - Department of Nuclear Medicine and Endocrine Oncology, Paris, France, University Paris-Saclay, Paris, France, Department of Endocrinology and Diabetology, Geneva, Switzerland, Faculty of Medicine (1 speakers): Sophie Leboulleux\n  - Department of Nuclear Medicine, Baden, Switzerland. (1 speakers): Irene Burger\n  - Department of Oncology Institute of Oncology Research Bellinzona Switzerland. (1 speakers): Davide Rossi\n  - Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland. (1 speakers): Anna D. Wagner\n  - Department of Oncology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland, Agora Cancer Research Center, Lausanne, Switzerland, Division of Oncology, Department of Medicine (1 speakers): Denarda Dangaj Laniti\n  - Department of Oncology, Ludwig Center for Cancer Research Lausanne and University of Lausanne, Lausanne, Switzerland. (1 speakers): Christophe Cisarovsky\n  - Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland. (1 speakers): Martina Imbimbo\n  - Department of Oncology, University Hospital CHUV, Lausanne, Switzerland. (1 speakers): Solange Peters\n  - Department of Oncology, University of Lausanne and Lausanne University Hospital, 1011 Lausanne, Switzerland. (1 speakers): Petr Szturz\n  - Department of Oncology/Hematology, Cantonal Hospital Winterthur, Winterthur, Switzerland. (1 speakers): Laetitia A. Mauti\n  - Department of Prosthodontics, Faculty of Dentistry, Ankara University, Beşevler, Ankara, Turkey. (1 speakers): Berna Ozdemir\n  - Department of Radiation Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland. (1 speakers): Antonio Angrisani\n  - Department of Radiation Oncology, University Hospital Basel, Basel, Switzerland. (1 speakers): Alexandros Papachristofilou\n  - Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland. (1 speakers): Isabelle Opitz\n  - Division Clinical Assessment, Bern, Switzerland. (1 speakers): Ulrich-Peter Rohr\n  - Division of Bone Diseases Geneva University Hospitals and Faculty of Medicine Rue Gabrielle Perret-Gentil, Geneva, Switzerland. (1 speakers): Emmanuel Biver\n  - Division of Medical Oncology, University Hospital Basel, Basel, Switzerland, Laboratory of Cancer Immunotherapy, Department of Biomedicine, University of Basel and University Hospital Basel, Basel. (1 speakers): Heinz Laubli\n  - Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. (1 speakers): Nicolas Thoma\n  - Gynecological Cancer Centre, University Hospital Basel and University of Basel, Basel, Switzerland. (1 speakers): Ruth S. Eller\n  - Institute of Oncology Research, Bellinzona, Switzerland, Faculty of Biomedical Sciences, Lugano, Switzerland, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland (1 speakers): Andrea Alimonti\n  - Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland. (1 speakers): David Schwappach\n  - Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland. (1 speakers): Inti Zlobec\n  - Lausanne University Hospital, Lausanne, Switzerland. (1 speakers): Ana M. Dolcan\n  - Medicine and Technology, Faculty of Law, University of Zurich, Zurich, Switzerland. (1 speakers): Simon Hediger\n  - Medicine, Faculty of Law, University of Zurich, Zurich 8001, Switzerland, Medicine, Department of Health Sciences and Technology, ETH (Federal Institute of Technology) Zurich, Zurich (1 speakers): Kerstin N. Vokinger\n  - Neu-Isenburg, Germany (G.M.), Kincraig, the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), E.C. (1 speakers): Thomas Suter\n  - Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland, Institute of Oncology Research (IOR), Bellinzona, Switzerland, Department of Engineering for Innovation Medicine (1 speakers): Sara Merler\n  - Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland. (2 speakers): Marta Nerone, Ursula Vogl\n  - Oncology Institute of Southern Switzerland, Bellinzona (1 speakers): Ilaria Colombo\n  - Oncology and Haematology Department, Bern, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Switzerland. (1 speakers): Sabine Schmid\n  - Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. (1 speakers): Aurelius G. Omlin\n  - University Center for Hematology and Oncology, Liestal, Switzerland. (1 speakers): Elena D. Chiru\n  - University Hospital of Geneva, Geneva, Switzerland. (1 speakers): Olivier A. Michielin\n  - University of Southern Switzerland (USI), 6500 Bellinzona, Switzerland. Electronic address: sara.dedosso@eoc.ch. (1 speakers): Sara De Dosso\n  - University of Zurich, Switzerland (C.E.G.G., L.W.). (1 speakers): Camille Glaus\n  - University of Zurich, Zurich, Switzerland. (1 speakers): Miquel S. Serra-Burriel\n  - Zurich University of Applied Sciences, 8401 Winterthur, Switzerland. (1 speakers): Sara K. Kohler\n  - cUniversity Hospital Zurich, Zurich, Switzerland. (1 speakers): Reinhard Dummer\n\n**Syria (1 institutions, 1 speakers)**\n  - AlBaironi Hospital, Damascus, Syria. (1 speakers): Maher Salamoon\n\n**TN (1 institutions, 1 speakers)**\n  - Sarah Cannon Research Institute, Nashville, TN. (1 speakers): Melissa L. Johnson\n\n**TO (1 institutions, 1 speakers)**\n  - Department of Oncology, University of Torino, San Luigi Gonzaga University Hospital, Orbassano, Italy. (1 speakers): Paolo Bironzo\n\n**TX (10 institutions, 10 speakers)**\n  -  (1 speakers): Mariana Chavez MacGregor\n  - Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. (1 speakers): Kanwal Raghav\n  - Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Amado J. Zurita\n  - Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX (1 speakers): Eric Jonasch\n  - Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX (1 speakers): Aung Naing\n  - Division of Hematology and Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. (1 speakers): Cathy Eng\n  - Gradalis, Inc, Suite 110, Carrollton, Dallas, TX (1 speakers): John Nemunaitis\n  - South Texas Accelerated Research Therapeutics, TX (1 speakers): Anthony W. Tolcher\n  - The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Siqing Fu\n  - The University of Texas MD Anderson Cancer Center, Houston, TX. (1 speakers): Vicente Valero\n\n**Taiwan (26 institutions, 27 speakers)**\n  -  (2 speakers): Pei Ju P. Lien, Pie-Hsin Chen\n  - City University of Hong Kong, 518057, P. R. China. (1 speakers): Yang Yao Ren\n  - Department of Anesthesiology, National Taiwan University Cancer Center, Taipei, Taiwan. (1 speakers): Wen-Ying Lin\n  - Department of Hematology and Oncology, Chang Gung Memorial Hospital at Linkou and College of Medicine, Chang Gung University, Taoyuan, Taiwan. Electronic address: f22338@cgmh.org.tw. (1 speakers): Yu-Shin Hung\n  - Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. (1 speakers): Chien-Jui Huang\n  - Department of Mechanical Engineering, University of California, Berkeley, CA 94720, USA. (1 speakers): Joseph C. Lin\n  - Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan. (1 speakers): Chien-Huai Chuang\n  - Department of Nursing, National Taiwan University Hospital Yunlin Branch, Douliou, Taiwan. (1 speakers): Hui-Wen Po\n  - Department of Nursing, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan, Research Center in Nursing Clinical Practice, Wan Fang Hospital, Taipei Medical University, Taipei 11696 (1 speakers): Mei Fen Tang\n  - Department of Nutrition, Chung Shan Medical University Hospital, Taiwan. (1 speakers): Ying Ru Chen\n  - Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Branch and Chang Gung University, Taoyuan, Taiwan. (1 speakers): Chyong-Huey Lai\n  - Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. (1 speakers): Hui-Jen Tsai\n  - Department of Oncology, National Taiwan University Hospital and Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan. (1 speakers): Tom Wei-Wu Chen\n  - Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. (1 speakers): Jhe-Cyuan Guo\n  - Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital and China Medical University, Taichung, Taiwan. (1 speakers): Li-Yuan Bai\n  - Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan. (1 speakers): Shao-Lun Lu\n  - Graduate Institute of Oncology, College of Medicine, National Taiwan University Taipei, Taiwan. (1 speakers): Ching-Tso Chen\n  - Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan (1 speakers): Ann-Lii Cheng\n  - Institute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, Taipei, Taiwan. (1 speakers): Pei-Hsing Chen\n  - National Institute of Cancer Research, National Health Research Institute, Tainan, Taiwan, Department of Oncology, College of Medicine, Tainan, Taiwan, Department of Internal Medicine (1 speakers): Li-Tzong Chen\n  - National Institute of Cancer Research, Tainan, Taiwan. (1 speakers): Yi-hsin Yang\n  - National Taiwan University Cancer Center and National Taiwan University Hospital, Taipei, Taiwan. (1 speakers): James Chih-Hsin Yang\n  - New Drug Research and Development Center, Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm), Taipei 100, Taiwan. (1 speakers): Chia-Nan Chen\n  - School of Medicine, College of Medicine, National Yang Ming Chiao Tung University Taipei, Taiwan. (1 speakers): Chia-I Shen\n  - School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. (1 speakers): Ming-Huang Chen\n  - School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan. (1 speakers): Yeur-Hur Lai\n\n**Thailand (8 institutions, 9 speakers)**\n  -  (2 speakers): Narawitch Sompornpailin, Thayanin Phongphaew\n  - Department of Medicine, Faculty of Medicine, Thammasat University Hospital, Thailand. (1 speakers): Panuch Eiamprapaporn\n  - Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. (1 speakers): Krittiya Korphaisarn\n  - Division of Medical Oncology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand. (1 speakers): Tawasapon Thambamroong\n  - Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Dusit, Bangkok (1 speakers): Aniwat Berpan\n  - Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. (1 speakers): Phichai Chansriwong\n  - Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. (1 speakers): Narumol Trachu\n  - Siriraj Cancer Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. (1 speakers): Pariyada Tanjak\n\n**Tunisia (4 institutions, 5 speakers)**\n  -  (2 speakers): Hend Mrad, Nesrine Kooli\n  - Department of Medical Oncology, Military Hospital of Tunis, Tunis 1007, Tunisia. (1 speakers): Mehdi Balti\n  - Department of Oncology Habib Bourguiba Hospital, Sfax, Tunisia. (1 speakers): Wala Ben Kridis\n  - Medical Oncology Department SOMA, Abderrahmen Mami Hospital, Ariana, Tunisia, Tunis El Manar University, Tunis. (1 speakers): Nesrine Mejri\n\n**Turkey (65 institutions, 75 speakers)**\n  -  (7 speakers): Banu Iskender Izgi, Enes B. Bay, Ilgin Akbiyik, Nigar Rustamova, Ozgun GOKMEN KAYA, Sumeyye N. Satin, Yasemin Ciraci Yasar\n  - Ankara University Cancer Research Institute, Ankara University, Ankara 06620, Turkey. (1 speakers): Mehmet Kayaalp\n  - Ankara University Cancer Research Institute, Ankara, Turkey. (1 speakers): Emre Yekeduz\n  - Author Affiliations: Department of Internal Medicine Nursing, Faculty of Nursing, Akdeniz University (Drs Karakuş and Özer), Antalya, and Department of Internal Medicine Nursing (1 speakers): Zeynep Karakus\n  - Author Affiliations: Gediz Vocational School of Health Services, Department of Medical Services and Techniques, Kutahya Health Sciences University, and School of Nursing (1 speakers): Melike Pehlivan\n  - Başkent University Faculty of Health Science, Ankara, Turkey. (1 speakers): Akile Karaaslan Eser\n  - Başkent University School of Medicine, Department of Gynecology and Obstetrics, Ankara, Turkiye. (1 speakers): Huseyin Akıllı\n  - Clinic of Medical Oncology, Faculty of Medicine, Necmettin Erbakan University, Konya 42090, Turkey. (1 speakers): Ahmet Oruc\n  - Cukurova University, Adana 01250, Turkey. (1 speakers): Mehmet M. Kidi\n  - Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Istanbul University, Faculty of Medicine, Istanbul, Turkey. (1 speakers): Samet Topuz\n  - Department of Internal Medicine, Division of Medical Oncology, Dokuz Eylul University, Izmir (1 speakers): Eda Caliskan Yildirim\n  - Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey. (1 speakers): Baris Tuzcu\n  - Department of Internal Medicine, Hacettepe University Hospital, Ankara (1 speakers): Turkan Aliyeva\n  - Department of Internal Medicine, Mugla University Medical Faculty, Mugla, Turkey. (1 speakers): Ismail Kırlı\n  - Department of Medical Oncology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey. (1 speakers): Furkan Ceylan\n  - Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, Turkey. (1 speakers): Kadriye Bir Yucel\n  - Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey. (1 speakers): Yuksel Urun\n  - Department of Medical Oncology, Ankara, Turkey. (1 speakers): Nurlan Mammadzada\n  - Department of Medical Oncology, Bower Hospital, Diyarbakır, Turkey. (1 speakers): Yakup Ergun\n  - Department of Medical Oncology, Ege University Medical Faculty, Izmir 35100, Turkey. (2 speakers): Gokhan Sahin, Haydar C. Yuksel\n  - Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey. (1 speakers): Orhun Akdogan\n  - Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey. (1 speakers): Hasan C. Yildirim\n  - Department of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey. (1 speakers): Mehmet C. Icli\n  - Department of Medical Oncology, Hacettepe University, Ankara, Turkey. (1 speakers): Deniz Can Guven\n  - Department of Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey. (1 speakers): Abdulmunir Azizy\n  - Department of Medical Oncology, Necmettin Erbakan University Hospital, Konya 04280, Turkey. (1 speakers): Mehmet Artac\n  - Department of Medical Oncology, School of Medicine, Hacettepe University, Ankara 06100, Turkey. (1 speakers): Taha Koray Sahin\n  - Department of Nursing, Faculty of Health Science, Başkent University, Etimesgut, Ankara, Turkey. citak@baskent.edu.tr. (1 speakers): Ebru Akgun cıtak\n  - Department of Nursing, Faculty of Health Science, Yeditepe University, Istanbul, Turkey. (1 speakers): Gokce Naz Cakır\n  - Department of Nursing, Faculty of Health Sciences, Bezmialem Vakif University, Istanbul, Turkey. (1 speakers): Funda Cam\n  - Department of Nursing, Gazi University Faculty of Health Sciences, Besevler, Turkey. (1 speakers): Sevinc Kutluturkan\n  - Department of Pathology, Hacettepe University, Ankara 06230, Turkey. (1 speakers): Fatma Gundogdu\n  - Department of Urology, Haseki Training and Research Hospital, Istanbul, Turkey. (1 speakers): Oguzhan Yildiz\n  - Division of Medical Oncology, Department of Internal Medicine, Istanbul University-Cerrahpaşa, Istanbul 34098, Turkey. (1 speakers): Ozkan Alan\n  - Division of Urologic Oncology, Department of Urology, Istanbul University, Turkey. (1 speakers): Selcuk Erdem\n  - Faculty of Health Sciences Department of Nursing, Baskent University, Ankara, Turkey. (1 speakers): Sultan Kav\n  - Faculty of Health Sciences, Antalya Bilim University, Antalya, Turkey. (1 speakers): Munevver Erkul\n  - Faculty of Pharmacy, Department of Clinical Pharmacy, 113886Hacettepe University, Ankara, Turkey. (1 speakers): Esin Aysel Kandemir\n  - Fethiye Faculty of Health Sciences, Muğla Sıtkı Koçman University, Fethiye, Muğla, Turkey. (1 speakers): Ferda Akyuz Ozdemir\n  - Gazi University Faculty of Medicine, Ankara 06560, Turkey. Electronic address: tubaugurgazi@edu.tr. (1 speakers): Tuba U. Tuzcu\n  - Gazi University Health Sciences Faculty, Nursing Department, Ankara, Turkey. (1 speakers): Gizem Cakir\n  - Gazi University Nursing Faculty Department of Pediatric Nursing, Ankara (1 speakers): Hazal Ozdemir Koyu\n  - Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey. (1 speakers): Sercan Aksoy\n  - Hacettepe University, Ankara, Turkey. msabri.kovanci@gmail.com. (1 speakers): Mustafa S. Kovanci\n  - Halic University, Istanbul, Turkey. (1 speakers): Aysenur Cetin Uceriz\n  - Institute of Cancer Research, Ankara University, Ankara, Turkey. (1 speakers): Enes Erul\n  - Internal Medicine Nursing Department, Faculty of Nursing, 37515Hacettepe University, Ankara, Turkey. (1 speakers): Imatullah Akyar\n  - Istanbul Arel University, Faculty of Health Sciences, Nursing Department, Istanbul (1 speakers): Tugba Pehlivan Sarıbudak\n  - Istanbul Technical University, Istanbul 34469, Turkey. (1 speakers): Onur O. Arslan\n  - Istanbul University-Cerrahpasa, Institute of Graduate Studies, Istanbul, Turkey. (1 speakers): Aycan Kucukkaya\n  - Istanbul University-Cerrahpasa, Istanbul, Turkey. (1 speakers): Gulbeyaz Can\n  - Istanbul University-Cerrahpaşa, Istanbul 34098, Turkey. (1 speakers): Seda N. Jeral\n  - Istanbul University-Cerrahpaşa, Turkey. (1 speakers): Fadil Umihanic\n  - Koç University Hospital, Department of Medical Oncology, Istanbul, Turkey. (1 speakers): Deniz Tural\n  - Medical Faculty, Department of Medical Oncology, Medipol University, No:1, Bagcilar, Istanbul, Turkey. (1 speakers): Sabin Goktas Aydin\n  - Medical Oncology Department, Etlik City Hospital, Ankara, Turkey. (4 speakers): Enes Yesilbas, Galip Can Uyar, Kadriye Baskurt, Osman Sutcuoglu\n  - Mental Health Nursing, School of Nursing, Istanbul Bilgi University, Istanbul, Turkey. (1 speakers): Perihan Guner\n  - Muğla Sitki Kocman University Faculty of Medicine, Department of Medical Oncology, Muğla (1 speakers): Ozgur Tanriverdi\n  - Psychiatric Nursing Department, Faculty of Nursing, Hacettepe University, Ankara, Turkey. (1 speakers): Sinem Ocalan\n  - Sabanci University Nanotechnology Research and Application Center (SUNUM), Istanbul, Turkey. (1 speakers): Ozlem Kutlu\n  - School of Nursing, Koç University, İstanbul, Turkey. (1 speakers): Remziye Semerci\n  - Selcuk University, Konya, Turkey. (1 speakers): Ulku S. Saygılı\n  - University of Health Sciences, Ankara, Turkey. (1 speakers): Gulten Guvenc\n  - University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Training and Research Hospital, Medical Oncology, Ankara, Turkey. (1 speakers): Ilknur Deliktas Onur\n  - Çukurova University Faculty of Medicine, Adana, Turkey. (1 speakers): Suheda Atas Ipek\n\n**US (2 institutions, 2 speakers)**\n  - Division of Hematology/Oncology, Department of Medicine, Irvine Medical Center, University of California, Orange, CA, USA. (1 speakers): Farshid Dayyani\n  - Weill Cornell Medical College of Cornell University, NY. (1 speakers): Scott T. Tagawa\n\n**USA (1 institutions, 1 speakers)**\n  - Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA. (1 speakers): Imran Khan\n\n**Ukraine (4 institutions, 6 speakers)**\n  -  (3 speakers): Kseniia Bolharina, Viktoriia Galytskaya, Yaroslava Haborets\n  - Department of Biochemistry, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine. (1 speakers): Mariana Kuryk\n  - INSTITUTE OF MEDICAL RADIOLOGY OF S. P. GRIGORIEV NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE, UKRAINE (1 speakers): Vladyslav S. Sukhin\n  - Institute of Molecular Biology and Genetics NASU, Kyiv, Ukraine. (1 speakers): Denys Kozakov\n\n**United Arab Emirates (5 institutions, 5 speakers)**\n  -  (1 speakers): Dawood Shaheenah\n  - Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi P.O. Box 92510 (1 speakers): Humaid O. Al-Shamsi\n  - Clemenceau Medical Center Dubai, Dubai, American University of Beirut, Beirut (1 speakers): Deborah Mukherji\n  - College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Building 14 (1 speakers): Milad Nourianpour\n  - Division of Hematology - Oncology Medicine, Hôtel Dieu de France Medical Center, Saint-Joseph University, Beirut (1 speakers): Marwan Ghosn\n\n**United Kingdom (188 institutions, 213 speakers)**\n  -  (18 speakers): Amar Challapalli, Anne Crockett, Anthony Collier, Chloe Cruickshank, Darren Callanan, Fred Van Someren, Ghita Housni, Gini Harrison, Huma Irshad, Isobel Read, Matthew Beggs, Pablo Jimenez Labaig, Perminder Tony Singh Dhillon, Racha Kussaibati, Rosie Edgerley, Shikiera Wheeler, Wadiya Sayeda, Zoe O'Neil\n  - Addenbrooke's Hospital, Amsterdam, the Netherlands. (1 speakers): Philip Schouten\n  - Allama Iqbal Memorial Trust Hospital, Gujranwala, Pakistan. (1 speakers): Sami Atiq\n  - Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London, UK. (2 speakers): Francesca Jackson-Spence, Sara Coca Membribes\n  - Barts Health Biomedical NIHR Research Centre, Queen Mary University of London, London, UK. (1 speakers): Thomas B. Powles\n  - Barts Health NHS Trust, London, United Kingdom of Great Britain and Northern Ireland. (1 speakers): Marco Gerlinger\n  - Betsi Cadwaladr University Health Board, Bangor, UK. jaya.vangara@wales.nhs.uk. (1 speakers): Jaya Vangara\n  - Bristol Medical School, University of Bristol, Bristol, UK. (1 speakers): Christina Thirlwell\n  - Broad Institute of MIT and Harvard, Cambridge, MA, USA. (1 speakers): Michael E. Bryan\n  - CLL Society, CA. (1 speakers): Chris Stewart\n  - CRUK Cambridge Centre, University of Cambridge, Cambridge, UK. (1 speakers): Mireia Crispin Ortuzar\n  - Cambridge (1 speakers): Miguel Pereira\n  - Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK. (1 speakers): Charlotte Spencer\n  - Cancer Institute, University College London, London, UK, University College London Hospitals, London (1 speakers): Gerhardt Attard\n  - Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. (1 speakers): Wing Kin Liu\n  - Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK, Pre-Cancer Immunology Laboratory (1 speakers): James L. Reading\n  - Cancer Research UK Manchester Institute, Manchester (1 speakers): Kok Haw Jonathan Lim\n  - Cancer Research UK Manchester Institute, Manchester M20 4BX, UK. R.M. is also in the Faculty of Biology, Medicine and Health, The University of Manchester. (1 speakers): Rebecca J. Lee\n  - Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London EC1M 6AU, UK. (1 speakers): Peter Schmid\n  - Centre for Host-Microbiome Interactions, King's College London, London, UK. (1 speakers): Anjali Chander\n  - Centre for Trials Research, Cardiff University, Cardiff, UK. (1 speakers): Magdalena Meissner\n  - Clinical Pharmacology and Therapeutics, School of Life and Medical Sciences, University College London, London, UK. (1 speakers): Oscar Della Pasqua\n  - Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK. (1 speakers): Christina Yap\n  - Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, King's College London, London, UK. (1 speakers): Matthaios Kapiris\n  - Conquest Hospital, UK. (1 speakers): Olivia Sharp\n  - Department of Behavioural Science and Health, Institute of Epidemiology and Health Care, University College London, UK. (1 speakers): Eleonora Iob\n  - Department of Cellular Pathology, Charing Cross Hospital Campus, London, UK. (1 speakers): Brian Hanley\n  - Department of Clinical Dentistry, Faculty of Medicine, University of Bergen, Bergen, Norway. (1 speakers): Farzana Haque\n  - Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Thitikorn Nuamek\n  - Department of Experimental Psychology, University of Oxford, Oxford (1 speakers): Urska Kosir\n  - Department of General Surgery, Sengkang General Hospital, Singapore, Singapore. (1 speakers): Wai Keong Wong\n  - Department of Genetics, Genomics and Cancer Sciences, University of Leicester, Leicester, UK md527@le.ac.uk. (1 speakers): Maurice Dungey\n  - Department of Infectious Diseases and Immunity, Faculty of Medicine and Wellcome Trust Centre for Clinical Tropical Medicine, Imperial College, Hammersmith Hospital, London, UK. (1 speakers): Jasim Uddin\n  - Department of Laboratory Medicine, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China (1 speakers): Yifan Xing\n  - Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK. (1 speakers): James Whitworth\n  - Department of Medical Oncology, Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK. (1 speakers): Mario Uccello\n  - Department of Medical Oncology, St George's University Hospitals NHS Foundation Trust, London, UK. (1 speakers): Melek Akay\n  - Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK, Division of Cancer Sciences, The University of Manchester, Manchester, UK. (1 speakers): Fiona Blackhall\n  - Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Ana Sofia D. Parreira\n  - Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London NW1 2PG, UK. (1 speakers): Charles Swanton\n  - Department of Medical Oncology, University Hospital of Ioannina, Greece. (1 speakers): Panagiotis Ntellas\n  - Department of Medicine, Royal Marsden Hospital, London and Surrey (1 speakers): Anderley Gordon\n  - Department of Oncology, Cambridge University NHS Foundation Trust, Cambridge, UK. (1 speakers): Will Ince\n  - Department of Oncology, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. (1 speakers): Kanggeon Kim\n  - Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK. (1 speakers): Elizabeth C. Smyth\n  - Department of Oncology, Oxford University, Oxford, UK. (1 speakers): Eileen E. Parkes\n  - Department of Oncology, University College London (UCL) Cancer Institute, UCL Hospitals, London, UK. (1 speakers): Rebecca S Kristeleit\n  - Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK. (1 speakers): Gemma Eminowicz\n  - Department of Oncology, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AH, UK, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge (1 speakers): Ionut Gabriel Funingana\n  - Department of Oncology, University of Cambridge, Cambridge, UK. (1 speakers): David M. Favara\n  - Department of Oncology, University of Oxford, Oxford, UK. (1 speakers): Benjamin P. Fairfax\n  - Department of Pathology, Aberdeen Royal Infirmary and Aberdeen University Medical School, Aberdeen, UK. (1 speakers): Keith M. Kerr\n  - Department of Pathology, Rush University Medical Center, Chicago, IL 60612, USA. Electronic address: lzc112@gmail.com. (1 speakers): Lin Cheng\n  - Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451 (1 speakers): Maha S. Almutairi\n  - Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. (1 speakers): Sanjay Khanna\n  - Department of Radiotherapy Related Research, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. (1 speakers): Corinne Faivre-Finn\n  - Department of Radiotherapy, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, Computational Oncology Laboratory, Institute of Global Health Innovation, Imperial College, London (1 speakers): Seema Dadhania\n  - Department of Research Oncology, Guys Hospital, Kings College London, SE1 9RT London, UK. (1 speakers): Debashis Sarker\n  - Department of Surgery and Cancer, Imperial College London, Faculty of Medicine, Hammersmith Hospital, W120NN, London, UK, Department of Translational Medicine (DIMET) (1 speakers): David J. Pinato\n  - Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK. (1 speakers): Iain McNeish\n  - Department of Surgery and Cancer, Imperial College London, London, United Kingdom of Great Britain and Northern Ireland. (1 speakers): Christina Fotopoulou\n  - Department of Surgery, Leiden University Medical Center, Albinusdreef 2, Leiden (1 speakers): Tessa P. Sandberg\n  - Department of Surgery, The Christie Hospital NHS Foundation Trust, Manchester M20 4BX, UK. (1 speakers): Ashwin Sachdeva\n  - Department of Surgery, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. (1 speakers): Grant D. Stewart\n  - Department of Thoracic Surgery, Clinic for Thoracic Surgery, Institute for Pulmonary Diseases of Vojvodina, University of Novi Sad. (1 speakers): Debra Montague\n  - Department of Vascular Surgery, York & Scarborough Teaching Hospitals NHS Trust, York, UK. (1 speakers): Andrew Thompson\n  - Department of medical oncology, Institute of Cancer Research, Sutton, SM2 5NG (1 speakers): Ian Chau\n  - Division of Cancer Sciences, Department of Medical Oncology, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Mairead G. McNamara\n  - Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK, The Christie NHS Foundation Trust, Manchester, UK, Cancer Research UK (1 speakers): Alicia-Marie Conway\n  - Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. (3 speakers): Andrew R. Clamp, Laura Spurgeon, Natalie Cook\n  - Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Cancer Research Centre, Manchester M20 4GJ, UK (1 speakers): Robert D. Morgan\n  - Division of Cancer Sciences, The University of Manchester and Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Matthew G. Krebs\n  - Division of Genetics and Epidemiology. (1 speakers): Clare A. Turnbull\n  - Division of Oncology, School of Medicine, University of Leeds, Leeds, UK. (1 speakers): James R. Platt\n  - Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK. dm742@cam.ac.uk. (1 speakers): Daniel Munoz-Espin\n  - Edinburgh Cancer Research, University of Edinburgh, Edinburgh, Scotland, UK. (1 speakers): Barry Laird\n  - Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. (1 speakers): Joecelyn Kirani Tan\n  - Faculty of Biosciences, Heidelberg University, Heidelberg, Germany. (1 speakers): Aino-Maija Leppa\n  - Faculty of Health Sciences and Medicine, Bond University, Robina, QLD, Australia. (1 speakers): John Leggett\n  - Gray Cancer Institute, Mount Vernon Hospital, Middlesex HA6 2JR, UK. (1 speakers): Susan M. Galbraith\n  - Guy's and St Thomas' NHS Foundation Trust and Sarah Cannon Research Institute, London, UK. (1 speakers): Simon Chowdhury\n  - Histopathology Department, The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Thomas Morrall\n  - Hull York Medical School, University of Hull, Hull, UK. (1 speakers): Holly Butler\n  - Imperial College Healthcare NHS Trust, London, UK. (1 speakers): Daria A. Ditri\n  - Institute of Cancer Research, Sutton, London, UK. (1 speakers): Terri P. McVeigh\n  - Institute of Cancer Sciences, College of Medical, University of Glasgow UK. (1 speakers): Andrew Biankin\n  - Institute of Head and Neck Studies and Education, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. (1 speakers): Hisham M. Mehanna\n  - Institute of Reproductive and Developmental Biology, Imperial College London, London, W12 0HS, UK. (1 speakers): Jonathan Krell\n  - John Sealy School of Medicine, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, USA. (1 speakers): Vishal Patel\n  - John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, UK. (1 speakers): Sergio Rutella\n  - Kidney Cancer UK, Guildford, UK. (1 speakers): Malcolm Packer\n  - King's College Hospital NHS Foundation Trust, King's College Hospital, London SE5 9RS, UK. (1 speakers): Sharmistha Ghosh\n  - King's College London, King's College London, United Kingdom. Electronic address: mary.tanay@kcl.ac.uk. (1 speakers): Mary A. Tanay\n  - Leeds Institute of Medical Research at St James's, University of Leeds, Leeds (1 speakers): Adel Samson\n  - Liverpool University Hospitals, NHS Foundation Trust, Liverpool, UK. (1 speakers): Christian H. Ottensmeier\n  - MB, The Christie Hospital NHS Foundation Trust, Manchester, MB, BCH, The Christie Hospital NHS Foundation Trust, Manchester, Division of Cancer Sciences, University of Manchester, Manchester (1 speakers): Sophia Kreft\n  - MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK. (1 speakers): Peter J. Godolphin\n  - MRC Clinical Trials Unit, University College London, London, UK. (1 speakers): Sophie Merrick\n  - Macmillan Lead Cancer Nurse and Nurse Consultant, Berkshire Cancer Centre, Royal Berkshire NHS Foundation Trust, Reading. (1 speakers): Mark R. Foulkes\n  - Male Genital Cancer Centre, Department of Andrology, University College London Hospitals (UCLH) NHS Foundation Trust, London, UK, Division of Surgery and Interventional Science (1 speakers): Asif Muneer\n  - Manchester Foundation Trust, Manchester, UK. (1 speakers): Sian Dobbs\n  - Medical Oncology Department, North West Cancer Centre, Western Health & Social Care Trust, Derry, Northern Ireland. (1 speakers): Hossam R. Abdulkhalek\n  - Medical Research Council Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK (1 speakers): Hoda Abdel-Aty\n  - Molecular Cancer Imaging Facility, Dana-Farber Cancer Institute, Boston, MA, USA. (1 speakers): Mark Dornan\n  - Montréal, QC, Canada. (1 speakers): Laura Morrison\n  - Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Center, University of Edinburgh, Edinburgh, UK. (1 speakers): Charlie Gourley\n  - North Middlesex University Hospital, London, UK. (1 speakers): Valerie E. Crolley\n  - Nuffield Department of Experimental Medicine, University of Oxford, Oxford, UK. (1 speakers): Simon Leedham\n  - Nuffield Department of Surgical Sciences, University of Oxford, Oxford (1 speakers): Elysia Upton\n  - Oncology R&D, AstraZeneca, Cambridge, UK. (1 speakers): Phillip M. Brailey\n  - Ontario Institute for Cancer Research, Toronto, Canada. (1 speakers): Lydia Y. Liu\n  - Oxford Haematology and Cancer Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford (1 speakers): Toby A. Eyre\n  - Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom of Great Britain and Northern Ireland. (1 speakers): Martin Little\n  - PRA International, Reading, Berkshire, RG2 0TD (1 speakers): Nermeen Varawalla\n  - Peter Gorer Department of Immunobiology, King's College London, London, UK. (1 speakers): Adrian Hayday\n  - Queen's University Belfast, BT9 7AE, United Kingdom. (1 speakers): Joe O'Sullivan\n  - Research Assistant, Brussels, Belgium. (1 speakers): Celia Diez de los Rios de la Serna\n  - Rome, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Federico Monaca\n  - Rosemere Cancer Centre, Lancashire Teaching Hospitals, Preston UK, University of Manchester, Manchester, UK, University of Central Lancashire, Preston, UK. (1 speakers): Alison J. Birtle\n  - Royal Marsden Hospital Sutton, London, UK. (1 speakers): Sarah Stapleton\n  - Royal Marsden Hospital and Institute for Cancer Research, London, UK. (1 speakers): James Larkin\n  - Royal Marsden Hospital and Institute of Cancer Research, London. (1 speakers): Nicholas C. Turner\n  - Royal Marsden Hospital, London SW3 6JJ, UK. (2 speakers): Naureen Starling, Sheela Rao\n  - Royal Marsden Hospital, Sutton, UK. (1 speakers): Johann S. De Bono\n  - Royal Marsden NHS Foundation Trust, London (1 speakers): Peta Hughes\n  - START-CIOCC, University Hospital HM Sanchinarro, Madrid, Spain. (1 speakers): Ramon Yarza\n  - Sarah Cannon Research Institute UK, London, UK. (3 speakers): Anja Williams, Matilde Saggese, Rachel Woodford\n  - School of Cancer Sciences, University of Glasgow, Bearsden, Glasgow G61 1QH, UK. (1 speakers): Maria Libera Ascierto\n  - School of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK. (1 speakers): Robert Jones\n  - School of Health & Social Care, Edinburgh Napier University, Edinburgh, UK. (1 speakers): Karen Campbell\n  - School of Medicine, University of St Andrews, UK. (1 speakers): Hazem Abdullah\n  - School of Nursing and Midwifery, Queen's University, Belfast, Ireland. (1 speakers): Mark Dornan\n  - Southampton Clinical Trials Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK. (1 speakers): Victoria Goss\n  - St Thomas' Hospital, London (1 speakers): Nikhil Aggarwal\n  - St. Georges University Hospitals Foundation Trust and The Royal Marsden Foundation Trust, London, UK. (1 speakers): Lisa M. Pickering\n  - Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M20 3LI, UK. (1 speakers): Kathleen Connors\n  - Sudan University of Science and Technology, Khartoum, Sudan. raniamamoun065@gmail.com. (1 speakers): Rania A. Mohammed\n  - Surgery, Alexandria Main University Hospitals, Alexandria, EGY. (1 speakers): Mohamed Farrag\n  - The Christie Hospital NHS Trust, Manchester University NHS Foundation Trust, Manchester, UK. (1 speakers): Yvonne Summers\n  - The Christie NHS Foundation Trust and University of Manchester, Manchester, UK. (1 speakers): Fiona Thistlethwaite\n  - The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Avanti A. Andhale\n  - The Francis Crick Institute, London, UK, The Royal Marsden Hospital, London, UK. (1 speakers): Samra Turajlic\n  - The Institute of Cancer Research, London, England, UK. (1 speakers): Kevin J. Harrington\n  - The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7AE, UK. (1 speakers): Wen Kyle Wong\n  - The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Midlothian, EH25 9RG, UK. (1 speakers): Richard I. Kuo\n  - The Royal Marsden Hospital and The Institute of Cancer Research, Sutton (1 speakers): Anna R. Minchom\n  - The Royal Marsden Hospital, London, SW3 6 JJ, UK. (1 speakers): Stephen R. Johnston\n  - The Royal Marsden Hospital, London, UK. (1 speakers): Sanjay Popat\n  - The Royal Marsden Hospital. (1 speakers): Maximilian Julve\n  - The Royal Marsden Hospital., The Institute of Cancer Research, The Royal Marsden Hospital. (1 speakers): Ben O'Leary\n  - The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK. (1 speakers): Susana Banerjee\n  - The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK. (1 speakers): Nicholas D. James\n  - The Royal Marsden NHS Foundation Trust, London, UK. (1 speakers): Shira Peleg Hasson\n  - The Symptom Control and Palliative Care Team, The Royal Marsden NHS Foundation Trust, London, UK. (1 speakers): Jayne E. Wood\n  - The University of Manchester, Manchester, United Kingdom. (1 speakers): Colin R R. Lindsay\n  - The University of Sheffield, Sheffield, UK. (1 speakers): James W. Catto\n  - Translational & Oncology Research (TOUR), King's College London, London, UK. (1 speakers): Louis Fox\n  - Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK. (1 speakers): Deborah Enting\n  - Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. (1 speakers): Debra Josephs\n  - UCL Cancer Institute, University College London, London (1 speakers): Sandra Strauss\n  - Ulster Hospital, South Eastern Health and Social Care Trust, Dundonald, UK. (1 speakers): Cherith J. Semple\n  - University College Hospital, London, UK. (1 speakers): Shibani Nicum\n  - University College London Cancer Institute, London (1 speakers): Mahaz Kayani\n  - University College London Hospital NHS Foundation Trust, London (1 speakers): Bernadett E. Szabados\n  - University College London Hospitals NHS Foundation Trust, London NW1 2BU, UK. (1 speakers): Katrina Ingley\n  - University College London, University College London, United Kingdom. (1 speakers): Kevin O'Neill\n  - University Hospital Southampton NHS Foundation Trust, Southampton, UK. (1 speakers): Zaed Hamady\n  - University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. (2 speakers): Helen L. Robbins, Philippe Taniere\n  - University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom of Great Britain and Northern Ireland. (1 speakers): Helen Winter\n  - University Hospitals Sussex NHS Foundation Trust, Brighton BN1 9RW, UK. (1 speakers): Rille Pihlak\n  - University Hospitals Sussex, England. (1 speakers): Bethany Maynard\n  - University of Cambridge School of Clinical Medicine, Cambridge, UK. (1 speakers): Rahul A. Shah\n  - University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK. (1 speakers): Eleanor Wheeler\n  - University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, CB2 0QQ Cambridge, UK. (1 speakers): Bristi Basu\n  - University of Coimbra, Coimbra, Portugal. (1 speakers): Marisa R. Durao Portela De Lima\n  - University of Huddersfield, Huddersfield, United Kingdom. (1 speakers): Toni Brook\n  - University of Leicester, Leicester, UK, University Hospitals of Leicester NHS Trust, Leicester, UK. (1 speakers): Dean A. Fennell\n  - University of Liverpool, Liverpool, Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany, Department of General (1 speakers): Daniel H. Palmer\n  - University of Oxford, Department of Oncology, Churchill Hospital, Oxford, UK. (1 speakers): Sarah P. Blagden\n  - University of Oxford, Oxford, UK. (2 speakers): Gusztav B. Milotay, Hannah F. Nentwich\n  - University of Oxford, Oxford, United Kingdom. Electronic address: edward.oneill@nds.ox.ac.uk. (1 speakers): Edward O'Neill\n  - University of Sheffield and Sheffield Teaching Hospitals NHS Trust, Weston Park Hospital Sheffield S10 2JF, UK. (1 speakers): Syed A. Hussain\n  - University of Southampton, Southampton (1 speakers): Nicole Keyworth\n  - Usher Institute, University of Edinburgh, Edinburgh, UK. (1 speakers): Peter S. Hall\n  - Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, Hampshire, UK. (1 speakers): David Hunt\n  - William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, London, UK. (1 speakers): Gracia Andriamiadana\n  - Wolfson Palliative Care Research Centre, University of Hull, Hull, UK. (1 speakers): Fliss Murtagh\n  - Women's Health Research Group, Leeds Institute of Medical Research, St James's University Hospital, University of Leeds, Leeds (1 speakers): Nicholas Bennett\n\n**United States of America (343 institutions, 382 speakers)**\n  -  (16 speakers): Bobbie Rimmel, Bryan Murphy-Eustis, Iole Ribizzi-Akhtar, Irati Rodriguez Matesanz, Jessie Desir, Jin Sun Bitar, Jose Avitia, Judith Perez Granado, Luis Felipe, Myeong Hwak Choe, Popi Siziopikou, Rita Furdyna, Sengathir Rajagopal, Stephan Rosenfeld, Stephanie Snider, Sydney E. Schultz\n  - . Hospital de Clínicas de Porto Alegre, Faculdade de Medicina, Brasil. (1 speakers): Wallace Klein Schwengber\n  - 19University of California, Los Angeles Medical Center, CA, USA. (1 speakers): Alexandra Drakaki\n  - 1Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (1 speakers): David S. Hong\n  - 1Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore (1 speakers): Govind Warrier\n  - 2Cedars-Sinai Medical Center, CA. (1 speakers): Stephen Freedland\n  - 3Division of Hematology-Oncology, Department of Medicine, VAGLAHS/David Geffen School of Medicine at University of California, CA. (1 speakers): Daniel S. Shin\n  - 3Medical College of Wisconsin Cancer Center, Milwaukee, WI. (1 speakers): Deepak Kilari\n  - Abramson Cancer Center, University of Pennsylvania, Philadelphia. (1 speakers): Charu Aggarwal\n  - Ahmanson Translational Theranostics Division, David Geffen School of Medicine, University of California Los Angeles (UCLA), USA. (1 speakers): Adrien Holzgreve\n  - Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California-Los Angeles, CA, USA. (1 speakers): Jeremie Calais\n  - AstraZeneca, Gaithersburg (1 speakers): Cristian Massacesi\n  - Atlanta, GA. (1 speakers): Kenneth W. Culver\n  - Baylor University Medical Center, US Oncology, Dallas, TX. (1 speakers): Joyce O'Shaughnessy\n  - Biomedical Research Center of University of Granada, Excellence Research Unit \"Modeling Nature\" (MNat), University of Granada, Spain. (1 speakers): Ashraf Abdelghany\n  - BostonGene Corporation, Waltham, MA 02453, USA. (1 speakers): Andrey Kravets\n  - CA, USA. (1 speakers): Jelena Levi\n  - Cambridge, MA, USA. (1 speakers): Mailin Li\n  - Cancer & Hematology Centers of Western Michigan, MI, USA. (1 speakers): Sreenivasa Chandana\n  - Cancer Center, SE, JP). (1 speakers): Loren N. Winters\n  - Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR (1 speakers): Nima Nabavizadeh\n  - Carolina Urologic Research Center, AU Clinics, SC, USA. (1 speakers): Neal D. Shore\n  - Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. (1 speakers): Jaydira Del Rivero\n  - Center for Cancer Research, National Institutes of Health, Bethesda, USA. (1 speakers): Ravi A. Madan\n  - Center for Neuro-Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA. (1 speakers): Lakshmi Nayak\n  - Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY (1 speakers): Yonina R. Murciano-Goroff\n  - Clinical Research, START, TX. (1 speakers): Kyriakos P. Papadopoulos\n  - Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston. (1 speakers): Andrew T. Chan\n  - Creighton University School of Medicine, Omaha, NE, USA. (1 speakers): Christina Curtin\n  - Dana-Farber Cancer Institute, Boston, MA, USA, Harvard Medical School, Boston, MA, USA. (2 speakers): Alicia K. Morgans, Clara Steiner\n  - Dana-Farber Cancer Institute, Boston, Massachusetts, USA. (1 speakers): Renee M. Saliby\n  - Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA, University of Milano, Milan, Italy. (1 speakers): Paolo Tarantino\n  - Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. (1 speakers): Jacob Sands\n  - Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. (1 speakers): Surender Kharbanda\n  - Dana-Farber Cancer Institute/Brigham and Women's Hospital Harvard Medical School, Boston, MA. (1 speakers): Ilana B. Epstein\n  - David Geffen School of Medicine at University of California, Los Angeles, Los Angeles. (1 speakers): Zev A. A. Wainberg\n  - Department of Bioengineering, McGill University, Montreal, QC, Canada. (1 speakers): Nikolaos M. Dimitriou\n  - Department of Bioengineering, Stanford University, Stanford, CA, USA. (1 speakers): Stephen R. Quake\n  - Department of Biomedical Engineering, GA, USA, Department of Biomedical Engineering, Emory University, GA, USA. (1 speakers): Mayukhmala Jana\n  - Department of Cancer Biology and Genetics, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, NY 10065. (1 speakers): Ram Kannan\n  - Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Calgary, AB T2N 5G2, Canada. (1 speakers): Lin Yang\n  - Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, Illinois 60208 (1 speakers): Donghoon Shin\n  - Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA. (1 speakers): Michael J. Hall\n  - Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. (1 speakers): Vernon K. Sondak\n  - Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA. (1 speakers): Lilit Karapetyan\n  - Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. (1 speakers): Camilo Jimenez\n  - Department of Gastroenterology and Hepatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH. (1 speakers): Aakash Desai\n  - Department of Gastroenterology and Hepatology, The 3rd Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, China. (1 speakers): Fei Wang\n  - Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Scott Kopetz\n  - Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. (2 speakers): Ryan Huey, Van Morris\n  - Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA. (1 speakers): Christina Curtis\n  - Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX (1 speakers): Sumit K. Subudhi\n  - Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. (1 speakers): Sangeeta Goswami\n  - Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Andrew W. Hahn\n  - Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. (1 speakers): Ana Aparicio\n  - Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Elizabeth Burton\n  - Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. (1 speakers): Scott Woodman\n  - Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (2 speakers): David M. Gershenson, Shannon Westin\n  - Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. (1 speakers): Neil Gross\n  - Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Cancer Neuroscience Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (1 speakers): Moran Amit\n  - Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX. (1 speakers): Sharon H. Giordano\n  - Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. (1 speakers): Hossein Borghaei\n  - Department of Hematology/Oncology, University of California Los Angeles, USA. (1 speakers): Richard S. Finn\n  - Department of Hematology/Oncology, Yale New Haven Hospital, CT, USA. (1 speakers): Amin Nassar\n  - Department of Internal Medicine and The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH. (1 speakers): Marcelo Bonomi\n  - Department of Internal Medicine, Hematology/Oncology, Abramson Cancer Center, Philadelphia, PA, USA. (1 speakers): Tara C. Mitchell\n  - Department of Internal Medicine, Loyola University Health System-MacNeal Hospital, Berwyn, IL, USA. (1 speakers): Krishna Doshi\n  - Department of Internal Medicine, University of Chicago, KCBD 7114, Chicago, IL 60637, USA. (1 speakers): Sulin Wu\n  - Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX. (1 speakers): Rodney E. Infante\n  - Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas. (2 speakers): Qian Qin, Tian Zhang\n  - Department of Internal Medicine, Yale New Haven Hospital, CT 06504, USA. (1 speakers): Ashish Sharma\n  - Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Apostolia Maria Tsimberidou\n  - Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston (1 speakers): Fadi G. Haddad\n  - Department of Leukemia, The University of Texas MD Anderson Cancer Center, TX, Houston, USA. (1 speakers): Jabra Zarka\n  - Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA. (2 speakers): Charles B. Nguyen, Neal S. Chawla\n  - Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA. (1 speakers): Hedyeh Ebrahimi\n  - Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA. (1 speakers): Jonathan Schoenfeld\n  - Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA. (2 speakers): Aditya Shreenivas, Amanda Reyes\n  - Department of Medical Oncology, Boston, MA, USA. (1 speakers): Ana C. Garrido-Castro\n  - Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. (1 speakers): Matt Freedman\n  - Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA. (1 speakers): Robert Haddad\n  - Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA. (1 speakers): Wenxin Xu\n  - Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts. (1 speakers): Tanvi Visal\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. (1 speakers): Chris Labaki\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (5 speakers): Bradley A. McGregor, Filipa Lynce, Karam Khaddour, Marc Eid, Nancy Lin\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. (1 speakers): Mustafa Saleh\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA, USA. (1 speakers): Sylvan Baca\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. (2 speakers): Eddy Saad, Marc Machaalani\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. (2 speakers): Glenn J. Hanna, Praful Ravi\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. (1 speakers): Himisha Beltran\n  - Department of Medical Oncology, Huntsman Cancer Institute, University of Utah (1 speakers): Zeynep Irem Ozay\n  - Department of Medical Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. (1 speakers): Julia Rotow\n  - Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA (1 speakers): Aparna Parikh\n  - Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, NY, USA. (1 speakers): Neil H. Segal\n  - Department of Medical Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA. (1 speakers): Mohammad Arfat Ganiyani\n  - Department of Medical Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA. (1 speakers): Balazs Halmos\n  - Department of Medicine (Medical Oncology), Yale School of Medicine and Yale Cancer Center, CT (1 speakers): Anne C. Chiang\n  - Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN. (1 speakers): Christine M. Lovly\n  - Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA. (1 speakers): James Lyon\n  - Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA 15213, USA. (1 speakers): Anwaar Saeed\n  - Department of Medicine, Division of Hematology Oncology, UT Health San Antonio, Mays Cancer Center, Texas, USA. (1 speakers): Virginia Kaklamani\n  - Department of Medicine, Division of Hematology and Oncology, Mayo Clinic College of Medicine and Science, Jacksonville, FL 32224, USA. (1 speakers): Hani Babiker\n  - Department of Medicine, Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA. (1 speakers): Saranya Chumsri\n  - Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. (1 speakers): Vikram Gorantla\n  - Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, CA. (1 speakers): Edward B. Garon\n  - Department of Medicine, Englander Institute for Precision Medicine, New York Presbyterian Hospital, NY, USA. (1 speakers): Eleonora Nicolo\n  - Department of Medicine, Icahn School of Medicine at Mount Sinai, NY. (1 speakers): Catherine Wu\n  - Department of Medicine, Massachusetts General Hospital, Boston, MA 02114 (1 speakers): Oladapo Yeku\n  - Department of Medicine, Mayo Clinic, Rochester, MN, USA. (1 speakers): Mariya Pogorelova\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center (1 speakers): Karen Autio\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY (1 speakers): Kenneth H. Yu\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, USA, Department of Medicine, Weil Cornell Medical College, NY, USA. (1 speakers): David H. Aggen\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, USA, Department of Medicine, Weill Cornell Medicine and New York Presbyterian Hospital, NY, USA. (1 speakers): Alan L. Ho\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, USA. (2 speakers): Pedram Razavi, Vicky Makker\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY. (3 speakers): Alissa J. Cooper, James J. Harding, Wungki Park\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, USA. (2 speakers): Ethan S. Barnett, Jamie Chaft\n  - Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136 (1 speakers): CARMEN CALFA\n  - Department of Medicine, New York University Langone Perlmutter Cancer Center, USA. (1 speakers): Elaine Shum\n  - Department of Medicine, School of Medicine, University of California San Diego, CA 92093, USA. (1 speakers): Rana R. McKay\n  - Department of Medicine, The University of Alabama at Birmingham and O'Neal Comprehensive Cancer Center, Birmingham, AL 35233 (1 speakers): Arnab Basu\n  - Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh, PA), USA (1 speakers): Charles E. Geyer\n  - Department of Medicine, University of Chicago, Chicago, IL, USA. (1 speakers): Frederick M. Howard\n  - Department of Medicine, the University of Chicago, Chicago, IL, USA. (1 speakers): Marina C. Garassino\n  - Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (2 speakers): Hussein A. Tawbi, Isabella C. Glitza\n  - Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada. (1 speakers): Jennifer Chan\n  - Department of Molecular Medicine, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea. (1 speakers): Seung-Hoon Lee\n  - Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN (1 speakers): Andrea E. Wahner Hendrickson\n  - Department of Neurology and Neurological Sciences, Stanford Cancer Institute, Stanford, CA, USA. (1 speakers): Seema Nagpal\n  - Department of Neurology, University of Toronto, Toronto, ON, Canada. (1 speakers): Andrew S. Lim\n  - Department of Neurosurgery, University of Southern California, CA, USA. (1 speakers): Lauren Liu\n  - Department of Obstetrics and Gynecology, University of California, Irvine-Medical Center, Orange, CA (1 speakers): Alyssa C. Bujnak\n  - Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, NY 10029, USA, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NY 10029 (1 speakers): Triparna Sen\n  - Department of Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA. (1 speakers): Smitha Krishnamurthi\n  - Department of Oncology, Mayo Clinic, Rochester, MN, USA. (1 speakers): Aminah Jatoi\n  - Department of Otolaryngology-Head and Neck Surgery Stanford University School of Medicine Stanford California USA. (1 speakers): Alexander Dimitrios Colevas\n  - Department of Palliative Care, Community Hospital of the Monterey Peninsula, Monterey, California, USA. (1 speakers): John Hausdorff\n  - Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, NY, USA. (2 speakers): Higinio Dopeso, Jamal Benhamida\n  - Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA. (1 speakers): Jennifer Chen\n  - Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (1 speakers): Berkay Simsek\n  - Department of Pathology, Memorial Sloan Kettering Cancer Center, NY, USA. (1 speakers): Chad M. Vanderbilt\n  - Department of Pathology, Yale University School of Medicine, Connecticut, USA. (1 speakers): Kurt Schalper\n  - Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA (1 speakers): Katherine Janeway\n  - Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA. (1 speakers): Suchi Raghunathan\n  - Department of Pharmacology, University of Pittsburgh, Pittsburgh, PA, USA. (1 speakers): Adrian Lee\n  - Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. (1 speakers): Paul L. Nguyen\n  - Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. (1 speakers): Simon Bernatz\n  - Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (2 speakers): Adam J. Grippin, Claudia S. Kettlun Leyton\n  - Department of Radiation Oncology, University of Arizona College of Medicine-Tucson, Tucson, AZ (1 speakers): Charles Hsu\n  - Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston. (1 speakers): Ashleigh Guadagnolo\n  - Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX (1 speakers): Andrew Z. Wang\n  - Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, Baltimore, USA. (1 speakers): George Sgouros\n  - Department of Radiology, New York-Presbyterian Hospital, Columbia University Irving Medical Center (1 speakers): Laurent Dercle\n  - Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. (1 speakers): Wei Zhong\n  - Department of Surgery, Memorial Sloan Kettering Cancer Center, NY. (1 speakers): Daniela Molena\n  - Department of Surgery, Weill Cornell Medical College, NY, USA, Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, GA, USA (1 speakers): Melissa B. Davis\n  - Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. (1 speakers): Jennifer Hwang\n  - Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Simon Heeke\n  - Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Yasir Y. Elamin\n  - Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): John Heymach\n  - Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. (1 speakers): Carl M. Gay\n  - Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. (1 speakers): Marina Schnauss\n  - Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), CA (1 speakers): Roger Lo\n  - Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA, Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125 (1 speakers): Andrew C. Lu\n  - Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA. (1 speakers): Avina Rami\n  - Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston 77030, TX USA. (1 speakers): Michael LaPelusa\n  - Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. (1 speakers): Randall Brand\n  - Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO (1 speakers): Premal H. Thaker\n  - Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, New York University Langone Health, NY (1 speakers): Kari Hacker\n  - Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, New York University Langone Health, NY, USA. (1 speakers): Bhavana Pothuri\n  - Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute, M210, Columbus, OH 43210 (1 speakers): Casey Cosgrove\n  - Division of Gynecologic Oncology; The Ohio State University Wexner Medical Center, OH 43210, United States of America. (1 speakers): David O'Malley\n  - Division of Hematology Oncology, Department of Medicine, Northwestern University, Chicago, IL, USA. (1 speakers): Sunandana Chandra\n  - Division of Hematology and Medical Oncology, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL (1 speakers): Shenduo Li\n  - Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital (1 speakers): Pinkal Desai\n  - Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA (1 speakers): Melina E. Marmarelis\n  - Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. (1 speakers): Gabrielle Rocque\n  - Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (1 speakers): Scott M. Haake\n  - Division of Hematology and Oncology, The Warren Alpert Medical School of Brown University, Providence, RI, USA. (1 speakers): Hina Khan\n  - Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. (1 speakers): Jonathan W. Riess\n  - Division of Hematology-Oncology, Mayo Clinic Rochester, Minnesota. (1 speakers): Jacob Orme\n  - Division of Hematology/Oncology Mass General Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts, U.S.A. (1 speakers): David M. Miller\n  - Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, CA. (1 speakers): Terence Friedlander\n  - Division of Hematology/Oncology, University of California San Francisco, California. (1 speakers): Rahul Aggarwal\n  - Division of Hematology/Oncology/Stem cell transplant Rush University Medical Center Chicago IL. (1 speakers): Mary J. Fidler\n  - Division of Hospital Medicine, OH 43210, USA. (1 speakers): Yuanquan A. Yang\n  - Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah Health, UT 84112, USA. (1 speakers): Georges Gebrael\n  - Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, UT. (1 speakers): Nicolas Sayegh\n  - Division of Medical Oncology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. (1 speakers): Aman Chauhan\n  - Division of Medical Oncology, Department of Medicine, University of Kentucky, Lexington, KY, USA. (1 speakers): Zhonglin Hao\n  - Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA. (1 speakers): Thorvardur R. Halfdanarson\n  - Division of Oncology and Hematology, University of California Irvine Medical Center, Orange, CA, USA. (1 speakers): Nataliya Mar\n  - Division of Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, NC, USA. (1 speakers): Siddharth Sheth\n  - Division of Oncology, Norris Comprehensive Cancer Center, University of Southern California, California. (1 speakers): Gino K. In\n  - Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA. (1 speakers): Ravi Uppaluri\n  - Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of California Los Angeles, CA, USA. (1 speakers): Noah Federman\n  - Division of Solid Tumor Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106 (1 speakers): Tanya Jindal\n  - Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, NY, USA. (1 speakers): Paul Johannet\n  - Division of Thoracic Surgery, Department of Surgery, University of California (1 speakers): Jay M. Lee\n  - Don S. Dizon, Massachusetts General Hospital, Boston, Dana-Farber Cancer Institute, Boston, MA, Alexandria, VA, University of California San Diego, Patricia A. Ganz (1 speakers): Erica Mayer\n  - Donostia International Physics Center (DIPC), Spain. (1 speakers): Carlos Garcia Fernandez\n  - Dr. Panjwani Center for Molecular Medicine and Drug Research, ICCBS, University of Karachi, Karachi, Pakistan. (1 speakers): Faiza Chaudhary\n  - Duke Cancer Institute, Duke University, Durham, NC, USA. (1 speakers): John H. Strickler\n  - Edinburgh Cancer Research, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK. (1 speakers): Muhammad Furqan\n  - Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA, USA. (1 speakers): Coyin Oh\n  - Episcopal High School in Bellaire, Houston, TX. (1 speakers): Anya Pant\n  - Faculty of Medicine, University of Brasilia, Brasilia, Brazil. (1 speakers): Leticia Assad Maia Sandoval\n  - Flatiron Health, NY, USA. (1 speakers): Cheryl Cho-Phan\n  - Florida Cancer Specialists and Research Institute, GOG Foundation, FL, USA. (1 speakers): Bradley J. Monk\n  - From Dana-Farber Cancer Institute (M.M.A., S.L., J.D., J.O.J., K.E.L., H.F., K.M.H., B.M.W., P.A.J., A.J.A.), Massachusetts General Hospital (R.S.H., Y.P.H.), and Brigham and Women's Hospital (L.M.S. (1 speakers): Kathryn C. Arbour\n  - From the Department of Diagnostic Radiology (J.N., D.P., K.L., E.W., M.K.G.), The University of Texas M.D. MD Anderson Cancer Center, Houston, TX 77030, USA (1 speakers): Maura Gillison\n  - GSK, London (1 speakers): Aikaterini Fameli\n  - Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Milind Javle\n  - Georgia Cancer Center of Excellence, GA, USA. (1 speakers): Giuseppe Del Priore\n  - Greco-Hainsworth Center for Cancer Research, Nashville, TN, USA. (1 speakers): Kathryn Beckermann\n  - Greehey Children's Cancer Research Institute, UT Health San Antonio, TX, USA. (1 speakers): Aparna Gorthi\n  - H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. (1 speakers): Ahmad A. Tarhini\n  - HOAG Family Cancer Institute, CA, USA. (1 speakers): Chaitali Nangia\n  - Helen Diller Family Cancer Center, University of California-San Francisco, CA (1 speakers): Vadim S. Koshkin\n  - Helen Diller Family Comprehensive Cancer Center, University of California, CA, USA. (1 speakers): Johnny Yu\n  - Hoag Family Cancer Institute, CA, USA. (1 speakers): David J. Benjamin\n  - HonorHealth Research Institute, Scottsdale, AZ, USA. (1 speakers): Michael Gordon\n  - Hospital Universitario La Paz, Madrid, Spain. (1 speakers): Carlos Torrado Martin\n  - Hospital for Special Surgery, NY 10021, USA. (1 speakers): Junho Song\n  - Huntsman Cancer Institute (NCI-CCC), University of Utah, UT. (1 speakers): Neeraj Agarwal\n  - Huntsman Cancer Institute, University of Utah, Utah, USA. (1 speakers): William B. McKean\n  - Inc. (OT), Evanston, Illinois. (1 speakers): Partha S. Ray\n  - Innovative Infant Feeding Disorders Research Program, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA. (1 speakers): Sahithee Batchu\n  - Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712, USA. (1 speakers): Joseph D. Dekker\n  - Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. (1 speakers): Yu-Wei Chen\n  - Institute of Dental Studies and Technologies, Uttar Pradesh, India. (1 speakers): Anmol Dia Agarwal\n  - Institute of Molecular Medicine, The Feinstein Institutes for Medical Research, Manhasset, NY 11030, USA. (1 speakers): Nyasha Chambwe\n  - Institute of Pharmacology and Toxicology, Medical Faculty, RWTH Aachen, University Hospital Aachen, Aachen, Germany. (1 speakers): Christian Martin\n  - Institute: Department of Internal Medicine, AdventHealth Sebring, FL, USA. (1 speakers): Muhammad Sohaib Asghar\n  - Islamic International Medical College, Rawalpindi (1 speakers): Muhammad Ahmed\n  - Ivy Brain Tumor Center, Barrow Neurological Institute, St. Joseph's Hospital & Medical Center, NRC 403, Phoenix, AZ, USA. (1 speakers): Nader Sanai\n  - Jonsson Comprehensive Cancer Center, University of California, USA. (1 speakers): Aaron Holmes\n  - Kidney Cancer Research Alliance, Alexandria, VA, USA. (1 speakers): Dena Battle\n  - Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. (1 speakers): Enrico Moiso\n  - Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, NY, USA. (1 speakers): Salman Punekar\n  - Legorreta Cancer Center, Brown University, and Lifespan Cancer Institute, Providence (1 speakers): Benedito A. Carneiro\n  - Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA. (1 speakers): Vijay Joish\n  - Lineberger Comprehensive Cancer Center, University of North Carolina At Chapel Hill, NC, USA. (1 speakers): Deborah Mayer\n  - Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC, USA, Department of Medicine, Division of Medical Oncology, University of North Carolina at Chapel Hill, NC (1 speakers): Stergios J. Moschos\n  - Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA. (1 speakers): Claudine Isaacs\n  - Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia. (1 speakers): Stephen V. Liu\n  - MD Anderson Cancer Center, Houston, TX. (1 speakers): N. Arvind Dasari\n  - MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. (1 speakers): Ecaterina E. Dumbrava\n  - MD Anderson Cancer Center, University of Texas, Houston, TX, USA. (1 speakers): Cindy Y. Jiang\n  - MSB Medical School Berlin, Rüdesheimerstr. 50, Germany. (1 speakers): Stephanie Schmidt\n  - Markey Cancer Center, University of Kentucky, Lexington, KY (1 speakers): Zin W. Myint\n  - Masonic Cancer Center and Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, USA. (1 speakers): Boris Winterhoff\n  - Mass General Cancer Center, Boston, MA, USA. (2 speakers): Gregory M. Cote, Jessica J. Lin\n  - Massachusetts General Hospital Cancer Center, Boston, MA (1 speakers): Ryan J. Sullivan\n  - Massachusetts General Hospital Cancer Center, Boston, MA, USA. (2 speakers): Lipika Goyal, Zofia Piotrowska\n  - Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. (1 speakers): Arielle J. Medford\n  - Mayo Clinic Cancer Center, Phoenix, AZ. (1 speakers): Tanios Bekaii-Saab\n  - Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA. (1 speakers): Oliver Sartor\n  - Mayo Clinic School of Graduate Medical Education, Mayo Clinic, Rochester, MN, USA. (1 speakers): Sanjna Rajput\n  - Medical Imaging Research Center, Illinois Institute of Technology, Suite 100, Chicago, IL, USA. (1 speakers): Albert Juan Ramon\n  - Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (1 speakers): Antonio Giordano\n  - Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. (1 speakers): Elahe Salehi\n  - Medical Oncology, Huntsman Cancer Institute Cancer Hospital, Utah, USA. (1 speakers): Ignacio Garrido-Laguna\n  - Medicine, Aulakh Hospital, Amritsar, IND. (1 speakers): Jasneet Randhawa\n  - Medivation, CA 94105 (1 speakers): Jeffrey N. Lindquist\n  - Melanoma and Cutaneous Medical Oncology, Perlmutter Cancer Center, NY University, Langone Health (1 speakers): Janice M. Mehnert\n  - Memorial Sloan Kettering Cancer Center, NY, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, NY (1 speakers): Samuel Bakhoum\n  - Memorial Sloan Kettering Cancer Center, NY, USA 10065. (1 speakers): Michael Bonner B. Foote\n  - Memorial Sloan Kettering Cancer Center, NY, USA. (1 speakers): Charles J Ryan\n  - Memorial Sloan Kettering Cancer Center, New York, NY. (1 speakers): Luke R. Pike\n  - Memorial Sloan Kettering Cancer Center, USA. (1 speakers): Michael V. Gormally\n  - Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA. (1 speakers): Zouina Sarfraz\n  - Miller School of Medicine/Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA. (1 speakers): Jonathan C. Trent\n  - Moffitt Cancer Center & Research Institute in Tampa, Tampa, Florida. (1 speakers): Amir Alishani Tabriz\n  - Moffitt Cancer Center, Tampa, FL, USA. (1 speakers): Jonathan R. Strosberg\n  - Mount Sinai Medical Center, Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, FL, USA. (1 speakers): Brian M. Slomovitz\n  - NYCH+H/Woodhull, Brooklyn, NY, USA. (1 speakers): Aria Khan\n  - National Isotope Centre, GNS Science, PO Box 30-368 (1 speakers): Andy Phillips\n  - Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon. (1 speakers): Jad El Masri\n  - Norfolk, VA. (1 speakers): Michael A. Danso\n  - Norris Comprehensive Cancer Center, University of Southern California, California. (1 speakers): Jacob Thomas\n  - Northwest Medical Specialties, Seattle, WA. (1 speakers): Sibel Blau\n  - OHDSI Center at the Roux Institute, Northeastern University, Boston, MA USA. (1 speakers): Asieh GOLOZAR\n  - Obstetrics and Gynecology Department, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma, USA. (1 speakers): Lauren E. Dockery\n  - Oregon Health & Science University. (1 speakers): Thomas Hwang\n  - Osteoncology, Bologna, Italy, Sylvester Comprehensive Cancer Center, University of Miami, FL 33136, USA, Miller School of Medicine, University of Miami, FL 33136, USA. (1 speakers): Emanuela Palmerini\n  - Pacific Cancer Research Consortium, NCORP, Swedish Medical Center-First Hill, Seattle, WA, USA. (1 speakers): Fernanda B. Musa\n  - Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. (1 speakers): Nicholas P. McAndrew\n  - Pfizer, NY, USA. (1 speakers): Matko Kalac\n  - Rogel Cancer Center, University of Michigan, MI, USA. (1 speakers): Paul L Swiecicki\n  - Ryan White Center for Pediatric Infectious Disease and Global Health, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN. (1 speakers): Wesley Boland\n  - Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, FL, USA. (1 speakers): Cesar A. Perez\n  - Sarah Cannon Research Institute, Nashville, TN (2 speakers): Erika P. Hamilton, Manish R. Patel\n  - Sarah Cannon Research Institute, Nashville, TN. (1 speakers): Vivek Subbiah\n  - Sarcoma Oncology Center/Cancer Center of Southern California, CA 90403, USA. (1 speakers): Samantha Jeffrey\n  - Sarcoma and Bone Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. (1 speakers): Erica M. Pimenta\n  - School of Medicine, University of California, CA, USA, Department of Emergency Medicine, University of California, CA (1 speakers): Michael Lauricella\n  - Seidman Cancer Center, University Hospitals, Case Western Reserve University, Cleveland, OH, USA, Tulane University, LA, USA. (1 speakers): Pedro Barata\n  - Shasqi Inc., 665 3rd St, Suite 501, San Francisco, California 94107, United States. (1 speakers): Jose Mejia Oneto\n  - Simmons Comprehensive Cancer Center, Dallas, Texas. (1 speakers): Tanner T. Hardy\n  - Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and Research, Kolar, IND. (1 speakers): Sravani Bhavanam\n  - Stephenson Oklahoma Cancer Center at the University of Oklahoma Health Sciences Center, OK. (1 speakers): Kathleen N. Moore\n  - Stratingh Institute for Chemistry, University of Groningen, Nijenborgh 4, AG Groningen (1 speakers): Hangyul Lee\n  - TRACTION platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Timothy Heffernan\n  - Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. (1 speakers): Shilpa Gupta\n  - Tegucigalpa, Honduras, USA. (1 speakers): MIchael Galo\n  - Texas Oncology-Fort Worth Cancer Center, TX, USA. (1 speakers): Noelle Cloven\n  - The Affiliated Brain Hospital, Guangzhou Medical University, No. 36, Guangzhou, Guangdong, P. R. China. (1 speakers): Xiaolei Shi\n  - The Angeles Clinic & Research Institute, California. (1 speakers): Justin T. Moyers\n  - The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Michael Dennis\n  - The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. (1 speakers): Jens Rueter\n  - The Jackson Laboratory, ME. (1 speakers): Ralph Gareus\n  - The Second Clinical Medical College of Guangzhou University of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, PR China (1 speakers): Lina Ding\n  - The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA. (1 speakers): Channing Paller\n  - The University of Alabama at Birmingham, School of Medicine, Birmingham, AL, USA. (1 speakers): Midhun Malla\n  - The University of Texas MD Anderson Cancer Center, Houston, TX (2 speakers): Amber Johnson, Xiuning Le\n  - The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. (1 speakers): Jordi Rodon\n  - The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. (1 speakers): Renata Ferrarotto\n  - The University of Texas MD MD Anderson Cancer Center, Houston, Texas. (1 speakers): Denise Langabeer\n  - The Winsor School, Boston, MA, USA. (1 speakers): Iris Shen\n  - Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NY, USA. (1 speakers): Matthew D. Galsky\n  - UPMC Hillman Cancer Center, Pittsburgh, PA. (1 speakers): Rushir Choksi\n  - University of Alicante, Alicante, Spain. (1 speakers): Guillermo Argiles Martinez\n  - University of California Irvine, Orange, CA, USA. (1 speakers): Natalie L. Ayoub\n  - University of California San Diego, CA, USA. (1 speakers): Soo Park\n  - University of California, Rebecca and John Moores Cancer Center, CA, USA. (1 speakers): Ramez N. Eskander\n  - University of Chicago Medical Center, Chicago, Illinois. (1 speakers): Chih-Yi A. Liao\n  - University of Illinois Cancer Center, Chicago, IL 60612, USA. (1 speakers): Oana Danciu\n  - University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA. (1 speakers): Jeffrey S. Miller\n  - University of Minnesota Medical School, University of Minnesota, Minneapolis, Minnesota, U.S.A. (1 speakers): Allison Dona\n  - University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address: hursting@email.unc.edu. (1 speakers): Stephen David Hursting\n  - University of Oklahoma Health Sciences Center, University of Oklahoma Health Sciences Center, Oklahoma City. (1 speakers): Satya Sai Venkata Lakshmi Arepalli\n  - University of Oklahoma Stephenson Cancer Center, OK (1 speakers): Adanma Ayanambakkam\n  - University of Virginia Cancer Center, Charlottesville, Virginia. (1 speakers): Linda R. Duska\n  - University of Washington Medical Center, Fred Hutchinson Cancer Center, Seattle, WA, USA. (1 speakers): Petros Grivas\n  - University of Washington School of Public Health, Seattle, WA, University of Washington Health Promotion Research Center, Seattle, WA (1 speakers): Jeffrey R. Harris\n  - Virginia Cancer Specialists, Fairfax, VA, USA. (1 speakers): Alexander I. Spira\n  - Washington University School of Medicine, MO. (1 speakers): Nikolaos Trikalinos\n  - Winship Cancer Institute of Emory University, Atlanta, Georgia, USA. (1 speakers): Ticiana A. Leal\n  - Winship Cancer Institute, Emory University, Atlanta, GA. (1 speakers): Kevin M. Kalinsky\n  - Women's Cancer Research Center, University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center (HCC), Magee-Womens Research Institute, Pittsburgh, PA. (1 speakers): Steffi Oesterreich\n  - Yale Cancer Center, Yale School of Medicine, CT (1 speakers): Maryam Lustberg\n  - Yale New Haven Hospital, CT, USA. (2 speakers): Michael Cecchini, Raghav Sundar\n  - a Department of Biology, City College of New York, NY, USA. (1 speakers): Emma Schatoff\n\n**Uruguay (1 institutions, 1 speakers)**\n  - Department of Clinical Oncology, Hospital de Clínicas, School of Medicine, Montevideo 11600, Uruguay. (1 speakers): Natalia Camejo\n\n**VIC (5 institutions, 5 speakers)**\n  - Department of Medical Oncology, Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore. (1 speakers): Puey Ling Chia\n  - Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia, The Sir Department of Medical Oncology, The University of Melbourne, Parkville, VIC, Australia. (1 speakers): Sherene Loi\n  - Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. (1 speakers): Ben J. Solomon\n  - Personalised Oncology Division, Walter and Eliza Hall Institute for Medical Research, Melbourne, VIC, Australia. (1 speakers): Jeanne Tie\n  - Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. (1 speakers): Linda Mileshkin\n\n**Valencia (5 institutions, 5 speakers)**\n  -  (1 speakers): Noelia Tarazona Llavero\n  - Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain. (1 speakers): Valentina Gambardella\n  - Department of Preventive Medicine & INCLIVA-Clinical Hospital, University of Valencia, Valencia, Spain. (1 speakers): Jose M. Martin-Moreno\n  - Medical Oncology Department, Hospital Clínico Universitario of Valencia. Biomedical Research Institute INCLIVA. CIBERONC, Valencia, Spain. (1 speakers): Jose Alejandro Perez Fidalgo\n  - The Institute of Cancer Research, London, UK, The Royal Marsden NHS Trust, London, UK. (1 speakers): Desamparados Roda Perez\n\n**Vietnam (5 institutions, 5 speakers)**\n  - Can Tho Central General Hospital, Ninh Kieu, Vietnam. (1 speakers): Phong D. Le Pham\n  - Department of Neurology, Yale School of Medicine, CT, USA. (1 speakers): Giang H. Pham\n  - Hanoi Medical University Hospital, Hanoi, 100000 Vietnam. (1 speakers): Hau X. Nguyen\n  - Harvard University, Boston, Massachusetts. (1 speakers): Dang N. Van Nguyen\n  - Ministry of Health, Hanoi, Vietnam. (1 speakers): Long T. Nguyen\n\n**WA (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK, Institute of Cancer Research, London, UK. (1 speakers): Robin L. Jones\n\n**West Bengal (1 institutions, 1 speakers)**\n  - Department of Clinical Psychology, Medica Superspecialty Hospital, Kolkata, India. (1 speakers): Arunima Datta\n\n**Yorkshire (1 institutions, 1 speakers)**\n  - Division of Oncology, Leeds Institute of Medical Research at St James's, School of Medicine, University of Leeds, Leeds, UK. (1 speakers): Jenny Seligmann\n\n**Zhejiang (1 institutions, 1 speakers)**\n  - Research and Development Center of Beijing Northland Biotechnology Company, Beijing 100085, China. (1 speakers): Yang Liu"
  },
  "renal_cell_carcinoma": {
    "top_institutions": {
      "columns": [
        "Institution",
        "# Studies",
        "Locations"
      ],
      "rows": [
        {
          "Institution": "MD Anderson Cancer Center, Houston",
          "# Studies": 62,
          "Locations": "Houston, United States of America, Surrey, Houston, United States of America, Houston, United States of America, TX"
        },
        {
          "Institution": "Medical Oncology Department",
          "# Studies": 58,
          "Locations": "Barcelona, Spain, Milan, Italy, Madrid, Spain"
        },
        {
          "Institution": "Dana-Farber Cancer Institute",
          "# Studies": 51,
          "Locations": "Boston, United States of America, Boston, United States of America, MA, New York, United States of America"
        },
        {
          "Institution": "Memorial Sloan Kettering Cancer Center",
          "# Studies": 47,
          "Locations": "New York, United States of America, NY, New York, United States of America, Commack, United States of America"
        },
        {
          "Institution": "Sun Yat-sen University Cancer Center",
          "# Studies": 29,
          "Locations": "Guangzhou, China, guangzhou, China, Guangzhou, China, Guangdong"
        },
        {
          "Institution": "Fudan University Shanghai Cancer Center",
          "# Studies": 22,
          "Locations": "Shanghai, China"
        },
        {
          "Institution": "Department of Internal Medicine",
          "# Studies": 19,
          "Locations": "Seoul, Republic of Korea, Salt Lake City, United States of America, Uijeongbu, Republic of Korea"
        },
        {
          "Institution": "National Cancer Center Hospital East",
          "# Studies": 19,
          "Locations": "Kashiwa, Japan, Kanagawa, Kashiwa, Japan, Kashiwa, Japan, Chiba"
        },
        {
          "Institution": "Medical Oncology Unit",
          "# Studies": 17,
          "Locations": "Parma, Italy, Pavia, Italy, Florence, Italy"
        },
        {
          "Institution": "Mayo Clinic",
          "# Studies": 14,
          "Locations": "Rochester, United States of America, Rochester, United States of America, MN, New Orleans, United States of America"
        },
        {
          "Institution": "Leiden University Medical Center",
          "# Studies": 13,
          "Locations": "Leiden, Netherlands, Belfast, United Kingdom"
        },
        {
          "Institution": "Department of Medicine I",
          "# Studies": 13,
          "Locations": "Vienna, Austria"
        },
        {
          "Institution": "IRCCS San Raffaele Hospital",
          "# Studies": 13,
          "Locations": "Milan, Italy, Pisa, Italy"
        },
        {
          "Institution": "Comprehensive Cancer Center",
          "# Studies": 12,
          "Locations": "Berlin, Germany, Munich, Germany, Rome, Italy"
        },
        {
          "Institution": "National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital",
          "# Studies": 12,
          "Locations": "Beijing, China, Bejing, China, Tianjin, China"
        },
        {
          "Institution": "University of Milan",
          "# Studies": 12,
          "Locations": "Milan, Italy"
        },
        {
          "Institution": "Netherlands Cancer Institute",
          "# Studies": 11,
          "Locations": "Amsterdam, Netherlands"
        },
        {
          "Institution": "Cancer Center",
          "# Studies": 11,
          "Locations": "Wuhan, China, Chengdu, China, Boston, United States of America"
        },
        {
          "Institution": "University of California San Francisco Helen Diller Family Comprehensive Cancer Center",
          "# Studies": 11,
          "Locations": "Los Angeles, United States of America, CA"
        },
        {
          "Institution": "University Hospital CHUV",
          "# Studies": 11,
          "Locations": "Lausanne, Switzerland"
        },
        {
          "Institution": "Oncology Department",
          "# Studies": 11,
          "Locations": "Seville, Spain, Reggio Emilia, Italy, Barcelona, Spain"
        },
        {
          "Institution": "University of California San Diego",
          "# Studies": 11,
          "Locations": "La Jolla, United States of America"
        },
        {
          "Institution": "Erasmus MC Cancer Institute",
          "# Studies": 10,
          "Locations": "Rotterdam, Netherlands"
        },
        {
          "Institution": "European Institute of Oncology",
          "# Studies": 10,
          "Locations": "Milan, Italy"
        },
        {
          "Institution": "Toronto General Hospital",
          "# Studies": 10,
          "Locations": "Toronto, Canada"
        },
        {
          "Institution": "West German Cancer Center",
          "# Studies": 10,
          "Locations": "Essen, Germany, Munster, Germany"
        },
        {
          "Institution": "Sarah Cannon Research Institute",
          "# Studies": 10,
          "Locations": "Nashville, United States of America, TN, Nashville, United States of America, Fort Myers, United States of America"
        },
        {
          "Institution": "Royal Marsden Hospital",
          "# Studies": 9,
          "Locations": "London, United Kingdom, Sutton, United Kingdom"
        },
        {
          "Institution": "Barts Cancer Institute",
          "# Studies": 9,
          "Locations": "London, United Kingdom"
        },
        {
          "Institution": "Vanderbilt-Ingram Cancer Center",
          "# Studies": 9,
          "Locations": "Nashville, United States of America, OH, Nashville, United States of America, TX"
        }
      ]
    },
    "table_context": "**TOP INSTITUTIONS TABLE:**\n| Institution                                                                            |   # Studies | Locations                                                                                                           |\n|:---------------------------------------------------------------------------------------|------------:|:--------------------------------------------------------------------------------------------------------------------|\n| MD Anderson Cancer Center, Houston                                                     |          62 | Houston, United States of America, Surrey, Houston, United States of America, Houston, United States of America, TX |\n| Medical Oncology Department                                                            |          58 | Barcelona, Spain, Milan, Italy, Madrid, Spain                                                                       |\n| Dana-Farber Cancer Institute                                                           |          51 | Boston, United States of America, Boston, United States of America, MA, New York, United States of America          |\n| Memorial Sloan Kettering Cancer Center                                                 |          47 | New York, United States of America, NY, New York, United States of America, Commack, United States of America       |\n| Sun Yat-sen University Cancer Center                                                   |          29 | Guangzhou, China, guangzhou, China, Guangzhou, China, Guangdong                                                     |\n| Fudan University Shanghai Cancer Center                                                |          22 | Shanghai, China                                                                                                     |\n| Department of Internal Medicine                                                        |          19 | Seoul, Republic of Korea, Salt Lake City, United States of America, Uijeongbu, Republic of Korea                    |\n| National Cancer Center Hospital East                                                   |          19 | Kashiwa, Japan, Kanagawa, Kashiwa, Japan, Kashiwa, Japan, Chiba                                                     |\n| Medical Oncology Unit                                                                  |          17 | Parma, Italy, Pavia, Italy, Florence, Italy                                                                         |\n| Mayo Clinic                                                                            |          14 | Rochester, United States of America, Rochester, United States of America, MN, New Orleans, United States of America |\n| Leiden University Medical Center                                                       |          13 | Leiden, Netherlands, Belfast, United Kingdom                                                                        |\n| Department of Medicine I                                                               |          13 | Vienna, Austria                                                                                                     |\n| IRCCS San Raffaele Hospital                                                            |          13 | Milan, Italy, Pisa, Italy                                                                                           |\n| Comprehensive Cancer Center                                                            |          12 | Berlin, Germany, Munich, Germany, Rome, Italy                                                                       |\n| National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital    |          12 | Beijing, China, Bejing, China, Tianjin, China                                                                       |\n| University of Milan                                                                    |          12 | Milan, Italy                                                                                                        |\n| Netherlands Cancer Institute                                                           |          11 | Amsterdam, Netherlands                                                                                              |\n| Cancer Center                                                                          |          11 | Wuhan, China, Chengdu, China, Boston, United States of America                                                      |\n| University of California San Francisco Helen Diller Family Comprehensive Cancer Center |          11 | Los Angeles, United States of America, CA                                                                           |\n| University Hospital CHUV                                                               |          11 | Lausanne, Switzerland                                                                                               |\n| Oncology Department                                                                    |          11 | Seville, Spain, Reggio Emilia, Italy, Barcelona, Spain                                                              |\n| University of California San Diego                                                     |          11 | La Jolla, United States of America                                                                                  |\n| Erasmus MC Cancer Institute                                                            |          10 | Rotterdam, Netherlands                                                                                              |\n| European Institute of Oncology                                                         |          10 | Milan, Italy                                                                                                        |\n| Toronto General Hospital                                                               |          10 | Toronto, Canada                                                                                                     |\n| West German Cancer Center                                                              |          10 | Essen, Germany, Munster, Germany                                                                                    |\n| Sarah Cannon Research Institute                                                        |          10 | Nashville, United States of America, TN, Nashville, United States of America, Fort Myers, United States of America  |\n| Royal Marsden Hospital                                                                 |           9 | London, United Kingdom, Sutton, United Kingdom                                                                      |\n| Barts Cancer Institute                                                                 |           9 | London, United Kingdom                                                                                              |\n| Vanderbilt-Ingram Cancer Center                                                        |           9 | Nashville, United States of America, OH, Nashville, United States of America, TX                                    |\n\n**ENRICHED INSTITUTION PROFILES (Top 10 with ClinicalTrials.gov Data):**\n\n\n**MD Anderson Cancer Center, Houston**\n  - ESMO 2025 Presentations: 62\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (65 total):\n    * Timothy Anthony Yap  - 924MO: First data disclosure of the first-in-class DNA polymerase theta inhibitor, ART6043, as monotherapy and in combination with olaparib, in patients with molecularly-selected advanced solid tumors (10/17/2025, 16:30 - 16:35, Heidelberg Auditorium - Hall 6.2)\n    * Xiuning Le  - LBA75: Sevabertinib (BAY 2927088) in advanced HER2-mutant non-small cell lung cancer (NSCLC): Results from the SOHO-01 study (10/17/2025, 16:25 - 16:35, Berlin Auditorium - Hub 27)\n    * Yasir Y. Elamin  - LBA72: NorthStar: A Phase II Randomized Study of Osimertinib (OSI) With or Without Local Consolidative Therapy (LCT) for Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) (10/17/2025, 16:00 - 16:10, Berlin Auditorium - Hub 27)\n    * Amado J. Zurita  - 2518TiP: Presurgical Phase II study of talazoparib in combination with enzalutamide in de novo metastatic to lymph nodes prostate cancer (TEN+) (10/18/2025, 12-13:00, Hall 25)\n    * Andrew W. Hahn  - LBA94: LenCabo: A randomized phase II multicenter trial of lenvatinib plus everolimus (len/eve) versus (vs) cabozantinib (cabo) in patients (pts) with metastatic clear cell RCC (ccRCC) that progressed on PD-1 immune checkpoint inhibition (ICI) (10/18/2025, 08:40 - 08:50, Berlin Auditorium - Hub 27)\n    * ... and 60 more presenters\n\n\n**Medical Oncology Department**\n  - ESMO 2025 Presentations: 58\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (73 total):\n    * Alejo Rodriguez-Vida  - : Optimising Outcomes: Patient-centred Care in mHSPC (10/17/2025, 18:00 - 19:30, Heidelberg Auditorium - Hall 6.2)\n    * Filippo Pietrantonio  - : How to move forward from early stage (10/17/2025, 16:45 - 17:00, Munich Auditorium - CityCube B)\n    * Alba Moll-Febrer  - 2986eP: Clinical profile of patients with lung cancer with multiple cancers: identifying a population at risk (10/18/2025, 12-13:00, Hall 25)\n    * Alfonso Cortes Salgado  - 1158P: Folate receptor alpha (FRalpha) expression in a molecularly characterized cohort of endometrial cancer (EC) cases: SPECTRUM-FRalpha/GEICO 163-T study. (10/18/2025, 12-13:00, Hall 25)\n    * Alvaro Pinto Marin  - 2652eP: Succinate-dehydrogenase B protein expression and prognosis of localized clear cell renal cell carcinoma (10/18/2025, 12-13:00, Hall 25)\n    * ... and 68 more presenters\n\n\n**Dana-Farber Cancer Institute**\n  - ESMO 2025 Presentations: 51\n  - Clinical Trials (2015-2025): 22 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06964958](https://clinicaltrials.gov/study/NCT06964958): LASER - a Phase 2 Trial of 177Lu-PSMA-617 as Systemic Therapy for Renal Cell Carcinoma (PHASE2, NOT_YET_RECRUITING, Started 2025)\n    * [NCT06318871](https://clinicaltrials.gov/study/NCT06318871): Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma (EARLY_PHASE1, RECRUITING, Started 2024)\n    * [NCT05899361](https://clinicaltrials.gov/study/NCT05899361): A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest (NA, RECRUITING, Started 2023)\n    * [NCT05700461](https://clinicaltrials.gov/study/NCT05700461): Drug Screening Using Novel IMD in Renal Cell Carcinoma (PHASE1, RECRUITING, Started 2023)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT05176288](https://clinicaltrials.gov/study/NCT05176288): Avelumab, Palbociclib and Axitinib in Advanced RCC (PHASE2, WITHDRAWN, Started 2024) [EMD-ALIGNED]\n    * [NCT04724018](https://clinicaltrials.gov/study/NCT04724018): Sacituzumab Govitecan Plus EV in Metastatic UC (PHASE1, ENROLLING_BY_INVITATION, Started 2021) [COMPETITOR]\n    * [NCT04339062](https://clinicaltrials.gov/study/NCT04339062): Cemiplimab in AlloSCT/SOT Recipients With CSCC (PHASE1, COMPLETED, Started 2020) [COMPETITOR]\n    * [NCT03203473](https://clinicaltrials.gov/study/NCT03203473): Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study) (PHASE2, ACTIVE_NOT_RECRUITING, Started 2017) [COMPETITOR]\n    * [NCT03239145](https://clinicaltrials.gov/study/NCT03239145): Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor (PHASE1, COMPLETED, Started 2017) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (53 total):\n    * Bradley A. McGregor  - : Invited Discussant (10/17/2025, 14:20 - 14:30, Dortmund Auditorium - Hall 7.1a)\n    * Clara Steiner  - : Invited Discussant (10/17/2025, 15:10 - 15:20, Dortmund Auditorium - Hall 7.1a)\n    * Pasi A. Janne  - LBA77: FLAURA2: exploratory overall survival (OS) analysis in patients (pts) with poorer prognostic factors treated with osimertinib (osi) +/- platinum-pemetrexed chemotherapy (CTx) as first-line (1L) treatment (tx) for EGFR-mutated (EGFRm) advanced NSCLC (10/17/2025, 17:00 - 17:10, Berlin Auditorium - Hub 27)\n    * Alicia K. Morgans  - 2455P: Prevalence and severity of hot flashes and their association with prostate-specific antigen (PSA) response: results from the initial treatment phase of LIBERTAS, a phase 3 study in metastatic hormone-sensitive prostate cancer (mHSPC) (10/18/2025, 12-13:00, Hall 25)\n    * Alicia K. Morgans  - 2477P: Real-world prostate-specific antigen (PSA) response with darolutamide or abiraterone in metastatic hormone-sensitive prostate cancer (mHSPC) triplet therapy (10/18/2025, 12-13:00, Hall 25)\n    * ... and 48 more presenters\n\n\n**Memorial Sloan Kettering Cancer Center**\n  - ESMO 2025 Presentations: 47\n  - Clinical Trials (2015-2025): 13 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT07065825](https://clinicaltrials.gov/study/NCT07065825): Tumor Rupture During Robotic Partial Nephrectomy (Phase Not Specified, NOT_YET_RECRUITING, Started 2025)\n    * [NCT06835972](https://clinicaltrials.gov/study/NCT06835972): A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC) (PHASE1, RECRUITING, Started 2025)\n    * [NCT05837767](https://clinicaltrials.gov/study/NCT05837767): A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue (NA, RECRUITING, Started 2023)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT06699602](https://clinicaltrials.gov/study/NCT06699602): A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma (PHASE2, RECRUITING, Started 2025) [COMPETITOR]\n    * [NCT06132945](https://clinicaltrials.gov/study/NCT06132945): A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain (PHASE1, RECRUITING, Started 2023) [COMPETITOR]\n    * [NCT04068831](https://clinicaltrials.gov/study/NCT04068831): Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma (PHASE2, COMPLETED, Started 2019) [EMD-ALIGNED]\n    * [NCT05868265](https://clinicaltrials.gov/study/NCT05868265): A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract (PHASE2, RECRUITING, Started 2023) [COMPETITOR]\n    * [NCT05239533](https://clinicaltrials.gov/study/NCT05239533): Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer (PHASE2, RECRUITING, Started 2022) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (51 total):\n    * Andrea Cercek  - : Discussion led by Chair (10/17/2025, 16:35 - 17:00, Cologne Auditorium - CityCube A)\n    * Dana E. Rathkopf  - LBA91: Patient (pt) reported outcomes (PROs) from AMPLITUDE, a randomized placebo-controlled phase 3 trial of niraparib (NIRA) and abiraterone acetate (AA) plus prednisone (P) in metastatic hormone-sensitive prostate cancer (mHSPC) with homologous recombination repair mutations (HRRm) (10/17/2025, 14:00 - 14:05, Heidelberg Auditorium - Hall 6.2)\n    * Helena A. Yu  - 921MO: Phase 1 Global Study of Iza-Bren (BL-B01D1), an EGFR x HER3 Bispecific Antibody-drug Conjugate (ADC), in Patients with Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors (10/17/2025, 16:00 - 16:05, Heidelberg Auditorium - Hall 6.2)\n    * Karen Autio  - 2385MO: Translational analyses of T-cell phenotypes and their association with clinical efficacy in the first-in-human (FIH) trial of JNJ-78278343 (pasritamig) in metastatic castration-resistant prostate cancer (mCRPC) (10/17/2025, 14:40 - 14:45, Heidelberg Auditorium - Hall 6.2)\n    * Michael Bonner B. Foote  - 925MO: First-in-human phase I/Ib study of the oral Werner (WRN) helicase inhibitor HRO761 in patients (pts) with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) advanced solid tumors: Interim safety and efficacy analysis from HRO761 single agent dose escalation (10/17/2025, 16:35 - 16:40, Heidelberg Auditorium - Hall 6.2)\n    * ... and 46 more presenters\n\n\n**Sun Yat-sen University Cancer Center**\n  - ESMO 2025 Presentations: 29\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (39 total):\n    * Jihong Liu  - 1212P: Iparomlimab and tuvonralimab (QL1706) vs cadonilimab for previously treated recurrent/metastatic cervical cancer (r/mCC): An unanchored matching-adjusted indirect comparison (MAIC) (10/18/2025, 12-13:00, Hall 25)\n    * Mian Xi  - LBA82: Tislelizumab combined with induction chemotherapy and concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, phase II trial (EC-CRT-002) (10/18/2025, 10:20 - 10:25, Hanover Auditorium - Hall 7.2c)\n    * Pei Dong  - 2602P: Safety and efficacy of iparomlimab and tuvonralimab (QL1706) plus lenvatinib in previously untreated patients with clear cell renal cell carcinoma: results from a phase 1b study (10/18/2025, 12-13:00, Hall 25)\n    * Pei Dong  - 2648P: Phase II Clinical Study of the Safety and Efficacy of Sintilimab in Combination with Axitinib and Stereotactic Radiotherapy in the Treatment of Local-regional Recurrent Renal Cell Carcinoma (10/18/2025, 12-13:00, Hall 25)\n    * Ting Zhou  - 1945P: Sacituzumab Tirumotecan (sac-TMT) in Participants (pts) With Previously Treated, Advanced KRAS-Mutant NSCLC: Results From Cohort 5d of the SKB264-II-08 Study (10/18/2025, 12-13:00, Hall 25)\n    * ... and 34 more presenters\n\n\n**Fudan University Shanghai Cancer Center**\n  - ESMO 2025 Presentations: 22\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (30 total):\n    * Bo Dai  - 2434P: The efficacy of rezvilutamide (Rez) plus androgen-deprivation therapy (ADT) in patients (pts) with high-volume, nonvisceral metastatic hormone-sensitive prostate cancer (HSPC): a post hoc analysis of CHART study (10/18/2025, 12-13:00, Hall 25)\n    * Dingwei Ye  - 3098P: Fibroblast Growth Factor Receptor 3 (FGFR3) - Driven Genomic Landscape and the Impact on Clinical Outcomes of Fexagratinib (Fexa) in Chinese metastatic or unresectable Urothelial Carcinoma (mUC) (10/18/2025, 12-13:00, Hall 25)\n    * Maoping Cai  - 3099P: Proteogenomic characterization of the non-muscle-invasive bladder cancer response to BCG reveals potential therapeutic strategies (10/18/2025, 12-13:00, Hall 25)\n    * Xiaohua Wu  - 1097P: Senaparib monotherapy for patients (pts) with BRCA1/2 mutated recurrent platinum-sensitive ovarian cancer (PSOC): final analysis of study SABRINA (10/18/2025, 12-13:00, Hall 25)\n    * Xiaojie Bian  - 2421P: Sacituzumab Tirumotecan (sac-TMT) + Pembrolizumab (Pembro) in Metastatic Castration-Resistant Prostate Cancer (mCRPC): Results from Phase 2 MK-2870-002/SKB264-II-06 Study (10/18/2025, 12-13:00, Hall 25)\n    * ... and 25 more presenters\n\n\n**Department of Internal Medicine**\n  - ESMO 2025 Presentations: 19\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (88 total):\n    * Markus Moehler  - : Welcome and introductions (10/17/2025, 10:15 - 11:45, Flensburg Auditorium - Hall 23)\n    * Markus Moehler  - : Lighting the way for targeted treatment in Claudin 18.2-positive advanced G/GEJ adenocarcinoma (10/17/2025, 10:15 - 11:45, Flensburg Auditorium - Hall 23)\n    * Markus Moehler  - : Bringing the patient to focus: A case-based exploration of Claudin 18.2-positive advanced G/GEJ adenocarcinoma (10/17/2025, 10:15 - 11:45, Flensburg Auditorium - Hall 23)\n    * Markus Moehler  - : Looking ahead: Anticipating the clinical impact of CLDN18.2 targeted treatments in advanced G/GEJ adenocarcinoma (10/17/2025, 10:15 - 11:45, Flensburg Auditorium - Hall 23)\n    * Markus Moehler  - : Symposium close (10/17/2025, 10:15 - 11:45, Flensburg Auditorium - Hall 23)\n    * ... and 83 more presenters\n\n\n**National Cancer Center Hospital East**\n  - ESMO 2025 Presentations: 19\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (23 total):\n    * Kenichi Harano  - : Novel immunotherapy (10/17/2025, 16:30 - 16:45, Hamburg Auditorium - CityCube A)\n    * Hideaki Bando  - 115MO: Comprehensive Multi-Omics Analysis of Early-Onset Cancer: Insights from the MONSTAR-SCREEN-2 Experience (10/18/2025, 08:58 - 09:03, Cologne Auditorium - CityCube A)\n    * Hiroki Izumi  - 2006P: Conducive multi-level screening of genetic and protein aberrations in non-small cell lung cancer: A report from LC-SCRUM-Asia (10/18/2025, 12-13:00, Hall 25)\n    * Misao Fukuda  - 1135P: Differential Expression of Key Therapeutic Target Proteins Across Ovarian Cancer Histologic Subtypes (10/18/2025, 12-13:00, Hall 25)\n    * Yoshitaka Zenke  - 1912P: Inflamed immune phenotype as a novel predictive marker of immune checkpoint inhibitors for non-small cell lung cancer (10/18/2025, 12-13:00, Hall 25)\n    * ... and 18 more presenters\n\n\n**Medical Oncology Unit**\n  - ESMO 2025 Presentations: 17\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (24 total):\n    * Alessandra Dodi  - 1910P: Development of a multiomic machine learning model to predict the outcome of advanced non-small cell lung cancer patients treated with immunotherapy. (10/18/2025, 12-13:00, Hall 25)\n    * Federico Sottotetti  - 2055eP: Occupational Exposure to Carcinogens and Non-Oncogene Addicted Phenotypes in Lung Cancer: Insights from a Real-Life Observational Study (10/18/2025, 12-13:00, Hall 25)\n    * Francesca Trentini  - 2985eP: Identification of Prognostic Immune-Genomic Signatures in Pleural Mesothelioma (PM) patients treated with immunotherapy (10/18/2025, 12-13:00, Hall 25)\n    * Giuseppe Lamberti  - 2786P: Baseline onconeural antibodies and immune-related adverse events on immune checkpoint inhibitors in patients with small-cell lung cancer: a prospective cohort study (10/18/2025, 12-13:00, Hall 25)\n    * Maria Gonzalez Cao  - 2779P: Phase Ib-II trial of tumor-loaded monocyte-derived dendritic cell vaccination plus atezolizumab in ES-SCLC (10/18/2025, 12-13:00, Hall 25)\n    * ... and 19 more presenters\n\n\n**Mayo Clinic**\n  - ESMO 2025 Presentations: 14\n  - Clinical Trials (2015-2025): 9 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06349642](https://clinicaltrials.gov/study/NCT06349642): Predicting Response to Immune Checkpoint Inhibitors Across Solid Tumors Using a Live Tumor Diagnostic Platform (Phase Not Specified, RECRUITING, Started 2024)\n    * [NCT05969860](https://clinicaltrials.gov/study/NCT05969860): At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer (PHASE2, RECRUITING, Started 2023)\n    * [NCT05112627](https://clinicaltrials.gov/study/NCT05112627): Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy (Phase Not Specified, COMPLETED, Started 2022)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT06265285](https://clinicaltrials.gov/study/NCT06265285): Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program (PHASE2, RECRUITING, Started 2024) [COMPETITOR]\n    * [NCT05269381](https://clinicaltrials.gov/study/NCT05269381): Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors (PHASE1, RECRUITING, Started 2022) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (17 total):\n    * Jacob Orme  - 1518MO: Rescuing Cancer Immunotherapy with Plasma Exchange in Melanoma (the ReCIPE-M1 study) (10/17/2025, 14:30 - 14:35, Nuremberg Auditorium - Hall 5.2)\n    * Aaron S. Mansfield  - 1948P: Treatment outcomes in patients (pts) with advanced c-Met overexpressing (OE) EGFR wildtype (WT) nonsquamous (NSQ) NSCLC who had telisotuzumab vedotin (Teliso-V) dose modifications in the LUMINOSITY trial (10/18/2025, 12-13:00, Hall 25)\n    * Andrea E. Wahner Hendrickson  - 1074P: Claudin- 6 (CLDN6) is a Therapeutic Target in Ovarian Cancer (OC): Emerging Results from the CATALINA 1 (CAT1) Study (10/18/2025, 12-13:00, Hall 25)\n    * Evanthia Galanis  - : Exploring personalized care in patients with IDH mutations: a multidisciplinary discussion in Glioma (10/18/2025, 13:00 - 14:30, Flensburg Auditorium - Hall 23)\n    * Oliver Sartor  - 2542eTiP: Phase 1/2 Dose Escalation and Expansion of AB001 in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC): The ARTISAN Trial (10/18/2025, 12-13:00, Hall 25)\n    * ... and 12 more presenters\n\n\n**COMPLETE SPEAKER DIRECTORY BY GEOGRAPHY:**\n\n\n** (1 institutions, 1 speakers)**\n  -  (1 speakers): \n\n**Aichi (2 institutions, 2 speakers)**\n  - Department of Gastrointestinal Surgery, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8550, Japan. (1 speakers): Dai Shimizu\n  - Department of Medical Oncology, Kindai University Hospital, Osaka-sayama, Japan. (1 speakers): Seiichiro Mitani\n\n**Algeria (2 institutions, 3 speakers)**\n  -  (2 speakers): Arezki Arab, Fatma zohra Macheroum\n  - Faculty of Medicine, Djillali Liabes University, Sidi Bel Abbes 22000, Algeria. (1 speakers): Zineddine Belabaci\n\n**Andhra Pradesh (1 institutions, 1 speakers)**\n  -  (1 speakers): Suresh V. Attili\n\n**Andorra (1 institutions, 1 speakers)**\n  - Hospital Clínic, IDIBAPS, Barcelona. (1 speakers): Cristina Royo\n\n**Argentina (6 institutions, 7 speakers)**\n  -  (2 speakers): Carlos A. Brocca, Guillermo Cordoba\n  - Alexander Fleming Institute, Buenos Aires 1426, Argentina. (1 speakers): Juan Manuel Ramon O'Connor\n  - Clinical Oncology Unit, Argentina. (1 speakers): Federico D. Waisberg\n  - Hospital Bernardo Houssay, Mar del Plata, Argentina. (1 speakers): Ignacio A. Casarini\n  - Junín 956, C1113AA, Argentina. (1 speakers): Viviana C. Blank\n  - Valencia University, 46010, Spain. (1 speakers): Enrique A. Diaz Canton\n\n**Armenia (1 institutions, 3 speakers)**\n  -  (3 speakers): Merine Babayan, Vahe Grigoryan, Yeva Ghukasyan\n\n**Atlantico (1 institutions, 1 speakers)**\n  - Clinical Oncology, Valledupar, Colombia. (1 speakers): Ray Manneh Kopp\n\n**Attica (1 institutions, 1 speakers)**\n  - Department of Oncology, Athens Medical Center, Marousi, Greece. (1 speakers): Marinos Tsiatas\n\n**Attiki (2 institutions, 2 speakers)**\n  - Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece. (1 speakers): Michalis Liontos\n  - First Department of Internal Medicine, Laikon General Hospital, School of Medicine, National Kapodistrian University of Athens, Athens, Greece. (1 speakers): Helen Gogas\n\n**Australia (49 institutions, 51 speakers)**\n  - 1 James Cook University, Townsville, Queensland, Australia. (1 speakers): Hayley Roberts\n  - Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Central Adelaide Local Health Network, Adelaide, SA 5011, Australia. (1 speakers): Timothy J. Price\n  - Biotechnology Research Centre, La Trobe University, Bendigo, Victoria 3552, Australia. (1 speakers): Daniel Tillett\n  - Cabrini Health, Malvern, Australia. (1 speakers): Shehara R. Mendis\n  - Cancer Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK. (1 speakers): Vineet Kwatra\n  - Centre for Cancer Cell Biology and Drug Discovery, Institute for Biomedicine and Glycomics, Griffith University, Southport, Queensland, Australia. (1 speakers): Devina Laurencia\n  - Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia. (1 speakers): Ye Kyaw Aung\n  - Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, NSW, Australia, Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. (1 speakers): Joe Wei\n  - Department of Child Health, Wates District Hospital, Kulonprogo, Yogyakarta, Indonesia. (1 speakers): Dian Anggraini\n  - Department of Internal Medicine, University of Michigan, MI 48109, USA. (1 speakers): Jason Qin\n  - Department of Medical Oncology, Bendigo Health, Bendigo, Victoria, Australia. (1 speakers): Samuel J. Harris\n  - Department of Medical Oncology, Peter MacCallum Cancer Centre, Australia, The Sir Peter MacCallum Department of Oncology, University of Melbourne (1 speakers): Wanda Cui\n  - Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. (1 speakers): Joanna Chan\n  - Department of Oncology, Alfred Health, Melbourne, Australia, Central Clinical School, Monash University, Melbourne, Australia. (1 speakers): Malaka Ameratunga\n  - Division of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China. (1 speakers): Chen Yong\n  - Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. (1 speakers): Victoria Choi\n  - Fiona Stanley Hospital and Edith Cowan University, Perth, WA, Australia. (1 speakers): Muhammad A. Khattak\n  - Garvan Institute of Medical Research, Darlinghurst, Australia. (1 speakers): Jia Jenny Liu\n  - Garvan Institute of Medical Research, Sydney, Australia. (3 speakers): Frank P. Lin, Rhiannon Mellor, Subotheni Thavaneswaran\n  - Liverpool Hospital, New South Wales, Australia. Electronic address: roger.liang@health.nsw.gov.au. (1 speakers): Roger L. Liang\n  - Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. (1 speakers): Nadia Hitchen\n  - Medical Oncology, The Kinghorn Cancer Care Centre, St Vincent's Hospital, Sydney, Australia. (1 speakers): Wei Yen Chan\n  - Medical School, University of Western Australia, Perth, WA 6009, Australia. (1 speakers): Anna K. Nowak\n  - Melanoma Institute Australia, The University of Sydney, NSW, Australia, Faculty of Medicine and Health, The University of Sydney, NSW, Australia (1 speakers): Andrea Boutros\n  - Melanoma Institute Australia, Wollstonecraft, Australia. (1 speakers): Ines Pires da Silva\n  - Monash Health, Clayton, VIC, Australia. (1 speakers): Khunthong Peechatanan\n  - Murdoch Children's Research Institute, Parkville, Victoria, Australia. (1 speakers): Kortnye Smith\n  - NHMRC Clinical Trials Centre, University of Sydney, Australia. (1 speakers): John Simes\n  - Pancreatic Cancer Translational Research Group, School of Biomedical Sciences, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia. (1 speakers): Omali Pitiyarachchi\n  - Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. (1 speakers): Jayesh Desai\n  - Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. (1 speakers): Shahneen K. Sandhu\n  - School of Biomedical Science and Pharmacy, University of Newcastle, Newcastle, Australia. (1 speakers): Darren Shafren\n  - School of Clinical Medicine, Faculty of Medicine and Health, University of NSW, Sydney, NSW 2010, Australia. (1 speakers): Maya Kansara\n  - School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia. (1 speakers): Lucy Haggstrom\n  - School of Clinical Medicine, University of New South Wales, Sydney, Australia. (1 speakers): Monica Tang\n  - School of Medicine, University of Sydney, Camperdown, NSW, Australia. (1 speakers): Tahlia Scheinberg\n  - Seoul National University, Seoul, Korea. (1 speakers): Nur Sakinah Zulkifli\n  - Sir Peter MacCallum Cancer Centre Department of Oncology, The University of Melbourne, Melbourne, Australia. (1 speakers): Roslyn Wallace\n  - Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. (1 speakers): Lavinia Spain\n  - Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia (1 speakers): Arun A. Azad\n  - Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia, Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. (1 speakers): Danny Rischin\n  - Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia, Department of Radiation Oncology, Peter MacCallum Cancer Centre (1 speakers): Shankar Siva\n  - Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. (1 speakers): Michael Michael\n  - Sunshine Coast University Private Hospital, Birtinya, Queensland, Australia. (1 speakers): Michelle Morris\n  - The Kinghorn Cancer Centre, St Vincent's Hospital Sydney, Darlinghurst, NSW 2010, Australia. (1 speakers): Barak Talmor\n  - Theranostics and Nuclear Medicine Department, St Vincent's Hospital Sydney, Darlinghurst, Australia (1 speakers): Louise Emmett\n  - University of Illinois Chicago, IL, USA. (1 speakers): Jennifer W. Lim\n  - University of Melbourne, VIC, Australia. (1 speakers): Louise K. Kostos\n  - University of Western Australia, Medical School, Division of Obstetrics and Gynaecology, Perth, Australia. (1 speakers): Paul A. Cohen\n\n**Austria (21 institutions, 25 speakers)**\n  -  (1 speakers): Emil T. Bauernhofer\n  - Department of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria. (1 speakers): Michaela Bayerle-Eder\n  - Department of Gynecology and Gynecological Oncology, Medical University of Vienna, Vienna, Austria. (1 speakers): Christine Deutschmann\n  - Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria. Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. (1 speakers): Christoph Minichsdorfer\n  - Department of Medicine I, Division of Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. (1 speakers): Rupert Bartsch\n  - Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria. (3 speakers): Elisabeth S. Bergen, Hannah C. Puhr, Julia M. Berger\n  - Department of Obstetrics and Gynaecology, Breast Cancer Center Tirol, Medical University of Innsbruck, Innsbruck, Austria. (1 speakers): Christian Marth\n  - Department of Obstetrics and Gynaecology, Comprehensive Cancer Center - Gynaecologic Cancer Unit, Medical University of Vienna, Vienna, Austria. (1 speakers): Nicole Concin\n  - Department of Orthopaedics and Traumatology, Medical University of Graz, Graz, Austria. (1 speakers): Andreas Leithner\n  - Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria. (1 speakers): Veronika I. Engele\n  - Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna/AKH Wien, Währinger Gürtel 18-20, Vienna, Austria. (1 speakers): Alina E. Sturdza\n  - Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. (1 speakers): Gero Kramer\n  - Division of Neuroradiology and Musculoskeletal Radiology, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria. (1 speakers): Julia Furtner\n  - Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. (1 speakers): Nina Dobric\n  - Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria, Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I (1 speakers): Angelika M. Starzer\n  - Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. (1 speakers): Gerald Prager\n  - Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. (3 speakers): Anna Sophie Berghoff, Lynn Gottmann, Markus Kleinberger\n  - Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Gürtel 18-20, Vienna (1 speakers): Vincent Sunder-Plassmann\n  - Institute for Nursing Science and Practice, Paracelsus Medical University, Salzburg (1 speakers): Verena Leinemann\n  - Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Clinic Floridsdorf, Vienna, Austria. (1 speakers): Maximilian J. Hochmair\n  - Sigmund Freud University, 1090 Vienna, Austria. (1 speakers): Louisa C. Hempel\n\n**Azerbaijan (1 institutions, 1 speakers)**\n  - National Center of Oncology, Baku, Azerbaijan. (1 speakers): Samira R. Mahmudova\n\n**BA (1 institutions, 1 speakers)**\n  - Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, Department of Surgical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. (1 speakers): Paula Ugalde\n\n**Barcelona (2 institutions, 2 speakers)**\n  - Cancer Institute and Blood Disorders, Hospital Clinic de Barcelona, Barcelona, Spain. (1 speakers): Milana A. Bergamino\n  - Medical Oncology Department, Badalona, Spain. (1 speakers): Beatriz Cirauqui Cirauqui\n\n**Beit Jala (1 institutions, 1 speakers)**\n  - Beit Jala Governmental Hospital, Ministry of Health, Palestine. (1 speakers): Bilal Awad\n\n**Belarus (1 institutions, 1 speakers)**\n  -  (1 speakers): Marina Puchinskaya\n\n**Belgium (47 institutions, 53 speakers)**\n  -  (4 speakers): Annika M. Nowak, Maya Matthews, Michele Morel, Patrick Schoeffski\n  - 1International Rice Research Institute, DAPO Box 7777, Los Baños (1 speakers): Joshua Cobb\n  - Antwerp, Belgium. (1 speakers): Andre Deschamps\n  - Berlin, EU-OPENSCREEN, Germany. (1 speakers): Wolfgang Fecke\n  - Breast Cancer Translational Research Laboratory J-C Heuson, Brussels, Belgium, Brussels, Belgium. (1 speakers): Marcela Carausu\n  - Breast Cancer Translational Research Laboratory, Brussels, Belgium. (1 speakers): Christos Sotiriou\n  - Breast Cancer Translational Research Laboratory, Department of Medical Oncology, Brussels, Belgium. (1 speakers): Laetitia Collet\n  - Brussels, Belgium. (1 speakers): Soraia Lobo-Martins\n  - Bruxelles 1070, Belgium. (1 speakers): Evandro De Azambuja\n  - Clinical Trials Conduct Unit, Brussels, Belgium. (1 speakers): Philippe Aftimos\n  - Department of Dermatology, University Hospital Ghent, Ghent, Belgium. (1 speakers): Amber Shen\n  - Department of General Medical Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, Leuven, B-3000, Belgium. (1 speakers): Hans Wildiers\n  - Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, Belgium. (1 speakers): Oliver E. Bechter\n  - Department of Hepatology and Digestive Oncology, University Hospital Gasthuisberg, Leuven, Belgium. (1 speakers): Chris Verslype\n  - Department of Medical Oncology - NETwerk, University Hospital Antwerp, Edegem, Flanders, Belgium. (1 speakers): Siddharth Chhajlani\n  - Department of Medical Oncology, Brussels, Belgium. (2 speakers): Emmanuel Seront, Gil Awada\n  - Department of Medical Oncology, Centres Hospitaliers Universitaires HELORA, La Louvière, Belgium. (1 speakers): Guillaume Grisay\n  - Department of Medical Oncology, Ghent University Hospital, Gent, Belgium. (1 speakers): Alexander Decruyenaere\n  - Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium. (2 speakers): Hannelore Denys, Michael Saerens\n  - Department of Medical Oncology, Institute Jules Bordet, Brussels, Belgium. (1 speakers): Michail Ignatiadis\n  - Department of Medical Oncology, Laarbeeklaan 101, Brussels, Belgium. (1 speakers): Nathalie Vanlaer\n  - Department of Medical Oncology, Maria Middelares Hospital, Gent, Belgium, Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium. (1 speakers): Christof Vulsteke\n  - Department of Oncology, Yvoir, Belgium. (1 speakers): Maxime Collin\n  - Department of Pulmonology and Thoracic Oncology, Jessa Hospital, Hasselt, Belgium. (1 speakers): Kristof Cuppens\n  - Department of Radiation Oncology, Wilrijk-Antwerp, Belgium, University of Antwerp, Faculty of Medicine and Health Sciences, Wilrijk-Antwerp, Belgium. (1 speakers): Philip Poortmans\n  - Department of Urology, Brussels, Belgium. (1 speakers): Bertrand Tombal\n  - Division of Gynaecological Oncology, Leuven Cancer Institute, University Hospital Leuven and KU Leuven, Leuven, Belgium. (1 speakers): Toon Van Gorp\n  - European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium. (1 speakers): Denis A. Lacombe\n  - European Organisation for Research and Treatment of Cancer, Belgium. (1 speakers): Iryna Shakhnenko\n  - General Hospital Sint-Maarten, Mechelen, Belgium. Electronic address: alex.decaluwe@bordet.be. (1 speakers): Alex De Caluwe\n  - Imaging and Pathology, Belgium, Department of Nuclear Medicine, University Hospitals UZ Leuven 3000 Leuven, Belgium. (1 speakers): Karolien Goffin\n  - Institut Roi Albert II, Cliniques Universitaires Saint-Luc and Institute for Experimental and Clinical Research (IREC, Brussels, Belgium. (1 speakers): Jean-Pascal Machiels\n  - King Albert II Cancer Institute, Department of Medical Oncology, B-1200, Brussels, Belgium. (1 speakers): Sandra Schmitz\n  - Laboratory for Medical and Molecular Oncology (LMMO), Translational Oncology Research Center (TORC), Brussels, Belgium. (1 speakers): Bart Neyns\n  - Laboratory for Medical and Molecular Oncology, Translational Oncology Research Center, Brussels, Belgium. (1 speakers): Marthe Verhaert\n  - Medical Oncology Department, Brussels (1 speakers): Anouk Goudsmit\n  - Medical Oncology Department, Brussels, Belgium. (1 speakers): Jeremy Blanc\n  - Niel, Belgium. (1 speakers): Dirk Goossens\n  - Patient Advocat, Hasselt, Belgium. (1 speakers): Erik A. Briers\n  - Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. (1 speakers): Madeline Pe\n  - School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul 34752, Türkiye. (1 speakers): Bengisu Karakose\n  - Science, Graz University of Technology, Graz, Austria. (1 speakers): Monica Racovita\n  - Team Laboratory for Medical and Molecular Oncology (LMMO), Translational Oncology Research Center (TORC), Laarbeeklaan 101, Belgium. (1 speakers): Iris Dirven\n  - University Hospitals Leuven (UZ), Louvain, Belgium. (1 speakers): Johan F. Vansteenkiste\n  - University Hospitals Leuven, Leuven, Belgium. (2 speakers): Annelies T. Verbiest, Eric Van Cutsem\n  - University of Brescia, Brescia, Italy. (1 speakers): Edoardo Pisani\n  - aDepartment of General Oncology, Center Oscar Lambret, Lille, France bMedical Oncology Clinic, Brussels, Belgium. (1 speakers): Nuria Kotecki\n\n**Bolivia (1 institutions, 1 speakers)**\n  - University Hospital Marqués de Valdecilla, Santander, Spain. (1 speakers): Lucia Richter Paz\n\n**Bolzano (1 institutions, 1 speakers)**\n  - Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK. (1 speakers): Melissa Frizziero\n\n**Brazil (40 institutions, 50 speakers)**\n  -  (11 speakers): Amanda F. Villarino, Andre L. Cicilini, Breno Jeha, Henrique Larsen, Leila C. Taguchi, Lin I. Ter, Lygia Maria Costa Soares Rego, Nathalia Machado Soldi, Patrick V. Cerqueira, Pedro Cacilhas, Taina Da Rosa Bourckhardt\n  - AC Camargo Cancer Center, São Paulo 01509-900, Brazil. (1 speakers): Marcos Camandaroba\n  - Alfenas Federal University (Unifal-MG), Minas Gerais, Brazil. Electronic address: daniel.faria@unifal-mg.edu.br. (1 speakers): Daniel V. Almeida\n  - BP-The São Paulo Portuguese Beneficence. (1 speakers): Jessica R. Gomes\n  - CLION, CAM Group, Salvador, Brazil. (1 speakers): Rodrigo S. Guindalini\n  - Clinical Oncology, Natal, Brazil. (1 speakers): Sulene C. Oliveira\n  - Clinical Research and Technological Development Division, Rio de Janeiro, Brazil. (1 speakers): Gustavo D. Bretas\n  - Department of Anthropology, University of Texas at San Antonio, TX, USA. (1 speakers): Fernando A. Campos\n  - Department of Clinical Oncology, A.C. Camargo Cancer Center, São Paulo 01509-010, Brazil. (1 speakers): Angelo B. Brito\n  - Department of Clinical Oncology, AC Camargo Cancer Center, São Paulo, Brazil. (1 speakers): Rachel Riechelmann\n  - Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas. (1 speakers): Denis Leonardo F. Jardim\n  - Department of Medical Biology, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia. (1 speakers): William William\n  - Department of Medical Oncology and Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, Hospital Israelita Albert, São Paulo, São Paulo, Brazil. (1 speakers): Miguel Zugman\n  - Department of Microbiology, School of Medicine, University of California, CA 90095-1747, USA. (1 speakers): Debora M. Santana\n  - Department of Oncology and Hematology, Santa Lucia Hospital, Brasília, Brazil. (1 speakers): Fernando S. Monteiro\n  - Department of Social Medicine, University of São Paulo, São Paulo, Brazil. (1 speakers): Joao Souza\n  - Division of Clinical Research and Technological Development, Rio de Janeiro, Brazil. (1 speakers): Bruna B. Lopes David\n  - Federal Fluminense University, Rio de Janeiro, Brazil. luis_leite@id.uff.br. (1 speakers): Luis F. Leite\n  - Federal University of Ceará Medical School, Fortaleza, Brazil. (1 speakers): Joao Evangelista P. Conrado\n  - Federal University of Ceará, Ceara, Brazil. (1 speakers): Mariana M. Noronha\n  - Graduate Program in Nutrition and Health, Health Sciences Center at the Federal University of Espírito Santo (UFES), Vitória 29040-091, ES, Brazil. (1 speakers): Luis Carlos Lopes-Junior\n  - Guarapuava, Brazil. (1 speakers): Maria I. Dacoregio\n  - HCor Hospital, SP, Brazil. (1 speakers): Henrique A. Helber\n  - Health Sciences Postgraduate Program, Federal University of Rio Grande Norte (UFRN), Natal, Brazil. (1 speakers): Kleyton S. Medeiros\n  - Hospital Beneficência Portuguesa, Departamento de Oncologia, São Paulo, SP, Brasil, Hospital Erasto Gaertner, Curitiba, PR, Brasil. (1 speakers): Murilo De Almeida Luz\n  - Hospital Sirio-Libanes, SP, Brazil. (1 speakers): Carlos H. Dos Anjos\n  - Hospital Universitário da Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil. vivi.reumato@gmail.com. (1 speakers): Viviane P. Basilio de Souza\n  - Hospital das Clínicas HCFMUSP, SP, Brazil. (1 speakers): Allan I. Strauss\n  - Instituto de Psiquiatria, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. (1 speakers): Rafael T. Costa\n  - Laboratory of Immunophysiology of Reproduction, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, MG, Brazil. (1 speakers): Fernanda C. Oliveira\n  - Laboratório de Desenvolvimento de Vacinas, Instituto Butantan, São Paulo, Brazil. (1 speakers): Luciana D. Leite\n  - Laboratório de Sanidade Animal (LSA), Universidade Estadual do Norte Fluminense Darcy Ribeiro (UENF), Campos dos Goytacazes, RJ, 28013-602, Brazil. (1 speakers): Luanna Oliveira\n  - Liga Norte Riograndense Contra O Câncer, Avenida Miguel Castro, 1355-Nossa Senhora de Nazaré, Natal, RN, 59062-000, Brazil. (1 speakers): Danielli De Almeida Matias\n  - National Institute of Cardiology, RJ, Brazil. (1 speakers): Mariana C. Carvalho\n  - Oncology Center, Albert Einstein Hospital, SP, Brazil. (1 speakers): Juliana R. Beal\n  - Oncology Research Center, Hospital São Lucas, Brazil. (1 speakers): Carlos H. Barrios\n  - Professor Edgard Santos University Hospital, Medical School, Salvador (BA), Brazil. (1 speakers): Diego Lopes Paim Miranda\n  - Research Centre in Sports, Health, University of Beira Interior, Portugal. (1 speakers): Joao P. Oliveira\n  - University of Campinas (UNICAMP), SP, Brazil. (1 speakers): Ericka F. Costa\n  - University of São Paulo, São Paulo, Brazil. (1 speakers): Larissa Garcia\n\n**British Columbia (2 institutions, 2 speakers)**\n  - Department of Medicine, University of British Columbia, Vancouver, Canada. (1 speakers): Kim Nguyen Chi\n  - Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. (1 speakers): Sharlene Gill\n\n**Bulgaria (3 institutions, 3 speakers)**\n  - Department of Radiotherapy, MHAT \"Heart and Brain\", Pleven, Bulgaria. (1 speakers): Kiril Z. Zhelev\n  - Oncodermatology Department, National Oncology Center, Sofia, Bulgaria. (1 speakers): Iva Gavrilova\n  - University of Amsterdam and Amsterdam Public Health research institute, University of Amsterdam and Amsterdam Public Health research institute, The Netherlands. (1 speakers): Tsvetan Y. Yordanov\n\n**CA (14 institutions, 14 speakers)**\n  - David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, California. (1 speakers): Gottfried E. Konecny\n  - Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA. (1 speakers): Sumanta K. Pal\n  - Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA (1 speakers): Marwan Fakih\n  - Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, USA. (1 speakers): Samuel J. Klempner\n  - Department of Medicine, Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA, USA. (1 speakers): Heather Wakelee\n  - Department of Surgery, University of California San Francisco, CA, USA. (1 speakers): Laura Esserman\n  - Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. (1 speakers): David R. Gandara\n  - Division of Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, CA 90048, USA, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, CA 90048, USA, Department of Urology (1 speakers): Edwin M. Posadas\n  - Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, CA, USA. (1 speakers): Heinz Josef Lenz\n  - Jonsson Comprehensive Cancer Center, University of California Los Angeles, CA, USA. (1 speakers): Antoni Ribas\n  - Sarcoma Oncology Center/Cancer Center of Southern California, CA 90403, USA. (1 speakers): Sant P. Chawla\n  - University of California San Diego Moores Cancer Center, CA, USA. (1 speakers): Lyudmila Bazhenova\n  - University of California San Francisco Helen Diller Family Comprehensive Cancer Center, CA (1 speakers): Hope S. Rugo\n  - University of Washington Fred Hutchinson Cancer Center, Seattle, WA, USA. (1 speakers): Sara A. Hurvitz\n\n**CEDEX (25 institutions, 25 speakers)**\n  - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London NW1 1AT, UK, Université de Lorraine, Service de Biopathologie, France. (1 speakers): Alexandre Harle\n  - Department of Cancer Medicine, Thoracic Group and International Center for Thoracic Cancers, Paris-Saclay University, Villejuif, France. (1 speakers): Benjamin Besse\n  - Department of Drug Development and Innovation (D3i), Paris, France. (1 speakers): Raphael Sanchez\n  - Department of Gastroenterology and Hepatology, Poitiers University Hospital, France. (1 speakers): David Tougeron\n  - Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. (1 speakers): Stephane Champiat\n  - Department of Medical Oncology, Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France. (1 speakers): Mehdi Brahmi\n  - Department of Medical Oncology, Hospital Foch, Suresnes, France. (1 speakers): Jaafar Bennouna\n  - Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France. (1 speakers): Maurice Perol\n  - Department of Medical Oncology, Strasbourg, France. (1 speakers): Justine Gantzer\n  - Department of Medical Oncology, University Hospital of Besançon, Besançon, France. (1 speakers): Stefano Kim\n  - Department of Medical Oncology, University Hospital of Strasbourg, Place de L'hopital, Strasbourg, France. (1 speakers): Philippe Barthelemy\n  - Department of Medical Oncology, University of Lyon, Centre Léon Bérard, Lyon, France. (1 speakers): Jerome Fayette\n  - Department of Medicine, Centre Leon Berard, UNICANCER & University Lyon I, Lyon, France. (1 speakers): Jean-Yves Blay\n  - Department of Oncology, University Hospital Besancon, Besancon, France. (1 speakers): Elsa Curtit\n  - Departments of Neurosurgery and Neurology, University Hospital Zurich, Ramistrasse 102, Zurich, Switzerland. (1 speakers): Emilie Le Rhun\n  - Drug Development Department, Gustave Roussy Cancer Campus, France. (1 speakers): Capucine Baldini\n  - Département d'Oncologie Médicale, France. (1 speakers): Vincent Massard\n  - EFS, INSERM, UMR RIGHT, France, Department of Medical Oncology, University Hospital of Besançon (1 speakers): Olivier Adotevi\n  - ICO René Gauducheau, France. (1 speakers): Mario Campone\n  - Medical Oncology Department, Centre Eugene - Marquis, Rennes, France. (1 speakers): Julien Edeline\n  - Medical Oncology Department, Centre Léon Bérard, GINECO, Lyon, France. (1 speakers): Isabelle L. Ray-Coquard\n  - Medical Oncology Department, Saint-Herblain, France. (1 speakers): Jean-Sebastien Frenel\n  - Medical Oncology Department, University Hospital Dupuytren, Limoges, France. (1 speakers): Elise Deluche\n  - Paris-Saclay University, Department of Cancer Medicine, Villejuif, France. (1 speakers): Jean-Charles Soria\n  - Unité d'Oncologie médicale, Groupement Hospitalier Sud, Pierre-Bénite, France. (1 speakers): Benoit You\n\n**CEDEX 10 (2 institutions, 2 speakers)**\n  - AP-HP Dermato-oncology, Cancer institute APHP.nord Paris cité, INSERM U976, Saint Louis Hospital, Paris, France. (1 speakers): Celeste Lebbe\n  - Department of Medical Oncology, Paris, France. (1 speakers): Sophie Frank\n\n**CEDEX 3 (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France. (1 speakers): Armelle Dufresne\n\n**CEDEX 5 (5 institutions, 5 speakers)**\n  - Columbia University Medical Center, Memorial Sloan Kettering Cancer Center, NY, Paris, Centre Antoine-Lacassagne, Nice, France, Leiden University Medical Center, Leiden, the Netherlands (1 speakers): Manuel J. Rodrigues\n  - Department of Medical Oncology, Institute Curie, Université Paris Cité, France. (1 speakers): Jean-Yves Pierga\n  - Department of Medical Oncology, PSL Research University, Paris, France. (1 speakers): Sophie Piperno-Neumann\n  - Montpellier Cancer Institute, Montpellier, France. (1 speakers): Diego Tosi\n  - Oncology Department, Centre for Cancer Immunotherapy, INSERM U932, PSL Research University, Paris, France. (1 speakers): Emanuela Romano\n\n**CEDEX 9 (1 institutions, 1 speakers)**\n  - Immunity and Cancer Team, Cancer Research Centre of Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Paoli-Calmettes Institute, Aix-Marseille University Marseille, France. (1 speakers): Philippe Rochigneux\n\n**CO (2 institutions, 2 speakers)**\n  - Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, University of Toronto, Toronto, ON, Canada. (1 speakers): Anna Spreafico\n  - University of Colorado Cancer Center, Aurora, CO. (1 speakers): Sapna P. Patel\n\n**Cambridgeshire (1 institutions, 1 speakers)**\n  - Cambridge University Hospitals NHS Foundation Trust (Addenbrooke's Hospital), Cambridge CB2 0QQ, UK. (1 speakers): Philippa G. Corrie\n\n**Canada (59 institutions, 64 speakers)**\n  -  (4 speakers): Alda Aleksi, Camille S. Piquette, Madeline Rhind, Marie-Frederique Damours\n  - BC Cancer Agency, Vancouver, Canada. (1 speakers): J. Connor Wells\n  - BC Cancer Research Centre, Vancouver, BC, Canada. (1 speakers): Stephen Chia\n  - BC Cancer, University of British Columbia, Vancouver, BC, Canada. (1 speakers): Janessa Laskin\n  - Cancer Therapeutics Program, The Ottawa Hospital Research Institute, Ottawa, Canada. (1 speakers): Terry L. Ng\n  - Centre Hospitalier de l'Université de Montréal, Montreal, QC H3C 3J7, Canada. (1 speakers): Denis Soulieres\n  - Centre Intégré de Cancérologie de la Montérégie, Université de Sherbrooke, Longueuil, QC J4V 2H1, Canada. (1 speakers): Nathalie Daaboul\n  - Centre de Recherche du Centre Hospitalier Universitaire de Montréal, Montréal, Canada. (1 speakers): Julie Malo\n  - Cumming School of Medicine, University of Calgary, Calgary, AB T2N 2T8, Canada. (1 speakers): Steven M. Yip\n  - Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. (1 speakers): Chloe Lim\n  - Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China. (1 speakers): Xin Ye\n  - Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada. (1 speakers): Francois-Michel Boisvert\n  - Department of Life Science, Aberystwyth University, UK. (1 speakers): Amanda J. Gibson\n  - Department of Medical Oncology, Juravinski Cancer Center, McMaster University, Hamilton, Ontario, Canada. (1 speakers): Aly-Khan Lalani\n  - Department of Medicine, Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Institut du cancer de Montréal, Montréal, Québec, Canada. (1 speakers): Fred Saad\n  - Department of Medicine, McGill University Health Centre, Montreal, QC, Canada, Center for Innovative Medicine, McGill University Health Centre, Montreal, QC (1 speakers): Thierry Alcindor\n  - Department of Medicine, Medical Oncology Division, BC Cancer, Vancouver Centre, University of British Columbia, BC, Canada. (1 speakers): Guliz Ozgun\n  - Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1 (1 speakers): Ana Elisa Lohmann\n  - Department of Medicine, University of Toronto, Toronto, ON, Canada. (2 speakers): David W. Cescon, Simron Singh\n  - Department of Molecular Oncology, BC Cancer Agency, Part of the Provincial Health Services Authority, Vancouver, Canada. (1 speakers): Annalena F. Renner\n  - Department of Oncology, McMaster University, Hamilton, ON, Canada. (1 speakers): Rosalyn Juergens\n  - Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada. (1 speakers): Omar F. Khan\n  - Department of Pathology & Laboratory Medicine, The University of British Columbia, Vancouver, Canada. (1 speakers): Diana Ionescu\n  - Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, 620 University Ave., Toronto, ON, M5G 2C1, Canada. (1 speakers): Camilla Zimmermann\n  - Department of Supportive Care, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. (1 speakers): Kaviya Devaraja\n  - Division of Cancer Care and Epidemiology, Sinclair Cancer Research Institute at Queen's University, Kingston, ON, Canada. (1 speakers): Christopher M. Booth\n  - Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada. (1 speakers): David Maj\n  - Division of Hematology-Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC H2X 0C1, Canada. (1 speakers): Marie Florescu\n  - Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. (1 speakers): Philippe L. Bedard\n  - Division of Medical Oncology and Haematology, Department of Medicine, Princess Margaret Hospital Cancer Centre, University of Toronto, Toronto, Ontario, Canada. (1 speakers): Erick F. Saldanha\n  - Division of Medical Oncology, Moncton Hospital, Moncton, NB, Canada. (1 speakers): Mahmoud Abdelsalam\n  - Division of Medical Oncology, Princess Margaret Cancer Centre (PMCC), University Health Network (UHN), Toronto, ON, Canada, Faculty of Medicine, University of Toronto, Toronto, ON (1 speakers): Jamie Feng\n  - Division of Medical Oncology, University of Toronto, Princess Margaret Cancer Center, Toronto, ON, Canada. (1 speakers): Srikala S. Sridhar\n  - Division of Urology, Department of Surgery, McMaster University, Hamilton, Ontario, Canada. (1 speakers): Jehonathan H. Pinthus\n  - Faculty of Medicine and Health Sciences of Sherbrooke, Sherbrooke, Canada. (1 speakers): Nissim M. Frija-Gruman\n  - Faculty of Medicine, King Saud Bin Abdul-Aziz University for Health Sciences (KSAU-HS), King Fahad Medical City, Riyadh (1 speakers): Anas A. Alghamdi\n  - Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. (1 speakers): Ali Shahini\n  - Faculty of Medicine, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada. (1 speakers): Sarah Yeo\n  - Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada. (1 speakers): Stephanie Mercier\n  - Faculty of Nursing, University of Calgary, Calgary, AB, Canada, Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada (1 speakers): Colleen Cuthbert\n  - Glans-Look Lung Cancer Research, Cumming School of Medicine, University of Calgary, Alberta, Canada. (1 speakers): Vishal Navani\n  - Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, Keele, UK. (1 speakers): James Nolan\n  - Montreal, Canada. (1 speakers): Patrick Gagnon-Sanschagrin\n  - Oncology Department, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. (1 speakers): Quincy Siu-chung Chu\n  - Princess Margaret Hospital, Toronto, ON, Canada. (1 speakers): Natasha Leighl\n  - Toronto General Hospital, Princess Margaret Centre, University of Toronto, Toronto, ON, Canada. (1 speakers): Arndt Vogel\n  - University Health Network, ON M5G 1L7, Canada. Electronic address: daniel.decarvalho@uhn.ca. (1 speakers): Daniel De Carvalho\n  - University Health Network-Princess Margaret Cancer Center, Ontario, Canada. (1 speakers): Beatriz E. Jimenez Munarriz\n  - University Medical Imaging Toronto, Joint Department Medical Imaging, University Health Network, Sinai Health System, Women's College Hospital, University of Toronto, Toronto, ON, M5G 2N2, Canada. (1 speakers): Patrick Veit-haibach\n  - University of British Columbia, BC, Canada. (2 speakers): Amy X. Wang, Florence T. Wu\n  - University of Montreal Hospital Research Centre, Cancer Axis, Montreal, Canada. (1 speakers): Bertrand Routy\n  - University of Montreal Research Center (CR-CHUM), Montreal, QC, Canada. (1 speakers): Jade Maillou\n  - University of Toronto 200 College St Toronto ON Canada., Department of Chemical Engineering and Applied Chemistry, University of Toronto 200 College St Toronto ON Canada. (1 speakers): Charles Y. Jia\n  - University of Western Ontario, Ontario, Canada. (1 speakers): Jonathan Moroniti\n  - Université de Montréal, Centre de Recherche du CHUM (CRCHUM), Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada. (1 speakers): Vanessa Samouelian\n  - Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. (1 speakers): Alexander W. Wyatt\n  - Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. (1 speakers): Sofie H. Tolmeijer\n  - Washington University School of Medicine in St Louis, St Louis, Missouri. (1 speakers): Justin D. Long\n  - Western University, Ontario, Canada. (1 speakers): CARLOS U. MUZLERA\n\n**Changning (1 institutions, 1 speakers)**\n  - Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. China. (1 speakers): Zhichao Wang\n\n**Chiba (4 institutions, 4 speakers)**\n  - Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. (1 speakers): Kohei Shitara\n  - Department of Head and Neck Medical Oncology, National Cancer Center East Hospital, Kashiwa, Chiba (1 speakers): Makoto Tahara\n  - Department of Hepato-Biliary-Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. (1 speakers): Shin Kobayashi\n  - Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Yoshitaka Zenke\n\n**Chile (1 institutions, 1 speakers)**\n  - eDepartment of Oncology, Bradford Hill Clinical Research Center, Santiago, Chile. (1 speakers): Mauricio Burotto\n\n**China (547 institutions, 604 speakers)**\n  -  (19 speakers): Anwaier Aihetaimujiang, Feiei Li, Guingying Wang, Huang Qingting, Huang Y. Jie, Ji Dongmei, Mi I. Xue, Nan'jieanjie Xiao, Quan-feng Shao, Ruihe Liu, Song Q. Le, Su Du, Tangtao Gong, Wang Xiao Hua, Wener He, Xiangting Dai, Xie Jiaxin, Yu Ruofan, ZHENG JINCAO\n  - Affiliated Hospital of Guizhou Medical University, Guizhou Cancer Hospital, Guiyang, Guizhou, China. (1 speakers): TAO WU\n  - Artificial Intelligence Innovation and Incubation Institute of Fudan University & Shanghai Academy of Artificial Intelligence for Science, Shanghai 201111, China. (1 speakers): Zixin Hu\n  - Aurora Sinai/Aurora St. Luke's Medical Centers, Milwaukee, WI, USA. (1 speakers): Chi Cho\n  - BGI Genomics, Shenzhen, China, HIM-BGI Omics Center, Hangzhou Institute of Medicine, BGI Research, Hangzhou (1 speakers): Kui Wu\n  - Beijing Cancer Hospital, Beijing, China. (1 speakers): Jifang Gong\n  - Beijing Institute of Biological Products Co., Ltd, Beijing, China. (1 speakers): Wanping Guo\n  - Beijing Shijitan Hospital, Capital Medical University, Beijing, China. (1 speakers): Liang Wang\n  - BioBank, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China. (1 speakers): Ying Yuan\n  - Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. (1 speakers): Jianli Zhao\n  - Breast Tumour Centre, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. (1 speakers): Erwei Song\n  - CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Shanghai, China. (1 speakers): Jin Li\n  - CAS Key Laboratory of Nutrition, Metabolism and Food Safety Shanghai Institute of Nutrition and Health University of Chinese Academy of Sciences Chinese Academy of Sciences Shanghai China. (1 speakers): Wei Zhang\n  - Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (1 speakers): Chenzhao Feng\n  - Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. (1 speakers): Ruixia Song\n  - Cancer Center, The First Hospital of Jilin University, Changchun, China. (1 speakers): Zhen Guo\n  - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (1 speakers): Xiaorong Dong\n  - Canhelp Genomics Research Center, Ltd., Hangzhou, China. (1 speakers): Qinghua Xu\n  - Center for Reproductive Medicine, Department of Reproductive Endocrinology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China. (1 speakers): Min Zheng\n  - Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, TX, USA. (1 speakers): Qiang Wang\n  - Center of Stomatology, Xiangya Hospital, Central South University, Changsha, China. (1 speakers): Jijia Li\n  - Central Laboratory, Fujian Medical University Union Hospital, Fuzhou, China. (1 speakers): Xiaofang Wen\n  - Central Laboratory, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center ... (1 speakers): CHONG DING\n  - Central Laboratory, School of Medicine, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, Fujian, P.R. China. (1 speakers): Yuxuan Wei\n  - Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge (1 speakers): Xin Yang\n  - Changchun University of Chinese Medicine, Jilin, Changchun, China. (1 speakers): Shuang Zhang\n  - Changzhi Cite People's Hospital, Changzhi, China. (1 speakers): Jun Zhao\n  - China Medical University, Shenyang, Liaoning, China. (1 speakers): Siyuan Chen\n  - China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. (1 speakers): Cai Chen Li\n  - Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. (1 speakers): Zhe Cao\n  - Clinical Medical College, Xuzhou Medical University, Xuzhou, Jiangsu 221000, China, Department of Gynecology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002 (1 speakers): Buze Chen\n  - Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China, Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China (1 speakers): Sufang Qiu\n  - Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China. (2 speakers): Ning Li, Shuhang Wang\n  - Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. (1 speakers): Peiwen Ma\n  - College & Hospital of Stomatology, Anhui Medical University, Key Lab. of Oral Diseases Research of Anhui, Hefei, China. (1 speakers): Qingqing Wang\n  - College of Animal Science and National Engineering Research Center for Breeding Swine Industry, South China Agricultural University, Guangdong, P.R. China. (1 speakers): Cineng Xu\n  - College of Animal Science and Technology, Henan University of Animal Husbandry and Economy, Zhengzhou, China. (1 speakers): Haoyuan Han\n  - College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi 712100, PR China. (1 speakers): Xiaoyu Wang\n  - College of Computer Science and Technology, Xinjiang University, Urumqi, China. (1 speakers): Cheng Chen\n  - College of Ecology Lanzhou University Lanzhou China. (1 speakers): Zhao Zhigang\n  - College of Health Science and Technology (B.S., L.W., X.L., J.T., J.X., Y.Z., H.Z.), Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Yan Zhou\n  - College of Life Sciences, Zhejiang University, Hangzhou 310058, PR China. (1 speakers): Can Chen\n  - Department of Abdominal Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (1 speakers): Xinjun Liang\n  - Department of Abdominal Oncology, Zhejiang Cancer Hospital, Hangzhou, China. (1 speakers): Jieer Ying\n  - Department of Abdominal Surgery, Ganzhou Cancer Hospital, Ganzhou, China. (1 speakers): Zhenhua Liu\n  - Department of Abdominal Surgery, Guiqian International Hospital, China. (1 speakers): Yang Jun\n  - Department of Anaesthesiology, Peking University First Hospital, Beijing, China. (1 speakers): Mo Li\n  - Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, China. (1 speakers): Ke Cui\n  - Department of Anesthesiology, Yantaishan Hospital Affiliated to Binzhou Medical University, Yantai, China. ni518866@163.com. (1 speakers): Shuqin Ni\n  - Department of Anorectal Surgery, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. (1 speakers): Qingming Wang\n  - Department of Basic Medicine, Haihe Clinical School, Tianjin Medical University, Tianjin 300350, China. (1 speakers): Guiying Xu\n  - Department of Basic Medicine, School of Medicine, Foshan University, Foshan, China. (1 speakers): Yang Xun\n  - Department of Basic Public Health, Guangzhou Center for Disease Control and Prevention, Guangzhou 510440, China. (1 speakers): Hui Liu\n  - Department of Biology, University of Washington, Seattle, WA 98195. (1 speakers): Renyu LI\n  - Department of Brain Disease, Nanjing Hospital of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China. (1 speakers): Xiaoyu Liu\n  - Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China. (1 speakers): Quchang Ouyang\n  - Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China. (1 speakers): Xiaoqi Zhang\n  - Department of Breast Disease, Henan Breast Cancer Center, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, No.127, Zhengzhou, People's Republic of China. (1 speakers): Hui Hui Sun\n  - Department of Breast Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China. (1 speakers): Shoubing Zhou\n  - Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. (1 speakers): Chunfang Hao\n  - Department of Breast Pathology and Lab, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer (1 speakers): Xiaojing Guo\n  - Department of Breast Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. (4 speakers): Chenglong Duan, Jianing Zhang, Jinsui Du, Yudong Zhou\n  - Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China. (1 speakers): Shunyi Liu\n  - Department of Breast Surgery, The First Affiliated Hospital With Nanjing Medical University, Nanjing, China. (1 speakers): Sujin Yang\n  - Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, China. (1 speakers): Juan Huang\n  - Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Chongqing Medical University Chongqing 400010 P. R. China 302118@cqmu.edu.cn. (1 speakers): Xiaoqing Yu\n  - Department of Breeding, Shandong Peanut Research Institute, Qingdao, China. Electronic address: 18761869832@163.com. (1 speakers): Qianqian Wang\n  - Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195. (1 speakers): Fei Zhou\n  - Department of Cancer Screening and Prevention, Zhongshan Hospital, Fudan University, Shanghai, China, Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China (1 speakers): Tianshu Liu\n  - Department of Chemistry, University of Warwick, Coventry CV4 7AL (1 speakers): Yujing Chang\n  - Department of Clinical Laboratory Center, Shaoxing People's Hospital, Shaoxing, Zhejiang, China. (1 speakers): Yi Feng\n  - Department of Clinical Laboratory, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin Neurosurgical Institute, Tianjin Huanhu Hospital, Tianjin, China. (1 speakers): Zhi Ji\n  - Department of Clinical Medicine, School of Medical, Wuhan University of Science and Technology, Wuhan 430065, China. (1 speakers): Huiting Wang\n  - Department of Clinical Oncology, Faculty of Medicine, Chinese University of Hong Kong, China. (1 speakers): Herbert Ho Fung Loong\n  - Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, China. (1 speakers): Tony S.K. Mok\n  - Department of Clinical Oncology, The University of Hong Kong (1 speakers): Aya El-Helali\n  - Department of Clinical Oncology, University of Hong Kong and Queen Mary Hospital (1 speakers): Dora L. Kwong\n  - Department of Clinical Pharmacology, School of Pharmacy, China Medical University, Liaoning (1 speakers): Yang Bai\n  - Department of Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (1 speakers): Da-wei Wu\n  - Department of Clinical and Health Informatics, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Suite 600, Houston, TX (1 speakers): Liwei Wang\n  - Department of Colorectal Surgery, Cancer Hospital Chinese Academy of Medical Sciences, Beijing 100021, China. (1 speakers): Xu Guan\n  - Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, PR China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, Shanghai, PR China. (1 speakers): Guoxiang Cai\n  - Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032 (1 speakers): Xinxiang Li\n  - Department of Colorectal Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. (1 speakers): Weifeng Lao\n  - Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Jing-Hua Tang\n  - Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China. (1 speakers): Pei-Rong Ding\n  - Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200080, China. (1 speakers): Mengting Chen\n  - Department of Day Ward, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China. (1 speakers): Yaoyao Jing\n  - Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. (1 speakers): Zihan Xue\n  - Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China, National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology (1 speakers): Hong Liu\n  - Department of Dermatology, Xiangya Hospital, Central South University, Hu Nan Key Laboratory of Aging Biology, Changsha, China. (1 speakers): Min Li\n  - Department of Digestive Surgery, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China. (1 speakers): Guanghui Xu\n  - Department of Disease Prevention and Control, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China. (1 speakers): Wei Ge\n  - Department of Early Drug Development Centre, Peking University Cancer Hospital and Institute, Beijing, China. (1 speakers): Ran Xue\n  - Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Ningning Zhang\n  - Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing 100044, China. (1 speakers): Fang Lv\n  - Department of Endocrinology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, People's Republic of China. (1 speakers): Ting Wang\n  - Department of Endoscopy, General Hospital of Northern Theater Command, China. (1 speakers): Zhuo Yang\n  - Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou 450001, China. (1 speakers): Linlin Li\n  - Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, P.R. China. (1 speakers): Ning Zhao\n  - Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200032, China. (1 speakers): Jing Gao\n  - Department of GI Medical Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin (1 speakers): Ting Deng\n  - Department of Gastric Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou 510060 (1 speakers): Run-Cong Nie\n  - Department of Gastric Surgery, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China. (1 speakers): Xuewei Ding\n  - Department of Gastroenterology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China. Electronic address: ndefy20358@ncu.edu.cn. (1 speakers): Lingling Yang\n  - Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. (1 speakers): Zheng-Hao Ye\n  - Department of Gastrointestinal Medical Oncology National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer (1 speakers): Rui Liu\n  - Department of Gastrointestinal Medical Oncology, Shanxi Province Cancer Hospital / Shanxi Hospital Affiliated to Cancer Hospital (1 speakers): Wenhui Yang\n  - Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China (1 speakers): Lin Shen\n  - Department of Gastrointestinal Oncology, The First Medical Center, Chinese PLA General Hospital, Beijing, China. (1 speakers): Rongrui Liu\n  - Department of Gastrointestinal Surgery Shandong Provincial Hospital Shandong University Jinan Shandong China. (1 speakers): Yuan Liu\n  - Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. (1 speakers): Leping Li\n  - Department of Gastrointestinal Surgery, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China. (1 speakers): FEI MA\n  - Department of Gastrointestinal Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China. (1 speakers): Jianping Zhou\n  - Department of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China (1 speakers): Chenan Liu\n  - Department of Gastrointestinal, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China. (1 speakers): Defeng Chen\n  - Department of General Surgery, Department of Colorectal Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. (1 speakers): Wentao Tang\n  - Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China. litao7706@163.com. (1 speakers): Qi-Hang Cao\n  - Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. (1 speakers): Qiwu Zhao\n  - Department of General Surgery, Sir Run Run Shaw Hospital & Zhejiang University School of Medicine, Hangzhou, China. (1 speakers): Defei Hong\n  - Department of General Surgery, Tangdu Hospital, The Air Force Medical University, Xi'an, China. (1 speakers): Jiaxing He\n  - Department of General Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, People's Republic of China. (1 speakers): Junyuan Lv\n  - Department of General Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. (1 speakers): Kai Xu\n  - Department of Gynaecologic Oncology Fudan University Shanghai Cancer Center, Fudan University Shanghai China. (2 speakers): Jin Li, Xiaohua Wu\n  - Department of Gynaecology and Obstetrics, West China Second Hospital, Sichuan University, No. 20, Sect. 3, Chengdu, Sichuan, People's Republic of China. (1 speakers): Yu Fan\n  - Department of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing 400030, China. (1 speakers): Dongling Zou\n  - Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. (1 speakers): Chunyan Song\n  - Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (1 speakers): Lingying Wu\n  - Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. (1 speakers): Jihong Liu\n  - Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (1 speakers): Canhui Cao\n  - Department of Gynecology and Oncology, Beijing Obstetrics and Gynecology Hospital Affiliated to Capital Medical University, Beijing, China. (1 speakers): Yue He\n  - Department of Gynecology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang 110042, China, Department of Gynecology (1 speakers): Danbo Wang\n  - Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, No. 420, Jin'an District, Fuzhou, Fujian, China. (2 speakers): Lele Chang, Yaxin Kang\n  - Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China. (4 speakers): Kang Ning, Shida Yan, Shuwei Chen, Xuekui Liu\n  - Department of Hematology, Jinan Central Hospital affiliated to Shandong First Medical University, Jinan, China. (1 speakers): Juan Wang\n  - Department of Hematology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. (1 speakers): Shuzhao Chen\n  - Department of Hematology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P.R. China. (2 speakers): Haotian Yan, Ruotong Chen\n  - Department of Hematology, Xuanwu Hospital, Capital Medical University, Beijing, China. (1 speakers): Li Su\n  - Department of Hepatobiliary Surgery & Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China. (1 speakers): Jian Zhou\n  - Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China, Key Laboratory of Carcinogenesis and Cancer Invasion (1 speakers): Hui-Chuan Sun\n  - Department of Hepatobiliary Surgery and Liver Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China (2 speakers): Guoming Shi, Jia Fan\n  - Department of Hepatobiliary Surgery and Liver Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China. (1 speakers): Xinrong Yang\n  - Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (1 speakers): Ruoyu Zhang\n  - Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang, China (1 speakers): Xueli Bai\n  - Department of Hospital Administration, Fourth People's Hospital of Changzhou, Changzhou, China. (1 speakers): Jingping Yu\n  - Department of Immunology, Medical School of Nantong University, Nantong, Jiangsu, China. (1 speakers): Ling Zuo\n  - Department of Internal Medicine Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Number 440, Jinan 250117, China. (1 speakers): Haiyong Wang\n  - Department of Internal Medicine-Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China. (1 speakers): Xiaoling Shang\n  - Department of Interventional Radiology, Guangdong Provincial People's Hospital, Guangzhou, People's Republic of China. (1 speakers): Feng Shi\n  - Department of Interventional Radiology, The First Affiliated Hospital of South University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen People's Hospital (1 speakers): Jianxi Guo\n  - Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. (1 speakers): Bailu Wu\n  - Department of Laboratory Medicine The Affiliated Changsha Hospital of Xiangya School of Medicine (The First Hospital of Changsha) Central South University Changsha Hunan China. (1 speakers): Wu Yong\n  - Department of Laboratory Medicine, Guangdong Second Provincial General Hospital, Guangzhou 510317, China. (1 speakers): Li-Mei ZHONG\n  - Department of Laboratory Medicine, School of Medical Technology, Tianjin Medical University, Tianjin, China. (1 speakers): Jinhao Yang\n  - Department of Laboratory Medicine, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China. (1 speakers): Ting Ye\n  - Department of Liver Surgery & Liver Transplantation, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy (1 speakers): Mingheng Liao\n  - Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. (1 speakers): Mingjian Piao\n  - Department of Liver Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China (1 speakers): Kefei Yuan\n  - Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China. (1 speakers): Xinhao Xiong\n  - Department of Lung Cancer Surgery, Tianjin Lung Cancer Institute, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. (1 speakers): Mengzhe Zhang\n  - Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. (1 speakers): Dongsheng Yue\n  - Department of Lymphoma & Head and Neck Oncology, College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou, China. (1 speakers): Jiesong Wang\n  - Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Yijing Li\n  - Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China. (1 speakers): Wenyu Li\n  - Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy (1 speakers): Yaxiao Lu\n  - Department of Medical Oncology Shanghai Pulmonary Hospital, School of Medicine, Tongji University Shanghai People's Republic of China. (1 speakers): Anwen Xiong\n  - Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China. (1 speakers): Danyun Ruan\n  - Department of Medical Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China. (1 speakers): Yanfang Zheng\n  - Department of Medical Oncology, Beijing Chao yang District San huan Cancer Hospital, Beijing, China. (1 speakers): Jinping Pi\n  - Department of Medical Oncology, Beijing Chaoyang District Sanhuan Cancer Hospital, Beijing, China, Department of Medical Oncology, The Second Hospital of Dalian Medical University, Liaoning, China. (1 speakers): Die Sang\n  - Department of Medical Oncology, Beijing Chaoyang District Sanhuan Cancer Hospital, Beijing, China. (1 speakers): Yanfang Su\n  - Department of Medical Oncology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China. (1 speakers): Yi-Kun Kang\n  - Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (2 speakers): Haohua Zhu, Yuan-Kai Shi\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (1 speakers): Jingrui Jiang\n  - Department of Medical Oncology, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China (2 speakers): RunKai Cai, Weixiang Zhan\n  - Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China. (1 speakers): Biyun Wang\n  - Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. (3 speakers): Jian Zhang, Weijian Guo, Yuxin Mu\n  - Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China. (1 speakers): Na Yao\n  - Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China. Electronic address: 0566@hrbmu.edu.cn. (1 speakers): Qingyuan Zhang\n  - Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (3 speakers): Jiayu Wang, Pin Zhang, Ying Fan\n  - Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (4 speakers): Hangcheng Xu, Jiaxuan Liu, Linyan Tian, Xuenan Peng\n  - Department of Medical Oncology, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (1 speakers): Liuliu Quan\n  - Department of Medical Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Shun Lu\n  - Department of Medical Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China. (1 speakers): Yongfeng Yu\n  - Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China. (1 speakers): Wengang Zhang\n  - Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. (1 speakers): Caicun Zhou\n  - Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Jiajia Huang\n  - Department of Medical Oncology, Sun Yat-sen University Cancer Center, China, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer (1 speakers): Ting Zhou\n  - Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China. (1 speakers): Zhi-Ming Li\n  - Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China. (1 speakers): Wen Feng Fang\n  - Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine (1 speakers): Huaqiang Zhou\n  - Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. (1 speakers): Ran Ran\n  - Department of Medical Oncology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453199, China. (1 speakers): Yinghua Ji\n  - Department of Medical Oncology, The affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing (1 speakers): Xiaohua Wang\n  - Department of Medical Oncology, The affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China. (1 speakers): Shuyi Hu\n  - Department of Medical Oncology, Xi'an, China. (1 speakers): Xiaohui Jia\n  - Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, China. (1 speakers): Yiyi Yu\n  - Department of Medical Oncology, the Fifth Medical Center, Chinese PLA General Hospital, Beijing 100071, China. (1 speakers): Guanghai Dai\n  - Department of Medical Ultrasound, Shandong Medicine and Health Key Laboratory of Abdominal Medical Imaging (1 speakers): Wei Liu\n  - Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, PR China, Department of Neurosurgery, Beijing Tiantan Hospital (1 speakers): You Zhai\n  - Department of Nasopharyngeal Carcinoma Sun Yat-sen University Cancer Center Guangzhou China. (1 speakers): Zhuoying Luo\n  - Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China. (1 speakers): Jie Yi Lin\n  - Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China. (1 speakers): Jingjing Miao\n  - Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China. (1 speakers): Xuguang Wang\n  - Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. (1 speakers): Zhuang Kang\n  - Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital Capital Medical University Beijing China. (1 speakers): Wenbin Li\n  - Department of Neurology Children's Hospital Capital Institute of Pediatrics Beijing China. (1 speakers): Jun Wang\n  - Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. (1 speakers): Fei Tian\n  - Department of Neurosurgery Xuanwu Hospital, China International Neuroscience Institute, Capital Medical University, National Center for Neurological Disorders Beijing China. (1 speakers): Tao Wang\n  - Department of Neurosurgery, Guangdong Provincial People's Hospital, Guangzhou, People's Republic of China (C.P.). (1 speakers): Chao Peng\n  - Department of Neurosurgery, Neurosurgery Centre, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China. (1 speakers): Aierpati Maimaiti\n  - Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (1 speakers): Wenjie Wu\n  - Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China. (1 speakers): Cheng Liu\n  - Department of Nursing, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China. (1 speakers): Ying Peng\n  - Department of Nutritional, Shanghai Pulmonary Hospital Affiliated to Tongji University, Shanghai, China. (1 speakers): Qin Ding\n  - Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. (2 speakers): MO LI, Qinglei Gao\n  - Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (1 speakers): Ting Peng\n  - Department of Obstetrics and Gynecology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China. (1 speakers): Shujuan Liu\n  - Department of Occupational and Environmental Health, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China (1 speakers): Shaowei Wu\n  - Department of Ocular Oncology and Orbital Diseases, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, People's Republic of China. (1 speakers): Lijuan Tang\n  - Department of Oncology Shanghai Medical College Fudan University Shanghai China. (1 speakers): Qifeng Wang\n  - Department of Oncology Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China. (1 speakers): Huiying Li\n  - Department of Oncology Zhujiang Hospital Southern Medical University Guangzhou Guangdong China. (1 speakers): Peng Luo\n  - Department of Oncology, Affiliated Hospital of Jiangnan University, Wuxi, China. (1 speakers): Hui Yu\n  - Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China. (1 speakers): Qing Lian Wen\n  - Department of Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China. (1 speakers): Weiran Xu\n  - Department of Oncology, Dongying People's Hospital, Dongying, China. (1 speakers): Longxiang Guo\n  - Department of Oncology, First Medical Center, General Hospital of the People'S Liberation Army, Beijing, China. (1 speakers): Sisi Ye\n  - Department of Oncology, Lishui Municipal Central Hospital, Lishui 323000, China. (1 speakers): Jianhui Huang\n  - Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. (1 speakers): Shudong Ma\n  - Department of Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. (1 speakers): Aiping Zhou\n  - Department of Oncology, Shanghai Dongfang Hospital, Tongji University, Shanghai, China. (1 speakers): Ye Guo\n  - Department of Oncology, Shanghai Medical College, Fudan University, Shanghai Genitourinary Cancer Institute, Shanghai 200032, China. (1 speakers): Linhui Zhang\n  - Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China. (1 speakers): Meiqi Shi\n  - Department of Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China. (1 speakers): Qiming Wang\n  - Department of Oncology, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou (1 speakers): Wenyu Zhu\n  - Department of Oncology, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou, China. (1 speakers): Hanjue Dai\n  - Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. cnhzxyq@163.com. (1 speakers): Zhengxiang Han\n  - Department of Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China. (1 speakers): Chuanhua Zhao\n  - Department of Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China. jmxu2003@163.com. (1 speakers): Jianming Xu\n  - Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, P. R. China. (1 speakers): Xicheng Wang\n  - Department of Oncology, The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, P. R. China. (1 speakers): Yiqian Liu\n  - Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. (1 speakers): Xiang Huang\n  - Department of Oncology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China. (1 speakers): Lijuan Meng\n  - Department of Oncology, The First Hospital of Jilin University, Changchun, China. (1 speakers): Ziling Liu\n  - Department of Oncology, The Second Affiliated Hospital, Guizhou Medical University, Kaili, China. (1 speakers): Lili Zhao\n  - Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China. (1 speakers): Qiping Zhuo\n  - Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. (1 speakers): Xueqing Zhang\n  - Department of Oncology, Yibin Second People's Hospital, Yibin, Sichuan, P.R. China. (1 speakers): ShanBing Wang\n  - Department of Oncology, the Second Affiliated Hospital of Harbin Medical University, Harbin, China. (1 speakers): Chengjuan Fan\n  - Department of Ophthalmology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China. (1 speakers): Liping Su\n  - Department of Orthopaedic Oncology Surgery, National Center for Orthopedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China. (1 speakers): Xiaohui Niu\n  - Department of Orthopaedic Oncology Surgery, Peking University Fourth School of Clinical Medicine, Beijing, China. (1 speakers): Qing Zhang\n  - Department of Orthopaedics, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Qiyuan Bao\n  - Department of Orthopaedics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. (1 speakers): Xingyu Yang\n  - Department of Orthopedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopedics, Ruijin Hospital (1 speakers): Yucheng Fu\n  - Department of Otolaryngology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. (1 speakers): Junhui Zhang\n  - Department of Otolaryngology, West China Second University Hospital, Sichuan University, Chengdu, China. (1 speakers): WEI KOU\n  - Department of Otolaryngology-Head Neck Surgery Sleep Medicine Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine Tsinghua University Beijing China. (1 speakers): Juan Li\n  - Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. (1 speakers): Xiaohong Chen\n  - Department of Otorhinolaryngology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. (1 speakers): Weiwei Wang\n  - Department of Palliative Care and Department of Geriatric Oncology, Chongqing University Cancer Hospital, Chongqing400030, People's Republic of China. (1 speakers): Huiqing Yu\n  - Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032 (1 speakers): Xianjun Yu\n  - Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. (1 speakers): HeLi Gao\n  - Department of Pathology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China. (1 speakers): Xiaowei Zhang\n  - Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China. (1 speakers): Midie Xu\n  - Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. (1 speakers): Xujie Sun\n  - Department of Pathology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): QIN YAN\n  - Department of Pathology, The Second Affiliated Hospital of Guilin Medical University, Guilin, China. (1 speakers): Yue Fu\n  - Department of Pathology, University of Massachusetts Medical School, Worcester, MA 01655, USA. (1 speakers): Siwei Nie\n  - Department of Pathology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang (1 speakers): Dan Su\n  - Department of Pediatric Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, China. (1 speakers): Hao Fu\n  - Department of Pediatrics, Wuhan Fourth Hospital, No.76, Wuhan, Hubei, China. (1 speakers): Jing Chen\n  - Department of Pharmacology and Regenerative Medicine, University of Illinois at Chicago, Chicago, IL 60612 (1 speakers): Xinyi Liu\n  - Department of Pharmacology, College of Basic Medical Sciences, Binzhou Medical University, Yantai, SD, China. (1 speakers): Xin Xie\n  - Department of Pharmacy College of Veterinary Medicine Sichuan Agricultural University Chengdu China. (1 speakers): Yang Chen\n  - Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai, China. (1 speakers): Jiefeng Luo\n  - Department of Pharmacy, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China. (1 speakers): Yin Zhang\n  - Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Feng Xu\n  - Department of Plastic and Reconstructive Surgery, Zhongda Hospital, Southeast University, Nanjing, China. (1 speakers): Ke Wang\n  - Department of Psychiatry, Zhejiang Hospital, Hangzhou, China. (1 speakers): Liling Ma\n  - Department of Pulmonary Oncology, Hubei Key Laboratory of Tumor Biological Behavior, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China (1 speakers): Conghua Xie\n  - Department of Pulmonary and Critical Care Medicine, Beijing Hospital, National Centre of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China. (1 speakers): Tongji Xie\n  - Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, China. (1 speakers): Yue Ma\n  - Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China. (1 speakers): Liwen Wang\n  - Department of Radiation Oncology, Beijing Tsinghua Changgeng Hospital, Tsinghua University, Beijing, China. (1 speakers): Guangxin Li\n  - Department of Radiation Oncology, Cancer Center, The Tenth Affiliated Hospital, China. (1 speakers): Tianwang Guan\n  - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China (3 speakers): Chaosu Hu, Weiqing Lu, Xiaomin Ou\n  - Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China hg7913@hotmail.com 39390822@qq.com. (1 speakers): Guang Han\n  - Department of Radiation Oncology, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan 410013, P.R. China. (1 speakers): Yaqian Han\n  - Department of Radiation Oncology, Institute of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, China. (1 speakers): Xinyu Sun\n  - Department of Radiation Oncology, Peking University First Hospital, Beijing, China. (1 speakers): Mingwei Ma\n  - Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center (1 speakers): Lei Wu\n  - Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiao Tong University Medical School of medicine, Shanghai, China. (1 speakers): Cheng Xu\n  - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China (1 speakers): JIanfeng Peng\n  - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. (1 speakers): Xudong Hu\n  - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Jinan, Shandong, China. (1 speakers): Changxing Feng\n  - Department of Radiation Oncology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, China. (1 speakers): Lin Ding\n  - Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Sifen Wang\n  - Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, China. (2 speakers): Baoqing Chen, Mian Xi\n  - Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China. (1 speakers): XinLei Ai\n  - Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, P.R. China. (2 speakers): Chunyan Chen, Yani Zhang\n  - Department of Radiation Oncology, The Affiliated Huizhou Hospital, Guangzhou Medical University, Huizhou, China. (1 speakers): Zhenyu Pan\n  - Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. (1 speakers): Shu Zhou\n  - Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, China. (1 speakers): Jingjing Wang\n  - Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China. (1 speakers): Qiao Qiao\n  - Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China. (1 speakers): Juan Li\n  - Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Hangzhou, Zhejiang, China. (1 speakers): Ting Jin\n  - Department of Radiation Oncology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. (1 speakers): Danfang Yan\n  - Department of Radiation Therapy, The First Affiliated Hospital With Nanjing Medical University, Nanjing, People's Republic of China. (1 speakers): Yinjiao Fei\n  - Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China. (1 speakers): Qiuji Wu\n  - Department of Radiology, China-Japan Friendship Hospital, Beijing, China. (1 speakers): Sheng Xie\n  - Department of Radiology, Peking University People's Hospital, No.11, Beijing, China. (1 speakers): Wenjia Zhang\n  - Department of Radiology, Shanghai Jiao Tong University School of Medicine Affiliated Shanghai Sixth People's Hospital, Shanghai 200233, China. (1 speakers): Hui Li\n  - Department of Radiology, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, China. (1 speakers): Menghong Zou\n  - Department of Radiology, The University of Hong Kong - Shenzhen Hospital, Shenzhen, PR China. (1 speakers): Ziyan Zhou\n  - Department of Radiology, Tianjin Medical University Baodi Hospital, China. (1 speakers): ZHENWEI MIAO\n  - Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P.R. China. (1 speakers): Yang Peng\n  - Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041 Sichuan, China. (1 speakers): Ying Liu\n  - Department of Radiotherapy, Jiangsu Province Hospital, Nanjing, China. (1 speakers): Weilin Xu\n  - Department of Radiotherapy, The 900th Hospital of the Joint Logistics Team (Dongfang Hospital), Xiamen University, Fuzhou, China, Department of Radiotherapy (1 speakers): Wenmin Ying\n  - Department of Radiotherapy, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China. (1 speakers): Liangjun Zhu\n  - Department of Respiratory Disease, Thoracic Disease Center, Zhejiang University School of Medicine First Affiliated Hospital, China. (1 speakers): Jianya Zhou\n  - Department of Respiratory Medicine, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China. (1 speakers): Lan Wang\n  - Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. (1 speakers): Xiaoyi Feng\n  - Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (4 speakers): Huawei Du, Kuofang Huang, Tianqing Chu, Yanwei Zhang\n  - Department of Rheumatology and Immunology, Deyang People's Hospital, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Deyang 618000, China. (1 speakers): Jie Zhang\n  - Department of Spine Surgery, Shanghai East Hospital, Tongji University School of Medicine Shanghai China. (1 speakers): Qian Wang\n  - Department of Stomatology Huashan Hospital, Fudan University, Shanghai, China. (1 speakers): Laiping Zhong\n  - Department of Surgery, NY 10065, USA, Key Laboratory of Pesticide and Chemical Biology (CCNU), Ministry of Education, College of Chemistry, Central China Normal University, Wuhan, Hubei 430079, China. (1 speakers): Lingling Feng\n  - Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, California, USA. (1 speakers): Rui Su\n  - Department of Thoracic Medical Oncology Cancer Hospital Chinese Academy of Medical Sciences Beijing China. (1 speakers): Jie Wang\n  - Department of Thoracic Oncology and Surgery, The First Affiliated Hospital of Guangzhou Medical University (1 speakers): Feng Li\n  - Department of Thoracic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. (1 speakers): Qian Chu\n  - Department of Thoracic Radiotherapy, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Hangzhou, China. Electronic address: xuyj@zjcc.org.cn. (1 speakers): Yujin Xu\n  - Department of Thoracic Surgery and Oncology, Hengqin Hospital, First Affiliated Hospital of Guangzhou Medical University, Hengqin, Guangdong, China. (1 speakers): Wenjun Ye\n  - Department of Thoracic Surgery and Oncology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (1 speakers): Shan Xiong\n  - Department of Thoracic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China. (1 speakers): Qiao Li\n  - Department of Thoracic Surgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou 45003, China. (1 speakers): Tian Xia\n  - Department of Thoracic Surgery, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China. (1 speakers): Chengzhi Ding\n  - Department of Thoracic Surgery, National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. (1 speakers): Runchen Wang\n  - Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China. (1 speakers): Shaoyi Chen\n  - Department of Thoracic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Wangrui Liu\n  - Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Zhigang Li\n  - Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. (1 speakers): Suyu Wang\n  - Department of Thoracic Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Yitao Yang\n  - Department of Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, China. (1 speakers): Xiaobing Li\n  - Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China. (1 speakers): Renquan Zhang\n  - Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi'an, Shaanxi, China. (1 speakers): Weibo Cao\n  - Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China. (1 speakers): Zhenyu Yang\n  - Department of Trauma Center, Zhongda Hospital, Southeast University, Nanjing, People's Republic of China. (1 speakers): Cheng Zhang\n  - Department of Ultrasound and Electrocardiography, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang, People's Republic of China. (1 speakers): Yu Cheng\n  - Department of Urology Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Yulu Peng\n  - Department of Urology Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China. (1 speakers): Pei Dong\n  - Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, China, West China School of Medicine, Sichuan University, Chengdu, China. (1 speakers): Qihao Wang\n  - Department of Urology, Affiliated Drum Tower Hospital Medical School of Nanjing University, Nanjing, People's Republic of China. (1 speakers): Shun Zhang\n  - Department of Urology, First People's Hospital of Kashi, Kashi, China. (1 speakers): Wenkai Zhu\n  - Department of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China (1 speakers): Bo Dai\n  - Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China (1 speakers): Xiaojie Bian\n  - Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China. (3 speakers): Maoping Cai, Xudong Ni, Yao Zhu\n  - Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China. dwyeli@163.com. (1 speakers): Dingwei Ye\n  - Department of Urology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine of Central South University, Changsha, China. (1 speakers): Shusuan Jiang\n  - Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, P.R. China . (1 speakers): Rang Gao\n  - Department of Urology, Institute of Urology, Sichuan Clinical Research Center for Kidney and Urologic Diseases, West China Hospital, Sichuan University, Chengdu, China. (1 speakers): Zilin Wang\n  - Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing, China. (1 speakers): Wenli Diao\n  - Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Institute of Urology, Nanjing University, China. (1 speakers): Tianlei Xie\n  - Department of Urology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, China. (1 speakers): Junlong Zhuang\n  - Department of Urology, Peking University First Hospital, Beijing 100034, China. (1 speakers): Kaiwei Yang\n  - Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Jiwei Huang\n  - Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (2 speakers): Jiayi Lu, Wei Xue\n  - Department of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, People's Republic of China. (1 speakers): Mao Ding\n  - Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Ruofan Shi\n  - Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Xingliang Tan\n  - Department of Urology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China. (1 speakers): Xuefeng Qiu\n  - Department of Urology, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo, China. (1 speakers): Jian-ting Xu\n  - Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China. (1 speakers): Qiang Song\n  - Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou (1 speakers): Bin Huang\n  - Department of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China. (1 speakers): Yurong Zhang\n  - Department of Urology, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Yichang, Hubei, China. (1 speakers): Cheng Yi\n  - Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China. (1 speakers): Sicong Zhang\n  - Department of Urology, The Second Affiliated Hospitalof Naval Medical Uiversity, Shanghai, China. (1 speakers): Duocai Li\n  - Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. (1 speakers): Jiahao Wang\n  - Department of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. (1 speakers): Cheng Hu\n  - Department of Urology, The Third Medical Center, Chinese PLA General Hospital, Beijing, China. (1 speakers): Liangyou Gu\n  - Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. (1 speakers): Kang Chen\n  - Department of Urology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany. (1 speakers): Yue Che\n  - Department of Urology, West China Hospital Sichuan University, Chengdu (1 speakers): Yige Bao\n  - Department of VIP Clinic General Division, Shanghai East Hospital, School of Medicine Tongji University Shanghai China. (1 speakers): Yan Zhang\n  - Department of the Comprehensive Cancer Center, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China. (1 speakers): Zhengyun Zou\n  - Department of urology, Peking University First Hospital, Beijing, China. (1 speakers): Yelin Mulati\n  - Departments of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou 350014, Fujian, China. (1 speakers): Fei Zhu\n  - Departments of Oncology Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China. (1 speakers): Sheng Yang\n  - Digital Diagnosis and Treatment Innovation Center for Cancer, Institute of Translational Medicine, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Wantao Chen\n  - Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041 Sichuan, China. Electronic address: maji@wchscu.cn. (1 speakers): Ji Ma\n  - Division of Abdominal Tumor Multimodality Treatment, Department of Radiation Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan (1 speakers): Yali Shen\n  - Division of Natural and Applied Sciences, Duke Kunshan University, Kunshan, Jiangsu, China. (1 speakers): Ferdinand Kappes\n  - Division of Pancreatic Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China. (1 speakers): Ziheng Guo\n  - Division of Thyroid Surgery, Department of General Surgery, Laboratory of Thyroid and Parathyroid Diseases, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital (1 speakers): Jiaye Liu\n  - ENT Institute and Department of Otorhinolaryngology, Eye and ENT Hospital, Fudan University, Shanghai, China. (1 speakers): Jinghan Wang\n  - Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. (1 speakers): Yijun Dong\n  - Endoscopy Center, Minhang District Central Hospital, Fudan University, Shanghai, China. (1 speakers): Feng Li\n  - GMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, Guangdong, China. (1 speakers): Linlin Wang\n  - Gastric Cancer Center/Cancer Center, West China Hospital, Sichuan University, Sichuan, China. (1 speakers): Mo Cheng\n  - Gastroenterology, Yanan University Affiliated Hospital, Yan'an, China. (1 speakers): Min Bai\n  - General Surgery Center, First Hospital of Jilin University, Changchun, China. (1 speakers): Zhongqi Fan\n  - Graduate School, Chinese PLA General Hospital/Medical School of Chinese PLA, Beijing, PR China. (1 speakers): An Wang\n  - Graduate School, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, PR China. (1 speakers): Jianan Jin\n  - Guangdong Laboratory of Lingnan Modern Agriculture, Genome Analysis Laboratory of the Ministry of Agriculture, Agricultural Genomics Institute at Shenzhen, Shenzhen, China. (1 speakers): Yance Feng\n  - Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. (2 speakers): Chen Huang, Si-Yang Liu\n  - Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. Electronic address: syylwu@live.cn. (1 speakers): Yi-Long Wu\n  - Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, People's Republic of China. (1 speakers): Wei-Chi Luo\n  - Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. (1 speakers): Xu-Chao Zhang\n  - Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China, Biomedical Innovation Center (1 speakers): Zerong Cai\n  - Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center (1 speakers): Yue Pan\n  - Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. chenyt58@mail.sysu.edu.cn. (1 speakers): Jiajia Li\n  - Guangzhou Institute of Respiratory Health, Guangzhou, China. (1 speakers): Bo Cheng\n  - Hainan Pharmaceutical Research and Development Science and Technology Park, Haikou, China. Electronic address: z_xp1412@163.com. (1 speakers): Xiaopo Zhang\n  - Hangzhou Cancer Institution, Affiliated Hangzhou Cancer Hospital, Zhejiang University School of Medicine, Hangzhou, China (1 speakers): Hongfang Zhang\n  - Harbin Medical University Cancer Hospital, Harbin, China. (1 speakers): Yanbin Zhao\n  - Hengqin Hospital, First Affiliated Hospital of Guangzhou Medical University, Hengqin, China. (1 speakers): Wenhai Fu\n  - Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. (2 speakers): Jia Jiang, Yue Huang\n  - Inc., Guangdong, Guangzhou, China. (1 speakers): Dongmei Chen\n  - Institute of Molecular Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Kangli Ma\n  - Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou 215003, China. (1 speakers): Jian Pan\n  - Jinan Central Hospital, Shandong University, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, People's Republic of China. (1 speakers): Mei Li Sun\n  - Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou 510632, China. (1 speakers): Yangqiu Li\n  - Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China. (1 speakers): FEILIN QU\n  - Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery, Precision Cancer Medicine Center, Fudan University Shanghai Cancer Center, Shanghai 200032, P. R. China. (1 speakers): Lei Fan\n  - Key Laboratory of Cancer Prevention and Therapy, The Sino-United States Center for Lymphoma and Leukemia Research, Tianjin, China. (1 speakers): Wenhua Wang\n  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Department of Lymphoma Peking University Cancer Hospital & Institute Beijing China. (1 speakers): Yuqin Song\n  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China. (1 speakers): Zhijie Wang\n  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Urology, Peking University Cancer Hospital & Institute, Beijing 100142, China. (1 speakers): Yudong Cao\n  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing (1 speakers): Xi Zhang\n  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genitourinary Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China. (1 speakers): Xinan Sheng\n  - Key Laboratory of Carcinogenesis and Translational Research, Department of Thoracic Surgery I, Peking University Cancer Hospital & Institute, Beijing, China. (1 speakers): Luyan Shen\n  - Laboratory of Aging Research and Cancer Drug Target State Key Laboratory of Biotherapy and Cancer Center National Clinical Research Center for Geriatrics West China Hospital Sichuan University Chengdu... (1 speakers): Xiangrong Song\n  - Laboratory of Biomaterials and Translational Medicine, Department of Joint and Trauma Surgery, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China. (1 speakers): Yu Tao\n  - Ltd, Shanghai, People's Republic of China. (1 speakers): Xiaohui Wang\n  - Marine College, Shandong University, Weihai, Shandong, PR China. (1 speakers): Chuanhao Zhang\n  - Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering, Shenzhen University Medical School (1 speakers): Jing Lin\n  - Medical Imaging Center, First Affiliated Hospital of Jinan University, Guangzhou, China. (1 speakers): Jing Li\n  - Michigan Center for Translational Pathology. (1 speakers): Yu Chang\n  - Musculoskeletal Tumor Center, Peking University People's Hospital, Beijing 100044, China. (1 speakers): Lu Xie\n  - Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, Nanjing, Jiangsu, People's Republic of China. (1 speakers): Xin Lv\n  - Nanjing Stomatological Hospital, Research institute of Stomatology, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. (1 speakers): Meng Yuan\n  - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China. (2 speakers): Fei Ma, Zheng Liu\n  - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang, Beijing, China. (1 speakers): Qingyao Shang\n  - National Institute of TCM, Beijing University of Chinese Medicine, Beijing, China. (1 speakers): Wang-Zhong Li\n  - Neurosurgery Department, Dezhou People's Hospital, Dezhou, PR China. (1 speakers): Li Zhang\n  - Ningxia Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Sciences, General Hospital of Ningxia Medical University, No. 804, Yinchuan, China. (1 speakers): Yujie Zhang\n  - Nursing Department, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. (1 speakers): Shiyu Liang\n  - Obstetrics & Gynecology Hospital of Fudan University, Shanghai, China. (2 speakers): Panpan Zhang, Qi Zhou\n  - Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China (2 speakers): Junjun Qiu, Keqin Hua\n  - Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. (1 speakers): Yongjie Xu\n  - Orthopedics, Ruijin Hospital, Shanghai, Shanghai, China. (1 speakers): Zhusheng Zhang\n  - Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. (1 speakers): Kuirong Jiang\n  - Pharmaron U.K., Pharmaron UK Ltd., Hoddesdon (1 speakers): Fang He\n  - Phase I Clinical Trial Center, Shanghai Cancer Center, Fudan University, Shanghai, China. (1 speakers): Yanchun Meng\n  - Precision Cancer Medicine Center, Fudan University Shanghai Cancer Center, Shanghai, China. (1 speakers): Xichun Hu\n  - Prince of Wales Hospital, Hong Kong Special Administrative Region, China. (1 speakers): Kingsley Sze Yuen Cheung\n  - Prince of Wales Hospital, The Chinese University of Hong Kong, China. (1 speakers): Brigette B. Ma\n  - Princess Margaret Hospital, Hong Kong, Hong Kong SAR. (1 speakers): Matthew Lun M. Wong\n  - Renmin Hospital of Wuhan University, Wuhan, China. (1 speakers): Junxiao Wang\n  - Research Center for Nanosensor Molecular Diagnostic & Treatment Technology, College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen, Guangdong 518060, P. R. China. (1 speakers): Yizhen Liu\n  - Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China. (1 speakers): Caining Zhao\n  - Research Institute of Chinese Medical Clinical Foundation and Immunology, College of Basic Medical Science, Hangzhou, China. (1 speakers): Zhangsheng Jiang\n  - School of Artificial Intelligence, The University of Chinese Academy of Sciences, Beijing 100190, China. (1 speakers): Yang Du\n  - School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China. (1 speakers): Ting Liu\n  - School of Basic Medicine, Ningxia Medical University, Yinchuan, P.R. China. (1 speakers): Jie Xu\n  - School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou, China. (1 speakers): Dong Luo\n  - School of Business, Guilin Tourism University, Guilin, Guangxi, China. (1 speakers): Yan Li\n  - School of Clinical Medicine, Peking University Health Science Center, Beijing 100191, China. (1 speakers): Huizhu Chen\n  - School of Food Science and Technology, State Key Laboratory of Food Science and Technology, National Engineering Research Center for Functional Food, Jiangnan University, Wuxi, China. (1 speakers): Li Wang\n  - School of Geography and Resources, Guizhou Education University, Guiyang 550018, China. (1 speakers): Xuqiang Luo\n  - School of Medicine, Tsinghua University, Beijing, China. (1 speakers): Xiaoshuang Lyu\n  - School of Pharmacy and Minhang Hospital, Fudan University, Shanghai 201203, China. (1 speakers): Wei Li\n  - School of Physics and Optoelectronic Engineering, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China. (1 speakers): Cong Sun\n  - School of Public Health, Fudan University, Shanghai, People's Republic of China. z_yibiao@hotmail.com. (1 speakers): Yu-Wen Zhou\n  - School of Sports Medicine and Rehabilitation, Beijing Sport University, Beijing 100084, China. (1 speakers): Yiting Li\n  - School of Textile Science and Engineering, Xi'an Polytechnic University, Xi'an (1 speakers): Wu Fan\n  - Senior Department of Cardiology, the Sixth Medical Center of Chinese PLA General Hospital, Beijing, China. (1 speakers): Jun Guo\n  - Senior Department of Hepatology, The 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China. (1 speakers): Hongli Yu\n  - Senior Department of Infectious Diseases The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases Beijing China. (1 speakers): Xiaoyan Li\n  - Shandong Cancer Hospital and Institute, 250117, China. (1 speakers): Zhonghui Z. Wei\n  - Shanghai Institute of Hematology, State Key Laboratory of Medica Genomics, National Research Center for Translational Medicine at Shanghai Ruijin Hospital Affiliated to Shanghai Jiao Tong University S... (1 speakers): Li Wang\n  - Shanghai Key Laboratory of Atmospheric Particle Pollution and Prevention (LAP3), Department of Environmental Science and Engineering, Fudan University, Shanghai 200433, China (1 speakers): Shanshan Wang\n  - Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China. (1 speakers): Yingjie Hu\n  - Shanghai University, Shanghai 200444, China. (1 speakers): Yufan Y. Zhao\n  - Shanghai, China. (1 speakers): Xiaokun Shen\n  - Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University Taiyuan 030001, Shanxi (1 speakers): Jinfeng Ma\n  - Shenzhen Key Laboratory of Modern Toxicology, Shenzhen Medical Key Discipline of Health Toxicology, Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, China. (1 speakers): Xiao Chen\n  - Shenzhen Research Institute, The Chinese University of Hong Kong, China. (1 speakers): Yuhan Zhang\n  - Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China. (1 speakers): Chen Zihan\n  - Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. (1 speakers): Hongming Pan\n  - State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. (1 speakers): Jie Liu\n  - State Key Laboratory of Flexible Electronics (LoFE) & Institute of Flexible Electronics (IFE), Xi'an Institute of Biomedical Materials & Engineering (IBME), Northwestern Polytechnical University (1 speakers): Kun Wang\n  - State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, China. (1 speakers): Lei Yang\n  - State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute (1 speakers): Changsong Qi\n  - State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China. (1 speakers): Zhi Peng\n  - State Key Laboratory of Molecular Oncology, First Department of Thoracic Surgery, Peking University Cancer Hospital & Institute, Beijing, China. (1 speakers): Shaohua Ma\n  - State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. (1 speakers): Yiran Zhou\n  - State Key Laboratory of Neurology and Oncology Drug Development, Ltd, Nanjing Simcere Medical Laboratory Science Co., Ltd, Nanjing, China. (1 speakers): Xing Zhang\n  - State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China. (1 speakers): YanFeng Chen\n  - State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Miaozhen Qiu\n  - State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Tian-Liang Xia\n  - State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. (1 speakers): Yunfei Yuan\n  - State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yatsen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China. (1 speakers): Yuan Zhang\n  - State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong Cancer Institute, Faculty of Medicine, The Chinese University of Hong Kong, China. (2 speakers): Stephen L. Chan, Winnie Yeo\n  - State Key Laboratory of Tropic Ocean Engineering Materials and Materials Evaluation, School of Materials Science and Engineering, Beihang University, Beijing, P. R. China. (1 speakers): Liwei Fan\n  - Sun Yat-Sen University Cancer Center, Guangzhou, China. (1 speakers): Shuhui Dong\n  - Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. Electronic address: xurh@sysucc.org.cn. (1 speakers): Rui-Hua Xu\n  - The 111 Project Laboratory of Biomechanics and Tissue Repair, College of Bioengineering, Chongqing University, Chongqing, China. (1 speakers): Zheng Wu\n  - The 900th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Fuzhou, China. (1 speakers): Xi Chen\n  - The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. (1 speakers): Min Yan\n  - The Chinese University of Hong Kong, Hong Kong, China. (1 speakers): Winnie KW W. So\n  - The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. (1 speakers): Yong Y. Chen\n  - The First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China. (1 speakers): Manya Yu\n  - The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China, Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou (1 speakers): Ruxue Lv\n  - The Harbin Medical University Cancer Hospital, Harbin, China. (1 speakers): Yanqiao Zhang\n  - The Key Laboratory of Biomarker High throughput screening and target translation of breast and gastrointestinal tumor, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China. (1 speakers): Guanxuan CHEN\n  - The School of Clinical Medicine, Fujian Medical University, Fuzhou 350000, Fujian, China. (1 speakers): Xiaojing Huang\n  - The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China. (1 speakers): Fuming Qiu\n  - The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, P. R. China. lamp197311@126.com. (1 speakers): Yongyi Zeng\n  - The Wistar Institute (1 speakers): Qing Zhu\n  - Third Affiliated Hospital of Southern Medical University, Guangzhou 510000, China. (1 speakers): Lei H. Tan\n  - Thoracic Oncology Institute and Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Peking University People's Hospital, Beijing, China. (1 speakers): Zheng Liu\n  - Tianjin Medical University Cancer Institute & Hospital, Tianjin, China. (2 speakers): Dingzhi Huang, Yehui Shi\n  - Tianjin Medical University Cancer Institute and Hospital, China. (1 speakers): Huikai Li\n  - Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. (1 speakers): Zhongsheng Tong\n  - Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China. (2 speakers): Chuntao Gao, Song Gao\n  - Translational Medical Research Platform for Thoracic Oncology, China. 18930858216@163.com. (1 speakers): Baohui Han\n  - University of Chinese Academy of Sciences, Beijing, China. (1 speakers): Dan Liu\n  - University of Western Australia, Western Australia 6009, Australia. (1 speakers): Chung B. Zhao\n  - Wenzhou Medical University, Wenzhou, China, Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou (1 speakers): Xiangdong Cheng\n  - West China School of Medicine West China Hospital Sichuan University Chengdu Sichuan China. (1 speakers): Chenhao Xu\n  - West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China. (1 speakers): Wei Peng\n  - Xiangya Stomatological Hospital, Changsha 410008, China. liwenj@csu.edu.cn. (1 speakers): Wenjie W. Li\n  - Xinjiang Key Laboratory of Herbivore Drug Research and Creation, College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi, Xinjiang, China. (1 speakers): Yang Li\n  - Yanbian University, Jilin, China. (1 speakers): Cai Gang G. Liu\n  - Zhejiang Cancer Hospital, The Key Laboratory of Zhejiang Province for Basic and Clinical Application of Functional Nucleic Acids, Hangzhou Institute of Medicine (HIM), Hangzhou, China. (1 speakers): Xiaojia Wang\n  - Zhejiang Chinese Medical University Affiliated Four-Province-Bordering Hospital of Traditional Chinese Medicine (Quzhou Hospital of Traditional Chinese Medicine), PR China. (1 speakers): Hong-Hong Zhu\n  - Zhejiang Engineering Research Centre for Tissue Repair Materials, University of Chinese Academy of Sciences, China. (1 speakers): Feng Wen\n  - Zhejiang Key Laboratory of Precision Medicine Research on Head & Neck Cancer, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China. (1 speakers): Jiajie Xu\n  - Zhejiang Provincial Clinical Research Center for CANCER, Cancer Center of Zhejiang University, Hangzhou, China. (1 speakers): Kefeng Ding\n  - Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, Research Center for Clinical Pharmacy, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou (1 speakers): Xingjiang Hu\n  - Zhongshan Hospital, Fudan University, Shanghai, China. (1 speakers): Wenbin Jiang\n  - iHuman Institute, ShanghaiTech University, Shanghai, China, School of Life Science and Technology, ShanghaiTech University, Shanghai, China. (1 speakers): Fei Xu\n\n**Colombia (3 institutions, 3 speakers)**\n  - Centre for Scientific and Technological Research of Extremadura (CICYTEX), Department of Horticulture, Finca La Orden, Regional Government of Extremadura, Highway A-V, Km 372, 06187 Guadajira, Badajoz, Spain. (1 speakers): Sandra Ximena Franco Millan\n  - Health Faculty, Cali 760035, Colombia. (1 speakers): Leidy T. Ordonez-Mora\n  - Universidad de La Sabana-Hospital Militar Central, Bogotá, Colombia. (1 speakers): Juan Guillermo Santacruz\n\n**Costa Rica (1 institutions, 1 speakers)**\n  - Hospital San Juan de Dios, San José (1 speakers): Allan Ramos-Esquivel\n\n**Croatia (2 institutions, 2 speakers)**\n  - Department of Hematology, Oncology and Clinical Immunology, General Hospital Varazdin, Croatia. (1 speakers): Renata Kelemenic-Drazin\n  - University J.J. Strossmayer Osijek, Osijek, Croatia. (1 speakers): Silvija Piskorjanac\n\n**Cuba (1 institutions, 1 speakers)**\n  -  (1 speakers): Lazara Y. Martinez Espinosa\n\n**Cyprus (3 institutions, 3 speakers)**\n  - Cyprus University of Technology, Limassol, Cyprus, Faculty for Dental Medicine and Health, Osijek, Croatia. (1 speakers): Nikolina Dodlek\n  - Department of Nursing, School of Sciences, Cyprus University of Technology, Limassol 3041, Cyprus. (1 speakers): Andreas Charalambous\n  - Karaiskakio Foundation, Nicosia, Cyprus. (1 speakers): Petroula Gerasimou\n\n**Czech Republic (6 institutions, 6 speakers)**\n  -  (1 speakers): Adam Vokurka\n  - Department of Gynaecology, Obstetrics and Neonatology, General University Hospital, Prague (1 speakers): David Cibula\n  - Department of Oncology, Palacký University Medical School and Teaching Hospital, I.P. Pavlova 6, Olomouc (1 speakers): Hana Studentova\n  - Department of Oncology, Regional Hospital Liberec, Liberec (1 speakers): Igor Richter\n  - Oncology Department of Czech Krumlov Hospital (1 speakers): Nadzeya Piatrouskaya\n  - Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno (1 speakers): Martin Bartosik\n\n**Delhi (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Fortis Memorial Research Institute, Gurugram, India. (1 speakers): Nitesh Rohatgi\n\n**Denmark (23 institutions, 31 speakers)**\n  -  (7 speakers): Asbjorn Kjaer, Astrid N. Vendelsoe, Kristina Norskov, Mette J. Syberg, Regina Wittchen Sorensen, Sebastian Soby, Yago Garitaonaindia Diaz\n  - Aarhus University Hospital, Aarhus N, Denmark. (1 speakers): Karen-Lise G. Spindler\n  - Centre for Physical Activity Research, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. (1 speakers): Casper Simonsen\n  - Copenhagen University Hospital, Rigshospitalet, Denmark. (1 speakers): Christine Federspiel Secher\n  - Danish Breast Cancer Group, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, Department of Clinical Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. (1 speakers): Tobias Berg\n  - Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital-Rigshospitalet & Department of Biomedical Sciences University of Copenhagen Copen... (1 speakers): Andreas Kjaer\n  - Department of Clinical Research, University of Southern Denmark, Campusvej 55, Odense (1 speakers): Laerke K. Tolstrup\n  - Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, Copenhagen, Denmark. (1 speakers): Lene Baeksgaard\n  - Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Denmark. (1 speakers): Troels D. Christensen\n  - Department of Oncology, National Center for Cancer Immune Therapy, Copenhagen University Hospital, Herlev, Denmark. (1 speakers): Eva Ellebaek\n  - Department of Oncology, National Center of Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Hovedstaden, Denmark. (1 speakers): Rebecca S. Jurlander\n  - Department of Oncology, Odense University Hospital, Odense, Denmark. (1 speakers): Christina H. Ruhlmann\n  - Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. (1 speakers): Bent Ejlertsen\n  - Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Denmark, Department of Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Denmark. (1 speakers): Maj Kamille Kjeldsen\n  - Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia. (1 speakers): Stine V. Eriksen\n  - Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. (1 speakers): Inna M. Chen\n  - National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. (1 speakers): Mario Presti\n  - National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, University Hospital Herlev, Herlev, Denmark. (1 speakers): Katharina Leuchte\n  - National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark. (1 speakers): Sidsel Pedersen\n  - National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. (3 speakers): Inge M. Noringriis, Inge Marie Svane, Marco Donia\n  - Odense University Hospital, University of Southern, Denmark. Electronic address: soeren.kjaer@rsyd.dk. (1 speakers): Soeren K. Petersen\n  - Research Center of Ageing and Osteoporosis, Department of Diagnostics, Copenhagen University Hospital Glostrup, Glostrup, Denmark. (1 speakers): Tina M. Kringelbach\n  - Xinhua Hospital, Shanghai, China. (1 speakers): Juanjuan U. Wang\n\n**Derbyshire (1 institutions, 1 speakers)**\n  - University Hospitals of Derby and Burton NHS Foundation Trust, Derby (1 speakers): Prantik Das\n\n**Ecuador (1 institutions, 1 speakers)**\n  - Respiralab Research Group, Guayaquil, Ecuador. (1 speakers): Walter Morquecho\n\n**Egypt (15 institutions, 19 speakers)**\n  -  (5 speakers): Dalia K. Harhash, Emadeldin Shash, Hebat Allah M. Ahmed, Lama Kamal, Rana El-Shewy\n  - Alexandria University, Alexandria, Egypt. (1 speakers): Israa Ahmed Ali Abdelrahem Qutob\n  - Beni-Suef University, Beni-Suef, Egypt. (1 speakers): Mennat-Allah Abdelsamed\n  - Cairo University, Cairo, Egypt. (1 speakers): Fatma M. Bektash\n  - Central Laboratory, Ministry of Higher Education and Scientific Research, Khartoum, Sudan. (1 speakers): Dina A. Hassan\n  - Clinical Oncology Department, Ain Shams University, Cairo, Egypt. (1 speakers): Hagar ElGhazawy\n  - Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt. (1 speakers): Amr S. Saad\n  - Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS (1 speakers): Mohamed Elgendy\n  - Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA. (1 speakers): H M. Amin\n  - Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo 12613, Egypt. (1 speakers): Omnia M. Korani\n  - Faculty of Medicine, Mansoura University, Egypt. (1 speakers): Khaled M. Abouelkhair\n  - Faculty of Medicine, Suez Canal, Egypt. (1 speakers): Ibrahim I. Hassan\n  - Helwan University, Cairo, Egypt. (1 speakers): Abdulrahman E. ElHelbawy\n  - Newgiza University, Giza, Egypt. (1 speakers): Yomna A. Mohamed\n  - Suez Canal University, Ismailia 41522, Egypt. (1 speakers): Kareem W. Raafat\n\n**Estonia (2 institutions, 2 speakers)**\n  - Pharmacy Department, Tartu University Hospital, Tartu, Estonia. (1 speakers): Marika Saar\n  - University of Tartu, Tartu 50090, Estonia. (1 speakers): Ann Valter\n\n**Ethiopia (1 institutions, 1 speakers)**\n  -  (1 speakers): Bethlehem Getachew Ayele\n\n**FL (2 institutions, 2 speakers)**\n  - Department of Biomedical Sciences and Human Oncology, University of Bari, Italy. (1 speakers): Mauro Cives\n  - Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, USA. (1 speakers): Jose Lutzky\n\n**FR (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Cochin University Hospital, Université Paris Cité, Institut du Cancer Paris CARPEM, Paris, France, Centre de Recherche des Cordeliers, UMR1138, Université Paris Cité (1 speakers): Guillaume Beinse\n\n**Finland (12 institutions, 13 speakers)**\n  - Cancer Gene Therapy Group, Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. (2 speakers): Elise Jirovec, Nea Ojala\n  - Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland. (1 speakers): Katriina Jalkanen\n  - Department of Chemistry University of Jyväskylä Jyväskylä Finland. (1 speakers): Sauli Vuoti\n  - Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Finland. (1 speakers): Mika Kontro\n  - Department of Nursing Science, University of Turku, Turku, Finland. Electronic address: hejopal@utu.fi. (1 speakers): Heli Arffman\n  - Department of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, Finland, Department of Obstetrics and Gynecology, Wellbeing Services County of Central Finland (1 speakers): Anna Rajavuori\n  - Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland. (1 speakers): Sari Voutilainen\n  - Department of Oncology, Tampere University Hospital, and University of Tampere, Tampere, Finland. (1 speakers): Pia J. Osterlund\n  - Department of Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. (1 speakers): Emerik Osterlund\n  - FICAN West Cancer Center, Turku, Finland. (1 speakers): Anniina E. Hyvakka\n  - Orionintie 1, FIN-02200, Espoo, Finland. (1 speakers): Anu Moilanen\n  - Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland. (1 speakers): Matilda Salko\n\n**Florida (1 institutions, 1 speakers)**\n  - Medical Oncology, Washington University in St. Louis, Siteman Cancer Center, St. Louis, Missouri. (1 speakers): Moh'd M. Khushman\n\n**France (182 institutions, 209 speakers)**\n  -  (18 speakers): ARNAUD DE GUNTEN, Diego Diaz-Jimenez, Elise Dominjon, Erwan Vo Quang, Flavien Minoc, Gauduchon Thibault, Hayat H. Mcheik, Jeanne Pongerard, Khalida Berkane, LOUIS-MARIE CHENET, Liora Bowers, Lucie Laplagne, Lucile Mercier, Marian Gil Delgado, Nael Alshatti, Roula Amine Hneineh, Teo Bodergat, Walid Ben Yedder\n  - AIDES, Pantin, France. (1 speakers): Tristan Alain\n  - ANTICIPE UMR 1086, Department of Pharmacology, Caen, France. (1 speakers): Louis Boismoreau\n  - ARCAD Foundation, Paris, France. (1 speakers): Morteza Raeisi\n  - Académie nationale de pharmacie, Unicancer, Paris, France. (1 speakers): Muriel Dahan\n  - Accenture, Paris, France. (1 speakers): Marion Narbeburu\n  - Augusta University, GA, USA. (1 speakers): Nadine Mansour\n  - CHU Besançon, Stomatologie et Odontologie Hospitalière, F-25000 Besançon, France. (1 speakers): Camille Gaudet\n  - CRCL, Centre Léon Bérard, Lyon, France. (1 speakers): Louise OLGIATI\n  - Cancer Committee of the French Association of Urology (CCAFU), France, Department of Medical Oncology, Gustave Roussy Cancer Campus, Paris-Saclay University, Villejuif, France. (1 speakers): Laurence Albiges\n  - Cancer Committee of the French Association of Urology (CCAFU), France, Department of Urology, AP-HP, Hôpital La Pitié-Salpétrière, Sorbonne University, Paris, France. (1 speakers): Morgan Roupret\n  - Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. (1 speakers): Heloise Halse\n  - Cancer Institute of Montpellier, INSERM U1194, University of Montpellier, Montpellier, France. (1 speakers): William Jacot\n  - Cancer Survivorship Program - INSERM Unit 981 Molecular Predictors and New Targets in Oncology - Gustave Roussy, Villejuif, France. (1 speakers): Antonio Di Meglio\n  - Centre Eugène Marquis, Rennes, France. (1 speakers): Thibault De La Motte Rouge\n  - Centre Francois-Baclesse, Medical Oncology, Caen, France. (1 speakers): Florence Joly Lobbedez\n  - Centre Léon Bérard, Lyon, France, Lyon, France, Centre de Recherche en Cancérologie de Lyon, Lyon, France. (1 speakers): Quentin Devin\n  - Centre Médical de Bligny, Briis-sous-Forges, France. (1 speakers): Ingrid Alexandre\n  - Chest Department and Thoracic Oncology, Tenon Hospital, Sorbonne Université, GRC4 Theranoscan, Paris, France. (1 speakers): Jacques Cadranel\n  - Clinical Study Center (CSC) of Charité and BIH, Berlin, Germany. (1 speakers): Petya Zyumbileva\n  - Computational Clinical Oncology Laboratory, Villejuif, France. (1 speakers): Elsa Bernard\n  - Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. (1 speakers): Emmanouil Angelidakis\n  - Department of Biostatistics and Epidemiology, University Paris-Saclay, Villejuif, France. (1 speakers): Stefan Michiels\n  - Department of Cancer Medicine, Gustave Roussy, Villejuif, France. (1 speakers): Tarek Ben Ahmed\n  - Department of Cancer Medicine, Thoracic Group and International Center for Thoracic Cancers, Paris-Saclay University, Villejuif, France. (3 speakers): Adrien Rousseau, Claudia Parisi, David Planchard\n  - Department of Cancer Medicine, University Paris-Saclay, Villejuif, France. (2 speakers): Suzette Delaloge, Thomas Pudlarz\n  - Department of Cancer Medicine, University of Paris Saclay, Villejuif, France. (1 speakers): Alice Bernard-Tessier\n  - Department of Cancer Medicine, University of Paris-Saclay Villejuif France. (1 speakers): Karim Fizazi\n  - Department of Cancer Medicine, University of Paris-Saclay, Villejuif, France. (1 speakers): David Malka\n  - Department of Cancer Medicine, Villejuif, France. (2 speakers): Jordi Remon Masip, Valerie Boige\n  - Department of Clinical Hematology, Gustave Roussy Institute, France. (1 speakers): Stephane De Botton\n  - Department of Drug Development & Innovation (D3i), Paris-Saclay University, Paris, France. (1 speakers): Christophe Le Tourneau\n  - Department of ENT-Head and Neck Surgery Toulouse University Hospital, Hôpital Larrey Toulouse France. (1 speakers): MATHILDE MIRALLIE\n  - Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, SIRIC CARPEM, Paris-Cité University, Paris, France. (1 speakers): Claire Gallois\n  - Department of Gastroenterology and Gastrointestinal Oncology, CARPEM Comprehensive Cancer Centre, Georges-Pompidou European Hospital, AP-HP, Université Paris-Cité, Paris, France. (1 speakers): Julien Taieb\n  - Department of Gastroenterology, Rennes University Hospital, Rennes, France. (1 speakers): Astrid Lievre\n  - Department of Gynecology and Obstetrics, Lille, France. (1 speakers): Julie Demetz\n  - Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon. (1 speakers): Hassan Badreddine\n  - Department of Hepato-Gastroenterology and Medical Oncology, University of Bordeaux Hospital, Haut Leveque Hospital, France. (1 speakers): Jean Frederic Blanc\n  - Department of Hepatogastroenterology and Digestive Oncology, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France. (1 speakers): Marie Muller\n  - Department of Hepatogastroenterology, La Pitié Salpétrière Hospital (APHP), Paris, France. (1 speakers): Manon Allaire\n  - Department of Hepatology and Gastroenterology, Groupement Hospitalier Lyon Nord, Lyon, France. (1 speakers): Philippe Merle\n  - Department of Internal Medicine Lyon, Centre Léon Bérard, Lyon, France; Department of Oncology, Centre Léon Bérard, Lyon, France. (1 speakers): Axel De Bernardi\n  - Department of Medical Imaging, Gustave Roussy Cancer Campus, Villejuif, France. (1 speakers): Julien Hadoux\n  - Department of Medical Oncology, Centre Léon Bérard, Cancer Research Center of Lyon (UMR Inserm 1052 - CNRS 5286), Lyon, France. (1 speakers): Olivier Tredan\n  - Department of Medical Oncology, Cochin University Hospital, Université Paris Cité, Institut du Cancer Paris CARPEM, Paris, France. (1 speakers): Juliette Renard\n  - Department of Medical Oncology, Georges Pompidou European Hospital, AP-HP, Paris Cité University, Paris, France. (1 speakers): Constance Thibault\n  - Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. (1 speakers): Anthony Tarabay\n  - Department of Medical Oncology, Henri Mondor Hospital, Créteil, France. (1 speakers): Pascal Piedbois\n  - Department of Medical Oncology, IMMUCARE, Centre Hospitalier Lyon Sud, France. (1 speakers): DENIS MAILLET\n  - Department of Medical Oncology, INSERM, PSL Research University, Paris, France. (1 speakers): Sarah Watson\n  - Department of Medical Oncology, Institut Bergonié, Bordeaux, France. (1 speakers): Guilhem Roubaud\n  - Department of Medical Oncology, Institut Bergonié, INSERM U1312 BRIC, Bordeaux, France. (1 speakers): Monica Arnedos\n  - Department of Medical Oncology, Leon Berard Cancer Center, Lyon, France. (1 speakers): Philippe Cassier\n  - Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France. (1 speakers): Aude Flechon\n  - Department of Medical Oncology, PSL Research University, Paris, France. (1 speakers): Francois Clement Bidard\n  - Department of Medical Oncology, Paris (1 speakers): Diana Bello Roufai\n  - Department of Medical Oncology, Sorbonne Université, Institut du Cancer Paris CARPEM, AP-HP, Paris, France. (1 speakers): Julie Berthet\n  - Department of Medical Oncology, Strasbourg, France. (1 speakers): Safa Abdallahoui\n  - Department of Medical Oncology, University Hospital of Besançon, Besançon, France. (1 speakers): Angelique Vienot\n  - Department of Medical Oncology, University Hospital of Strasbourg, Place de L'hopital, Strasbourg, France. (1 speakers): Fabien Moinard-Butot\n  - Department of Medical Oncology, Villejuif, France, Paris-Saclay University, Paris, France, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston (1 speakers): Mihaela Aldea\n  - Department of Medical Oncology, Villejuif, France. (3 speakers): Benjamin Verret, Chayma Bousrih, Ronan Flippot\n  - Department of Medicine, Institut Bergonié, Bordeaux, France, Faculty of Medicine, University of Bordeaux, Bordeaux, France, Bordeaux, France. (1 speakers): Florent Peyraud\n  - Department of Medicine, Villejuif (1 speakers): Antoine Lefevre\n  - Department of Multidisciplinary Oncology and Therapeutic Innovations, Aix Marseille University, Marseille, France. (1 speakers): Laurent Greillier\n  - Department of Neurology 2-Mazarin, INSERM, CNRS, Brain and Spine Institute, ICM, AP-HP, Hôpital Pitié-Salpêtrière Sorbonne Université Paris France. (1 speakers): Khe Hoang-Xuan\n  - Department of Nuclear Medicine, Cancer Institute Eugene Marquis, Rennes, France. (1 speakers): Etienne Garin\n  - Department of Oncology, Sorbonne University, Tenon Hospital, AP-HP, Paris, France. (1 speakers): Joseph Gligorov\n  - Department of Ophthalmology, Faculty of Medicine, Beykent University, Istanbul, Turkey. (1 speakers): Semih Dogan\n  - Department of Otorhinolaryngology - Head and Neck Surgery, Gustave Roussy Cancer Center, Villejuif, France. (1 speakers): Caroline Even\n  - Department of Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, UMR INSERM 1240, University Clermont Auvergne, Clermont-Ferrand, France. (1 speakers): Frederique Penault-Llorca\n  - Department of Pathology, Groupe Hospitalier Henri Mondor, Créteil, France. (1 speakers): Julien Calderaro\n  - Department of Pathology, Saint Louis Hospital, Université Paris Cité, Paris, France. (1 speakers): Maxime Remond\n  - Department of Pediatric Hematology-Oncology, Trousseau Hospital, Paris, France. (1 speakers): Celine Khouri\n  - Department of Pneumology, Angers University Hospital, Angers, France. (1 speakers): Gregoire Justeau\n  - Department of Pneumology, Lyon, France. (1 speakers): Thomas Pierret\n  - Department of Prevention, Cancer and Environment, Léon Bérard Cancer Center, Lyon, France. (1 speakers): Beatrice Fervers\n  - Department of Pulmonary and Thoracic Oncology, Centre Hospitalier Universitaire Lille, University of Lille, U1019 INSERM, Center of Infection and Immunity of Lille, Lille, France. (1 speakers): Arnaud Scherpereel\n  - Department of Pulmonology, Centre Hospitalier Le Mans, France. (1 speakers): Olivier Molinier\n  - Department of Pulmonology, Hôpital Larrey, University Hospital of Toulouse, Toulouse, France. (1 speakers): Julien Mazieres\n  - Department of Radiation Oncology Institut Gustave Roussy University of Paris Saclay Villejuif France. (1 speakers): Pierre Blanchard\n  - Department of Radiation Oncology, CHU de Bordeaux, Pessac, France. (1 speakers): Veronique Vendrely\n  - Department of Radiation Oncology, François Baclesse Comprehensive Cancer Center, Caen, France. (1 speakers): DInu STEFAN\n  - Department of Radiation Oncology, Paris-Saclay University, Villejuif, France. (1 speakers): Yungan Tao\n  - Department of Radiotherapy, Hartmann Radiotherapy Center Levallois-Perret France, Rafael Institute, center for integrative oncology Levallois-Perret France. (1 speakers): Nathaniel Scher\n  - Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway. (1 speakers): Elisabete Weiderpass\n  - Department of Respiratory Medicine and Early Phase (EPSILYON), Louis Pradel Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France. (1 speakers): Michael Duruisseaux\n  - Department of Supportive and Palliative Care, CNRS, INSERM, Marseille, France. (1 speakers): Vanessa Collin\n  - Department of Surgery, Paul-Brousse Hospital, Centre Hépato-Biliaire, Villejuif, France. (1 speakers): Rene Adam\n  - Department of Surgical Oncology, Paoli-Calmettes Institute, Marseille, France. (1 speakers): Geraldine Pignot\n  - Department of Urology, Foch Hospital, Paris-Saclay University, Suresnes, France. (1 speakers): Yann Neuzillet\n  - Department of Urology, UROSUD, La Croix Du Sud Hospital, Quint-Fonsegrives, France. (1 speakers): Benjamin Pradere\n  - Dermatology Department, University Hospital of Caen, Caen (1 speakers): Elena Prospero\n  - Drug Development Department (DITEP), Gustave-Roussy, Université Paris-Saclay, Villejuif, France, INSERM U1030, Université Paris-Saclay, Villejuif, France, Centre Léon Bérard, Lyon (1 speakers): Loic Verlingue\n  - Drug Development Department (DITEP), Villejuif, France. (1 speakers): Julien Vibert\n  - Drug Development Department, Villejuif, France, INSERM U1015, CIC1428 BIOTHERIS, Villejuif, France, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA (1 speakers): Francois-Xavier Danlos\n  - Drug Development Department, Villejuif, France. (1 speakers): Kaissa Ouali\n  - Département de Médecine, Villejuif, France. (1 speakers): Geraldine M Camilleri\n  - EORTC HQ, Belgium, Villejuif, France. (1 speakers): Marie Morfouace\n  - Edouard Herriot University Hospital, Lyon, France. (1 speakers): Thomas Walter\n  - Equipe d'Accueil 7285, Risk and safety in clinical medicine for women and perinatal health, University Versailles-Saint-Quentin, Montigny-le-Bretonneux (1 speakers): Delphine Hequet\n  - Equity Research Team, Centre d'Epidémiologie et de Recherche en santé des POPulations (CERPOP), UMR 1295 (Team Labellised « Ligue Contre le Cancer »), Inserm, University Toulouse III Paul Sabatier (1 speakers): Nadine Hamieh\n  - Faculty of Medicine, University of Bordeaux, Bordeaux, France. (1 speakers): Antoine Italiano\n  - France (L.D., S.A., J.H., S. Morer, C.D., F. Bidault, C.B., S. Muller, N.L.), Université Paris-Saclay, Inserm, Centre national de la recherche scientifique, Villejuif, France (Y.B., L. Lawrance, O.G. (1 speakers): Maria Fernanda Mosele\n  - GI Oncology, Medical Oncology Department, Curie Institute, Versailles Saint-Quentin University-Paris Saclay University, France, Hepato-Gastroenterology Department, Ambroise Paré University Hospital (1 speakers): Cindy Neuzillet\n  - GI Oncology, Medical Oncology Department, Curie Institute, Versailles Saint-Quentin University-Paris Saclay University, France. (1 speakers): Matthieu Delaye\n  - Gastro-enterology, Hopital Beaujon, Clichy, France. (1 speakers): Louis De Mestier du Bourg\n  - Grenoble-Alpes University Hospital, Grenoble, France. (1 speakers): Anne Claire Toffart\n  - Gustave Roussy Cancer Campus, ClinicObiome, Villejuif, France. (1 speakers): Marine Fidelle\n  - Gustave Roussy Cancer Center, INSERM U981, and Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Villejuif, France. (1 speakers): Alexandra Leary\n  - Gustave Roussy Cancer Center, Université Paris-Saclay, Villejuif, France. (1 speakers): Pablo Berlanga\n  - Gustave Roussy Institute, Villejuif, France. (1 speakers): Arthur Geraud\n  - Gustave Roussy and Paris Saclay University, Villejuif, France. (1 speakers): Caroline Robert\n  - Gustave-Roussy, Villejuif, France, Sorbonne Université, Paris (1 speakers): Alexandre Xu-Vuillard\n  - HUPSSD, Hôpital René Muret, AP-HP, Sevran, France. (1 speakers): Thierry Landre\n  - Health Technologies Institute, Inserm, Paris, France. (1 speakers): Frederique Nowak\n  - Hematology Department, Gustave Roussy Institute, Villejuif, France. (1 speakers): Camille Bigenwald\n  - Hematology Department, Institut Gustave Roussy, Villejuif, France. (1 speakers): Myriam Ben Khelil\n  - Henri Mondor Hospital, Créteil, France. (1 speakers): Iona Campo le Brun\n  - INSERM U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. (1 speakers): Cinzia Ungolo\n  - INSERM U1242, University of Rennes, Rennes, France. (1 speakers): Alice Blondel\n  - INSERM U1245, Department of Metabolic Biochemistry, UNIROUEN, CHU Rouen, Rouen, France. (1 speakers): Jean David HEISBOURG\n  - INSERM U981, Villejuif, France, Department of Medical Oncology, Villejuif, France, Department of Oncology and Hematology-Oncology, University of Milano, Milan, Italy. (1 speakers): Federica Giugliano\n  - INSERM, EFS, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France. (1 speakers): Caroline Laheurte\n  - INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France. (1 speakers): Maria Alice Franzoi\n  - Imaging Department, BIOMAPS, UMR1281, INSERM, CEA, CNRS, Villejuif, Paris, France. (1 speakers): Caroline Caramella\n  - Inserm U1242, University of Rennes, France, Centre de Lutte Contre le Cancer Eugène Marquis, France. (1 speakers): Sophie MARTIN\n  - Inserm, IRD, ISSPAM, SESSTIM, Marseille, France. (1 speakers): Julien Mancini\n  - Institut Bergonié, Bordeaux, France. (1 speakers): Jerome Caron\n  - Institut Hospitalo-Universitaire des Cancers des Femmes (ANR-23-IAHU-0006), Saint-Cloud, France. Electronic address: etienne.brain@curie.fr. (1 speakers): Etienne G. Brain\n  - Institut Régional du Cancer de Montpellier, Montpellier, France. (1 speakers): Emmanuelle Samalin-Scalzi\n  - Institute of Materials Science (1 speakers): NGUYEN T. Yen\n  - Interdisciplinary Department for the Organization of Patient Course (Supportive Care Department), Paris-Saclay University, Villejuif, France. (1 speakers): Florian Scotte\n  - Interdisciplinary Department for the Organization of Patient Pathways (DIOPP), Gustave Roussy, Villejuif, France. (1 speakers): Ines V. Vaz-Luis\n  - International Agency for Research on Cancer, Lyon, France. (1 speakers): Joachim Schuz\n  - International Agency for Research on Cancer, World Health Organization, Lyon, France. (1 speakers): Carolina Espina\n  - Jonsson Comprehensive Cancer Center, University of California Los Angeles, CA, Massachusetts General Hospital Cancer Center, Boston, MA, Gustave Roussy Cancer Center, Villejuif, France (1 speakers): Barbara Pistilli\n  - La Paz University Hospital, 28046 Madrid, Spain. (1 speakers): Maria Virginia Sanchez Becerra\n  - Laboratoire d'Imagerie Biomedicale Multimodale Paris-Saclay (BioMAPS), Université Paris-Saclay, Inserm, Centre National de la Recherche Scientifique, Villejuif 94800, France, Département d'Imagerie (1 speakers): Aurelie Choucair\n  - Liver Cancer Unit, Beaujon University Hospital, Clichy, France. (1 speakers): Mohamed Bouattour\n  - Medical Oncology Departement, Centre Léon Bérard, Lyon, France. (1 speakers): Christelle De la Fouchardiere\n  - Medical Oncology Department, Paris, France. (1 speakers): Paul Matte\n  - Medical Oncology Department, Poitiers University Hospital, Poitiers, France. (1 speakers): Matthieu Bainaud\n  - Medical Oncology Department, Strasbourg, France. (1 speakers): Jean-Baptiste Barbe-Richaud\n  - Medical Oncology Dept, Hospital Universitario 12 de Octubre and i+12 Research Institute, Madrid, Spain. (1 speakers): Nerea Munoz\n  - Medical oncology Department, Georges-Pompidou European Hospital, Paris Cité University, Paris, France. (1 speakers): Charles Vauchier\n  - Memorial Sloan Kettering Cancer Center, NY, USA, CHU Poitiers, Université de Poitiers, Poitiers, France. (1 speakers): Violaine Randrian\n  - Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France. (1 speakers): Killian Carnet Le Provost\n  - Military Hospital Begin, France, 33 679526487. (1 speakers): Carole F. Helissey\n  - Oncostat U1018, Institut National de la Santé et de la Recherche Médicale (INSERM), Ligue Contre le Cancer, Paris-Saclay University, Villejuif, France. (1 speakers): Noemie Simon-Tillaux\n  - PSL University, Paris 75014, France. (1 speakers): Nicolas A. Fraunhoffer Navarro\n  - Paris Descartes University, Necker Hospital, Paris, France. (1 speakers): Simon Nicoletti\n  - Paris, France, Clinical Pharmacy, Cochin University Hospital, AP-HP, Centre-Université Paris-Cité, Paris, France. (1 speakers): Christophe Bardin\n  - Paris, France. (4 speakers): Alexandre Grimaldi, Corentin Wiscart, Oussama Tchita, Paul H. Cottu\n  - Paris-Saclay University, Villejuif, France. (2 speakers): Filippo G. Dall'Olio, Francesco Facchinetti\n  - Pneumology Department, Intercommunal Hospital of Creteil, Créteil, France. (1 speakers): Christos Chouaid\n  - Radiation Oncology Department, La Pitié Salpêtrière University Hospital, Assistance Publique des Hôpitaux de Paris.Sorbonne University, France. (1 speakers): Raphael Serre\n  - Research On Healthcare Performance (RESHAPE), INSERM, Lyon, France. (1 speakers): Romain Varnier\n  - Research on Healthcare Performance (RESHAPE), INSERM U1290, Lyon, France. (1 speakers): Gisele Chvetzoff\n  - Respiratory Diseases Department, University Hospital of Reims, Reims, France. (1 speakers): Julien Ancel\n  - Respiratory Medicine Department, GHRMSA, Hospital Emile Muller, Mulhouse, France. (1 speakers): Didier Debieuvre\n  - Respiratory Medicine Department, L'Hôpital Nord-Ouest, Villefranche-Sur-Saône, France. (1 speakers): Lionel Falchero\n  - Saint-Herblain, France. (1 speakers): Judith Raimbourg\n  - Service de Pneumologie, Hôpital Cochin, AP-HP. Centre, Université Paris Cité, Paris, France. (1 speakers): Gaspard Naulleau\n  - Sorbonne University and Department of Medical Oncology, Saint-Antoine Hospital, Paris 75015, France. (1 speakers): Romain Cohen\n  - Sorbonne University, Department of Hepato-Gastroenterology, Pitié-Salpêtrière Hospital, Paris, France. (1 speakers): Jean-Baptiste Bachet\n  - Sorbonne Université, CNRS, Villefranche-sur-mer, France. (1 speakers): Francois Lahaye\n  - Thorax Institute Curie Montsouris, Department of Medical Oncology, Paris, France. (1 speakers): Nicolas Girard\n  - Toulouse CEDEX, France. (1 speakers): Pierre Fons\n  - University Hospital of Montpellier, Montpellier, France. (1 speakers): Adrien C. Maire\n  - University of Burgundy, Dijon, France. (1 speakers): Francois Ghiringhelli\n  - University of Grenoble Alpes, Institute for Advanced Biosciences, Grenoble, France. (1 speakers): Thomas Decaens\n  - University of Paris Saclay, Villejuif, France. (1 speakers): Aurelien Marabelle\n  - University of Paris-Saclay, Villejuif, France. (1 speakers): Michel P. Ducreux\n  - Université Paris Cité, EA-3518, University Hospital Saint-Louis, Paris, France. (1 speakers): Nicolas Boissel\n  - Université Paris Cité, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, France. (1 speakers): Jeanne Duval\n  - Université Paris Cité, Paris, France. (1 speakers): Gustave Ronteix\n  - Université Paris-Saclay, Gustave-Roussy Cancer Campus, Inserm U981, Villejuif, France. (1 speakers): Elisa Yaniz\n  - Université Paris-Saclay, Inserm, Radiothérapie Moléculaire, France. (1 speakers): Kenza Nedara\n  - Université de Paris, BFA, UMR 8251, CNRS, Paris, France (Q.N., J.B., W.Z., L.-C.B., R.L., F.B., J.-M.D., F.R.L.), Key Laboratory of Marine Drugs, School of Medicine and Pharmacy (1 speakers): Christine Chomienne\n  - Université de Paris, Institut du Cancer Paris CARPEM, F-75006 Paris, France, Department of medical oncology, APHP.Centre, Paris, France. (1 speakers): Claire Gervais\n\n**Fujian (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Fujian Medical University Cancer Hospital and Fujian Cancer Hospital, Fuzhou, Fujian, People's Republic of China. (1 speakers): Rongbo Lin\n\n**Fukushima (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Fukushima Medical University School of Medicine, Fukushima, Japan. (1 speakers): Shigehira Saji\n\n**GA (1 institutions, 1 speakers)**\n  - Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA. (1 speakers): Nabil F. Saba\n\n**Georgia (1 institutions, 1 speakers)**\n  - Todua Clinic Department of Oncology and Haematology, Tbilisi, Georgia. (1 speakers): Elene Mariamidze\n\n**Germany (206 institutions, 219 speakers)**\n  -  (8 speakers): Anke Pregler, Ellen Ahmann, Isabell Kaufhold, Katharina Rauscher-Stamer, Lis Puga, Nicoline Ehrhardt, Timo Gottlieb, Tina Holzgen\n  - 3rd Department of Medicine, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, Mannheim (1 speakers): Hanna Hirschinger\n  - Asklepios Cancer Center, Hamburg, Germany. (1 speakers): Dirk Arnold\n  - Breast Center, Department of Gynecology & Obstetrics & Comprehensive Cancer Center Munich, Ludwig-Maximilians-University (LMU) University Hospital, Munich, Germany. (1 speakers): Nadia Harbeck\n  - Center for Integrated Oncology (CIO) Köln-Bonn, Cologne, Germany. (1 speakers): Axel Heidenreich\n  - Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany. (1 speakers): Jurgen Wolf\n  - Charité Comprehensive Cancer Center, Charité-Universitätsmedizin Berlin, Berlin, Germany. (2 speakers): Max Schmidt, Nikolaj Frost\n  - Charité-University Medicine Berlin, Berlin, Germany. (1 speakers): Nele Danielle Wagener\n  - Christoph Pöttgen, Karl-Heinz Jöckel, University Hospital Essen, University of Duisburg-Essen, Ruhrlandklinik, Essen, University Hospital Tübingen, University of Tübingen, Tübingen (1 speakers): Martin H. Schuler\n  - Claudia Von Schilling Comprehensive Cancer Center Lower Saxony, Hannover, Germany. (1 speakers): Tabea Frohlich\n  - Clinic I for Internal Medicine, University Clinic Cologne, Germany. (1 speakers): Anna Rasokat\n  - Clinic for Visceral-, General, University Medicine Magdeburg, Otto-von Guericke University Magdeburg, Magdeburg, Germany. (1 speakers): Wenjie Shi\n  - Clinic of Cardiology and Pneumology, Esslingen Hospital, Germany. (1 speakers): Martin Faehling\n  - Clinical Department for Internal Medicine II, University Medical Center, Technical University of Munich (TUM), Germany. (1 speakers): Sebastian Lange\n  - Clinical State Registry Baden-Württemberg GmbH, Baden-Württemberg Cancer Registry (BWCR), Stuttgart, Germany. (1 speakers): Irina Surovtsova\n  - Clinics for Obstetrics and Gynecology, University Medicine Charité Campus Virchow, Berlin, Germany. (1 speakers): Ioana Braicu\n  - Comprehensive Cancer Center (CCC Munich LMU), LMU University Hospital Munich, Munich, Germany. (1 speakers): Christoph Benedikt Westphalen\n  - Comprehensive Cancer Center, Ludwig Maximilian University Hospital Munich, Pettenkoferstrße 8a, Munich, Germany (1 speakers): Rachel Wuerstlein\n  - Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Lung Cancer Group Cologne (1 speakers): Heather Scharpenseel\n  - Department for Health Economics and Health Care Management, School of Public Health, Bielefeld University, Bielefeld, Germany. (1 speakers): Sophie Pauge\n  - Department for Oncology, University Comprehensive Cancer Center, Hamburg, Germany. (1 speakers): Nikolaus Berenbrok\n  - Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Germany. (1 speakers): Wiebke Pirschel\n  - Department of Biostatistics, University of North Carolina, NC, USA. (1 speakers): Elena Kharitonova\n  - Department of Clinical Oncology, Hamburg, Germany. (1 speakers): Georgia Schilling\n  - Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Berlin, Germany. (1 speakers): Fenja Klima\n  - Department of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim. (1 speakers): Freba Grawe\n  - Department of Dermatology, Elbe Clinic Buxtehude, Buxtehude, Germany. (1 speakers): Peter Mohr\n  - Department of Dermatology, Skin Cancer Center, University Hospital Schleswig-Holstein, Kiel, Germany. (1 speakers): Michael Weichenthal\n  - Department of Dermatology, University Hospital Essen, Essen, Germany. (1 speakers): Lea Jessica Albrecht\n  - Department of Dermatology, University Hospital Essen, University of Duisburg-Essen, Germany, German Cancer Consortium (DKTK), Germany, University Alliance Ruhr, Research Center One Health (1 speakers): Dirk Schadendorf\n  - Department of Dermatology, University Hospital Heidelberg Dermatological Clinic Centre, Heidelberg, Germany. (1 speakers): Jessica C. Hassel\n  - Department of Dermatology, University Hospital Tuebingen, Tübingen, Germany. (1 speakers): Lukas Flatz\n  - Department of Gastroenterology, Hepatology, University Hospital Heidelberg, Heidelberg, Germany. (1 speakers): Michael T. Dill\n  - Department of Gynaecology and Obstetrics, University Hospital Aachen, Aachen, Germany. (1 speakers): Elmar Stickeler\n  - Department of Gynaecology and Obstetrics, University Hospital of Essen, Germany. (1 speakers): Fabinshy Thangarajah\n  - Department of Gynaecology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg, Germany. (1 speakers): Elena Laakmann\n  - Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitaetsstrasse 21-23 (1 speakers): Peter A. Fasching\n  - Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, CCC, NCT Dresden, Technische Universität Dresden, Dresden, Germany. (1 speakers): Pauline Wimberger\n  - Department of Gynecology and Obstetrics, University Hospital Mannheim, Mannheim, Germany. (1 speakers): Frederik Marme\n  - Department of Gynecology and Obstetrics, University Hospital Münster, Münster, Germany. (1 speakers): Ludwig Kiesel\n  - Department of Gynecology and Obstetrics, University Hospital Ulm, Germany. (3 speakers): Angelina Fink, Kerstin Pfister, Wolfgang Janni\n  - Department of Gynecology, Hamburg-Eppendorf University Medical Center, Martinistraße 52, Hamburg, Germany. (1 speakers): Volkmar Mueller\n  - Department of Gynecology, Medical Center, Leipzig University, Germany. (1 speakers): Laura Weydandt\n  - Department of Gynecology, University Medical Center Hamburg-Eppendorf, Germany, Colposcopy Center at the Jerusalem Hospital Hamburg, Germany. (1 speakers): Linn Woelber\n  - Department of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Universitätsstraße 25, Bielefeld, Germany. (1 speakers): Birthe Aufenberg\n  - Department of Hematology and Oncology, UCT-University Cancer Center, Frankfurt, Germany. (1 speakers): Akin Atmaca\n  - Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany. (1 speakers): Emre Kocakavuk\n  - Department of Hematology, Berlin, Germany. (1 speakers): Christopher Neumann\n  - Department of Hematology, Charité University Medicine Berlin, Berlin, Germany. (1 speakers): Lars Bullinger\n  - Department of Hematology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany. (1 speakers): Sebastian Stintzing\n  - Department of Hematology, Ernst von Bergmann Hospital Potsdam, Germany, Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg (1 speakers): Karin Jordan\n  - Department of Hematology, Hemostasis, Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany. (1 speakers): Viktor Gruenwald\n  - Department of Hematology, Oncology, and Cancer Immunology, Charité University Hospital Berlin, Berlin, Germany. (1 speakers): Dominik P. Modest\n  - Department of Hematology/Oncology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany. (1 speakers): Marit Ahrens\n  - Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Berlin, Germany. (1 speakers): Andrey Mitroshkin\n  - Department of Internal Medicine I, Ulm University Hospital, Albert-Einstein-Allee 23, Ulm, Germany. (1 speakers): Anton Lahusen\n  - Department of Internal Medicine I, University Hospital Frankfurt, Goethe University Frankfurt Am Main, Theodor-Stern-Kai 7, Germany. (1 speakers): Christine Koch\n  - Department of Internal Medicine I, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany. (1 speakers): Markus Moehler\n  - Department of Internal Medicine II, Hematology, Oncology, University Hospital Frankfurt, Frankfurt, Germany. (1 speakers): Sophie Heinzen\n  - Department of Internal Medicine III (Haematology/Medical Oncology), Technical University of Munich Hospital Rechts der Isar, Munich, Germany. (1 speakers): Sylvie Lorenzen\n  - Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany. (1 speakers): Daniel Heudobler\n  - Department of Internal Medicine and Nature-Based Therapies, Immanuel Hospital Berlin, Berlin, Germany. (1 speakers): Carolin Breinlinger\n  - Department of Internal Medicine, University Hospital of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. (1 speakers): Thorsten Langer\n  - Department of Medical Oncology, Memorial Hospital, Antalya, Turkey. (1 speakers): Mevlude Ergen\n  - Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. (1 speakers): Stefanie Zschabitz\n  - Department of Medical Oncology, University Hospital Heidelberg, Heidelberg, Germany. (1 speakers): Bruno C. Kohler\n  - Department of Medical Oncology, University Hospital of Wuerzburg, Wuerzburg, Germany. (1 speakers): Volker Kunzmann\n  - Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany. (1 speakers): Martin Metzenmacher\n  - Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, Essen 45147, Germany. (1 speakers): Stefan Kasper-Virchow\n  - Department of Medicine 1, Endocrinology and Diabetology, Friedrich Alexander University of Erlangen-Nürnberg, Erlangen, Germany. (1 speakers): Marianne E. Pavel\n  - Department of Medicine 2, University Cancer Center Leipzig (UCCL), Leipzig University Medical Center, Cancer Center Central Germany (CCCG), Leipzig, Germany. (1 speakers): Benjamin Kobitzsch\n  - Department of Medicine A, Hematology, Hemostaseology, Oncology and Pneumology, University Hospital Muenster, Münster, Germany. (1 speakers): Marcel Kemper\n  - Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany. (1 speakers): Wolfgang E. Berdel\n  - Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. (1 speakers): Jann Arends\n  - Department of Medicine II, Hematology/Oncology, University Hospital Frankfurt, Frankfurt, Germany. (1 speakers): Friederike Althoff\n  - Department of Medicine II, Hospital of the LMU, Munich, Germany. (1 speakers): Jianying Xu\n  - Department of Medicine II, University Hospital Schleswig-Holstein - Campus Kiel, Kiel, Germany. (1 speakers): Christiane Pott\n  - Department of Medicine II, University Hospital, LMU Munich, Munich, Germany. (1 speakers): Alexander B. Philipp\n  - Department of Medicine III LMU University Hospital LMU Munich Munich Germany. (1 speakers): Marion Subklewe\n  - Department of Medicine III and Comprehensive Cancer Center, LMU University Hospital, LMU Munich, Marchioninistr. 15, Munich, Germany. (1 speakers): Lena Weiss\n  - Department of Medicine V, LMU University Hospital, Munich, Germany. (2 speakers): Amanda Tufman, Blerina Resuli\n  - Department of Medicine, Clinic III - Hematology, Oncology, Rostock University Medical Center, University of Rostock, Germany. (1 speakers): Claudia Maletzki\n  - Department of Medicine, Clinic III - Hematology, Oncology, Rostock University Medical Center, University of Rostock, Rostock, Germany. (2 speakers): Philipp Kaps, Thomas Freitag\n  - Department of Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. (1 speakers): Lynn Leppla\n  - Department of Molecular Oncology and Pneumological Oncology, Robert-Bosch-Centrum für Tumorerkrankungen, Robert-Bosch Hospital, Stuttgart, Germany. (1 speakers): Hans-Georg Kopp\n  - Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany. (1 speakers): Wolfgang Wick\n  - Department of Neurology, Klinikum Großhadern, Ludwig-Maximilians-University, Marchioninistr. 15, Munich 81377, Germany. (1 speakers): Louisa Von Baumgarten\n  - Department of Nuclear Medicine, CURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany. (1 speakers): Richard P. Baum\n  - Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany. (1 speakers): Sebastian Hoberuck\n  - Department of Nuclear Medicine, University Hospital Essen, German Cancer Consortium, West German Cancer Center, Essen, Germany. (1 speakers): Alina T. Kuper\n  - Department of Nuclear Medicine, University Hospital Muenster, Albert-Schweitzer-Campus 1, Muenster (1 speakers): Kambiz Rahbar\n  - Department of Nuclear Medicine, West German Cancer Center, German Cancer Consortium and National Center for Tumor Diseases site, University Hospital Essen, Essen, Germany. (1 speakers): Ken Herrmann\n  - Department of Obstetrics and Gynecology, Technical University of Munich, Munich, Germany, Cancer Center Kempten/ Allgäu (CCKA) (1 speakers): Johannes Ettl\n  - Department of Obstetrics and Gynecology, University Hospital of Schleswig-Holstein, Campus Lübeck, Lubeck, Germany. (1 speakers): Nikolas Tauber\n  - Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany. (1 speakers): Fabian Trillsch\n  - Department of Obstetrics, Charite University Hospital Berlin, Berlin, Germany. (1 speakers): Jalid Sehouli\n  - Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. (1 speakers): Antonia Beitzen-Heineke\n  - Department of Oncology, Hematology and Stem Cell Transplantation with Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. (1 speakers): Finn-Ole Paulsen\n  - Department of Otolaryngology and Head & Neck Surgery, Hospital of the Ludwig-Maximilians-University, Munich, Germany. (1 speakers): Susanne Flach\n  - Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University Medical Center and Comprehensive Cancer Center Ulm, Ulm, Germany. (1 speakers): Simon Laban\n  - Department of Otorhinolaryngology, Head and Neck Surgery, Luzerner Kantonsspital, Switzerland. (1 speakers): Christoph R. Schlegel\n  - Department of Otorhinolaryngology, University of Leipzig Medical Center, Leipzig, Germany. (1 speakers): Andreas Dietz\n  - Department of Pneumology, Berlin, Germany. (1 speakers): Christian Grohe\n  - Department of Pneumology, University Hospital Ulm, Ulm, Germany. (1 speakers): Cornelia Kropf-Sanchen\n  - Department of Radiation Therapy and Special Oncology, Medical School Hannover, Hannover, Germany. (1 speakers): Burcu Babadag Savas\n  - Department of Radiology, University Hospital RWTH Aachen, Aachen, Germany. (1 speakers): Daniel Truhn\n  - Department of Radiooncology and Radiotherapy, Charite University Hospital, Berlin, Germany. (1 speakers): Ingeborg Tinhofer-Keilholz\n  - Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Germany. (1 speakers): Soren Schnellhardt\n  - Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Homburg, Germany. (1 speakers): Markus Hecht\n  - Department of Surgery, Mannheim School of Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim (1 speakers): Cui Yang\n  - Department of Surgery, University of Lübeck & University Medical Center Schleswig-Holstein/Lübeck, Lübeck, Germany. (1 speakers): Larysa Liubich\n  - Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Airway Research Censer North, German Center of Lung Research, Grosshansdorf, Germany. (1 speakers): Martin Reck\n  - Department of Thoracic Oncology, Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany. (1 speakers): Michael Thomas\n  - Department of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. (1 speakers): Johannes Bragelmann\n  - Department of Translational Pulmonology, Heidelberg University Hospital, Heidelberg, Germany. (1 speakers): Petros Christopoulos\n  - Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg, Germany. (1 speakers): Jana Loptien\n  - Department of Urology Uro-Oncology, University Hospital Cologne, Köln, Germany. (1 speakers): Richard Weiten\n  - Department of Urology and Paediatric Urology, Julius Maximilians University Medical Center of Würzburg, Würzburg, Germany. (1 speakers): Charis Kalogirou\n  - Department of Urology and Transplantation Surgery, Eva Mayr-Stihl Cancer Center, Stuttgart, Germany. (1 speakers): Jens Bedke\n  - Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria, Department of Urology, Charité Universitätsmedizin Berlin, Berlin, Germany. (1 speakers): Maria De Santis\n  - Department of Urology, Faculty of Medicine, University Hospital Cologne, University Cologne, Cologne, Germany. (1 speakers): David Pfister\n  - Department of Urology, Friedrich-Schiller-University Jena, Jena University Hospital, Germany. (1 speakers): Marc-Oliver Grimm\n  - Department of Urology, Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany, Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. (1 speakers): Philipp Mandel\n  - Department of Urology, University Hospital Bonn, Bonn, Germany. (1 speakers): Niklas Klumper\n  - Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany. (1 speakers): Cristina Cano Garcia\n  - Department of Urology, University of Cologne, Cologne, Germany. (2 speakers): Julian Heidenreich, Olivia Steenbock\n  - Department of Urology, University of Muenster Medical Center, Muenster, Germany, West German Cancer Center, Muenster, Germany. (1 speakers): Martin Boegemann\n  - Department of Urology, Uro-Oncology, University Hospital Cologne, Cologne, Germany. (1 speakers): Constantin Rieger\n  - Department of Urology, Urooncology, University Hospital Magdeburg, Otto-von Guericke University Magdeburg, Magdeburg, Germany. (1 speakers): Melis Gur\n  - Director of the I. Medical Department at the University Medical Center, Johannes Gutenberg University, Mainz, Germany. (1 speakers): Peter R. Galle\n  - Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany. (1 speakers): Sebastian Kobold\n  - Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany. (1 speakers): Florian Van Bommel\n  - Division of Personalized Cancer Therapy, Fraunhofer Institute of Toxicology and Experimental Medicine ITEM-R, Regensburg, Germany. (1 speakers): Bernhard Polzer\n  - Else Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany. (1 speakers): Jakob N. Kather\n  - Essen, Germany and Department of Gynecology with Breast Unit, Charité Hospital Berlin, Berlin, Germany. (1 speakers): Sherko Kuemmel\n  - FOM University of Applied Sciences, Essen, Germany. (1 speakers): Florian Kron\n  - Faculty of Medicine, Institute for Medical Information Processing, Biometry, LMU Munich, Munich, Germany. (1 speakers): Verena Loidl\n  - Fraunhofer Institute for Toxicology and Experimental Medicine ITEM-R, Germany. (1 speakers): Giancarlo Feliciello\n  - From the Department of Visceral, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. (1 speakers): David Digomann\n  - From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany, Department of Nuclear Medicine (1 speakers): Konstantin E. Seifert\n  - GBG Forschungs GmbH and Goethe University Frankfurt, Neu-Isenburg, Germany. (1 speakers): Sibylle Loibl\n  - Gerhard-Domagk-Institute of Pathology, University Hospital Muenster, Germany. (1 speakers): Eva Wardelmann\n  - German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany. (1 speakers): Sebastian Bauer\n  - German Cancer Research Center (DKFZ), Division of Signaling and Functional Genomics and Heidelberg University, Department Cell and Molecular Biology, Heidelberg, Germany. (1 speakers): Johannes Werner\n  - Goethe University Frankfurt, University Hospital, Department of Urology, Frankfurt am Main, Germany. (1 speakers): Mike Wenzel\n  - GynOnco Duesseldorf, Duesseldorf, Germany. (1 speakers): Athina Kostara\n  - Gynecology, Obstetrics and Senology, Faculty of Medicine, University of Augsburg, Breast Center, University Hospital Augsburg, CCC Alliance WERA, Augsburg, Germany. (1 speakers): Nina Ditsch\n  - Health Service Research Working Group| Acute Care, Medical Faculty of Martin Luther, University Medicine Halle (Saale), University Halle-Wittenberg, Halle, Germany. (1 speakers): Patrick Jahn\n  - Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany, Division of Stem Cells and Cancer, Heidelberg, Germany, German Cancer Consortium (DKTK) (1 speakers): Christian Eisen\n  - Heidelberg University Hospital, Heidelberg, Germany. danielmichaeli@yahoo.com. (1 speakers): Daniel T. Michaeli\n  - Hospital Gemeinschaftskrankenhaus Havelhöhe, Berlin, Germany. (1 speakers): Friedemann T. Schad\n  - Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Department of Urology, Germany. (1 speakers): Jonathan Jeutner\n  - II. Medical Clinic and Polyclinic, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. (1 speakers): Joseph Tintelnot\n  - Immanuel Hospital Berlin, Berlin, Germany. (1 speakers): Daniela Koppold\n  - Immanuel Hospital Märkische Schweiz & Immanuel Campus Rüdersdorf, Rüdersdorf bei Berlin, Germany. (1 speakers): Diana I. Luftner\n  - Institute for Diabetes and Cancer, Helmholtz Center Munich - German Research Center for Environmental Health, Neuherberg, Germany. (1 speakers): Bhargavi Karna\n  - Institute for Patient Safety (IfPS), Medical Faculty, University Hospital Bonn, Bonn, Germany. (1 speakers): Larissa Brust\n  - Institute for Quality and Efficiency in Health Care, Cologne, Germany. (1 speakers): Beate Wieseler\n  - Institute of Clinical Cancer Research IKF, Frankfurt am Main, Germany. (1 speakers): Thorsten O. Goetze\n  - Institute of Human Genetics, Heidelberg University Hospital, Heidelberg Germany and German Cancer Consortium (DKTK), Heidelberg, Germany, Division of Translational Medical Oncology (1 speakers): Stefan Frohling\n  - Institute of Immunology, Medical Faculty, University of Duisburg-Essen, Hufelandstr. 55, Germany. (1 speakers): Karl Lang\n  - Institute of Pathology, Ludwig Maximilians University, Munich, Germany, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. (1 speakers): Philipp Jurmeister\n  - Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. (1 speakers): Markus Eckstein\n  - Institute of Pathology, University Medical Center Hamburg-Eppendorf, Germany. (1 speakers): Florian Viehweger\n  - Institute of Pathology, University of Erlangen-Nuremberg, Erlangen, Germany. (1 speakers): Abbas Agaimy\n  - Institute of Pathology, Universitätsklinikum Marburg, Marburg, Germany. (1 speakers): Marcel Romey\n  - LMU University Hospital, Munich, Germany. (1 speakers): Dorit Di Gioia\n  - Laboratory of Experimental Oncology, Department of Oncology, University Medical Center Hamburg-Eppendorf, Germany. (1 speakers): Gunhild Von Amsberg\n  - Ludwig Maximilians University, LMU University Hospital, Department of Obstetrics and Gynecology, Munich, Germany. (1 speakers): Sven Mahner\n  - Lung Cancer Center, Hospital Havelhöhe, Germany. (1 speakers): Christian Grah\n  - MVZ am Klinikum Aschaffenburg, Aschaffenburg, Germany. (1 speakers): Manfred K. Welslau\n  - Mannheim Cancer Center (MCC), Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany. (1 speakers): Bernd Kasper\n  - Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. (1 speakers): Derya Tilki\n  - Medical Bioninformatics Workgroup, Pathological Institute, University Hospital Heidelberg, Heidelberg, Germany. (1 speakers): Albrecht Stenzinger\n  - Medical Clinic II, University Hospital Frankfurt, Frankfurt, Germany. (1 speakers): Lothar Bergmann\n  - Medical Clinic and Polyclinic I, University Hospital Carl Gustav Carus, Dresden, Germany. (1 speakers): Gunnar Folprecht\n  - Medical Faculty and University Hospital Magdeburg, Clinic for General, Visceral, Otto-von-Guericke University, Magdeburg, Germany. (1 speakers): Ulf Dietrich Kahlert\n  - Medical University Hospital, Tuebingen, Germany. Electronic address: linus.kloker@med.uni-tuebingen.de. (1 speakers): Linus Daniel Kloker\n  - Mindpeak, Hamburg, Germany. (1 speakers): Patrick Frey\n  - NMI TT Pharmaservices, Berlin, Germany. (1 speakers): Gerrit Erdmann\n  - National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany. (1 speakers): Simon Kreutzfeldt\n  - National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany, Clinical Trial Center, NCT Heidelberg, Heidelberg (1 speakers): Richard F. Schlenk\n  - National Center for Tumor Diseases, University Hospital Carl Gustav Carus TU Dresden, Germany. (1 speakers): Martin Wermke\n  - Quality Conferences Office at the Clinical State Registry Baden-Württemberg GmbH, Baden-Württemberg Cancer Registry (BWCR), Stuttgart, Germany. (1 speakers): Philipp Morakis\n  - Research Institute Havelhöhe, Germany. (1 speakers): Shiao Li Oei\n  - Richard-Willstätter-Allee, D-76128 Karlsruhe (Germany), Fax: (+49) 721-6084823. (1 speakers): Rainer Nitsche\n  - Risk Adapted Cancer Prevention Group, Division of Primary Cancer Prevention, German Cancer Research Center (DKFZ), Germany. (1 speakers): Zehui Chen\n  - School of Medicine and Health Sciences, University Department Internal Medicine-Oncology, Oldenburg, Germany. (1 speakers): Frank Griesinger\n  - Section Global Health, Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany, Department of Medicine II, Hematology and Oncology, University Hospital (1 speakers): Maximilian Rost\n  - Transfusion Medicine Center Bayreuth, Kurpromenade 2, Germany. (1 speakers): Monika Pizon\n  - University Cancer Center Frankfurt (UCT), Frankfurt am Main, Germany, Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany, German Cancer Research Center (DKFZ) Heidelberg (1 speakers): Martin Sebastian\n  - University Hospital Carl Gustav Carus, Dresden, Germany. (1 speakers): Miriam Gediga\n  - University Hospital Ludwig-Maximilians-University Munich, Munich, Germany. (1 speakers): Martin H. Dreyling\n  - University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany. (1 speakers): Axel S. Merseburger\n  - University Hospital Schleswig-Holstein, University Cancer Center Schleswig-Holstein, Kiel, Germany. (1 speakers): Anne Letsch\n  - University Medical Center Hamburg-Eppendorf, Department of Gynecology and Gynecologic Oncology, Hamburg, Germany. (1 speakers): Barbara Schmalfeldt\n  - University Medical Center Hamburg-Eppendorf, Hamburg, Germany. (1 speakers): Charlotte L. Sachs\n  - University of Freiburg, 79106, Germany. (1 speakers): Christian J. Gratzke\n  - University of Greifswald, Institute for Community Medicine, Greifswald, Germany. (1 speakers): Thomas Kohlmann\n  - University of Leipzig Medical Center, Department of Gynecology, Leipzig, Germany. (1 speakers): Bahriye Aktas\n  - Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstr. 55, Essen, Deutschland. (1 speakers): Wilfried E. Eberhardt\n  - Universitätsklinikum Tübingen & M3 Research Center, Universitätsklinikum Tübingen. (1 speakers): Christoph Stein-Thoeringer\n  - Urology, Ulm University Hospital, Ulm, Germany. (1 speakers): Friedemann Zengerling\n  - West German Cancer Center, Essen, Germany. (1 speakers): Simon S. Bogner\n  - West German Cancer Center, University Hospital Muenster, Muenster, Germany. (1 speakers): Katharina M. Richter\n  - eAsklepios Lung Clinic, German Center for Lung Research (DZL), Munich-Gauting, Germany. (1 speakers): Niels Reinmuth\n\n**Greece (22 institutions, 28 speakers)**\n  -  (5 speakers): Antonios Mingos, Asimina Pelteki, Evangeli Bista, Katerina C. Aravantinou Fatorou, Sofia I. CHRYSOGLOU\n  - 2nd Department of Internal Medicine, Attikon University Hospital, Athens, Greece. (1 speakers): Maria Anastasiou\n  - 401 General Military Hospital of Athens, Athens, Greece. (1 speakers): Nikolaos G. Tsoukalas\n  - 4th Oncology Dept. & Comprehensive Clinical Trials Center, Metropolitan Hospital, Ethn. Makariou 9, Athens 18547, Greece. (1 speakers): Stavroula Sgourou\n  - Department of Cardiology, Venizeleion General Hospital, GRC. (1 speakers): Eleni Eleftheriadou\n  - Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra General Hospital, Greece. (3 speakers): Charalampos Filippatos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis\n  - Department of Gynecology, Euroclinic Hospital, Athens. (1 speakers): George Marios Makris\n  - Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Greece. (1 speakers): Panagiotis Filis\n  - Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece. (1 speakers): Dimitrios Mavroudis\n  - Department of Nursing, School of Health Sciences, University of Peloponnese, Tripoli, Greece. (1 speakers): Athanasios Pitis\n  - Division of Oncology, Department of Medicine, University of Patras Medical School, Patras, Greece. (1 speakers): Fotinos-Ioannis D. Dimitrakopoulos\n  - First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens - School of Medicine, Athens, Greece. (1 speakers): Dimitrios C. Ziogas\n  - Fourth Department of Medical Oncology and Clinical Trials Unit, Henry Dunant Hospital Center Athens, Greece. (1 speakers): Giannis Mountzios\n  - Hellenic Ministry of Health, Athens, Greece. (1 speakers): Dimitrios Protogiros\n  - Laboratory of Biochemistry, Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece. (1 speakers): Nikolaos Politis\n  - Medical Oncology Unit, 2nd Department of Internal Medicine-Propaedeutic, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Chaidari, Greece. (1 speakers): Amanda Psyrri\n  - School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece. (1 speakers): STYLIANOS KATSARAGAKIS\n  - Second Department of Internal Medicine, Attikon University Hospital, Athens, Greece. (1 speakers): Anna Boulouta\n  - Second Propaedeutic Department of Medicine, Attikon University Hospital, Chaidari, Greece. (1 speakers): Anastasios Pantazopoulos\n  - Thessaloniki, Greece, Medical Oncology Department, Euromedica General Clinic, Thessaloniki, Greece, Interbalkan European Medical Center, Thessaloniki, Greece. (1 speakers): Konstantinos Papazisis\n  - Third Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece. (1 speakers): Anastasios Boutis\n  - University of Crete, 70013 Heraklion, Greece. (1 speakers): Andreas V. Koulouris\n\n**Guangdong (3 institutions, 3 speakers)**\n  - Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, The People's Republic of China. chmingy@mail.sysu.edu.cn. (1 speakers): Mingyuan Chen\n  - Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. (1 speakers): Wangjun Liao\n  - Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China (1 speakers): Jin-Ji Yang\n\n**Gyeonsang Nam-Do (1 institutions, 1 speakers)**\n  - Division of Pulmonology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea. (1 speakers): Yun Seong Kim\n\n**Helsinki (1 institutions, 1 speakers)**\n  - Gynecological Cancer Patients in Finland, Helsinki, Finland. (1 speakers): Eva-Maria Stromsholm\n\n**Henan (1 institutions, 1 speakers)**\n  - The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. (1 speakers): Hong Zong\n\n**Hiroshima (1 institutions, 1 speakers)**\n  - Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. (1 speakers): Takahiro Mimae\n\n**Hunan (1 institutions, 1 speakers)**\n  - Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China, Hunan Cancer Mega-Data Intelligent Application and Engineering Research Centre, Changsha, Hunan (1 speakers): Fang Wu\n\n**Hungary (2 institutions, 3 speakers)**\n  -  (2 speakers): Seba Aljomaa, Viola Z. Koros-Angyal\n  - Department of Pulmonology, Semmelweis University, Budapest, Hungary. (1 speakers): Veronika Muller\n\n**IL (2 institutions, 2 speakers)**\n  - Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell School of Medicine, NY, USA. (1 speakers): Massimo Cristofanilli\n  - Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. (1 speakers): William J. Gradishar\n\n**India (39 institutions, 49 speakers)**\n  -  (11 speakers): Abhishikha Sharma, Antapura H. Rudresha, Ashwini K Nanda, Bharatsinha Bhosale, FNU Prateek, Himaprathyusha Parupalli, Ishita Rastogi, Madhavi R. Indani, Nallabothula S. Kiran, Roopesh Narayanachary, Supreeth N. Ramesh\n  - Armed Forces Medical College, Maharashtra, India. bisht53rahul@gmail.com. (1 speakers): Rahul S. Bisht\n  - Armed Forces Medical College, Pune, 411040 India. (1 speakers): Makarand A. Randive\n  - Army Hospital (R&R), Delhi, India. (1 speakers): Niharika Bisht\n  - Aster International Institute Of Oncology, Aster Hospitals, Bengaluru, India. (1 speakers): Ashwin Kr\n  - Biosciences, College of Life and Environmental Sciences, University of Exeter, EX4 4PS, UK. (1 speakers): Debapriya Mondal\n  - Chemomicrobiomics Laboratory, Department of Biochemistry and Microbiology, KMCH Research Foundation, Coimbatore, India. (1 speakers): Srinidhi Narayani Seenivasan\n  - Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, India. (1 speakers): Arnab Pal\n  - Department of Biotechnology, School of Life Sciences, Central University of Kashmir, Tulmulla, Jammu, Kashmir, India. (1 speakers): Santosh Kumar\n  - Department of General Medicine, Institute of Medical Sciences, Banaras Hindu University, India. (1 speakers): Ankur N. Varshney\n  - Department of Gynaecological Oncology, Churchill Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. (1 speakers): Aakriti Aggarwal\n  - Department of Interventional Pulmonology Yashoda Hospitals Hyderabad India. (1 speakers): Hari Kishan Gonuguntla\n  - Department of Medical Oncology and Hematology, Institute of Oncology, AIG Hospitals, Hyderabad, India. (1 speakers): Vamshi Krishna Muddu\n  - Department of Medical Oncology, All India Institute of Medical Sciences, India. (1 speakers): Sameer Rastogi\n  - Department of Medical Oncology, Apollo Cancer Center, Chennai, India. (1 speakers): Raja Thirumalairaj\n  - Department of Medical Oncology, Rajagiri Cancer Centre, Rajagiri Hospital, Kochi, India. (1 speakers): Aswin Joy\n  - Department of Medical Oncology, Saroj Gupta Cancer Centre and Research Institute, Kolkata, India. (1 speakers): Nihanthy D. Sreenath\n  - Department of Medical Oncology, Shalby Hospital, Ahmedabad, Gujarat, India. (1 speakers): Viraj Lavingia\n  - Department of Medical Oncology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, India. (1 speakers): Ajas Ibrahim\n  - Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha Cancer Hospital, Sangrur, Punjab, India. (1 speakers): Alok K. Goel\n  - Department of Medical Oncology, Yashoda Hospitals, Somajiguda, Hyderabad, Telangana 500082, India. (1 speakers): Nikhil S. Ghadyalpatil\n  - Department of Psychiatry, AIIMS, India. (1 speakers): Barre Vijaya Prasad\n  - Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India. (1 speakers): Navneet Singh\n  - Department of Radiation Oncology, Mahamana Pandit Madan Mohan Malaviya Cancer Centre and Homi Bhabha Cancer Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India. (1 speakers): Abhishek Shinghal\n  - Dr. Rai - Comprehensive Blood and Cancer Center Oncology Services, Tamil Nadu, India. (1 speakers): Rajesh K. Narayanasamy\n  - Homi Bhabha National Institute, Training School Complex, Mumbai, Maharashtra, India, Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India. (1 speakers): Vijay M. Patil\n  - Institute of Breast Disease, Netaji Subhas Chandra Bose Cancer Hospital, Kolkata, India. (1 speakers): Soumen Das\n  - Medanta Cancer Institute, Gurugram, Haryana, India. (1 speakers): Ashok Kumar Vaid\n  - Medical Oncologist, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana 500034 India. (1 speakers): Krishna Mohan Mallavarapu\n  - Medical Oncology, Caritas Hospital, Kottayam, IND. (1 speakers): Boben Thomas\n  - Medical Oncology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences (AIIMS), India. (1 speakers): Atul Batra\n  - Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, India. (1 speakers): Mansi Sharma\n  - Medical Services, Medical Affairs Division, Mumbai, IND. (1 speakers): Maneesha Khalse\n  - Netaji Subhas Cancer Hospital, Kolkata, India. Electronic address: tanmoy.nrs@gmail.com. (1 speakers): Tanmoy K. Mandal\n  - North-East Cancer Hospital and Research Institute, Guwahati 781023, Assam, India. (1 speakers): Imliwati Longkumer\n  - SVKM's Dr. Bhanuben Nanavati College of Pharmacy, 400056, India. (1 speakers): Swapnil R. Raut\n  - Sir HN Reliance Foundation Hospital and Research Centre, Mumbai, India. (1 speakers): Sewanti Limaye\n  - TSET Health Promotion Research Center, Stephenson Cancer Center, The University of Oklahoma Health Sciences, OK 73104, USA. (1 speakers): Gaurav Kumar\n  - Tata Memorial Hospital, Mumbai 400 012, India. (1 speakers): Goutam S. Panda\n\n**Indonesia (1 institutions, 4 speakers)**\n  -  (4 speakers): Annes Waren, Faisal Syarifuddin, Michelle A. Hutapea, Nanda N. Nasution\n\n**Iran (4 institutions, 4 speakers)**\n  - Clinical Research Development Center, Amir Oncology Teaching Hospital, Shiraz University of Medical Sciences, Shiraz (1 speakers): Sadra Valiee\n  - Department of Clinical Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran. (1 speakers): Zohreh Ghoreishi\n  - Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran, Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. (1 speakers): Fatemeh Alizadeh\n  - Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran. (1 speakers): Seyed Reza Abdipour Mehrian\n\n**Iraq (1 institutions, 2 speakers)**\n  -  (2 speakers): Ariwan O. Saeed, Moez J. Mobarek\n\n**Ireland (24 institutions, 26 speakers)**\n  -  (3 speakers): Aoife Walshe, Julie Twomey, Ornagh Kestell\n  - Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland, Sidney Kimmel Comprehensive Cancer Centre at Johns Hopkins University, USA. (1 speakers): Jarushka Naidoo\n  - Cork University Hospital, Wilton, T12 DC4A Cork, Ireland. (1 speakers): Hailey K. Carroll\n  - Department of Cardio-Oncology, Gill Heart & Vascular Institute, University of Kentucky, Gill Heart & Vascular Institute, University of Kentucky, Lexington, KY, USA. (1 speakers): Zain Ul Abedin\n  - Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland. (1 speakers): Ciara S. McNevin\n  - Department of Imaging Sciences and Interventional Radiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum 695011, India. (1 speakers): Abhishek Nayak\n  - Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA. (1 speakers): Abeera Mehmood\n  - Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland. (1 speakers): John P. Crown\n  - Department of Oncology, Letterkenny University Hospital, Donegal, Ireland. (1 speakers): Janice Richmond\n  - Department of Oncology, St. John of God Hospital, Subiaco, WA, Australia. (1 speakers): Alice Talbot\n  - Dublin, Ireland. (1 speakers): Conor Moloney\n  - Medical Oncology, Beaumont RCSI Cancer Centre, Dublin, Ireland. (1 speakers): Maggie L. O'Connor\n  - Oncology Department, Midlands Regional Hospital, Tullamore, Co. Offaly, Ireland. (1 speakers): Elizabeth Meade\n  - Princess Margaret Cancer Centre, Toronto, ON M5G 1Z5, Canada. (1 speakers): Harry M. Harvey\n  - School of Nursing and Midwifery, University of Galway, Ireland. (1 speakers): Maura Dowling\n  - St Vincent's University Hospital and School of Medicine, Dublin, Republic of Ireland. (1 speakers): Grainne M. O'Kane\n  - St Vincent's University Hospital and University College Dublin, Dublin, Ireland. (1 speakers): Mary O. O'Reilly\n  - St. Vincent's University Hospital & University College Dublin, Dublin, Ireland. (1 speakers): Donal O' Shea\n  - Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland, St James's Hospital, Dublin, Ireland. (1 speakers): Niamh Coleman\n  - Trinity St. James Cancer Institute, Trinity College Dublin, Dublin, Ireland. (1 speakers): Maeve A. Lowery\n  - Trinity Translational Medicine Institute, Trinity College, University of Dublin, Ireland. (1 speakers): Anne-Marie Baird\n  - UCD School of Computer Science, University College Dublin, Ireland. (1 speakers): Polat Goktas\n  - University Hospital Galway, Galway, Ireland. (1 speakers): Aoife Lowery\n  - University of Limerick Hospital Group, Health Service Executive, Limerick, Ireland. (1 speakers): Ruth Hutch\n\n**Ishikawa (1 institutions, 1 speakers)**\n  - Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Ishikawa 920-8641, Japan. (1 speakers): Seiji Yano\n\n**Israel (18 institutions, 18 speakers)**\n  - Davidoff Cancer Center. Rabin Medical Center, Israel. (1 speakers): Ofer Rotem\n  - Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel. (1 speakers): Nathan I. Cherny\n  - Department of Occupational Therapy, Stanley Steyer School of Health Professions, Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Tel-Aviv, Israel. (1 speakers): Khawla Loubani\n  - Department of Oncology, Shaare Zedek Medical Center, Jerusalem 9103102, Israel. (1 speakers): Nir Peled\n  - Division of Oncology, Rambam Health Care Campus, Haifa, Israel. (1 speakers): Tarek Taha\n  - Division of Oncology, Tel Aviv Sourasky Medical Center, Israel. (1 speakers): Mirika Brezis\n  - Division of Oncology, Tel-Aviv Sourasky Medical Center, Israel. (1 speakers): Tal Etan\n  - Ella Lemelbaum Institute for Immuno-Oncology, Chaim Sheba Medical Center, Israel. (1 speakers): Shirly Grynberg\n  - Fishman Oncology Institute, Rambam Health Care Campus, Haifa, Israel. (1 speakers): Sameh Daher\n  - Fred Hutchinson Cancer Research Center, Seattle, WA, USA. (1 speakers): Noa Granot\n  - Institue of Oncology, Sheba Medical Center, Tel-Hashomer, Gray Faculty of Medicine and Health Sciences, Tel-Aviv University, Tel-Aviv 69978, Israel. (1 speakers): Talia Golan\n  - Institute of Oncology, Rambam Health Campus, Haifa, Israel. (1 speakers): Alona Zer\n  - Israel, Department of Public Health, Faculty of Medicine, Tel Aviv University, Israel. (1 speakers): Bar Levy\n  - Jusidman Institute of Oncology, Sheba Medical Center, Israel. (1 speakers): Jair Bar\n  - Sharett Institute of Oncology, Hadassah University Medical Center, Jerusalem, Israel. (1 speakers): Shani Paluch-Shimon\n  - Technion Integrated Cancer Center, Technion-Israel Institute of Technology, Haifa, Israel. i_benaharon@rambam.health.gov.il. (1 speakers): Irit Ben-Aharon\n  - The Institute of Oncology, Sheba Medical Center, Tel-Hashomer, Israel. (1 speakers): Rinat Bernstein Molho\n  - The Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel-Canada of The Faculty of Medicine, The Hebrew University Hadassah Medical School, Jerusalem, Israel. (1 speakers): Pini Tsukerman\n\n**Italy (225 institutions, 267 speakers)**\n  -  (9 speakers): Arianna Scipilliti, Delia Lucia Bellino, Filippo Morocutti, Giorgia Bortolus, Letizia Matera, Maria Giorgia D'Alonzo, Maria Laura Malgarini, Rebecca Mencarini, Serena Ricchiuto\n  - Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, Milan, Italy. (1 speakers): Roberto Grasso\n  - Applied Research Division for Cognitive and Psychological Science, IEO European Institute of Oncology IRCCS, Milan, Italy. (1 speakers): Gabriella Pravettoni\n  - August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy, Division of Medical Oncology (1 speakers): Benedetta Conte\n  - Aviano, Italy. (1 speakers): Lucia Cadorin\n  - Bergamo, Italy. (1 speakers): Vittoria Fotia\n  - Biomedical, Clinical and Experimental Sciences, Department of Medicine, University of Verona, Verona, Italy, Department of Engineering for Innovation Medicine (DIMI) (1 speakers): Alice Avancini\n  - Bruxelles, Belgium, Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy. (1 speakers): Chiara Dauccia\n  - Cancer Epidemiology Unit, National Cancer Institute, Aviano, Italy. (1 speakers): Diego Serraino\n  - Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy. (1 speakers): Emilio F. Giunta\n  - Careggi University Hospital, Italy. (1 speakers): Luca Visani\n  - Clinical Oncology Unit, Careggi University Hospital, Florence, Italy. (1 speakers): Giulia Massaro\n  - Clinical and Experimental Medicine Program, University of Modena and Reggio Emilia, Modena, Italy. (1 speakers): Lucia Trudu\n  - Clinical and Translational Oncology, Napoli 80134, Italy, Department of Breast & Thoracic Oncology, Division of Breast Medical Oncology, Napoli, Italy. (1 speakers): Roberto Buonaiuto\n  - Comprehensive Cancer Center, Agostino Gemelli University Polyclinic (IRCCS), Rome, Italy. (1 speakers): Floriana Camarda\n  - Comprehensive Cancer Center, Fondazione Policlinico Universitario A. Gemelli, I.R.C.C.S., Rome, Italy. (1 speakers): Antonio Vitale\n  - Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. (1 speakers): Maria Alessandra Calegari\n  - Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy. (1 speakers): Sergio Pannunzio\n  - Current Affiliation: Department of Medical Oncology, Careggi University Hospital, Florence, Italy. (1 speakers): Jacopo Venturini\n  - Department of Agraria, Mediterranean University of Reggio Calabria, Italy. (1 speakers): Francesco Larocca\n  - Department of Biomedical Sciences, Humanitas University, Milan, Italy, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. (1 speakers): Antonella Cammarota\n  - Department of Biomedicine and Prevention, Tor Vergata University of Rome, Rome, Italy. (1 speakers): Federica Lacarbonara\n  - Department of Clinical Medicine Sapienza University of Rome Rome Italy. (1 speakers): Alessandro Laviano\n  - Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy. (1 speakers): Annarita Peddio\n  - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. (1 speakers): Alessandra Longobardi\n  - Department of Diagnostic Imaging and Radiotherapy, Milan - Italy. (1 speakers): Sarah C. Frasca\n  - Department of Diagnostic and Interventional Radiology, Milan, Italy. (1 speakers): Andrea Vanzulli\n  - Department of Electronics, Information, Polytechnic University of Milan, Milan, Italy. (1 speakers): Arsela Prelaj\n  - Department of Experimental Oncology, European Institute of Oncology IRCCS (IEO), Milan, Italy. (1 speakers): Luca Mazzarella\n  - Department of Experimental, University of Bologna, Sant' Orsola-Malpighi Hospital, Bologna I-40138, Italy. (1 speakers): Daria Maria Filippini\n  - Department of Food, Italy. (1 speakers): Letizia Negrini\n  - Department of Health Sciences - University of Genova (1 speakers): Gianluca Catania\n  - Department of Health Sciences, University of Florence, Florence, Italy. (1 speakers): Carla Amato\n  - Department of Hematology, Oncology, Italy, Department of Oncology and Hemato-Oncology, Milano, Italy. (1 speakers): Caterina Vaghi\n  - Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. (1 speakers): Luca Arecco\n  - Department of Internal Medicine and Medical Specialties (DIMI), School, University of Genova, Genoa, Italy, Medical Oncology Department, U.O.C. Clinica di Oncologia Medica (1 speakers): Matteo Lambertini\n  - Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy. (1 speakers): Chiara Molinelli\n  - Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Italy. (1 speakers): Valentino Martelli\n  - Department of Internal Medicine and Medical Therapy, University of Pavia, Italy. (1 speakers): Federica Mascaro\n  - Department of Medical Epidemiology, Milan, Italy. (1 speakers): Cristina Bosetti\n  - Department of Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy. (2 speakers): Chiara Barigazzi, Pasquale Persico\n  - Department of Medical Oncology and Hematology, IRCCS Humanitas Research Hospital, Milan, Italy. (1 speakers): Matteo Simonelli\n  - Department of Medical Oncology and Medicine, Galliera Hospital, Genoa, Italy. (1 speakers): Alessio Carbone\n  - Department of Medical Oncology, CRO di Aviano, National Cancer Institute, IRCCS, Italy, Department of Medicine, University of Udine, Italy. (1 speakers): Lorenzo Foffano\n  - Department of Medical Oncology, Fondazione IRCCS, Milan, Italy. (3 speakers): Amedeo Nuzzo, Eleonora Gusmaroli, Patrizia Giannatempo\n  - Department of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico & University Campus Bio-Medico, Rome, Italy. (2 speakers): Alessandro Mazzocca, Bruno Vincenzi\n  - Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy, Unit of Medical Oncology 2, Pisa, Italy. (1 speakers): Chiara Mercinelli\n  - Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy, Vita-Salute San Raffaele University, Milan, Italy. (1 speakers): Andrea Necchi\n  - Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy. (1 speakers): Valentina Tateo\n  - Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy. (1 speakers): Francesca Rita Ogliari\n  - Department of Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy. (1 speakers): Francesco G. Sullo\n  - Department of Medical Oncology, Meldola, Italy. (3 speakers): Alberto Farolfi, Michela Palleschi, Ugo De Giorgi\n  - Department of Medical Oncology, Milan, Italy. (7 speakers): Anna Maria Frezza, Brigida A. Maiorano, Elena Verzoni, Francesca Ricchini, Mario Occhipinti, Silvia Stacchiotti, Teresa Beninato\n  - Department of Medical Oncology, Milano, Italy. (1 speakers): Roberta Fazio\n  - Department of Medical Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy. (1 speakers): Giuseppe Lombardi\n  - Department of Medical Oncology, Pancreas Translational & Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy. (1 speakers): Michele Reni\n  - Department of Medical Oncology, San Raffaele Hospital, Milan, Italy. (1 speakers): Giampaolo Bianchini\n  - Department of Medical Oncology, San Raffaele Scientific Institute IRCCS, Milan, Italy. (1 speakers): Andrea Casadei Gardini\n  - Department of Medical Oncology, University Hospital of Udine, Udine, Italy. (1 speakers): Francesco Cortiula\n  - Department of Medical and Surgical Sciences (DIMEC) - Alma Mater Studiorum, University of Bologna, Italy. (1 speakers): Elisa Andrini\n  - Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum-University of Bologna, Medical Oncology Unit, Bologna, Italy. (1 speakers): Giuseppe Lamberti\n  - Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. (2 speakers): Matteo Rosellini, Veronica Mollica\n  - Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. (1 speakers): Ilaria Ricciotti\n  - Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy. (1 speakers): Valentina Biagioli\n  - Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, Brescia, Italy. (1 speakers): Greta Schivardi\n  - Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, School of Medicine, Brescia, Italy. (1 speakers): Claudia Assoni\n  - Department of Medicine (DAME), University of Udine, Udine, Italy. (1 speakers): Giulia Zapelloni\n  - Department of Medicine and Surgery, Federico II University, Naples, Italy. (1 speakers): Giuseppe Neola\n  - Department of Medicine and Surgery, Medical Oncology Unit, University Hospital of Parma, Parma, Italy. (2 speakers): Alessandra Dodi, Marcello Tiseo\n  - Department of Medicine, University of Padua, Italy, Veneto Institute of Oncology, IOV-IRCCS, Padua (1 speakers): Matteo Fassan\n  - Department of Medicine, University of Salerno, Baronissi, Italy. (1 speakers): Valeria Conti\n  - Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Naples, Italy. (1 speakers): Margaret Ottaviano\n  - Department of Neurology, \"SS Annunziata\" Hospital, Italy. (1 speakers): Antonio Di Muzio\n  - Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy. (1 speakers): Antonio Marra\n  - Department of Oncology and Haematology, University of Milan, Milan, Italy, European Institute of Oncology, IRCCS, Milan, Italy. (1 speakers): Dario Trapani\n  - Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy, Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan (1 speakers): Carmen Criscitiello\n  - Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. (3 speakers): Gianluca Mauri, Julian D. Etessami, Lisa F. Licitra\n  - Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy. (1 speakers): Stefano Cavalieri\n  - Department of Oncology and Hematology Azienda Ospedaliero-Universitaria di Modena Modena Italy. Electronic address: hbc@unimore.it. (1 speakers): Laura Cortesi\n  - Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy. (1 speakers): Claudio Vernieri\n  - Department of Oncology and Onco-Hematology, University of Milan and Hematology Section Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. (1 speakers): Niccolo Bolli\n  - Department of Oncology, Hospital of Prato Azienda USL Toscana Centro, Prato, Italy. (1 speakers): Laura Biganzoli\n  - Department of Oncology, IRCCS Humanitas Research Hospital, Milan, Italy. (1 speakers): Luigi G. Cecchi\n  - Department of Oncology, IRCCS Ospedale Policlinico San Martino and University of Genova, Genova, Italy. (1 speakers): Gianluca Sacco\n  - Department of Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto IOV, IRCCS, Padova, Italy. (1 speakers): Antonella Brunello\n  - Department of Oncology, Molecular Biotechnology Center, University of Torino, Torino, Italy, IFOM ETS, The AIRC Institute of Molecular Oncology, Milano, Italy. (1 speakers): Alberto Bardelli\n  - Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Italy. (1 speakers): Giulia Cerretti\n  - Department of Oncology, Ospedale San Rocco ASL Caserta, Sessa Aurunca 81037, Campania, Italy. mariar.damato@gmail.com. (1 speakers): Mariarosaria D'amato\n  - Department of Oncology, Spedali Riuniti University of Brescia, Brescia 25123, Italy. (1 speakers): Alfredo Berruti\n  - Department of Oncology, Terni, Italy. (1 speakers): Annalisa Guida\n  - Department of Oncology, University of Torino, San Luigi Gonzaga University Hospital, Orbassano, Italy. (1 speakers): Silvia Novello\n  - Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital-Orbassano, Turin, Italy. (1 speakers): Massimiliano Cani\n  - Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Torino, Italy. (1 speakers): Ornella Cantale\n  - Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy. (2 speakers): Giovanni Farinea, Luca Cozzone\n  - Department of Oncology, University of Turin, Turin, Italy. (1 speakers): Massimo Di Maio\n  - Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. (1 speakers): Sara Lonardi\n  - Department of Otolaryngology-Head and Neck Surgery, Provincial Hospital of Bolzano (SABES-ASDAA), Bolzano, Italy. (1 speakers): Francesca Zanghi\n  - Department of Precision Medicine in Medical, Section of Medical Oncology, University of Palermo, Italy. (1 speakers): Lorena Incorvaia\n  - Department of Precision Medicine in Medical, Section of Medical Oncology, University of Palermo, Palermo, Italy. (1 speakers): Clarissa Mujacic\n  - Department of Precision Medicine in Medical, University of Palermo, Palermo, Italy. (1 speakers): Tancredi Didier Bazan Russo\n  - Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Section of Pharmacology, University of Bari Aldo Moro Medical School, Bari, Italy. (1 speakers): Vanessa Desantis\n  - Department of Public Health, Università degli Studi di Napoli-AOU Federico II, Naples, Italy. (1 speakers): Umberto Malapelle\n  - Department of Radiation Oncology, Institute of Radiology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. (1 speakers): Luca Tagliaferri\n  - Department of Research, Milan, Italy. (1 speakers): Mario P. Colombo\n  - Department of Surgery, Milan, Italy. (1 speakers): Paolo G. Casali\n  - Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy, Division of Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padova, Italy. (1 speakers): Maria Vittoria Dieci\n  - Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, IT, Italy. (2 speakers): Federica Miglietta, Michele Bottosso\n  - Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy. (2 speakers): Laura Bonanno, Loc Carlo Bao\n  - Department of Surgery, University of Padova, Padova, Italy. (1 speakers): Valentina Guarneri\n  - Department of Surgical, Section of Medical Oncology, University of Palermo, Palermo, Italy. (1 speakers): Alessandra Dimino\n  - Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. (1 speakers): Ada Taravella\n  - Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy. (2 speakers): Carlotta Antoniotti, Chiara Cremolini\n  - Department of Woman, Child and Public Health, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy. (1 speakers): Camilla Nero\n  - Department of Women's and Children's Health, Padua, Italy. (1 speakers): Andrea Mastria\n  - Dietetics and Clinical Nutrition Unit, Hospital Policlinico San Matteo of Pavia, Pavia, Italy. (1 speakers): Riccardo Caccialanza\n  - Digestive Molecular Clinical Oncology Research Unit, Verona, Italy. (1 speakers): Alberto Quinzii\n  - Dipartimento di Internistica Clinica e Sperimentale \"F. Magrassi\", Napoli, Italy. (1 speakers): Claudia Cardone\n  - Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO), IRCCS, Milan, Italy. (1 speakers): Francesca Spada\n  - Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milan, Italy, Molecular Medicine Department, University of Pavia, Pavia, Italy. (1 speakers): Lorenzo Gervaso\n  - Division of Gynecologic Oncology, European Institute of Oncology, IRCCS, Milan, Italy. (1 speakers): Marta Mongillo\n  - Division of Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy. (1 speakers): Gaia Griguolo\n  - Division of Medical Oncology, Maggiore University Hospital, Italy. (1 speakers): Ida Taglialatela\n  - Division of Medical Oncology, Maggiore University Hospital, Novara, Italy. (1 speakers): Alessandra Gennari\n  - Division of Medical Senology, European Institute of Oncology IRCCS, Milan, Italy. (1 speakers): Emilia Montagna\n  - Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy. (1 speakers): Nadia Bianco\n  - Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy, Department of Oncology and Hemato-Oncology, University of Milan, Milan (2 speakers): Gabriele Antonarelli, Jalissa Katrini\n  - Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy. (1 speakers): Federica Biello\n  - Division of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy. (1 speakers): Stefano Partelli\n  - Division of Radiotherapy - Department of Imaging Diagnostics, \"A. Gemelli\" University Hospital Foundation IRCCS. 00168 Rome, Italy. (1 speakers): Valeria Masiello\n  - Division of Thoracic Oncology, European Institute of Oncology, IEO, IRCCS, Milan 20141, Italy. (1 speakers): Antonio Passaro\n  - European Institute of Oncology IRCCS and University of Milan-Bicocca, Milan, Italy. (1 speakers): Nicoletta Colombo\n  - European Institute of Oncology IRCCS, Milan, Italy, University of Milano, Milan, Italy. (1 speakers): Giuseppe Curigliano\n  - FPO-IRCCS, Candiolo Cancer Institute, Department of Medical Oncology, Candiolo, Italy. (1 speakers): Elena Geuna\n  - Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy. (1 speakers): Tiziano Zinicola\n  - Gastroenterology and Digestive Oncology Department, Georges Pompidou European Hospital, AP-HP, Paris, France, Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy (1 speakers): Annalice Gandini\n  - Genoa, Italy. (1 speakers): Eugenia Cella\n  - Gynecologic Oncology Department, European Institute of Oncology, Milan, Italy. (1 speakers): Fedro A. Peccatori\n  - Gynecologic Oncology Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy. (1 speakers): Rosanna Mancari\n  - Head and Neck Medical Oncology Department, Milan, Italy. (1 speakers): Laura D. Locati\n  - Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, MI, Italy. (2 speakers): Flavia Jacobs, Mariangela Gaudio\n  - Humanitas Hospital San Pio X, Humanitas University, Milan, Italy. (1 speakers): Domenica Lorusso\n  - IRCCS Humanitas Research Hospital, Cancer Center, Rozzano, Italy. (2 speakers): Luca Toschi, Sara Farinatti\n  - IRCCS Humanitas Research Hospital, Rozzano, Italy. (1 speakers): Agnese Losurdo\n  - IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy. (1 speakers): Francesca Gaino\n  - IRCCS Ospedale Policlinico San Martino, Genova, Italy. (1 speakers): Lorenzo Ferrando\n  - IRCCS Regina Elena National Cancer Institute, Rome, Italy. (1 speakers): Federico Cappuzzo\n  - IRCCS San Raffaele Scientific Institute, Milan, Italy. (1 speakers): Andres J. Ferreri\n  - Institute of Pharmacological Research Mario Negri, Department of Oncology, Milan, Italy. (1 speakers): Valter Torri\n  - Interdisciplinary Department of Medicina, Division of Medical Oncology, University of Bari \"Aldo Moro\", A.O.U. Consorziale Policlinico di Bari, Bari, Italy. (1 speakers): Mimma Rizzo\n  - Interdisciplinary Department of Medicine, University of Bari \"Aldo Moro\", Bari, Italy. (1 speakers): Nada Chaoul\n  - Maggiore University Hospital, 28100 Novara, Italy. (1 speakers): Tommaso L. Landolfo\n  - Maugeri Clinical Research Institutes IRCCS, Pavia, Italy. (1 speakers): Sara Demurtas\n  - Medical Oncologist, Department of Otorhinolaryngology, IRCCS San Raffaele Scientific Institute, Milano, Italy. (1 speakers): Aurora Mirabile\n  - Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy. (1 speakers): Giulia Pasello\n  - Medical Oncology Department, Milan, Italy. (4 speakers): Filippo Pietrantonio, Marta Brambilla, Monica Ganzinelli, Simone Oldani\n  - Medical Oncology Department, National Cancer Institute, Aviano, Italy. (1 speakers): Lucia Fratino\n  - Medical Oncology Department, University and Hospital Trust of Verona, Verona, Italy. (1 speakers): Jessica Menis\n  - Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy. (1 speakers): Veronica Murianni\n  - Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Liguria, Italy. (1 speakers): Alessandro Pastorino\n  - Medical Oncology Unit 2, Italy, University of Milano, Italy. (1 speakers): Claudia Giani\n  - Medical Oncology Unit, AST1, Pesaro, Italy. (1 speakers): Rita Chiari\n  - Medical Oncology Unit, Bergamo, Italy, Department of Biomedical Sciences, Humanitas University, Rozzano, Italy. (1 speakers): Erika Stucchi\n  - Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Italy. (1 speakers): Matteo Carpani\n  - Medical Oncology Unit, Department of Oncology and Hematology, Belcolle Hospital, Viterbo, Italy. (1 speakers): Marta Schirripa\n  - Medical Oncology Unit, Department of Oncology, Azienda USL Toscana Centro, Florence, Italy. (1 speakers): Maria Simona Pino\n  - Medical Oncology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy. (1 speakers): Cristina Morelli\n  - Medical Oncology Unit, Pavia, Italy. (1 speakers): Federico Sottotetti\n  - Medical Oncology Unit, Sant'Andrea Hospital of Rome, Italy. (1 speakers): Raffaele Giusti\n  - Medical Oncology Unit, Savona 17100, Italy. (1 speakers): Sara Elena Rebuzzi\n  - Medical Oncology Unit, University Hospital and University of Cagliari, Italy. (1 speakers): Andrea Pretta\n  - Medical Oncology Unit, University Hospital of Parma, Parma, Italy. (2 speakers): Francesca Trentini, Sebastiano Buti\n  - Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. (1 speakers): Lorenza Rimassa\n  - Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy, Department of Biomedical Sciences, Humanitas University, Milan, Italy. (2 speakers): Carlo Resteghini, Paolo Bossi\n  - Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. (1 speakers): Luigi Lorini\n  - Medical Oncology, Bologna, Italy, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. (1 speakers): Francesco Massari\n  - Medical Oncology, Comprehensive Cancer Centre IRCCS - AUSL Reggio Emilia, Italy. (1 speakers): Cristina Masini\n  - Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy. (2 speakers): Elena Speziale, Luisana Sisca\n  - Medical Oncology, Rome, Italy. (1 speakers): Antonio Cigliola\n  - Medical Oncology, Sant'Andrea University Hospital, Rome, Italy. (1 speakers): Marco Siringo\n  - Medical Oncology, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy. (1 speakers): Giulio Metro\n  - Medical Oncology, St Andrea Hospital, Rome, Italy. (1 speakers): Marco Filetti\n  - Medical Oncology, University and University Hospital of Cagliari, Cagliari, Italy. (1 speakers): Mara Persano\n  - Medical Oncology, Versilia Hospital, Azienda USL Toscana Nord Ovest, Lido di Camaiore, Italy. (1 speakers): Andrea Camerini\n  - Melanoma, Oncological Immunotherapy and Innovative Therapies Department INT - IRCCS \"Fondazione G. Pascale\" Naples Italy. (1 speakers): Paolo A. Ascierto\n  - Meldola, Italy. (1 speakers): Nicola Normanno\n  - Memorial Sloan Kettering Cancer Center, NY, USA. (1 speakers): Michelangelo Marasco\n  - Milan - Italy. (1 speakers): Giovanni Leuzzi\n  - Milan, Italy. (2 speakers): Michele Del Vecchio, Patrizia Pasanisi\n  - Monaldi Hospital AO Dei Colli, 80131 Naples, Italy. (1 speakers): Maria D'Amato\n  - Naples, Italy. (1 speakers): Anna Maria Trotta\n  - National Centre for HIV Oncology, Chelsea Westminster Hospital, London, UK, Milan, Italy. (1 speakers): Alberto Giovanni Leone\n  - NearLab, Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milan, Italy. (1 speakers): Alessandra Pedrocchi\n  - Nervous System Medical Oncology Department, Bologna, Italy. (1 speakers): Vincenzo Di Nunno\n  - Niguarda Cancer Center, Milan, Italy. (1 speakers): Silvia Marsoni\n  - Niguarda Cancer Center, Milano, Italy, Department of Hematology & Oncology, University of Milan, Milan, Italy. (1 speakers): Rebecca Romano\n  - Oncology Department, Azienda USL-IRCCS di Reggio Emilia, Italy. (1 speakers): Carmine Pinto\n  - Pisa, Italy. (1 speakers): Chiara Maria Mazzanti\n  - Policlinico Umberto I University Hospital, Rome, Italy. (1 speakers): Mattia A. Di Civita\n  - Policlinico Umberto I, Department of Radiological, ″Sapienza″ University of Rome, Rome, Italy. (1 speakers): Giuseppe Minniti\n  - Policlinico Umberto I, Rome, Italy, Department of Radiological, Sapienza University, Rome, Italy. (1 speakers): Andrea Botticelli\n  - Radiation Oncology Department, Milan, Italy, Department of Oncology, University of Milan, Milan, Italy. (1 speakers): Andrea Riccardo Filippi\n  - Research Nurses Team, European Institute of Oncology, Milan, Italy. (1 speakers): Teresa Profeta\n  - San Maurizio Central Hospital of Bolzano, BZ, Italy. Electronic address: gaboristvan.liposits@sabes.it. (1 speakers): Gabor I. Liposits\n  - Sapienza University of Rome, Rome, Italy. (1 speakers): Federica D'Antonio\n  - Section of Medical Oncology, Department of Precision Medicine in Medical, University of Palermo, Palermo, Italy. (1 speakers): Daniele Fanale\n  - Section of Oncology, Department of Engineering for Innovation Medicine (DIMI), University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy. (4 speakers): Daniela Tregnago, Lorenzo Belluomini, Sara Pilotto, Serena Eccher\n  - Translational Research Unit, Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy. (1 speakers): Luca Malorni\n  - U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy. (1 speakers): Eva Blondeaux\n  - Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy. (1 speakers): Marzia Del Re\n  - Unit of Medical Oncology 2, Pisa, Italy, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. (2 speakers): Martina Carullo, Veronica Conca\n  - Unit of Medical Oncology 2, Pisa, Italy, Institute of Interdisciplinary Research \"Health Science, Pisa, Italy, Unit of Medical Oncology 2, Pisa, Italy (1 speakers): Virginia Genovesi\n  - Unit of Medical Oncology and Biomolecular Therapy, Department of Medical and Surgical Sciences, University of Foggia, Policlinico Riuniti, Foggia, Italy. (1 speakers): Vincenza Conteduca\n  - Unit of Medical Oncology, Carpi Civil Hospital, Carpi, Medicine Department, Local Health Unit, Modena, Italy. (1 speakers): Emilia Gianotti\n  - Unit of Medical Oncology, Department of Medical and Surgical Specialties, and Public Health, University of Brescia, Brescia, Italy. (1 speakers): Marco Bergamini\n  - Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Milan, Italy. (1 speakers): Alice Indini\n  - Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Naples, Italy. (1 speakers): Claudia Trojaniello\n  - University Department of Anesthesiology and Intensive Care Medicine, University Hospital Tübingen, Eberhard Karls University, Tübingen, Germany. (1 speakers): Eleonora Gorgati\n  - University Hospital of Modena, 41124 Modena, Italy. (1 speakers): Elisa D'Agostino\n  - University of Bari \"A. Moro\" and Division of Medical Oncology, Bari, Italy. (1 speakers): Camillo Guglielmo Porta\n  - University of Campania Luigi Vanvitelli, 80131 Naples, Italy. (1 speakers): Caterina De Rosa\n  - University of Milan, Milan, Italy. (1 speakers): Filippo Guglielmo Maria De Braud\n  - University of Naples \"Federico II\", Naples 80131, Italy. (1 speakers): Andrea D'Arienzo\n  - University of Perugia, Santa Maria Misericordia Hospital, Perugia, Italy. (1 speakers): Mario Mandala\n  - University of Pisa, Pisa, Italy. (1 speakers): Marco Maria M. Germani\n  - Vita-Salute San Raffaele University, Milan. (1 speakers): Giovanni Luigi Pastorino\n\n**Japan (93 institutions, 103 speakers)**\n  -  (6 speakers): Emiko Tange, Giorgia Amelia Intilisano, Ishida Masaki, NAOTO KOASHI, Shota Uesawa, Tsumugu Harada\n  - Advanced Cancer Translational Research Institute, Showa Medical University, Tokyo, Japan. (1 speakers): Junji Tsurutani\n  - Biostatistics Division, Center for Research Administration and Support, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Masashi Wakabayashi\n  - Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan. (1 speakers): Yukinori Ozaki\n  - Breast Oncology Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Ariake, Koto, Tokyo, Japan. (1 speakers): Meiko Nishimura\n  - Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan. (1 speakers): Toshifumi Yamaguchi\n  - Clinical Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Takashi Ikeno\n  - Department of Advanced Clinical Research and Development, Graduate School of Medical Sciences, Nagoya City University, Aichi, Japan. (1 speakers): Kazuki Nozawa\n  - Department of Breast Medical Oncology, The Cancer Institute Hospital of JFCR, Tokyo, Japan. (1 speakers): Takayuki Kobayashi\n  - Department of Breast and Endocrine Surgery, Graduate School of Medicine, University of Osaka, Suita, Osaka 565-0871, Japan. (1 speakers): Tetsuhiro Yoshinami\n  - Department of Breast and Endocrine Surgical Oncology Graduate School of Medicine Tohoku University, Aoba-ku, Sendai 980-8574, Japan. (1 speakers): Akiko Ebata\n  - Department of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan. (1 speakers): Hiroshi Tada\n  - Department of Breast and Thyroid Surgery, Kawasaki Medical School Hospital, Kurashiki, Japan. (1 speakers): Takayuki Iwamoto\n  - Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Japan. (1 speakers): Yoshito Komatsu\n  - Department of Clinical Oncology, Aichi Cancer Center Hospital, Chikusa-Ku, Nagoya, Aichi, Japan. (1 speakers): Yasunobu Ishizuka\n  - Department of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan. (1 speakers): Motoo Nomura\n  - Department of Clinical Oncology, St. Marianna University School of Medicine, Sugao, Miyamae-ku, Kawasaki, Kanagawa, Japan. y.suna0825@gmail.com. (1 speakers): Yu Sunakawa\n  - Department of Clinical Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan. (1 speakers): Hisato Kawakami\n  - Department of Dermatologic Oncology, National Cancer Center Hospital, Chuo-Ku, Tokyo, Japan. (1 speakers): Eiji Nakano\n  - Department of Dermatology, Kawasaki Municipal Hospital. (1 speakers): Sayuka Arakawa\n  - Department of Early Clinical Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan. (1 speakers): Chiaki Suzuki\n  - Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. (1 speakers): Chikako Funasaka\n  - Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Koto-Ku, Tokyo, Japan. (1 speakers): Keitaro Shimozaki\n  - Department of Gastroenterological Chemotherapy, Japanese Foundation for Cancer Research, Ganken Ariake Byoin Cancer Institute Hospital, Koto-ku, Tokyo, Japan. (1 speakers): Shota Fukuoka\n  - Department of Gastroenterological Surgery, Gifu University Hospital, Gifu, Gifu 501-1194, Japan. (1 speakers): Ryoma Yokoi\n  - Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan. (4 speakers): Kazumasa Yamamoto, Tadayoshi Hashimoto, Yasutoshi Kuboki, Yuki Matsubara\n  - Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Nagasaki, Japan. (1 speakers): Kohei Hayashi\n  - Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan. (1 speakers): Nobumasa Mizuno\n  - Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan. (1 speakers): Keisuke Koroki\n  - Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division Kanagawa Cancer Center Yokohama Japan. (1 speakers): Makoto Ueno\n  - Department of Gastroenterology, Institute of Biomedical & Health Sciences, Hiroshima University, Japan. (1 speakers): Tomokazu Kawaoka\n  - Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. (1 speakers): Ken Kato\n  - Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan. (2 speakers): Hideaki Bando, Yoshiaki Nakamura\n  - Department of Hematology and Cell Therapy, NHO Kyushu Cancer Center, Minami-ku, Fukuoka 811-1395, Japan. (1 speakers): Youko Suehiro\n  - Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. (1 speakers): Yuri Maegawa\n  - Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Hiroshi Imaoka\n  - Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. (1 speakers): Yuta Maruki\n  - Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. (1 speakers): Kouji Izumi\n  - Department of Medical Oncology and Hematology, Cancer Center, Kobe University Hospital, Kobe, Japan, Japan Clinical Oncology Group (JCOG) Data Center, National Cancer Center Hospital, Tokyo, Japan (1 speakers): Koichiro Wasano\n  - Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research (JFCR), Koto-ku, Tokyo 135-8550, Japan. (1 speakers): Yuji Miura\n  - Department of Medical Oncology, Hokkaido University Hospital, N14, W5, Kita-ku, Sapporo, Japan. (1 speakers): Yasushi Shimizu\n  - Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Misao Fukuda\n  - Department of Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, Japan. (2 speakers): Mai Hoshino, Rui Kitadai\n  - Department of Medical Oncology, Saitama Medical University International Medical Center, Saitama, Japan. (1 speakers): Yoshiaki Mihara\n  - Department of Medical Oncology, Tohoku University Hospital, Sendai 980-8547, Japan. (1 speakers): Shiori Ishikawa\n  - Department of Molecular Imaging and Diagnosis, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan. (1 speakers): Koji Yamashita\n  - Department of Orthopaedic Oncology and Surgery, Saitama Medical University International Medical Center, Saitama, Japan. (1 speakers): Takuya Watanabe\n  - Department of Otolaryngology-Head & Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. (1 speakers): Akihiro Homma\n  - Department of Otorhinolaryngology and Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan. (1 speakers): Sho Iwaki\n  - Department of Palliative Medicine, Kobe University Graduate School of Medicine, Kobe, Japan. (1 speakers): Takashi Yamaguchi\n  - Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan. (1 speakers): Hiroto Ishiki\n  - Department of Pediatric Surgery (1 speakers): Masayasu Sato\n  - Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kajii-cho, Kamigyo-ku, Kyoto 602-8566, Japan. (1 speakers): Tadaaki Yamada\n  - Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. (1 speakers): Haruka Nakatani\n  - Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan. (1 speakers): Shunsuke Misono\n  - Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. (1 speakers): Takeshi Kodaira\n  - Department of Radiation Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. (1 speakers): Tairo Kashihara\n  - Department of Radiology, Kawasaki Medical School, Okayama, Japan. (1 speakers): Yuki Sato\n  - Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Aomori, Japan. (1 speakers): Tomonori Makiguchi\n  - Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. (1 speakers): Hisashi Tanaka\n  - Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan. (1 speakers): Akinari Tsukada\n  - Department of Respiratory Medicine, Osaka International Cancer Institute, Osaka, Japan. (1 speakers): Kiyohide Komuta\n  - Department of Surgery National Hospital Organization Osaka National Hospital Osaka Japan. (1 speakers): Masaaki Miyo\n  - Department of Surgery Osaka Rosai Hospital Sakai Japan. (1 speakers): Ryohei Kawabata\n  - Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. (1 speakers): Ryosuke Mizuno\n  - Department of Surgery, Kyoto University Graduate School of Medicine, Sakyo-Ku, Kyoto, Japan. (1 speakers): Haruku Fujita\n  - Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Minami-ku, Hiroshima, Hiroshima, Japan. (1 speakers): Momoko Takaya\n  - Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo, Tokyo, Japan. (1 speakers): Shingo Kitagawa\n  - Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan. (1 speakers): Seigo Katakura\n  - Department of Thoracic Surgery, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan (1 speakers): Fumihiro Shoji\n  - Department of Urology, University of Tsukuba Institute of Medicine, Tsukuba, Ibaraki, Japan. (1 speakers): Yoshiyuki Nagumo\n  - Division of Cancer Evolution, National Cancer Center Japan Research Institute, Tokyo, Japan. (1 speakers): Yuji Uehara\n  - Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Shinjuku-ku, Japan. (1 speakers): Kenro Hirata\n  - Division of Gastrointestinal Oncology, Shizuoka Cancer Center Hospital, Shizuoka, Japan. (1 speakers): Tomoya Yokota\n  - Division of Lower G.I., Department of Gastroenterological Surgery, School of Medicine, Hyogo Medical University, Nishinomiya 663-8501, Japan. (1 speakers): Kozo Kataoka\n  - Division of Lower GI, Department of Gastroenterological Surgery, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya, Hyogo (1 speakers): Yuko Fukumoto\n  - Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, Chuo-ku, Kobe, Hyogo, Japan. (1 speakers): Yoshiaki Nagatani\n  - Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan. (1 speakers): Tetsuo Shimizu\n  - Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, Nagaizumi, Japan. (1 speakers): KAZUSHIGE WAKUDA\n  - Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan. (1 speakers): Akira Hamada\n  - Ltd, Tsukuba, Japan. (1 speakers): Ken Ito\n  - MSD K.K., Tokyo, Japan. (1 speakers): Tetsu Kamitani\n  - Molecular Pharmacology Research Group, Department of Pharmacology and Toxicology, German University in Cairo, Egypt. (1 speakers): Nada H. Hussein\n  - National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Hiroki Izumi\n  - Neutron Science and Technology Center, Comprehensive Research Organization for Science and Society, Tokai 319-1106, Japan. (1 speakers): Kazuki Iida\n  - Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Osaka, Japan. (1 speakers): Hiroki Yukami\n  - Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, Center for Genomic Medicine and Cardiovascular Research Center, Massachusetts General Hospital, Boston (1 speakers): Satoshi Koyama\n  - Shien-Lab, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo, Japan. (1 speakers): Takeshi Sawada\n  - The Cancer Institute Hospital, Tokyo, Koto-ku, Japan. (1 speakers): Hiroki Osumi\n  - Translational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Mitsuho Imai\n  - University of Tsukuba, Tsukuba, Japan. (1 speakers): Markus Y. Widjaja Lomanto\n  - Wakayama Medical University, Wakayama 641-8509, Japan. (1 speakers): Ryota Shibaki\n  - Wakayama Medical University, Wakayama, Japan. (1 speakers): Yuichi Ozawa\n\n**Jerusalem (1 institutions, 1 speakers)**\n  - Radiation Oncology Department, Augusta Victoria Hospital, Jerusalem 9511208, Palestine. (1 speakers): Elias E. Lahham\n\n**Jordan (8 institutions, 9 speakers)**\n  -  (1 speakers): Awab Al-Ani\n  - Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan, School of Medicine, The University of Jordan. Amman, Jordan. (2 speakers): Hikmat Abdel-Razeq, Kamal Al-rabi\n  - King Hussein Cancer Center, 11941, Jordan. (1 speakers): Faris T. Tamimi\n  - King Hussein Cancer Center, Amman, Jordan. (1 speakers): Anas M. Zayed\n  - Mater Misericordiae University Hospital, Dublin, Ireland. (1 speakers): Khaled N. Taha\n  - Medical Oncology, Faculty of Medicine, Al-Balqa' Applied University, Amman, JOR. (1 speakers): Bara M. Hammadeh\n  - School of Medicine, The University of Jordan, Amman, Jordan. (1 speakers): Yazan I. Hamadneh\n  - University of Jordan, Amman, Jordan. (1 speakers): Hamza M. Alakhras\n\n**Kanagawa (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan. (1 speakers): Kenichi Harano\n\n**Karnataka (2 institutions, 2 speakers)**\n  - Department of Oncology, Mysore Medical College & Research Institute, India. Electronic address: dal_muk1@hotmail.com. (1 speakers): Mukesh Shanthilal\n  - Manipal Hospital, Bengaluru, Karnataka, India. (1 speakers): Amit Rauthan\n\n**Kazakhstan (2 institutions, 2 speakers)**\n  -  (1 speakers): Mariya Dmitrenko\n  - Department of Oncology, Astana Medical University, Oncologist-Surgeon, Multidisciplinary Medical Center, Astana, Kazakhstan. (1 speakers): Aizhan Bekisheva\n\n**Kenya (2 institutions, 2 speakers)**\n  -  (1 speakers): Sujana Bhikam Babu\n  - Avenue Hospital, Nairobi, Kenya. (1 speakers): Karishma Sharma\n\n**Kerala (1 institutions, 1 speakers)**\n  - Department of Radiation Oncology, All India Institute of Medical Sciences, India. (1 speakers): Anjali V. Ramdulari\n\n**Latvia (1 institutions, 1 speakers)**\n  -  (1 speakers): Lasma Nikolaisone\n\n**Lebanon (2 institutions, 2 speakers)**\n  - American University of Beirut, Hariri School of Nursing, Beirut, Lebanon. (1 speakers): Myrna Doumit\n  - Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. (1 speakers): Hazem I. Assi\n\n**Libya (1 institutions, 1 speakers)**\n  - University of Tripoli, Tripoli, Libya. (1 speakers): Ekram H. Hasanin\n\n**Lithuania (1 institutions, 1 speakers)**\n  -  (1 speakers): Edita Balasova\n\n**London (1 institutions, 1 speakers)**\n  - Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK. (1 speakers): Sergio Quezada\n\n**Luxembourg (1 institutions, 1 speakers)**\n  -  (1 speakers): Ingrid Krucken\n\n**MA (8 institutions, 8 speakers)**\n  -  (1 speakers): Guillermo Antonio De Velasco Oria\n  - Boston, Massachusetts (1 speakers): Rachel Salazar\n  - Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA. (1 speakers): Lori J. Wirth\n  - Dana-Farber Cancer Institute/Brigham and Women's Hospital Harvard Medical School, Boston, MA. (1 speakers): Joaquim Bellmunt\n  - Dana-Farber/Harvard Cancer Center, Boston, MA, USA. (1 speakers): Sara M. Tolaney\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (1 speakers): Pasi A. Janne\n  - Massachusetts General Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA, USA. (1 speakers): Dejan Juric\n  - South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia. (1 speakers): Christopher Sweeney\n\n**MASSACHUSSETS (1 institutions, 1 speakers)**\n  - Medical Oncology, INCLIVA, Valencia, Spain. (1 speakers): Tania C. Fleitas\n\n**MD (3 institutions, 3 speakers)**\n  - Cork University Hospital, Wilton, T12 DC4A Cork, Ireland. (1 speakers): Roisin M. Connolly\n  - Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, US. (1 speakers): Suzanne L. Topalian\n  - Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, USA. (1 speakers): Julie R. Brahmer\n\n**MI (1 institutions, 1 speakers)**\n  - Yale University Cancer Center, Connecticut. (1 speakers): Patricia M. Lorusso\n\n**MN (3 institutions, 3 speakers)**\n  - Department of Medicine, Gastrointestinal Research Unit, Mayo Clinic Alix School of Medicine, Rochester, MN (1 speakers): Frank A. Sinicrope\n  - Department of Oncology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. (1 speakers): Evanthia Galanis\n  - Department of Oncology, Mayo Clinic, Rochester, MN, USA. (1 speakers): Aaron S. Mansfield\n\n**MO (1 institutions, 1 speakers)**\n  - Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Tina Cascone\n\n**Madrid (1 institutions, 1 speakers)**\n  - Valencia, Spain. (1 speakers): Sonia Macia\n\n**Martinique (1 institutions, 1 speakers)**\n  - Inserm, IRD, SESSTIM, ISSPAM, Marseille, France, University Hospital of Martinique, Research & Development in Oncology, Oncology Hematology Urology department, Fort-de-France (1 speakers): Remi Houpert\n\n**Mexico (10 institutions, 11 speakers)**\n  -  (2 speakers): Josette R. Staufert Gutierrez, Luisa Rivero Zambrano\n  - Hospital School of Veterinary Medicine, University of Buenos Aires, Argentina. (1 speakers): Victor A. Castillo\n  - Instituto Nacional de Cancerología (INCan), Mexico. (1 speakers): Norma Y. Hernandez-Pedro\n  - Instituto Nacional de Cancerología, Mexico City 14080, Mexico. (1 speakers): Oscar Gerardo Arrieta Rodriguez\n  - Instituto Nacional de Cancerología, Mexico. (1 speakers): Enrique Caballe Perez\n  - National Institute of Cancer (Instituto Nacional de Cancerología, INCan), Mexico. (1 speakers): Rosa Maria Alvarez-Gomez\n  - Personalized Medicine Laboratory, Instituto Nacional de Cancerología (INCan), Mexico City, 14080, Mexico. (1 speakers): Jose M. Lucio-Lozada\n  - Santiago de Querétaro, Mexico. (1 speakers): Carla D. Robles-Espinoza\n  - State University of Londrina, 86051-990, Brazil. (1 speakers): Brenda L. Alvarez Diaz\n  - University Center Against Cancer, University Hospital \"José E. González\", Monterrey, Mexico. (1 speakers): Adelina Alcorta-Garza\n\n**Middlesex (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, Middlesex, HA6 2RN, UK. (1 speakers): Paul Nathan\n\n**Morocco (6 institutions, 8 speakers)**\n  -  (3 speakers): IHSANE SKITIOUI, Rania Chakir, Salma Ichou\n  - Department of Medical Oncology, Hassan II University Hospital, Fez 30000, Morocco. (1 speakers): Karima Oualla\n  - Medical Oncology, Mohammed VI University Hospital, Oujda, Morocco. (1 speakers): Ouissam Al Jarroudi\n  - Médical Oncology, Régional Hospital Center, Tangier, Morocco. (1 speakers): Saoussane Kharmoum\n  - National Institute of Oncology, Ibn Sina University Hospital Center, Mohammed V University, Rabat, Morocco. (1 speakers): Hassan Errihani\n  - National Institute of Oncology, Morocco. (1 speakers): Amine Lachgar\n\n**Mozambique (1 institutions, 1 speakers)**\n  - Department of Medicine, Universidade Eduardo Mondlane, Maputo, Mozambique. (1 speakers): Assaina T. Tomo\n\n**N. Faliro (1 institutions, 1 speakers)**\n  - Fourth Oncology Department & Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece. (1 speakers): Helena Linardou\n\n**NC (1 institutions, 1 speakers)**\n  - The Department of Medicine, Duke Cancer Institute, Durham, NC 27710, USA. (1 speakers): Jeffrey Crawford\n\n**NSW (3 institutions, 3 speakers)**\n  - Cancer Care Centre, St George Hospital, Kogarah, NSW, Australia. (1 speakers): Katrin Sjoquist\n  - Department of Medical Oncology, Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, NSW, Australia, St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia (1 speakers): Megan Crumbaker\n  - Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia. (1 speakers): David Goldstein\n\n**NY (10 institutions, 15 speakers)**\n  - Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, NY, USA. (1 speakers): Richard J. Gralla\n  - Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. (1 speakers): Shigehisa Kitano\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, USA. (4 speakers): Dana E. Rathkopf, Helena A. Yu, Jonathan E. Rosenberg, Neil M. Iyengar\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY. (3 speakers): Andrea Cercek, Ghassan K. Abou-Alfa, Yelena Y. Janjigian\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, USA. (1 speakers): William D. Tap\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, NY, USA. (1 speakers): Shanu Modi\n  - Department of Medicine, Weill Cornell Medical College, NY, Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY (1 speakers): Carol Aghajanian\n  - Departments of Pathology, Upstate Medical University, Syracuse, NY USA. (1 speakers): Jeffrey S. Ross\n  - H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. (1 speakers): Nikhil I. Khushalani\n  - Memorial Sloan Kettering Cancer Center, Department of Medicine, NY. (1 speakers): Tiffany A. Traina\n\n**Nepal (2 institutions, 2 speakers)**\n  - B.P. Koirala Institute of Health Sciences, Dharan, Nepal. (1 speakers): Nitesh K. Karna\n  - Tribhuvan University Teaching Hospital Kathmandu Nepal. (1 speakers): Naveen Gautam\n\n**Netherlands (109 institutions, 124 speakers)**\n  -  (9 speakers): Cato D. Boreel, Deborah Ophoff, Jet Wies Ankersmid-Matos Miguel, Karlijn D. Joode, Laura Lammens, Niels Klaassen, Sissi Chen, Stef Elings, Tissing Wim\n  - Amsterdam (1 speakers): Ralf Herold\n  - Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands. (1 speakers): Judith S. Quik\n  - Amsterdam UMC, Department of Medical Oncology, Amsterdam. (1 speakers): Sebastiaan Siegerink\n  - Amsterdam University Medical Center, Naples, Italy (P.A.A.). (1 speakers): Judith Lijnsvelt\n  - Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, the Netherlands. (1 speakers): Suresh Senan\n  - Amsterdam, the Netherlands. (1 speakers): Francesco Pignatti\n  - Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands. (1 speakers): Anna Visser\n  - Cardiovascular Research Center, Massachusetts General Hospital, CPZN3200, Boston, MA 02114, USA, Department of Pharmaceutical Sciences, Utrecht University, Netherlands. (1 speakers): Sheraz Ditta\n  - Catharina Hospital, 5623 EJ Eindhoven, The Netherlands. (1 speakers): Sofia L. Peeters\n  - Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden (1 speakers): Amy Rieborn\n  - Department of Clinical Pharmacy and Toxicology, CARIM, Research Institute for Cardiovascular Diseases, Maastricht University Medical Center+, Maastricht (1 speakers): Paul D. Kruithof\n  - Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands. (1 speakers): Marlies Wakkee\n  - Department of Epidemiology and Health Economics, Julius Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. (1 speakers): Denice Kamp\n  - Department of Epidemiology, GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands. (1 speakers): Nadira R. Querido\n  - Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam (1 speakers): Yara L. Verschoor\n  - Department of General, University Hospital Heidelberg, Heidelberg, Germany. (1 speakers): Nerma Crnovrsanin\n  - Department of Health Policy, Zeist, Netherlands. (1 speakers): Atse Huisman\n  - Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands. (1 speakers): Michiel Zietse\n  - Department of Hospital Pharmacy, Rotterdam, The Netherlands. (1 speakers): Tom J. Uyl\n  - Department of Internal Medicine, University Medical Center Groningen, Groningen (1 speakers): Carolien Schroder\n  - Department of Internal Medicine, University Medical Centre Utrecht, Utrecht (1 speakers): Hilde Nienhuis\n  - Department of Medical Informatics, Erasmus MC, Rotterdam (1 speakers): Anton Barchuk\n  - Department of Medical Oncology, Amsterdam UMC, Free University, Amsterdam, the Netherlands, Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands. (1 speakers): Sarah Derks\n  - Department of Medical Oncology, Elisabeth-TweeSteden Hospital, Dr. Deelenlaan 5, Tilburg, the Netherlands. (1 speakers): Laurens V. Beerepoot\n  - Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands. (1 speakers): Barend J. Sikkema\n  - Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands, Department of Clinical Chemistry, Erasmus University Medical Centre (1 speakers): Niels Heersche\n  - Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands. (1 speakers): Noor Wortelboer\n  - Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Netherlands. (1 speakers): Ingrid A. Boere\n  - Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands, Dutch Breast Cancer Research Group (BOOG), the Netherlands. (1 speakers): Judith R. Kroep\n  - Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands. (2 speakers): Ellen Kapiteijn, Hans Gelderblom\n  - Department of Medical Oncology, Netherlands Cancer Institute (NKI), Amsterdam (2 speakers): John B. Haanen, Sebastian Klobuch\n  - Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam (2 speakers): Femke Burgers, Marleen Kok\n  - Department of Medical Oncology, Netherlands Cancer Institute-Antoni Van Leeuwenhoek, Amsterdam, CX (1 speakers): Olga Husson\n  - Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. (1 speakers): Niven Mehra\n  - Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands. (2 speakers): Mathilde Jalving, Sjoukje F. Oosting\n  - Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. (1 speakers): Anna Reyners\n  - Department of Medical Oncology, University Medical Center Utrecht, Utrecht (1 speakers): Danielle Zweers\n  - Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht (1 speakers): Renee A. Lunenberg\n  - Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht 80125, the Netherlands. (1 speakers): Jeanine Roodhart\n  - Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam (1 speakers): Jasmine Moustaquim\n  - Department of Medical Psychology, Radboud Institute for Health Sciences, Radboud University Medical Center, P.O. Box 9101, Radboudumc, Nijmegen 6500 HB, the Netherlands. (1 speakers): Jose Custers\n  - Department of Medicine, University Medical Center Utrecht, Netherlands. (1 speakers): Marie-Christine E. Bakker\n  - Department of Molecular Biology, Faculty of Science, Oncode Institute, Radboud University Nijmegen, Nijmegen, Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam (1 speakers): Michiel Vermeulen\n  - Department of Neurosurgery Haaglanden Medical Center The Hague, the Netherlands. (1 speakers): Marike Broekman\n  - Department of Nursing Studies, University of Applied Sciences Utrecht, Utrecht (1 speakers): Sandrien Weda\n  - Department of Pathology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Amsterdam, the Netherlands, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. (1 speakers): Petur Snaebjornsson\n  - Department of Pathology, Erasmus Medical Center, Rotterdam, the Netherlands. (1 speakers): Jan Von der Thusen\n  - Department of Psychosocial Oncology and Epidemiology, Netherlands Cancer Institute, Amsterdam (1 speakers): Mees Egeler\n  - Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam (1 speakers): Harry De Koning\n  - Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, Netherlands. (1 speakers): Anne-Marie C. Dingemans\n  - Department of Pulmonary Diseases, GROW-School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands. (1 speakers): Lizza Hendriks\n  - Department of Pulmonary Medicine, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands. (1 speakers): Ilias Houda\n  - Department of Radiology, Leiden University Medical Center, Leiden, Biomedical Photonic Imaging Group, University of Twente, Enschede (1 speakers): Fleur Kleiburg\n  - Department of Radiology, The Netherlands Cancer Institute, Amsterdam (1 speakers): Sajjad Rostami\n  - Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, the Netherlands. (1 speakers): Ritse Mann\n  - Department of Radiotherapy, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. (1 speakers): Francine E. Voncken\n  - Department of Research and Development, IKNL, Utrecht, the Netherlands. (1 speakers): Femke J. Jacobs\n  - Department of Surgery, Amsterdam UMC, Location University of Amsterdam, Amsterdam (1 speakers): Annuska Schoorlemmer\n  - Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands. (1 speakers): Bas Groot Koerkamp\n  - Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands. (1 speakers): Marie-France Jilderda\n  - Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, Department of Pulmonary Diseases, Leiden University Medical Centre, Leiden (1 speakers): Egbert F. Smit\n  - Department of Urology Radboud University Medical Center Nijmegen the Netherlands. (1 speakers): Dianne Bosch\n  - Department of Urology, Erasmus Medical Center, Rotterdam (1 speakers): Lionne Venderbos\n  - Department of Urology, University Medical Center Groningen, Groningen (1 speakers): Igle Jan de Jong\n  - Dept. of Research, The Netherlands Comprehensive Cancer Organisation, Utrecht, IQ Health Department, Radboud University Medical Center, Nijmegen (1 speakers): Anke Richters\n  - Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands. (2 speakers): Nan Ding, Renee Visserman\n  - Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Oncode Institute, Plesmanlaan 121, the Netherlands. (1 speakers): Lotte Hoeijmakers\n  - Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam (1 speakers): Jos Jonkers\n  - Division of Pharmacology, Netherlands Cancer Institute, Amsterdam, Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam (1 speakers): Pauline Buitelaar\n  - Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. (1 speakers): Adrianne L. Rolfes\n  - Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands. (1 speakers): Songul Kucukcelebi\n  - Erasmus University Medical Center, Rotterdam 3015GD, Netherlands. (1 speakers): Astrid A. Van der Veldt\n  - Erasmus University Medical Center, Rotterdam, The Netherlands. (1 speakers): Winette T. Van Der Graaf\n  - Erasmus University Medical Center, Rotterdam, the Netherlands. (1 speakers): Daan Lanser\n  - Erasmus University, Rotterdam, the Netherlands. (1 speakers): Hannah M. Van Schoubroeck\n  - European Research Institute for the Biology of Ageing, University of Groningen, Groningen (1 speakers): Ruifang Tian\n  - Hartwig Medical Foundation, Amsterdam, the Netherlands. (1 speakers): Paul Roepman\n  - Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. (1 speakers): Pedro B. Tan\n  - Isala Hospital, Zwolle (1 speakers): Elise Smolders\n  - Isala Hospital, Zwolle, the Netherlands. (1 speakers): Elianne De Boer\n  - Leiden University Medical Center, Amsterdam, the Netherlands. s.f.haj_mohammad@lumc.nl. (1 speakers): Soemeya F. Haj Mohammad\n  - Leiden University Medical Center, Department of Medical Oncology, Leiden (1 speakers): Merve Kaya\n  - Leiden University Medical Center, Leiden, The Netherlands. (1 speakers): Judith V. Bovee\n  - Leiden University Medical Center, Leiden, the Netherlands. (2 speakers): Ellen De Nijs, Sahar B. Van Waalwijk van Doorn-Khosrovani\n  - Leiden University, Leiden, Netherlands. (1 speakers): Gerard Van Oortmerssen\n  - Location University of Amsterdam, Amsterdam, the Netherlands. (1 speakers): Peter De Gooyer\n  - Medical oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands. (1 speakers): Bianca Mostert\n  - Netherland Cancer Institute, Amsterdam (1 speakers): Winan Van Houdt\n  - Netherlands Cancer Institute, Amsterdam, the Netherlands. (1 speakers): Berit M. Van Linder\n  - Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: ms.vd.heijden@nki.nl. (1 speakers): Michiel S. Van der Heijden\n  - Netherlands Cancer Institute, Division of Medical Oncology, Amsterdam, the Netherlands. (2 speakers): Minke W. Lucas, Willemijn S. Tak\n  - Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. (1 speakers): Merel Van Klinken\n  - Onze Lieve Vrouwe Hospital, Amsterdam, the Netherlands. (1 speakers): Aernout Ogilvie\n  - Radboud University Medical Center, Nijmegen, The Netherlands. (1 speakers): Kim J. Van der Velden\n  - The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. (1 speakers): Diana I. Rodriguez Sanchez\n  - The Netherlands Cancer Institute, Amsterdam, the Netherlands. (1 speakers): Daniela S. Thommen\n  - The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. (1 speakers): Gerrina Ruiter\n  - The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China. (1 speakers): En Hu\n  - Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. (1 speakers): Yan Sun\n  - University Medical Center Groningen, Groningen, Netherlands. (1 speakers): Floris Foijer\n  - University Medical Center Groningen, Groningen, The Netherlands. (1 speakers): E.G. Elisabeth De Vries\n  - University Medical Center Rotterdam, 3000 CA Rotterdam, the Netherlands. (1 speakers): Andrea Van Puffelen\n  - University Medical Center Rotterdam, Rotterdam, the Netherlands. (1 speakers): Tanja C. Van Dijk\n  - University Medical Center Utrecht & Princess Maxima Center, Utrecht, Netherlands, Comprehensive Cancer Center Munchen of the Technical University Munich & Ludwig Maximilians University, Munich (1 speakers): Alexander M. Eggermont\n  - University Medical Center, Rotterdam, The Netherlands. (1 speakers): Micha J. De Neijs\n  - University of Groningen, Groningen, The Netherlands. (1 speakers): Anthonie Jan Van Der Wekken\n  - University of Oulu, Oulu, Finland. (1 speakers): Renske Visser\n  - Wageningen University & Research, Wageningen, The Netherlands. (1 speakers): Nienke R. Zwart\n\n**Noord Brabant (1 institutions, 1 speakers)**\n  - Department of Pulmonary Medicine, Erasmus Medical Centre, Rotterdam, the Netherlands, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam (1 speakers): Joachim G. Aerts\n\n**Norway (19 institutions, 26 speakers)**\n  -  (5 speakers): Live Fagereng, Magdalena S. Robertsen, Mari F. Ystgaard, Martin Stoyten, Synne-Kristin H. Bohn\n  - Cancer Clinic, Haukeland University Hospital, Bergen, Norway. (2 speakers): Halfdan Sorbye, Siren Morken\n  - Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø (1 speakers): Endre Gabrielsen\n  - Department of Oncology, Akershus University Hospital, L⊘renskog, Norway, Medical Faculty, University of Oslo, Oslo, Norway. (1 speakers): Jan Oldenburg\n  - Department of Oncology, Lovisenberg Diaconal Hospital, Oslo, Norway. (1 speakers): Katarina Puco\n  - Department of Oncology, Oslo University Hospital, Oslo, Norway. (1 speakers): Henrik Horndalsveen\n  - Department of Oncology, Oslo University Hospital, Oslo, Norway. pbk@ous-hf.no. (1 speakers): Kjetil Boye\n  - Department of Pathology, Stavanger University Hospital, Stavanger, Norway. (1 speakers): Emiel A. Janssen\n  - Department of Surgical Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway. (1 speakers): Kristina Lindemann\n  - Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway. (1 speakers): Wanja Kildal\n  - Institute for Cancer Research, Oslo University Hospital, Oslo, Norway, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. (1 speakers): Ingrid Dyvik\n  - Institute of Basic Medical Sciences, Section of Physiology, University of Oslo, Oslo, Norway. (1 speakers): Anna Christina Garvert\n  - Institute of Clinical Medicine, UIT-The Arctic University, Tromsø, Norway. (1 speakers): Hege Sagstuen Haugnes\n  - KG Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. (1 speakers): Kjetil Tasken\n  - Oslo University Hospital, Oslo, Norway. (3 speakers): Hanne Marte G. Nymoen, Saima J. Farooqi, Sigmund Brabrand\n  - Oslo University Hospital, Oslo, Norway. solthu@ous-hf.no. (1 speakers): Solfrid M. Thunold\n  - The Norwegian Radium Hospital, Oslo, Norway. (1 speakers): Lise H. Willumsen\n  - University of Oslo, Oslo, Norway. (1 speakers): Mari E. Rasmussen\n  - Western Norway University of Applied Sciences, Bergen, Norway. (1 speakers): Elisabeth G. Beisland\n\n**Nuevo Leon (1 institutions, 1 speakers)**\n  - Brigham and Women's Hospital, Memorial Sloan Kettering Cancer Center, New York (R.J.M.). (1 speakers): Victor M. Oyervides Juarez\n\n**OH (1 institutions, 1 speakers)**\n  - Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. (1 speakers): Brian I. Rini\n\n**Oman (1 institutions, 1 speakers)**\n  - Armed Forces Hospital, Muscat, Oman. (1 speakers): Khalid Nasser M. Al Hashmi\n\n**Ontario (5 institutions, 5 speakers)**\n  - Department of Medicine, University of Ottawa, and the Ottawa Hospital Research Institute, Ottawa, ON K1H8L6, Canada. (1 speakers): Glenwood Goss\n  - Department of Medicine, University of Queensland, Brisbane, QLD 4072, Australia. (1 speakers): Aaron R. Hansen\n  - Division of Medical Oncology & Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. (1 speakers): Lillian L. Siu\n  - Medical Oncology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. (1 speakers): Mark D. Vincent\n  - Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Department of Immunology, University of Toronto, Toronto, ON, Canada. (1 speakers): Marcus O. Butler\n\n**Oxfordshire (2 institutions, 2 speakers)**\n  - Churchill Hospital and University of Oxford, Oxford (1 speakers): Mark R. Middleton\n  - Department of Oncology, Queen Elizabeth Hospital, Birmingham B15 2GW, UK. (1 speakers): Shivan Sivakumar\n\n**PA (2 institutions, 2 speakers)**\n  - Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA (1 speakers): Adam M. Brufsky\n  - Penn Medicine Abramson Cancer Center, Philadelphia, PA, USA. (1 speakers): Angela DeMichele\n\n**PO (2 institutions, 2 speakers)**\n  - Department of Medical Oncology, Prato, Italy. (1 speakers): Samantha Di Donato\n  - Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro, Florence, Italy. (1 speakers): Emanuela Risi\n\n**PT (1 institutions, 1 speakers)**\n  - Faculty of Nutrition and Food Sciences of the University of Porto, Porto, Portugal. Electronic address: tamaral@fcna.up.pt. (1 speakers): Teresa M. Amaral\n\n**Pakistan (11 institutions, 13 speakers)**\n  - Aga Khan University Hospital, Karachi, Pakistan. (1 speakers): Asfia A. Khursheed\n  - Department of Medical Oncology, Aga Khan University Hospital, Karachi, Pakistan. (1 speakers): Saad Nasir\n  - Department of Medicine, Ziauddin Medical College, Karachi, Pakistan. (2 speakers): Anoud Khan, Aryan Tareen\n  - Medicine, Nishtar Medical University, Multan, PAK. (1 speakers): Furqan Hassan\n  - Rawalpindi Medical University, Pakistan. (1 speakers): Anam Rafique\n  - Rawalpindi Medical University, Rawalpindi, Pakistan. (2 speakers): Hina Javed, Shahzaib M. Maqbool\n  - Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, Department of Pharmacy, Kohat University of Science and Technology, Kohat 26000, Pakistan. (1 speakers): Saeed Ahmad Khan\n  - School of Public Health, Dow University of Health Sciences, Department of Medicine, Aga Khan University, Karachi, Pakistan. (1 speakers): Akbar Shoukat\n  - Surgery, Rawalpindi Medical University, Rawalpindi, PAK. (1 speakers): Hafsa Arshad Azam Raja\n  - The Aga University Hospital, Karachi, Pakistan. (1 speakers): Laraib Khan\n  - University of Texas Southwestern Medical Center/Parkland Memorial Hospital, Dallas, TX. (1 speakers): Syed M. Kazmi\n\n**Peru (3 institutions, 3 speakers)**\n  -  (1 speakers): Wagner E. Cruz Diaz\n  - Hospital San Vicente de Paul, San José, Costa Rica. (1 speakers): Daniel Delgado Quezada\n  - Trujillo, Peru. (1 speakers): Shamir Barros-Sevillano\n\n**Philippines (2 institutions, 2 speakers)**\n  -  (1 speakers): BERNARD JOHANNES A. JIMENO\n  - National Cancer Institute, MD, United States. (1 speakers): Mary Antonette G. Ong\n\n**Pokfulam (2 institutions, 2 speakers)**\n  - Department of Medical Oncology, The University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China. (1 speakers): Janice Wing-Hang Tsang\n  - School of Nursing, The Hong Kong Polytechnic University, China, College of Arts, Humanities and Education, University of Derby, Derby (1 speakers): Alex Molasiotis\n\n**Poland (17 institutions, 19 speakers)**\n  -  (2 speakers): Agata I. Polinska, Claudia S. Sienko\n  - Breast Cancer Center, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland. (1 speakers): Marcin Kubeczko\n  - Clinical Department of Oncology, Oncology Centre - Prof. Franciszek Łukaszczyk Memorial Hospital, Bydgoszcz, Poland. (1 speakers): Jedrzej Borowczak\n  - Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. (1 speakers): Katarzyna Pogoda\n  - Department of Clinical Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland. (1 speakers): Rafal Dziadziuszko\n  - Department of General and Transplantation Surgery, Medical University of Warsaw, Warsaw, Poland. (1 speakers): Paulina Kalman\n  - Department of Lung Cancer and Thoracic Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. (1 speakers): Sylwia Tabor\n  - Department of Nursing, Faculty of Health, University of Applied Sciences in Tarnów, Poland. (1 speakers): Malgorzata Pasek\n  - Department of Oncology, Wrocław Medical University, Poland, Lower Silesian Comprehensive Cancer Center, Poland. (1 speakers): Malgorzata Pieniazek\n  - Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland, Maria Sklodowska-Curie National Research Institute of Oncology (1 speakers): Pawel Teterycz\n  - Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. (2 speakers): Anna M. Czarnecka, Katarzyna Kozak\n  - Department of Soft Tissue/Bone Sarcoma and Melanoma, The Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Warsaw, Poland. (1 speakers): Piotr Rutkowski\n  - Department of Transplantology, Immunology, Medical University of Warsaw, Poland. (1 speakers): Rafał Staros\n  - Laboratory of Hematology and Flow Cytometry, Department of Internal Medicine and Hematology, Military Institute of Medicine-National Research Institute, Szaserów 128 Street, Poland. (1 speakers): Alicja Dudzik\n  - Lung Cancer and Chest Tumours Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. (1 speakers): Magdalena Knetki-Wroblewska\n  - Maria Sklodowska-Curie National Research Institute of Oncology Warsaw Poland, Warsaw, Poland. (1 speakers): Katarzyna E. Kisielewska\n  - Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. (1 speakers): Iwona Lugowska\n\n**Pordenone (1 institutions, 1 speakers)**\n  - National Cancer Institute, Aviano, Italy. (1 speakers): Maurizio Polano\n\n**Portugal (30 institutions, 30 speakers)**\n  -  (1 speakers): Gil R. Magalhaes\n  - Berlin, Germany. (1 speakers): Anabela Isidro\n  - Cancer Signalling and Metabolism Group do Instituto de Investigação e Inovação em Saúde-i3s, Rua Alfredo Allen 208, 4200-135 Porto, Portugal. (1 speakers): Arnaud D. Da Cruz Paula\n  - Center for Drug Discovery and Innovative Medicines (MedInUP) and RISE-Health: Health Research Network, Portugal. (1 speakers): Diogo Silva\n  - Centre of Marine Sciences, Campus de Gambelas, Faro, Portugal. (1 speakers): Sandra C. Silva\n  - Centro Hospitalar Do Algarve, Faro, Portugal. (1 speakers): Cristiana Honrado Martins\n  - Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal. (1 speakers): Joana C. Marinho\n  - Centro Hospitalar de Entre Douro e Vouga, Santa Maria da Feira, PRT. (1 speakers): Ana R. Aranha\n  - Centro Hospitalar e Universitário São João, Porto, Portugal. (1 speakers): Marisa C. Couto\n  - Champalimaud Clinical Center/Champalimaud Foundation and ABC Global Alliance, Lisbon, Portugal. (1 speakers): Fatima Cardoso\n  - Champalimaud Foundation and Lisbon University Faculty of Medicine, Champalimaud Foundation and Lisbon University Faculty of Medicine, Portugal. (1 speakers): Maria-Joao D. Cardoso\n  - Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal. (1 speakers): Rita Fior\n  - Coimbra Hospital and University Centre (CHUC), Coimbra, Portugal. (1 speakers): Leonor I. Silva Pinto\n  - Department of Genetics, Laboratory of Human Cytogenetics, Federal University of Pará, Guamá, Belém, Pará 66075-970, Brazil. (1 speakers): Bruno M. Soares\n  - Faculty of Medicine University of Coimbra Cuf Hospitais Coimbra Portugal. (1 speakers): Ricardo Leao\n  - Faculty of Medicine, Porto University, Portugal. (1 speakers): Jorge Lima\n  - Hospital Divino Espírito Santo, Ponta Delgada, Portugal. (1 speakers): Tiago A. Pina Cabral\n  - Hospital São Francisco Xavier, Lisbon, PRT. (1 speakers): Vanessa Duarte Branco\n  - Hospital de Braga, Braga, Portugal. (1 speakers): Marta Sofia C. Viana Pereira\n  - Medical Oncology Department, Pedro Hispano Hospital, Portugal. (1 speakers): Catarina Lopes Fernandes\n  - Medical Oncology Department, Porto, Portugal. (1 speakers): Maria Joao Oura\n  - Polytechnic Institute of Beja, 7800-000 Beja, Portugal. (1 speakers): Helga T. Martins\n  - Portuguese Oncology Institute, Lisbon, Portugal. (1 speakers): Bernardo A. Pereira\n  - Pulmonology Department. Hospital Beatriz Ângelo. Unidade Local de Saúde Loures-Odivelas. Lisboa. Portugal. (1 speakers): Sofia Silva\n  - Research Institute for Medicines (iMed.ULisboa), 1649-003 Lisbon, Portugal. Electronic address: aimatos@ff.ulisboa.pt. (1 speakers): Ana C. Pardal de Matos\n  - School of Medicine, Braga, PRT. (1 speakers): Maria M. Pereira\n  - University of Lisbon - Católica Medical School, Lisbon, Portugal. Electronic address: pravasco@ucp.pt. (1 speakers): Paula C. Ravasco\n  - University of Porto, Porto, Portugal. (1 speakers): Luisa Soares Miranda\n  - University of Porto, University of Porto, Portugal. (1 speakers): Catia S. Teixeira\n  - Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK. (1 speakers): Ana Rita Dias\n\n**QLD (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Royal North Shore Hospital, Australia, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia. (1 speakers): Rahul Ladwa\n\n**Qatar (3 institutions, 3 speakers)**\n  -  (1 speakers): Zaineh Alnoubani\n  - Division of Internal Medicine, Department of Medicine, Hamad Medical Corporation, Doha 3050, Qatar. (1 speakers): Muhammed Hajmusa\n  - Hamad General Hospital, Doha, Qatar. (1 speakers): Salha B. Al-Bader\n\n**Republic of Korea (58 institutions, 61 speakers)**\n  -  (2 speakers): Minseung Suh, Yooonyoung Lee\n  - Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Korea. (1 speakers): Do-Youn Oh\n  - College of Medicine, Cancer Research Institute, The Catholic University of Korea, Seoul, Republic of Korea. (1 speakers): SORA JEON\n  - Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea. (1 speakers): Ho-Shin Gwak\n  - Department of Functional Genomics, Korea Research Institute of Bioscience and Biotechnology (KRIBB) School of Bioscience, University of Science and Technology, Daejeon 34113, Korea. (1 speakers): Byul Moon\n  - Department of Hematology and Oncology Ulsan University Hospital College of Medicine University of Ulsan Ulsan Republic of Korea. (1 speakers): Sujin Koh\n  - Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea. (1 speakers): Hye Ryeon Kim\n  - Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. (1 speakers): Keun-Wook Lee\n  - Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Republic of Korea. (1 speakers): Jee Hung Kim\n  - Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University, Seoul, Republic of Korea. (1 speakers): Jeesun Yoon\n  - Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. (1 speakers): Bhumsuk Keam\n  - Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. (1 speakers): Ho Jung An\n  - Department of Life Science, College of Science, Ewha Womans University, Seoul, Republic of Korea. (1 speakers): Sanghyuk Lee\n  - Department of Medical Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. (2 speakers): Sook Ryun Park, Sung-Bae Kim\n  - Department of Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam (1 speakers): Hong Jae Chon\n  - Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Republic of Korea. (1 speakers): Eun-Jung Yang\n  - Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Republic of Korea. (1 speakers): Jung-Yun Lee\n  - Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: svass@yuhs.ac. (1 speakers): Yong Jae Lee\n  - Department of Oceanography, Pusan National University, Busan (1 speakers): InHee Lee\n  - Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea. (1 speakers): Jaewon Hyung\n  - Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. (1 speakers): Yeonghak Bang\n  - Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. (1 speakers): Hyehyun Jeong\n  - Department of Oral and Maxillofacial Surgery, School of Medicine, Ewha Womans University, Seoul, Republic of Korea. (1 speakers): Jin Woo Kim\n  - Department of Pathology, College of Medicine, Hanyang University, Seoul, Republic of Korea. (1 speakers): Jae  Kyung Myung\n  - Department of Pharmacology, Columbia University, USA. (1 speakers): Misun Park\n  - Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seodaemun-Gu, Seoul, Republic of Korea. carnival0126@gmail.com. (1 speakers): Sunyoung Lee\n  - Department of Science in Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea. (1 speakers): Seung Hyeon Lee\n  - Department of Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea. (1 speakers): Kwang Hyun Yoon\n  - Department of Thoracic and Cardiovascular Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea. (1 speakers): Sehhoon Park\n  - Department of Urology, Kangwon National University School of Medicine, Chuncheon, Korea. (1 speakers): Jeong-Hyun Kim\n  - Department of Urology, Kyungpook National University School of Medicine, Daegu, Korea. (1 speakers): Tae-Hwan Kim\n  - Department of Urology, Seoul National University Hospital, Jongno-Gu, Seoul, Republic of Korea. (1 speakers): Seung-hwan Jeong\n  - Division of Breast Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. (1 speakers): Jin Ah Lee\n  - Division of Cardiology, Hallym University Medical Center, Seoul (1 speakers): Min Kyung Kang\n  - Division of Hemato-Oncology, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea. (1 speakers): Sora Kang\n  - Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. (2 speakers): Jin Seok Ahn, Yeon Hee Park\n  - Division of Hematology-Oncology, Department of Medicine, Seoul, Republic of Korea. (1 speakers): Jong-Mu Sun\n  - Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea. (1 speakers): Hee Kyung Ahn\n  - Division of Medical Oncology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. (1 speakers): Seoyoung Lee\n  - Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea. (1 speakers): Soohyeon Lee\n  - Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. (1 speakers): Chang Gon Kim\n  - Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. (1 speakers): Byoung Chul Cho\n  - Division of Nuclear Medicine, Department of Radiology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea. (1 speakers): Joo Hyun O\n  - Division of Pediatric Neurosurgery, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea. (1 speakers): Seung Ah Choi\n  - Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. (1 speakers): Shihwan Chang\n  - Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. (1 speakers): Kyu Yean Kim\n  - Divisions of Hematology-Oncology, Korea University School of Medicine, Korea University Medical Center, Seoul (1 speakers): Seung T. Kim\n  - Graduate School of Inha University, Michuhol-gu, Incheon, Republic of Korea. (1 speakers): Minwoo Baek\n  - Hanyang University Medical Center, Seoul, Republic of Korea. (1 speakers): Chihwan D. Cha\n  - Hematology-Oncology Department, Samsung Medical Center (SMC), Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. (1 speakers): Myung-Ju Ahn\n  - Institute of BioInnovation Research, Inc., Magok-dong (1 speakers): Jinwon Seo\n  - Jason TG, Seoul, Korea. (1 speakers): Min-Hyeok Jeong\n  - Laboratory of Biomedical Genomics, Department of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea. (1 speakers): Sunyoung Jang\n  - Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggi-, Republic of Korea. (1 speakers): Won Suk Lee\n  - ROKIT HEALTHCARE, Seoul 08514, Republic of Korea. (1 speakers): Jeehee Kim\n  - Rare & Pediatric Cancer Branch and Immuno-oncology Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang, Republic of Korea. (1 speakers): Myong Cheol Lim\n  - Seoul National University College of Medicine, Department of Obstetrics and Gynecology, Seoul, Republic of Korea. (1 speakers): Se Ik Kim\n  - Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Republic of Korea. (1 speakers): Sun Young Rha\n\n**Romania (4 institutions, 4 speakers)**\n  - \"Carol Davila\" University of Medicine and Pharmacy, Romania. (1 speakers): Ancuta Nastac\n  - 'Iuliu Hateganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania. (1 speakers): Radu A. Vidra\n  - Advanced Center for Research and Development in Experimental Medicine (CEMEX), \"Grigore T. Popa\" University of Medicine and Pharmacy, Iași, Romania. (1 speakers): Ioana Creanga-Murariu\n  - Youth Cancer Europe, Cluj-Napoca, Romania. (1 speakers): Katie Rizvi\n\n**Russian Federation (8 institutions, 11 speakers)**\n  -  (4 speakers): Alina Kolomeytseva, Amina Yusupova, Angelina Letuchikh, Nadezhda Sultanbaeva\n  - Central Clinical Hospital of the Russian Academy of Sciences, Russia. (1 speakers): Evgenii Goncharov\n  - Institute for Personalized Oncology, Sechenov First Moscow State Medical University, Moscow 119048, Russia. (1 speakers): Alexandra Lebedeva\n  - Institute of Strength Physics and Material Science, Av. Akademicheskii, Russia. (1 speakers): Elena Glazkova\n  - N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia. (1 speakers): Alexey Rumyantsev\n  - N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation. (1 speakers): Edgar R. Israelyan\n  - Oncological Center No.1 of Moscow City Hospital Named After S.S. Yudin, Moscow, Russia. (1 speakers): Ilya Pokataev\n  - Russian Society of Clinical Oncology, Kidney Cancer Research Bureau, Moscow, Russia. (1 speakers): Ilya Tsimafeyeu\n\n**SA (2 institutions, 2 speakers)**\n  - Flinders University, SA, Australia. (1 speakers): Shawgi Sukumaran\n  - National Cancer Centre Singapore, Singapore, Singapore. (1 speakers): Johan Chan\n\n**SP (2 institutions, 2 speakers)**\n  - Center for Translational Research in Oncology, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. (1 speakers): Camila Motta Venchiarutti Moniz\n  - Yale Cancer Center, Yale School of Medicine, CT, USA. (1 speakers): Adriana Kahn\n\n**Samoa American (1 institutions, 1 speakers)**\n  - College of Life Sciences, Northwest A&F University, Yangling, Shaanxi, China. (1 speakers): Abdur Rehman\n\n**Saudi Arabia (3 institutions, 3 speakers)**\n  -  (1 speakers): Sultana M. Al Harbi\n  - Medical Oncology King Faisal Specialist Hospital & Research Centre. (1 speakers): Khadijah Al Shankati\n  - School of Physics, University College Dublin, Belfield, Dublin 4, Ireland. (1 speakers): Ahmed Alanazi\n\n**Schleswig-Holstein (1 institutions, 1 speakers)**\n  - Department of Dermatology, University Medical Center Schleswig-Holstein (UKSH), Kiel, Germany. (1 speakers): Axel Hauschild\n\n**Sec. 2 (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Georges Francois Leclerc Cancer Centre, Dijon, France. (1 speakers): Silvia Mihaela Ilie\n\n**Serbia (3 institutions, 4 speakers)**\n  - Center of Research Excellence in Nutrition and Metabolism, Institute for Medical Research-National Institute of Republic of Serbia, University of Belgrade, Serbia. (2 speakers): Aleksandra Arsic, Snjezana Petrovic\n  - Faculty of Chemistry, University of Belgrade, Serbia. (1 speakers): Aleksandar Popovic\n  - Medical Oncology Department, Institute of Oncology and Radiology of Serbia, Belgrade. (1 speakers): Ivana Bozovic Spasojevic\n\n**Singapore (18 institutions, 20 speakers)**\n  -  (2 speakers): Jonan Z. Tan, Pei Li Stephanie Saw\n  - Cancer Therapeutics Research Laboratory, National Cancer Centre Singapore, Singapore 168583, Singapore, Duke-NUS Medical School, National University of Singapore, Singapore 169857, Singapore. (1 speakers): N Gopalakrishna Iyer\n  - Department of Haematology-Oncology, National University Cancer Institute Singapore, Singapore 119074, Singapore. (1 speakers): Cheng Ean Chee\n  - Department of Haematology-Oncology, National University Cancer Institute, Level 7, Singapore 119228, Singapore. (1 speakers): Robert J. Walsh\n  - Department of Haematology-Oncology, National University Cancer Institute, Singapore. (1 speakers): David SP Tan\n  - Department of Hematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore. (1 speakers): Gloria Chan\n  - Department of Medicine, National University Hospital, Singapore, Singapore, Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Yong Loo Lin School of Medicine (1 speakers): Joseph J. Zhao\n  - Department of Radiation Oncology, National Cancer Center Singapore, Singapore, Singapore. (1 speakers): Melvin Lee Kiang Chua\n  - Department of Radiation Oncology, National University Cancer Institute, Singapore, Singapore. (1 speakers): Yu Yang Soon\n  - Division of Medical Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, Singapore, Singapore. (1 speakers): Nicole-Ann Lim\n  - Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Duke-NUS Medical School, National University of Singapore, Singapore. (1 speakers): Daniel Shao Weng Tan\n  - Duke-NUS Medical School, Singapore, Singapore. (1 speakers): David W. Tai\n  - National Cancer Center Singapore, Singapore, Singapore. (1 speakers): Rebecca A. Dent\n  - National University Hospital, Singapore, Singapore. (2 speakers): Kenneth Sooi, Ross A. Soo\n  - National University of Singapore, National University of Singapore, Singapore. (1 speakers): Ryan M. Lim\n  - Office of Academic and Clinical Development, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore. (1 speakers): Darren Wan-Teck Lim\n  - Translational Immunology Institute, SingHealth Duke-NUS Academic Medical Centre, Singapore, Singapore. (1 speakers): Florent Ginhoux\n  - Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. (1 speakers): Wei Yu Chua\n\n**Slovakia (1 institutions, 1 speakers)**\n  - Faculty Hospital Trencin, Department of Oncology and Faculty of Health Sciences, Trencin University, Trencin 91171, Slovakia. (1 speakers): Filip Kohutek\n\n**Slovenia (5 institutions, 5 speakers)**\n  -  (1 speakers): Amadej Senk Juh\n  - Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia, Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. (1 speakers): Tina Pavlin\n  - Faculty of Medicine, University of Ljubljana, Slovenia. (1 speakers): Tit Albreht\n  - Ljubljana, Slovenia and Europa Donna - The European Breast Cancer Coalition, Milan, Italy. (1 speakers): Tanja Spanic\n  - Medical Oncology Department, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia. (1 speakers): Katja Mohorcic\n\n**South Africa (2 institutions, 2 speakers)**\n  - The Medical Oncology Centre of Rosebank, Clinical and Translational Research Unit (CTRU), Saxonwold, South Africa and Department of Immunology, Faculty of Health Sciences, University of Pretoria (1 speakers): Bernardo L. Rapoport\n  - The Medical Oncology Centre of Rosebank, Johannesburg (1 speakers): Teresa Smit\n\n**South Australia (1 institutions, 1 speakers)**\n  - College of Medicine and Public Health, Flinders University, Australia. (1 speakers): Sina Vatandoust\n\n**South Moravian (1 institutions, 1 speakers)**\n  - Masaryk University, Brno, Czech Republic. (1 speakers): Radka L. Obermannova\n\n**South Yorkshire (1 institutions, 1 speakers)**\n  - Weston Park Hospital, Sheffield, UK. (1 speakers): Robin Young\n\n**Spain (144 institutions, 175 speakers)**\n  -  (27 speakers): Berta Vilar Anglada, Carlos Galamba, Cristina Saura Manich, David Lluis Garulo, Diego A. Gomez Puerto, Edurne Arriola Aperribay, Elena Nunez Berrueco, Isabela Diaz de Corcuera Frutos, Jesus G. Yaringano Cerna, Jorgina Serra Lopez, Judit Sanz Beltran, Lucia Navarro Berlanga, Marc Oliva Bernal, Marco Sanduzzi Zamparelli, Maria Die-Trill, Mariam Stephanie Rojas Piedra, Marianela Bringas Beranek, Natalia Jimenez Blasco, Pablo Flores Paco, Pablo Martinez-Albaladejo, Pablo Palao Contell, Patricia Capdevila Gaudens, Pau Mascaro Baselga, Rodrigo Sanchez Bayona, Sandra Llop Serna, Wagner G. Parra Paladines, Zara Vidales Sepulveda\n  - August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. (1 speakers): Aleix Prat\n  - Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain, Medical Oncology Department, Vall d'Hebron Hospital, Barcelona (1 speakers): Mafalda Oliveira\n  - CCUN, Navarra University Clinic, Pamplona, Spain. (1 speakers): Bruno Sangro\n  - Cellular Immunotherapies for Cancer, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. (1 speakers): Sonia Guedan\n  - Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. (1 speakers): Lisardo Ugidos De La Varga\n  - Childhood Cancer and Blood Disorders Research Group, Vall d'Hebron Research Institute, Barcelona, Spain. (1 speakers): Lorena Valero-Arrese\n  - Complejo Hospitalario Universitario de Badajoz, E-06080 Badajoz, Spain. (1 speakers): Alvaro B. Garcia\n  - Departamento de Eléctrica, Electrónica y Telecomunicaciones, Sangolquí 171103, Ecuador. (1 speakers): Kevin Valencia\n  - Department of Ecology and Evolution, Estación Biológica de Doñana (CSIC), Seville, Spain. (1 speakers): Antonio Rueda Lara\n  - Department of Gastrointestinal Surgery Section 2, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China (1 speakers): Weiyao Li\n  - Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, Spain. (1 speakers): Ibone Labiano\n  - Department of Medical Oncology and Program in Solid Tumors Cima-Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Madrid, Spain. (1 speakers): Antonio Gonzalez-Martin\n  - Department of Medical Oncology, Catalan Institute of Oncology Girona, IDIBGI-CERCA, Girona, Spain. (1 speakers): Maria Pilar Barretina Ginesta\n  - Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain. (1 speakers): Laura Mezquita\n  - Department of Medical Oncology, Hospital Clinico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Valencia, Spain. (1 speakers): Andres Cervantes\n  - Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. (1 speakers): Noemi Reguart\n  - Department of Medical Oncology, Hospital General Universitario Gregorio Marañon Instituto de Investigacion Sanitaria Gregorio Marañon, Madrid, Spain. (1 speakers): Miguel Martin\n  - Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain. (1 speakers): Jesus Pena-Lopez\n  - Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Majadahonda. IDIPHISA, Madrid, Spain. (1 speakers): Ana Ruiz-Casado\n  - Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Spain. (1 speakers): Pablo Alvarez Ballesteros\n  - Department of Medical Oncology, L'Hospitalet de Llobregat, Barcelona, Spain. (1 speakers): Noelia Vilarino\n  - Department of Medical Oncology, La Paz Hospital, Madrid, Spain. (1 speakers): Andres Redondo\n  - Department of Medical Oncology, Ramon y Cajal University Hospital, Madrid, Spain. (1 speakers): Patricia Guerrero\n  - Department of Medical Oncology, Spain. (1 speakers): Teresa Zumarraga Lizundia\n  - Department of Medical Oncology, Vall D'Hebron University Hospital, Spain, Vall d'Hebron Institute of Oncology, Spain. (1 speakers): Joan Carles Galceran\n  - Department of Medical Oncology, Vall d'Hebron Barcelona Hospital Campus, Spain. (2 speakers): Elena Garralda, Irene Brana\n  - Department of Medical Oncology, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain. (1 speakers): Elena Elez Fernandez\n  - Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. (1 speakers): Jaume Capdevila\n  - Department of Medical Oncology, Vall d´Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Barcelona, Spain. (1 speakers): Ilaria Priano\n  - Department of Oncology, CUN, CCUN and IdisNA, University of Navarra, Pamplona, Spain. (1 speakers): Maria Pilar Andueza\n  - Department of Oncology, Hospital Universitari Arnau de Vilanova, University of Lleida, IRB-Lleida, No. 80, Lleida, Spain. (1 speakers): Antonio Llombart Cussac\n  - Department of Oncology, Hospital of the Holy Cross and Saint Paul, Barcelona, Catalonia, Spain. (1 speakers): Alejandra Romano Cardozo\n  - Department of Oncology, University Hospital Marqués of Valdecilla, IDIVAL Santander, Cantabria, Spain. (1 speakers): Ignacio Duran\n  - Department of Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain. (1 speakers): Cristina Suarez Rodriguez\n  - Department of Surgery, Hospital Universitario San Agustín, Spain. (1 speakers): Nuria Aguado\n  - Department of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain. (1 speakers): Felix Guerrero-Ramos\n  - Departments of Immunology-Immunotherapy and Radiation Oncology, Cancer Center Clinica Universidad de Navarra, Pamplona, Navarra, Spain. (1 speakers): Maria E. RodrIguez-Ruiz\n  - ETSI Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain. Electronic address: a.gutierrez@upm.es. (1 speakers): Alvaro Lopez Gutierrez\n  - Escuela de Química, AA 678, Bucaramanga, Colombia. (1 speakers): Diego F. Rodriguez\n  - European University of Madrid, Madrid, Spain. (1 speakers): Maria Pilar Juan Gonzalez\n  - Fundación Jiménez Díaz University Hospital - Health Research Institute Fundación Jiménez Díaz (IIS-FJD) - Universidad Autónoma de Madrid (UAM), Madrid, Spain. (1 speakers): Angela Lamarca\n  - Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain. (1 speakers): Mercedes Avedillo Ruidiaz\n  - Galdakao University Hospital, Galdakao, Spain. (1 speakers): Amaia Moreno Paul\n  - Guangdong Provincial Key Laboratory of Food Quality and Safety, College of Food Science, South China Agricultural University, China. (1 speakers): Mengxin Zhou\n  - H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (imas12)/Spanish National Cancer Research Center (CNIO), Madrid, Spain. (1 speakers): Jon Zugazagoitia\n  - H12O-CNIO Lung Cancer Clinical Research Unit, Instituto de Investigación Hospital 12 de Octubre (i+12) & Centro Nacional de Investigaciones Oncológicas (CNIO), CIBERONC, UCM, Madrid, Spain. (1 speakers): Luis Paz-Ares\n  - Heriot-Watt University, Edinburgh EH14 4AS, United Kingdom. (1 speakers): Natalia S. Tissera Valencia\n  - Hospital 12 de Octubre, 28041, Spain. (1 speakers): Katerin I. Rojas Laimito\n  - Hospital 12 de Octubre, Madrid, Spain. (1 speakers): Juan Carlos Laguna Montes\n  - Hospital Clinic de Barcelona, CIBEREHD, Barcelona, Spain. (1 speakers): Joan Maurel\n  - Hospital Clinic of Barcelona, Barcelona, Spain. (1 speakers): Lydia Gaba Garcia\n  - Hospital Clinic, Barcelona, Spain. (1 speakers): Marta Garcia De Herreros\n  - Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain. (1 speakers): Maria Jose De Miguel Arroyo\n  - Hospital Clínico Universitario Miguel Servet, Zaragoza, Spain. (1 speakers): Maria Elisa Reig Monzon\n  - Hospital General Universitario Gregorio Marañón, Spanish Society of Medical Oncology (SEOM), Spain. (1 speakers): Javier Soto Alsar\n  - Hospital General Universitario, Valencia, Spain. (1 speakers): Lucas Sanz Monge\n  - Hospital HM Sanchinarro, Madrid, Spain. (1 speakers): Maria Jose De Miguel\n  - Hospital Reina Sofía, Córdoba, Spain. (1 speakers): Maria Jesus Rubio Perez\n  - Hospital Universitario 12 de Octubre, Madrid, Spain. (1 speakers): Daniel E. Castellano Gauna\n  - Hospital Universitario Puerta de Hierro, Madrid, Spain. (1 speakers): Beatriz Nunez Garcia\n  - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. (1 speakers): Jose Vicente Monton Bueno\n  - Hospital Universitario Ramon y Cajal, Madrid, Spain. (1 speakers): Miguel Garcia Pardo de Santayana\n  - Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain. (1 speakers): Diana I. Rosero Rodriguez\n  - Hospital Universitario Ramón y Cajal, Spain. (1 speakers): Pilar Garrido Lopez\n  - Hospital Universitario Río Hortega., Oncología Médica, Hospital Universitario Río Hortega. (1 speakers): Paula M. Molina Terron\n  - Hospital Universitario Santa Lucía, Murcia, España. (1 speakers): Sofia Wikstrom Fernandez\n  - Hospital Universitario de Araba - Txagorritxu, Araba, Spain. (1 speakers): Mireia Martinez Kareaga\n  - Hospital Universitario de Canarias, Spain. (1 speakers): Valle Rodriguez-Moron\n  - Hospital Universitario de Donostia, Donostia, Spain. (1 speakers): Laura Basterretxea\n  - Hospital del Mar Research Institute (IMIM), Barcelona, Spain. (1 speakers): Clara Montagut\n  - INCLIVA, CIBERONC, GEICO, Hospital Clinico Universitario de Valencia, Valencia, Spain. (1 speakers): Ignacio Romero\n  - Institute for Research in Biomedicine Barcelona, The Barcelona Institute of Science and Technology, Barcelona, Spain. (1 speakers): Nuria Lopez-Bigas\n  - Institute of Rare Diseases Research, 28029 Madrid, Spain. elopez@isciii.es. (1 speakers): Estrella Varga Lopez\n  - International Breast Cancer Center (IBCC), Barcelona, Spain. (1 speakers): Javier C. Cortes\n  - La Paz University Hospital, Madrid, Spain. (1 speakers): Susana M. Cedres Perez\n  - MD Anderson Cancer Center, Madrid, Spain. (1 speakers): Enrique Grande Pulido\n  - Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain. (1 speakers): Pablo Perez-Martinez\n  - Medical Oncology Department, Barcelona, Spain, Universitat de Barcelona, Barcelona, Spain. (1 speakers): Cristina Santos Vivas\n  - Medical Oncology Department, Hospital Clinic of Barcelona, Barcelona, Spain, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona (1 speakers): Francesco Schettini\n  - Medical Oncology Department, Hospital Clinico Universitario de Valencia-INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain. (1 speakers): Gema Bruixola\n  - Medical Oncology Department, Hospital Clínic-IDIBAPS, Barcelona, Spain. (2 speakers): Alba Moll-Febrer, Joan Padrosa\n  - Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain. (2 speakers): Andres J. Munoz Martin, Ivan Marquez-Rodas\n  - Medical Oncology Department, Hospital Universitario 12 de Octubre, IIS Imas12, Facultad de Medicina, Madrid, Spain. (1 speakers): Rocio Garcia-Carbonero\n  - Medical Oncology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain. (1 speakers): Maria Gion\n  - Medical Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain. (1 speakers): Ruth Vera Garcia\n  - Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona (1 speakers): Francisco J. Pelegrin Mateo\n  - Medical Oncology Department, Hospital del Mar, Barcelona, Spain. (1 speakers): Alejo Rodriguez-Vida\n  - Medical Oncology Department, L'Hospitalet de Llobregat, Spain. (1 speakers): Sonia Pernas Simon\n  - Medical Oncology Department, Ramón y Cajal University Hospital, Km 9.100, Madrid, CP, Spain. (1 speakers): Alfonso Cortes Salgado\n  - Medical Oncology Department, University Hospital La Paz (1 speakers): Alvaro Pinto Marin\n  - Medical Oncology Department, University Hospital of Salamanca, Salamanca, Spain. (1 speakers): Luis Posado-Dominguez\n  - Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain. (1 speakers): Pedro Rocha\n  - Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. (1 speakers): Alejandro Garcia Alvarez\n  - Medical Oncology Department. Hospital, Institute of Oncology (VHIO), Barcelona, Spain. (1 speakers): Eva Munoz-Couselo\n  - Medical Oncology Departments: Hospital Universitario Donostia-OSI Donostialdea, Gipuzkoa, Spain. (1 speakers): Laura Basterrechea Badiola\n  - Medical Oncology Service, Hospital Clínico Universitario Lozano Blesa, Zaragoza (1 speakers): Raquel Andres Conejero\n  - Medical Oncology Service, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. (1 speakers): Ana Oaknin\n  - Medical Oncology, Catalan Institute of Oncology (ICO), Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. (1 speakers): Marta Gil Martin\n  - Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Spain. (1 speakers): Juan Martin-Liberal\n  - Medical Oncology, Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain. (1 speakers): Maria Torrente\n  - Morales Meseguer University Hospital, Murcia, Spain. (1 speakers): Javier Lopez Robles\n  - National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre, London, UK. (1 speakers): Patricia Toquero Diez\n  - Navarra Institute for Health Research (IDISNA), Pamplona, Spain. (1 speakers): Ignacio Melero\n  - New York University, NY, USA. (1 speakers): Manuel Pedregal Trujillo\n  - Oncology Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain. (1 speakers): Begona Perez Valderrama\n  - Oncology Department, University Hospital of Salamanca, Salamanca, Spain. (1 speakers): Eduardo Teran Brage\n  - Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain. (1 speakers): Enriqueta Felip\n  - Pathology Department, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 de Octubre (imas12), CIBERONC, Madrid, Spain. (1 speakers): Fernando Lopez-Rios\n  - Pfizer S.L.U, Alcobendas, Madrid, Spain. maria.montoro@pfizer.com. (1 speakers): Maria Isabel Sanchez Montoro\n  - Preclinical and experimental research in thoracic tumors (PRETT) group, ONCOBELL Program, L'Hospitalet de Llobregat, Spain, Department of Medical Oncology, Institut Català d'Oncologia (1 speakers): Ernest Nadal\n  - Quiron Dexeus University Hospital, Barcelona 08028, Spain, Barcelona 08028, Spain, 3 Medical Oncology Unit, Human Pathology Department, University of Messina, Messina 98122, Italy (1 speakers): Maria Gonzalez Cao\n  - Ramon y Cajal University Hospital, Madrid, Spain. (2 speakers): Ana Maria Barrill Corpa, Coral Garcia de Quevedo Suero\n  - Reina Sofia University Hospital, Cordoba, Spain. (1 speakers): Alvaro Arjona-Sanchez\n  - Research Health Institute of Fundacion Jimenez Diaz (IIS/FJD, UAM), Madrid, Spain. (1 speakers): Javier Martin-Broto\n  - Southern Illinois University Carbondale, IL, United States. Electronic address: agustinjz@siu.edu. (1 speakers): Francisco J Jimenez-Ruiz\n  - Spanish lung cancer group (Grupo Español de Cancer de Pulmón (GECP)), Barcelona, Spain, Hospital Universitario Alicante, Alicante, Spain. (1 speakers): Bartomeu Massuti Sureda\n  - The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey (1 speakers): Victor Moreno Garcia\n  - Thoracic Surgery Department, Hospital de la Santa Creu i Sant Pau and Hospital del Mar, Barcelona, Spain. (1 speakers): Juan Carlos Trujillo\n  - UOMI Cancer Center, Barcelona, Cataluña, Spain. (1 speakers): Santiago Viteri\n  - Universidad Bolivariana de Venezuela, Caracas, Venezuela. (1 speakers): Jose Carlos Benitez Montanez\n  - University Hospital A Coruña. Biomedical Research Institute (INIBIC, Galicia, Spain. (1 speakers): Beatriz Alonso de Castro\n  - University Hospital La Fe, Valencia, Spain. (1 speakers): Maribel Del Olmo\n  - University Hospital of Salamanca (HUS/IBSAL), Salamanca, Spain. (1 speakers): Marina Garcia Gomez\n  - University Hospital of Salamanca/IBSAL, Salamanca, Spain. (1 speakers): Maria-Victoria Mateos\n  - University Hospital of Torrevieja, Alicante, Spain. (1 speakers): Jose Miguel Jurado Garcia\n  - University of Alcalá de Henares, 28805 Madrid, Spain. (1 speakers): Guillermo Hernandez Torrado\n  - University of Barcelona, Barcelona, Spain. (1 speakers): Daniel Olmo Gonzalez\n  - University of León, 24071 León, Spain. (1 speakers): Elena Castro Marcos\n  - University of Valencia, Valencia, Spain. (1 speakers): Isabel Redondo Canovas del Castillo\n  - University of Valladolid, Castilla y León, Spain. (1 speakers): Irene Lopez Sanchez\n  - Vall D'Hebron University Hospital (HUVH) and Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain. (1 speakers): Francisco Javier Ros Montana\n  - Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, IOB-Quirón, Barcelona, Spain. (1 speakers): Josep Tabernero\n  - Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), 08035, Spain. (1 speakers): Clara Salva de Torres\n  - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. (1 speakers): Maria Alsina Maqueda\n  - Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. (1 speakers): Rodrigo Dienstmann\n  - Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain. (1 speakers): Omar Saavedra\n  - Vall d'Hebron Institute of Oncology, Barcelona, Spain. (1 speakers): Paolo G. Nuciforo\n  - Vall d'Hebron Institute of Oncology, Spain. (1 speakers): Stefania Napoli\n  - Vall d'Hebron Research Institute (VHIR), Barcelona, Spain. (1 speakers): Alejandro Olivares Hernandez\n  - Vall d'Hebron University Hospital, 08035 Barcelona, Spain. (1 speakers): Kreina S. Vega Cano\n  - Vall d'Hebron University Hospital, Barcelona, Spain. (2 speakers): Pedro F. Simoes da Rocha, Teresa Macarulla Mercade\n  - Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. (1 speakers): Jorge Hernando Cubero\n  - Virgen of Arrixaca University Clinical Hospital, Murcia, Spain. (1 speakers): Ana Paisan Ruiz\n\n**Sudan (1 institutions, 1 speakers)**\n  - Faculty of Medicine, International University of Africa, Khartoum, Sudan. (1 speakers): Mohamed Hisham Alamin\n\n**Surrey (6 institutions, 6 speakers)**\n  - Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. (1 speakers): Timothy Anthony Yap\n  - Department of Medicine, The Royal Marsden National Health Service Foundation Trust, London and Surrey, UK. (1 speakers): Sing Yu Moorcraft\n  - Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, UK. (1 speakers): Angela George\n  - Radiology Department, The Royal Marsden Hospital Trust and Institute of Cancer Research, Sutton, London, SM2 5NG, UK. (1 speakers): Raquel Perez Lopez\n  - The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, Surrey, London (1 speakers): Nina Tunariu\n  - The Institute of Cancer Research, Sutton, Surrey SM2 5NG (1 speakers): Ros Eeles\n\n**Sweden (38 institutions, 41 speakers)**\n  -  (2 speakers): Anki Delin Eriksson, Elin Backman-Staelnacke\n  - Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden. (1 speakers): Daniel R. Smith\n  - Department of Care Science, Sophiahemmet University, Stockholm, Sweden, Regional Cancer Centre Stockholm-Gotland, Stockholm (1 speakers): Bodil Westman\n  - Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden. (3 speakers): Balazs Acs, Johan Hartman, Sanna Steen\n  - Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden. (1 speakers): Shabane Barot\n  - Department of Clinical Science, Solna, Sweden. (1 speakers): Berit H. Sunde\n  - Department of Clinical Sciences, Division of Internal Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden. (1 speakers): Fredrika Wannberg\n  - Department of Hematology and Oncology Akademiska Hospital Uppsala Sweden. (1 speakers): Ingrid Glimelius\n  - Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. (1 speakers): Camilla Skold\n  - Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. (1 speakers): Julia Winter\n  - Department of Neurobiology, Karolinska Institutet, Stockholm, Sweden. (1 speakers): Kathrin Wode\n  - Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden. (1 speakers): Theodoros Foukakis\n  - Department of Oncology, Faculty of Medicine and Health, Örebro University Hospital, Örebro University, Örebro SE-70182, Sweden. (1 speakers): Antonis Valachis\n  - Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Carina Dahlen\n  - Department of Oncology, Uppsala University Hospital, Uppsala 751 85, Sweden. (1 speakers): Henrik Lindman\n  - Department of Oncology, Uppsala University Hospital, Uppsala, Sweden. (1 speakers): Gustav Ullenhag\n  - Department of Oncology-Pathology & Karolinska Comprehensive Cancer Center, Solna, Sweden. (1 speakers): Helena Ullgren\n  - Department of Oncology-Pathology, Karolinska Institute and Breast Center, Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Alexios Matikas\n  - Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. (1 speakers): Qiao Yang\n  - Department of Upper Abdominal Diseases, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Tina Gustavell\n  - Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden. (1 speakers): Astrid Kuylenstierna\n  - Division of Biomolecular and Cellular Medicine, Karolinska Institutet, ANA Futura, Huddinge, Stockholm, Sweden. (1 speakers): Maximilian Kordes\n  - Division of Medical/Radiation Oncology and Hematology, Skåne University Hospital, Lund, Sweden. (1 speakers): Gilberto Morgan\n  - Division of Oncology and Therapeutic Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. (1 speakers): Sara Wahlin\n  - Division of Oncology, Department of Clinical Sciences Lund, and Lund University Cancer Center, Lund University, Lund, Sweden. (1 speakers): Jenny-Maria Jonsson\n  - Division of Oncology, Department of Clinical Sciences, Lund, Faculty of Medicine, Lund University, Lund, Sweden. (1 speakers): Martin Sjostrom\n  - Division of Surgery and Oncology, Department of Clinical Science, Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Magnus Nilsson\n  - Karolinska Institutet and Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Renske Altena\n  - Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Shahrzad S. Kordnejad\n  - Lund University and IHE, Lund, Sweden. (1 speakers): Thomas Hofmarcher\n  - Regional Cancer Center, Stockholm, Gotland, Sweden. (1 speakers): Lena Sharp\n  - Sahlgrenska Center for Cancer Research, University of Gothenburg, Göteborg, Sweden. (1 speakers): Jonas A. Nilsson\n  - Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden. (1 speakers): Thomas Helleday\n  - Theme Cancer, Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Hildur Helgadottir\n  - Thoracic Oncology Center, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden. (1 speakers): Simon Ekman\n  - University Health Research Centre, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. (1 speakers): Sofia Axelsson\n  - University of Gothenburg, Gothenburg, Sweden. (1 speakers): Axel F. Nelson\n  - Value & Implementation Outcomes Research, MSD, Stockholm, Sweden. (1 speakers): Stina Salomonsson\n\n**Switzerland (55 institutions, 56 speakers)**\n  -  (1 speakers): Leonhard Schatz\n  - Breast Centre, Luzern, Switzerland, University of Lucerne, Department of Health Sciences and Medicine, Luzern, Switzerland. (1 speakers): Peter Dubsky\n  - Cantonal Hospital St. Gallen, St. Gallen, Switzerland. (1 speakers): Matthias B. Hellberg-Naegele\n  - Center of Research in Epidemiology and Statistics (CRESS-U1153), Université Paris Cité, INSERM, Paris, France. (1 speakers): Silvia Metelli\n  - Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. (1 speakers): Louis C. Gros\n  - Clinic of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland. (1 speakers): Anastasios Stathis\n  - Department of Computational Biology, University of Lausanne, Lausanne, Switzerland, Swiss Cancer Center Léman, Lausanne, Switzerland, Swiss Institute of Bioinformatics, Lausanne, Switzerland. (1 speakers): Giovanni Ciriello\n  - Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. (1 speakers): Joanna Mangana\n  - Department of Dermatology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland. (1 speakers): Egle Ramelyte\n  - Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland. (1 speakers): Laura A. Boos\n  - Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland. (1 speakers): Anja Lorch\n  - Department of Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland. (1 speakers): Richard Cathomas\n  - Department of Medical Oncology, Tumor Center Aarau, Aarau, Switzerland. (1 speakers): Razvan A. Popescu\n  - Department of Medical Oncology, University Hospital Basel, Basel, Switzerland. (1 speakers): Sacha I. Rothschild\n  - Department of Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. (1 speakers): Michel Obeid\n  - Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland. (1 speakers): Michael Weller\n  - Department of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland. (1 speakers): Raffaella Casolino\n  - Department of Nuclear Medicine and Endocrine Oncology, Paris, France, University Paris-Saclay, Paris, France, Department of Endocrinology and Diabetology, Geneva, Switzerland, Faculty of Medicine (1 speakers): Sophie Leboulleux\n  - Department of Nuclear Medicine, Baden, Switzerland. (1 speakers): Irene Burger\n  - Department of Oncology Institute of Oncology Research Bellinzona Switzerland. (1 speakers): Davide Rossi\n  - Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland. (1 speakers): Anna D. Wagner\n  - Department of Oncology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland, Agora Cancer Research Center, Lausanne, Switzerland, Division of Oncology, Department of Medicine (1 speakers): Denarda Dangaj Laniti\n  - Department of Oncology, Ludwig Center for Cancer Research Lausanne and University of Lausanne, Lausanne, Switzerland. (1 speakers): Christophe Cisarovsky\n  - Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland. (1 speakers): Martina Imbimbo\n  - Department of Oncology, University Hospital CHUV, Lausanne, Switzerland. (1 speakers): Solange Peters\n  - Department of Oncology, University of Lausanne and Lausanne University Hospital, 1011 Lausanne, Switzerland. (1 speakers): Petr Szturz\n  - Department of Oncology/Hematology, Cantonal Hospital Winterthur, Winterthur, Switzerland. (1 speakers): Laetitia A. Mauti\n  - Department of Prosthodontics, Faculty of Dentistry, Ankara University, Beşevler, Ankara, Turkey. (1 speakers): Berna Ozdemir\n  - Department of Radiation Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland. (1 speakers): Antonio Angrisani\n  - Department of Radiation Oncology, University Hospital Basel, Basel, Switzerland. (1 speakers): Alexandros Papachristofilou\n  - Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland. (1 speakers): Isabelle Opitz\n  - Division Clinical Assessment, Bern, Switzerland. (1 speakers): Ulrich-Peter Rohr\n  - Division of Bone Diseases Geneva University Hospitals and Faculty of Medicine Rue Gabrielle Perret-Gentil, Geneva, Switzerland. (1 speakers): Emmanuel Biver\n  - Division of Medical Oncology, University Hospital Basel, Basel, Switzerland, Laboratory of Cancer Immunotherapy, Department of Biomedicine, University of Basel and University Hospital Basel, Basel. (1 speakers): Heinz Laubli\n  - Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. (1 speakers): Nicolas Thoma\n  - Gynecological Cancer Centre, University Hospital Basel and University of Basel, Basel, Switzerland. (1 speakers): Ruth S. Eller\n  - Institute of Oncology Research, Bellinzona, Switzerland, Faculty of Biomedical Sciences, Lugano, Switzerland, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland (1 speakers): Andrea Alimonti\n  - Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland. (1 speakers): David Schwappach\n  - Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland. (1 speakers): Inti Zlobec\n  - Lausanne University Hospital, Lausanne, Switzerland. (1 speakers): Ana M. Dolcan\n  - Medicine and Technology, Faculty of Law, University of Zurich, Zurich, Switzerland. (1 speakers): Simon Hediger\n  - Medicine, Faculty of Law, University of Zurich, Zurich 8001, Switzerland, Medicine, Department of Health Sciences and Technology, ETH (Federal Institute of Technology) Zurich, Zurich (1 speakers): Kerstin N. Vokinger\n  - Neu-Isenburg, Germany (G.M.), Kincraig, the Breast European Adjuvant Study Team (BrEAST) Data Center (E.A., N.R.), the Breast International Group (D.Z., A.A.), E.C. (1 speakers): Thomas Suter\n  - Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland, Institute of Oncology Research (IOR), Bellinzona, Switzerland, Department of Engineering for Innovation Medicine (1 speakers): Sara Merler\n  - Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland. (2 speakers): Marta Nerone, Ursula Vogl\n  - Oncology Institute of Southern Switzerland, Bellinzona (1 speakers): Ilaria Colombo\n  - Oncology and Haematology Department, Bern, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Switzerland. (1 speakers): Sabine Schmid\n  - Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. (1 speakers): Aurelius G. Omlin\n  - University Center for Hematology and Oncology, Liestal, Switzerland. (1 speakers): Elena D. Chiru\n  - University Hospital of Geneva, Geneva, Switzerland. (1 speakers): Olivier A. Michielin\n  - University of Southern Switzerland (USI), 6500 Bellinzona, Switzerland. Electronic address: sara.dedosso@eoc.ch. (1 speakers): Sara De Dosso\n  - University of Zurich, Switzerland (C.E.G.G., L.W.). (1 speakers): Camille Glaus\n  - University of Zurich, Zurich, Switzerland. (1 speakers): Miquel S. Serra-Burriel\n  - Zurich University of Applied Sciences, 8401 Winterthur, Switzerland. (1 speakers): Sara K. Kohler\n  - cUniversity Hospital Zurich, Zurich, Switzerland. (1 speakers): Reinhard Dummer\n\n**Syria (1 institutions, 1 speakers)**\n  - AlBaironi Hospital, Damascus, Syria. (1 speakers): Maher Salamoon\n\n**TN (1 institutions, 1 speakers)**\n  - Sarah Cannon Research Institute, Nashville, TN. (1 speakers): Melissa L. Johnson\n\n**TO (1 institutions, 1 speakers)**\n  - Department of Oncology, University of Torino, San Luigi Gonzaga University Hospital, Orbassano, Italy. (1 speakers): Paolo Bironzo\n\n**TX (10 institutions, 10 speakers)**\n  -  (1 speakers): Mariana Chavez MacGregor\n  - Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. (1 speakers): Kanwal Raghav\n  - Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Amado J. Zurita\n  - Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX (1 speakers): Eric Jonasch\n  - Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX (1 speakers): Aung Naing\n  - Division of Hematology and Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. (1 speakers): Cathy Eng\n  - Gradalis, Inc, Suite 110, Carrollton, Dallas, TX (1 speakers): John Nemunaitis\n  - South Texas Accelerated Research Therapeutics, TX (1 speakers): Anthony W. Tolcher\n  - The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Siqing Fu\n  - The University of Texas MD Anderson Cancer Center, Houston, TX. (1 speakers): Vicente Valero\n\n**Taiwan (26 institutions, 27 speakers)**\n  -  (2 speakers): Pei Ju P. Lien, Pie-Hsin Chen\n  - City University of Hong Kong, 518057, P. R. China. (1 speakers): Yang Yao Ren\n  - Department of Anesthesiology, National Taiwan University Cancer Center, Taipei, Taiwan. (1 speakers): Wen-Ying Lin\n  - Department of Hematology and Oncology, Chang Gung Memorial Hospital at Linkou and College of Medicine, Chang Gung University, Taoyuan, Taiwan. Electronic address: f22338@cgmh.org.tw. (1 speakers): Yu-Shin Hung\n  - Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. (1 speakers): Chien-Jui Huang\n  - Department of Mechanical Engineering, University of California, Berkeley, CA 94720, USA. (1 speakers): Joseph C. Lin\n  - Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan. (1 speakers): Chien-Huai Chuang\n  - Department of Nursing, National Taiwan University Hospital Yunlin Branch, Douliou, Taiwan. (1 speakers): Hui-Wen Po\n  - Department of Nursing, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan, Research Center in Nursing Clinical Practice, Wan Fang Hospital, Taipei Medical University, Taipei 11696 (1 speakers): Mei Fen Tang\n  - Department of Nutrition, Chung Shan Medical University Hospital, Taiwan. (1 speakers): Ying Ru Chen\n  - Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Branch and Chang Gung University, Taoyuan, Taiwan. (1 speakers): Chyong-Huey Lai\n  - Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. (1 speakers): Hui-Jen Tsai\n  - Department of Oncology, National Taiwan University Hospital and Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan. (1 speakers): Tom Wei-Wu Chen\n  - Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. (1 speakers): Jhe-Cyuan Guo\n  - Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital and China Medical University, Taichung, Taiwan. (1 speakers): Li-Yuan Bai\n  - Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan. (1 speakers): Shao-Lun Lu\n  - Graduate Institute of Oncology, College of Medicine, National Taiwan University Taipei, Taiwan. (1 speakers): Ching-Tso Chen\n  - Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan (1 speakers): Ann-Lii Cheng\n  - Institute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, Taipei, Taiwan. (1 speakers): Pei-Hsing Chen\n  - National Institute of Cancer Research, National Health Research Institute, Tainan, Taiwan, Department of Oncology, College of Medicine, Tainan, Taiwan, Department of Internal Medicine (1 speakers): Li-Tzong Chen\n  - National Institute of Cancer Research, Tainan, Taiwan. (1 speakers): Yi-hsin Yang\n  - National Taiwan University Cancer Center and National Taiwan University Hospital, Taipei, Taiwan. (1 speakers): James Chih-Hsin Yang\n  - New Drug Research and Development Center, Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm), Taipei 100, Taiwan. (1 speakers): Chia-Nan Chen\n  - School of Medicine, College of Medicine, National Yang Ming Chiao Tung University Taipei, Taiwan. (1 speakers): Chia-I Shen\n  - School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. (1 speakers): Ming-Huang Chen\n  - School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan. (1 speakers): Yeur-Hur Lai\n\n**Thailand (8 institutions, 9 speakers)**\n  -  (2 speakers): Narawitch Sompornpailin, Thayanin Phongphaew\n  - Department of Medicine, Faculty of Medicine, Thammasat University Hospital, Thailand. (1 speakers): Panuch Eiamprapaporn\n  - Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. (1 speakers): Krittiya Korphaisarn\n  - Division of Medical Oncology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand. (1 speakers): Tawasapon Thambamroong\n  - Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Dusit, Bangkok (1 speakers): Aniwat Berpan\n  - Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. (1 speakers): Phichai Chansriwong\n  - Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. (1 speakers): Narumol Trachu\n  - Siriraj Cancer Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. (1 speakers): Pariyada Tanjak\n\n**Tunisia (4 institutions, 5 speakers)**\n  -  (2 speakers): Hend Mrad, Nesrine Kooli\n  - Department of Medical Oncology, Military Hospital of Tunis, Tunis 1007, Tunisia. (1 speakers): Mehdi Balti\n  - Department of Oncology Habib Bourguiba Hospital, Sfax, Tunisia. (1 speakers): Wala Ben Kridis\n  - Medical Oncology Department SOMA, Abderrahmen Mami Hospital, Ariana, Tunisia, Tunis El Manar University, Tunis. (1 speakers): Nesrine Mejri\n\n**Turkey (65 institutions, 75 speakers)**\n  -  (7 speakers): Banu Iskender Izgi, Enes B. Bay, Ilgin Akbiyik, Nigar Rustamova, Ozgun GOKMEN KAYA, Sumeyye N. Satin, Yasemin Ciraci Yasar\n  - Ankara University Cancer Research Institute, Ankara University, Ankara 06620, Turkey. (1 speakers): Mehmet Kayaalp\n  - Ankara University Cancer Research Institute, Ankara, Turkey. (1 speakers): Emre Yekeduz\n  - Author Affiliations: Department of Internal Medicine Nursing, Faculty of Nursing, Akdeniz University (Drs Karakuş and Özer), Antalya, and Department of Internal Medicine Nursing (1 speakers): Zeynep Karakus\n  - Author Affiliations: Gediz Vocational School of Health Services, Department of Medical Services and Techniques, Kutahya Health Sciences University, and School of Nursing (1 speakers): Melike Pehlivan\n  - Başkent University Faculty of Health Science, Ankara, Turkey. (1 speakers): Akile Karaaslan Eser\n  - Başkent University School of Medicine, Department of Gynecology and Obstetrics, Ankara, Turkiye. (1 speakers): Huseyin Akıllı\n  - Clinic of Medical Oncology, Faculty of Medicine, Necmettin Erbakan University, Konya 42090, Turkey. (1 speakers): Ahmet Oruc\n  - Cukurova University, Adana 01250, Turkey. (1 speakers): Mehmet M. Kidi\n  - Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Istanbul University, Faculty of Medicine, Istanbul, Turkey. (1 speakers): Samet Topuz\n  - Department of Internal Medicine, Division of Medical Oncology, Dokuz Eylul University, Izmir (1 speakers): Eda Caliskan Yildirim\n  - Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey. (1 speakers): Baris Tuzcu\n  - Department of Internal Medicine, Hacettepe University Hospital, Ankara (1 speakers): Turkan Aliyeva\n  - Department of Internal Medicine, Mugla University Medical Faculty, Mugla, Turkey. (1 speakers): Ismail Kırlı\n  - Department of Medical Oncology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey. (1 speakers): Furkan Ceylan\n  - Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, Turkey. (1 speakers): Kadriye Bir Yucel\n  - Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey. (1 speakers): Yuksel Urun\n  - Department of Medical Oncology, Ankara, Turkey. (1 speakers): Nurlan Mammadzada\n  - Department of Medical Oncology, Bower Hospital, Diyarbakır, Turkey. (1 speakers): Yakup Ergun\n  - Department of Medical Oncology, Ege University Medical Faculty, Izmir 35100, Turkey. (2 speakers): Gokhan Sahin, Haydar C. Yuksel\n  - Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey. (1 speakers): Orhun Akdogan\n  - Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey. (1 speakers): Hasan C. Yildirim\n  - Department of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey. (1 speakers): Mehmet C. Icli\n  - Department of Medical Oncology, Hacettepe University, Ankara, Turkey. (1 speakers): Deniz Can Guven\n  - Department of Medical Oncology, Istanbul University Institute of Oncology, Istanbul, Turkey. (1 speakers): Abdulmunir Azizy\n  - Department of Medical Oncology, Necmettin Erbakan University Hospital, Konya 04280, Turkey. (1 speakers): Mehmet Artac\n  - Department of Medical Oncology, School of Medicine, Hacettepe University, Ankara 06100, Turkey. (1 speakers): Taha Koray Sahin\n  - Department of Nursing, Faculty of Health Science, Başkent University, Etimesgut, Ankara, Turkey. citak@baskent.edu.tr. (1 speakers): Ebru Akgun cıtak\n  - Department of Nursing, Faculty of Health Science, Yeditepe University, Istanbul, Turkey. (1 speakers): Gokce Naz Cakır\n  - Department of Nursing, Faculty of Health Sciences, Bezmialem Vakif University, Istanbul, Turkey. (1 speakers): Funda Cam\n  - Department of Nursing, Gazi University Faculty of Health Sciences, Besevler, Turkey. (1 speakers): Sevinc Kutluturkan\n  - Department of Pathology, Hacettepe University, Ankara 06230, Turkey. (1 speakers): Fatma Gundogdu\n  - Department of Urology, Haseki Training and Research Hospital, Istanbul, Turkey. (1 speakers): Oguzhan Yildiz\n  - Division of Medical Oncology, Department of Internal Medicine, Istanbul University-Cerrahpaşa, Istanbul 34098, Turkey. (1 speakers): Ozkan Alan\n  - Division of Urologic Oncology, Department of Urology, Istanbul University, Turkey. (1 speakers): Selcuk Erdem\n  - Faculty of Health Sciences Department of Nursing, Baskent University, Ankara, Turkey. (1 speakers): Sultan Kav\n  - Faculty of Health Sciences, Antalya Bilim University, Antalya, Turkey. (1 speakers): Munevver Erkul\n  - Faculty of Pharmacy, Department of Clinical Pharmacy, 113886Hacettepe University, Ankara, Turkey. (1 speakers): Esin Aysel Kandemir\n  - Fethiye Faculty of Health Sciences, Muğla Sıtkı Koçman University, Fethiye, Muğla, Turkey. (1 speakers): Ferda Akyuz Ozdemir\n  - Gazi University Faculty of Medicine, Ankara 06560, Turkey. Electronic address: tubaugurgazi@edu.tr. (1 speakers): Tuba U. Tuzcu\n  - Gazi University Health Sciences Faculty, Nursing Department, Ankara, Turkey. (1 speakers): Gizem Cakir\n  - Gazi University Nursing Faculty Department of Pediatric Nursing, Ankara (1 speakers): Hazal Ozdemir Koyu\n  - Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey. (1 speakers): Sercan Aksoy\n  - Hacettepe University, Ankara, Turkey. msabri.kovanci@gmail.com. (1 speakers): Mustafa S. Kovanci\n  - Halic University, Istanbul, Turkey. (1 speakers): Aysenur Cetin Uceriz\n  - Institute of Cancer Research, Ankara University, Ankara, Turkey. (1 speakers): Enes Erul\n  - Internal Medicine Nursing Department, Faculty of Nursing, 37515Hacettepe University, Ankara, Turkey. (1 speakers): Imatullah Akyar\n  - Istanbul Arel University, Faculty of Health Sciences, Nursing Department, Istanbul (1 speakers): Tugba Pehlivan Sarıbudak\n  - Istanbul Technical University, Istanbul 34469, Turkey. (1 speakers): Onur O. Arslan\n  - Istanbul University-Cerrahpasa, Institute of Graduate Studies, Istanbul, Turkey. (1 speakers): Aycan Kucukkaya\n  - Istanbul University-Cerrahpasa, Istanbul, Turkey. (1 speakers): Gulbeyaz Can\n  - Istanbul University-Cerrahpaşa, Istanbul 34098, Turkey. (1 speakers): Seda N. Jeral\n  - Istanbul University-Cerrahpaşa, Turkey. (1 speakers): Fadil Umihanic\n  - Koç University Hospital, Department of Medical Oncology, Istanbul, Turkey. (1 speakers): Deniz Tural\n  - Medical Faculty, Department of Medical Oncology, Medipol University, No:1, Bagcilar, Istanbul, Turkey. (1 speakers): Sabin Goktas Aydin\n  - Medical Oncology Department, Etlik City Hospital, Ankara, Turkey. (4 speakers): Enes Yesilbas, Galip Can Uyar, Kadriye Baskurt, Osman Sutcuoglu\n  - Mental Health Nursing, School of Nursing, Istanbul Bilgi University, Istanbul, Turkey. (1 speakers): Perihan Guner\n  - Muğla Sitki Kocman University Faculty of Medicine, Department of Medical Oncology, Muğla (1 speakers): Ozgur Tanriverdi\n  - Psychiatric Nursing Department, Faculty of Nursing, Hacettepe University, Ankara, Turkey. (1 speakers): Sinem Ocalan\n  - Sabanci University Nanotechnology Research and Application Center (SUNUM), Istanbul, Turkey. (1 speakers): Ozlem Kutlu\n  - School of Nursing, Koç University, İstanbul, Turkey. (1 speakers): Remziye Semerci\n  - Selcuk University, Konya, Turkey. (1 speakers): Ulku S. Saygılı\n  - University of Health Sciences, Ankara, Turkey. (1 speakers): Gulten Guvenc\n  - University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Training and Research Hospital, Medical Oncology, Ankara, Turkey. (1 speakers): Ilknur Deliktas Onur\n  - Çukurova University Faculty of Medicine, Adana, Turkey. (1 speakers): Suheda Atas Ipek\n\n**US (2 institutions, 2 speakers)**\n  - Division of Hematology/Oncology, Department of Medicine, Irvine Medical Center, University of California, Orange, CA, USA. (1 speakers): Farshid Dayyani\n  - Weill Cornell Medical College of Cornell University, NY. (1 speakers): Scott T. Tagawa\n\n**USA (1 institutions, 1 speakers)**\n  - Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA. (1 speakers): Imran Khan\n\n**Ukraine (4 institutions, 6 speakers)**\n  -  (3 speakers): Kseniia Bolharina, Viktoriia Galytskaya, Yaroslava Haborets\n  - Department of Biochemistry, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine. (1 speakers): Mariana Kuryk\n  - INSTITUTE OF MEDICAL RADIOLOGY OF S. P. GRIGORIEV NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE, UKRAINE (1 speakers): Vladyslav S. Sukhin\n  - Institute of Molecular Biology and Genetics NASU, Kyiv, Ukraine. (1 speakers): Denys Kozakov\n\n**United Arab Emirates (5 institutions, 5 speakers)**\n  -  (1 speakers): Dawood Shaheenah\n  - Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi P.O. Box 92510 (1 speakers): Humaid O. Al-Shamsi\n  - Clemenceau Medical Center Dubai, Dubai, American University of Beirut, Beirut (1 speakers): Deborah Mukherji\n  - College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Building 14 (1 speakers): Milad Nourianpour\n  - Division of Hematology - Oncology Medicine, Hôtel Dieu de France Medical Center, Saint-Joseph University, Beirut (1 speakers): Marwan Ghosn\n\n**United Kingdom (188 institutions, 213 speakers)**\n  -  (18 speakers): Amar Challapalli, Anne Crockett, Anthony Collier, Chloe Cruickshank, Darren Callanan, Fred Van Someren, Ghita Housni, Gini Harrison, Huma Irshad, Isobel Read, Matthew Beggs, Pablo Jimenez Labaig, Perminder Tony Singh Dhillon, Racha Kussaibati, Rosie Edgerley, Shikiera Wheeler, Wadiya Sayeda, Zoe O'Neil\n  - Addenbrooke's Hospital, Amsterdam, the Netherlands. (1 speakers): Philip Schouten\n  - Allama Iqbal Memorial Trust Hospital, Gujranwala, Pakistan. (1 speakers): Sami Atiq\n  - Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London, UK. (2 speakers): Francesca Jackson-Spence, Sara Coca Membribes\n  - Barts Health Biomedical NIHR Research Centre, Queen Mary University of London, London, UK. (1 speakers): Thomas B. Powles\n  - Barts Health NHS Trust, London, United Kingdom of Great Britain and Northern Ireland. (1 speakers): Marco Gerlinger\n  - Betsi Cadwaladr University Health Board, Bangor, UK. jaya.vangara@wales.nhs.uk. (1 speakers): Jaya Vangara\n  - Bristol Medical School, University of Bristol, Bristol, UK. (1 speakers): Christina Thirlwell\n  - Broad Institute of MIT and Harvard, Cambridge, MA, USA. (1 speakers): Michael E. Bryan\n  - CLL Society, CA. (1 speakers): Chris Stewart\n  - CRUK Cambridge Centre, University of Cambridge, Cambridge, UK. (1 speakers): Mireia Crispin Ortuzar\n  - Cambridge (1 speakers): Miguel Pereira\n  - Cancer Dynamics Laboratory, The Francis Crick Institute, London NW1 1AT, UK. (1 speakers): Charlotte Spencer\n  - Cancer Institute, University College London, London, UK, University College London Hospitals, London (1 speakers): Gerhardt Attard\n  - Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. (1 speakers): Wing Kin Liu\n  - Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK, Pre-Cancer Immunology Laboratory (1 speakers): James L. Reading\n  - Cancer Research UK Manchester Institute, Manchester (1 speakers): Kok Haw Jonathan Lim\n  - Cancer Research UK Manchester Institute, Manchester M20 4BX, UK. R.M. is also in the Faculty of Biology, Medicine and Health, The University of Manchester. (1 speakers): Rebecca J. Lee\n  - Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London EC1M 6AU, UK. (1 speakers): Peter Schmid\n  - Centre for Host-Microbiome Interactions, King's College London, London, UK. (1 speakers): Anjali Chander\n  - Centre for Trials Research, Cardiff University, Cardiff, UK. (1 speakers): Magdalena Meissner\n  - Clinical Pharmacology and Therapeutics, School of Life and Medical Sciences, University College London, London, UK. (1 speakers): Oscar Della Pasqua\n  - Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK. (1 speakers): Christina Yap\n  - Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, Guy's Cancer Centre, King's College London, London, UK. (1 speakers): Matthaios Kapiris\n  - Conquest Hospital, UK. (1 speakers): Olivia Sharp\n  - Department of Behavioural Science and Health, Institute of Epidemiology and Health Care, University College London, UK. (1 speakers): Eleonora Iob\n  - Department of Cellular Pathology, Charing Cross Hospital Campus, London, UK. (1 speakers): Brian Hanley\n  - Department of Clinical Dentistry, Faculty of Medicine, University of Bergen, Bergen, Norway. (1 speakers): Farzana Haque\n  - Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Thitikorn Nuamek\n  - Department of Experimental Psychology, University of Oxford, Oxford (1 speakers): Urska Kosir\n  - Department of General Surgery, Sengkang General Hospital, Singapore, Singapore. (1 speakers): Wai Keong Wong\n  - Department of Genetics, Genomics and Cancer Sciences, University of Leicester, Leicester, UK md527@le.ac.uk. (1 speakers): Maurice Dungey\n  - Department of Infectious Diseases and Immunity, Faculty of Medicine and Wellcome Trust Centre for Clinical Tropical Medicine, Imperial College, Hammersmith Hospital, London, UK. (1 speakers): Jasim Uddin\n  - Department of Laboratory Medicine, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China (1 speakers): Yifan Xing\n  - Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK. (1 speakers): James Whitworth\n  - Department of Medical Oncology, Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK. (1 speakers): Mario Uccello\n  - Department of Medical Oncology, St George's University Hospitals NHS Foundation Trust, London, UK. (1 speakers): Melek Akay\n  - Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK, Division of Cancer Sciences, The University of Manchester, Manchester, UK. (1 speakers): Fiona Blackhall\n  - Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Ana Sofia D. Parreira\n  - Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London NW1 2PG, UK. (1 speakers): Charles Swanton\n  - Department of Medical Oncology, University Hospital of Ioannina, Greece. (1 speakers): Panagiotis Ntellas\n  - Department of Medicine, Royal Marsden Hospital, London and Surrey (1 speakers): Anderley Gordon\n  - Department of Oncology, Cambridge University NHS Foundation Trust, Cambridge, UK. (1 speakers): Will Ince\n  - Department of Oncology, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. (1 speakers): Kanggeon Kim\n  - Department of Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK. (1 speakers): Elizabeth C. Smyth\n  - Department of Oncology, Oxford University, Oxford, UK. (1 speakers): Eileen E. Parkes\n  - Department of Oncology, University College London (UCL) Cancer Institute, UCL Hospitals, London, UK. (1 speakers): Rebecca S Kristeleit\n  - Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK. (1 speakers): Gemma Eminowicz\n  - Department of Oncology, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AH, UK, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge (1 speakers): Ionut Gabriel Funingana\n  - Department of Oncology, University of Cambridge, Cambridge, UK. (1 speakers): David M. Favara\n  - Department of Oncology, University of Oxford, Oxford, UK. (1 speakers): Benjamin P. Fairfax\n  - Department of Pathology, Aberdeen Royal Infirmary and Aberdeen University Medical School, Aberdeen, UK. (1 speakers): Keith M. Kerr\n  - Department of Pathology, Rush University Medical Center, Chicago, IL 60612, USA. Electronic address: lzc112@gmail.com. (1 speakers): Lin Cheng\n  - Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451 (1 speakers): Maha S. Almutairi\n  - Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. (1 speakers): Sanjay Khanna\n  - Department of Radiotherapy Related Research, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. (1 speakers): Corinne Faivre-Finn\n  - Department of Radiotherapy, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, Computational Oncology Laboratory, Institute of Global Health Innovation, Imperial College, London (1 speakers): Seema Dadhania\n  - Department of Research Oncology, Guys Hospital, Kings College London, SE1 9RT London, UK. (1 speakers): Debashis Sarker\n  - Department of Surgery and Cancer, Imperial College London, Faculty of Medicine, Hammersmith Hospital, W120NN, London, UK, Department of Translational Medicine (DIMET) (1 speakers): David J. Pinato\n  - Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK. (1 speakers): Iain McNeish\n  - Department of Surgery and Cancer, Imperial College London, London, United Kingdom of Great Britain and Northern Ireland. (1 speakers): Christina Fotopoulou\n  - Department of Surgery, Leiden University Medical Center, Albinusdreef 2, Leiden (1 speakers): Tessa P. Sandberg\n  - Department of Surgery, The Christie Hospital NHS Foundation Trust, Manchester M20 4BX, UK. (1 speakers): Ashwin Sachdeva\n  - Department of Surgery, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. (1 speakers): Grant D. Stewart\n  - Department of Thoracic Surgery, Clinic for Thoracic Surgery, Institute for Pulmonary Diseases of Vojvodina, University of Novi Sad. (1 speakers): Debra Montague\n  - Department of Vascular Surgery, York & Scarborough Teaching Hospitals NHS Trust, York, UK. (1 speakers): Andrew Thompson\n  - Department of medical oncology, Institute of Cancer Research, Sutton, SM2 5NG (1 speakers): Ian Chau\n  - Division of Cancer Sciences, Department of Medical Oncology, University of Manchester, The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Mairead G. McNamara\n  - Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK, The Christie NHS Foundation Trust, Manchester, UK, Cancer Research UK (1 speakers): Alicia-Marie Conway\n  - Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. (3 speakers): Andrew R. Clamp, Laura Spurgeon, Natalie Cook\n  - Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Cancer Research Centre, Manchester M20 4GJ, UK (1 speakers): Robert D. Morgan\n  - Division of Cancer Sciences, The University of Manchester and Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Matthew G. Krebs\n  - Division of Genetics and Epidemiology. (1 speakers): Clare A. Turnbull\n  - Division of Oncology, School of Medicine, University of Leeds, Leeds, UK. (1 speakers): James R. Platt\n  - Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK. dm742@cam.ac.uk. (1 speakers): Daniel Munoz-Espin\n  - Edinburgh Cancer Research, University of Edinburgh, Edinburgh, Scotland, UK. (1 speakers): Barry Laird\n  - Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. (1 speakers): Joecelyn Kirani Tan\n  - Faculty of Biosciences, Heidelberg University, Heidelberg, Germany. (1 speakers): Aino-Maija Leppa\n  - Faculty of Health Sciences and Medicine, Bond University, Robina, QLD, Australia. (1 speakers): John Leggett\n  - Gray Cancer Institute, Mount Vernon Hospital, Middlesex HA6 2JR, UK. (1 speakers): Susan M. Galbraith\n  - Guy's and St Thomas' NHS Foundation Trust and Sarah Cannon Research Institute, London, UK. (1 speakers): Simon Chowdhury\n  - Histopathology Department, The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Thomas Morrall\n  - Hull York Medical School, University of Hull, Hull, UK. (1 speakers): Holly Butler\n  - Imperial College Healthcare NHS Trust, London, UK. (1 speakers): Daria A. Ditri\n  - Institute of Cancer Research, Sutton, London, UK. (1 speakers): Terri P. McVeigh\n  - Institute of Cancer Sciences, College of Medical, University of Glasgow UK. (1 speakers): Andrew Biankin\n  - Institute of Head and Neck Studies and Education, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. (1 speakers): Hisham M. Mehanna\n  - Institute of Reproductive and Developmental Biology, Imperial College London, London, W12 0HS, UK. (1 speakers): Jonathan Krell\n  - John Sealy School of Medicine, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, USA. (1 speakers): Vishal Patel\n  - John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, UK. (1 speakers): Sergio Rutella\n  - Kidney Cancer UK, Guildford, UK. (1 speakers): Malcolm Packer\n  - King's College Hospital NHS Foundation Trust, King's College Hospital, London SE5 9RS, UK. (1 speakers): Sharmistha Ghosh\n  - King's College London, King's College London, United Kingdom. Electronic address: mary.tanay@kcl.ac.uk. (1 speakers): Mary A. Tanay\n  - Leeds Institute of Medical Research at St James's, University of Leeds, Leeds (1 speakers): Adel Samson\n  - Liverpool University Hospitals, NHS Foundation Trust, Liverpool, UK. (1 speakers): Christian H. Ottensmeier\n  - MB, The Christie Hospital NHS Foundation Trust, Manchester, MB, BCH, The Christie Hospital NHS Foundation Trust, Manchester, Division of Cancer Sciences, University of Manchester, Manchester (1 speakers): Sophia Kreft\n  - MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK. (1 speakers): Peter J. Godolphin\n  - MRC Clinical Trials Unit, University College London, London, UK. (1 speakers): Sophie Merrick\n  - Macmillan Lead Cancer Nurse and Nurse Consultant, Berkshire Cancer Centre, Royal Berkshire NHS Foundation Trust, Reading. (1 speakers): Mark R. Foulkes\n  - Male Genital Cancer Centre, Department of Andrology, University College London Hospitals (UCLH) NHS Foundation Trust, London, UK, Division of Surgery and Interventional Science (1 speakers): Asif Muneer\n  - Manchester Foundation Trust, Manchester, UK. (1 speakers): Sian Dobbs\n  - Medical Oncology Department, North West Cancer Centre, Western Health & Social Care Trust, Derry, Northern Ireland. (1 speakers): Hossam R. Abdulkhalek\n  - Medical Research Council Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK (1 speakers): Hoda Abdel-Aty\n  - Molecular Cancer Imaging Facility, Dana-Farber Cancer Institute, Boston, MA, USA. (1 speakers): Mark Dornan\n  - Montréal, QC, Canada. (1 speakers): Laura Morrison\n  - Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Center, University of Edinburgh, Edinburgh, UK. (1 speakers): Charlie Gourley\n  - North Middlesex University Hospital, London, UK. (1 speakers): Valerie E. Crolley\n  - Nuffield Department of Experimental Medicine, University of Oxford, Oxford, UK. (1 speakers): Simon Leedham\n  - Nuffield Department of Surgical Sciences, University of Oxford, Oxford (1 speakers): Elysia Upton\n  - Oncology R&D, AstraZeneca, Cambridge, UK. (1 speakers): Phillip M. Brailey\n  - Ontario Institute for Cancer Research, Toronto, Canada. (1 speakers): Lydia Y. Liu\n  - Oxford Haematology and Cancer Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford (1 speakers): Toby A. Eyre\n  - Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom of Great Britain and Northern Ireland. (1 speakers): Martin Little\n  - PRA International, Reading, Berkshire, RG2 0TD (1 speakers): Nermeen Varawalla\n  - Peter Gorer Department of Immunobiology, King's College London, London, UK. (1 speakers): Adrian Hayday\n  - Queen's University Belfast, BT9 7AE, United Kingdom. (1 speakers): Joe O'Sullivan\n  - Research Assistant, Brussels, Belgium. (1 speakers): Celia Diez de los Rios de la Serna\n  - Rome, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Federico Monaca\n  - Rosemere Cancer Centre, Lancashire Teaching Hospitals, Preston UK, University of Manchester, Manchester, UK, University of Central Lancashire, Preston, UK. (1 speakers): Alison J. Birtle\n  - Royal Marsden Hospital Sutton, London, UK. (1 speakers): Sarah Stapleton\n  - Royal Marsden Hospital and Institute for Cancer Research, London, UK. (1 speakers): James Larkin\n  - Royal Marsden Hospital and Institute of Cancer Research, London. (1 speakers): Nicholas C. Turner\n  - Royal Marsden Hospital, London SW3 6JJ, UK. (2 speakers): Naureen Starling, Sheela Rao\n  - Royal Marsden Hospital, Sutton, UK. (1 speakers): Johann S. De Bono\n  - Royal Marsden NHS Foundation Trust, London (1 speakers): Peta Hughes\n  - START-CIOCC, University Hospital HM Sanchinarro, Madrid, Spain. (1 speakers): Ramon Yarza\n  - Sarah Cannon Research Institute UK, London, UK. (3 speakers): Anja Williams, Matilde Saggese, Rachel Woodford\n  - School of Cancer Sciences, University of Glasgow, Bearsden, Glasgow G61 1QH, UK. (1 speakers): Maria Libera Ascierto\n  - School of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK. (1 speakers): Robert Jones\n  - School of Health & Social Care, Edinburgh Napier University, Edinburgh, UK. (1 speakers): Karen Campbell\n  - School of Medicine, University of St Andrews, UK. (1 speakers): Hazem Abdullah\n  - School of Nursing and Midwifery, Queen's University, Belfast, Ireland. (1 speakers): Mark Dornan\n  - Southampton Clinical Trials Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK. (1 speakers): Victoria Goss\n  - St Thomas' Hospital, London (1 speakers): Nikhil Aggarwal\n  - St. Georges University Hospitals Foundation Trust and The Royal Marsden Foundation Trust, London, UK. (1 speakers): Lisa M. Pickering\n  - Stem Cell and Leukaemia Proteomics Laboratory, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M20 3LI, UK. (1 speakers): Kathleen Connors\n  - Sudan University of Science and Technology, Khartoum, Sudan. raniamamoun065@gmail.com. (1 speakers): Rania A. Mohammed\n  - Surgery, Alexandria Main University Hospitals, Alexandria, EGY. (1 speakers): Mohamed Farrag\n  - The Christie Hospital NHS Trust, Manchester University NHS Foundation Trust, Manchester, UK. (1 speakers): Yvonne Summers\n  - The Christie NHS Foundation Trust and University of Manchester, Manchester, UK. (1 speakers): Fiona Thistlethwaite\n  - The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Avanti A. Andhale\n  - The Francis Crick Institute, London, UK, The Royal Marsden Hospital, London, UK. (1 speakers): Samra Turajlic\n  - The Institute of Cancer Research, London, England, UK. (1 speakers): Kevin J. Harrington\n  - The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7AE, UK. (1 speakers): Wen Kyle Wong\n  - The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Midlothian, EH25 9RG, UK. (1 speakers): Richard I. Kuo\n  - The Royal Marsden Hospital and The Institute of Cancer Research, Sutton (1 speakers): Anna R. Minchom\n  - The Royal Marsden Hospital, London, SW3 6 JJ, UK. (1 speakers): Stephen R. Johnston\n  - The Royal Marsden Hospital, London, UK. (1 speakers): Sanjay Popat\n  - The Royal Marsden Hospital. (1 speakers): Maximilian Julve\n  - The Royal Marsden Hospital., The Institute of Cancer Research, The Royal Marsden Hospital. (1 speakers): Ben O'Leary\n  - The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK. (1 speakers): Susana Banerjee\n  - The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK. (1 speakers): Nicholas D. James\n  - The Royal Marsden NHS Foundation Trust, London, UK. (1 speakers): Shira Peleg Hasson\n  - The Symptom Control and Palliative Care Team, The Royal Marsden NHS Foundation Trust, London, UK. (1 speakers): Jayne E. Wood\n  - The University of Manchester, Manchester, United Kingdom. (1 speakers): Colin R R. Lindsay\n  - The University of Sheffield, Sheffield, UK. (1 speakers): James W. Catto\n  - Translational & Oncology Research (TOUR), King's College London, London, UK. (1 speakers): Louis Fox\n  - Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK. (1 speakers): Deborah Enting\n  - Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. (1 speakers): Debra Josephs\n  - UCL Cancer Institute, University College London, London (1 speakers): Sandra Strauss\n  - Ulster Hospital, South Eastern Health and Social Care Trust, Dundonald, UK. (1 speakers): Cherith J. Semple\n  - University College Hospital, London, UK. (1 speakers): Shibani Nicum\n  - University College London Cancer Institute, London (1 speakers): Mahaz Kayani\n  - University College London Hospital NHS Foundation Trust, London (1 speakers): Bernadett E. Szabados\n  - University College London Hospitals NHS Foundation Trust, London NW1 2BU, UK. (1 speakers): Katrina Ingley\n  - University College London, University College London, United Kingdom. (1 speakers): Kevin O'Neill\n  - University Hospital Southampton NHS Foundation Trust, Southampton, UK. (1 speakers): Zaed Hamady\n  - University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. (2 speakers): Helen L. Robbins, Philippe Taniere\n  - University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom of Great Britain and Northern Ireland. (1 speakers): Helen Winter\n  - University Hospitals Sussex NHS Foundation Trust, Brighton BN1 9RW, UK. (1 speakers): Rille Pihlak\n  - University Hospitals Sussex, England. (1 speakers): Bethany Maynard\n  - University of Cambridge School of Clinical Medicine, Cambridge, UK. (1 speakers): Rahul A. Shah\n  - University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK. (1 speakers): Eleanor Wheeler\n  - University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, CB2 0QQ Cambridge, UK. (1 speakers): Bristi Basu\n  - University of Coimbra, Coimbra, Portugal. (1 speakers): Marisa R. Durao Portela De Lima\n  - University of Huddersfield, Huddersfield, United Kingdom. (1 speakers): Toni Brook\n  - University of Leicester, Leicester, UK, University Hospitals of Leicester NHS Trust, Leicester, UK. (1 speakers): Dean A. Fennell\n  - University of Liverpool, Liverpool, Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany, Department of General (1 speakers): Daniel H. Palmer\n  - University of Oxford, Department of Oncology, Churchill Hospital, Oxford, UK. (1 speakers): Sarah P. Blagden\n  - University of Oxford, Oxford, UK. (2 speakers): Gusztav B. Milotay, Hannah F. Nentwich\n  - University of Oxford, Oxford, United Kingdom. Electronic address: edward.oneill@nds.ox.ac.uk. (1 speakers): Edward O'Neill\n  - University of Sheffield and Sheffield Teaching Hospitals NHS Trust, Weston Park Hospital Sheffield S10 2JF, UK. (1 speakers): Syed A. Hussain\n  - University of Southampton, Southampton (1 speakers): Nicole Keyworth\n  - Usher Institute, University of Edinburgh, Edinburgh, UK. (1 speakers): Peter S. Hall\n  - Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, Hampshire, UK. (1 speakers): David Hunt\n  - William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, London, UK. (1 speakers): Gracia Andriamiadana\n  - Wolfson Palliative Care Research Centre, University of Hull, Hull, UK. (1 speakers): Fliss Murtagh\n  - Women's Health Research Group, Leeds Institute of Medical Research, St James's University Hospital, University of Leeds, Leeds (1 speakers): Nicholas Bennett\n\n**United States of America (343 institutions, 382 speakers)**\n  -  (16 speakers): Bobbie Rimmel, Bryan Murphy-Eustis, Iole Ribizzi-Akhtar, Irati Rodriguez Matesanz, Jessie Desir, Jin Sun Bitar, Jose Avitia, Judith Perez Granado, Luis Felipe, Myeong Hwak Choe, Popi Siziopikou, Rita Furdyna, Sengathir Rajagopal, Stephan Rosenfeld, Stephanie Snider, Sydney E. Schultz\n  - . Hospital de Clínicas de Porto Alegre, Faculdade de Medicina, Brasil. (1 speakers): Wallace Klein Schwengber\n  - 19University of California, Los Angeles Medical Center, CA, USA. (1 speakers): Alexandra Drakaki\n  - 1Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (1 speakers): David S. Hong\n  - 1Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Baltimore (1 speakers): Govind Warrier\n  - 2Cedars-Sinai Medical Center, CA. (1 speakers): Stephen Freedland\n  - 3Division of Hematology-Oncology, Department of Medicine, VAGLAHS/David Geffen School of Medicine at University of California, CA. (1 speakers): Daniel S. Shin\n  - 3Medical College of Wisconsin Cancer Center, Milwaukee, WI. (1 speakers): Deepak Kilari\n  - Abramson Cancer Center, University of Pennsylvania, Philadelphia. (1 speakers): Charu Aggarwal\n  - Ahmanson Translational Theranostics Division, David Geffen School of Medicine, University of California Los Angeles (UCLA), USA. (1 speakers): Adrien Holzgreve\n  - Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California-Los Angeles, CA, USA. (1 speakers): Jeremie Calais\n  - AstraZeneca, Gaithersburg (1 speakers): Cristian Massacesi\n  - Atlanta, GA. (1 speakers): Kenneth W. Culver\n  - Baylor University Medical Center, US Oncology, Dallas, TX. (1 speakers): Joyce O'Shaughnessy\n  - Biomedical Research Center of University of Granada, Excellence Research Unit \"Modeling Nature\" (MNat), University of Granada, Spain. (1 speakers): Ashraf Abdelghany\n  - BostonGene Corporation, Waltham, MA 02453, USA. (1 speakers): Andrey Kravets\n  - CA, USA. (1 speakers): Jelena Levi\n  - Cambridge, MA, USA. (1 speakers): Mailin Li\n  - Cancer & Hematology Centers of Western Michigan, MI, USA. (1 speakers): Sreenivasa Chandana\n  - Cancer Center, SE, JP). (1 speakers): Loren N. Winters\n  - Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR (1 speakers): Nima Nabavizadeh\n  - Carolina Urologic Research Center, AU Clinics, SC, USA. (1 speakers): Neal D. Shore\n  - Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. (1 speakers): Jaydira Del Rivero\n  - Center for Cancer Research, National Institutes of Health, Bethesda, USA. (1 speakers): Ravi A. Madan\n  - Center for Neuro-Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA. (1 speakers): Lakshmi Nayak\n  - Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY (1 speakers): Yonina R. Murciano-Goroff\n  - Clinical Research, START, TX. (1 speakers): Kyriakos P. Papadopoulos\n  - Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston. (1 speakers): Andrew T. Chan\n  - Creighton University School of Medicine, Omaha, NE, USA. (1 speakers): Christina Curtin\n  - Dana-Farber Cancer Institute, Boston, MA, USA, Harvard Medical School, Boston, MA, USA. (2 speakers): Alicia K. Morgans, Clara Steiner\n  - Dana-Farber Cancer Institute, Boston, Massachusetts, USA. (1 speakers): Renee M. Saliby\n  - Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA, University of Milano, Milan, Italy. (1 speakers): Paolo Tarantino\n  - Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. (1 speakers): Jacob Sands\n  - Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. (1 speakers): Surender Kharbanda\n  - Dana-Farber Cancer Institute/Brigham and Women's Hospital Harvard Medical School, Boston, MA. (1 speakers): Ilana B. Epstein\n  - David Geffen School of Medicine at University of California, Los Angeles, Los Angeles. (1 speakers): Zev A. A. Wainberg\n  - Department of Bioengineering, McGill University, Montreal, QC, Canada. (1 speakers): Nikolaos M. Dimitriou\n  - Department of Bioengineering, Stanford University, Stanford, CA, USA. (1 speakers): Stephen R. Quake\n  - Department of Biomedical Engineering, GA, USA, Department of Biomedical Engineering, Emory University, GA, USA. (1 speakers): Mayukhmala Jana\n  - Department of Cancer Biology and Genetics, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, NY 10065. (1 speakers): Ram Kannan\n  - Department of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Calgary, AB T2N 5G2, Canada. (1 speakers): Lin Yang\n  - Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, Illinois 60208 (1 speakers): Donghoon Shin\n  - Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA. (1 speakers): Michael J. Hall\n  - Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. (1 speakers): Vernon K. Sondak\n  - Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA. (1 speakers): Lilit Karapetyan\n  - Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. (1 speakers): Camilo Jimenez\n  - Department of Gastroenterology and Hepatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH. (1 speakers): Aakash Desai\n  - Department of Gastroenterology and Hepatology, The 3rd Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, China. (1 speakers): Fei Wang\n  - Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Scott Kopetz\n  - Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. (2 speakers): Ryan Huey, Van Morris\n  - Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA. (1 speakers): Christina Curtis\n  - Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX (1 speakers): Sumit K. Subudhi\n  - Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. (1 speakers): Sangeeta Goswami\n  - Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Andrew W. Hahn\n  - Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. (1 speakers): Ana Aparicio\n  - Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Elizabeth Burton\n  - Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. (1 speakers): Scott Woodman\n  - Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (2 speakers): David M. Gershenson, Shannon Westin\n  - Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. (1 speakers): Neil Gross\n  - Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Cancer Neuroscience Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (1 speakers): Moran Amit\n  - Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX. (1 speakers): Sharon H. Giordano\n  - Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. (1 speakers): Hossein Borghaei\n  - Department of Hematology/Oncology, University of California Los Angeles, USA. (1 speakers): Richard S. Finn\n  - Department of Hematology/Oncology, Yale New Haven Hospital, CT, USA. (1 speakers): Amin Nassar\n  - Department of Internal Medicine and The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH. (1 speakers): Marcelo Bonomi\n  - Department of Internal Medicine, Hematology/Oncology, Abramson Cancer Center, Philadelphia, PA, USA. (1 speakers): Tara C. Mitchell\n  - Department of Internal Medicine, Loyola University Health System-MacNeal Hospital, Berwyn, IL, USA. (1 speakers): Krishna Doshi\n  - Department of Internal Medicine, University of Chicago, KCBD 7114, Chicago, IL 60637, USA. (1 speakers): Sulin Wu\n  - Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX. (1 speakers): Rodney E. Infante\n  - Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas. (2 speakers): Qian Qin, Tian Zhang\n  - Department of Internal Medicine, Yale New Haven Hospital, CT 06504, USA. (1 speakers): Ashish Sharma\n  - Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Apostolia Maria Tsimberidou\n  - Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston (1 speakers): Fadi G. Haddad\n  - Department of Leukemia, The University of Texas MD Anderson Cancer Center, TX, Houston, USA. (1 speakers): Jabra Zarka\n  - Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA. (2 speakers): Charles B. Nguyen, Neal S. Chawla\n  - Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA. (1 speakers): Hedyeh Ebrahimi\n  - Department of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA. (1 speakers): Jonathan Schoenfeld\n  - Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA. (2 speakers): Aditya Shreenivas, Amanda Reyes\n  - Department of Medical Oncology, Boston, MA, USA. (1 speakers): Ana C. Garrido-Castro\n  - Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. (1 speakers): Matt Freedman\n  - Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA. (1 speakers): Robert Haddad\n  - Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA. (1 speakers): Wenxin Xu\n  - Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts. (1 speakers): Tanvi Visal\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. (1 speakers): Chris Labaki\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (5 speakers): Bradley A. McGregor, Filipa Lynce, Karam Khaddour, Marc Eid, Nancy Lin\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. (1 speakers): Mustafa Saleh\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA, USA. (1 speakers): Sylvan Baca\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. (2 speakers): Eddy Saad, Marc Machaalani\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. (2 speakers): Glenn J. Hanna, Praful Ravi\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. (1 speakers): Himisha Beltran\n  - Department of Medical Oncology, Huntsman Cancer Institute, University of Utah (1 speakers): Zeynep Irem Ozay\n  - Department of Medical Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. (1 speakers): Julia Rotow\n  - Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA (1 speakers): Aparna Parikh\n  - Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, NY, USA. (1 speakers): Neil H. Segal\n  - Department of Medical Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA. (1 speakers): Mohammad Arfat Ganiyani\n  - Department of Medical Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA. (1 speakers): Balazs Halmos\n  - Department of Medicine (Medical Oncology), Yale School of Medicine and Yale Cancer Center, CT (1 speakers): Anne C. Chiang\n  - Department of Medicine and Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN. (1 speakers): Christine M. Lovly\n  - Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA. (1 speakers): James Lyon\n  - Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA 15213, USA. (1 speakers): Anwaar Saeed\n  - Department of Medicine, Division of Hematology Oncology, UT Health San Antonio, Mays Cancer Center, Texas, USA. (1 speakers): Virginia Kaklamani\n  - Department of Medicine, Division of Hematology and Oncology, Mayo Clinic College of Medicine and Science, Jacksonville, FL 32224, USA. (1 speakers): Hani Babiker\n  - Department of Medicine, Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA. (1 speakers): Saranya Chumsri\n  - Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. (1 speakers): Vikram Gorantla\n  - Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, CA. (1 speakers): Edward B. Garon\n  - Department of Medicine, Englander Institute for Precision Medicine, New York Presbyterian Hospital, NY, USA. (1 speakers): Eleonora Nicolo\n  - Department of Medicine, Icahn School of Medicine at Mount Sinai, NY. (1 speakers): Catherine Wu\n  - Department of Medicine, Massachusetts General Hospital, Boston, MA 02114 (1 speakers): Oladapo Yeku\n  - Department of Medicine, Mayo Clinic, Rochester, MN, USA. (1 speakers): Mariya Pogorelova\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center (1 speakers): Karen Autio\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY (1 speakers): Kenneth H. Yu\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, USA, Department of Medicine, Weil Cornell Medical College, NY, USA. (1 speakers): David H. Aggen\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, USA, Department of Medicine, Weill Cornell Medicine and New York Presbyterian Hospital, NY, USA. (1 speakers): Alan L. Ho\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, USA. (2 speakers): Pedram Razavi, Vicky Makker\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, NY. (3 speakers): Alissa J. Cooper, James J. Harding, Wungki Park\n  - Department of Medicine, Memorial Sloan Kettering Cancer Center, USA. (2 speakers): Ethan S. Barnett, Jamie Chaft\n  - Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136 (1 speakers): CARMEN CALFA\n  - Department of Medicine, New York University Langone Perlmutter Cancer Center, USA. (1 speakers): Elaine Shum\n  - Department of Medicine, School of Medicine, University of California San Diego, CA 92093, USA. (1 speakers): Rana R. McKay\n  - Department of Medicine, The University of Alabama at Birmingham and O'Neal Comprehensive Cancer Center, Birmingham, AL 35233 (1 speakers): Arnab Basu\n  - Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh, PA), USA (1 speakers): Charles E. Geyer\n  - Department of Medicine, University of Chicago, Chicago, IL, USA. (1 speakers): Frederick M. Howard\n  - Department of Medicine, the University of Chicago, Chicago, IL, USA. (1 speakers): Marina C. Garassino\n  - Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (2 speakers): Hussein A. Tawbi, Isabella C. Glitza\n  - Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada. (1 speakers): Jennifer Chan\n  - Department of Molecular Medicine, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea. (1 speakers): Seung-Hoon Lee\n  - Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN (1 speakers): Andrea E. Wahner Hendrickson\n  - Department of Neurology and Neurological Sciences, Stanford Cancer Institute, Stanford, CA, USA. (1 speakers): Seema Nagpal\n  - Department of Neurology, University of Toronto, Toronto, ON, Canada. (1 speakers): Andrew S. Lim\n  - Department of Neurosurgery, University of Southern California, CA, USA. (1 speakers): Lauren Liu\n  - Department of Obstetrics and Gynecology, University of California, Irvine-Medical Center, Orange, CA (1 speakers): Alyssa C. Bujnak\n  - Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, NY 10029, USA, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NY 10029 (1 speakers): Triparna Sen\n  - Department of Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA. (1 speakers): Smitha Krishnamurthi\n  - Department of Oncology, Mayo Clinic, Rochester, MN, USA. (1 speakers): Aminah Jatoi\n  - Department of Otolaryngology-Head and Neck Surgery Stanford University School of Medicine Stanford California USA. (1 speakers): Alexander Dimitrios Colevas\n  - Department of Palliative Care, Community Hospital of the Monterey Peninsula, Monterey, California, USA. (1 speakers): John Hausdorff\n  - Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, NY, USA. (2 speakers): Higinio Dopeso, Jamal Benhamida\n  - Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA. (1 speakers): Jennifer Chen\n  - Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (1 speakers): Berkay Simsek\n  - Department of Pathology, Memorial Sloan Kettering Cancer Center, NY, USA. (1 speakers): Chad M. Vanderbilt\n  - Department of Pathology, Yale University School of Medicine, Connecticut, USA. (1 speakers): Kurt Schalper\n  - Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA (1 speakers): Katherine Janeway\n  - Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA. (1 speakers): Suchi Raghunathan\n  - Department of Pharmacology, University of Pittsburgh, Pittsburgh, PA, USA. (1 speakers): Adrian Lee\n  - Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. (1 speakers): Paul L. Nguyen\n  - Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. (1 speakers): Simon Bernatz\n  - Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (2 speakers): Adam J. Grippin, Claudia S. Kettlun Leyton\n  - Department of Radiation Oncology, University of Arizona College of Medicine-Tucson, Tucson, AZ (1 speakers): Charles Hsu\n  - Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston. (1 speakers): Ashleigh Guadagnolo\n  - Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX (1 speakers): Andrew Z. Wang\n  - Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, Baltimore, USA. (1 speakers): George Sgouros\n  - Department of Radiology, New York-Presbyterian Hospital, Columbia University Irving Medical Center (1 speakers): Laurent Dercle\n  - Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China. (1 speakers): Wei Zhong\n  - Department of Surgery, Memorial Sloan Kettering Cancer Center, NY. (1 speakers): Daniela Molena\n  - Department of Surgery, Weill Cornell Medical College, NY, USA, Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, GA, USA (1 speakers): Melissa B. Davis\n  - Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. (1 speakers): Jennifer Hwang\n  - Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Simon Heeke\n  - Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Yasir Y. Elamin\n  - Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): John Heymach\n  - Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. (1 speakers): Carl M. Gay\n  - Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. (1 speakers): Marina Schnauss\n  - Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), CA (1 speakers): Roger Lo\n  - Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA, Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125 (1 speakers): Andrew C. Lu\n  - Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA. (1 speakers): Avina Rami\n  - Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston 77030, TX USA. (1 speakers): Michael LaPelusa\n  - Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. (1 speakers): Randall Brand\n  - Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO (1 speakers): Premal H. Thaker\n  - Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, New York University Langone Health, NY (1 speakers): Kari Hacker\n  - Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, New York University Langone Health, NY, USA. (1 speakers): Bhavana Pothuri\n  - Division of Gynecologic Oncology, The Ohio State University Wexner Medical Center, The James Cancer Hospital and Solove Research Institute, M210, Columbus, OH 43210 (1 speakers): Casey Cosgrove\n  - Division of Gynecologic Oncology; The Ohio State University Wexner Medical Center, OH 43210, United States of America. (1 speakers): David O'Malley\n  - Division of Hematology Oncology, Department of Medicine, Northwestern University, Chicago, IL, USA. (1 speakers): Sunandana Chandra\n  - Division of Hematology and Medical Oncology, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL (1 speakers): Shenduo Li\n  - Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital (1 speakers): Pinkal Desai\n  - Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA (1 speakers): Melina E. Marmarelis\n  - Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. (1 speakers): Gabrielle Rocque\n  - Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (1 speakers): Scott M. Haake\n  - Division of Hematology and Oncology, The Warren Alpert Medical School of Brown University, Providence, RI, USA. (1 speakers): Hina Khan\n  - Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA, USA. (1 speakers): Jonathan W. Riess\n  - Division of Hematology-Oncology, Mayo Clinic Rochester, Minnesota. (1 speakers): Jacob Orme\n  - Division of Hematology/Oncology Mass General Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts, U.S.A. (1 speakers): David M. Miller\n  - Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, CA. (1 speakers): Terence Friedlander\n  - Division of Hematology/Oncology, University of California San Francisco, California. (1 speakers): Rahul Aggarwal\n  - Division of Hematology/Oncology/Stem cell transplant Rush University Medical Center Chicago IL. (1 speakers): Mary J. Fidler\n  - Division of Hospital Medicine, OH 43210, USA. (1 speakers): Yuanquan A. Yang\n  - Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah Health, UT 84112, USA. (1 speakers): Georges Gebrael\n  - Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, UT. (1 speakers): Nicolas Sayegh\n  - Division of Medical Oncology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. (1 speakers): Aman Chauhan\n  - Division of Medical Oncology, Department of Medicine, University of Kentucky, Lexington, KY, USA. (1 speakers): Zhonglin Hao\n  - Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA. (1 speakers): Thorvardur R. Halfdanarson\n  - Division of Oncology and Hematology, University of California Irvine Medical Center, Orange, CA, USA. (1 speakers): Nataliya Mar\n  - Division of Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, NC, USA. (1 speakers): Siddharth Sheth\n  - Division of Oncology, Norris Comprehensive Cancer Center, University of Southern California, California. (1 speakers): Gino K. In\n  - Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA. (1 speakers): Ravi Uppaluri\n  - Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of California Los Angeles, CA, USA. (1 speakers): Noah Federman\n  - Division of Solid Tumor Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106 (1 speakers): Tanya Jindal\n  - Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, NY, USA. (1 speakers): Paul Johannet\n  - Division of Thoracic Surgery, Department of Surgery, University of California (1 speakers): Jay M. Lee\n  - Don S. Dizon, Massachusetts General Hospital, Boston, Dana-Farber Cancer Institute, Boston, MA, Alexandria, VA, University of California San Diego, Patricia A. Ganz (1 speakers): Erica Mayer\n  - Donostia International Physics Center (DIPC), Spain. (1 speakers): Carlos Garcia Fernandez\n  - Dr. Panjwani Center for Molecular Medicine and Drug Research, ICCBS, University of Karachi, Karachi, Pakistan. (1 speakers): Faiza Chaudhary\n  - Duke Cancer Institute, Duke University, Durham, NC, USA. (1 speakers): John H. Strickler\n  - Edinburgh Cancer Research, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK. (1 speakers): Muhammad Furqan\n  - Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA, USA. (1 speakers): Coyin Oh\n  - Episcopal High School in Bellaire, Houston, TX. (1 speakers): Anya Pant\n  - Faculty of Medicine, University of Brasilia, Brasilia, Brazil. (1 speakers): Leticia Assad Maia Sandoval\n  - Flatiron Health, NY, USA. (1 speakers): Cheryl Cho-Phan\n  - Florida Cancer Specialists and Research Institute, GOG Foundation, FL, USA. (1 speakers): Bradley J. Monk\n  - From Dana-Farber Cancer Institute (M.M.A., S.L., J.D., J.O.J., K.E.L., H.F., K.M.H., B.M.W., P.A.J., A.J.A.), Massachusetts General Hospital (R.S.H., Y.P.H.), and Brigham and Women's Hospital (L.M.S. (1 speakers): Kathryn C. Arbour\n  - From the Department of Diagnostic Radiology (J.N., D.P., K.L., E.W., M.K.G.), The University of Texas M.D. MD Anderson Cancer Center, Houston, TX 77030, USA (1 speakers): Maura Gillison\n  - GSK, London (1 speakers): Aikaterini Fameli\n  - Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Milind Javle\n  - Georgia Cancer Center of Excellence, GA, USA. (1 speakers): Giuseppe Del Priore\n  - Greco-Hainsworth Center for Cancer Research, Nashville, TN, USA. (1 speakers): Kathryn Beckermann\n  - Greehey Children's Cancer Research Institute, UT Health San Antonio, TX, USA. (1 speakers): Aparna Gorthi\n  - H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. (1 speakers): Ahmad A. Tarhini\n  - HOAG Family Cancer Institute, CA, USA. (1 speakers): Chaitali Nangia\n  - Helen Diller Family Cancer Center, University of California-San Francisco, CA (1 speakers): Vadim S. Koshkin\n  - Helen Diller Family Comprehensive Cancer Center, University of California, CA, USA. (1 speakers): Johnny Yu\n  - Hoag Family Cancer Institute, CA, USA. (1 speakers): David J. Benjamin\n  - HonorHealth Research Institute, Scottsdale, AZ, USA. (1 speakers): Michael Gordon\n  - Hospital Universitario La Paz, Madrid, Spain. (1 speakers): Carlos Torrado Martin\n  - Hospital for Special Surgery, NY 10021, USA. (1 speakers): Junho Song\n  - Huntsman Cancer Institute (NCI-CCC), University of Utah, UT. (1 speakers): Neeraj Agarwal\n  - Huntsman Cancer Institute, University of Utah, Utah, USA. (1 speakers): William B. McKean\n  - Inc. (OT), Evanston, Illinois. (1 speakers): Partha S. Ray\n  - Innovative Infant Feeding Disorders Research Program, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA. (1 speakers): Sahithee Batchu\n  - Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712, USA. (1 speakers): Joseph D. Dekker\n  - Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. (1 speakers): Yu-Wei Chen\n  - Institute of Dental Studies and Technologies, Uttar Pradesh, India. (1 speakers): Anmol Dia Agarwal\n  - Institute of Molecular Medicine, The Feinstein Institutes for Medical Research, Manhasset, NY 11030, USA. (1 speakers): Nyasha Chambwe\n  - Institute of Pharmacology and Toxicology, Medical Faculty, RWTH Aachen, University Hospital Aachen, Aachen, Germany. (1 speakers): Christian Martin\n  - Institute: Department of Internal Medicine, AdventHealth Sebring, FL, USA. (1 speakers): Muhammad Sohaib Asghar\n  - Islamic International Medical College, Rawalpindi (1 speakers): Muhammad Ahmed\n  - Ivy Brain Tumor Center, Barrow Neurological Institute, St. Joseph's Hospital & Medical Center, NRC 403, Phoenix, AZ, USA. (1 speakers): Nader Sanai\n  - Jonsson Comprehensive Cancer Center, University of California, USA. (1 speakers): Aaron Holmes\n  - Kidney Cancer Research Alliance, Alexandria, VA, USA. (1 speakers): Dena Battle\n  - Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. (1 speakers): Enrico Moiso\n  - Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, NY, USA. (1 speakers): Salman Punekar\n  - Legorreta Cancer Center, Brown University, and Lifespan Cancer Institute, Providence (1 speakers): Benedito A. Carneiro\n  - Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA. (1 speakers): Vijay Joish\n  - Lineberger Comprehensive Cancer Center, University of North Carolina At Chapel Hill, NC, USA. (1 speakers): Deborah Mayer\n  - Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC, USA, Department of Medicine, Division of Medical Oncology, University of North Carolina at Chapel Hill, NC (1 speakers): Stergios J. Moschos\n  - Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA. (1 speakers): Claudine Isaacs\n  - Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia. (1 speakers): Stephen V. Liu\n  - MD Anderson Cancer Center, Houston, TX. (1 speakers): N. Arvind Dasari\n  - MD Anderson Cancer Center, The University of Texas, Houston, TX, USA. (1 speakers): Ecaterina E. Dumbrava\n  - MD Anderson Cancer Center, University of Texas, Houston, TX, USA. (1 speakers): Cindy Y. Jiang\n  - MSB Medical School Berlin, Rüdesheimerstr. 50, Germany. (1 speakers): Stephanie Schmidt\n  - Markey Cancer Center, University of Kentucky, Lexington, KY (1 speakers): Zin W. Myint\n  - Masonic Cancer Center and Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, USA. (1 speakers): Boris Winterhoff\n  - Mass General Cancer Center, Boston, MA, USA. (2 speakers): Gregory M. Cote, Jessica J. Lin\n  - Massachusetts General Hospital Cancer Center, Boston, MA (1 speakers): Ryan J. Sullivan\n  - Massachusetts General Hospital Cancer Center, Boston, MA, USA. (2 speakers): Lipika Goyal, Zofia Piotrowska\n  - Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. (1 speakers): Arielle J. Medford\n  - Mayo Clinic Cancer Center, Phoenix, AZ. (1 speakers): Tanios Bekaii-Saab\n  - Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA. (1 speakers): Oliver Sartor\n  - Mayo Clinic School of Graduate Medical Education, Mayo Clinic, Rochester, MN, USA. (1 speakers): Sanjna Rajput\n  - Medical Imaging Research Center, Illinois Institute of Technology, Suite 100, Chicago, IL, USA. (1 speakers): Albert Juan Ramon\n  - Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (1 speakers): Antonio Giordano\n  - Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. (1 speakers): Elahe Salehi\n  - Medical Oncology, Huntsman Cancer Institute Cancer Hospital, Utah, USA. (1 speakers): Ignacio Garrido-Laguna\n  - Medicine, Aulakh Hospital, Amritsar, IND. (1 speakers): Jasneet Randhawa\n  - Medivation, CA 94105 (1 speakers): Jeffrey N. Lindquist\n  - Melanoma and Cutaneous Medical Oncology, Perlmutter Cancer Center, NY University, Langone Health (1 speakers): Janice M. Mehnert\n  - Memorial Sloan Kettering Cancer Center, NY, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, NY (1 speakers): Samuel Bakhoum\n  - Memorial Sloan Kettering Cancer Center, NY, USA 10065. (1 speakers): Michael Bonner B. Foote\n  - Memorial Sloan Kettering Cancer Center, NY, USA. (1 speakers): Charles J Ryan\n  - Memorial Sloan Kettering Cancer Center, New York, NY. (1 speakers): Luke R. Pike\n  - Memorial Sloan Kettering Cancer Center, USA. (1 speakers): Michael V. Gormally\n  - Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA. (1 speakers): Zouina Sarfraz\n  - Miller School of Medicine/Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA. (1 speakers): Jonathan C. Trent\n  - Moffitt Cancer Center & Research Institute in Tampa, Tampa, Florida. (1 speakers): Amir Alishani Tabriz\n  - Moffitt Cancer Center, Tampa, FL, USA. (1 speakers): Jonathan R. Strosberg\n  - Mount Sinai Medical Center, Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, FL, USA. (1 speakers): Brian M. Slomovitz\n  - NYCH+H/Woodhull, Brooklyn, NY, USA. (1 speakers): Aria Khan\n  - National Isotope Centre, GNS Science, PO Box 30-368 (1 speakers): Andy Phillips\n  - Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon. (1 speakers): Jad El Masri\n  - Norfolk, VA. (1 speakers): Michael A. Danso\n  - Norris Comprehensive Cancer Center, University of Southern California, California. (1 speakers): Jacob Thomas\n  - Northwest Medical Specialties, Seattle, WA. (1 speakers): Sibel Blau\n  - OHDSI Center at the Roux Institute, Northeastern University, Boston, MA USA. (1 speakers): Asieh GOLOZAR\n  - Obstetrics and Gynecology Department, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma, USA. (1 speakers): Lauren E. Dockery\n  - Oregon Health & Science University. (1 speakers): Thomas Hwang\n  - Osteoncology, Bologna, Italy, Sylvester Comprehensive Cancer Center, University of Miami, FL 33136, USA, Miller School of Medicine, University of Miami, FL 33136, USA. (1 speakers): Emanuela Palmerini\n  - Pacific Cancer Research Consortium, NCORP, Swedish Medical Center-First Hill, Seattle, WA, USA. (1 speakers): Fernanda B. Musa\n  - Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. (1 speakers): Nicholas P. McAndrew\n  - Pfizer, NY, USA. (1 speakers): Matko Kalac\n  - Rogel Cancer Center, University of Michigan, MI, USA. (1 speakers): Paul L Swiecicki\n  - Ryan White Center for Pediatric Infectious Disease and Global Health, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN. (1 speakers): Wesley Boland\n  - Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, FL, USA. (1 speakers): Cesar A. Perez\n  - Sarah Cannon Research Institute, Nashville, TN (2 speakers): Erika P. Hamilton, Manish R. Patel\n  - Sarah Cannon Research Institute, Nashville, TN. (1 speakers): Vivek Subbiah\n  - Sarcoma Oncology Center/Cancer Center of Southern California, CA 90403, USA. (1 speakers): Samantha Jeffrey\n  - Sarcoma and Bone Cancer Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. (1 speakers): Erica M. Pimenta\n  - School of Medicine, University of California, CA, USA, Department of Emergency Medicine, University of California, CA (1 speakers): Michael Lauricella\n  - Seidman Cancer Center, University Hospitals, Case Western Reserve University, Cleveland, OH, USA, Tulane University, LA, USA. (1 speakers): Pedro Barata\n  - Shasqi Inc., 665 3rd St, Suite 501, San Francisco, California 94107, United States. (1 speakers): Jose Mejia Oneto\n  - Simmons Comprehensive Cancer Center, Dallas, Texas. (1 speakers): Tanner T. Hardy\n  - Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and Research, Kolar, IND. (1 speakers): Sravani Bhavanam\n  - Stephenson Oklahoma Cancer Center at the University of Oklahoma Health Sciences Center, OK. (1 speakers): Kathleen N. Moore\n  - Stratingh Institute for Chemistry, University of Groningen, Nijenborgh 4, AG Groningen (1 speakers): Hangyul Lee\n  - TRACTION platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Timothy Heffernan\n  - Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. (1 speakers): Shilpa Gupta\n  - Tegucigalpa, Honduras, USA. (1 speakers): MIchael Galo\n  - Texas Oncology-Fort Worth Cancer Center, TX, USA. (1 speakers): Noelle Cloven\n  - The Affiliated Brain Hospital, Guangzhou Medical University, No. 36, Guangzhou, Guangdong, P. R. China. (1 speakers): Xiaolei Shi\n  - The Angeles Clinic & Research Institute, California. (1 speakers): Justin T. Moyers\n  - The Christie NHS Foundation Trust, Manchester, UK. (1 speakers): Michael Dennis\n  - The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. (1 speakers): Jens Rueter\n  - The Jackson Laboratory, ME. (1 speakers): Ralph Gareus\n  - The Second Clinical Medical College of Guangzhou University of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, PR China (1 speakers): Lina Ding\n  - The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA. (1 speakers): Channing Paller\n  - The University of Alabama at Birmingham, School of Medicine, Birmingham, AL, USA. (1 speakers): Midhun Malla\n  - The University of Texas MD Anderson Cancer Center, Houston, TX (2 speakers): Amber Johnson, Xiuning Le\n  - The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. (1 speakers): Jordi Rodon\n  - The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. (1 speakers): Renata Ferrarotto\n  - The University of Texas MD MD Anderson Cancer Center, Houston, Texas. (1 speakers): Denise Langabeer\n  - The Winsor School, Boston, MA, USA. (1 speakers): Iris Shen\n  - Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NY, USA. (1 speakers): Matthew D. Galsky\n  - UPMC Hillman Cancer Center, Pittsburgh, PA. (1 speakers): Rushir Choksi\n  - University of Alicante, Alicante, Spain. (1 speakers): Guillermo Argiles Martinez\n  - University of California Irvine, Orange, CA, USA. (1 speakers): Natalie L. Ayoub\n  - University of California San Diego, CA, USA. (1 speakers): Soo Park\n  - University of California, Rebecca and John Moores Cancer Center, CA, USA. (1 speakers): Ramez N. Eskander\n  - University of Chicago Medical Center, Chicago, Illinois. (1 speakers): Chih-Yi A. Liao\n  - University of Illinois Cancer Center, Chicago, IL 60612, USA. (1 speakers): Oana Danciu\n  - University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA. (1 speakers): Jeffrey S. Miller\n  - University of Minnesota Medical School, University of Minnesota, Minneapolis, Minnesota, U.S.A. (1 speakers): Allison Dona\n  - University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address: hursting@email.unc.edu. (1 speakers): Stephen David Hursting\n  - University of Oklahoma Health Sciences Center, University of Oklahoma Health Sciences Center, Oklahoma City. (1 speakers): Satya Sai Venkata Lakshmi Arepalli\n  - University of Oklahoma Stephenson Cancer Center, OK (1 speakers): Adanma Ayanambakkam\n  - University of Virginia Cancer Center, Charlottesville, Virginia. (1 speakers): Linda R. Duska\n  - University of Washington Medical Center, Fred Hutchinson Cancer Center, Seattle, WA, USA. (1 speakers): Petros Grivas\n  - University of Washington School of Public Health, Seattle, WA, University of Washington Health Promotion Research Center, Seattle, WA (1 speakers): Jeffrey R. Harris\n  - Virginia Cancer Specialists, Fairfax, VA, USA. (1 speakers): Alexander I. Spira\n  - Washington University School of Medicine, MO. (1 speakers): Nikolaos Trikalinos\n  - Winship Cancer Institute of Emory University, Atlanta, Georgia, USA. (1 speakers): Ticiana A. Leal\n  - Winship Cancer Institute, Emory University, Atlanta, GA. (1 speakers): Kevin M. Kalinsky\n  - Women's Cancer Research Center, University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center (HCC), Magee-Womens Research Institute, Pittsburgh, PA. (1 speakers): Steffi Oesterreich\n  - Yale Cancer Center, Yale School of Medicine, CT (1 speakers): Maryam Lustberg\n  - Yale New Haven Hospital, CT, USA. (2 speakers): Michael Cecchini, Raghav Sundar\n  - a Department of Biology, City College of New York, NY, USA. (1 speakers): Emma Schatoff\n\n**Uruguay (1 institutions, 1 speakers)**\n  - Department of Clinical Oncology, Hospital de Clínicas, School of Medicine, Montevideo 11600, Uruguay. (1 speakers): Natalia Camejo\n\n**VIC (5 institutions, 5 speakers)**\n  - Department of Medical Oncology, Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore. (1 speakers): Puey Ling Chia\n  - Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia, The Sir Department of Medical Oncology, The University of Melbourne, Parkville, VIC, Australia. (1 speakers): Sherene Loi\n  - Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. (1 speakers): Ben J. Solomon\n  - Personalised Oncology Division, Walter and Eliza Hall Institute for Medical Research, Melbourne, VIC, Australia. (1 speakers): Jeanne Tie\n  - Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. (1 speakers): Linda Mileshkin\n\n**Valencia (5 institutions, 5 speakers)**\n  -  (1 speakers): Noelia Tarazona Llavero\n  - Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain. (1 speakers): Valentina Gambardella\n  - Department of Preventive Medicine & INCLIVA-Clinical Hospital, University of Valencia, Valencia, Spain. (1 speakers): Jose M. Martin-Moreno\n  - Medical Oncology Department, Hospital Clínico Universitario of Valencia. Biomedical Research Institute INCLIVA. CIBERONC, Valencia, Spain. (1 speakers): Jose Alejandro Perez Fidalgo\n  - The Institute of Cancer Research, London, UK, The Royal Marsden NHS Trust, London, UK. (1 speakers): Desamparados Roda Perez\n\n**Vietnam (5 institutions, 5 speakers)**\n  - Can Tho Central General Hospital, Ninh Kieu, Vietnam. (1 speakers): Phong D. Le Pham\n  - Department of Neurology, Yale School of Medicine, CT, USA. (1 speakers): Giang H. Pham\n  - Hanoi Medical University Hospital, Hanoi, 100000 Vietnam. (1 speakers): Hau X. Nguyen\n  - Harvard University, Boston, Massachusetts. (1 speakers): Dang N. Van Nguyen\n  - Ministry of Health, Hanoi, Vietnam. (1 speakers): Long T. Nguyen\n\n**WA (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK, Institute of Cancer Research, London, UK. (1 speakers): Robin L. Jones\n\n**West Bengal (1 institutions, 1 speakers)**\n  - Department of Clinical Psychology, Medica Superspecialty Hospital, Kolkata, India. (1 speakers): Arunima Datta\n\n**Yorkshire (1 institutions, 1 speakers)**\n  - Division of Oncology, Leeds Institute of Medical Research at St James's, School of Medicine, University of Leeds, Leeds, UK. (1 speakers): Jenny Seligmann\n\n**Zhejiang (1 institutions, 1 speakers)**\n  - Research and Development Center of Beijing Northland Biotechnology Company, Beijing 100085, China. (1 speakers): Yang Liu"
  },
  "merkel_cell": {
    "top_institutions": {
      "columns": [
        "Institution",
        "# Studies",
        "Locations"
      ],
      "rows": [
        {
          "Institution": "Dana-Farber Cancer Institute",
          "# Studies": 1,
          "Locations": "Boston, United States of America"
        },
        {
          "Institution": "Medical Oncology Department",
          "# Studies": 1,
          "Locations": "Milan, Italy"
        },
        {
          "Institution": "Melanoma and Cutaneous Medical Oncology",
          "# Studies": 1,
          "Locations": "New York, United States of America"
        }
      ]
    },
    "table_context": "**TOP INSTITUTIONS TABLE:**\n| Institution                             |   # Studies | Locations                          |\n|:----------------------------------------|------------:|:-----------------------------------|\n| Dana-Farber Cancer Institute            |           1 | Boston, United States of America   |\n| Medical Oncology Department             |           1 | Milan, Italy                       |\n| Melanoma and Cutaneous Medical Oncology |           1 | New York, United States of America |\n\n**ENRICHED INSTITUTION PROFILES (Top 10 with ClinicalTrials.gov Data):**\n\n\n**Dana-Farber Cancer Institute**\n  - ESMO 2025 Presentations: 1\n  - Clinical Trials (2015-2025): 2 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT04160065](https://clinicaltrials.gov/study/NCT04160065): Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers (PHASE1, COMPLETED, Started 2020)\n    * [NCT02514824](https://clinicaltrials.gov/study/NCT02514824): MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma (PHASE1, COMPLETED, Started 2015)\n  - Relevant to EMD Serono/Merck KGaA: None identified in ClinicalTrials.gov (2015-2025)\n  - Key Presenters at ESMO 2025 (1 total):\n    * Karam Khaddour  - 1669P: Prognostic impact of organ-specific metastasis on survival in patients with Merkel cell carcinoma (10/20/2025, 12-13:00, Hall 25)\n\n\n**Medical Oncology Department**\n  - ESMO 2025 Presentations: 1\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (1 total):\n    * Simone Oldani  - 1739eTiP: Chemio-immunotherapy in naive advanced Merkel cell carcinoma (MCC): the phase II PANDORA Trial (10/20/2025, 12-13:00, Hall 25)\n\n\n**Melanoma and Cutaneous Medical Oncology**\n  - ESMO 2025 Presentations: 1\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (1 total):\n    * Janice M. Mehnert  - LBA56: ECOG-ACRIN EA6174: STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma with Pembrolizumab, a Phase III Trial (10/20/2025, 09:30 - 09:40, Cologne Auditorium - CityCube A)\n\n\n**COMPLETE SPEAKER DIRECTORY BY GEOGRAPHY:**\n\n\n**Egypt (1 institutions, 1 speakers)**\n  -  (1 speakers): Lama Kamal\n\n**Italy (1 institutions, 1 speakers)**\n  - Medical Oncology Department, Milan, Italy. (1 speakers): Simone Oldani\n\n**United States of America (2 institutions, 2 speakers)**\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (1 speakers): Karam Khaddour\n  - Melanoma and Cutaneous Medical Oncology, Perlmutter Cancer Center, NY University, Langone Health (1 speakers): Janice M. Mehnert"
  },
  "renal_cancer": {
    "top_institutions": {
      "columns": [
        "Institution",
        "# Studies",
        "Locations"
      ],
      "rows": [
        {
          "Institution": "Dana-Farber Cancer Institute",
          "# Studies": 7,
          "Locations": "Boston, United States of America"
        },
        {
          "Institution": "Cancer Committee of the French Association of Urology (CCAFU)",
          "# Studies": 6,
          "Locations": "Villejuif, France"
        },
        {
          "Institution": "Renji Hospital",
          "# Studies": 4,
          "Locations": "Shanghai, China"
        },
        {
          "Institution": "MD Anderson Cancer Center, Houston",
          "# Studies": 3,
          "Locations": "Houston, United States of America, Sao Paulo, Brazil, Houston, United States of America, TX"
        },
        {
          "Institution": "Eva Mayr-Stihl Cancer Center",
          "# Studies": 3,
          "Locations": "Stuttgart, Germany"
        },
        {
          "Institution": "University of Texas",
          "# Studies": 3,
          "Locations": "Dallas, United States of America"
        },
        {
          "Institution": "Medical Oncology Unit",
          "# Studies": 3,
          "Locations": "Savona, Italy, Parma, Italy"
        },
        {
          "Institution": "University Hospital of Strasbourg",
          "# Studies": 3,
          "Locations": "Strasbourg, France, Strasbourg, France, CEDEX"
        },
        {
          "Institution": "Department of Internal Medicine",
          "# Studies": 2,
          "Locations": "Seoul, Republic of Korea, Salt Lake City, United States of America"
        },
        {
          "Institution": "Hemostasis",
          "# Studies": 2,
          "Locations": "Essen, Germany"
        },
        {
          "Institution": "Miami Cancer Institute",
          "# Studies": 2,
          "Locations": "Miami, United States of America"
        },
        {
          "Institution": "Shanghai Medical College",
          "# Studies": 2,
          "Locations": "Shanghai, China"
        },
        {
          "Institution": "City of Hope Comprehensive Cancer Center",
          "# Studies": 2,
          "Locations": "Duarte, United States of America, CA, Sao Paulo, Brazil"
        },
        {
          "Institution": "University of Bologna",
          "# Studies": 2,
          "Locations": "Bologna, Italy"
        },
        {
          "Institution": "University of California San Diego",
          "# Studies": 2,
          "Locations": "La Jolla, United States of America"
        },
        {
          "Institution": "The Third Medical Center",
          "# Studies": 2,
          "Locations": "Beijing, China"
        },
        {
          "Institution": "The Second Hospital of Tianjin Medical University",
          "# Studies": 2,
          "Locations": "Shanghai, China"
        },
        {
          "Institution": "Sun Yat-sen University Cancer Center",
          "# Studies": 2,
          "Locations": "Guangzhou, China"
        },
        {
          "Institution": "Ege University Medical Faculty",
          "# Studies": 1,
          "Locations": "Izmir, Turkey"
        },
        {
          "Institution": "Department of Urology",
          "# Studies": 1,
          "Locations": "Istanbul, Turkey"
        },
        {
          "Institution": "College of Animal Science and Technology",
          "# Studies": 1,
          "Locations": "Nanjing, China"
        },
        {
          "Institution": "Endocrinology and Diabetology",
          "# Studies": 1,
          "Locations": "Erlangen, Germany"
        },
        {
          "Institution": "Barts Cancer Institute",
          "# Studies": 1,
          "Locations": "London, United Kingdom"
        },
        {
          "Institution": "Cancer Institute Hospital",
          "# Studies": 1,
          "Locations": "Koto-ku, Japan"
        },
        {
          "Institution": "Centro Hospitalar Do Algarve",
          "# Studies": 1,
          "Locations": "Braga, Portugal"
        },
        {
          "Institution": "BC Cancer Agency",
          "# Studies": 1,
          "Locations": "Vancouver, Canada"
        },
        {
          "Institution": "Augusta University",
          "# Studies": 1,
          "Locations": "Paris, France"
        },
        {
          "Institution": "Brigham and Women's Hospital",
          "# Studies": 1,
          "Locations": "Boston, United States of America"
        },
        {
          "Institution": "19University of California",
          "# Studies": 1,
          "Locations": "Los Angeles, United States of America"
        },
        {
          "Institution": "Comprehensive Cancer Center",
          "# Studies": 1,
          "Locations": "Helsinki, Finland"
        }
      ]
    },
    "table_context": "**TOP INSTITUTIONS TABLE:**\n| Institution                                                   |   # Studies | Locations                                                                                   |\n|:--------------------------------------------------------------|------------:|:--------------------------------------------------------------------------------------------|\n| Dana-Farber Cancer Institute                                  |           7 | Boston, United States of America                                                            |\n| Cancer Committee of the French Association of Urology (CCAFU) |           6 | Villejuif, France                                                                           |\n| Renji Hospital                                                |           4 | Shanghai, China                                                                             |\n| MD Anderson Cancer Center, Houston                            |           3 | Houston, United States of America, Sao Paulo, Brazil, Houston, United States of America, TX |\n| Eva Mayr-Stihl Cancer Center                                  |           3 | Stuttgart, Germany                                                                          |\n| University of Texas                                           |           3 | Dallas, United States of America                                                            |\n| Medical Oncology Unit                                         |           3 | Savona, Italy, Parma, Italy                                                                 |\n| University Hospital of Strasbourg                             |           3 | Strasbourg, France, Strasbourg, France, CEDEX                                               |\n| Department of Internal Medicine                               |           2 | Seoul, Republic of Korea, Salt Lake City, United States of America                          |\n| Hemostasis                                                    |           2 | Essen, Germany                                                                              |\n| Miami Cancer Institute                                        |           2 | Miami, United States of America                                                             |\n| Shanghai Medical College                                      |           2 | Shanghai, China                                                                             |\n| City of Hope Comprehensive Cancer Center                      |           2 | Duarte, United States of America, CA, Sao Paulo, Brazil                                     |\n| University of Bologna                                         |           2 | Bologna, Italy                                                                              |\n| University of California San Diego                            |           2 | La Jolla, United States of America                                                          |\n| The Third Medical Center                                      |           2 | Beijing, China                                                                              |\n| The Second Hospital of Tianjin Medical University             |           2 | Shanghai, China                                                                             |\n| Sun Yat-sen University Cancer Center                          |           2 | Guangzhou, China                                                                            |\n| Ege University Medical Faculty                                |           1 | Izmir, Turkey                                                                               |\n| Department of Urology                                         |           1 | Istanbul, Turkey                                                                            |\n| College of Animal Science and Technology                      |           1 | Nanjing, China                                                                              |\n| Endocrinology and Diabetology                                 |           1 | Erlangen, Germany                                                                           |\n| Barts Cancer Institute                                        |           1 | London, United Kingdom                                                                      |\n| Cancer Institute Hospital                                     |           1 | Koto-ku, Japan                                                                              |\n| Centro Hospitalar Do Algarve                                  |           1 | Braga, Portugal                                                                             |\n| BC Cancer Agency                                              |           1 | Vancouver, Canada                                                                           |\n| Augusta University                                            |           1 | Paris, France                                                                               |\n| Brigham and Women's Hospital                                  |           1 | Boston, United States of America                                                            |\n| 19University of California                                    |           1 | Los Angeles, United States of America                                                       |\n| Comprehensive Cancer Center                                   |           1 | Helsinki, Finland                                                                           |\n\n**ENRICHED INSTITUTION PROFILES (Top 10 with ClinicalTrials.gov Data):**\n\n\n**Dana-Farber Cancer Institute**\n  - ESMO 2025 Presentations: 7\n  - Clinical Trials (2015-2025): 25 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06964958](https://clinicaltrials.gov/study/NCT06964958): LASER - a Phase 2 Trial of 177Lu-PSMA-617 as Systemic Therapy for Renal Cell Carcinoma (PHASE2, NOT_YET_RECRUITING, Started 2025)\n    * [NCT06318871](https://clinicaltrials.gov/study/NCT06318871): Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma (EARLY_PHASE1, RECRUITING, Started 2024)\n    * [NCT06483139](https://clinicaltrials.gov/study/NCT06483139): Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy (Phase Not Specified, RECRUITING, Started 2024)\n    * [NCT05899361](https://clinicaltrials.gov/study/NCT05899361): A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest (NA, RECRUITING, Started 2023)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT05176288](https://clinicaltrials.gov/study/NCT05176288): Avelumab, Palbociclib and Axitinib in Advanced RCC (PHASE2, WITHDRAWN, Started 2024) [EMD-ALIGNED]\n    * [NCT04724018](https://clinicaltrials.gov/study/NCT04724018): Sacituzumab Govitecan Plus EV in Metastatic UC (PHASE1, ENROLLING_BY_INVITATION, Started 2021) [COMPETITOR]\n    * [NCT04339062](https://clinicaltrials.gov/study/NCT04339062): Cemiplimab in AlloSCT/SOT Recipients With CSCC (PHASE1, COMPLETED, Started 2020) [COMPETITOR]\n    * [NCT04416568](https://clinicaltrials.gov/study/NCT04416568): Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers (PHASE2, ACTIVE_NOT_RECRUITING, Started 2020) [COMPETITOR]\n    * [NCT03203473](https://clinicaltrials.gov/study/NCT03203473): Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study) (PHASE2, ACTIVE_NOT_RECRUITING, Started 2017) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (6 total):\n    * Bradley A. McGregor  - : Invited Discussant (10/17/2025, 14:20 - 14:30, Dortmund Auditorium - Hall 7.1a)\n    * Clara Steiner  - : Invited Discussant (10/17/2025, 15:10 - 15:20, Dortmund Auditorium - Hall 7.1a)\n    * Clara Steiner  - 2606P: Transcriptomic predictors of metastatic sites in renal cell carcinoma - a post-hoc analysis of the COSMIC-313 trial (10/18/2025, 12-13:00, Hall 25)\n    * Marc Eid  - 2666eP: Genomic determinants of primary resistance to immune checkpoint inhibition in metastatic renal cell carcinoma (10/18/2025, 12-13:00, Hall 25)\n    * Renee M. Saliby  - 2601P: Peripheral and tumor cytokines in exceptional responders to immunotherapy: Results from a phase III trial (10/18/2025, 12-13:00, Hall 25)\n    * ... and 1 more presenters\n\n\n**Cancer Committee of the French Association of Urology (CCAFU)**\n  - ESMO 2025 Presentations: 6\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (0 total):\n\n\n**Renji Hospital**\n  - ESMO 2025 Presentations: 4\n  - Clinical Trials (2015-2025): 25 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06730932](https://clinicaltrials.gov/study/NCT06730932): A Prospective，Single Arm, Multicenter Clinical Study of BTLA Monoclonal Antibody JS004 (B/T Lymphocyte Attenuator Factor Monoclonal Antibody) in Combination With Toripalimab in Patients With Unresectable or Advanced Renal Cell Carcinoma Who Had Failed Previous Immunotherapy (PHASE2, NOT_YET_RECRUITING, Started 2025)\n    * [NCT06870279](https://clinicaltrials.gov/study/NCT06870279): A Clinical Research of CD70-targeted CAR-NKT Cells (CGC738) Therapy in RCC (PHASE1, NOT_YET_RECRUITING, Started 2025)\n    * [NCT06873672](https://clinicaltrials.gov/study/NCT06873672): Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China (Phase Not Specified, NOT_YET_RECRUITING, Started 2025)\n    * [NCT06852638](https://clinicaltrials.gov/study/NCT06852638): CD70-targeted immunoPET Imaging of Malignant Cancers (NA, RECRUITING, Started 2024)\n    * [NCT06680089](https://clinicaltrials.gov/study/NCT06680089): CD70-targeted immunoPET Imaging of Kidney Cancer (NA, RECRUITING, Started 2024)\n  - Relevant to EMD Serono/Merck KGaA: None identified in ClinicalTrials.gov (2015-2025)\n  - Key Presenters at ESMO 2025 (4 total):\n    * Jiayi Lu  - 2661eP: Multi-omics Uncovers the Molecular Machinery Underlying Autophagic Regulation Leading to Metastasis in Chromophobe Renal Cell Carcinoma (10/18/2025, 12-13:00, Hall 25)\n    * Jiwei Huang  - 2623P: CLEAR-IT: Preliminary Results from a Phase II Study Evaluating Cadonilimab Plus Lenvatinib in Previously Immunotherapy-Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma (ccRCC) (10/18/2025, 12-13:00, Hall 25)\n    * Jiwei Huang  - 2660eP: Clinical Value of Dynamic ctDNA-MRD Monitoring in Advanced mRCC Patients Receiving TKIs Plus PD-1 Inhibitor Therapy (10/18/2025, 12-13:00, Hall 25)\n    * Kangli Ma  - 2598MO: The Intratumor Mycobiome Promotes Clear Cell Renal Cell Carcinoma Progression via Neutrophil-Mediated Immune Suppression (10/19/2025, 09:35 - 09:40, Bonn Auditorium - Hall 7.1c)\n\n\n**MD Anderson Cancer Center, Houston**\n  - ESMO 2025 Presentations: 3\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (3 total):\n    * Andrew W. Hahn  - LBA94: LenCabo: A randomized phase II multicenter trial of lenvatinib plus everolimus (len/eve) versus (vs) cabozantinib (cabo) in patients (pts) with metastatic clear cell RCC (ccRCC) that progressed on PD-1 immune checkpoint inhibition (ICI) (10/18/2025, 08:40 - 08:50, Berlin Auditorium - Hub 27)\n    * Denis Leonardo F. Jardim  - 2643P: Urinary microbiome diversity and composition as a biomarker for advanced kidney cancer (10/18/2025, 12-13:00, Hall 25)\n    * Eric Jonasch  - 2631P: Unmet Needs & Disparities in Kidney Cancer (KC): International Kidney Cancer Coalition (IKCC) Global Patient Survey (GPS) (10/18/2025, 12-13:00, Hall 25)\n\n\n**Eva Mayr-Stihl Cancer Center**\n  - ESMO 2025 Presentations: 3\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (3 total):\n    * Jens Bedke  - : Panel Discussion and closing remarks (10/19/2025, 18:30 - 20:00, Essen Auditorium - Hall 7.2a)\n    * Jens Bedke  - : Welcome and introductions (10/19/2025, 18:30 - 20:00, Essen Auditorium - Hall 7.2a)\n    * Jens Bedke  - : Q&A (10/19/2025, 18:30 - 20:00, Essen Auditorium - Hall 7.2a)\n\n\n**University of Texas**\n  - ESMO 2025 Presentations: 3\n  - Clinical Trials (2015-2025): 19 total, 0 active\n  - Latest Trials (5 most recent):\n    * [NCT06601296](https://clinicaltrials.gov/study/NCT06601296): Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer (PHASE2, RECRUITING, Started 2025)\n    * [NCT06422312](https://clinicaltrials.gov/study/NCT06422312): A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients. (NA, WITHDRAWN, Started 2024)\n    * [NCT06483139](https://clinicaltrials.gov/study/NCT06483139): Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy (Phase Not Specified, RECRUITING, Started 2024)\n    * [NCT05931393](https://clinicaltrials.gov/study/NCT05931393): Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC) (PHASE2, RECRUITING, Started 2023)\n  - Relevant to EMD Serono/Merck KGaA:\n    * [NCT06794229](https://clinicaltrials.gov/study/NCT06794229): Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis (PHASE2, NOT_YET_RECRUITING, Started 2025) [COMPETITOR]\n    * [NCT05319015](https://clinicaltrials.gov/study/NCT05319015): Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus (PHASE2, RECRUITING, Started 2023) [COMPETITOR]\n    * [NCT04006522](https://clinicaltrials.gov/study/NCT04006522): 89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (PHASE2, RECRUITING, Started 2019) [COMPETITOR]\n    * [NCT03065179](https://clinicaltrials.gov/study/NCT03065179): SBRT (Stereotactic Body Radiation Therapy) in Combination With Nivolumab/Ipilimumab in Renal Cell Carcinoma (RCC) / Kidney Cancer Patients (PHASE2, COMPLETED, Started 2017) [COMPETITOR]\n    * [NCT02781506](https://clinicaltrials.gov/study/NCT02781506): Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma (PHASE2, TERMINATED, Started 2016) [COMPETITOR]\n  - Key Presenters at ESMO 2025 (7 total):\n    * Andrew W. Hahn  - LBA94: LenCabo: A randomized phase II multicenter trial of lenvatinib plus everolimus (len/eve) versus (vs) cabozantinib (cabo) in patients (pts) with metastatic clear cell RCC (ccRCC) that progressed on PD-1 immune checkpoint inhibition (ICI) (10/18/2025, 08:40 - 08:50, Berlin Auditorium - Hub 27)\n    * Denis Leonardo F. Jardim  - 2643P: Urinary microbiome diversity and composition as a biomarker for advanced kidney cancer (10/18/2025, 12-13:00, Hall 25)\n    * Eric Jonasch  - 2631P: Unmet Needs & Disparities in Kidney Cancer (KC): International Kidney Cancer Coalition (IKCC) Global Patient Survey (GPS) (10/18/2025, 12-13:00, Hall 25)\n    * Qian Qin  - 2627P: HIF2-dependent Regulation of Paraneoplastic Hypercalcemia in Aggressive Clear Cell Renal Cell Carcinoma (10/18/2025, 12-13:00, Hall 25)\n    * Qian Qin  - 2682eTiP: EXPLORE-RCC: a phase II study of neoadjuvant zanzalintinib (ZANZA) plus nivolumab (NIVO) in patients with locally advanced and/or inoperable clear cell renal cell carcinoma (ccRCC) (10/18/2025, 12-13:00, Hall 25)\n    * ... and 2 more presenters\n\n\n**Medical Oncology Unit**\n  - ESMO 2025 Presentations: 3\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (4 total):\n    * Sara Elena Rebuzzi  - 2645P: Prognostic performance of the Meet-URO Score in an International Real-World Cohort of Metastatic Renal Cell Carcinoma (mRCC) patients receiving 1st line Immune-Combinations. (10/18/2025, 12-13:00, Hall 25)\n    * Sara Elena Rebuzzi  - 2658eP: Prognostic validation of the Meet-URO score compared with the IMDC score in Metastatic Renal Cell Carcinoma (mRCC) patients receiving 1st line systemic treatment (Meet-URO 33 study). (10/18/2025, 12-13:00, Hall 25)\n    * Veronica Murianni  - 2674eP: Real-world outcomes of nivolumab-based immunotherapy and prognostic stratification using the Meet-URO score in older patients (>=70 years) with metastatic renal cell carcinoma (10/18/2025, 12-13:00, Hall 25)\n    * Sebastiano Buti  - 228eP: ABCA1 and ABCG1 cholesterol transporters expression on metastatic renal cell carcinoma, blood cholesterol and triglycerides, CONUT score: impact on immunotherapy outcomes (CHOMET study) (10/20/2025, 12-13:00, Hall 25)\n\n\n**University Hospital of Strasbourg**\n  - ESMO 2025 Presentations: 3\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (3 total):\n    * Fabien Moinard-Butot  - 2614P: Insights in patterns of Recurrence After Local Treatment for Clear Cell Renal Cell Carcinoma (ccRCC): french national SOPRANO Study (UroCCR Ndeg213) (10/18/2025, 12-13:00, Hall 25)\n    * Fabien Moinard-Butot  - 2622P: Complete Response (CR) after systemic immunotherapy (IO) +/- resection of residual disease in metastatic Clear Cell Renal Cell Carcinoma (mRCC) : the CORSAIR study (UroCCR Ndeg193) (10/18/2025, 12-13:00, Hall 25)\n    * Philippe Barthelemy  - 2626P: CaboCombo international real-world study: second interim analysis of cabozantinib plus nivolumab (CaboNivo) as first-line (1L) treatment for advanced renal cell carcinoma (aRCC) (10/18/2025, 12-13:00, Hall 25)\n\n\n**Department of Internal Medicine**\n  - ESMO 2025 Presentations: 2\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (5 total):\n    * Chang Gon Kim  - 2624P: Artificial intelligence (AI)-powered immune phenotype (IP) predicts differential benefit from nivolumab plus ipilimumab (NIVO+IPI) versus sunitinib (SUN) in advanced clear cell renal cell carcinoma (ccRCC) (10/18/2025, 12-13:00, Hall 25)\n    * Nicolas Sayegh  - 2647P: Impact of First-Line (1L) Immune Checkpoint Inhibitor (ICI)-based Therapies (Rx) on Overall Survival (OS) in Real World Patients (Pts) in the US With Metastatic Clear Cell Renal Cell Carcinoma (mccRCC) (10/18/2025, 12-13:00, Hall 25)\n    * Qian Qin  - 2627P: HIF2-dependent Regulation of Paraneoplastic Hypercalcemia in Aggressive Clear Cell Renal Cell Carcinoma (10/18/2025, 12-13:00, Hall 25)\n    * Qian Qin  - 2682eTiP: EXPLORE-RCC: a phase II study of neoadjuvant zanzalintinib (ZANZA) plus nivolumab (NIVO) in patients with locally advanced and/or inoperable clear cell renal cell carcinoma (ccRCC) (10/18/2025, 12-13:00, Hall 25)\n    * Tian Zhang  - : Invited Discussant (10/19/2025, 09:45 - 09:55, Bonn Auditorium - Hall 7.1c)\n\n\n**Hemostasis**\n  - ESMO 2025 Presentations: 2\n  - Clinical Trials (2015-2025): 0 total, 0 active\n  - Key Presenters at ESMO 2025 (2 total):\n    * Viktor Gruenwald  - : Analyses on Impact of Tumor Burden at Progression in RCC (10/17/2025, 10:15 - 11:45, Solingen Auditorium - Hall 23)\n    * Viktor Gruenwald  - 2617P: Coaching of renal cell cancer patients on side effects of systemic cancer treatment: Lessons from the phase III PREPARE trial [PREPARE; AIO-NZK-0115/ass; IAG-N] (10/18/2025, 12-13:00, Hall 25)\n\n\n**COMPLETE SPEAKER DIRECTORY BY GEOGRAPHY:**\n\n\n** (1 institutions, 1 speakers)**\n  -  (1 speakers): \n\n**Belgium (2 institutions, 2 speakers)**\n  - Department of Medical Oncology, Brussels, Belgium. (1 speakers): Emmanuel Seront\n  - Department of Medical Oncology, Ghent University Hospital, Gent, Belgium. (1 speakers): Alexander Decruyenaere\n\n**Brazil (2 institutions, 2 speakers)**\n  - Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas. (1 speakers): Denis Leonardo F. Jardim\n  - Department of Medical Oncology and Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, Hospital Israelita Albert, São Paulo, São Paulo, Brazil. (1 speakers): Miguel Zugman\n\n**CA (1 institutions, 1 speakers)**\n  - Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA. (1 speakers): Sumanta K. Pal\n\n**CEDEX (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, University Hospital of Strasbourg, Place de L'hopital, Strasbourg, France. (1 speakers): Philippe Barthelemy\n\n**Canada (4 institutions, 4 speakers)**\n  - BC Cancer Agency, Vancouver, Canada. (1 speakers): J. Connor Wells\n  - Department of Medical Oncology, Juravinski Cancer Center, McMaster University, Hamilton, Ontario, Canada. (1 speakers): Aly-Khan Lalani\n  - Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada. (1 speakers): David Maj\n  - Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. (1 speakers): Ali Shahini\n\n**China (18 institutions, 18 speakers)**\n  -  (1 speakers): Anwaier Aihetaimujiang\n  - College of Animal Science and Technology, Henan University of Animal Husbandry and Economy, Zhengzhou, China. (1 speakers): Haoyuan Han\n  - Department of Abdominal Surgery, Ganzhou Cancer Hospital, Ganzhou, China. (1 speakers): Zhenhua Liu\n  - Department of Oncology, Shanghai Medical College, Fudan University, Shanghai Genitourinary Cancer Institute, Shanghai 200032, China. (1 speakers): Linhui Zhang\n  - Department of Urology Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. (1 speakers): Yulu Peng\n  - Department of Urology Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China. (1 speakers): Pei Dong\n  - Department of Urology, Institute of Urology, Sichuan Clinical Research Center for Kidney and Urologic Diseases, West China Hospital, Sichuan University, Chengdu, China. (1 speakers): Zilin Wang\n  - Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. (1 speakers): Jiwei Huang\n  - Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Jiayi Lu\n  - Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China. (1 speakers): Qiang Song\n  - Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. (1 speakers): Jiahao Wang\n  - Department of Urology, The Third Medical Center, Chinese PLA General Hospital, Beijing, China. (1 speakers): Liangyou Gu\n  - Hainan Pharmaceutical Research and Development Science and Technology Park, Haikou, China. Electronic address: z_xp1412@163.com. (1 speakers): Xiaopo Zhang\n  - Institute of Molecular Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. (1 speakers): Kangli Ma\n  - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Genitourinary Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China. (1 speakers): Xinan Sheng\n  - The Key Laboratory of Biomarker High throughput screening and target translation of breast and gastrointestinal tumor, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China. (1 speakers): Guanxuan CHEN\n  - West China School of Medicine West China Hospital Sichuan University Chengdu Sichuan China. (1 speakers): Chenhao Xu\n  - Zhongshan Hospital, Fudan University, Shanghai, China. (1 speakers): Wenbin Jiang\n\n**Denmark (1 institutions, 1 speakers)**\n  -  (1 speakers): Mette J. Syberg\n\n**Derbyshire (1 institutions, 1 speakers)**\n  - University Hospitals of Derby and Burton NHS Foundation Trust, Derby (1 speakers): Prantik Das\n\n**Finland (1 institutions, 1 speakers)**\n  - Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland. (1 speakers): Katriina Jalkanen\n\n**France (6 institutions, 6 speakers)**\n  -  (1 speakers): Elise Dominjon\n  - Augusta University, GA, USA. (1 speakers): Nadine Mansour\n  - Cancer Committee of the French Association of Urology (CCAFU), France, Department of Medical Oncology, Gustave Roussy Cancer Campus, Paris-Saclay University, Villejuif, France. (1 speakers): Laurence Albiges\n  - Department of Cancer Medicine, Thoracic Group and International Center for Thoracic Cancers, Paris-Saclay University, Villejuif, France. (1 speakers): Adrien Rousseau\n  - Department of Medical Oncology, University Hospital of Strasbourg, Place de L'hopital, Strasbourg, France. (1 speakers): Fabien Moinard-Butot\n  - INSERM U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. (1 speakers): Cinzia Ungolo\n\n**Germany (9 institutions, 9 speakers)**\n  - Department of Hematology, Hemostasis, Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany. (1 speakers): Viktor Gruenwald\n  - Department of Hematology/Oncology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany. (1 speakers): Marit Ahrens\n  - Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. (1 speakers): Stefanie Zschabitz\n  - Department of Medicine 1, Endocrinology and Diabetology, Friedrich Alexander University of Erlangen-Nürnberg, Erlangen, Germany. (1 speakers): Marianne E. Pavel\n  - Department of Nuclear Medicine, University Hospital Essen, German Cancer Consortium, West German Cancer Center, Essen, Germany. (1 speakers): Alina T. Kuper\n  - Department of Urology and Paediatric Urology, Julius Maximilians University Medical Center of Würzburg, Würzburg, Germany. (1 speakers): Charis Kalogirou\n  - Department of Urology and Transplantation Surgery, Eva Mayr-Stihl Cancer Center, Stuttgart, Germany. (1 speakers): Jens Bedke\n  - Department of Urology, Friedrich-Schiller-University Jena, Jena University Hospital, Germany. (1 speakers): Marc-Oliver Grimm\n  - Medical Clinic II, University Hospital Frankfurt, Frankfurt, Germany. (1 speakers): Lothar Bergmann\n\n**Italy (13 institutions, 14 speakers)**\n  -  (1 speakers): Arianna Scipilliti\n  - Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy, Unit of Medical Oncology 2, Pisa, Italy. (1 speakers): Chiara Mercinelli\n  - Department of Medical Oncology, Milan, Italy. (1 speakers): Elena Verzoni\n  - Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. (2 speakers): Matteo Rosellini, Veronica Mollica\n  - Department of Oncology, Terni, Italy. (1 speakers): Annalisa Guida\n  - Department of Surgical, Section of Medical Oncology, University of Palermo, Palermo, Italy. (1 speakers): Alessandra Dimino\n  - Interdisciplinary Department of Medicina, Division of Medical Oncology, University of Bari \"Aldo Moro\", A.O.U. Consorziale Policlinico di Bari, Bari, Italy. (1 speakers): Mimma Rizzo\n  - Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy. (1 speakers): Veronica Murianni\n  - Medical Oncology Unit, Savona 17100, Italy. (1 speakers): Sara Elena Rebuzzi\n  - Medical Oncology Unit, University Hospital of Parma, Parma, Italy. (1 speakers): Sebastiano Buti\n  - Medical Oncology, Bologna, Italy, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy. (1 speakers): Francesco Massari\n  - Medical Oncology, Rome, Italy. (1 speakers): Antonio Cigliola\n  - University of Bari \"A. Moro\" and Division of Medical Oncology, Bari, Italy. (1 speakers): Camillo Guglielmo Porta\n\n**Japan (1 institutions, 1 speakers)**\n  - Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research (JFCR), Koto-ku, Tokyo 135-8550, Japan. (1 speakers): Yuji Miura\n\n**MA (1 institutions, 1 speakers)**\n  -  (1 speakers): Guillermo Antonio De Velasco Oria\n\n**Netherlands (2 institutions, 2 speakers)**\n  - Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden (1 speakers): Amy Rieborn\n  - Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam (1 speakers): Femke Burgers\n\n**OH (1 institutions, 1 speakers)**\n  - Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. (1 speakers): Brian I. Rini\n\n**Portugal (1 institutions, 1 speakers)**\n  - Centro Hospitalar Do Algarve, Faro, Portugal. (1 speakers): Cristiana Honrado Martins\n\n**Republic of Korea (1 institutions, 1 speakers)**\n  - Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. (1 speakers): Chang Gon Kim\n\n**Russian Federation (1 institutions, 1 speakers)**\n  - Russian Society of Clinical Oncology, Kidney Cancer Research Bureau, Moscow, Russia. (1 speakers): Ilya Tsimafeyeu\n\n**Spain (3 institutions, 3 speakers)**\n  - Department of Oncology, University Hospital Marqués of Valdecilla, IDIVAL Santander, Cantabria, Spain. (1 speakers): Ignacio Duran\n  - Department of Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain. (1 speakers): Cristina Suarez Rodriguez\n  - Medical Oncology Department, University Hospital La Paz (1 speakers): Alvaro Pinto Marin\n\n**Surrey (1 institutions, 1 speakers)**\n  - Department of Medicine, The Royal Marsden National Health Service Foundation Trust, London and Surrey, UK. (1 speakers): Sing Yu Moorcraft\n\n**TX (1 institutions, 1 speakers)**\n  - Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX (1 speakers): Eric Jonasch\n\n**Turkey (3 institutions, 3 speakers)**\n  - Department of Medical Oncology, Ege University Medical Faculty, Izmir 35100, Turkey. (1 speakers): Gokhan Sahin\n  - Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey. (1 speakers): Orhun Akdogan\n  - Division of Urologic Oncology, Department of Urology, Istanbul University, Turkey. (1 speakers): Selcuk Erdem\n\n**United Arab Emirates (1 institutions, 1 speakers)**\n  - Division of Hematology - Oncology Medicine, Hôtel Dieu de France Medical Center, Saint-Joseph University, Beirut (1 speakers): Marwan Ghosn\n\n**United Kingdom (7 institutions, 7 speakers)**\n  - Barts Cancer Institute, Queen Mary University of London, Barts Health NHS Trust Biomedical Research Centre, London, UK. (1 speakers): Sara Coca Membribes\n  - Kidney Cancer UK, Guildford, UK. (1 speakers): Malcolm Packer\n  - MRC Clinical Trials Unit, University College London, London, UK. (1 speakers): Sophie Merrick\n  - Royal Marsden Hospital and Institute for Cancer Research, London, UK. (1 speakers): James Larkin\n  - School of Medicine, University of St Andrews, UK. (1 speakers): Hazem Abdullah\n  - St. Georges University Hospitals Foundation Trust and The Royal Marsden Foundation Trust, London, UK. (1 speakers): Lisa M. Pickering\n  - The Royal Marsden Hospital. (1 speakers): Maximilian Julve\n\n**United States of America (21 institutions, 23 speakers)**\n  -  (1 speakers): Myeong Hwak Choe\n  - 19University of California, Los Angeles Medical Center, CA, USA. (1 speakers): Alexandra Drakaki\n  - Dana-Farber Cancer Institute, Boston, MA, USA, Harvard Medical School, Boston, MA, USA. (1 speakers): Clara Steiner\n  - Dana-Farber Cancer Institute, Boston, Massachusetts, USA. (1 speakers): Renee M. Saliby\n  - Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. (1 speakers): Andrew W. Hahn\n  - Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, Texas. (2 speakers): Qian Qin, Tian Zhang\n  - Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA. (1 speakers): Wenxin Xu\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. (2 speakers): Bradley A. McGregor, Marc Eid\n  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. (1 speakers): Marc Machaalani\n  - Department of Medical Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA. (1 speakers): Mohammad Arfat Ganiyani\n  - Department of Medicine, School of Medicine, University of California San Diego, CA 92093, USA. (1 speakers): Rana R. McKay\n  - Department of Medicine, The University of Alabama at Birmingham and O'Neal Comprehensive Cancer Center, Birmingham, AL 35233 (1 speakers): Arnab Basu\n  - Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (1 speakers): Berkay Simsek\n  - Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX (1 speakers): Andrew Z. Wang\n  - Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (1 speakers): Scott M. Haake\n  - Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, UT. (1 speakers): Nicolas Sayegh\n  - Greco-Hainsworth Center for Cancer Research, Nashville, TN, USA. (1 speakers): Kathryn Beckermann\n  - Kidney Cancer Research Alliance, Alexandria, VA, USA. (1 speakers): Dena Battle\n  - Simmons Comprehensive Cancer Center, Dallas, Texas. (1 speakers): Tanner T. Hardy\n  - Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. (1 speakers): Shilpa Gupta\n  - University of Oklahoma Stephenson Cancer Center, OK (1 speakers): Adanma Ayanambakkam"
  }
}